Citrus Sinensis ID: 011196
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 491 | 2.2.26 [Sep-21-2011] | |||||||
| Q39086 | 843 | Receptor-like serine/thre | yes | no | 0.397 | 0.231 | 0.539 | 1e-57 | |
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.450 | 0.330 | 0.473 | 1e-57 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.405 | 0.233 | 0.539 | 7e-57 | |
| Q8L7G3 | 659 | Cysteine-rich receptor-li | no | no | 0.450 | 0.335 | 0.465 | 7e-57 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.397 | 0.230 | 0.529 | 1e-56 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.409 | 0.236 | 0.530 | 9e-56 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.478 | 0.279 | 0.485 | 2e-54 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.439 | 0.259 | 0.497 | 2e-54 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.384 | 0.279 | 0.530 | 4e-54 | |
| Q8W4G6 | 627 | Cysteine-rich receptor-li | no | no | 0.391 | 0.306 | 0.502 | 4e-54 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 224 bits (571), Expect = 1e-57, Method: Compositional matrix adjust.
Identities = 109/202 (53%), Positives = 141/202 (69%), Gaps = 7/202 (3%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
++ ++ASNVLLD M PKISDFGMARIFG ++EANT RVVGTYGYM+PEYAM+GIFS+K
Sbjct: 642 HRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMK 701
Query: 357 SDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA- 415
SDVFSFGV+LLEIISGK++ GFY+ +LL ++W+ W EG+ E++D + S
Sbjct: 702 SDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKF 761
Query: 416 ---ELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSVSRV---ASGQ 469
E+L+ I IGLLCVQE DRP MSSV VML S+ +P+P +P F + R A
Sbjct: 762 PTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSS 821
Query: 470 FVSHSEDHCSVNAITLSTMSPR 491
+ +D C+VN ITLS + R
Sbjct: 822 SSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 224 bits (571), Expect = 1e-57, Method: Compositional matrix adjust.
Identities = 109/230 (47%), Positives = 158/230 (68%), Gaps = 9/230 (3%)
Query: 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFG 325
++R+ I A I+ +L S L I ++ ++ASN+LLD +MNPKI+DFGMARIFG
Sbjct: 445 TRRYKIIGGVARGIL-YLHQDSRLTII----HRDLKASNILLDADMNPKIADFGMARIFG 499
Query: 326 GNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGP 385
+Q+E NT+R+VGTYGYM+PEYAM G +S+KSDV+SFGV++LEIISGKK+S FY +
Sbjct: 500 LDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAH 559
Query: 386 SLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
L++Y W LW G EL+D + ++C + E+++ +HIGLLCVQEDP +RPT+S++ +ML
Sbjct: 560 DLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLML 619
Query: 446 ASDIVTLPKPTQPA-FSVSRVASGQFVSHSEDHC---SVNAITLSTMSPR 491
S+ VTLP P QP F SR+ + + SV+ +++ + PR
Sbjct: 620 TSNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDASITDIHPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 222 bits (565), Expect = 7e-57, Method: Compositional matrix adjust.
Identities = 109/202 (53%), Positives = 145/202 (71%), Gaps = 3/202 (1%)
Query: 293 IRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI 352
+R ++ ++ SN+LLD EMNPKISDFG+ARIFGG+++ ANTNRVVGTYGYM+PEYA+EG+
Sbjct: 651 LRIIHRDLKTSNILLDEEMNPKISDFGLARIFGGSETSANTNRVVGTYGYMSPEYALEGL 710
Query: 353 FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 412
FS KSDVFSFGVV++E ISGK+++GF+ E SLL + W LW EL+D +++SC
Sbjct: 711 FSFKSDVFSFGVVVIETISGKRNTGFHEPEKSLSLLGHAWDLWKAERGIELLDQALQESC 770
Query: 413 DQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLA-SDIVTLPKPTQPAFSVSR--VASGQ 469
+ LK +++GLLCVQEDP DRPTMS+V ML S+ TLP P QPAF + R +S
Sbjct: 771 ETEGFLKCLNVGLLCVQEDPNDRPTMSNVVFMLGSSEAATLPTPKQPAFVLRRCPSSSKA 830
Query: 470 FVSHSEDHCSVNAITLSTMSPR 491
S + CS N +T++ R
Sbjct: 831 SSSTKPETCSENELTITLEDGR 852
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (564), Expect = 7e-57, Method: Compositional matrix adjust.
Identities = 108/232 (46%), Positives = 158/232 (68%), Gaps = 11/232 (4%)
Query: 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFG 325
++R+ I A I+ +L S L I R ++ASN+LLD +MNPKI+DFGMARIFG
Sbjct: 433 TQRYHIIGGIARGIL-YLHQDSRLTIIHRD----LKASNILLDADMNPKIADFGMARIFG 487
Query: 326 GNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGP 385
+Q++ NT+R+VGTYGYM+PEYAM G FS+KSDV+SFGV++LEIISG+K++ F +
Sbjct: 488 MDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQ 547
Query: 386 SLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
L+ + W+LW G A +L+D + SC ++E+++ HIGLLCVQEDP+ RP MS+++VML
Sbjct: 548 DLVTHAWRLWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVML 607
Query: 446 ASDIVTLPKPTQPAFSV------SRVASGQFVSHSEDHCSVNAITLSTMSPR 491
S+ + LP P QP F V +R+ S Q ++ S++ ++S + PR
Sbjct: 608 TSNTMALPAPQQPGFFVRSRPGTNRLDSDQSTTNKSVTVSIDDKSMSDLDPR 659
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 221 bits (563), Expect = 1e-56, Method: Compositional matrix adjust.
Identities = 107/202 (52%), Positives = 139/202 (68%), Gaps = 7/202 (3%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
++ ++ASNVLLD M PKISDFGMARIFG ++EANT RVVGTYGYM+PEYAM+GIFS+K
Sbjct: 646 HRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMK 705
Query: 357 SDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSV----VKQSC 412
SDVFSFGV+LLEIISGK++ GFY+ +LL ++W+ W EG E++D + +
Sbjct: 706 SDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEF 765
Query: 413 DQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSVSR---VASGQ 469
E+L+ I IGLLCVQE DRP MSSV VML S+ +P+P +P F V R
Sbjct: 766 PTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSS 825
Query: 470 FVSHSEDHCSVNAITLSTMSPR 491
+ +D C+VN +TLS + R
Sbjct: 826 SSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 218 bits (555), Expect = 9e-56, Method: Compositional matrix adjust.
Identities = 114/215 (53%), Positives = 146/215 (67%), Gaps = 14/215 (6%)
Query: 262 PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIR-----RRNKRVR-------ASNVLLDH 309
PNK S + E A+I + L S + I R R+ R+R SNVLLD
Sbjct: 606 PNK-SLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDA 664
Query: 310 EMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEI 369
EMNPKISDFGMARIFGGNQ+EANT RVVGTYGYM+PEYAMEG+FSVKSDV+SFGV+LLEI
Sbjct: 665 EMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEI 724
Query: 370 ISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQ 429
+SGK+++ EHG SL+ Y W L+ G + EL+D ++ +C + E L+ IH+ +LCVQ
Sbjct: 725 VSGKRNTSLRSSEHG-SLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQ 783
Query: 430 EDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSVSR 464
+ +RP M+SV +ML SD TL P QP F+ +R
Sbjct: 784 DSAAERPNMASVLLMLESDTATLAAPRQPTFTSTR 818
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (543), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 120/247 (48%), Positives = 153/247 (61%), Gaps = 12/247 (4%)
Query: 247 LYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVL 306
L RFL D + KRW I A ++ +L S L I R ++ASN+L
Sbjct: 606 LDRFLFDE---SKQGSLDWRKRWEVIGGIARGLL-YLHRDSRLKIIHRD----LKASNIL 657
Query: 307 LDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVL 366
LD EMNPKISDFGMARIF Q ANT RVVGTYGYMAPEYAMEGIFS KSDV+SFGV++
Sbjct: 658 LDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLI 717
Query: 367 LEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLL 426
LEI+SG+K+ F +HG SL+ Y W LW +G E++D +VK + D E ++ IH+G+L
Sbjct: 718 LEIVSGRKNVSFRGTDHG-SLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGML 776
Query: 427 CVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSVSRVASGQFVSHSEDH--CSVNAIT 484
C Q+ + RP M SV +ML S LP P QP F S + SG + + H SVN +T
Sbjct: 777 CTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFH-SFLNSGDIELNFDGHDVASVNDVT 835
Query: 485 LSTMSPR 491
+T+ R
Sbjct: 836 FTTIVGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 213 bits (542), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 112/225 (49%), Positives = 151/225 (67%), Gaps = 9/225 (4%)
Query: 270 ITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQS 329
+ I + I++L S L I ++ ++ASN+LLD EM PKISDFGMARIFGGNQ
Sbjct: 615 MEIVRGIARGILYLHQDSRLRII----HRDLKASNILLDSEMIPKISDFGMARIFGGNQM 670
Query: 330 EANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLA 389
E T+RVVGT+GYMAPEYAMEG FS+KSDV+SFGV++LEII+GKK+S F+ E +L+
Sbjct: 671 EGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFH--EESSNLVG 728
Query: 390 YIWKLWCEGHAAELMDSVVKQSC-DQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448
+IW LW G A E++D+++ Q D+ E++K I IGLLCVQE+ DR MSSV +ML +
Sbjct: 729 HIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHN 788
Query: 449 IVTLPKPTQPAFSVSRVASGQFVS--HSEDHCSVNAITLSTMSPR 491
LP P PAF+ +R G+ + + SVN +T S + R
Sbjct: 789 ATNLPNPKHPAFTSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 213 bits (541), Expect = 4e-54, Method: Compositional matrix adjust.
Identities = 103/194 (53%), Positives = 140/194 (72%), Gaps = 5/194 (2%)
Query: 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGG 326
+R+ I A I+ +L S L I R ++ASN+LLD ++NPKI+DFGMARIFG
Sbjct: 451 QRYNIIGGIARGIL-YLHQDSRLTIIHRD----LKASNILLDADINPKIADFGMARIFGL 505
Query: 327 NQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPS 386
+Q++ NT+R+VGTYGYMAPEYAM G FS+KSDV+SFGV++LEIISG+K+S F +
Sbjct: 506 DQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQD 565
Query: 387 LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLA 446
LL + W+LW A +L+D ++ +C +E+++ IHIGLLCVQEDP RPT+S+V +ML
Sbjct: 566 LLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLT 625
Query: 447 SDIVTLPKPTQPAF 460
S+ VTLP P QP F
Sbjct: 626 SNTVTLPVPRQPGF 639
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 213 bits (541), Expect = 4e-54, Method: Compositional matrix adjust.
Identities = 99/197 (50%), Positives = 145/197 (73%), Gaps = 5/197 (2%)
Query: 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFG 325
++R+ I A I+ +L S L I ++ ++ASN+LLD +MNPK++DFG+ARIFG
Sbjct: 434 TRRYKVIGGIARGIL-YLHQDSRLTII----HRDLKASNILLDADMNPKLADFGLARIFG 488
Query: 326 GNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGP 385
+Q++ NT+R+VGT+GYMAPEYA+ G FSVKSDV+SFGV++LEIISGKK++ FY +
Sbjct: 489 MDQTQENTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYETDGAH 548
Query: 386 SLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
L+ + W+LW G A +L+D ++ +C ++E+++ IHI LLCVQEDP +RP +S++ +ML
Sbjct: 549 DLVTHAWRLWSNGTALDLVDPIIIDNCQKSEVVRCIHICLLCVQEDPAERPILSTIFMML 608
Query: 446 ASDIVTLPKPTQPAFSV 462
S+ VTLP P QP F V
Sbjct: 609 TSNTVTLPVPLQPGFPV 625
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 491 | ||||||
| 296088918 | 519 | unnamed protein product [Vitis vinifera] | 0.916 | 0.867 | 0.368 | 2e-79 | |
| 224076400 | 666 | predicted protein [Populus trichocarpa] | 0.450 | 0.331 | 0.604 | 2e-71 | |
| 224113927 | 381 | predicted protein [Populus trichocarpa] | 0.450 | 0.580 | 0.595 | 2e-71 | |
| 356554939 | 662 | PREDICTED: cysteine-rich receptor-like p | 0.450 | 0.333 | 0.592 | 8e-68 | |
| 356510387 | 647 | PREDICTED: cysteine-rich receptor-like p | 0.405 | 0.307 | 0.645 | 3e-67 | |
| 356546303 | 662 | PREDICTED: cysteine-rich receptor-like p | 0.397 | 0.294 | 0.622 | 1e-66 | |
| 449454859 | 1122 | PREDICTED: cysteine-rich receptor-like p | 0.861 | 0.377 | 0.346 | 1e-66 | |
| 357515489 | 670 | S-locus lectin protein kinase family pro | 0.405 | 0.297 | 0.631 | 6e-66 | |
| 358346817 | 626 | Cysteine-rich receptor-like protein kina | 0.405 | 0.317 | 0.61 | 1e-65 | |
| 358346648 | 573 | Cysteine-rich receptor-like protein kina | 0.405 | 0.347 | 0.61 | 4e-65 |
| >gi|296088918|emb|CBI38478.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 303 bits (775), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 184/499 (36%), Positives = 264/499 (52%), Gaps = 49/499 (9%)
Query: 36 EYQYKFCPRGTNN-TASIIYIYNLSKLFNRKLHEEGGNSLYRNASVGDNPDKVYGLFLCR 94
++ Y C G N T + Y NL+ L + + N S G N DKV + LCR
Sbjct: 27 KFLYYRCSNGVGNYTNNSTYKANLNTLLTSLSSNNEIDYGFYNFSAGQNSDKVNAIALCR 86
Query: 95 FDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVCYSNKFFATTLDTSPFLCVKNE 154
DV C++CI D+ L C KEA WYD CM+ YSN TSP + N
Sbjct: 87 GDVMPTACRSCINDSRIQLTRLCPNQKEAIGWYDGCMLRYSNDSIFGKAQTSPTFTMWNL 146
Query: 155 NYTTEPDKLAQILNQTFNDEIRNAASSD--SKYAAQTINISSFDTLQTTVHCIPDLSKSD 212
+ + Q+L AAS D K+A + N++SF ++ + C PDLS+
Sbjct: 147 QNVSNVEDFNQVLGNLMASLRSKAASGDWRRKFATEEANVTSFQSIYGLMQCTPDLSELS 206
Query: 213 CNVCLNSAVAQIPTCSKGKLGARIFCASCSIRYELYRFL--------------------- 251
C+ CL A+ +IPTC + R+ SC++RY Y F
Sbjct: 207 CSNCLEGAINEIPTCCNRRKAGRVVKPSCNLRYATYHFYDITAANAPPPSPPSADLSPPP 266
Query: 252 ----VDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLL 307
T + A +R+ I A ++ +L S L I ++ ++ASN+LL
Sbjct: 267 LANTTSTQDLIRRAQLDWERRYKIIGGIARGLL-YLHEDSRLRII----HRDLKASNILL 321
Query: 308 DHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLL 367
D EMNPKISDFGMAR+F +Q++ +T+R+VGTYGYMAPEYAM G FSVK+DV+SFGV++L
Sbjct: 322 DAEMNPKISDFGMARLFLVDQTQGSTSRIVGTYGYMAPEYAMHGHFSVKTDVYSFGVLVL 381
Query: 368 EIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLC 427
E++SG++++ F E+ LL+Y WK W EG A L+D ++ S +E+++ IHIGLLC
Sbjct: 382 ELVSGQRNNCFRVSENIEHLLSYAWKNWREGTATNLIDPTMRIS-SISEIMRCIHIGLLC 440
Query: 428 VQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSV---------------SRVASGQFVS 472
VQE+ DRPTM+S+A+ML S ++LP P+ PAF + SRVA ++
Sbjct: 441 VQENEADRPTMASIALMLNSYSLSLPVPSHPAFFMNTSMNRDMSLELEDNSRVAQSNYLP 500
Query: 473 HSEDHCSVNAITLSTMSPR 491
H SVN +++ PR
Sbjct: 501 SRSSHFSVNEASITDPYPR 519
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076400|ref|XP_002304937.1| predicted protein [Populus trichocarpa] gi|222847901|gb|EEE85448.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 276 bits (705), Expect = 2e-71, Method: Compositional matrix adjust.
Identities = 136/225 (60%), Positives = 170/225 (75%), Gaps = 4/225 (1%)
Query: 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGG 326
+R ++I + +++L S L I R ++ASN+LLD+EMNPKISDFGMARIFGG
Sbjct: 446 QRRLSIINGIARGLLYLHEDSRLRIIHRD----LKASNILLDYEMNPKISDFGMARIFGG 501
Query: 327 NQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPS 386
N SEANTNR+VGTYGYMAPEYAMEG+ SVKSDVFSFGV++LEIISGK++ GF+ E G S
Sbjct: 502 NHSEANTNRIVGTYGYMAPEYAMEGLSSVKSDVFSFGVLMLEIISGKRNGGFHLSEEGKS 561
Query: 387 LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLA 446
LL + WKLW EG ELMDS++++S E+LK IHIGLLCVQEDP+DRPTMSSV VMLA
Sbjct: 562 LLNFTWKLWSEGKGLELMDSLLEKSSVATEVLKCIHIGLLCVQEDPVDRPTMSSVVVMLA 621
Query: 447 SDIVTLPKPTQPAFSVSRVASGQFVSHSEDHCSVNAITLSTMSPR 491
D +P PT+PAFSV R+ + + S ++ SVN +TLS + PR
Sbjct: 622 GDNFKIPIPTKPAFSVGRIVAEETTSSNQRVSSVNKVTLSNVLPR 666
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113927|ref|XP_002316616.1| predicted protein [Populus trichocarpa] gi|222859681|gb|EEE97228.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 276 bits (705), Expect = 2e-71, Method: Compositional matrix adjust.
Identities = 134/225 (59%), Positives = 170/225 (75%), Gaps = 4/225 (1%)
Query: 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGG 326
+R ++I + +++L S L I ++ ++ SN+LLD+EMNPKISDFGMARIFGG
Sbjct: 161 QRRLSIINGIARGLLYLHEDSRLRII----HRDLKTSNILLDYEMNPKISDFGMARIFGG 216
Query: 327 NQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPS 386
NQSEANTNR+VGTYGYMAPEYAM G+FSVKSDVFSFGV+LLEIISG+K+ GF+ E G S
Sbjct: 217 NQSEANTNRIVGTYGYMAPEYAMVGLFSVKSDVFSFGVLLLEIISGEKNVGFHLSEEGES 276
Query: 387 LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLA 446
LL + WKLW +G ELMD ++++S E+L+ IHIGLLCVQEDP DRPTMSSV MLA
Sbjct: 277 LLTFAWKLWSDGQGLELMDPMLEKSGVATEVLRCIHIGLLCVQEDPADRPTMSSVLHMLA 336
Query: 447 SDIVTLPKPTQPAFSVSRVASGQFVSHSEDHCSVNAITLSTMSPR 491
SD +TLP P QPAFS+ R + + S ++ CS N +T+S +SPR
Sbjct: 337 SDTITLPIPKQPAFSIGRFVAMEGQSSNQKVCSSNELTISVLSPR 381
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356554939|ref|XP_003545798.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 264 bits (674), Expect = 8e-68, Method: Compositional matrix adjust.
Identities = 134/226 (59%), Positives = 166/226 (73%), Gaps = 5/226 (2%)
Query: 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGG 326
K ++I + I++L S L I R ++ASNVLLDH+MNPKISDFG+AR F
Sbjct: 441 KLRLSIINGIARGILYLHEDSRLRVIHRD----LKASNVLLDHDMNPKISDFGLARAFSK 496
Query: 327 NQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPS 386
Q +ANTNRV+GTYGYMAPEYAMEG+FSVKSDVFSFGV++LEII GKK+SGFY E G
Sbjct: 497 GQKQANTNRVMGTYGYMAPEYAMEGLFSVKSDVFSFGVLVLEIICGKKNSGFYLSECGQG 556
Query: 387 LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLA 446
LL Y WK+WC G EL+D V+++SC ++E++K IHIGLLCVQED DRP MS+V VMLA
Sbjct: 557 LLLYAWKIWCAGKFLELLDPVLEESCIESEVVKCIHIGLLCVQEDAADRPNMSTVVVMLA 616
Query: 447 SDIVTLPKPTQPAFSVSRVASGQF-VSHSEDHCSVNAITLSTMSPR 491
SD + LPKP +PAFSV R+A G S S + S+N IT+S + PR
Sbjct: 617 SDTMVLPKPNRPAFSVGRMALGDASTSKSSNKHSINDITISNILPR 662
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356510387|ref|XP_003523920.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 262 bits (669), Expect = 3e-67, Method: Compositional matrix adjust.
Identities = 129/200 (64%), Positives = 157/200 (78%), Gaps = 1/200 (0%)
Query: 293 IRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI 352
+R ++ ++ASN+LLDHEMNPKISDFG+AR FGG+Q +ANT RVVGTYGYMAPEYAMEG+
Sbjct: 448 LRVIHRDLKASNILLDHEMNPKISDFGLARTFGGDQKQANTIRVVGTYGYMAPEYAMEGL 507
Query: 353 FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 412
FSVKSDVFSFGV+LLEIISGK+SS FY + G SLL Y W LWCE ELMD ++++SC
Sbjct: 508 FSVKSDVFSFGVLLLEIISGKRSSKFYLSDQGQSLLIYAWNLWCERKGLELMDPIIEKSC 567
Query: 413 DQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSVSR-VASGQFV 471
++E+LK +HIGLLCVQED DRP MSSV MLASD V+L PT+PAFSV R V +
Sbjct: 568 VRSEVLKCMHIGLLCVQEDAADRPKMSSVVHMLASDTVSLSVPTRPAFSVGRAVTERECS 627
Query: 472 SHSEDHCSVNAITLSTMSPR 491
S++ H SVN T+S + PR
Sbjct: 628 SNTSMHYSVNEATVSEVIPR 647
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546303|ref|XP_003541568.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 260 bits (665), Expect = 1e-66, Method: Compositional matrix adjust.
Identities = 122/196 (62%), Positives = 157/196 (80%), Gaps = 1/196 (0%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
++ ++ASN+LLD EMNPKISDFG+AR F Q++ANTNRV+GTYGYM+PEYAMEG+FSVK
Sbjct: 467 HRDLKASNILLDDEMNPKISDFGLARAFEKGQNQANTNRVMGTYGYMSPEYAMEGLFSVK 526
Query: 357 SDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAE 416
SDVFS+GV++LEII GKK+SGFY E G SL Y WK+WC G + ELMD V+++SC ++E
Sbjct: 527 SDVFSYGVLVLEIICGKKNSGFYLSECGQSLTLYAWKIWCAGKSLELMDPVLEKSCIESE 586
Query: 417 LLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSVSRVA-SGQFVSHSE 475
++K IHIGLLCVQED DRPTMS+V VMLASD ++LP+P QPAFSV R+ G S S
Sbjct: 587 VMKCIHIGLLCVQEDAADRPTMSTVVVMLASDKMSLPEPNQPAFSVGRMTLEGASTSKSS 646
Query: 476 DHCSVNAITLSTMSPR 491
+ S+N +T++ + PR
Sbjct: 647 KNLSINDVTVTNILPR 662
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454859|ref|XP_004145171.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 260 bits (664), Expect = 1e-66, Method: Compositional matrix adjust.
Identities = 154/444 (34%), Positives = 233/444 (52%), Gaps = 21/444 (4%)
Query: 43 PRGTNNTASIIYIYNLSKLFNRKLHEEGGNSLYRNASVGDNP-DKVYGLFLCRFDVSHQV 101
P + S IY +L+ LF+ G + + N SV P D VYG+F CR D +
Sbjct: 649 PSSNTISTSEIYESSLNLLFSTLSTNAPGTNGFFNYSVIRTPNDTVYGIFQCRGDTTDGS 708
Query: 102 CQNCIFDAI-DILVESCNGTKEATIWYDICMVCYSNKFFATTLDTSPFLCVKNE-NYTTE 159
C++C+ +A ++ + C K A +WYD C++ YS++ F + + T P + + + +
Sbjct: 709 CRDCVMEATRNVAYQFCPFRKSAVVWYDDCLLRYSDQNFFSVVSTEPLYELDSRVDIAFD 768
Query: 160 PDKLAQILNQTFNDEIRNAAS--SDSKYAAQTINISSFDTLQTTVHCIPDLSKSDCNVCL 217
+ Q++ T NA+S +A +S TL T C DLS ++C CL
Sbjct: 769 TTRFNQLVMATLTAIAANASSLVVGEMFATHEAIFTSNITLYTLAQCNSDLSNTECQDCL 828
Query: 218 NSAVAQIPTCSKGKLGARIFCASCSIRYELYRFLV----------------DTPTVTVTA 261
+ IP C + K+G R+ SC +RYELY F P + +
Sbjct: 829 TRVIRGIPGCCRNKIGGRLLFPSCYVRYELYPFYQLSWTNQVPPSESATPDQQPPLHSSE 888
Query: 262 PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321
K+ + I I +L ++ R R V + EMNPKISDFGMA
Sbjct: 889 QGKSKSLNVMIIAIVLPITASILLLVLCLSVLLWRANRKYMILVKQESEMNPKISDFGMA 948
Query: 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHL 381
RI +++ NT R+ GT+ YM+PEYAM GIFS+KSDV+SFGV+LLEII+GKK F L
Sbjct: 949 RIIQIDETHINTRRIAGTFCYMSPEYAMHGIFSIKSDVYSFGVLLLEIITGKKHQTFSLL 1008
Query: 382 EHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSV 441
G + Y WKLW +G ++++S ++ C + +++ IHI LLCV +DP+ RP+M+S+
Sbjct: 1009 GIGEDISTYAWKLWNDGTPLDILESSLRDKCSRDMVIRCIHIALLCVHDDPVQRPSMASI 1068
Query: 442 AVMLASDIVTLPKPTQPAFSVSRV 465
+ML S VTLP+P +P + S +
Sbjct: 1069 VLMLNSYSVTLPEPKEPMYFKSNI 1092
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357515489|ref|XP_003628033.1| S-locus lectin protein kinase family protein [Medicago truncatula] gi|355522055|gb|AET02509.1| S-locus lectin protein kinase family protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 258 bits (658), Expect = 6e-66, Method: Compositional matrix adjust.
Identities = 127/201 (63%), Positives = 160/201 (79%), Gaps = 2/201 (0%)
Query: 293 IRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI 352
+R ++ ++ASNVLLDHEMNPKISDFG+AR F Q++ANT R++GTYGYMAPEYAMEG+
Sbjct: 455 LRVIHRDLKASNVLLDHEMNPKISDFGLARAFDIGQNQANTRRIMGTYGYMAPEYAMEGV 514
Query: 353 FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 412
FSVK+DVFSFGV++LEIISGKK++GFY EHG SLL Y WK WCEG E+MDSV+ +SC
Sbjct: 515 FSVKTDVFSFGVLVLEIISGKKNTGFYLSEHGQSLLLYTWKKWCEGTCLEIMDSVLGKSC 574
Query: 413 -DQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSVSRV-ASGQF 470
D E+++ I+IGLLCVQED DRPTMS+V VMLASD +TLPKP QPAFS+ R+ ++
Sbjct: 575 IDDNEVVRCINIGLLCVQEDAADRPTMSTVVVMLASDTMTLPKPKQPAFSIGRMTSTDSS 634
Query: 471 VSHSEDHCSVNAITLSTMSPR 491
S S S+N +T+S + PR
Sbjct: 635 SSKSFKDPSINDVTVSNILPR 655
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358346817|ref|XP_003637461.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355503396|gb|AES84599.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 256 bits (655), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 122/200 (61%), Positives = 153/200 (76%), Gaps = 1/200 (0%)
Query: 293 IRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI 352
+R ++ ++ASNVLLD EMNPKISDFG+AR F +Q + NT RVVGTYGYMAPEYAMEG+
Sbjct: 427 LRVIHRDLKASNVLLDQEMNPKISDFGLARAFEKDQCQENTRRVVGTYGYMAPEYAMEGL 486
Query: 353 FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 412
+SVKSDVFSFGV+LLEII G+++ GFY EHG SLL Y W LWCE + EL+D ++K +
Sbjct: 487 YSVKSDVFSFGVLLLEIICGRRNGGFYLAEHGQSLLVYSWNLWCEDKSLELLDPILKNTY 546
Query: 413 DQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSVSR-VASGQFV 471
E++K IHIGLLCVQED +DRPTMS+V VMLASD +TLP P PAFSV R V G+
Sbjct: 547 TTNEVIKCIHIGLLCVQEDAVDRPTMSNVVVMLASDTMTLPNPNHPAFSVGRKVVEGEST 606
Query: 472 SHSEDHCSVNAITLSTMSPR 491
S + + SVN +T++ + PR
Sbjct: 607 SKASNDPSVNEVTVTNILPR 626
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358346648|ref|XP_003637378.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355503313|gb|AES84516.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 255 bits (652), Expect = 4e-65, Method: Compositional matrix adjust.
Identities = 122/200 (61%), Positives = 153/200 (76%), Gaps = 1/200 (0%)
Query: 293 IRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI 352
+R ++ ++ASNVLLD EMNPKISDFG+AR F +Q + NT RVVGTYGYMAPEYAMEG+
Sbjct: 374 LRVIHRDLKASNVLLDQEMNPKISDFGLARAFEKDQCQENTRRVVGTYGYMAPEYAMEGL 433
Query: 353 FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 412
+SVKSDVFSFGV+LLEII G+++ GFY EHG SLL Y W LWCE + EL+D ++K +
Sbjct: 434 YSVKSDVFSFGVLLLEIICGRRNGGFYLAEHGQSLLVYSWNLWCEDKSLELLDPILKNTY 493
Query: 413 DQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSVSR-VASGQFV 471
E++K IHIGLLCVQED +DRPTMS+V VMLASD +TLP P PAFSV R V G+
Sbjct: 494 TTNEVIKCIHIGLLCVQEDAVDRPTMSNVVVMLASDTMTLPNPNHPAFSVGRKVVEGEST 553
Query: 472 SHSEDHCSVNAITLSTMSPR 491
S + + SVN +T++ + PR
Sbjct: 554 SKASNDPSVNEVTVTNILPR 573
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 491 | ||||||
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.450 | 0.330 | 0.482 | 1.2e-89 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.338 | 0.245 | 0.566 | 2.2e-84 | |
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.386 | 0.281 | 0.510 | 4e-83 | |
| TAIR|locus:2121626 | 830 | CRK23 "cysteine-rich RLK (RECE | 0.476 | 0.281 | 0.449 | 4.9e-77 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.448 | 0.325 | 0.451 | 5.4e-71 | |
| TAIR|locus:2141762 | 665 | CRK26 "cysteine-rich RLK (RECE | 0.405 | 0.299 | 0.448 | 8.2e-71 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.450 | 0.330 | 0.467 | 1.4e-70 | |
| TAIR|locus:2123056 | 656 | CRK32 "cysteine-rich RLK (RECE | 0.334 | 0.25 | 0.527 | 2.9e-68 | |
| TAIR|locus:2141201 | 679 | CRK29 "cysteine-rich RLK (RECE | 0.395 | 0.285 | 0.472 | 5e-68 | |
| TAIR|locus:2123071 | 636 | CRK33 "cysteine-rich RLK (RECE | 0.386 | 0.298 | 0.489 | 3.3e-65 |
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 539 (194.8 bits), Expect = 1.2e-89, Sum P(2) = 1.2e-89
Identities = 111/230 (48%), Positives = 158/230 (68%)
Query: 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFG 325
++R+ I A I+ +L S L II R ++ASN+LLD +MNPKI+DFGMARIFG
Sbjct: 445 TRRYKIIGGVARGIL-YLHQDSRL-TIIHRD---LKASNILLDADMNPKIADFGMARIFG 499
Query: 326 GNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGP 385
+Q+E NT+R+VGTYGYM+PEYAM G +S+KSDV+SFGV++LEIISGKK+S FY +
Sbjct: 500 LDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAH 559
Query: 386 SLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
L++Y W LW G EL+D + ++C + E+++ +HIGLLCVQEDP +RPT+S++ +ML
Sbjct: 560 DLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLML 619
Query: 446 ASDIVTLPKPTQPA-FSVSRVASGQFVSHSEDHC---SVNAITLSTMSPR 491
S+ VTLP P QP F SR+ + + SV+ +++ + PR
Sbjct: 620 TSNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDASITDIHPR 669
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 513 (185.6 bits), Expect = 2.2e-84, Sum P(2) = 2.2e-84
Identities = 94/166 (56%), Positives = 130/166 (78%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
++ ++ASN+LLD ++NPKI+DFGMARIFG +Q++ NT+R+VGTYGYMAPEYAM G FS+K
Sbjct: 476 HRDLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMK 535
Query: 357 SDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAE 416
SDV+SFGV++LEIISG+K+S F + LL + W+LW A +L+D ++ +C +E
Sbjct: 536 SDVYSFGVLVLEIISGRKNSSFDESDGAQDLLTHTWRLWTNRTALDLVDPLIANNCQNSE 595
Query: 417 LLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSV 462
+++ IHIGLLCVQEDP RPT+S+V +ML S+ VTLP P QP F +
Sbjct: 596 VVRCIHIGLLCVQEDPAKRPTISTVFMMLTSNTVTLPVPRQPGFFI 641
|
|
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 484 (175.4 bits), Expect = 4.0e-83, Sum P(2) = 4.0e-83
Identities = 99/194 (51%), Positives = 136/194 (70%)
Query: 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGG 326
+R I E + I++L S L II R ++ASN+LLD +M+PKISDFGMARIFG
Sbjct: 444 QRRYKIIEGIARGILYLHRDSRL-TIIHRD---LKASNILLDADMHPKISDFGMARIFGV 499
Query: 327 NQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPS 386
+Q++ANT R+VGTYGYM+PEYA+ G +SVKSDV+SFGV++LE+I+GKK+S FY +
Sbjct: 500 DQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGD 559
Query: 387 LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLA 446
L+ Y+WKLW E EL+D ++ + E+++ IHI LLCVQED +RP+M + VM+
Sbjct: 560 LVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDILVMMN 619
Query: 447 SDIVTLPKPTQPAF 460
S VTLP P + F
Sbjct: 620 SFTVTLPIPKRSGF 633
|
|
| TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 480 (174.0 bits), Expect = 4.9e-77, Sum P(2) = 4.9e-77
Identities = 111/247 (44%), Positives = 152/247 (61%)
Query: 250 FLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH 309
FL DT T+ ++R+ I A I+ +L S L II R ++A N+LLD
Sbjct: 592 FLFDT---TMKRQLDWTRRYKIIGGIARGIL-YLHQDSRL-TIIHRD---LKAGNILLDA 643
Query: 310 EMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEI 369
+MNPK++DFGMARIFG +Q+EANT RVVGTYGYMAPEYAM G FS+KSDV+SFGV++ EI
Sbjct: 644 DMNPKVADFGMARIFGMDQTEANTRRVVGTYGYMAPEYAMYGQFSMKSDVYSFGVLVFEI 703
Query: 370 ISGKKSSGFYHLEHGPS-LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCV 428
ISG K+S Y ++ S L+ Y W+LW G +L+D + ++ + IHI LLCV
Sbjct: 704 ISGMKNSSLYQMDDSVSNLVTYTWRLWSNGSQLDLVDPSFGDNYQTHDITRCIHIALLCV 763
Query: 429 QEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSV-SRVASGQFVSHSEDH---CSVNAIT 484
QED DRP MS++ ML + + L P QP F R V S D CS++ +
Sbjct: 764 QEDVDDRPNMSAIVQMLTTSSIVLAVPKQPGFFFRGRHEQVGEVGSSVDRLALCSIDDAS 823
Query: 485 LSTMSPR 491
+++++PR
Sbjct: 824 ITSVAPR 830
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 458 (166.3 bits), Expect = 5.4e-71, Sum P(2) = 5.4e-71
Identities = 106/235 (45%), Positives = 149/235 (63%)
Query: 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFG 325
++R+ I A I+ +L S L II R ++A N+LL +MN KI+DFGMARIFG
Sbjct: 448 TRRYKIIGGIARGIL-YLHQDSRL-TIIHRD---LKAGNILLGDDMNAKIADFGMARIFG 502
Query: 326 GNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGP 385
+Q+EANT R+VGTYGYM+PEYAM G FS+KSDV+SFGV++LEIISGKK+S Y ++ G
Sbjct: 503 MDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQMD-GT 561
Query: 386 S---LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVA 442
S L+ Y W+LW G EL+D + + E+ + IHI LLCVQE+ DRPTMS++
Sbjct: 562 SAGNLVTYTWRLWSNGSPLELVDPSFRDNYRINEVSRCIHIALLCVQEEAEDRPTMSAIV 621
Query: 443 VMLASDIVTLPKPTQPAF---SVSRVASG---QFVSHSEDHCSVNAITLSTMSPR 491
ML + + L P +P F S G + ++ CSV+ +++ ++PR
Sbjct: 622 QMLTTSSIALAVPQRPGFFFRSSKHEQVGLVDRLSINTSALCSVDDASITNVTPR 676
|
|
| TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 427 (155.4 bits), Expect = 8.2e-71, Sum P(2) = 8.2e-71
Identities = 91/203 (44%), Positives = 134/203 (66%)
Query: 293 IRRRNKRVRASNVLLDHEMNPKISDFGMARIFG-GNQSEANTNRVVGTYGYMAPEYAMEG 351
+R ++ ++ASN+LLD EM PKI+DFGMAR+F + ++ TNR+VGT+GYMAPEY M G
Sbjct: 463 LRIIHRDLKASNILLDEEMTPKIADFGMARLFDIDHTTQRYTNRIVGTFGYMAPEYVMHG 522
Query: 352 IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK-- 409
FS K+DV+SFGV++LEIISGKK+SGF + L+++ W+ W EG A L+D ++
Sbjct: 523 QFSFKTDVYSFGVLVLEIISGKKNSGFSSEDSMGDLISFAWRNWKEGVALNLVDKILMTM 582
Query: 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAF-SVSRVASG 468
S +++ I+IGLLCVQE +RP+M+SV +ML + L +P++PAF S S S
Sbjct: 583 SSYSSNMIMRCINIGLLCVQEKVAERPSMASVVLMLDGHTIALSEPSKPAFFSHSNAVSD 642
Query: 469 QFVSHSEDHCSVNAITLSTMSPR 491
S + + N + + + PR
Sbjct: 643 SSSSLGHNAKTSNYNSNTELYPR 665
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 500 (181.1 bits), Expect = 1.4e-70, Sum P(2) = 1.4e-70
Identities = 109/233 (46%), Positives = 152/233 (65%)
Query: 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFG 325
++R+ I A I+ +L S L II R ++ASN+LLD +MNPKI+DFGMARIFG
Sbjct: 442 TRRYNIIGGIARGIL-YLHQDSRL-TIIHRD---LKASNILLDADMNPKIADFGMARIFG 496
Query: 326 GNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEH-G 384
+QS+ANT R+ GT+GYM+PEYAM G FS+KSDV+SFGV++LEIISGKK+S FY+++ G
Sbjct: 497 VDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSG 556
Query: 385 PSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444
+L+ + W+LW G EL+D + +S +E + IHI LLCVQEDP DRP + ++ +M
Sbjct: 557 SNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAIIMM 616
Query: 445 LASDIVTLPKPTQPAFSVS-RVASGQFVSHSEDHC-----SVNAITLSTMSPR 491
L S TL P P F +S R V ++E S+N +++ PR
Sbjct: 617 LTSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSINDASITEFYPR 669
|
|
| TAIR|locus:2123056 CRK32 "cysteine-rich RLK (RECEPTOR-like protein kinase) 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 482 (174.7 bits), Expect = 2.9e-68, Sum P(2) = 2.9e-68
Identities = 87/165 (52%), Positives = 123/165 (74%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
++ ++ASN+LLD +MNPKI+DFGMAR F +Q+E NT RVVGT+GYM PEY G FS K
Sbjct: 452 HRDIKASNILLDADMNPKIADFGMARNFRVDQTEDNTRRVVGTFGYMPPEYVTHGQFSTK 511
Query: 357 SDVFSFGVVLLEIISGKKSSGFYHLEH-GPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 415
SDV+SFGV++LEI+ GKK+S FY ++ G +L+ ++W+LW +L+D +++SCD
Sbjct: 512 SDVYSFGVLILEIVCGKKNSSFYKIDDSGGNLVTHVWRLWNNDSPLDLIDPAIEESCDND 571
Query: 416 ELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAF 460
++++ IHIGLLCVQE P+DRP MS++ ML + +TLP P P F
Sbjct: 572 KVIRCIHIGLLCVQETPVDRPEMSTIFQMLTNSSITLPVPRPPGF 616
|
|
| TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 448 (162.8 bits), Expect = 5.0e-68, Sum P(2) = 5.0e-68
Identities = 95/201 (47%), Positives = 135/201 (67%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEAN--TNRVVGTYGYMAPEYAMEGIFS 354
++ ++ASN+LLD EMNPKI+DFG+A++F Q+ + T+R+ GTYGYMAPEYAM G FS
Sbjct: 480 HRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFTSRIAGTYGYMAPEYAMHGQFS 539
Query: 355 VKSDVFSFGVVLLEIISGKKSS--GFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 412
VK+DVFSFGV+++EII+GK+++ G E LL+++W+ W E ++D +
Sbjct: 540 VKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDLLSWVWRSWREDTILSVIDPSLTAG- 598
Query: 413 DQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSVSRVASGQFVS 472
+ E+L+ IHIGLLCVQE RPTM++V++ML S TLP P +PAF + V VS
Sbjct: 599 SRNEILRCIHIGLLCVQESAATRPTMATVSLMLNSYSFTLPTPLRPAFVLESVVIPSNVS 658
Query: 473 HSED--HCSVNAITLSTMSPR 491
S + S N +T+S SPR
Sbjct: 659 SSTEGLQMSSNDVTVSEFSPR 679
|
|
| TAIR|locus:2123071 CRK33 "cysteine-rich RLK (RECEPTOR-like protein kinase) 33" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 466 (169.1 bits), Expect = 3.3e-65, Sum P(2) = 3.3e-65
Identities = 96/196 (48%), Positives = 135/196 (68%)
Query: 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFG 325
+KR+ I A I+ +L S L I ++ ++ASN+LLD EM PK++DFGMARIF
Sbjct: 418 AKRYKIIVGTARGIL-YLHHDSPLKII----HRDLKASNILLDAEMEPKVADFGMARIFR 472
Query: 326 GNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHL-EHG 384
+QS A+T RVVGT+GY++PEY M G FSVKSDV+SFGV++LEIISGK++S F+ E G
Sbjct: 473 VDQSRADTRRVVGTHGYISPEYLMHGQFSVKSDVYSFGVLVLEIISGKRNSNFHETDESG 532
Query: 385 PSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444
+L+ Y W+ W G EL+DS ++++ E+ + IHI LLCVQ DP RP +S++ +M
Sbjct: 533 KNLVTYAWRHWRNGSPLELVDSELEKNYQSNEVFRCIHIALLCVQNDPEQRPNLSTIIMM 592
Query: 445 LASDIVTLPKPTQPAF 460
L S+ +TLP P P +
Sbjct: 593 LTSNSITLPVPQSPVY 608
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.IV.1878.1 | hypothetical protein (648 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 491 | |||
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 3e-18 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-17 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-17 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-17 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 8e-17 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-16 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-16 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-16 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-16 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-14 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-13 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-12 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-11 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-10 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-10 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-10 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-10 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-08 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-08 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-08 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-07 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-07 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-07 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-06 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-06 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-06 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-06 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-05 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-05 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-05 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-05 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-05 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-04 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-04 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-04 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-04 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-04 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-04 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.001 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.001 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.001 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 0.001 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 0.002 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.002 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 0.002 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 0.002 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 0.002 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 0.002 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 0.002 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.002 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 0.002 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 0.002 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 0.002 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 0.002 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 0.002 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.002 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 0.002 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.002 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 0.003 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.003 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 0.003 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.003 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.004 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 0.004 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-18
Identities = 31/104 (29%), Positives = 46/104 (44%), Gaps = 7/104 (6%)
Query: 39 YKFCPRGTNN---TASIIYIYNLSKLFNRKLHEE---GGNSLYRNASVGDNPDKVYGLFL 92
+ C T+ TA+ + NL+ L + L + + G PD VYGL
Sbjct: 1 FHLCSSNTSGNYTTANSTFESNLNALLSS-LSSNAASSSGKGFAAGTSGAAPDTVYGLAQ 59
Query: 93 CRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVCYSN 136
CR D+S C++C+ A+ L C K IWYD C + Y +
Sbjct: 60 CRGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYES 103
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 48/148 (32%), Positives = 73/148 (49%), Gaps = 21/148 (14%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
A N L+ ++ KISDFG++R ++ + T + +MAPE +GIF+ KSDV+
Sbjct: 133 ARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPESLKDGIFTSKSDVW 191
Query: 361 SFGVVLLEIISGKKS--SGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELL 418
SFGV+L EI + + G + E +L Y+ +G+ + C EL
Sbjct: 192 SFGVLLWEIFTLGATPYPGLSNEE----VLEYL----RKGYRLPKPE-----YCPD-ELY 237
Query: 419 KYIHIGLLCVQEDPMDRPTMSSVAVMLA 446
+ + L C Q DP DRPT S + L
Sbjct: 238 ELM---LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 46/137 (33%), Positives = 59/137 (43%), Gaps = 13/137 (9%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI-FSVKSDVFS 361
N+LLD KI+DFG+A+ + S T VGT YMAPE + G + K DV+S
Sbjct: 127 ENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYGPKVDVWS 184
Query: 362 FGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421
GV+L E+++GK F E+ L I L K S E I
Sbjct: 185 LGVILYELLTGK--PPFSG-ENILDQLQLI----RRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 422 HIGLLCVQEDPMDRPTM 438
L DP RPT
Sbjct: 238 K-KCLNK--DPSKRPTA 251
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 7e-17
Identities = 36/135 (26%), Positives = 58/135 (42%), Gaps = 16/135 (11%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSF 362
N+LLD + + K++DFG+AR + VGT YMAPE + + D++S
Sbjct: 126 ENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGKGYGKAVDIWSL 182
Query: 363 GVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422
GV+L E+++G G L ++K + S + +L++
Sbjct: 183 GVILYELLTG------KPPFPGDDQLLELFKKIGKPK-PPFPPPEWDISPEAKDLIR--- 232
Query: 423 IGLLCVQEDPMDRPT 437
LL DP R T
Sbjct: 233 -KLLVK--DPEKRLT 244
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-17
Identities = 41/104 (39%), Positives = 52/104 (50%), Gaps = 2/104 (1%)
Query: 149 LCVKN--ENYTTEPDKLAQILNQTFNDEIRNAASSDSKYAAQTINISSFDTLQTTVHCIP 206
LC N NYTT LN + NAASS K A + ++ DT+ C
Sbjct: 3 LCSSNTSGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRG 62
Query: 207 DLSKSDCNVCLNSAVAQIPTCSKGKLGARIFCASCSIRYELYRF 250
DLS SDC CL +AV+++ C K G RI+ SC +RYE Y F
Sbjct: 63 DLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 3e-16
Identities = 45/147 (30%), Positives = 66/147 (44%), Gaps = 30/147 (20%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGT---YGYMAPEYAMEGIFSVKSD 358
A N L+ + KISDFG++R + + + R G +MAPE EG F+ KSD
Sbjct: 130 ARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSD 185
Query: 359 VFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWK---LWCEGHAAELMDSVVKQSCDQ 414
V+SFGV+L EI + G++ Y +L Y+ L + + ++ Q
Sbjct: 186 VWSFGVLLWEIFTLGEQP---YPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQ---- 238
Query: 415 AELLKYIHIGLLCVQEDPMDRPTMSSV 441
C EDP DRPT S +
Sbjct: 239 ------------CWAEDPEDRPTFSEL 253
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (193), Expect = 3e-16
Identities = 47/155 (30%), Positives = 63/155 (40%), Gaps = 33/155 (21%)
Query: 300 VRASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSD 358
+ A N L+ + KISDFG++R I+ + + +MAPE +G F+ KSD
Sbjct: 128 LAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIKWMAPESLKDGKFTSKSD 186
Query: 359 VFSFGVVLLEIIS-------GKKSSGFY-HLEHGPSLLAYIWKLWCEGHAAELMDSVVKQ 410
V+SFGV+L EI + G + LE G L C ELM
Sbjct: 187 VWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRP---ENCPDELYELM------ 237
Query: 411 SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
L C DP DRPT S + L
Sbjct: 238 --------------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 4e-16
Identities = 46/147 (31%), Positives = 68/147 (46%), Gaps = 30/147 (20%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGT---YGYMAPEYAMEGIFSVKSD 358
A N L+ + KISDFG++R + + + +V G +MAPE EG F+ KSD
Sbjct: 131 ARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSD 186
Query: 359 VFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWK---LWCEGHAAELMDSVVKQSCDQ 414
V+SFGV+L EI + G++ Y +L Y+ K L + + ++ Q
Sbjct: 187 VWSFGVLLWEIFTLGEEP---YPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQ---- 239
Query: 415 AELLKYIHIGLLCVQEDPMDRPTMSSV 441
C EDP DRPT S +
Sbjct: 240 ------------CWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 7e-16
Identities = 28/72 (38%), Positives = 46/72 (63%), Gaps = 4/72 (5%)
Query: 300 VRASNVLLDH-EMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-YAMEGIFSVKS 357
++ N+LLD K++DFG++++ ++S T +VGT YMAPE +G +S KS
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKS 175
Query: 358 DVFSFGVVLLEI 369
D++S GV+L E+
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 3e-14
Identities = 36/138 (26%), Positives = 65/138 (47%), Gaps = 14/138 (10%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
++ +N+L+D + K++DFG A+ G ++ T V GT +MAPE + +D+
Sbjct: 127 IKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADI 186
Query: 360 FSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLK 419
+S G ++E+ +GK + L + + L I G + E + S + + L
Sbjct: 187 WSLGCTVIEMATGKPP--WSELGNPMAALYKI------GSSGEPPEIPEHLSEEAKDFL- 237
Query: 420 YIHIGLLCVQEDPMDRPT 437
C++ DP RPT
Sbjct: 238 -----RKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 40/141 (28%), Positives = 63/141 (44%), Gaps = 26/141 (18%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSF 362
SN+L++ + KI+DFG++++ + NT VGT YM+PE +S +D++S
Sbjct: 129 SNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSPERIQGESYSYAADIWSL 186
Query: 363 GVVLLEIISGK------KSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAE 416
G+ LLE GK F+ L+ I C+G L E
Sbjct: 187 GLTLLECALGKFPFLPPGQPSFF------ELMQAI----CDGPPPSLPAEEFSP-----E 231
Query: 417 LLKYIHIGLLCVQEDPMDRPT 437
+I C+Q+DP RP+
Sbjct: 232 FRDFIS---ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (159), Expect = 8e-12
Identities = 26/70 (37%), Positives = 41/70 (58%), Gaps = 2/70 (2%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363
N+LLD + + K++DFG+A+ S NT GT Y+APE + + D +S G
Sbjct: 123 NILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGYGKAVDWWSLG 180
Query: 364 VVLLEIISGK 373
V+L E+++GK
Sbjct: 181 VLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 8e-12
Identities = 31/82 (37%), Positives = 50/82 (60%), Gaps = 4/82 (4%)
Query: 293 IRRRN---KRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM 349
I R+N + +RA+N+L+ + KI+DFG+AR+ N+ A + APE
Sbjct: 118 IERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAIN 176
Query: 350 EGIFSVKSDVFSFGVVLLEIIS 371
G F++KSDV+SFG++L EI++
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 8e-12
Identities = 59/211 (27%), Positives = 84/211 (39%), Gaps = 42/211 (19%)
Query: 247 LYRFLVDTPTVTVTAPNKTSKRWITIAEAASAI---IVFLLSTSFLWCIIRRRNKRVRAS 303
L ++L + V + E A + + +L S F+ ++ + A
Sbjct: 82 LLKYLKKRREIPV----------SDLKELAHQVAMGMAYLESKHFV-------HRDLAAR 124
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTY--GYMAPEYAMEGIFSVKSDVFS 361
NVLL + KISDFGM+R G S+ G + + APE G FS KSDV+S
Sbjct: 125 NVLLVNRHQAKISDFGMSRALGAG-SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWS 183
Query: 362 FGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKY 420
+GV L E S G K Y G ++A + G + C Q
Sbjct: 184 YGVTLWEAFSYGAKP---YGEMKGAEVIAMLES----GERLPRPE-----ECPQ-----E 226
Query: 421 IH-IGLLCVQEDPMDRPTMSSVAVMLASDIV 450
I+ I L C + P DRPT S + D
Sbjct: 227 IYSIMLSCWKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 20/140 (14%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI-FSVKSDVFS 361
N+ L K+ DFG++++ A T VVGT Y++PE + ++ KSD++S
Sbjct: 132 QNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPE-LCQNKPYNYKSDIWS 188
Query: 362 FGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421
G VL E+ + K F G +LL K+ +G + S + L+
Sbjct: 189 LGCVLYELCTLKHP--FE----GENLLELALKI-LKGQYPPIPSQY---SSELRNLVS-- 236
Query: 422 HIGLLCVQEDPMDRPTMSSV 441
+Q+DP +RP+++ +
Sbjct: 237 ----SLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 30/85 (35%), Positives = 49/85 (57%), Gaps = 10/85 (11%)
Query: 293 IRRRN---KRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGT---YGYMAPE 346
+ RN + + A N+L+ + KI+DFG+AR+ ++ A G + APE
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPE 174
Query: 347 YAMEGIFSVKSDVFSFGVVLLEIIS 371
A G F++KSDV+SFG++L EI++
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 27/70 (38%), Positives = 40/70 (57%), Gaps = 2/70 (2%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363
N+ LD N K+ DFG+A+I G + S A T VGT YM+PE + KSD++S G
Sbjct: 140 NIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQLNHMSYDEKSDIWSLG 197
Query: 364 VVLLEIISGK 373
++ E+ +
Sbjct: 198 CLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 5e-11
Identities = 23/74 (31%), Positives = 40/74 (54%), Gaps = 3/74 (4%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
++A+N+LL + K+ DFG++ N +VGT +MAPE + K+D+
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDYKADI 180
Query: 360 FSFGVVLLEIISGK 373
+S G+ +E+ GK
Sbjct: 181 WSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 30/74 (40%), Positives = 47/74 (63%), Gaps = 2/74 (2%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
+++ N+ LD N KI D G+A++ N + ANT +VGT Y++PE + ++ KSDV
Sbjct: 127 IKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCEDKPYNEKSDV 184
Query: 360 FSFGVVLLEIISGK 373
++ GVVL E +GK
Sbjct: 185 WALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 26/74 (35%), Positives = 46/74 (62%), Gaps = 2/74 (2%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
++A N+LL+ E K++DFG++ ++ NT V+GT +MAPE E ++ K+D+
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNNKADI 182
Query: 360 FSFGVVLLEIISGK 373
+S G+ +E+ GK
Sbjct: 183 WSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 39/159 (24%), Positives = 60/159 (37%), Gaps = 36/159 (22%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSE----ANTNRVVGTYGYMAPEYAMEGIFSVKS 357
A N+L++ E KISDFG+A++ + + + Y APE FS S
Sbjct: 137 ARNILVESEDLVKISDFGLAKVL--PEDKDYYYVKEPGESPIFWY-APECLRTSKFSSAS 193
Query: 358 DVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAEL 417
DV+SFGV L E+ F + + S A ++ EL
Sbjct: 194 DVWSFGVTLYEL--------FTYGDPSQSPPAEFLRMIGIAQG-------QMIVTRLLEL 238
Query: 418 LK--------------YIHIGLLCVQEDPMDRPTMSSVA 442
LK + LC + +P DRP+ + +
Sbjct: 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 9e-11
Identities = 29/73 (39%), Positives = 43/73 (58%), Gaps = 7/73 (9%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGT---YGYMAPEYAMEGIFSVKSD 358
A NVL+ K++DFG+AR+ + EA G + APE A+ FS+KSD
Sbjct: 131 ARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSIKSD 186
Query: 359 VFSFGVVLLEIIS 371
V+SFG++L EI++
Sbjct: 187 VWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 27/70 (38%), Positives = 36/70 (51%), Gaps = 3/70 (4%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363
NVLLD N +ISD G+A G + GT GYMAPE ++ D F+ G
Sbjct: 125 NVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALG 181
Query: 364 VVLLEIISGK 373
L E+I+G+
Sbjct: 182 CTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 32/82 (39%), Positives = 47/82 (57%), Gaps = 7/82 (8%)
Query: 292 IIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEG 351
II R V+ SN+L++ K+ DFG++ S A T VGT YMAPE
Sbjct: 122 IIHRD---VKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTF--VGTSSYMAPERIQGN 174
Query: 352 IFSVKSDVFSFGVVLLEIISGK 373
+SVKSD++S G+ L+E+ +G+
Sbjct: 175 DYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 30/75 (40%), Positives = 43/75 (57%), Gaps = 10/75 (13%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTNRVVGT----YGYMAPEYAMEGIFSVK 356
A N ++ ++ KI DFGM R I+ E + R G +MAPE +G+F+ K
Sbjct: 147 ARNCMVAEDLTVKIGDFGMTRDIY-----ETDYYRKGGKGLLPVRWMAPESLKDGVFTTK 201
Query: 357 SDVFSFGVVLLEIIS 371
SDV+SFGVVL E+ +
Sbjct: 202 SDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 30/72 (41%), Positives = 42/72 (58%), Gaps = 9/72 (12%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTY--GYMAPEYAMEGIFSVKSDV 359
A NVL+ ++ K+SDFG+A+ EA+ + G + APE E FS KSDV
Sbjct: 130 ARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182
Query: 360 FSFGVVLLEIIS 371
+SFG++L EI S
Sbjct: 183 WSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 25/88 (28%), Positives = 43/88 (48%), Gaps = 18/88 (20%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRV------------------VGTYGYMAP 345
N+LLD +M+ KI+DFG A++ N S + VGT Y++P
Sbjct: 132 NILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSP 191
Query: 346 EYAMEGIFSVKSDVFSFGVVLLEIISGK 373
E E SD+++ G ++ ++++GK
Sbjct: 192 ELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 61.7 bits (148), Expect = 3e-10
Identities = 38/146 (26%), Positives = 65/146 (44%), Gaps = 12/146 (8%)
Query: 303 SNVLLDHEMN-PKISDFGMARIFGGNQSEAN----TNRVVGTYGYMAPEYAM---EGIFS 354
N+LLD + K+ DFG+A++ S ++ + VGT GYMAPE + S
Sbjct: 130 ENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYAS 189
Query: 355 VKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQ 414
SD++S G+ L E+++G + E S + K+ E + S + S +
Sbjct: 190 SSSDIWSLGITLYELLTGLPP---FEGEKNSSATSQTLKIILEL-PTPSLASPLSPSNPE 245
Query: 415 AELLKYIHIGLLCVQEDPMDRPTMSS 440
+ + +DP +R + SS
Sbjct: 246 LISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 26/70 (37%), Positives = 45/70 (64%), Gaps = 2/70 (2%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
A N+L+ ++ K++DFG+AR+ + ++ ++ Y + APE A G FS KSDV+S
Sbjct: 132 ARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKSDVWS 189
Query: 362 FGVVLLEIIS 371
FG++L E+ +
Sbjct: 190 FGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 5e-10
Identities = 25/73 (34%), Positives = 42/73 (57%), Gaps = 2/73 (2%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM-EGIFSVKSDVF 360
SN+L++++ K++DFG+AR + S TNRV+ T Y PE + + + D++
Sbjct: 128 GSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRYGPEVDMW 186
Query: 361 SFGVVLLEIISGK 373
S G +L E+ GK
Sbjct: 187 SVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 6e-10
Identities = 32/82 (39%), Positives = 50/82 (60%), Gaps = 4/82 (4%)
Query: 293 IRRRN---KRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM 349
I R+N + +RA+NVL+ + KI+DFG+AR+ N+ A + APE
Sbjct: 119 IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAIN 177
Query: 350 EGIFSVKSDVFSFGVVLLEIIS 371
G F++KSDV+SFG++L EI++
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 34/103 (33%), Positives = 48/103 (46%), Gaps = 11/103 (10%)
Query: 272 IAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEA 331
I E A+ +L S II R ++ N+LLD + + I+DF +A +
Sbjct: 106 ICEIVLALE-YLHSKG----IIHRD---IKPDNILLDEQGHVHITDFNIATKVTPDT--- 154
Query: 332 NTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKK 374
T GT GYMAPE +SV D +S GV E + GK+
Sbjct: 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 23/158 (14%)
Query: 293 IRRRN---KRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM 349
I R N + +RA+N+L+ + KI+DFG+AR+ N+ A + APE A+
Sbjct: 118 IERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 176
Query: 350 EGIFSVKSDVFSFGVVLLEIISGKKS--SGFYHLEHGPSLLAYIWKLWCEGHAAELMDSV 407
G F++KSDV+SFG++L E+++ + G + E E ++
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-----------------VLEQVERG 219
Query: 408 VKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
+ C Q + LC ++DP +RPT + L
Sbjct: 220 YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 30/82 (36%), Positives = 51/82 (62%), Gaps = 4/82 (4%)
Query: 293 IRRRN---KRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM 349
I R N + +R++N+L+ + KI+DFG+AR+ N+ A + APE A+
Sbjct: 118 IERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 176
Query: 350 EGIFSVKSDVFSFGVVLLEIIS 371
G F++KSDV+SFG++L E+++
Sbjct: 177 YGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 41/156 (26%), Positives = 77/156 (49%), Gaps = 19/156 (12%)
Query: 293 IRRRN---KRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM 349
I +RN + +RA+N+L+ + KI+DFG+AR+ N+ A + APE
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAIN 176
Query: 350 EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK 409
G F++KSDV+SFG++L+EI++ + Y P ++ + + G+ ++ +
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIP--YPGMSNPEVIRALER----GYRMPRPENCPE 230
Query: 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
+ + I + C + P +RPT + +L
Sbjct: 231 ELYN---------IMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 41/146 (28%), Positives = 69/146 (47%), Gaps = 18/146 (12%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
++ N+ L K+ DFG+++I G S A T VVGT YM+PE ++ KSD+
Sbjct: 127 IKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKYNFKSDI 184
Query: 360 FSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLK 419
++ G VL E+++ K++ F + L + K+ + + S +EL+
Sbjct: 185 WALGCVLYELLTLKRT--F----DATNPLNLVVKIVQGNYTPVV-------SVYSSELIS 231
Query: 420 YIHIGLLCVQEDPMDRPTMSSVAVML 445
+H +Q+DP RPT V
Sbjct: 232 LVH---SLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 34/106 (32%), Positives = 62/106 (58%), Gaps = 10/106 (9%)
Query: 272 IAEAASAIIV--FLLSTSFLWC--IIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGN 327
IAE ++I+ L++ ++ +I R ++A+N+L+ + N K+ DFG+A + N
Sbjct: 98 IAEKYISVIIREVLVALKYIHKVGVIHRD---IKAANILVTNTGNVKLCDFGVAALLNQN 154
Query: 328 QSEANTNRVVGTYGYMAPEYAMEGI-FSVKSDVFSFGVVLLEIISG 372
S+ +T VGT +MAPE EG + K+D++S G+ + E+ +G
Sbjct: 155 SSKRST--FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 32/162 (19%)
Query: 291 CIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG-----YMAP 345
CI R V A NVLL KI DFG+AR ++N VV +MAP
Sbjct: 233 CIHRD----VAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAP 283
Query: 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLL--AYIWKLWCEGHAAEL 403
E + +++V+SDV+S+G++L EI S KS Y P +L + +K+ G+
Sbjct: 284 ESIFDCVYTVQSDVWSYGILLWEIFSLGKSP--Y-----PGILVNSKFYKMVKRGY---- 332
Query: 404 MDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
+ S + I +C +P +RPT S ++ ++
Sbjct: 333 -----QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 27/75 (36%), Positives = 48/75 (64%), Gaps = 1/75 (1%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
++ +RA+N+L+ + K++DFG+AR+ N+ A + APE A+ G F++K
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 183
Query: 357 SDVFSFGVVLLEIIS 371
SDV+SFG++L E+ +
Sbjct: 184 SDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 46/160 (28%), Positives = 65/160 (40%), Gaps = 37/160 (23%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVG---TYGYMAPEYAMEGIFSVKSD 358
N+L++ E KI DFG+ ++ ++ E R G + Y APE E FSV SD
Sbjct: 136 TRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESLTESKFSVASD 193
Query: 359 VFSFGVVLLEII--SGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAE 416
V+SFGVVL E+ S K S P ++ + + + E
Sbjct: 194 VWSFGVVLYELFTYSDKSCS--------PPAE-FMRMMGNDKQGQMI-------VYHLIE 237
Query: 417 LLKY-------------IH-IGLLCVQEDPMDRPTMSSVA 442
LLK I+ I C DP RP+ S +A
Sbjct: 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELA 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 27/71 (38%), Positives = 42/71 (59%), Gaps = 2/71 (2%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
A N L+ + KISDFG++R I+ + + ++ +M PE + G F+ +SD++
Sbjct: 152 ARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIW 210
Query: 361 SFGVVLLEIIS 371
SFGVVL EI S
Sbjct: 211 SFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 8e-09
Identities = 44/143 (30%), Positives = 76/143 (53%), Gaps = 20/143 (13%)
Query: 300 VRASNVLLD-HEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSD 358
++ N+LLD H+M KI DFG+++I ++S+A T VVGT Y++PE ++ KSD
Sbjct: 127 LKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYT--VVGTPCYISPELCEGKPYNQKSD 183
Query: 359 VFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELL 418
+++ G VL E+ S K++ + + P+L+ I G A + D + L
Sbjct: 184 IWALGCVLYELASLKRA---FEAANLPALVLKIMS----GTFAPISDRY-------SPDL 229
Query: 419 KYIHIGLLCVQEDPMDRPTMSSV 441
+ + + +L DP RP +S +
Sbjct: 230 RQLILSML--NLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 50/153 (32%), Positives = 73/153 (47%), Gaps = 26/153 (16%)
Query: 292 IIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEG 351
II R ++ SN+LL + K+ DFG++ S A T GT YMAPE
Sbjct: 126 IIHRD---IKPSNILLTRKGQVKLCDFGVSGELV--NSLAGT--FTGTSFYMAPERIQGK 178
Query: 352 IFSVKSDVFSFGVVLLEIISGK---KSSGFYHLEHGP-SLLAYIWKLWCEGHAAELMD-- 405
+S+ SDV+S G+ LLE+ + G L GP LL+YI + EL D
Sbjct: 179 PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL--GPIELLSYIVNM----PNPELKDEP 232
Query: 406 -SVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT 437
+ +K S + + +K C+++DP RPT
Sbjct: 233 GNGIKWSEEFKDFIKQ------CLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 49/141 (34%), Positives = 69/141 (48%), Gaps = 21/141 (14%)
Query: 302 ASNVLL--DHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
A NVL+ DH M KI+DFG+AR T +MAPE + +++ +SDV
Sbjct: 160 ARNVLVTEDHVM--KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDV 217
Query: 360 FSFGVVLLEIISGKKSSGFYHLEHGPSL-LAYIWKLWCEGHAAELMDSVVKQSCDQAELL 418
+SFGV+L EI + S Y P + + ++KL EG+ M+ Q+C Q EL
Sbjct: 218 WSFGVLLWEIFTLGGSP--Y-----PGIPVEELFKLLKEGYR---MEK--PQNCTQ-ELY 264
Query: 419 KYIHIGLLCVQEDPMDRPTMS 439
H+ C E P RPT
Sbjct: 265 ---HLMRDCWHEVPSQRPTFK 282
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 31/89 (34%), Positives = 54/89 (60%), Gaps = 8/89 (8%)
Query: 287 SFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGN--QSEANTNRVVGTYGYMA 344
++L+ + R ++ ++ SN+L++ K+ DFG++ G S A+T VGT YM+
Sbjct: 117 TYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADT--FVGTSTYMS 170
Query: 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGK 373
PE G ++VKSDV+S G+ ++E+ GK
Sbjct: 171 PERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 27/59 (45%), Positives = 38/59 (64%), Gaps = 2/59 (3%)
Query: 314 KISDFGMAR-IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS 371
KI+DFGMAR I+ + R + +M PE ++GIF+ K+DV+SFGV+L EI S
Sbjct: 159 KIADFGMARDIYRASYYRKG-GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 2/87 (2%)
Query: 294 RRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIF 353
R+ ++ ++A+NVLL + + K++DFG+A Q + NT VGT +MAPE + +
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAY 178
Query: 354 SVKSDVFSFGVVLLEIISGKKSSGFYH 380
K+D++S G+ +E+ G+ + H
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLH 205
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 24/73 (32%), Positives = 43/73 (58%), Gaps = 2/73 (2%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
+++ N+LL + + K++DFG A +S+ N+ VVGT +MAPE + K D+
Sbjct: 142 IKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYGPKVDI 199
Query: 360 FSFGVVLLEIISG 372
+S G++ +E+ G
Sbjct: 200 WSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 23/70 (32%), Positives = 40/70 (57%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
A N+L++ + K+SDFG++R +++ T + APE F+ SDV+S
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWS 193
Query: 362 FGVVLLEIIS 371
FG+V+ E++S
Sbjct: 194 FGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 13/93 (13%)
Query: 282 FLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR-IFGGNQ--SEANTNRVVG 338
FL S + CI R + A NVLL H KI DFG+AR I + + N V
Sbjct: 156 FLASKN---CIHRD----LAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 339 TYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS 371
+MAPE +++ +SDV+S+G++L EI S
Sbjct: 209 ---WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 37/145 (25%), Positives = 68/145 (46%), Gaps = 31/145 (21%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
++A+N+LL E + K++DFG++ S+ NT VGT +MAPE + + K+D+
Sbjct: 124 IKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQSGYDEKADI 181
Query: 360 FSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLK 419
+S G+ +E+ G+ P L + H ++ + K + E K
Sbjct: 182 WSLGITAIELAKGE-----------PPL--------SDLHPMRVLFLIPKNNPPSLEGNK 222
Query: 420 Y-------IHIGLLCVQEDPMDRPT 437
+ + LC+ +DP +RP+
Sbjct: 223 FSKPFKDFVS---LCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 25/74 (33%), Positives = 44/74 (59%), Gaps = 1/74 (1%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
A NVL+ + KI+DFG+A++ ++ E + +MA E + I++ KSDV+S
Sbjct: 137 ARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWS 196
Query: 362 FGVVLLEIIS-GKK 374
+GV + E+++ G K
Sbjct: 197 YGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 28/72 (38%), Positives = 41/72 (56%), Gaps = 6/72 (8%)
Query: 304 NVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
NVLLD E + KI+DFGM + I GG T+ GT Y+APE + D ++
Sbjct: 126 NVLLDSEGHIKIADFGMCKEGILGGVT----TSTFCGTPDYIAPEILSYQPYGPAVDWWA 181
Query: 362 FGVVLLEIISGK 373
GV+L E+++G+
Sbjct: 182 LGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 35/145 (24%), Positives = 69/145 (47%), Gaps = 18/145 (12%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIF--GGNQSEANTNRVVGTYGYMAPEYAMEGI-FSVK 356
++A N+LL + + KI+DFG++ GG+++ VGT +MAPE + + K
Sbjct: 128 IKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFK 187
Query: 357 SDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA- 415
+D++SFG+ +E+ +G + + L+ + + L + ++
Sbjct: 188 ADIWSFGITAIELATGA--APYSKYPPMKVLMLTL-----QNDPPSLETGADYKKYSKSF 240
Query: 416 -ELLKYIHIGLLCVQEDPMDRPTMS 439
+++ LC+Q+DP RPT
Sbjct: 241 RKMIS------LCLQKDPSKRPTAE 259
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 27/74 (36%), Positives = 45/74 (60%), Gaps = 5/74 (6%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI-FSVKSD 358
++ +N+LLD + +ISD G+A F + A+ VGT+GYMAPE +G+ + +D
Sbjct: 123 LKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDSSAD 178
Query: 359 VFSFGVVLLEIISG 372
FS G +L +++ G
Sbjct: 179 WFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 50/198 (25%), Positives = 89/198 (44%), Gaps = 47/198 (23%)
Query: 260 TAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319
TA TS++ + A + + +L F+ ++ + A NVL+ + KI+DFG
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFI-------HRDLAARNVLVGENLASKIADFG 164
Query: 320 MARIFGGNQSEANTNRVVGTYG--YMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSG 377
++R E + +G +MA E +++ KSDV+SFGV+L EI+S
Sbjct: 165 LSR-----GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS------ 213
Query: 378 FYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK-------QSCDQA--ELLKYIHIGLLCV 428
L P +C AEL + + + ++CD EL++ C
Sbjct: 214 ---LGGTP---------YCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQ------CW 255
Query: 429 QEDPMDRPTMSSVAVMLA 446
++ P +RP + ++V L+
Sbjct: 256 RDRPYERPPFAQISVQLS 273
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 7e-08
Identities = 25/75 (33%), Positives = 43/75 (57%), Gaps = 4/75 (5%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-YAMEGIFSVKSD 358
++A+N+L + K++DFG+A + + VVGT +MAPE M G S SD
Sbjct: 125 IKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEMSGA-STASD 181
Query: 359 VFSFGVVLLEIISGK 373
++S G ++E+++G
Sbjct: 182 IWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 27/87 (31%), Positives = 51/87 (58%), Gaps = 2/87 (2%)
Query: 294 RRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIF 353
++ ++ ++A+NVLL + + K++DFG+A Q + NT VGT +MAPE + +
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSAY 178
Query: 354 SVKSDVFSFGVVLLEIISGKKSSGFYH 380
K+D++S G+ +E+ G+ + H
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 14/102 (13%)
Query: 273 AEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR--IFGGNQSE 330
AE SA++ FL ++ + ++ NVLLDHE + K++DFGM + IF G
Sbjct: 103 AEITSALM-FLHDKGIIY-------RDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---- 150
Query: 331 ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISG 372
T+ GT Y+APE E ++ D ++ GV+L E++ G
Sbjct: 151 KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 29/76 (38%), Positives = 45/76 (59%), Gaps = 2/76 (2%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSV 355
+K + A N+L+ +++ KISD G++R I+ + ++ +M PE M G FS
Sbjct: 147 HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR-WMPPEAIMYGKFSS 205
Query: 356 KSDVFSFGVVLLEIIS 371
SD++SFGVVL EI S
Sbjct: 206 DSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 28/74 (37%), Positives = 41/74 (55%), Gaps = 2/74 (2%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
++ NVLLD++ N +ISD G+A QS+ T GT G+MAPE + D
Sbjct: 123 LKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDY 180
Query: 360 FSFGVVLLEIISGK 373
F+ GV L E+I+ +
Sbjct: 181 FALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 41/166 (24%), Positives = 67/166 (40%), Gaps = 22/166 (13%)
Query: 276 ASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 335
A+A + +L S + CI R + A N L+ KISDFGM+R G +
Sbjct: 102 AAAGMEYLESKN---CIHRD----LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154
Query: 336 VVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLW 395
+ APE G ++ +SDV+S+G++L E S + +
Sbjct: 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTP---------------YPGM 199
Query: 396 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSV 441
E ++S + Q + + L C DP +RP+ S +
Sbjct: 200 SNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 37/142 (26%), Positives = 66/142 (46%), Gaps = 25/142 (17%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEAN--TNRVVGTYGYMAPEYAM-EGIFSVK 356
++ +N+L+D K++DFGMA+ Q G+ +MAPE +G + +
Sbjct: 128 IKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLA 182
Query: 357 SDVFSFGVVLLEIISGKKS-SGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 415
+D++S G +LE+ +GK S +A ++K+ + D + ++ D
Sbjct: 183 ADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKELPPIPDHLSDEAKD-- 233
Query: 416 ELLKYIHIGLLCVQEDPMDRPT 437
+I L C+Q DP RPT
Sbjct: 234 ----FI---LKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 38/125 (30%), Positives = 57/125 (45%), Gaps = 23/125 (18%)
Query: 263 NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322
+ I + A+ +V+L S F+ R+ R N L+ +++ KI DFGM+R
Sbjct: 120 TLSQLLQIAVQIASG--MVYLASQHFV-----HRDLATR--NCLVGYDLVVKIGDFGMSR 170
Query: 323 IFGGNQSEANTN---RVVGT----YGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKS 375
+ T RV G +M PE M F+ +SDV+SFGVVL EI + K
Sbjct: 171 -------DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
Query: 376 SGFYH 380
+
Sbjct: 224 PWYGL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 40/143 (27%), Positives = 67/143 (46%), Gaps = 19/143 (13%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
A NVL+ KISDFG++R S ++ +MA E + I++ +SDV+S
Sbjct: 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWS 214
Query: 362 FGVVLLEIIS--GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLK 419
FGV+L EI++ G G P L + L G+ E + +C +
Sbjct: 215 FGVLLWEIVTLGGNPYPGI-----APERL---FNLLKTGYRMERPE-----NCSEE---- 257
Query: 420 YIHIGLLCVQEDPMDRPTMSSVA 442
++ L C +++P RPT + ++
Sbjct: 258 MYNLMLTCWKQEPDKRPTFADIS 280
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 25/76 (32%), Positives = 42/76 (55%), Gaps = 3/76 (3%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKS 357
+ ++ NVLLD + N ++SD G+A ++ + GT GYMAPE E +S
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 358 DVFSFGVVLLEIISGK 373
D F+ G + E+++G+
Sbjct: 176 DWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 24/153 (15%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG-----YMAPEYAMEGIFSVK 356
A N+LL H KI DFG+AR ++N VV +MAPE +++ +
Sbjct: 242 ARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 296
Query: 357 SDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAE 416
SDV+S+G++L EI S S G + + +K+ EG+ M S C +E
Sbjct: 297 SDVWSYGILLWEIFSLGSSP-----YPGMPVDSKFYKMIKEGYR---MLS---PECAPSE 345
Query: 417 LLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449
+ + C DP+ RPT + ++ +
Sbjct: 346 MYDIMKS---CWDADPLKRPTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 27/76 (35%), Positives = 45/76 (59%), Gaps = 5/76 (6%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI-FSVK 356
+ ++ +N+LLD + +ISD G+A F + A+ VGT+GYMAPE +G +
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGTAYDSS 176
Query: 357 SDVFSFGVVLLEIISG 372
+D FS G +L +++ G
Sbjct: 177 ADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 23/156 (14%)
Query: 287 SFLWCI-IRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345
++LW + I R+ V+ SN+L++ K+ DFG++ S A T VGT YMAP
Sbjct: 109 TYLWSLKILHRD--VKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKT--YVGTNAYMAP 162
Query: 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMD 405
E + + SDV+S G+ +E+ G+ F + + I K +L+
Sbjct: 163 ERISGEQYGIHSDVWSLGISFMELALGR----FPYPQ--------IQKNQGSLMPLQLLQ 210
Query: 406 SVVKQSC----DQAELLKYIHIGLLCVQEDPMDRPT 437
+V + K++H C+++ P +RP
Sbjct: 211 CIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 7/93 (7%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTY--GYMAPEYAMEGIFSVKSDV 359
A NVLL ++ KISDFG+++ G + S R G + + APE FS +SDV
Sbjct: 123 ARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECINFRKFSSRSDV 181
Query: 360 FSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYI 391
+S+G+ + E S G+K Y GP ++++I
Sbjct: 182 WSYGITMWEAFSYGQKP---YKKMKGPEVMSFI 211
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 25/70 (35%), Positives = 40/70 (57%), Gaps = 5/70 (7%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
A N+L+ + K+SDFG+AR+ + +++ + APE FS KSDV+S
Sbjct: 128 ARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKFSSKSDVWS 182
Query: 362 FGVVLLEIIS 371
+GV+L E+ S
Sbjct: 183 YGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 47/198 (23%)
Query: 260 TAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319
TA +S++ + A + + +L F+ ++ + A N+L+ KI+DFG
Sbjct: 105 TASTLSSQQLLHFAADVARGMDYLSQKQFI-------HRDLAARNILVGENYVAKIADFG 157
Query: 320 MARIFGGNQSEANTNRVVGTYG--YMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSG 377
++R E + +G +MA E +++ SDV+S+GV+L EI+S
Sbjct: 158 LSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------ 206
Query: 378 FYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK-------QSCDQA--ELLKYIHIGLLCV 428
L P +C AEL + + + +CD +L++ C
Sbjct: 207 ---LGGTP---------YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQ------CW 248
Query: 429 QEDPMDRPTMSSVAVMLA 446
+E P +RP+ + + V L
Sbjct: 249 REKPYERPSFAQILVSLN 266
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 36/140 (25%), Positives = 65/140 (46%), Gaps = 13/140 (9%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE--YAMEGIFSVKS 357
++A N+L+D + KISDFG+++ + G+ +MAPE ++ +S K
Sbjct: 134 LKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKV 193
Query: 358 DVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAEL 417
D++S G V+LE+ +G++ E +A ++KL + A + V A
Sbjct: 194 DIWSLGCVVLEMFAGRRPWS--DEE----AIAAMFKLGNKRSAPPIPPDVSMNLSPVA-- 245
Query: 418 LKYIHIGLLCVQEDPMDRPT 437
+ C +P +RPT
Sbjct: 246 ---LDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 40/145 (27%), Positives = 64/145 (44%), Gaps = 18/145 (12%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANT--NRVVGTYGYMAPEYAMEGIFSVK- 356
++ +N+ LDH K+ DFG A N + + GT YMAPE G
Sbjct: 125 IKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHG 184
Query: 357 --SDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQ 414
+D++S G V+LE+ +GK+ E ++ + GH + DS ++ S +
Sbjct: 185 RAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHV-GAGHKPPIPDS-LQLSPEG 237
Query: 415 AELLKYIHIGLLCVQEDPMDRPTMS 439
+ L C++ DP RPT S
Sbjct: 238 KDFLD------RCLESDPKKRPTAS 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 26/77 (33%), Positives = 46/77 (59%), Gaps = 4/77 (5%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
++ V+ SN+L++ K+ DFG++ G ++ N VGT YM+PE +SV+
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 357 SDVFSFGVVLLEIISGK 373
SD++S G+ L+E+ G+
Sbjct: 183 SDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 45/144 (31%), Positives = 66/144 (45%), Gaps = 14/144 (9%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
A N+LL KI DFG+AR + +MAPE + +++ +SDV+S
Sbjct: 202 ARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWS 261
Query: 362 FGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421
FGV+L EI S L P I + +C+ L D ++ + A Y
Sbjct: 262 FGVLLWEIFS---------LGASPYPGVQINEEFCQ----RLKDGTRMRAPENATPEIY- 307
Query: 422 HIGLLCVQEDPMDRPTMSSVAVML 445
I L C Q DP +RPT S++ +L
Sbjct: 308 RIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 23/87 (26%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE------------- 346
++ SN+L++ N KI+DFG++RI Q+ N VGT YM+PE
Sbjct: 194 IKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDG 251
Query: 347 YAMEGIFSVKSDVFSFGVVLLEIISGK 373
YA D++S GV +LE G+
Sbjct: 252 YA--------GDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 27/72 (37%), Positives = 41/72 (56%), Gaps = 6/72 (8%)
Query: 304 NVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
NVLLD + + KI+DFGM + + G E + GT Y+APE ++ D +S
Sbjct: 126 NVLLDKDGHIKIADFGMCKENMNG----EGKASTFCGTPDYIAPEILKGQKYNESVDWWS 181
Query: 362 FGVVLLEIISGK 373
FGV+L E++ G+
Sbjct: 182 FGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 46/168 (27%), Positives = 68/168 (40%), Gaps = 45/168 (26%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE--YAM-EGIFSVK 356
++A N+LL K++DFG A + S AN+ VGT +MAPE AM EG + K
Sbjct: 141 IKAGNILLTEPGTVKLADFGSASL----VSPANS--FVGTPYWMAPEVILAMDEGQYDGK 194
Query: 357 SDVFSFGVVLLEIISGKKS-------SGFYHLEHG--PSLLAYIWKLWCEGHAAELMDSV 407
DV+S G+ +E+ K S YH+ P+L + W
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSD------------- 241
Query: 408 VKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKP 455
++ C+Q+ P DRP S +L V +P
Sbjct: 242 --------YFRNFVD---SCLQKIPQDRP---SSEELLKHRFVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 27/78 (34%), Positives = 46/78 (58%), Gaps = 6/78 (7%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSV 355
+ ++ N+LLD + + KI+DFGM + + G +A T GT Y+APE + ++
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILLGQKYNT 175
Query: 356 KSDVFSFGVVLLEIISGK 373
D +SFGV+L E++ G+
Sbjct: 176 SVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 26/70 (37%), Positives = 37/70 (52%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
A N+LL KI DFG+AR + +MAPE + +++ +SDV+S
Sbjct: 201 ARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWS 260
Query: 362 FGVVLLEIIS 371
FGV+L EI S
Sbjct: 261 FGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 28/76 (36%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGT---YGYMAPEYAMEGIFSVKSD 358
A N L+ + K+SDFG+AR +Q ++ GT + PE FS KSD
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 359 VFSFGVVLLEIISGKK 374
V+SFGV++ E+ S K
Sbjct: 184 VWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 30/108 (27%), Positives = 57/108 (52%), Gaps = 3/108 (2%)
Query: 342 YMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401
Y+APE + KSD++ FG++L+E+++GK + HG S++ + + + H
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLD 902
Query: 402 ELMDSVVKQ--SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLAS 447
+D ++ S +Q E+++ +++ L C DP RP + V L S
Sbjct: 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 29/72 (40%), Positives = 42/72 (58%), Gaps = 6/72 (8%)
Query: 304 NVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
NV+LD E + KI+DFGM + IFGG T GT Y+APE + D ++
Sbjct: 131 NVMLDAEGHIKIADFGMCKENIFGG----KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWA 186
Query: 362 FGVVLLEIISGK 373
FGV+L E+++G+
Sbjct: 187 FGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 35/86 (40%), Positives = 45/86 (52%), Gaps = 11/86 (12%)
Query: 292 IIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE----Y 347
II R V+ SN+LLD N K+ DFG I G R G YMAPE
Sbjct: 129 IIHRD---VKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDPS 182
Query: 348 AMEGIFSVKSDVFSFGVVLLEIISGK 373
A +G + V+SDV+S G+ L E+ +GK
Sbjct: 183 ARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 42/153 (27%), Positives = 66/153 (43%), Gaps = 43/153 (28%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGN--QSEANTNRVVGTYGYMAPE-----YAMEGI 352
V+ SNVL++ K+ DFG++ G S A T G YMAPE +G
Sbjct: 130 VKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDA-GCKPYMAPERINPELNQKG- 183
Query: 353 FSVKSDVFSFGVVLLEIISGKK-----SSGFYHLE---HGPSLLAYIWKLWCEGHAAELM 404
+ VKSDV+S G+ ++E+ +G+ + F L+ PS +L E + E
Sbjct: 184 YDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP-----QLPAEKFSPEFQ 238
Query: 405 DSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT 437
D V K C++++ +RP
Sbjct: 239 DFVNK-----------------CLKKNYKERPN 254
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 7e-07
Identities = 25/87 (28%), Positives = 47/87 (54%), Gaps = 2/87 (2%)
Query: 294 RRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIF 353
++ ++ ++A+NVLL K++DFG+A ++ N VGT +MAPE + +
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 354 SVKSDVFSFGVVLLEIISGKKSSGFYH 380
K+D++S G+ +E+ G+ H
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 26/77 (33%), Positives = 46/77 (59%), Gaps = 4/77 (5%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
++ V+ SN+L++ K+ DFG++ G ++ N VGT YM+PE +SV+
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 357 SDVFSFGVVLLEIISGK 373
SD++S G+ L+E+ G+
Sbjct: 183 SDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 32/106 (30%), Positives = 53/106 (50%), Gaps = 8/106 (7%)
Query: 270 ITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQS 329
+ IA ++ +V+L S F+ ++ + N L+ + KI DFGM+R
Sbjct: 125 LAIASQIASGMVYLASLHFV-------HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 177
Query: 330 EANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKK 374
R + +M PE + F+ +SD++SFGVVL EI + GK+
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 25/74 (33%), Positives = 44/74 (59%), Gaps = 4/74 (5%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
V+ SN+L++ K+ DFG++ G ++ N VGT YM+PE ++V+SD+
Sbjct: 126 VKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDI 181
Query: 360 FSFGVVLLEIISGK 373
+S G+ L+E+ G+
Sbjct: 182 WSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 47/190 (24%), Positives = 81/190 (42%), Gaps = 26/190 (13%)
Query: 262 PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321
P T + I +A + + +L + F+ ++ + A N ++ H+ KI DFGM
Sbjct: 114 PPPTLQEMIQMAAEIADGMAYLNAKKFV-------HRDLAARNCMVAHDFTVKIGDFGMT 166
Query: 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHL 381
R + + +MAPE +G+F+ SD++SFGVVL EI S + Y
Sbjct: 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQG 224
Query: 382 EHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAE-LLKYIH-IGLLCVQEDPMDRPTMS 439
+L ++ MD DQ + + + + +C Q +P RPT
Sbjct: 225 LSNEQVLKFV------------MDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFL 269
Query: 440 SVAVMLASDI 449
+ +L D+
Sbjct: 270 EIVNLLKDDL 279
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 28/76 (36%), Positives = 47/76 (61%), Gaps = 2/76 (2%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSV 355
+K + NVL+ ++N KISD G+ R ++ + + N ++ +M+PE M G FS+
Sbjct: 147 HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR-WMSPEAIMYGKFSI 205
Query: 356 KSDVFSFGVVLLEIIS 371
SD++S+GVVL E+ S
Sbjct: 206 DSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 19/144 (13%)
Query: 304 NVLLDHEMNPKISDFGMAR-IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSF 362
N L+ M KI+DFG++R I+ + +A+ N + +M PE ++ +SDV+++
Sbjct: 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAY 218
Query: 363 GVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421
GVVL EI S G + +Y + H ++ Y+ +G+ SC L+
Sbjct: 219 GVVLWEIFSYGMQP--YYGMAH-EEVIYYVR----DGNVL---------SCPDNCPLELY 262
Query: 422 HIGLLCVQEDPMDRPTMSSVAVML 445
++ LC + P DRP+ +S+ +L
Sbjct: 263 NLMRLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (120), Expect = 1e-06
Identities = 27/78 (34%), Positives = 42/78 (53%), Gaps = 15/78 (19%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-------YAMEGIFSV 355
N+L++ + K++DFG+AR F G T+ VV T Y APE Y+ +V
Sbjct: 127 QNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEILLGSKHYST----AV 180
Query: 356 KSDVFSFGVVLLEIISGK 373
D++S G + E+I+GK
Sbjct: 181 --DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 27/78 (34%), Positives = 46/78 (58%), Gaps = 6/78 (7%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSV 355
+ ++ NV+LD + + KI+DFGM + +FG N++ GT Y+APE ++
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST----FCGTPDYIAPEILQGLKYTF 175
Query: 356 KSDVFSFGVVLLEIISGK 373
D +SFGV+L E++ G+
Sbjct: 176 SVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 39/139 (28%), Positives = 64/139 (46%), Gaps = 18/139 (12%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM---EGIF 353
++ ++A N+LL K++DFG A I S AN+ VGT +MAPE + EG +
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSASI----ASPANS--FVGTPYWMAPEVILAMDEGQY 201
Query: 354 SVKSDVFSFGVVLLEIISGKKS-------SGFYHL--EHGPSLLAYIWKLWCEGHAAELM 404
K DV+S G+ +E+ K S YH+ P+L + W + +
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL 261
Query: 405 DSVVKQSCDQAELLKYIHI 423
+ + ELLK++ +
Sbjct: 262 QKIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 27/86 (31%), Positives = 54/86 (62%), Gaps = 7/86 (8%)
Query: 292 IIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGN--QSEANTNR--VVGTYGYMAPEY 347
II R ++ +N+L+D++ KISDFG+++ N ++ N R + G+ +MAPE
Sbjct: 127 IIHRD---IKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183
Query: 348 AMEGIFSVKSDVFSFGVVLLEIISGK 373
+ ++ K+D++S G +++E+++GK
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 27/70 (38%), Positives = 36/70 (51%), Gaps = 5/70 (7%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
A NVL+ + K+SDFG+ + Q + APE E FS KSDV+S
Sbjct: 130 ARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSDVWS 184
Query: 362 FGVVLLEIIS 371
FG++L EI S
Sbjct: 185 FGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 24/77 (31%), Positives = 46/77 (59%), Gaps = 2/77 (2%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
++ +++ NVLL + + K++DFG QS+ +T +VGT +MAPE + K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 195
Query: 357 SDVFSFGVVLLEIISGK 373
D++S G++ +E++ G+
Sbjct: 196 VDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 23/59 (38%), Positives = 38/59 (64%), Gaps = 2/59 (3%)
Query: 314 KISDFGMAR-IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS 371
KI DFG+AR I+ + ++ +MAPE ++G F+ +SDV+SFGV++ EI++
Sbjct: 151 KIGDFGLARDIYKSDYYRKEGEGLLPVR-WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 41/142 (28%), Positives = 64/142 (45%), Gaps = 21/142 (14%)
Query: 291 CIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM- 349
+I R ++A N+LL K++DFG A S AN+ VGT +MAPE +
Sbjct: 141 NMIHRD---IKAGNILLTEPGQVKLADFGSASK----SSPANS--FVGTPYWMAPEVILA 191
Query: 350 --EGIFSVKSDVFSFGVVLLEIISGKKS-------SGFYHLEH--GPSLLAYIWKLWCEG 398
EG + K DV+S G+ +E+ K S YH+ P+L + W G
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG 251
Query: 399 HAAELMDSVVKQSCDQAELLKY 420
+ + ++ AELL++
Sbjct: 252 FVDYCLQKIPQERPASAELLRH 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 39/149 (26%), Positives = 62/149 (41%), Gaps = 29/149 (19%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
++ +NV + K+ D G+ R F + A++ +VGT YM+PE E ++ KSD+
Sbjct: 132 IKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDI 189
Query: 360 FSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK-QSCDQAELL 418
+S G +L E+ + + S FY G L K + CD L
Sbjct: 190 WSLGCLLYEMAALQ--SPFY------------------GDKMNLYSLCKKIEKCDYPPLP 229
Query: 419 KYI------HIGLLCVQEDPMDRPTMSSV 441
+ C+ DP RP +S V
Sbjct: 230 ADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 25/73 (34%), Positives = 39/73 (53%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
++ + A N ++ + KI DFGM R + + +M+PE +G+F+
Sbjct: 142 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY 201
Query: 357 SDVFSFGVVLLEI 369
SDV+SFGVVL EI
Sbjct: 202 SDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 26/70 (37%), Positives = 38/70 (54%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
A N+LL KI DFG+AR + +MAPE + +++++SDV+S
Sbjct: 207 ARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 266
Query: 362 FGVVLLEIIS 371
FGV+L EI S
Sbjct: 267 FGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 25/70 (35%), Positives = 38/70 (54%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
A NVLL KI DFG+AR + + + +MAPE + +++ SDV+S
Sbjct: 265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWS 324
Query: 362 FGVVLLEIIS 371
+G++L EI S
Sbjct: 325 YGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 29/79 (36%), Positives = 46/79 (58%), Gaps = 9/79 (11%)
Query: 300 VRASNVLLDHEMNPKISDFGMA-RIFGGNQSEANTNRVVGTYGYMAPEY----AMEGIFS 354
V+ SN+LLD N K+ DFG++ R+ S+A T R G YMAPE +
Sbjct: 141 VKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYMAPERIDPPDPNPKYD 196
Query: 355 VKSDVFSFGVVLLEIISGK 373
+++DV+S G+ L+E+ +G+
Sbjct: 197 IRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 40/146 (27%), Positives = 72/146 (49%), Gaps = 19/146 (13%)
Query: 297 NKRVRASNVLLDHE-MNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSV 355
++ +++ N+ L M K+ DFG+AR + A T VGT Y++PE ++
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYLSPEICQNRPYNN 181
Query: 356 KSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 415
K+D++S G VL E+ + K H G +L + K+ C+G+ A + + S D
Sbjct: 182 KTDIWSLGCVLYELCTLK------HPFEGNNLHQLVLKI-CQGYFAPISPNF---SRDLR 231
Query: 416 ELLKYIHIGLLCVQEDPMDRPTMSSV 441
L+ + + P DRP+++S+
Sbjct: 232 SLISQL------FKVSPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 42/144 (29%), Positives = 67/144 (46%), Gaps = 24/144 (16%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM---EGIF 353
++ V+A N+LL K+ DFG A I A N VGT +MAPE + EG +
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEGQY 191
Query: 354 SVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCD 413
K DV+S G+ +E+ ++ +++ +L H A+ +S QS
Sbjct: 192 DGKVDVWSLGITCIEL--AERKPPLFNMNAMSALY----------HIAQ-NESPALQSGH 238
Query: 414 QAELLKYIHIGLLCVQEDPMDRPT 437
+E + + C+Q+ P DRPT
Sbjct: 239 WSEYFR--NFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 5e-06
Identities = 23/70 (32%), Positives = 36/70 (51%), Gaps = 3/70 (4%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363
N+LLD K+ DFG A+ Q T GT Y+APE + + D +S G
Sbjct: 123 NLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLG 179
Query: 364 VVLLEIISGK 373
++L E+++G+
Sbjct: 180 ILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 24/151 (15%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI----FSVKS 357
A NVLL + KISDFG+++ G ++ N + + YA E + FS KS
Sbjct: 123 ARNVLLVTQHYAKISDFGLSKALG---ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKS 179
Query: 358 DVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAE 416
DV+SFGV++ E S G+K Y G + I E M+ + + +
Sbjct: 180 DVWSFGVLMWEAFSYGQKP---YKGMKGNEVTQMIES-------GERMECPQRCPPEMYD 229
Query: 417 LLKYIHIGLLCVQEDPMDRPTMSSVAVMLAS 447
L+K LC +RP + V + L +
Sbjct: 230 LMK------LCWTYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 7e-06
Identities = 29/86 (33%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 294 RRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIF 353
R ++ + A NVL+ + KI+DFG+AR+ G++ E N + +MA E F
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 354 SVKSDVFSFGVVLLEIIS--GKKSSG 377
+ +SDV+S+GV + E+++ GK G
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 7e-06
Identities = 25/75 (33%), Positives = 37/75 (49%), Gaps = 6/75 (8%)
Query: 304 NVLLDHEMNPKISDFG------MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKS 357
N+L+D + K++DFG + R N E R+VGT Y+APE + S
Sbjct: 123 NILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTV 182
Query: 358 DVFSFGVVLLEIISG 372
D +S G +L E + G
Sbjct: 183 DWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 32/118 (27%), Positives = 58/118 (49%), Gaps = 12/118 (10%)
Query: 272 IAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR-IFGGNQSE 330
IA ++ +V+L S F+ ++ + N L+ + KI DFGM+R ++ +
Sbjct: 128 IASQIASGMVYLASQHFV-------HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 180
Query: 331 ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLL 388
+ ++ +M PE M F+ +SDV+SFGV+L EI + K F + + +
Sbjct: 181 VGGHTMLPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF---QLSNTEV 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 8e-06
Identities = 23/77 (29%), Positives = 46/77 (59%), Gaps = 2/77 (2%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
++ +++ N+LL + + K++DFG QS+ +T +VGT +MAPE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 195
Query: 357 SDVFSFGVVLLEIISGK 373
D++S G++ +E++ G+
Sbjct: 196 VDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 44/154 (28%), Positives = 69/154 (44%), Gaps = 30/154 (19%)
Query: 292 IIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGN--QSEANTNRVVGTYGYMAPEY-- 347
II R V+ +NVL++ K+ DFG++ GN S A TN +G YMAPE
Sbjct: 124 IIHRD---VKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTN--IGCQSYMAPERIK 174
Query: 348 ----AMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAEL 403
++V+SDV+S G+ +LE+ G+ Y E ++ A + + +G L
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYP---YPPETYANIFAQLSAI-VDGDPPTL 230
Query: 404 MDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT 437
S D + + C+ + P RPT
Sbjct: 231 PSGY---SDDAQDFVA------KCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 24/76 (31%), Positives = 43/76 (56%), Gaps = 2/76 (2%)
Query: 294 RRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIF 353
R ++ ++ +NV + K+ D G+ R F + A++ +VGT YM+PE E +
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGY 183
Query: 354 SVKSDVFSFGVVLLEI 369
+ KSD++S G +L E+
Sbjct: 184 NFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 10/114 (8%)
Query: 264 KTSKRWITIAEAASAIIVFLLSTSFL---WCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320
+T K+ +E ++ L + L W I+ R K SN+LL++ KI DFG+
Sbjct: 97 ETMKQPFLQSEVKCLMLQLLSGVAHLHDNW-ILHRDLK---TSNLLLNNRGILKICDFGL 152
Query: 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAM-EGIFSVKSDVFSFGVVLLEIISGK 373
AR +G T VV T Y APE + +S D++S G + E+++ K
Sbjct: 153 AREYGSPLKPY-TQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 6/83 (7%)
Query: 292 IIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEG 351
II R ++ N+LLD E + ++DFG+++ F + E GT YMAPE G
Sbjct: 126 IIYRD---IKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGG 181
Query: 352 I--FSVKSDVFSFGVVLLEIISG 372
D +S GV+ E+++G
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 23/77 (29%), Positives = 46/77 (59%), Gaps = 2/77 (2%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
++ +++ N+LL + + K++DFG QS+ +T +VGT +MAPE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 195
Query: 357 SDVFSFGVVLLEIISGK 373
D++S G++ +E++ G+
Sbjct: 196 VDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 26/75 (34%), Positives = 46/75 (61%), Gaps = 2/75 (2%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM-EGIFSVKSD 358
++ SN+LL+++ K++DFG+AR++ +S TN+V+ T Y PE + E + D
Sbjct: 142 IKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAID 200
Query: 359 VFSFGVVLLEIISGK 373
V+S G +L E+ + K
Sbjct: 201 VWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 30/87 (34%), Positives = 44/87 (50%), Gaps = 10/87 (11%)
Query: 291 CIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGT---YGYMAPEY 347
+I R + A N L+ K+SDFGM R +Q ++T GT + +PE
Sbjct: 120 NVIHRD---LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEV 172
Query: 348 AMEGIFSVKSDVFSFGVVLLEIISGKK 374
+S KSDV+SFGV++ E+ S K
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 37/159 (23%)
Query: 294 RRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIF 353
R ++ ++ +NV + K+ D G+ R F + A++ +VGT YM+PE E +
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGY 183
Query: 354 SVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK--QS 411
+ KSD++S G +L E+ + + S FY G + Y S+ K +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQ--SPFY----GDKMNLY---------------SLCKKIEQ 222
Query: 412 CD---------QAELLKYIHIGLLCVQEDPMDRPTMSSV 441
CD EL + ++ +C+ DP RP ++ V
Sbjct: 223 CDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 29/71 (40%), Positives = 44/71 (61%), Gaps = 2/71 (2%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
A NVL+ + KI+DFG+AR I + + TN + +MAPE + I++ +SDV+
Sbjct: 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVW 226
Query: 361 SFGVVLLEIIS 371
SFGV+L EI +
Sbjct: 227 SFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 24/69 (34%), Positives = 39/69 (56%), Gaps = 2/69 (2%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363
N+LLD E + K++DFG+++ E GT YMAPE + +D +SFG
Sbjct: 128 NILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFG 185
Query: 364 VVLLEIISG 372
V++ E+++G
Sbjct: 186 VLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 25/72 (34%), Positives = 35/72 (48%), Gaps = 3/72 (4%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQS--EANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
A N+LL + KI DFG+ R N+ + V + + APE FS SDV
Sbjct: 125 ARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRTRTFSHASDV 183
Query: 360 FSFGVVLLEIIS 371
+ FGV L E+ +
Sbjct: 184 WMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 16/115 (13%)
Query: 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIF 324
T + + IA+ +A +V+L S F+ ++ + N L+ + KI DFGM+R
Sbjct: 118 TQSQMLHIAQQIAAGMVYLASQHFV-------HRDLATRNCLVGENLLVKIGDFGMSR-- 168
Query: 325 GGNQSEANTNRVVG----TYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKK 374
+ + RV G +M PE M F+ +SDV+S GVVL EI + GK+
Sbjct: 169 --DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.3 bits (109), Expect = 2e-05
Identities = 23/77 (29%), Positives = 45/77 (58%), Gaps = 2/77 (2%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
++ +++ N+LL + + K++DFG QS+ + +VGT +MAPE + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 357 SDVFSFGVVLLEIISGK 373
D++S G++ +E+I G+
Sbjct: 197 VDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 26/76 (34%), Positives = 43/76 (56%), Gaps = 5/76 (6%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE--YAMEGIFSVKS 357
++ N+L++ E K++DFG+AR FG T+ VV T Y APE +G +S
Sbjct: 124 LKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVV-TRWYRAPELLLGDKG-YSTPV 180
Query: 358 DVFSFGVVLLEIISGK 373
D++S G + E++S +
Sbjct: 181 DIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 26/93 (27%), Positives = 51/93 (54%), Gaps = 11/93 (11%)
Query: 290 WCI-----------IRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVG 338
WC+ +R ++ + A NVL+ + KI+DFG+AR+ +++E + +
Sbjct: 114 WCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 173
Query: 339 TYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS 371
+MA E + F+ +SDV+S+GV + E+++
Sbjct: 174 PIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 39/141 (27%), Positives = 67/141 (47%), Gaps = 18/141 (12%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
A N L+ K++DFG++R+ G+ A+ + APE FS+KSDV++
Sbjct: 132 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWA 190
Query: 362 FGVVLLEIISGKKSSGFYHLEHGPSL-LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKY 420
FGV+L EI + Y + P + L+ +++L +G+ E + C K
Sbjct: 191 FGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKGYRMER-----PEGCPP----KV 234
Query: 421 IHIGLLCVQEDPMDRPTMSSV 441
+ C Q +P DRP+ + +
Sbjct: 235 YELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 25/76 (32%), Positives = 42/76 (55%), Gaps = 11/76 (14%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG------YMAPEYAMEGIFSV 355
A N+L++ + K+SDFG++R+ + A T R G + APE F+
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTAPEAIAYRKFTS 188
Query: 356 KSDVFSFGVVLLEIIS 371
SDV+S+G+V+ E++S
Sbjct: 189 ASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 25/72 (34%), Positives = 40/72 (55%), Gaps = 6/72 (8%)
Query: 304 NVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
N+LLD E + K++DFGM + I G T GT Y+APE E + D ++
Sbjct: 126 NILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPDYIAPEILQELEYGPSVDWWA 181
Query: 362 FGVVLLEIISGK 373
GV++ E+++G+
Sbjct: 182 LGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 26/78 (33%), Positives = 44/78 (56%), Gaps = 6/78 (7%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSV 355
+ ++ NV+LD E + KI+DFGM + ++ G T GT Y+APE +
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFCGTPDYIAPEIIAYQPYGK 180
Query: 356 KSDVFSFGVVLLEIISGK 373
D ++FGV+L E+++G+
Sbjct: 181 SVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 23/70 (32%), Positives = 43/70 (61%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
A NVL+ + KI+DFG+A++ G ++ E + +MA E + I++ +SDV+S
Sbjct: 137 ARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 196
Query: 362 FGVVLLEIIS 371
+GV + E+++
Sbjct: 197 YGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 23/79 (29%), Positives = 38/79 (48%), Gaps = 7/79 (8%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-----YAMEGIFS 354
++ N+LL K+ DFG++ NT +GT +MAPE + +
Sbjct: 139 IKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--FIGTPYWMAPEVIACDEQPDASYD 196
Query: 355 VKSDVFSFGVVLLEIISGK 373
+SDV+S G+ +E+ GK
Sbjct: 197 ARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 24/68 (35%), Positives = 35/68 (51%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363
N L+ + KI+DFGM+R R V +MA E + G F+ SDV++FG
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218
Query: 364 VVLLEIIS 371
V L E+ +
Sbjct: 219 VTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 25/76 (32%), Positives = 41/76 (53%), Gaps = 3/76 (3%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKS 357
+ ++ N+LLD + +ISD G+A Q+ VGT GYMAPE ++
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEVVKNERYTFSP 182
Query: 358 DVFSFGVVLLEIISGK 373
D ++ G +L E+I+G+
Sbjct: 183 DWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 26/69 (37%), Positives = 39/69 (56%), Gaps = 2/69 (2%)
Query: 304 NVLLDHEMNPKISDFGMAR-IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSF 362
N L+ + KI+DFGM+R ++ G+ R V +MA E + G F+ SDV++F
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQ-GRAVLPIRWMAWECILMGKFTTASDVWAF 226
Query: 363 GVVLLEIIS 371
GV L EI+
Sbjct: 227 GVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 29/75 (38%), Positives = 42/75 (56%), Gaps = 9/75 (12%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGNQ----SEANTNRVVGTYGYMAPEYAMEGIFSVK 356
A NVLLD++ KI DFG+A+ + G++ E + V + A E E FS
Sbjct: 135 ARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----WYAVECLKENKFSYA 190
Query: 357 SDVFSFGVVLLEIIS 371
SDV+SFGV L E+++
Sbjct: 191 SDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 27/76 (35%), Positives = 44/76 (57%), Gaps = 8/76 (10%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGT---YGYMAPEYAMEGIFSVKSD 358
A N L+D + K+SDFG++R ++ ++ VG+ + PE + FS KSD
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 359 VFSFGVVLLEIIS-GK 373
V++FGV++ E+ S GK
Sbjct: 184 VWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 25/77 (32%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRV-VGTYGYMAPEYAMEGIFSVK 356
+ ++ NV+LD E + KI+DFGM + + + T R GT Y+APE +
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKS 181
Query: 357 SDVFSFGVVLLEIISGK 373
D +++GV+L E+++G+
Sbjct: 182 VDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 15/30 (50%), Positives = 22/30 (73%)
Query: 342 YMAPEYAMEGIFSVKSDVFSFGVVLLEIIS 371
++APE E FS KSDV+SFGV++ E+ +
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 4/86 (4%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKS 357
+ ++ N++LD + + KI+DFG+ + G A GT Y+APE + +
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 358 DVFSFGVVLLEIISGKKSSGFYHLEH 383
D + GVV+ E++ G+ FY+ +H
Sbjct: 177 DWWGLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 30/82 (36%), Positives = 44/82 (53%), Gaps = 8/82 (9%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGT----YGYMAPEYAMEGIFSVKSDV 359
N L+ KI+DFGM+R N ++ RV G +MA E + G F+ KSDV
Sbjct: 160 NCLVGKNYTIKIADFGMSR----NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215
Query: 360 FSFGVVLLEIISGKKSSGFYHL 381
++FGV L EI++ + + HL
Sbjct: 216 WAFGVTLWEILTLCREQPYEHL 237
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
++++N+LL KI D G++++ N A T +GT YMAPE +S KSD+
Sbjct: 129 LKSANILLVANDLVKIGDLGISKVLKKNM--AKT--QIGTPHYMAPEVWKGRPYSYKSDI 184
Query: 360 FSFGVVLLEIISGK 373
+S G +L E+ +
Sbjct: 185 WSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 25/75 (33%), Positives = 41/75 (54%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
++ + A NVL+ KI+DFG+AR T +MAPE + +++ +
Sbjct: 160 HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 219
Query: 357 SDVFSFGVVLLEIIS 371
SDV+SFGV++ EI +
Sbjct: 220 SDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 12/85 (14%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIF---------GGNQSEAN-TNRVVGTYGYMAPEYAM 349
++A+N+L+D++ KI+DFG+AR + GG TN VV T Y PE +
Sbjct: 141 IKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV-TRWYRPPELLL 199
Query: 350 -EGIFSVKSDVFSFGVVLLEIISGK 373
E ++ D++ G V E+ + +
Sbjct: 200 GERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 26/75 (34%), Positives = 42/75 (56%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
++ + A NVL+ + KI+DFG+AR T +MAPE + +++ +
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 216
Query: 357 SDVFSFGVVLLEIIS 371
SDV+SFGV+L EI +
Sbjct: 217 SDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 21/78 (26%), Positives = 47/78 (60%), Gaps = 4/78 (5%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGM-ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSV 355
++ +++ ++LL H+ K+SDFG A++ ++ +VGT +MAPE +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPELISRLPYGP 195
Query: 356 KSDVFSFGVVLLEIISGK 373
+ D++S G++++E++ G+
Sbjct: 196 EVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 24/70 (34%), Positives = 40/70 (57%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
A NVL+ + KI+DFG+AR T+ +MAPE + +++ +SDV+S
Sbjct: 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWS 221
Query: 362 FGVVLLEIIS 371
FG+++ EI +
Sbjct: 222 FGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 24/75 (32%), Positives = 44/75 (58%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
++++N+LL K+ DFG ++++ S+ GT Y+APE +S K+D+
Sbjct: 169 IKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADM 228
Query: 360 FSFGVVLLEIISGKK 374
FS GV+L E+++ K+
Sbjct: 229 FSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 25/80 (31%), Positives = 42/80 (52%), Gaps = 2/80 (2%)
Query: 294 RRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIF 353
R ++ +++ N+ L K+ DFG AR+ + A T VGT Y+ PE +
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPY 177
Query: 354 SVKSDVFSFGVVLLEIISGK 373
+ KSD++S G +L E+ + K
Sbjct: 178 NNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 22/76 (28%), Positives = 43/76 (56%), Gaps = 6/76 (7%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR--VVGTYGYMAPEYAMEGIFSVKS 357
+++ ++LL + K+SDFG F S+ R +VGT +MAPE + +
Sbjct: 141 IKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEV 196
Query: 358 DVFSFGVVLLEIISGK 373
D++S G++++E++ G+
Sbjct: 197 DIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 24/74 (32%), Positives = 38/74 (51%), Gaps = 3/74 (4%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
++ N+LLD + +ISD G+A ++ VGT GYMAPE ++ D
Sbjct: 128 LKPENILLDDYGHIRISDLGLAVEIPEGETIRGR---VGTVGYMAPEVVKNERYTFSPDW 184
Query: 360 FSFGVVLLEIISGK 373
+ G ++ E+I GK
Sbjct: 185 WGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 23/76 (30%), Positives = 43/76 (56%), Gaps = 2/76 (2%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKS 357
+ ++ NVLLD E + K++D+GM + G + T+ GT Y+APE +
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 358 DVFSFGVVLLEIISGK 373
D ++ GV++ E+++G+
Sbjct: 178 DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 2/74 (2%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
+++ N+ L + K+ DFG+AR+ A T +GT Y++PE ++ KSD+
Sbjct: 127 IKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEICENRPYNNKSDI 184
Query: 360 FSFGVVLLEIISGK 373
++ G VL E+ + K
Sbjct: 185 WALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 25/77 (32%), Positives = 41/77 (53%), Gaps = 5/77 (6%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMA-RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
+ ++ N+LLD + +ISD G+A +I G VGT GYMAPE +++
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLNNQRYTLS 181
Query: 357 SDVFSFGVVLLEIISGK 373
D + G ++ E+I G+
Sbjct: 182 PDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 41/118 (34%), Positives = 53/118 (44%), Gaps = 23/118 (19%)
Query: 262 PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIR---RRNKRVRASNVLLDHEMNPKISDF 318
P K I + E A+A + +L S CI R RN V NVL KISDF
Sbjct: 89 PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVL-------KISDF 138
Query: 319 GMARIFGGNQSEANTNRVVG-----TYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS 371
GM+R + E G + APE G +S +SDV+SFG++L E S
Sbjct: 139 GMSR-----EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 25/93 (26%), Positives = 48/93 (51%), Gaps = 1/93 (1%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
++ + A N+LL + +I+DFG+A + + + + +MA E + G ++ +
Sbjct: 132 HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQ 191
Query: 357 SDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLL 388
SDV+S+GV + E++S G + P LL
Sbjct: 192 SDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 40/156 (25%), Positives = 67/156 (42%), Gaps = 39/156 (25%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGN---QSEANTNRVVGTYGYMAPEYAMEGIFSVKS 357
A N +L +M ++DFG+++ I+ G+ Q V ++A E + +++ KS
Sbjct: 141 ARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV----KWIAIESLADRVYTSKS 196
Query: 358 DVFSFGVVLLEIIS-------GKKSSGFY-HLEHGPSLLAYIWKLWCEGHAAELMDSVVK 409
DV++FGV + EI + G ++ Y +L HG L E EL D +
Sbjct: 197 DVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ------PEDCLDELYDLMYS 250
Query: 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
C + DP DRPT + + +L
Sbjct: 251 -----------------CWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 25/86 (29%), Positives = 46/86 (53%), Gaps = 4/86 (4%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKS 357
+ ++ N++LD + + KI+DFG+ + G + A GT Y+APE + +
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAV 177
Query: 358 DVFSFGVVLLEIISGKKSSGFYHLEH 383
D + GVV+ E++ G+ FY+ +H
Sbjct: 178 DWWGLGVVMYEMMCGRLP--FYNQDH 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 23/73 (31%), Positives = 41/73 (56%), Gaps = 3/73 (4%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVG---TYGYMAPEYAMEGIFSVKSD 358
A N+L++ + K+SDFG++R + S+ +G + APE F+ SD
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASD 193
Query: 359 VFSFGVVLLEIIS 371
V+S+G+V+ E++S
Sbjct: 194 VWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 45/195 (23%), Positives = 79/195 (40%), Gaps = 43/195 (22%)
Query: 260 TAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319
TA +S++ + A + + +L F+ ++ + A N+L+ KI+DFG
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQKQFI-------HRDLAARNILVGENYVAKIADFG 169
Query: 320 MARIFGGNQSEANTNRVVGTYG--YMAPEYAMEGIFSVKSDVFSFGVVLLEIIS------ 371
++R E + +G +MA E +++ SDV+S+GV+L EI+S
Sbjct: 170 LSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224
Query: 372 -GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQE 430
G + Y E P L C+ +LM C +E
Sbjct: 225 CGMTCAELY--EKLPQGYRLEKPLNCDDEVYDLMRQ--------------------CWRE 262
Query: 431 DPMDRPTMSSVAVML 445
P +RP+ + + V L
Sbjct: 263 KPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 30/98 (30%), Positives = 52/98 (53%), Gaps = 13/98 (13%)
Query: 287 SFLWCIIR-------RR--NKRVRASNVLLDHEMNP-KISDFGMARIFGGNQSEANTNRV 336
++L+ I+R R ++ ++ N+L+D N K++DFG+AR F G T+ V
Sbjct: 106 TYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEV 164
Query: 337 VGTYGYMAPEYAMEG-IFSVKSDVFSFGVVLLEIISGK 373
V T Y APE + +S D++S G + E+++ K
Sbjct: 165 V-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 25/74 (33%), Positives = 42/74 (56%), Gaps = 8/74 (10%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK-SD 358
++ N+L+D + K++DFG++R N+ + VGT Y+APE + G+ K SD
Sbjct: 123 IKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPE-TILGVGDDKMSD 175
Query: 359 VFSFGVVLLEIISG 372
+S G V+ E + G
Sbjct: 176 WWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 28/82 (34%), Positives = 39/82 (47%), Gaps = 18/82 (21%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRV----VGTYGYMAPE-------YAMEG 351
SN+LL+ + K++DFG+AR E N V V T Y APE Y
Sbjct: 136 SNILLNSDCRVKLADFGLARSL-SELEENPENPVLTDYVATRWYRAPEILLGSTRYT--- 191
Query: 352 IFSVKSDVFSFGVVLLEIISGK 373
V D++S G +L E++ GK
Sbjct: 192 -KGV--DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 38/110 (34%), Positives = 57/110 (51%), Gaps = 16/110 (14%)
Query: 266 SKRWITIAEAASAIIVFLLSTSFLWCIIR---RRNKRVRASNVLLDHEMNPKISDFGMAR 322
+K+ + A A+A + +L S + CI R RN V +NVL KISDFGM+R
Sbjct: 92 TKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVL-------KISDFGMSR 141
Query: 323 IF-GGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS 371
G S + ++ + APE G +S +SDV+S+G++L E S
Sbjct: 142 QEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 4/86 (4%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKS 357
+ ++ N++LD + + KI+DFG+ + G A GT Y+APE + +
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 358 DVFSFGVVLLEIISGKKSSGFYHLEH 383
D + GVV+ E++ G+ FY+ +H
Sbjct: 177 DWWGLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 25/76 (32%), Positives = 41/76 (53%), Gaps = 11/76 (14%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG------YMAPEYAMEGIFSV 355
A N+L++ + K+SDFG++R+ E + T G + APE F+
Sbjct: 135 ARNILVNSNLECKVSDFGLSRVL-----EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 356 KSDVFSFGVVLLEIIS 371
SDV+SFG+V+ E++S
Sbjct: 190 ASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 2e-04
Identities = 24/74 (32%), Positives = 38/74 (51%), Gaps = 15/74 (20%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK-----SD 358
N+LLD + KI+DFG A+ G T + GT Y+APE I K D
Sbjct: 131 NLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPE-----IILSKGYGKAVD 180
Query: 359 VFSFGVVLLEIISG 372
++ G+++ E+++G
Sbjct: 181 WWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 27/72 (37%), Positives = 39/72 (54%), Gaps = 2/72 (2%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGN-QSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
A N +LD K++DFG+AR I+ S N +MA E F+ KSDV
Sbjct: 126 ARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDV 185
Query: 360 FSFGVVLLEIIS 371
+SFGV+L E+++
Sbjct: 186 WSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 26/77 (33%), Positives = 40/77 (51%), Gaps = 5/77 (6%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR-VVGTYGYMAPEYAMEGIFSVK 356
+ ++ N+LLD + +ISD G+A E T R VGT GYMAPE ++
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAV----QIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 357 SDVFSFGVVLLEIISGK 373
D + G ++ E+I G+
Sbjct: 182 PDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 26/76 (34%), Positives = 43/76 (56%), Gaps = 3/76 (3%)
Query: 294 RRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIF 353
R ++ ++A N+ L + + KI DFG++R+ G+ A T GT YM+PE +
Sbjct: 126 RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEALKHQGY 182
Query: 354 SVKSDVFSFGVVLLEI 369
KSD++S G +L E+
Sbjct: 183 DSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 28/87 (32%), Positives = 47/87 (54%), Gaps = 7/87 (8%)
Query: 291 CIIRRRNKRVRASNVLLDHEMNPKISDFGMAR---IFGGNQSEANTNRVV-GTYGYMAPE 346
C++ R ++ +NV+L K+ DFG AR G + + +N + + GT +MAPE
Sbjct: 122 CVVHRD---IKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 347 YAMEGIFSVKSDVFSFGVVLLEIISGK 373
E + KSD++S G + E+ +GK
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 17/127 (13%)
Query: 245 YELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASN 304
+ LY L D P P + +++T + AS + +L S SF+ ++ + A N
Sbjct: 96 FLLYSRLGDCP---QYLPTQMLVKFMT--DIASGM-EYLSSKSFI-------HRDLAARN 142
Query: 305 VLLDHEMNPKISDFGMAR-IFGGNQSEANTNRVVGT-YGYMAPEYAMEGIFSVKSDVFSF 362
+L+ MN ++DFG+++ I+ G+ R+ ++A E + +++ KSDV+SF
Sbjct: 143 CMLNENMNVCVADFGLSKKIYNGDYYR--QGRIAKMPVKWIAIESLADRVYTTKSDVWSF 200
Query: 363 GVVLLEI 369
GV + EI
Sbjct: 201 GVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 26/72 (36%), Positives = 43/72 (59%), Gaps = 6/72 (8%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY--AMEGIFSVKSDVFS 361
NVLLD E + K++D+GM + G + T+ GT Y+APE + FSV D ++
Sbjct: 126 NVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV--DWWA 181
Query: 362 FGVVLLEIISGK 373
GV++ E+++G+
Sbjct: 182 LGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 24/72 (33%), Positives = 39/72 (54%), Gaps = 3/72 (4%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQS--EANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
A NVL++ E KI DFG+ + ++ + + Y APE ++ F + SDV
Sbjct: 137 ARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDV 195
Query: 360 FSFGVVLLEIIS 371
+SFGV L E+++
Sbjct: 196 WSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 22/80 (27%), Positives = 43/80 (53%), Gaps = 14/80 (17%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-------YAMEGI 352
++ +N+L+ + KI+DFG+AR+F + +++ V T Y APE Y G+
Sbjct: 125 LKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPELLYGARKYD-PGV 182
Query: 353 FSVKSDVFSFGVVLLEIISG 372
D+++ G + E+++G
Sbjct: 183 -----DLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 26/75 (34%), Positives = 41/75 (54%), Gaps = 6/75 (8%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME-GIFSVKSD 358
++ SN+L++ + KI DFG+ARI Q T V Y Y APE + + V+ D
Sbjct: 134 LKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRY-YRAPEIMLTWQKYDVEVD 188
Query: 359 VFSFGVVLLEIISGK 373
++S G + E++ GK
Sbjct: 189 IWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 25/71 (35%), Positives = 40/71 (56%), Gaps = 3/71 (4%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEG-IFSVKSDVFSF 362
N+L+D E K++DFG+AR F G T+ VV T Y APE + +S D++S
Sbjct: 129 NLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGSRQYSTPVDIWSI 186
Query: 363 GVVLLEIISGK 373
G + E+++ +
Sbjct: 187 GCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 38/129 (29%), Positives = 58/129 (44%), Gaps = 20/129 (15%)
Query: 314 KISDFGMA-RIFGGNQSEANTNRVVGTYGYMAPEYAMEGI--FSVKSDVFSFGVVLLEII 370
KISDFG + R+ G N T GT YMAPE +G + +D++S G ++E+
Sbjct: 149 KISDFGTSKRLAGINPC---TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMA 205
Query: 371 SGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQE 430
+GK F L A ++K+ E+ +S+ AE +I L C +
Sbjct: 206 TGKPP--FIELG---EPQAAMFKVGMFKIHPEIPESL------SAEAKNFI---LRCFEP 251
Query: 431 DPMDRPTMS 439
DP R +
Sbjct: 252 DPDKRASAH 260
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 4e-04
Identities = 24/74 (32%), Positives = 40/74 (54%), Gaps = 4/74 (5%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEAN--TNRVVGTYGYMAPEYAMEGI-FSVKSDV 359
SN+L++ + KI DFG+AR ++ E T VV T Y APE + ++ D+
Sbjct: 132 SNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAIDI 190
Query: 360 FSFGVVLLEIISGK 373
+S G + E+++ K
Sbjct: 191 WSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 24/70 (34%), Positives = 37/70 (52%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
A NVL+ KI DFG+AR + + + +MAPE +++ SDV+S
Sbjct: 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWS 326
Query: 362 FGVVLLEIIS 371
FG++L EI +
Sbjct: 327 FGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 289 LWCIIRRRNKR-VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY 347
L+C RR R ++ N+L+D++ K++DFG+AR F G T+ VV T Y APE
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEV 172
Query: 348 AMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPS 386
+ +S D++S G + E+ + K L HG S
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKP------LFHGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 8/94 (8%)
Query: 282 FLLSTSFLW--CIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGT 339
FL FL CI+ R ++ N+L+ K++DFG+ARI+ + VV T
Sbjct: 117 FLRGLDFLHANCIVHRD---LKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVT 170
Query: 340 YGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGK 373
Y APE ++ ++ D++S G + E+ K
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 22/80 (27%), Positives = 41/80 (51%), Gaps = 3/80 (3%)
Query: 294 RRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIF 353
R ++ ++ N+L+ K++DFG+ARI+ + VV T Y APE ++ +
Sbjct: 130 RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSY 186
Query: 354 SVKSDVFSFGVVLLEIISGK 373
+ D++S G + E+ K
Sbjct: 187 ATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 26/73 (35%), Positives = 42/73 (57%), Gaps = 7/73 (9%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANT--NRVVGTYGYMAPEYAMEG-IFSVKSDVF 360
N+L++ K++DFG+AR FG NT N VV T Y AP+ + +S D++
Sbjct: 130 NLLINKRGELKLADFGLARAFG---IPVNTFSNEVV-TLWYRAPDVLLGSRTYSTSIDIW 185
Query: 361 SFGVVLLEIISGK 373
S G ++ E+I+G+
Sbjct: 186 SVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 22/74 (29%), Positives = 44/74 (59%), Gaps = 4/74 (5%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEAN-TNRVVGTYGYMAPEYAMEGIFSVKSD 358
++ N+LLD++ + + DFG+ ++ N + + TN GT Y+APE + ++ D
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKL---NMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175
Query: 359 VFSFGVVLLEIISG 372
++ GV+L E+++G
Sbjct: 176 WWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 25/81 (30%), Positives = 43/81 (53%), Gaps = 12/81 (14%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKS 357
+ ++ N+LLD E + ++DFG+++ F + E T GT YMAPE I K
Sbjct: 129 RDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPE-----IIRGKG 182
Query: 358 ------DVFSFGVVLLEIISG 372
D +S G+++ E+++G
Sbjct: 183 GHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 1/75 (1%)
Query: 300 VRASNVLLDHEMNPKISDFGMA-RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSD 358
++ +N+L D N K+ DFG + R+ S V GT +M+PE + K+D
Sbjct: 130 IKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKAD 189
Query: 359 VFSFGVVLLEIISGK 373
V+S G ++E+++ K
Sbjct: 190 VWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 22/76 (28%), Positives = 42/76 (55%), Gaps = 2/76 (2%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKS 357
+ ++ NVLLD + + K++D+GM + G T+ GT Y+APE +
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177
Query: 358 DVFSFGVVLLEIISGK 373
D ++ GV++ E+++G+
Sbjct: 178 DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 30/114 (26%), Positives = 59/114 (51%), Gaps = 22/114 (19%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGN---QSEANTNRVVGTYGYMAPEYAMEGIFSVKS 357
A N +L+ M ++DFG+++ I+ G+ Q A+ V ++A E + +++ S
Sbjct: 141 ARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV----KWLALESLADNVYTTHS 196
Query: 358 DVFSFGVVLLEIIS-------GKKSSGFYH-------LEHGPSLLAYIWKLWCE 397
DV++FGV + EI++ G ++S Y+ L+ P L +++L C+
Sbjct: 197 DVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQ 250
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 28/97 (28%), Positives = 45/97 (46%), Gaps = 8/97 (8%)
Query: 281 VFLLSTSFLWC----IIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRV 336
++ L + WC I+ R ++ N+L+ H K+ DFG AR S AN
Sbjct: 106 IYQLIKAIHWCHKNDIVHRD---IKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEY 161
Query: 337 VGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGK 373
V T Y +PE + + D++S G +L E+ G+
Sbjct: 162 VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 37/141 (26%), Positives = 62/141 (43%), Gaps = 17/141 (12%)
Query: 300 VRASNVLLDHE-MNPKISDFGMARIFGGNQSEAN--TNRVVGTYGYMAPEYAMEGIFSVK 356
V+ +N+L+D +I+DFG A + A +++GT +MAPE +
Sbjct: 129 VKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRS 188
Query: 357 SDVFSFGVVLLEIISGKKSSGFY-HLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 415
DV+S G V++E+ + K H H LA I+K+ A + + + D
Sbjct: 189 CDVWSVGCVIIEMATAKPPWNAEKHSNH----LALIFKIASATTAPSIPEHLSPGLRD-- 242
Query: 416 ELLKYIHIGLLCVQEDPMDRP 436
+ L C++ P DRP
Sbjct: 243 -------VTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 8e-04
Identities = 24/79 (30%), Positives = 36/79 (45%), Gaps = 13/79 (16%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG------YMAPEYAMEGIFSV 355
A N L+ K+SDFGM R ++ + G + PE +S
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVLDDE-------YTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 356 KSDVFSFGVVLLEIISGKK 374
KSDV+SFGV++ E+ + K
Sbjct: 181 KSDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 23/77 (29%), Positives = 41/77 (53%), Gaps = 2/77 (2%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
++ ++ NV L K+ D G+AR+ A+T ++GT YM+PE ++ K
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNYK 182
Query: 357 SDVFSFGVVLLEIISGK 373
SDV++ G + E+ + K
Sbjct: 183 SDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 2/79 (2%)
Query: 304 NVLLDHEMNPKISDFGMAR-IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSF 362
N L+ KI+DFGM+R ++ G+ R V +M+ E + G F+ SDV++F
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQ-GRAVLPIRWMSWESILLGKFTTASDVWAF 218
Query: 363 GVVLLEIISGKKSSGFYHL 381
GV L EI++ K + L
Sbjct: 219 GVTLWEILTLCKEQPYSQL 237
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 23/71 (32%), Positives = 39/71 (54%), Gaps = 2/71 (2%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI-FSVKSDVFSF 362
N+L++ KI DFG+AR+ ++S+ T VV Y Y APE M ++ D++S
Sbjct: 133 NLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILMGSRHYTSAVDIWSV 191
Query: 363 GVVLLEIISGK 373
G + E++ +
Sbjct: 192 GCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 30/100 (30%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 273 AEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEAN 332
AE ASAI +L S + ++ + ++ N+LLD + + ++DFG+ + G + E
Sbjct: 103 AEVASAI-GYLHSLNIIY-------RDLKPENILLDSQGHVVLTDFGLCK--EGVEPEET 152
Query: 333 TNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISG 372
T+ GT Y+APE + + D + G VL E++ G
Sbjct: 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 21/78 (26%), Positives = 46/78 (58%), Gaps = 4/78 (5%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGM-ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSV 355
++ +++ ++LL + K+SDFG A+I ++ +VGT +MAPE +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGT 196
Query: 356 KSDVFSFGVVLLEIISGK 373
+ D++S G++++E++ G+
Sbjct: 197 EVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 23/71 (32%), Positives = 38/71 (53%), Gaps = 6/71 (8%)
Query: 304 NVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
N+LLD + + K++DFG+ + I G T+ GT YMAPE M D +S
Sbjct: 130 NILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEYMAPEILMRSGHGKAVDWWS 185
Query: 362 FGVVLLEIISG 372
G ++ ++++G
Sbjct: 186 LGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 6/77 (7%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMAR-IFGGNQS--EANTNRVVGTYGYMAPEYAMEGIFS 354
K + A N ++D E+ KI+D ++R +F + N NR V +MA E + +S
Sbjct: 141 KDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---WMALESLVNKEYS 197
Query: 355 VKSDVFSFGVVLLEIIS 371
SDV+SFGV+L E+++
Sbjct: 198 SASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 36.1 bits (84), Expect = 0.002
Identities = 15/48 (31%), Positives = 24/48 (50%), Gaps = 3/48 (6%)
Query: 447 SDIVTLPKPTQPAFSVSRVASGQFVSHS---EDHCSVNAITLSTMSPR 491
S+ +P+P QP F V R S S ++ +VN +T+S + R
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 19/49 (38%), Positives = 30/49 (61%), Gaps = 4/49 (8%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEAN---TNRVVGTYGYMAPE 346
+A+N+L+ + K++DFG+AR F +++ TNRVV T Y PE
Sbjct: 146 KAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 14/88 (15%)
Query: 291 CIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME 350
II R K SN+LL + KI+DFG+AR + G ++ T +VV T Y APE
Sbjct: 128 FIIHRDLK---VSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWYRAPEL--- 179
Query: 351 GIFSVKS-----DVFSFGVVLLEIISGK 373
+ + D+++ G +L E+++ K
Sbjct: 180 -LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 23/78 (29%), Positives = 42/78 (53%), Gaps = 1/78 (1%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMA-RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSV 355
++ ++ +N+L D N K+ DFG + R+ S V GT +M+PE +
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGR 188
Query: 356 KSDVFSFGVVLLEIISGK 373
K+DV+S G ++E+++ K
Sbjct: 189 KADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 22/77 (28%), Positives = 42/77 (54%), Gaps = 3/77 (3%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM--EGIFSV 355
+ ++ N+LLD + ++DFG+++ F ++ E GT YMAP+ +G
Sbjct: 129 RDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDK 187
Query: 356 KSDVFSFGVVLLEIISG 372
D +S GV++ E+++G
Sbjct: 188 AVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 25/80 (31%), Positives = 42/80 (52%), Gaps = 4/80 (5%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363
N++LD + + KI+DFG+ + G A GT Y+APE + + D + G
Sbjct: 125 NLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 364 VVLLEIISGKKSSGFYHLEH 383
VV+ E++ G+ FY+ +H
Sbjct: 183 VVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 10/100 (10%)
Query: 273 AEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEAN 332
AE ASA+ +L S + II R K N+LLD + + ++DFG+ + G +
Sbjct: 103 AEIASAL-GYLHSLN----IIYRDLK---PENILLDSQGHVVLTDFGLCK--EGIEHSKT 152
Query: 333 TNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISG 372
T+ GT Y+APE + + D + G VL E++ G
Sbjct: 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 26/84 (30%), Positives = 44/84 (52%), Gaps = 12/84 (14%)
Query: 292 IIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANT-NRVVGTYGYMAPEYAME 350
+I R K A N+LL + + K++DFG++ N+S + +GT +MAPE
Sbjct: 124 VIHRDLK---AGNILLTLDGDVKLADFGVS---AKNKSTLQKRDTFIGTPYWMAPEVVAC 177
Query: 351 GIFS-----VKSDVFSFGVVLLEI 369
F K+D++S G+ L+E+
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 22/81 (27%), Positives = 41/81 (50%), Gaps = 7/81 (8%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM-----EG 351
++ ++ NVLL K+ DFG++ +++ N +GT +MAPE +
Sbjct: 134 HRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDENPDA 191
Query: 352 IFSVKSDVFSFGVVLLEIISG 372
+ KSD++S G+ +E+ G
Sbjct: 192 TYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 23/79 (29%), Positives = 45/79 (56%), Gaps = 6/79 (7%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR--VVGTYGYMAPEYAMEGIFS 354
++ +++ ++LL + K+SDFG F S+ R +VGT +MAPE +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 355 VKSDVFSFGVVLLEIISGK 373
+ D++S G++++E+I G+
Sbjct: 197 TEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 27/101 (26%), Positives = 44/101 (43%), Gaps = 15/101 (14%)
Query: 280 IVFLLSTSFLWC----IIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 335
++ L + +C II R ++ N+L+ K+ DFG AR + T+
Sbjct: 105 YIWQLLQAIAYCHSHNIIHRD---IKPENILVSESGVLKLCDFGFARALRARPASPLTDY 161
Query: 336 VVGTYGYMAPE----YAMEGIFSVKSDVFSFGVVLLEIISG 372
V T Y APE G V DV++ G ++ E++ G
Sbjct: 162 VA-TRWYRAPELLVGDTNYG-KPV--DVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 6/82 (7%)
Query: 292 IIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEG 351
II R K SN+++ + KI DFG+AR G + T VV Y Y APE +
Sbjct: 139 IIHRDLK---PSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGM 192
Query: 352 IFSVKSDVFSFGVVLLEIISGK 373
+ D++S G ++ E+I G
Sbjct: 193 GYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.002
Identities = 24/73 (32%), Positives = 41/73 (56%), Gaps = 5/73 (6%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEG--IFSVKSDVF 360
+N+L+ + K++DFG+AR F G+ + T++VV T Y APE G + V D++
Sbjct: 131 NNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVV-TRWYRAPELLF-GARHYGVGVDMW 187
Query: 361 SFGVVLLEIISGK 373
S G + E++
Sbjct: 188 SVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 22/78 (28%), Positives = 45/78 (57%), Gaps = 7/78 (8%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM-----EG 351
++ ++A NVLL + + K++DFG++ ++ + +GT +MAPE M +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 352 IFSVKSDVFSFGVVLLEI 369
+ K+D++S G+ L+E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 23/69 (33%), Positives = 37/69 (53%), Gaps = 5/69 (7%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363
N+LLD++ + K++DFG A+ + T + GT Y+APE D ++ G
Sbjct: 148 NLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMG 202
Query: 364 VVLLEIISG 372
V+L E I+G
Sbjct: 203 VLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 28/80 (35%), Positives = 43/80 (53%), Gaps = 7/80 (8%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY--AMEG----IF 353
++ NVL+D + K++DFG A N+ N+ VGT Y+APE M G +
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTY 186
Query: 354 SVKSDVFSFGVVLLEIISGK 373
V+ D +S GV+ E+I G+
Sbjct: 187 GVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 26/72 (36%), Positives = 40/72 (55%), Gaps = 9/72 (12%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE--YAMEGIFSVKSDVF 360
N L+D + K++DFG+++ G + AN+ VVG+ YMAPE F+V D +
Sbjct: 130 ENFLIDASGHIKLTDFGLSK---GIVTYANS--VVGSPDYMAPEVLRGKGYDFTV--DYW 182
Query: 361 SFGVVLLEIISG 372
S G +L E + G
Sbjct: 183 SLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 21/84 (25%), Positives = 37/84 (44%), Gaps = 6/84 (7%)
Query: 292 IIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEG 351
II R V+ N+ ++ I D G A+ + GT APE
Sbjct: 178 IIHRD---VKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLAGTVETNAPEVLARD 231
Query: 352 IFSVKSDVFSFGVVLLEIISGKKS 375
++ K+D++S G+VL E+++ +
Sbjct: 232 KYNSKADIWSAGIVLFEMLAYPST 255
|
Length = 357 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 29/103 (28%), Positives = 50/103 (48%), Gaps = 11/103 (10%)
Query: 279 IIVFLLSTSFLWCIIRRRNKR----VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 334
II ++L + + NK V+ +N+LL E K+ DFG++ + NT+
Sbjct: 125 IIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 184
Query: 335 RVVGTYGYMAPEY-----AMEGIFSVKSDVFSFGVVLLEIISG 372
VGT +MAPE ++ + + DV+S G+ +E+ G
Sbjct: 185 --VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.004
Identities = 24/96 (25%), Positives = 39/96 (40%), Gaps = 27/96 (28%)
Query: 304 NVLLDHEMNPKISDFGMA---------------------------RIFGGNQSEANTNRV 336
N+L+D + + K++DFG+ R Q N
Sbjct: 131 NILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANST 190
Query: 337 VGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISG 372
VGT Y+APE + ++ D +S GV+L E++ G
Sbjct: 191 VGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 491 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.94 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.92 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.92 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.92 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.92 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.92 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.91 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.91 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.91 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.91 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.9 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.9 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.9 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.9 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.9 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.9 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.89 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.89 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.89 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.89 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.89 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.88 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.88 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.88 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.88 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.88 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.88 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.88 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.88 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.87 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.87 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.87 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.87 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.87 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.87 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.87 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.87 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.87 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.87 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.87 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.87 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.87 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.87 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.87 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.87 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.86 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.86 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.86 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.86 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.86 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.86 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.86 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.86 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.86 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.86 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.86 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.86 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.86 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.86 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.86 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.86 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.86 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.86 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.86 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.85 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.85 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.85 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.85 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.85 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.85 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.85 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.85 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.85 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.85 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.85 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.85 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.85 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.85 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.85 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.85 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.85 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.85 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.85 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.85 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.85 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.85 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.85 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.85 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.85 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.84 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.84 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.84 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.84 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.84 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.84 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.84 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.84 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.84 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.84 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.84 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.84 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.84 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.84 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.84 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.84 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.84 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.84 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.84 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.84 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.84 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.84 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.84 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.84 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.84 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.84 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.84 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.84 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.84 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.84 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.84 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.84 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.84 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.84 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.84 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.83 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.83 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.83 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.83 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.83 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.83 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.83 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.83 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.83 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.83 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.83 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.83 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.83 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.83 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.83 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.83 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.83 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.83 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.83 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.83 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.83 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.83 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.83 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.83 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.83 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.82 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.82 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.82 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.82 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.82 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.82 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.82 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.82 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.82 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.82 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.82 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.82 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.82 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.82 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.82 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.82 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.82 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.82 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.82 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.82 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.82 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.82 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.82 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.82 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.82 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.82 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.82 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.82 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.82 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.82 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.81 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.81 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.81 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.81 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.81 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.81 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.81 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.81 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.81 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.81 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.81 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.81 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.81 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.81 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.81 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.81 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.81 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.81 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.81 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.81 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.81 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.81 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.81 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.81 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.81 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.81 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.81 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.81 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.81 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.8 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.8 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.8 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.8 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.8 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.8 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.8 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.8 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.8 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.8 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.8 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.8 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.8 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.8 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.8 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.8 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.8 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.8 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.8 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.8 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.8 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.8 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.8 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.8 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.8 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.8 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.8 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.8 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.8 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.8 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.8 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.8 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.8 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.8 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.8 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.79 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.79 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.79 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.79 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.79 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.79 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.79 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.79 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.79 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.79 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.79 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.79 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.79 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.79 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.79 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.79 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.79 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.79 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.79 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.79 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.79 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.79 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.79 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.79 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.78 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.78 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.78 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.78 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.78 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.78 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.78 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.78 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.78 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.78 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.78 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.78 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.78 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.78 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.78 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.78 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.78 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.78 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.78 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.77 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.77 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.77 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.77 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.77 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.77 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.77 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.77 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.77 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.77 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.77 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.76 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.76 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.76 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.76 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.76 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.76 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.76 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.76 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.76 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.75 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.75 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.75 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.75 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.75 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.75 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.75 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.74 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.74 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.74 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.74 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.74 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.73 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.73 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.73 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.73 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.73 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.72 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.7 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.68 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.67 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.66 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.65 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.65 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.65 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.64 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.64 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.63 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.63 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.63 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.62 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.61 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.58 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.5 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.44 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.37 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.37 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.35 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.34 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.31 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.24 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.24 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.21 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.19 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.09 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.09 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.07 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.05 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 98.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.71 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 98.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 98.64 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 98.63 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 98.6 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 98.49 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 98.28 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 98.26 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.13 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.13 | |
| smart00090 | 237 | RIO RIO-like kinase. | 97.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.86 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 97.8 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 97.78 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 97.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 97.62 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.52 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 97.52 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 97.46 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 97.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 97.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 97.32 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 97.25 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 97.14 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 96.89 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 96.36 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 96.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 96.08 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 95.57 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 95.5 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 95.45 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 95.26 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 94.63 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 92.72 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 91.99 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 91.71 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 90.26 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 89.85 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 89.17 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 86.92 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 86.33 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 84.91 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 84.25 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 83.67 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 83.6 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 83.47 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 83.06 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 82.45 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 82.26 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 81.32 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 80.67 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 80.42 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=267.31 Aligned_cols=201 Identities=32% Similarity=0.500 Sum_probs=167.3
Q ss_pred eeeeecccccCCCCccccCC----CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEecc
Q 011196 243 IRYELYRFLVDTPTVTVTAP----NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDF 318 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~Df 318 (491)
.+..+|.|..++++...+.. +..|.+++.|+..++.++.|||... ..++||||||++|||||+++++||+||
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~----~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC----PPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC----CCCEecCCCCHHHeeECCCCCEEccCc
Confidence 47889999988765333221 4468899999999999999999853 335679999999999999999999999
Q ss_pred CcceecCCCCcccccCce-eecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 319 GMARIFGGNQSEANTNRV-VGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
|+++..+.. ....... .||.+|++||++..+..+.|+|||||||+++|+++|+++.+.........+..|++..+.+
T Consensus 222 GLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 222 GLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred cCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999765431 1111112 7999999999999999999999999999999999999987765545556689999999999
Q ss_pred CCccccccchhc-CCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 398 GHAAELMDSVVK-QSCDQ-AELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 398 ~~~~~~~d~~l~-~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
+.+.+++|+.+. ..++. +++.++..++.+|++.+|++||+|.||+++|+...
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 999999999987 55554 68999999999999999999999999999995543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=227.58 Aligned_cols=227 Identities=18% Similarity=0.170 Sum_probs=152.4
Q ss_pred CCccEEEEEecCCCCCccchhHHHHHHhhccccccCCCCCcEEEceecc-----eeeeecccccCCCCccccCC--CCCC
Q 011196 194 SFDTLQTTVHCIPDLSKSDCNVCLNSAVAQIPTCSKGKLGARIFCASCS-----IRYELYRFLVDTPTVTVTAP--NKTS 266 (491)
Q Consensus 194 ~~~~vyglaQC~~Dls~~dC~~Cl~~~~~~~~~~~~~~~~g~i~~~~C~-----lry~~~~f~~~~~~~~~~~~--~~~~ 266 (491)
...++|++=-=..+..+..+++=++++-..-.-.++. .|-+.+++ ..+....|.+.+++...... .-..
T Consensus 102 ~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spy----IV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E 177 (364)
T KOG0581|consen 102 PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPY----IVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPE 177 (364)
T ss_pred CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCC----eeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCH
Confidence 4577999887788888999988888775443333332 22222322 23445667766665333221 1122
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
+....++..+..++.||| +.++||||||||+|||++..|.+||+|||.++.+.+. ....++||..|||||
T Consensus 178 ~~L~~ia~~VL~GL~YLh------~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPE 247 (364)
T KOG0581|consen 178 PVLGKIARAVLRGLSYLH------EERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPE 247 (364)
T ss_pred HHHHHHHHHHHHHHHHHh------hccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChh
Confidence 333445555555555554 3456669999999999999999999999999877543 445689999999999
Q ss_pred hhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHH
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLL 426 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~ 426 (491)
-+.+..|+.++||||||++++|+.+|+.|+.... .......+. ...+..+..+.+.+. ....++.+++..
T Consensus 248 Ri~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-~~~~~~~~L-l~~Iv~~ppP~lP~~--------~fS~ef~~FV~~ 317 (364)
T KOG0581|consen 248 RISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-PPYLDIFEL-LCAIVDEPPPRLPEG--------EFSPEFRSFVSC 317 (364)
T ss_pred hhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-CCCCCHHHH-HHHHhcCCCCCCCcc--------cCCHHHHHHHHH
Confidence 9999999999999999999999999999975431 111111111 111112221211111 234567789999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 011196 427 CVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 427 cl~~dP~~RPs~~evl~~ 444 (491)
||++||.+||+++|++++
T Consensus 318 CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 318 CLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HhcCCcccCCCHHHHhcC
Confidence 999999999999988754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=231.61 Aligned_cols=183 Identities=22% Similarity=0.309 Sum_probs=135.0
Q ss_pred eecccccCCCCccccC----CCCCCcchhhhHhHHHHHHHHHhhee-eEEeEEeeeccccccccccccCCC-CceEeccC
Q 011196 246 ELYRFLVDTPTVTVTA----PNKTSKRWITIAEAASAIIVFLLSTS-FLWCIIRRRNKRVRASNVLLDHEM-NPKISDFG 319 (491)
Q Consensus 246 ~~~~f~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~iHrDlKp~NILl~~~~-~~kl~DfG 319 (491)
.+..|..++.....+. .......++.++.+++.++.|||... ++ ||||||+|||++.++ ++||+|||
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iI-------HrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPII-------HRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCee-------ecccChhhEEEcCCCCEEEECCCc
Confidence 3455555555544432 23345667889999999999999987 55 999999999999997 99999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhh--hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAM--EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
+++...... .......||..|||||++. +.+|+.|+|||||||++|||++|+.||..... ...+......
T Consensus 190 lsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~ 261 (362)
T KOG0192|consen 190 LSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVG 261 (362)
T ss_pred cceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhc
Confidence 998764322 1222368999999999999 56899999999999999999999999753221 2222222222
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCC
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTL 452 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 452 (491)
+... ..+......+..++.+||+.||++||++.+++..|+......
T Consensus 262 ~~Rp---------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 262 GLRP---------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred CCCC---------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 2211 222234556778899999999999999999999998664433
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-26 Score=228.45 Aligned_cols=187 Identities=25% Similarity=0.375 Sum_probs=140.4
Q ss_pred ceecce---eeeecccccCCCCccccCC----CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC
Q 011196 238 CASCSI---RYELYRFLVDTPTVTVTAP----NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE 310 (491)
Q Consensus 238 ~~~C~l---ry~~~~f~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~ 310 (491)
+..|.. -|.+..|...+.++..+.. .....+.+.++.+|+.++.||....++ ||||.++|||++++
T Consensus 267 ~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~I-------HRDLAARNiLV~~~ 339 (468)
T KOG0197|consen 267 YGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYI-------HRDLAARNILVDED 339 (468)
T ss_pred EEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCcc-------chhhhhhheeeccC
Confidence 344554 4677778777766555433 122446778999999999999999888 99999999999999
Q ss_pred CCceEeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHH
Q 011196 311 MNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLA 389 (491)
Q Consensus 311 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~ 389 (491)
..+||+|||+++...++.... .....-++.|.|||.+..+.|+.|||||||||+||||+| |+.|+... ...+
T Consensus 340 ~~vKIsDFGLAr~~~d~~Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m---sn~e--- 412 (468)
T KOG0197|consen 340 LVVKISDFGLARLIGDDEYTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM---SNEE--- 412 (468)
T ss_pred ceEEEcccccccccCCCceee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC---CHHH---
Confidence 999999999999654443322 222334778999999999999999999999999999998 77775422 1111
Q ss_pred HHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 390 YIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 390 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+.+.. +...+...|..++..+.+||..||+.+|++|||++.+...|+..
T Consensus 413 -v~~~l---------e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 413 -VLELL---------ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred -HHHHH---------hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 22222 22223344556677788999999999999999999988888765
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=218.76 Aligned_cols=219 Identities=22% Similarity=0.357 Sum_probs=149.3
Q ss_pred CCccchhHHHHHHhhccc---cccCCCCCcEEEceecceee-----eecccccCCCCccccC----CCCCCcchhhhHhH
Q 011196 208 LSKSDCNVCLNSAVAQIP---TCSKGKLGARIFCASCSIRY-----ELYRFLVDTPTVTVTA----PNKTSKRWITIAEA 275 (491)
Q Consensus 208 ls~~dC~~Cl~~~~~~~~---~~~~~~~~g~i~~~~C~lry-----~~~~f~~~~~~~~~~~----~~~~~~~~~~~~~~ 275 (491)
++-++|+.=|+.+..++. .+-+- .|.-..|.|.+ -+.+|...++.+.+.. ........-++..+
T Consensus 59 inLEkc~~~ld~l~kE~~~msl~~HP----NIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre 134 (516)
T KOG0582|consen 59 INLEKCNNDLDALRKEVQTMSLIDHP----NIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILRE 134 (516)
T ss_pred eehhhhhhhHHHHHHHHHHhhhcCCC----CcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHH
Confidence 455667766766665543 23332 34556666654 4778988888766542 22334556678888
Q ss_pred HHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCC-ccccc-CceeecCCCChhhhhhhC--
Q 011196 276 ASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQ-SEANT-NRVVGTYGYMAPEYAMEG-- 351 (491)
Q Consensus 276 ~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~-~~~~gt~~y~aPE~~~~~-- 351 (491)
+..++.|||..+++ |||||+.||||+.+|.+||+|||++-.+.... ..... ..++||+.|||||++++.
T Consensus 135 ~LkaL~YLH~~G~I-------HRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~ 207 (516)
T KOG0582|consen 135 VLKALDYLHQNGHI-------HRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLH 207 (516)
T ss_pred HHHHHHHHHhcCce-------ecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhccc
Confidence 99999999999988 99999999999999999999999987554322 21112 567999999999997653
Q ss_pred CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCC
Q 011196 352 IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQED 431 (491)
Q Consensus 352 ~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~d 431 (491)
.|+.|+|||||||+..|+.+|+.||..+... +-++. .. ++..+...-..+..+........+.+++-.||++|
T Consensus 208 GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kvLl~----tL-qn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kD 280 (516)
T KOG0582|consen 208 GYDFKADIWSFGITACELAHGHAPFSKYPPM--KVLLL----TL-QNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKD 280 (516)
T ss_pred CccchhhhhhhhHHHHHHhcCCCCcccCChH--HHHHH----Hh-cCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcC
Confidence 4899999999999999999999997643221 11111 11 11111111111111111122336778889999999
Q ss_pred CCCCCCHHHHHHH
Q 011196 432 PMDRPTMSSVAVM 444 (491)
Q Consensus 432 P~~RPs~~evl~~ 444 (491)
|++|||++++++.
T Consensus 281 P~kRptAskLlkh 293 (516)
T KOG0582|consen 281 PSKRPTASKLLKH 293 (516)
T ss_pred cccCCCHHHHhcc
Confidence 9999999998764
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=185.31 Aligned_cols=101 Identities=32% Similarity=0.699 Sum_probs=77.9
Q ss_pred ccCCC-C-CCcc-CCCChHHHHHHHHHHHhhhhhcCC--CCccccccCCCCCeEEEEEeccCCCChhhHHHHHHHHHHHH
Q 011196 39 YKFCP-R-GTNN-TASIIYIYNLSKLFNRKLHEEGGN--SLYRNASVGDNPDKVYGLFLCRFDVSHQVCQNCIFDAIDIL 113 (491)
Q Consensus 39 ~~~C~-~-~~~~-~~~s~~~~nl~~ll~~l~~~~~~~--~~f~~~~~g~~~~~vygl~~C~~d~~~~~C~~Cl~~a~~~~ 113 (491)
|+.|+ + .++| +++++|++||+.||+.|.++++.. .+|++++.|.++++|||++||++|+++++|..||+.|+..+
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~ 80 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANI 80 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCH
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHH
Confidence 57898 4 3567 578889999999999999998653 47999988989999999999999999999999999999999
Q ss_pred HHhCCCCccEEEEccccEEEEccccc
Q 011196 114 VESCNGTKEATIWYDICMVCYSNKFF 139 (491)
Q Consensus 114 ~~~C~~~~~~~~~~~~C~~ry~~~~f 139 (491)
.+.|+.++||+||++.|+||||+++|
T Consensus 81 ~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 81 SSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHhCCCCceEEEECCCEEEEEECCCC
Confidence 99999999999999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=223.04 Aligned_cols=180 Identities=18% Similarity=0.292 Sum_probs=132.4
Q ss_pred ceeeeecccccCCCCccccCC-CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 242 SIRYELYRFLVDTPTVTVTAP-NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 242 ~lry~~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
..-|-++.|.+++.+...... .....+.-.+.+.+..++.+||..+++ |||||.+|||++.++.+||+|||+
T Consensus 343 deLWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIi-------HrDIKSDnILL~~~g~vKltDFGF 415 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGII-------HRDIKSDNILLTMDGSVKLTDFGF 415 (550)
T ss_pred ceeEEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhccee-------eeccccceeEeccCCcEEEeeeee
Confidence 334556677776664433222 123555666677777777888877777 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
+..+...+. .....+||++|||||++....|++|+||||||++++||+-|++||-+ .+.+...+....++..
T Consensus 416 caqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln------E~PlrAlyLIa~ng~P 487 (550)
T KOG0578|consen 416 CAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN------ENPLRALYLIATNGTP 487 (550)
T ss_pred eeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC------CChHHHHHHHhhcCCC
Confidence 988765544 33457999999999999999999999999999999999999999642 2223333433333332
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
++.. ++.-...+.+++.+||+.|+++||++.|+|++
T Consensus 488 -~lk~-------~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 488 -KLKN-------PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -CcCC-------ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2221 12223456778889999999999999998863
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-26 Score=220.79 Aligned_cols=178 Identities=21% Similarity=0.272 Sum_probs=128.8
Q ss_pred eeecccccCCCCccccCC--CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC---CCceEeccC
Q 011196 245 YELYRFLVDTPTVTVTAP--NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE---MNPKISDFG 319 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~---~~~kl~DfG 319 (491)
|.+..|..++.+..-... .......+.+..++..++.|||..++. ||||||+|||+..+ ..+||.|||
T Consensus 252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~-------HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGII-------HRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcc-------cccCCcceEEeccCCcceEEEecccc
Confidence 667777777665433222 223444567888999999999998888 99999999999766 679999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCC---CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI---FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC 396 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 396 (491)
+++..+.. ....+++||+.|.|||++.+.. +..++|+||+||+||-+++|.+||..... .+.+.+.+.
T Consensus 325 lAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~--~~sl~eQI~---- 395 (475)
T KOG0615|consen 325 LAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT--DPSLKEQIL---- 395 (475)
T ss_pred hhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC--CccHHHHHh----
Confidence 99987532 2345689999999999998654 33588999999999999999999754322 222333332
Q ss_pred cCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 397 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 397 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.+.... -+ ....+..++.++++.+||..||++|||+.|++++
T Consensus 396 ~G~y~f--~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 396 KGRYAF--GP----LQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cCcccc--cC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 222111 11 1122445667889999999999999999988753
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-25 Score=204.37 Aligned_cols=162 Identities=22% Similarity=0.266 Sum_probs=119.7
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhh
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY 347 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 347 (491)
..+.+..+++.++..+|.. +...-++||||||.||+|+.+|.+||+|||+++.+...... ....+||+.||+||.
T Consensus 125 ~Vwk~f~QL~~AL~~cH~~---~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tf--A~S~VGTPyYMSPE~ 199 (375)
T KOG0591|consen 125 TVWKYFVQLCRALYHCHSK---IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTF--AHSLVGTPYYMSPER 199 (375)
T ss_pred HHHHHHHHHHHHHHHHhcc---ccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHH--HHhhcCCCcccCHHH
Confidence 3444555555555555551 11122569999999999999999999999999988655443 445899999999999
Q ss_pred hhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHc
Q 011196 348 AMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLC 427 (491)
Q Consensus 348 ~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~c 427 (491)
+.+.+|+.|+||||+||+++||..-++||... ++. ...+.+.++....+.+. -....+.+|+..|
T Consensus 200 i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~-~L~~KI~qgd~~~~p~~--------~YS~~l~~li~~c 264 (375)
T KOG0591|consen 200 IHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLL-SLCKKIEQGDYPPLPDE--------HYSTDLRELINMC 264 (375)
T ss_pred HhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHH-HHHHHHHcCCCCCCcHH--------HhhhHHHHHHHHH
Confidence 99999999999999999999999999997532 222 23344555544433322 2344567789999
Q ss_pred ccCCCCCCCCHHHHHHHhhcCC
Q 011196 428 VQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 428 l~~dP~~RPs~~evl~~L~~~~ 449 (491)
+..||+.||+...++..+.+++
T Consensus 265 i~vd~~~RP~t~~~v~di~~~l 286 (375)
T KOG0591|consen 265 IAVDPEQRPDTVPYVQDIQSEL 286 (375)
T ss_pred ccCCcccCCCcchHHHHHHHHh
Confidence 9999999999777777766653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-25 Score=222.66 Aligned_cols=154 Identities=19% Similarity=0.269 Sum_probs=120.4
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.+.....+..|++.++.|||...++ |||||..|++|++++++||+|||+|..+..+... ..+.+||+-|.|
T Consensus 116 tEpEary~l~QIv~GlkYLH~~~Ii-------HRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er--k~TlCGTPNYIA 186 (592)
T KOG0575|consen 116 TEPEARYFLRQIVEGLKYLHSLGII-------HRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER--KKTLCGTPNYIA 186 (592)
T ss_pred CcHHHHHHHHHHHHHHHHHHhcCce-------ecccchhheeecCcCcEEecccceeeeecCcccc--cceecCCCcccC
Confidence 3556777889999999999998877 9999999999999999999999999987644332 335899999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||++....++..+||||+|||+|-|+.|++||.... +......++... .. +|..-.....+|+
T Consensus 187 PEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------vkety~~Ik~~~---Y~-------~P~~ls~~A~dLI 249 (592)
T KOG0575|consen 187 PEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------VKETYNKIKLNE---YS-------MPSHLSAEAKDLI 249 (592)
T ss_pred hhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-------HHHHHHHHHhcC---cc-------cccccCHHHHHHH
Confidence 999999999999999999999999999999985321 222222222211 11 1112223455788
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 011196 425 LLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~ 444 (491)
.++|+.||.+|||+++|+.+
T Consensus 250 ~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 250 RKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHhcCCcccCCCHHHHhcC
Confidence 89999999999999999864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-25 Score=230.64 Aligned_cols=165 Identities=27% Similarity=0.378 Sum_probs=136.2
Q ss_pred CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCC
Q 011196 263 NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGY 342 (491)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 342 (491)
+.+..+.+.|+.+|+.++.||-...++ ||||-.+|+||.++..+||+|||+++..-..+.+....+-.-.++|
T Consensus 599 ~L~~~q~L~iA~QIAaGM~YLs~~~FV-------HRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRW 671 (774)
T KOG1026|consen 599 PLSTSQFLHIATQIAAGMEYLSSHHFV-------HRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRW 671 (774)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCccc-------ccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeec
Confidence 345678899999999999999998888 9999999999999999999999999977655555544445568899
Q ss_pred ChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 343 MAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 343 ~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
|+||.+..++|+++||||||||+|||+++ |+.|+..... +++.+...++.+. +.++.++.++.
T Consensus 672 MppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-------~EVIe~i~~g~lL---------~~Pe~CP~~vY 735 (774)
T KOG1026|consen 672 MPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-------QEVIECIRAGQLL---------SCPENCPTEVY 735 (774)
T ss_pred CCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-------HHHHHHHHcCCcc---------cCCCCCCHHHH
Confidence 99999999999999999999999999998 8888643322 2334444444432 34667778899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAVMLASDIV 450 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 450 (491)
+||+.||+.+|++||+++||-..|+.-..
T Consensus 736 ~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 736 SLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 99999999999999999999999987643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-25 Score=204.54 Aligned_cols=168 Identities=18% Similarity=0.213 Sum_probs=119.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......+..++..++.++|...++ ||||||+||||+.++.+||+|||+|+.+..+. ...+..+.|.+|+||
T Consensus 100 ~~~vk~~l~Q~l~ai~~cHk~n~I-------HRDIKPENILit~~gvvKLCDFGFAR~L~~pg--d~YTDYVATRWYRaP 170 (396)
T KOG0593|consen 100 SELVKKYLYQLLKAIHFCHKNNCI-------HRDIKPENILITQNGVVKLCDFGFARTLSAPG--DNYTDYVATRWYRAP 170 (396)
T ss_pred HHHHHHHHHHHHHHhhhhhhcCee-------cccCChhheEEecCCcEEeccchhhHhhcCCc--chhhhhhhhhhccCh
Confidence 455677888888888888877666 99999999999999999999999999876322 123356789999999
Q ss_pred hhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHH--------HHHhhcC------Cccccccchh-c
Q 011196 346 EYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYI--------WKLWCEG------HAAELMDSVV-K 409 (491)
Q Consensus 346 E~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~------~~~~~~d~~l-~ 409 (491)
|.+.+ .+|+..+|||++||++.||++|.+-|...++-+....+... ...+... .+++.-++.. .
T Consensus 171 ELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe 250 (396)
T KOG0593|consen 171 ELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLE 250 (396)
T ss_pred hhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchh
Confidence 99998 68999999999999999999999988754433221111111 1111111 1111111111 1
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 410 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
..++ ....-++++++.||+.||.+|++-+|++.
T Consensus 251 ~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 251 RKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111 22335789999999999999999999774
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-25 Score=215.74 Aligned_cols=171 Identities=19% Similarity=0.152 Sum_probs=125.4
Q ss_pred CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
......+.|..|+..++.++|..++. |||+||+|||+.....+||+|||+++...+.... +..+.|.+|+
T Consensus 107 fse~~irnim~QilqGL~hiHk~GfF-------HRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY---TeYVSTRWYR 176 (538)
T KOG0661|consen 107 FSESDIRNIMYQILQGLAHIHKHGFF-------HRDLKPENILISGNDVIKIADFGLAREVRSKPPY---TEYVSTRWYR 176 (538)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCcc-------cccCChhheEecccceeEecccccccccccCCCc---chhhhccccc
Confidence 34667888999999999999999999 9999999999998889999999999987655443 3468899999
Q ss_pred hhhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccc--------------cccchh
Q 011196 344 APEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAE--------------LMDSVV 408 (491)
Q Consensus 344 aPE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~d~~l 408 (491)
|||++.. +-|+.+.|||++|||++|+.+-++.|...+..+....+..+........+.+ ...-.+
T Consensus 177 APEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l 256 (538)
T KOG0661|consen 177 APEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPL 256 (538)
T ss_pred chHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCCh
Confidence 9999875 6799999999999999999999988764333222222222211111112211 100011
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 011196 409 KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445 (491)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 445 (491)
..-.+ ....++++++..|+.+||++|||+.|.+++-
T Consensus 257 ~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 257 KDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 11112 2456788999999999999999999988763
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-24 Score=211.36 Aligned_cols=237 Identities=18% Similarity=0.188 Sum_probs=151.4
Q ss_pred CccEEEEEecCCCCCccchhHHHHHHhhccccccCC---CCCcEEEceecceeeeecccccCCCC--ccccCCCCCCcch
Q 011196 195 FDTLQTTVHCIPDLSKSDCNVCLNSAVAQIPTCSKG---KLGARIFCASCSIRYELYRFLVDTPT--VTVTAPNKTSKRW 269 (491)
Q Consensus 195 ~~~vyglaQC~~Dls~~dC~~Cl~~~~~~~~~~~~~---~~~g~i~~~~C~lry~~~~f~~~~~~--~~~~~~~~~~~~~ 269 (491)
.+++++|-.-+=|.....=-.+-..=|.-+++--+- +..+.|...--.-.|.+.+|++..-. +..+.-.....+.
T Consensus 141 tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qI 220 (560)
T KOG0600|consen 141 TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQI 220 (560)
T ss_pred cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHH
Confidence 456778777666654444333333323333332221 22344444412233566666543321 1111223456678
Q ss_pred hhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhh
Q 011196 270 ITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM 349 (491)
Q Consensus 270 ~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 349 (491)
+-+..|+..++.|+|..+++ |||||.+|||||.+|++||+|||+++++........+ ..+-|.+|+|||.+.
T Consensus 221 Kc~mkQLl~Gl~~cH~~gvl-------HRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T-~rVvTLWYRpPELLL 292 (560)
T KOG0600|consen 221 KCYMKQLLEGLEYCHSRGVL-------HRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYT-SRVVTLWYRPPELLL 292 (560)
T ss_pred HHHHHHHHHHHHHHhhcCee-------eccccccceEEcCCCCEEeccccceeeccCCCCcccc-cceEEeeccChHHhc
Confidence 88899999999999999998 9999999999999999999999999987665544434 456699999999998
Q ss_pred hC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc---CCcc-------ccccch------hcCCC
Q 011196 350 EG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE---GHAA-------ELMDSV------VKQSC 412 (491)
Q Consensus 350 ~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~-------~~~d~~------l~~~~ 412 (491)
+. .|+.++|+||.|||+.||+.|++.+..... .+.+..+.+.-.. ..|. ..+.+. +.+.
T Consensus 293 G~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE---veQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~- 368 (560)
T KOG0600|consen 293 GATSYGTAVDLWSVGCILAELFLGKPILQGRTE---VEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRET- 368 (560)
T ss_pred CCcccccceeehhhhHHHHHHHcCCCCcCCccH---HHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHH-
Confidence 75 599999999999999999999998764322 2233333322211 1111 111111 1100
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 413 DQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 413 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
-..-....++|+..+|..||.+|.|+.++++
T Consensus 369 ~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 369 FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0011234678888999999999999988764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-24 Score=214.75 Aligned_cols=153 Identities=22% Similarity=0.306 Sum_probs=117.6
Q ss_pred hhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc-----------cccCcee
Q 011196 269 WITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE-----------ANTNRVV 337 (491)
Q Consensus 269 ~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~-----------~~~~~~~ 337 (491)
..-.+.++..++.|||..+++ ||||||+|||||++|++||.|||.++.+...... .....++
T Consensus 176 aR~YAAeIldAleylH~~GII-------HRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFV 248 (604)
T KOG0592|consen 176 ARFYAAEILDALEYLHSNGII-------HRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFV 248 (604)
T ss_pred HHHHHHHHHHHHHHHHhcCce-------eccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCccccee
Confidence 345677888899999998888 9999999999999999999999999987542211 1114589
Q ss_pred ecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHH
Q 011196 338 GTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAEL 417 (491)
Q Consensus 338 gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 417 (491)
||-.|.+||++..+..+..+|+|+|||++|+|+.|++||...+ .-...+.+... +- ++++...
T Consensus 249 GTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N---eyliFqkI~~l----------~y----~fp~~fp 311 (604)
T KOG0592|consen 249 GTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN---EYLIFQKIQAL----------DY----EFPEGFP 311 (604)
T ss_pred eeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc---HHHHHHHHHHh----------cc----cCCCCCC
Confidence 9999999999999999999999999999999999999975322 11122222111 00 1122222
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 011196 418 LKYIHIGLLCVQEDPMDRPTMSSVAVML 445 (491)
Q Consensus 418 ~~~~~l~~~cl~~dP~~RPs~~evl~~L 445 (491)
+...+|+.+.|..||.+|++.+||.++.
T Consensus 312 ~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 312 EDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHHHHHHHHccCccccccHHHHhhCc
Confidence 4466788999999999999999998875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-24 Score=210.01 Aligned_cols=163 Identities=22% Similarity=0.290 Sum_probs=119.7
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC-CCCceEeccCcceecCC-CCcccccCceeecCCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH-EMNPKISDFGMARIFGG-NQSEANTNRVVGTYGY 342 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~-~~~~kl~DfGla~~~~~-~~~~~~~~~~~gt~~y 342 (491)
+.........++..++.|||..+++ ||||||+|||++. ++.+||+|||+++.... ...........||+.|
T Consensus 115 ~E~~v~~ytr~iL~GL~ylHs~g~v-------H~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~ 187 (313)
T KOG0198|consen 115 PEPLVRRYTRQILEGLAYLHSKGIV-------HCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNY 187 (313)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEe-------ccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccc
Confidence 3455677888999999999998888 9999999999999 79999999999987653 1112223357899999
Q ss_pred ChhhhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 343 MAPEYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 343 ~aPE~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
||||++..+. ...++||||+||++.||+||++||..+ ................+++.+ .-.....
T Consensus 188 maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~ip~---------~ls~~a~ 253 (313)
T KOG0198|consen 188 MAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEIPD---------SLSDEAK 253 (313)
T ss_pred cCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCCCc---------ccCHHHH
Confidence 9999998643 345999999999999999999998643 111222222222222222221 1223455
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+++.+|++.||++||||.+++++.--.
T Consensus 254 ~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 254 DFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred HHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 688899999999999999998876544
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=210.90 Aligned_cols=174 Identities=17% Similarity=0.253 Sum_probs=122.8
Q ss_pred eecccccCCCCccccCCCC--CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCccee
Q 011196 246 ELYRFLVDTPTVTVTAPNK--TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARI 323 (491)
Q Consensus 246 ~~~~f~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~ 323 (491)
..+.|..++....++.+.+ .......+...+..++.|+|..... |||||+.|||+..+|.+||+|||++-.
T Consensus 88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~ki-------HrDIKaanil~s~~g~vkl~DfgVa~q 160 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKI-------HRDIKAANILLSESGDVKLADFGVAGQ 160 (467)
T ss_pred HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhccee-------cccccccceeEeccCcEEEEecceeee
Confidence 3455566666555544332 2333334555555556666554444 999999999999999999999999987
Q ss_pred cCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcccc
Q 011196 324 FGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAEL 403 (491)
Q Consensus 324 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (491)
+....... .+++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+...+...... .+.+-
T Consensus 161 l~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------------lIpk~ 226 (467)
T KOG0201|consen 161 LTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------------LIPKS 226 (467)
T ss_pred eechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------------eccCC
Confidence 76544333 56899999999999998889999999999999999999999976443321110 01111
Q ss_pred ccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 404 MDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 404 ~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..|.+.+. ....+.+++..||++||+.||+|.+++++
T Consensus 227 ~PP~L~~~----~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 227 APPRLDGD----FSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCccccc----cCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22333332 23346778889999999999999998764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=211.99 Aligned_cols=162 Identities=27% Similarity=0.382 Sum_probs=119.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............++..|+||
T Consensus 173 ~~~~~~~~~qi~~aL~~LH~~~iv-------HrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 173 MEDLICYSFQVARGMEFLASRKCI-------HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEE-------CCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 344566778899999999987776 9999999999999999999999999865433222222334567789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++|||++ |..||...... . ........+.... .+......+.+|+
T Consensus 246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~---~---~~~~~~~~~~~~~---------~~~~~~~~l~~li 310 (338)
T cd05102 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN---E---EFCQRLKDGTRMR---------APENATPEIYRIM 310 (338)
T ss_pred HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc---H---HHHHHHhcCCCCC---------CCCCCCHHHHHHH
Confidence 99998899999999999999999997 99997542211 1 1112222221111 1112234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
.+||+.||++||++.||++.|+...
T Consensus 311 ~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 311 LACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=215.23 Aligned_cols=190 Identities=21% Similarity=0.330 Sum_probs=136.9
Q ss_pred ecccccCCCCccccCCC--CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceec
Q 011196 247 LYRFLVDTPTVTVTAPN--KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIF 324 (491)
Q Consensus 247 ~~~f~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~ 324 (491)
++.|...+++...+... -.......+...|+.++.|||...++ |||||.-||||..+..+||+|||.++..
T Consensus 190 iMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKII-------HRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKII-------HRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHh-------hhccCCCceEeeccceEEeccccchHhh
Confidence 44555555543333221 12334567888999999999886665 9999999999999999999999999876
Q ss_pred CCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccc
Q 011196 325 GGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELM 404 (491)
Q Consensus 325 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (491)
.... ..-.+.||..|||||++...+.+.|+||||||||||||+||.-|+..... ...+|.. +
T Consensus 263 ~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds------sAIIwGV---G------ 324 (904)
T KOG4721|consen 263 SDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS------SAIIWGV---G------ 324 (904)
T ss_pred hhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch------heeEEec---c------
Confidence 4432 22348999999999999999999999999999999999999999653211 1122221 1
Q ss_pred cchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCCCCCCCCee
Q 011196 405 DSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFS 461 (491)
Q Consensus 405 d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~~p~~~ 461 (491)
...+.-..+..+..-+.-|+++||+..|..||++++|+.+|.=...++-.-++-.||
T Consensus 325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee~yf 381 (904)
T KOG4721|consen 325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTEETYF 381 (904)
T ss_pred CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHHHHH
Confidence 122222334444455666889999999999999999999998766555444444444
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-24 Score=194.14 Aligned_cols=182 Identities=20% Similarity=0.228 Sum_probs=129.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.++..+++|+|...++ ||||||.|+||+.+|.+||+|||+++.++....... ..+-|.+|+||
T Consensus 100 pa~iK~y~~m~LkGl~y~H~~~Il-------HRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~--~~V~TRWYRAP 170 (318)
T KOG0659|consen 100 PADIKSYMLMTLKGLAYCHSKWIL-------HRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT--HQVVTRWYRAP 170 (318)
T ss_pred HHHHHHHHHHHHHHHHHHHhhhhh-------cccCCccceEEcCCCcEEeecccchhccCCCCcccc--cceeeeeccCh
Confidence 445667788888889999998888 999999999999999999999999998875443322 23669999999
Q ss_pred hhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC---Cccccc---c---------chhc
Q 011196 346 EYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG---HAAELM---D---------SVVK 409 (491)
Q Consensus 346 E~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---d---------~~l~ 409 (491)
|.+.+. +|+..+||||.||++.||+-|.+-+.. +.+.+.+..+.+..... .|+++. | +.+.
T Consensus 171 ELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG---~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~ 247 (318)
T KOG0659|consen 171 ELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG---DSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLN 247 (318)
T ss_pred HHhccchhcCCcchhhhHHHHHHHHHccCCCCCC---CchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccc
Confidence 999875 599999999999999999998876543 33344444444433322 222221 0 1111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCCCCCCCCeee
Q 011196 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSV 462 (491)
Q Consensus 410 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~~p~~~~ 462 (491)
. .-.......++++.++|..||.+|++++|++++= .....|.|..|.-..
T Consensus 248 ~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~--yf~~~P~pt~~~~lp 297 (318)
T KOG0659|consen 248 N-LFPAASSDALDLLSKMLTYNPKKRITASQALKHP--YFKSLPLPTPPSKLP 297 (318)
T ss_pred c-ccccccHHHHHHHHhhhccCchhcccHHHHhcch--hhhcCCCCCChhhCc
Confidence 1 1122334568999999999999999999987643 233356665554443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-24 Score=204.78 Aligned_cols=146 Identities=21% Similarity=0.247 Sum_probs=107.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
..+..-.+..++.++.+||..+++ ||||||+|||||..|+++|.|||+++...... ..+..++||+.||||
T Consensus 124 E~~arfYlaEi~lAL~~LH~~gIi-------yRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAP 194 (357)
T KOG0598|consen 124 EDRARFYLAEIVLALGYLHSKGII-------YRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAP 194 (357)
T ss_pred hhHHHHHHHHHHHHHHHHHhCCee-------eccCCHHHeeecCCCcEEEeccccchhcccCC--CccccccCCccccCh
Confidence 334444566777888999998888 99999999999999999999999998643332 234458999999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|++.+..|+..+|-||+|+++|||++|.+||...+. ....+. +..+.... .+.--..+..+++.
T Consensus 195 Eil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~---~~~~~~----I~~~k~~~---------~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 195 EILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV---KKMYDK----ILKGKLPL---------PPGYLSEEARDLLK 258 (357)
T ss_pred HHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH---HHHHHH----HhcCcCCC---------CCccCCHHHHHHHH
Confidence 999999999999999999999999999999753221 111111 11111000 01101234567888
Q ss_pred HcccCCCCCCC
Q 011196 426 LCVQEDPMDRP 436 (491)
Q Consensus 426 ~cl~~dP~~RP 436 (491)
+.|+.||++|.
T Consensus 259 ~LL~rdp~~RL 269 (357)
T KOG0598|consen 259 KLLKRDPRQRL 269 (357)
T ss_pred HHhccCHHHhc
Confidence 99999999996
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=211.72 Aligned_cols=169 Identities=22% Similarity=0.341 Sum_probs=124.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
-.+.+.|+++++.++.|||+..|+ |||||..||++.++++|||+|||++..-..-..........|..-||||
T Consensus 487 m~~~idIAqQiaqGM~YLHAK~II-------HrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAP 559 (678)
T KOG0193|consen 487 MNTTIDIAQQIAQGMDYLHAKNII-------HRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAP 559 (678)
T ss_pred HHHHHHHHHHHHHhhhhhhhhhhh-------hhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcH
Confidence 456788999999999999998888 9999999999999999999999998653221111222345678899999
Q ss_pred hhhhh---CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHH
Q 011196 346 EYAME---GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 346 E~~~~---~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
|++.. .+|++.+||||||+|+|||++|..|+.....+ +.+|. ...+ .-..|.... ......++.+
T Consensus 560 EvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d------qIifm-VGrG--~l~pd~s~~---~s~~pk~mk~ 627 (678)
T KOG0193|consen 560 EVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD------QIIFM-VGRG--YLMPDLSKI---RSNCPKAMKR 627 (678)
T ss_pred HHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh------heEEE-eccc--ccCccchhh---hccCHHHHHH
Confidence 99974 46999999999999999999999997622111 11111 1111 111111111 1234456778
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhhcCCCCCC
Q 011196 423 IGLLCVQEDPMDRPTMSSVAVMLASDIVTLP 453 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 453 (491)
|+..||..++++||.+.+|+.+|+.....+|
T Consensus 628 Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 628 LLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred HHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 8889999999999999999998888765443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=199.07 Aligned_cols=165 Identities=22% Similarity=0.321 Sum_probs=117.4
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
.....++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............++..|+|||
T Consensus 138 ~~~~~i~~~i~~al~~lH~~~iv-------H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE 210 (304)
T cd05096 138 SSLLHVALQIASGMKYLSSLNFV-------HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWE 210 (304)
T ss_pred HHHHHHHHHHHHHHHHHHHCCcc-------ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHH
Confidence 34567888999999999987766 99999999999999999999999998654333222233345678899999
Q ss_pred hhhhCCCCcccceeehhHHHHHHHhC--CCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIISG--KKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~elltG--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
++..+.++.++||||||+++|||+++ ..|+... ........+...+...... .. . ..+......+.+|+
T Consensus 211 ~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~---~~~~~~~~~~~~~~~~~~~-~~-~----~~~~~~~~~~~~li 281 (304)
T cd05096 211 CILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL---TDEQVIENAGEFFRDQGRQ-VY-L----FRPPPCPQGLYELM 281 (304)
T ss_pred HHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC---CHHHHHHHHHHHhhhcccc-cc-c----cCCCCCCHHHHHHH
Confidence 99988999999999999999999975 4454322 1222222222211111100 00 0 01112234578899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhc
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.+||+.||++|||+.+|.+.|++
T Consensus 282 ~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 282 LQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred HHHccCCchhCcCHHHHHHHHhC
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=195.93 Aligned_cols=218 Identities=19% Similarity=0.165 Sum_probs=148.9
Q ss_pred EEEceecceeeeecccccCCC--CccccCCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC
Q 011196 235 RIFCASCSIRYELYRFLVDTP--TVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN 312 (491)
Q Consensus 235 ~i~~~~C~lry~~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~ 312 (491)
.|.|..=.-.|.++.|.+..- .......+......+.+..|+..++.|||...++ |||||++|+|+...|.
T Consensus 143 VVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wil-------HRDLK~SNLLm~~~G~ 215 (419)
T KOG0663|consen 143 VVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWIL-------HRDLKTSNLLLSHKGI 215 (419)
T ss_pred EEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeE-------ecccchhheeeccCCc
Confidence 344444455677777765331 1111123444566778888999999999998888 9999999999999999
Q ss_pred ceEeccCcceecCCCCcccccCceeecCCCChhhhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHH
Q 011196 313 PKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYI 391 (491)
Q Consensus 313 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 391 (491)
+||+|||+|+.+++... ..+..+-|.+|+|||.+.+.+ |++++|+||+|||+.|++++++.|.... ..+.+..+
T Consensus 216 lKiaDFGLAR~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s---E~dQl~~I 290 (419)
T KOG0663|consen 216 LKIADFGLAREYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS---EIDQLDKI 290 (419)
T ss_pred EEecccchhhhhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc---hHHHHHHH
Confidence 99999999998876532 234567799999999999864 9999999999999999999998865432 33344444
Q ss_pred HHHhhcC---Cccccc--------------cchhcCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCC
Q 011196 392 WKLWCEG---HAAELM--------------DSVVKQSCDQA-ELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLP 453 (491)
Q Consensus 392 ~~~~~~~---~~~~~~--------------d~~l~~~~~~~-~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 453 (491)
.+..... .++.+. ...++..+... -...-.+++..+|.+||++|.|+.|.+++ .-..+.|
T Consensus 291 f~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P 368 (419)
T KOG0663|consen 291 FKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETP 368 (419)
T ss_pred HHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCC
Confidence 3332211 111111 11111112211 12445678889999999999999886542 3345567
Q ss_pred CCCCCCeeecccC
Q 011196 454 KPTQPAFSVSRVA 466 (491)
Q Consensus 454 ~p~~p~~~~~~~~ 466 (491)
.|..|.++.....
T Consensus 369 ~p~~P~~~Pt~P~ 381 (419)
T KOG0663|consen 369 LPIDPSMFPTWPA 381 (419)
T ss_pred CCCChhhcCCCcc
Confidence 8888888765543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=205.38 Aligned_cols=158 Identities=26% Similarity=0.383 Sum_probs=119.9
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
...+.++.+++.++.+||..+++ ||||||+||++++++.+||+|||+++...............++..|+|||
T Consensus 124 ~~~~~~~~~l~~al~~lH~~~i~-------H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 196 (283)
T cd05048 124 SDFLHIAIQIAAGMEYLSSHHFV-------HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPE 196 (283)
T ss_pred HHHHHHHHHHHHHHHHHHhCCee-------ccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHH
Confidence 34567888889999999988777 99999999999999999999999998654333222233456688899999
Q ss_pred hhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
++.++.++.++|||||||++|||++ |..||..... . .....+..+.... .+.....++.+|+.
T Consensus 197 ~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~----~~~~~i~~~~~~~---------~~~~~~~~~~~l~~ 260 (283)
T cd05048 197 AILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---Q----EVIEMIRSRQLLP---------CPEDCPARVYALMI 260 (283)
T ss_pred HhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---H----HHHHHHHcCCcCC---------CcccCCHHHHHHHH
Confidence 9998899999999999999999998 9888753221 1 1222222222111 12233456778999
Q ss_pred HcccCCCCCCCCHHHHHHHhhc
Q 011196 426 LCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L~~ 447 (491)
+||+.||++||+++||+++|++
T Consensus 261 ~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 261 ECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHccCChhhCcCHHHHHHHHhc
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-24 Score=203.36 Aligned_cols=172 Identities=20% Similarity=0.210 Sum_probs=119.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
..-..-+.+|+..++.|+|+.+++ ||||||+|+|++.+-.+||+|||+++...........+..+-|.+|+||
T Consensus 124 d~H~q~f~YQiLrgLKyiHSAnVi-------HRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAP 196 (359)
T KOG0660|consen 124 DDHAQYFLYQILRGLKYIHSANVI-------HRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAP 196 (359)
T ss_pred HHHHHHHHHHHHHhcchhhccccc-------ccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCH
Confidence 344556788888888888888888 9999999999999999999999999987544223333567889999999
Q ss_pred hhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHH--------HhhcCCccccccchhc-CCCCH-
Q 011196 346 EYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWK--------LWCEGHAAELMDSVVK-QSCDQ- 414 (491)
Q Consensus 346 E~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~d~~l~-~~~~~- 414 (491)
|++.. ..|+...||||.|||+.||++|++-|.+.+.-+...++..+.. ..........+..... ...+.
T Consensus 197 Elll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~ 276 (359)
T KOG0660|consen 197 ELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFS 276 (359)
T ss_pred HHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHH
Confidence 99875 5699999999999999999999998875443332222222111 1111101111110000 00010
Q ss_pred ----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 415 ----AELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 415 ----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
......++|+.+||..||++|+|++|.+++
T Consensus 277 ~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 277 SIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 112356789999999999999999998874
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-23 Score=203.20 Aligned_cols=177 Identities=18% Similarity=0.203 Sum_probs=123.2
Q ss_pred eeecccccCCCCccccCC--CCCCcchhhhHhHHHHHHHHHhhe-eeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 245 YELYRFLVDTPTVTVTAP--NKTSKRWITIAEAASAIIVFLLST-SFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
+.++.|..++.+...... .........++.+++.++.++|.. +.. ||||||+|||++.++.+||+|||++
T Consensus 98 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-------Hrdlkp~nill~~~~~~kl~dfg~~ 170 (283)
T PHA02988 98 SLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP-------YKNLTSVSFLVTENYKLKIICHGLE 170 (283)
T ss_pred EEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCC-------CCcCChhhEEECCCCcEEEcccchH
Confidence 445566655544333211 122445566777788888888863 433 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhh--CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAME--GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
+...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+. ..+.
T Consensus 171 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~---~~~~~~~i~---~~~~ 239 (283)
T PHA02988 171 KILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT---TKEIYDLII---NKNN 239 (283)
T ss_pred hhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC---HHHHHHHHH---hcCC
Confidence 8653321 12467889999999976 678999999999999999999999975321 111111111 1111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.. ..+......+.+++.+||+.||++|||+.||++.|+..
T Consensus 240 ~~---------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 240 SL---------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CC---------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 00 11112234577899999999999999999999999764
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-23 Score=193.65 Aligned_cols=157 Identities=23% Similarity=0.317 Sum_probs=119.5
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
+.++..++..++..++.|+|+..++ ||||||+|||+|++.++||+|||++..+..+.. ....+||++|+|
T Consensus 121 SEK~tR~iMrqlfegVeylHa~~IV-------HRDLKpENILlddn~~i~isDFGFa~~l~~Gek---LrelCGTPgYLA 190 (411)
T KOG0599|consen 121 SEKETRRIMRQLFEGVEYLHARNIV-------HRDLKPENILLDDNMNIKISDFGFACQLEPGEK---LRELCGTPGYLA 190 (411)
T ss_pred cHHHHHHHHHHHHHHHHHHHHhhhh-------hcccChhheeeccccceEEeccceeeccCCchh---HHHhcCCCcccC
Confidence 4677888999999999999999888 999999999999999999999999998765443 345799999999
Q ss_pred hhhhh------hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHH
Q 011196 345 PEYAM------EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELL 418 (491)
Q Consensus 345 PE~~~------~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 418 (491)
||.+. ...|+..+|+|++|+++|-++.|.+|| ++..+ + ...+++.++...- - .+.-.+...
T Consensus 191 PEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF--wHRkQ---m--lMLR~ImeGkyqF-~-----speWadis~ 257 (411)
T KOG0599|consen 191 PETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF--WHRKQ---M--LMLRMIMEGKYQF-R-----SPEWADISA 257 (411)
T ss_pred hhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch--hHHHH---H--HHHHHHHhccccc-C-----Ccchhhccc
Confidence 99875 234889999999999999999999995 22111 1 1122222332110 0 011123344
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 419 KYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 419 ~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
...+|+.+||+.||.+|.|++|++++
T Consensus 258 ~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 258 TVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cHHHHHHHHHeeCchhcccHHHHhcC
Confidence 56779999999999999999998764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=197.40 Aligned_cols=125 Identities=22% Similarity=0.369 Sum_probs=104.0
Q ss_pred eeeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC------CCce
Q 011196 243 IRYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE------MNPK 314 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~------~~~k 314 (491)
.-|.++.|.+++++..... ........+.+..+++.++++||..+++ ||||||.||||+.. -.+|
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~Ii-------HRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNII-------HRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee-------eccCCcceEEeccCCCCCCCceEE
Confidence 4567778887776644432 2334566778999999999999998888 99999999999865 4579
Q ss_pred EeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCC
Q 011196 315 ISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSG 377 (491)
Q Consensus 315 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~ 377 (491)
|+|||+++.+... ....+.+|++.|||||++..++|+.|+|+||+|+++||+++|+.||+
T Consensus 156 IADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 156 IADFGFARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred ecccchhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999999987533 23456899999999999999999999999999999999999999975
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-23 Score=204.52 Aligned_cols=165 Identities=19% Similarity=0.193 Sum_probs=116.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++..... .......|+..|+||
T Consensus 109 ~~~~~~i~~qi~~aL~~lH~~~ii-------H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aP 178 (290)
T cd07862 109 TETIKDMMFQLLRGLDFLHSHRVV-------HRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAP 178 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------eCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccCh
Confidence 445667888999999999988776 9999999999999999999999999865432 122345789999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc---CCccc---cccchhc--CCCC----
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE---GHAAE---LMDSVVK--QSCD---- 413 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~---~~d~~l~--~~~~---- 413 (491)
|++.+..++.++|||||||++|||++|++||..... ......+...... ..+.. +...... ...+
T Consensus 179 E~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (290)
T cd07862 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKF 255 (290)
T ss_pred HHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHH
Confidence 999988899999999999999999999999753221 1222222111110 00000 0000000 0000
Q ss_pred -HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 414 -QAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 414 -~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
......+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 256 VTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred ccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 112234568999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-23 Score=211.44 Aligned_cols=161 Identities=25% Similarity=0.393 Sum_probs=118.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||+++++.+||+|||+++...............++..|+||
T Consensus 211 ~~~~~~i~~qi~~aL~yLH~~gii-------HrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP 283 (374)
T cd05106 211 LDDLLRFSSQVAQGMDFLASKNCI-------HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 283 (374)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEE-------eccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCH
Confidence 344567888899999999988776 9999999999999999999999999865433322222223456789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++|||++ |+.||...... .. .+.....+.... . +......+.+++
T Consensus 284 E~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~--~~----~~~~~~~~~~~~--~-------~~~~~~~l~~li 348 (374)
T cd05106 284 ESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--SK----FYKMVKRGYQMS--R-------PDFAPPEIYSIM 348 (374)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--HH----HHHHHHcccCcc--C-------CCCCCHHHHHHH
Confidence 99988899999999999999999997 99997543211 11 111111111000 0 001124567889
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++||++.+|+++|++.
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-23 Score=207.23 Aligned_cols=161 Identities=27% Similarity=0.374 Sum_probs=120.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..+++ ||||||+|||+++++.+||+|||+++.+.............++..|+||
T Consensus 172 ~~~~~~~~~qi~~aL~~lH~~~iv-------HrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 172 LEDLISYSFQVARGMEFLASRKCI-------HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 455677888999999999988777 9999999999999999999999999875433322223334567789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++|||||||+++|+++ |..||...... . ........+.... .+.....++.+++
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---~---~~~~~~~~~~~~~---------~~~~~~~~~~~l~ 309 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---E---EFCRRLKEGTRMR---------APEYATPEIYSIM 309 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---H---HHHHHHhccCCCC---------CCccCCHHHHHHH
Confidence 99999999999999999999999998 99887532111 1 1111111111110 1112234578899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.+|++||++.||+++|+..
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-23 Score=204.20 Aligned_cols=162 Identities=25% Similarity=0.326 Sum_probs=121.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++................++..|+||
T Consensus 122 ~~~~~~i~~~i~~al~~lH~~~i~-------H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 194 (291)
T cd05094 122 LSQMLHIASQIASGMVYLASQHFV-------HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 194 (291)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------ecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecCh
Confidence 345667788888889999887776 9999999999999999999999999765433222222334567889999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++|||++ |+.|+..... .. .+.....+...+. +......+.+++
T Consensus 195 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~----~~~~~~~~~~~~~---------~~~~~~~~~~li 258 (291)
T cd05094 195 ESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TE----VIECITQGRVLER---------PRVCPKEVYDIM 258 (291)
T ss_pred HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HH----HHHHHhCCCCCCC---------CccCCHHHHHHH
Confidence 99998889999999999999999998 9988643211 11 2222222222211 111234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcCCC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASDIV 450 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~~~ 450 (491)
.+||+.||++||++.+|+++|+....
T Consensus 259 ~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 259 LGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHcccChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-23 Score=226.21 Aligned_cols=185 Identities=26% Similarity=0.330 Sum_probs=139.5
Q ss_pred ceeeeecccccCCCCcccc---------CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC
Q 011196 242 SIRYELYRFLVDTPTVTVT---------APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN 312 (491)
Q Consensus 242 ~lry~~~~f~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~ 312 (491)
.-++.+.+|.+++++.... +....-++.+.++.+++.++.||+...++ ||||-.+|+||++...
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fv-------HRDLAaRNCLL~~~r~ 840 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFV-------HRDLAARNCLLDERRV 840 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCc-------CcchhhhheeecccCc
Confidence 3455666777777654332 22334567888999999999999999888 9999999999999999
Q ss_pred ceEeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHH
Q 011196 313 PKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYI 391 (491)
Q Consensus 313 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 391 (491)
+||+|||+++.+-..+.........-...|||||.+..+.|+.|+|||||||++||+++ |..|+...+ +.++.
T Consensus 841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~---n~~v~--- 914 (1025)
T KOG1095|consen 841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS---NFEVL--- 914 (1025)
T ss_pred EEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc---hHHHH---
Confidence 99999999996544444433333345679999999999999999999999999999999 788865322 22222
Q ss_pred HHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 392 WKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 392 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
..+.++. +-+.+..+...+.+||+.||+.+|++||++..|++.+....
T Consensus 915 -~~~~~gg---------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 915 -LDVLEGG---------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred -HHHHhCC---------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 2122222 11234456677889999999999999999999999886653
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-23 Score=197.41 Aligned_cols=195 Identities=18% Similarity=0.205 Sum_probs=132.8
Q ss_pred EEEceecceeeeecccccCCCCccccCCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCce
Q 011196 235 RIFCASCSIRYELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPK 314 (491)
Q Consensus 235 ~i~~~~C~lry~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~k 314 (491)
.++..--++..+..+|+...+... ........+++..|+..++.++|...++ ||||||.||||+++|.+|
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~---~g~~~~~ik~~m~Qll~gl~~~H~~~Il-------HRDLKPQNlLi~~~G~lK 160 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKP---QGLPPRLIKSFMRQLLRGLAFLHSHGIL-------HRDLKPQNLLISSSGVLK 160 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccc---cCCCHHHHHHHHHHHHHHHHHHHhCCee-------cccCCcceEEECCCCcEe
Confidence 444444444444555554333211 1111245778899999999999998888 999999999999999999
Q ss_pred EeccCcceecCCCCcccccCceeecCCCChhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHH
Q 011196 315 ISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWK 393 (491)
Q Consensus 315 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 393 (491)
|+|||+++...-+.. .....++|.+|+|||++.+. .|+...||||+||++.||+++++-|..... .+.+..+.+
T Consensus 161 laDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~ 235 (323)
T KOG0594|consen 161 LADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFR 235 (323)
T ss_pred eeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHH
Confidence 999999996653322 13346789999999999987 699999999999999999998887754332 344444444
Q ss_pred HhhcC---Cccccc---c---chhcC----CCCH---HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 394 LWCEG---HAAELM---D---SVVKQ----SCDQ---AELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 394 ~~~~~---~~~~~~---d---~~l~~----~~~~---~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..... .|+.+. + +.... .... .......+++.+||+++|++|.|++.++.+
T Consensus 236 ~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 236 LLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 33222 222111 0 00000 0000 001357789999999999999999998876
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-23 Score=217.49 Aligned_cols=178 Identities=19% Similarity=0.210 Sum_probs=125.9
Q ss_pred eeeecccccCCCCccccC------CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEec
Q 011196 244 RYELYRFLVDTPTVTVTA------PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISD 317 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~D 317 (491)
.+.++.|..++.+..... ..........++.+++.++.++|..+++ ||||||+|||++.++.+||+|
T Consensus 114 i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~Ii-------HrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMI-------HRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred EEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEe-------cCCCCHHHEEEeCCCCEEEEe
Confidence 455666666554432211 1122334556777888888899887666 999999999999999999999
Q ss_pred cCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 318 FGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 318 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ... +......
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~-~~~~~~~ 259 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEE-VMHKTLA 259 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHH-HHHHHhc
Confidence 999987654332223344679999999999999899999999999999999999999975321 111 1111111
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
+.... .+......+.+++.+||+.||++||++.+++++
T Consensus 260 ~~~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRYDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111 111223457789999999999999999999864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.9e-23 Score=208.13 Aligned_cols=154 Identities=22% Similarity=0.248 Sum_probs=121.2
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
..+.......++..++.|.|+.++. ||||||+|+|||.++++||+|||+|.....+. ...+.+|++.|.+
T Consensus 110 ~e~eaa~ff~QIi~gv~yCH~~~ic-------HRDLKpENlLLd~~~nIKIADFGMAsLe~~gk---lLeTSCGSPHYA~ 179 (786)
T KOG0588|consen 110 PEREAAHFFRQILDGVSYCHAFNIC-------HRDLKPENLLLDVKNNIKIADFGMASLEVPGK---LLETSCGSPHYAA 179 (786)
T ss_pred CCHHHHHHHHHHHHHHHHHhhhcce-------eccCCchhhhhhcccCEeeeccceeecccCCc---cccccCCCcccCC
Confidence 4666777888999999999998888 99999999999999999999999998654433 2345799999999
Q ss_pred hhhhhhCCCC-cccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFS-VKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s-~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+.+|. .++||||+||||+.|++|+.||+ +++...++..+. .|. .++ +.....++.+|
T Consensus 180 PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV~----~G~-f~M---------Ps~Is~eaQdL 242 (786)
T KOG0588|consen 180 PEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKVQ----RGV-FEM---------PSNISSEAQDL 242 (786)
T ss_pred chhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHHH----cCc-ccC---------CCcCCHHHHHH
Confidence 9999999985 68999999999999999999986 223233333332 221 122 22233456778
Q ss_pred HHHcccCCCCCCCCHHHHHHHh
Q 011196 424 GLLCVQEDPMDRPTMSSVAVML 445 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L 445 (491)
+.+|+..||++|.|++||+++-
T Consensus 243 Lr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 243 LRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HHHHhccCccccccHHHHhhCc
Confidence 9999999999999999999863
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-22 Score=198.86 Aligned_cols=155 Identities=21% Similarity=0.250 Sum_probs=114.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++........ .....|+..|+||
T Consensus 101 ~~~~~~~~~qi~~~l~~lH~~~ii-------H~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aP 170 (285)
T cd05631 101 EQRAIFYAAELCCGLEDLQRERIV-------YRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAP 170 (285)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEE-------eCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---ecCCCCCCCccCH
Confidence 445667788889999999988777 999999999999999999999999987543222 1235689999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|++.+..++.++|||||||++|||++|+.||....... ............. . .++......+.+|+.
T Consensus 171 E~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~-~---------~~~~~~s~~~~~li~ 237 (285)
T cd05631 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---KREEVDRRVKEDQ-E---------EYSEKFSEDAKSICR 237 (285)
T ss_pred hhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch---hHHHHHHHhhccc-c---------cCCccCCHHHHHHHH
Confidence 99999999999999999999999999999976432211 1111111111110 0 011112235677899
Q ss_pred HcccCCCCCCCC-----HHHHHH
Q 011196 426 LCVQEDPMDRPT-----MSSVAV 443 (491)
Q Consensus 426 ~cl~~dP~~RPs-----~~evl~ 443 (491)
+||+.||++||+ +.++++
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhc
Confidence 999999999997 777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.5e-23 Score=206.48 Aligned_cols=173 Identities=19% Similarity=0.241 Sum_probs=127.8
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC-CCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE-MNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~-~~~kl~DfGl 320 (491)
-|.+..|..++.+..... ..........+..|++.++.|+|..+++ ||||||+|||++.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~-------HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIV-------HRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEe-------eCCCCHHHEEecCCCCCEEEecccc
Confidence 556666665544432221 2223456777899999999999999998 99999999999999 9999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCC-CC-cccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI-FS-VKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+. .....+... +..+
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d---~~~~~l~~k----i~~~ 238 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD---SNVPNLYRK----IRKG 238 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC---ccHHHHHHH----HhcC
Confidence 98774 1222344579999999999999877 86 789999999999999999999864 222222221 2221
Q ss_pred C--ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 399 H--AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 399 ~--~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
. .+..++ ...+..++.+|++.||.+|+++.+|++
T Consensus 239 ~~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 239 EFKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1 111111 345677899999999999999999983
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-23 Score=200.45 Aligned_cols=160 Identities=20% Similarity=0.272 Sum_probs=118.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..+++ ||||||+|||+++++.+||+|||+++...............++..|++|
T Consensus 108 ~~~~~~i~~qi~~~l~~lH~~~ii-------H~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~p 180 (279)
T cd05111 108 PQRLLNWCVQIAKGMYYLEEHRMV-------HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180 (279)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEe-------ccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCH
Confidence 445677888999999999987766 9999999999999999999999999876433322222334567889999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.++.++.++||||||+++||+++ |+.|+..... .. . ......+.... .+. .....+.+++
T Consensus 181 E~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~-~---~~~~~~~~~~~--~~~-------~~~~~~~~li 244 (279)
T cd05111 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---HE-V---PDLLEKGERLA--QPQ-------ICTIDVYMVM 244 (279)
T ss_pred HHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HH-H---HHHHHCCCcCC--CCC-------CCCHHHHHHH
Confidence 99998899999999999999999998 9888743211 11 1 11111211111 110 1123456788
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||..||++||++.|+++.|...
T Consensus 245 ~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 245 VKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred HHHcCCCcccCcCHHHHHHHHHHH
Confidence 999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.7e-23 Score=186.05 Aligned_cols=188 Identities=15% Similarity=0.139 Sum_probs=132.9
Q ss_pred ecceeeeecccccCCCCccccCC------CCCCcchhhhHhHHHHHHHHHhhee--eEEeEEeeeccccccccccccCCC
Q 011196 240 SCSIRYELYRFLVDTPTVTVTAP------NKTSKRWITIAEAASAIIVFLLSTS--FLWCIIRRRNKRVRASNVLLDHEM 311 (491)
Q Consensus 240 ~C~lry~~~~f~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~~iHrDlKp~NILl~~~~ 311 (491)
+-...|.+.|||..++....... ..+..+.+.+...+..++.++|... +. ||||||.|||+.+++
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yA-------H~DiKP~NILls~~~ 166 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYA-------HRDIKPANILLSDSG 166 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCccc-------ccCCCcceeEecCCC
Confidence 34567889999988866433211 1234566777888888999999887 66 999999999999999
Q ss_pred CceEeccCcceecCCC---Cc----ccccCceeecCCCChhhhhh---hCCCCcccceeehhHHHHHHHhCCCCCCCccC
Q 011196 312 NPKISDFGMARIFGGN---QS----EANTNRVVGTYGYMAPEYAM---EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHL 381 (491)
Q Consensus 312 ~~kl~DfGla~~~~~~---~~----~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~ 381 (491)
.++|.|||.+....-. .. .........|..|+|||.+. +...++++|||||||++|+|+.|..||+..-.
T Consensus 167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 9999999998764311 10 01112235688999999886 34578999999999999999999999752111
Q ss_pred CCcccHHHHHHHHhhcCCc-cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 382 EHGPSLLAYIWKLWCEGHA-AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
..+.+ ..+....+.........+.+.+++.+|++.||.+||++.+++..+...
T Consensus 247 --------------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 --------------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred --------------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111 111121221111222456688899999999999999999999988754
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.6e-23 Score=209.36 Aligned_cols=161 Identities=24% Similarity=0.403 Sum_probs=118.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............++..|+||
T Consensus 213 ~~~~~~~~~qi~~~l~~lH~~~iv-------H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 285 (375)
T cd05104 213 TEDLLSFSYQVAKGMSFLASKNCI-------HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAP 285 (375)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------ccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeCh
Confidence 455677888999999999988776 9999999999999999999999999876443322222233456789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++|||++ |..||..... .. ..++....+.... . +.....++.+|+
T Consensus 286 E~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--~~----~~~~~~~~~~~~~--~-------~~~~~~~l~~li 350 (375)
T cd05104 286 ESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DS----KFYKMIKEGYRML--S-------PECAPSEMYDIM 350 (375)
T ss_pred hHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--hH----HHHHHHHhCccCC--C-------CCCCCHHHHHHH
Confidence 99999999999999999999999998 7888643211 11 1122222221110 0 011123567899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++||++.||+++|++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHccCChhHCcCHHHHHHHHHhh
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-23 Score=200.19 Aligned_cols=197 Identities=20% Similarity=0.211 Sum_probs=127.8
Q ss_pred eeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 244 RYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.|.++.|+.......... ........+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~-------H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYI-------HRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCee-------ccccChheEEEcCCCcEEEeeccccc
Confidence 345555554443322211 1233455677888888999999987766 99999999999999999999999998
Q ss_pred ecCCCCccc-ccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 323 IFGGNQSEA-NTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 323 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
......... ......++..|++||.+.+..++.++||||||++++||++|..|+......- .................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLI 234 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhh
Confidence 664322211 1112345667999999988889999999999999999999999864322110 00000000000000111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+..+.......+......+.+++.+||+.||++||++++|+++|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111111111222345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.2e-23 Score=201.47 Aligned_cols=157 Identities=27% Similarity=0.372 Sum_probs=115.8
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhh
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY 347 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 347 (491)
....++.+++.++.++|..+++ ||||||+||++++++.+||+|||+++...............+++.|+|||+
T Consensus 125 ~~~~~~~ql~~aL~~lH~~gi~-------H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 197 (283)
T cd05091 125 DFVHIVTQIAAGMEFLSSHHVV-------HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEA 197 (283)
T ss_pred HHHHHHHHHHHHHHHHHHcCcc-------ccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHH
Confidence 4556778888899999987766 999999999999999999999999886543322222233455778999999
Q ss_pred hhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHH
Q 011196 348 AMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLL 426 (491)
Q Consensus 348 ~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~ 426 (491)
+.++.++.++||||||+++|||++ |..|+.... ... ............ .+......+.+++..
T Consensus 198 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~----~~~~i~~~~~~~---------~~~~~~~~~~~li~~ 261 (283)
T cd05091 198 IMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQD----VIEMIRNRQVLP---------CPDDCPAWVYTLMLE 261 (283)
T ss_pred HhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---HHH----HHHHHHcCCcCC---------CCCCCCHHHHHHHHH
Confidence 998889999999999999999998 777764321 111 122222221111 111223446789999
Q ss_pred cccCCCCCCCCHHHHHHHhhc
Q 011196 427 CVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 427 cl~~dP~~RPs~~evl~~L~~ 447 (491)
||+.+|++||++.+|+..|+.
T Consensus 262 cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 262 CWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HhCCCcccCCCHHHHHHHhhC
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-22 Score=197.48 Aligned_cols=164 Identities=13% Similarity=0.110 Sum_probs=117.4
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc-----cccCceeecCC
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE-----ANTNRVVGTYG 341 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~ 341 (491)
.....++.+++.++.++|..+++ ||||||+|||++.++.+||+|||+++.+...... .......||+.
T Consensus 126 ~~~~~i~~qi~~~l~~lH~~~ii-------HrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~ 198 (294)
T PHA02882 126 KLIKNIMKDMLTTLEYIHEHGIS-------HGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLY 198 (294)
T ss_pred HHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCcc
Confidence 34556888899999999987776 9999999999999999999999999876422111 11223468999
Q ss_pred CChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 342 YMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 342 y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
|+|||++.+..++.++|||||||+++||++|+.||...... ..........+. ..+....+... .....+.
T Consensus 199 y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~---~~~~~~~ 269 (294)
T PHA02882 199 YAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN--GNLIHAAKCDFI----KRLHEGKIKIK---NANKFIY 269 (294)
T ss_pred ccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc--hHHHHHhHHHHH----HHhhhhhhccC---CCCHHHH
Confidence 99999999889999999999999999999999998643221 121111111000 00000100000 1134577
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhh
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~~L~ 446 (491)
+++..||+.+|++||++.++++.|.
T Consensus 270 ~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 270 DFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 8999999999999999999998763
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.8e-23 Score=201.55 Aligned_cols=167 Identities=19% Similarity=0.181 Sum_probs=116.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++........ ......|+..|+||
T Consensus 99 ~~~~~~~~~qi~~~L~~lH~~~i~-------H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aP 170 (287)
T cd07848 99 PEKVRSYIYQLIKAIHWCHKNDIV-------HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSP 170 (287)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccCCc
Confidence 445667888899999999988777 9999999999999999999999999875432221 12245789999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHH-----------Hhh-cCCccccccchhcCC--
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWK-----------LWC-EGHAAELMDSVVKQS-- 411 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~-----------~~~-~~~~~~~~d~~l~~~-- 411 (491)
|++.+..++.++|||||||++|||++|+.||...... .....+.. .+. .........+.....
T Consensus 171 E~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (287)
T cd07848 171 ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI---DQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQS 247 (287)
T ss_pred HHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCccc
Confidence 9999888999999999999999999999997643211 11111110 000 000000000000000
Q ss_pred ----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 412 ----CDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 412 ----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
........+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 248 LERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00112345788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-22 Score=195.35 Aligned_cols=158 Identities=23% Similarity=0.370 Sum_probs=115.2
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
.....++.+++.++.+||..+++ ||||||+||++++++.+||+|||+++...............++..|+|||
T Consensus 119 ~~~~~~~~~l~~~l~~lH~~~~v-------H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05062 119 KKMIQMAGEIADGMAYLNANKFV-------HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHCCcc-------cCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChh
Confidence 34556677888899999987766 99999999999999999999999987654332222222234577899999
Q ss_pred hhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
++.++.++.++||||||+++|||++ |..||.... ... ............. +......+.+++.
T Consensus 192 ~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~---~~~----~~~~~~~~~~~~~---------~~~~~~~~~~li~ 255 (277)
T cd05062 192 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS---NEQ----VLRFVMEGGLLDK---------PDNCPDMLFELMR 255 (277)
T ss_pred HhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHH----HHHHHHcCCcCCC---------CCCCCHHHHHHHH
Confidence 9998889999999999999999999 677764221 111 1111222211111 1112345778999
Q ss_pred HcccCCCCCCCCHHHHHHHhhc
Q 011196 426 LCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L~~ 447 (491)
+||+.||++||++.|+++.|++
T Consensus 256 ~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 256 MCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCChhhCcCHHHHHHHhhC
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.5e-23 Score=200.43 Aligned_cols=184 Identities=16% Similarity=0.219 Sum_probs=131.6
Q ss_pred ceeeeecccccCCCCccccCCC--CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 242 SIRYELYRFLVDTPTVTVTAPN--KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 242 ~lry~~~~f~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
.-.|.+..|...++..-.+... ......+.+...+..++.|||..+++ ||||||+|+||+++|++||+|||
T Consensus 183 ~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qgii-------HRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 183 DKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGII-------HRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred CceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCee-------ccccchhheEEcCCCcEEeeccc
Confidence 3445566665544432222222 34667788999999999999998888 99999999999999999999999
Q ss_pred cceecCCCCc---ccccCceeecCCCChhhhhhhCC----CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHH
Q 011196 320 MARIFGGNQS---EANTNRVVGTYGYMAPEYAMEGI----FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIW 392 (491)
Q Consensus 320 la~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 392 (491)
.+..+..... .......+||+.|+|||.+.++. .+.+.||||+||+||.++.|+.||-. + ......
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~---~----~~~~l~ 328 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD---D----FELELF 328 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---c----hHHHHH
Confidence 9987633211 11223468999999999998743 35789999999999999999999742 1 111112
Q ss_pred HHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 011196 393 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 393 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
..+ +...+.....+++...+.+|++++|++||++|.+..+|..+.--
T Consensus 329 ~KI--------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 329 DKI--------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred HHH--------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 211 22222222233556677889999999999999999999877643
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-22 Score=205.34 Aligned_cols=172 Identities=19% Similarity=0.217 Sum_probs=119.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............||..|+||
T Consensus 184 ~~~~~~i~~ql~~aL~~LH~~giv-------HrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aP 256 (392)
T PHA03207 184 LEQAITIQRRLLEALAYLHGRGII-------HRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSP 256 (392)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------ccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCH
Confidence 456677888899999999987766 9999999999999999999999999765443332233346789999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc-------cc------ccchhcCCC
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA-------EL------MDSVVKQSC 412 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~------~d~~l~~~~ 412 (491)
|++.+..++.++|||||||++|||++|+.||...........+..+.+........ .+ .....+...
T Consensus 257 E~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (392)
T PHA03207 257 ELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPY 336 (392)
T ss_pred hHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCc
Confidence 99998899999999999999999999999975433322222222222211110000 00 000000000
Q ss_pred C-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 413 D-------QAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 413 ~-------~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
. ......+.+++.+||+.||++||++.|++.+
T Consensus 337 ~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 337 TIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0112346678899999999999999998875
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=198.05 Aligned_cols=158 Identities=26% Similarity=0.355 Sum_probs=116.3
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
.....+..+++.++.++|..++. ||||||+||+++.++.+||+|||+++...............++..|+|||
T Consensus 122 ~~~~~~~~~i~~~l~~lH~~~i~-------h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (280)
T cd05049 122 SQLLQIAVQIASGMVYLASQHFV-------HRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPE 194 (280)
T ss_pred HHHHHHHHHHHHHHHHHhhCCee-------ccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChh
Confidence 34566777888888889887766 99999999999999999999999997653322222222345578899999
Q ss_pred hhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
++.++.++.++||||||+++|||++ |..||.... ....... ...+..... +......+.+++.
T Consensus 195 ~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~---~~~~~~~----~~~~~~~~~---------~~~~~~~~~~li~ 258 (280)
T cd05049 195 SIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS---NEEVIEC----ITQGRLLQR---------PRTCPSEVYDIML 258 (280)
T ss_pred hhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH----HHcCCcCCC---------CCCCCHHHHHHHH
Confidence 9999999999999999999999998 999864221 1112221 112211111 1112345678999
Q ss_pred HcccCCCCCCCCHHHHHHHhhc
Q 011196 426 LCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L~~ 447 (491)
+||+.||++||++.||++.|++
T Consensus 259 ~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 259 GCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHcCCCcccCCCHHHHHHHhhC
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=196.42 Aligned_cols=159 Identities=20% Similarity=0.348 Sum_probs=117.1
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
.....++.+++.++.++|..++. ||||||+||++++++.+||+|||+++...............++..|++||
T Consensus 113 ~~~~~~~~~i~~aL~~lH~~~i~-------H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 185 (273)
T cd05035 113 QTLLKFMVDIALGMEYLSNRNFI-------HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE 185 (273)
T ss_pred HHHHHHHHHHHHHHHHHHhCCee-------ccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHh
Confidence 34566778888888999887766 99999999999999999999999998764433222222233467899999
Q ss_pred hhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
++.+..++.++||||||+++|||++ |..||... ......... ..+.... .+......+.+++.
T Consensus 186 ~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~---~~~~~~~~~----~~~~~~~---------~~~~~~~~~~~li~ 249 (273)
T cd05035 186 SLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV---ENHEIYDYL----RHGNRLK---------QPEDCLDELYDLMY 249 (273)
T ss_pred hcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHH----HcCCCCC---------CCcCCCHHHHHHHH
Confidence 9988889999999999999999999 88886432 112222221 1111111 11123346788999
Q ss_pred HcccCCCCCCCCHHHHHHHhhcC
Q 011196 426 LCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+||+.||++||++.||++.|+..
T Consensus 250 ~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 250 SCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHcCCChhhCcCHHHHHHHHHhh
Confidence 99999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-22 Score=201.59 Aligned_cols=178 Identities=16% Similarity=0.185 Sum_probs=121.9
Q ss_pred eeeecccccCCCCccccCC--CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTAP--NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.+..|+.++.+...... .........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 68 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~-------HrDlkp~Nili~~~~~~kl~Dfg~~ 140 (312)
T cd05585 68 LYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI-------YRDLKPENILLDYQGHIALCDFGLC 140 (312)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE-------eCCCCHHHeEECCCCcEEEEECccc
Confidence 3555566655443222211 123445566778888999999988777 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+....... ......||+.|+|||++.+..++.++|||||||+++||++|+.||.... ... ..+.......
T Consensus 141 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~-~~~~~~~~~~- 210 (312)
T cd05585 141 KLNMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNE-MYRKILQEPL- 210 (312)
T ss_pred ccCccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHH-HHHHHHcCCC-
Confidence 75432221 2234678999999999999889999999999999999999999975321 111 1111111110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
..+......+.+++.+||+.||++||++.++.+.|+.
T Consensus 211 ---------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 211 ---------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 0111122346678999999999999865444444444
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-22 Score=204.32 Aligned_cols=170 Identities=16% Similarity=0.139 Sum_probs=114.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.++|..+++ ||||||+|||++.++.+||+|||+++...... ........||+.|+||
T Consensus 181 ~~~~~~i~~qi~~aL~ylH~~~Iv-------HrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aP 252 (391)
T PHA03212 181 ICDILAIERSVLRAIQYLHENRII-------HRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAP 252 (391)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------cCCCChHhEEEcCCCCEEEEeCCccccccccc-ccccccccCccCCCCh
Confidence 445667788888999999987666 99999999999999999999999997532211 1122245789999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCC----cccHHHHHHHHhhcCC--c--------cccc-------
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEH----GPSLLAYIWKLWCEGH--A--------AELM------- 404 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~----~~~~~~~~~~~~~~~~--~--------~~~~------- 404 (491)
|++.+..++.++|||||||++|||++|+.|+....... ....+..+........ . .+..
T Consensus 253 E~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 332 (391)
T PHA03212 253 ELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKS 332 (391)
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhcc
Confidence 99998899999999999999999999998753221110 0111111111110000 0 0000
Q ss_pred --cchhcCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 405 --DSVVKQS--CDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 405 --d~~l~~~--~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+..... ........+.+|+.+||+.||++|||+.|+++
T Consensus 333 ~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 333 SRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred CCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 00112346778999999999999999999885
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=198.05 Aligned_cols=160 Identities=21% Similarity=0.293 Sum_probs=117.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..+++ ||||||+|||+++++.+||+|||+++...............++..|++|
T Consensus 108 ~~~~~~~~~qi~~~L~~lH~~~ii-------H~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~P 180 (279)
T cd05109 108 SQDLLNWCVQIAKGMSYLEEVRLV-------HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180 (279)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------ccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCH
Confidence 445677888999999999987776 9999999999999999999999999876433222112223346789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|...+..++.++||||||+++||+++ |..|+.... ..... .....+..... +......+.+++
T Consensus 181 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~----~~~~~~~~~~~---------~~~~~~~~~~li 244 (279)
T cd05109 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP---AREIP----DLLEKGERLPQ---------PPICTIDVYMIM 244 (279)
T ss_pred HHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHH----HHHHCCCcCCC---------CccCCHHHHHHH
Confidence 99988889999999999999999998 888864321 11111 11111111110 111234567899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++||++.++++.|+..
T Consensus 245 ~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 245 VKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHh
Confidence 999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=193.64 Aligned_cols=165 Identities=22% Similarity=0.317 Sum_probs=116.1
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
.....++.+++.++++||..++. ||||||+||+++.++.+||+|||++................++..|+|||
T Consensus 129 ~~~~~i~~~i~~al~~lH~~~i~-------H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 201 (295)
T cd05097 129 ANLLYMAVQIASGMKYLASLNFV-------HRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE 201 (295)
T ss_pred HHHHHHHHHHHHHHHHHHhcCee-------ccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChh
Confidence 34566788888999999988777 99999999999999999999999997653322222223345577899999
Q ss_pred hhhhCCCCcccceeehhHHHHHHHh--CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIIS--GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
++.++.++.++||||||++++||++ |..||.... ...........+......... ..+......+.+|+
T Consensus 202 ~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li 272 (295)
T cd05097 202 SILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS---DEQVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLM 272 (295)
T ss_pred hhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC---hHHHHHHHHHhhhhccccccC------CCCCCCCHHHHHHH
Confidence 9998889999999999999999998 445543221 122222222211111110000 00111234678899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhc
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.+||+.||++||++.+|++.|+.
T Consensus 273 ~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 273 MRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHcCCCchhCcCHHHHHHHHhC
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-22 Score=192.52 Aligned_cols=163 Identities=18% Similarity=0.171 Sum_probs=117.3
Q ss_pred hhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC-CCceEeccCcceecCCCCcccccCceeecCCCChhhh
Q 011196 269 WITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE-MNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY 347 (491)
Q Consensus 269 ~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~-~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 347 (491)
.+....|+..++.|||..++. ||||||.|+|+|.+ |.+||+|||.|+.+..++.. ....-|..|+|||.
T Consensus 127 iKLYt~Qlfrgl~yLh~~~Ic-------HRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPEL 196 (364)
T KOG0658|consen 127 IKLYTYQLFRGLAYLHSHGIC-------HRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPEL 196 (364)
T ss_pred eHHHHHHHHHHHHHHHhcCcc-------cCCCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHH
Confidence 445677888888888887777 99999999999987 88999999999987655443 23567899999999
Q ss_pred hhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc----------ccccchhcC-----C
Q 011196 348 AMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA----------ELMDSVVKQ-----S 411 (491)
Q Consensus 348 ~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~d~~l~~-----~ 411 (491)
+.+. .|+.+.||||.|||+.||+-|++-|... ...+.+..+.+.+....-. +...+.+.. -
T Consensus 197 ifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~---s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~ 273 (364)
T KOG0658|consen 197 IFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD---SSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKV 273 (364)
T ss_pred HcCccccCceeEEhhhhHHHHHHhcCCcccCCC---CHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceee
Confidence 9875 5999999999999999999999987653 2333333333333222111 111111111 0
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 412 CDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 412 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.......+.++++.++|+++|.+|.++.|++.+
T Consensus 274 ~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 274 FFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 122334567789999999999999999987754
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-22 Score=212.16 Aligned_cols=177 Identities=15% Similarity=0.142 Sum_probs=124.4
Q ss_pred eeeecccccCCCCcccc------CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEec
Q 011196 244 RYELYRFLVDTPTVTVT------APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISD 317 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~D 317 (491)
.|.++.|..++++.... ..+........++.+++.++.++|..+++ ||||||+|||++.++.+||+|
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iv-------HrDlkp~NIll~~~~~~kL~D 212 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMM-------HRDLKSANIFLMPTGIIKLGD 212 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEE-------ECCcCHHhEEECCCCcEEEEe
Confidence 45666676655543211 11122334555777888888999887766 999999999999999999999
Q ss_pred cCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 318 FGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 318 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...... ... .
T Consensus 213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~---~~~~~~---~~~-~ 285 (478)
T PTZ00267 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS---QREIMQ---QVL-Y 285 (478)
T ss_pred CcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHH---HHH-h
Confidence 999987654332223344679999999999998889999999999999999999999974211 111111 111 1
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
+... + .+......+.+++.+||+.||++||++.+++.
T Consensus 286 ~~~~----~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 286 GKYD----P-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCC----C-----CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1111 0 11112245778999999999999999999864
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=202.66 Aligned_cols=160 Identities=21% Similarity=0.331 Sum_probs=117.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............++..|++|
T Consensus 108 ~~~~~~~~~qi~~~L~~LH~~~ii-------H~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ap 180 (316)
T cd05108 108 SQYLLNWCVQIAKGMNYLEERRLV-------HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCee-------ccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecCh
Confidence 344566788899999999987766 9999999999999999999999999876543322222223346789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++||+++ |+.|+.... ... .......+... ..+......+.+++
T Consensus 181 E~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~---~~~----~~~~~~~~~~~---------~~~~~~~~~~~~li 244 (316)
T cd05108 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASE----ISSILEKGERL---------PQPPICTIDVYMIM 244 (316)
T ss_pred HHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHH----HHHHHhCCCCC---------CCCCCCCHHHHHHH
Confidence 99999999999999999999999998 888874321 111 11111111100 00111223567899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++||++.+++..|...
T Consensus 245 ~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 245 VKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred HHHccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=203.04 Aligned_cols=175 Identities=17% Similarity=0.179 Sum_probs=122.1
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 70 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iv-------HrDlkp~NIll~~~~~~kl~DfG~a 142 (323)
T cd05571 70 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVV-------YRDLKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeE-------eCCCCHHHEEECCCCCEEEeeCCCC
Confidence 345556655544322211 1223445566778899999999988777 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...... ....+..
T Consensus 143 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~----~~~~~~~- 212 (323)
T cd05571 143 KEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFE----LILMEEI- 212 (323)
T ss_pred cccccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHHHHH----HHHcCCC-
Confidence 7532211 12234679999999999998889999999999999999999999974321 111111 1111110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAVM 444 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 444 (491)
.++......+.+++.+||+.||++|| ++.+++++
T Consensus 213 ---------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 213 ---------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ---------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 01111234567789999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-22 Score=198.37 Aligned_cols=158 Identities=28% Similarity=0.407 Sum_probs=115.4
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
.....++.+++.++.++|..+++ ||||||+|||++.++.+||+|||+++...............++..|+|||
T Consensus 124 ~~~~~i~~~i~~al~~lH~~~i~-------H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 196 (283)
T cd05090 124 GDFLHIAIQIAAGMEYLSSHFFV-------HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPE 196 (283)
T ss_pred HHHHHHHHHHHHHHHHHHhcCee-------hhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChH
Confidence 34556778888889999987766 99999999999999999999999998654332222223344567899999
Q ss_pred hhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
++.++.++.++||||||++++||++ |..||.... ..... .......... .+.....++.+++.
T Consensus 197 ~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~---~~~~~----~~~~~~~~~~---------~~~~~~~~~~~li~ 260 (283)
T cd05090 197 AIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---NQEVI----EMVRKRQLLP---------CSEDCPPRMYSLMT 260 (283)
T ss_pred HhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHH----HHHHcCCcCC---------CCCCCCHHHHHHHH
Confidence 9988889999999999999999998 888864321 11111 1111111111 11112245677899
Q ss_pred HcccCCCCCCCCHHHHHHHhhc
Q 011196 426 LCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L~~ 447 (491)
+||+.||++||++.+|.++|+.
T Consensus 261 ~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 261 ECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHcccCcccCcCHHHHHHHhhc
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-22 Score=199.72 Aligned_cols=166 Identities=14% Similarity=0.139 Sum_probs=113.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... ......++..|+||
T Consensus 102 ~~~~~~~~~qi~~aL~~LH~~~iv-------H~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aP 172 (288)
T cd07871 102 MHNVKIFMFQLLRGLSYCHKRKIL-------HRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPP 172 (288)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------cCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cccCceecccccCh
Confidence 345566788899999999987766 999999999999999999999999976533221 12235679999999
Q ss_pred hhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC---Cccc---------cccchhcCC-
Q 011196 346 EYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG---HAAE---------LMDSVVKQS- 411 (491)
Q Consensus 346 E~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~---------~~d~~l~~~- 411 (491)
|++.+ ..++.++||||+||++|||++|+.||..... .............. .+.. ...+.....
T Consensus 173 E~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
T cd07871 173 DVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV---KEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQP 249 (288)
T ss_pred HHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCc
Confidence 99875 4589999999999999999999999753221 11222221111100 0000 000000000
Q ss_pred ---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 412 ---CDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 412 ---~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.........++++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 250 LINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00011234678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-22 Score=196.12 Aligned_cols=160 Identities=28% Similarity=0.372 Sum_probs=117.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCccc-ccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEA-NTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~a 344 (491)
......++.+++.++.++|..+++ ||||||+||+++.++.+||+|||+++......... ......++..|+|
T Consensus 94 ~~~~~~i~~qi~~al~~lH~~~i~-------H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 166 (257)
T cd05116 94 EKNITELVHQVSMGMKYLEETNFV-------HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYA 166 (257)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEe-------ecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccC
Confidence 455677888899999999987766 99999999999999999999999998664332211 1112234578999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||.+....++.++||||||+++|||++ |+.||.... ...... ....+.... .+......+.++
T Consensus 167 PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~----~i~~~~~~~---------~~~~~~~~l~~l 230 (257)
T cd05116 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK---GNEVTQ----MIESGERME---------CPQRCPPEMYDL 230 (257)
T ss_pred HhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHH----HHHCCCCCC---------CCCCCCHHHHHH
Confidence 999988889999999999999999998 999975321 111111 122221111 111223456789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+.+||+.||++||++.+|++.|++-
T Consensus 231 i~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 231 MKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-22 Score=200.16 Aligned_cols=179 Identities=17% Similarity=0.193 Sum_probs=121.5
Q ss_pred eeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 245 YELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
|.++.|..++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv-------HrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIV-------YRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcE-------ecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 44555655544322211 1223455667788899999999987776 99999999999999999999999997
Q ss_pred ecCCCCcccccCceeecCCCChhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
........ ......||..|+|||++.+. .++.++|||||||++|||++|+.||........ ...+.......
T Consensus 154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~~~~~~~~~--- 226 (332)
T cd05614 154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QSEVSRRILKC--- 226 (332)
T ss_pred cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HHHHHHHHhcC---
Confidence 65332221 22345789999999999765 478899999999999999999999854322221 11121111111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAVM 444 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 444 (491)
++.+ +......+.+++.+||+.||++|| ++++++++
T Consensus 227 ---~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 ---DPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1111 111223466789999999999999 66677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.2e-22 Score=195.58 Aligned_cols=166 Identities=22% Similarity=0.322 Sum_probs=118.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++...............++..|+||
T Consensus 129 ~~~~~~~~~~i~~al~~LH~~~i~-------H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 201 (296)
T cd05051 129 FSTLLYMATQIASGMRYLESLNFV-------HRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW 201 (296)
T ss_pred HHHHHHHHHHHHHHHHHHHHcCcc-------ccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCH
Confidence 344566788888999999987766 9999999999999999999999999865433322223334567789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh--CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS--GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
|++.++.++.++||||||+++|||++ |..|+... ............+.......... .+.....++.++
T Consensus 202 E~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~l 272 (296)
T cd05051 202 ESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL---TDQQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYEL 272 (296)
T ss_pred HHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc---ChHHHHHHHHhccccccccccCC------CccCCCHHHHHH
Confidence 99988889999999999999999998 55564321 12222222222222111111111 111223467889
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhc
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
+.+||+.||++||++.||++.|+.
T Consensus 273 i~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 273 MLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHhccChhcCCCHHHHHHHhcC
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-22 Score=196.32 Aligned_cols=161 Identities=25% Similarity=0.344 Sum_probs=118.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.++|..+++ ||||||+||++++++.+||+|||+++...............++..|+||
T Consensus 119 ~~~~~~~~~ql~~aL~~lH~~~i~-------H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 191 (288)
T cd05093 119 QSQMLHIAQQIAAGMVYLASQHFV-------HRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 191 (288)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------ecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCH
Confidence 445667788888999999887776 9999999999999999999999999865433222222234457789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||++++||++ |..||.... ... .......+..... ... ....+.+|+
T Consensus 192 E~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~---~~~----~~~~i~~~~~~~~-----~~~----~~~~l~~li 255 (288)
T cd05093 192 ESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNE----VIECITQGRVLQR-----PRT----CPKEVYDLM 255 (288)
T ss_pred HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHH----HHHHHHcCCcCCC-----CCC----CCHHHHHHH
Confidence 99988889999999999999999998 888864221 111 1122222221111 111 223578899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
.+||+.||.+||++.+|++.|+...
T Consensus 256 ~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 256 LGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHHccCChhhCCCHHHHHHHHHHHH
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.4e-22 Score=199.04 Aligned_cols=176 Identities=17% Similarity=0.255 Sum_probs=121.2
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++...... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 71 ~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iv-------H~Dikp~Nili~~~~~~kL~DfG~~ 143 (329)
T cd05618 71 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGII-------YRDLKLDNVLLDSEGHIKLTDYGMC 143 (329)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee-------eCCCCHHHEEECCCCCEEEeeCCcc
Confidence 35555665544432211 11223445566788899999999988777 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCC--cccHHHHHHHHhhcCC
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEH--GPSLLAYIWKLWCEGH 399 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~ 399 (491)
+....... ......||..|+|||++.+..++.++||||||+++|||++|+.||....... ......+.+.......
T Consensus 144 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~ 221 (329)
T cd05618 144 KEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 221 (329)
T ss_pred ccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC
Confidence 75322111 2234678999999999999899999999999999999999999985422221 1122223333222221
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTM 438 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 438 (491)
. ..+......+.+++.+||+.||++||++
T Consensus 222 ~----------~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 222 I----------RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred C----------CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1 0111223456689999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.5e-23 Score=189.24 Aligned_cols=150 Identities=21% Similarity=0.347 Sum_probs=106.0
Q ss_pred hHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhh--
Q 011196 272 IAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM-- 349 (491)
Q Consensus 272 ~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-- 349 (491)
+...+..++.||.. .+.++|||+||+|||+|+.|++|++|||.+-.+.....+ .+..|.+.|||||-+.
T Consensus 196 ~tva~v~AL~YLKe------KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh---trsAGC~~YMaPERidp~ 266 (391)
T KOG0983|consen 196 MTVAIVKALYYLKE------KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH---TRSAGCAAYMAPERIDPP 266 (391)
T ss_pred hHHHHHHHHHHHHH------hcceeecccCccceEEccCCCEEeecccccceeeccccc---ccccCCccccCccccCCC
Confidence 33334445555543 345579999999999999999999999999766443332 3457899999999886
Q ss_pred -hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcc
Q 011196 350 -EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCV 428 (491)
Q Consensus 350 -~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl 428 (491)
...|+..+||||||+.++|+.||+.|+.....+ .+.+..+.. ... |.+.... .....+++++..||
T Consensus 267 ~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvln----~eP-----P~L~~~~--gFSp~F~~fv~~CL 333 (391)
T KOG0983|consen 267 DKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVLN----EEP-----PLLPGHM--GFSPDFQSFVKDCL 333 (391)
T ss_pred CCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHHh----cCC-----CCCCccc--CcCHHHHHHHHHHh
Confidence 346899999999999999999999997643322 223332222 111 2221111 12345788899999
Q ss_pred cCCCCCCCCHHHHHH
Q 011196 429 QEDPMDRPTMSSVAV 443 (491)
Q Consensus 429 ~~dP~~RPs~~evl~ 443 (491)
++|+.+||...++++
T Consensus 334 ~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 334 TKDHRKRPKYNKLLE 348 (391)
T ss_pred hcCcccCcchHHHhc
Confidence 999999999988765
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-22 Score=195.02 Aligned_cols=159 Identities=25% Similarity=0.374 Sum_probs=117.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+||++++++.+||+|||+++........ ......++..|+||
T Consensus 103 ~~~~~~~~~ql~~~l~~lH~~~i~-------H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aP 174 (263)
T cd05052 103 AVVLLYMATQISSAMEYLEKKNFI-------HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAP 174 (263)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEe-------ecccCcceEEEcCCCcEEeCCCccccccccceee-ccCCCCCccccCCH
Confidence 344566788899999999988777 9999999999999999999999999865432211 11122345679999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++|||++ |..|+.... ....+......... ..+......+.+++
T Consensus 175 E~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~~~~~li 238 (263)
T cd05052 175 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLEKGYRM---------ERPEGCPPKVYELM 238 (263)
T ss_pred HHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHHCCCCC---------CCCCCCCHHHHHHH
Confidence 99988889999999999999999998 888864221 11122222221111 11112234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++||++.+++++|+..
T Consensus 239 ~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 239 RACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHccCCcccCCCHHHHHHHHHhh
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-22 Score=209.17 Aligned_cols=165 Identities=16% Similarity=0.178 Sum_probs=113.3
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC-CceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM-NPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
.....++.+++.++.+||..+++ ||||||+|||++.++ .+||+|||+++....... .....|++.|+||
T Consensus 170 ~~~~~~~~qi~~gL~yLH~~~Ii-------HrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aP 239 (440)
T PTZ00036 170 FLVKLYSYQLCRALAYIHSKFIC-------HRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAP 239 (440)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEe-------cCCcCHHHEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCH
Confidence 34556777888999999988776 999999999999665 699999999986543222 2235679999999
Q ss_pred hhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC---------------ccccccchhc
Q 011196 346 EYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH---------------AAELMDSVVK 409 (491)
Q Consensus 346 E~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~d~~l~ 409 (491)
|++.+. .++.++|||||||++|||++|.+||.... ....+..+........ ...+....+.
T Consensus 240 E~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~ 316 (440)
T PTZ00036 240 ELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS---SVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLK 316 (440)
T ss_pred HHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHH
Confidence 998764 68999999999999999999999975322 1112222221111100 0111111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 410 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..++.....++.+++.+||+.||++|||+.|++++
T Consensus 317 ~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 317 KVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 11121223467889999999999999999998754
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-22 Score=198.34 Aligned_cols=105 Identities=22% Similarity=0.355 Sum_probs=85.9
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccc----cCCCCceEeccCcceecCCCCc-ccccCceeecCC
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLL----DHEMNPKISDFGMARIFGGNQS-EANTNRVVGTYG 341 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl----~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~ 341 (491)
.....++.+++.++.+||..+++ ||||||+|||+ +..+.+||+|||+++....... ........||..
T Consensus 108 ~~~~~i~~qi~~al~~LH~~~iv-------HrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~ 180 (317)
T cd07868 108 GMVKSLLYQILDGIHYLHANWVL-------HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180 (317)
T ss_pred HHHHHHHHHHHHHHHHHHhCCEE-------cCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCcccccc
Confidence 34567888999999999988777 99999999999 4567899999999987643321 122334678999
Q ss_pred CChhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCC
Q 011196 342 YMAPEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGF 378 (491)
Q Consensus 342 y~aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~ 378 (491)
|+|||++.+. .++.++||||+||+++||++|+.||..
T Consensus 181 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 9999999874 588999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-22 Score=198.41 Aligned_cols=160 Identities=28% Similarity=0.350 Sum_probs=117.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++...............++..|+||
T Consensus 131 ~~~~~~i~~qi~~al~~LH~~~iv-------H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 203 (293)
T cd05053 131 QKDLVSFAYQVARGMEFLASKKCI-------HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAP 203 (293)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------ccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCH
Confidence 344566788888999999987766 9999999999999999999999999876443222222223456789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++|||||||++||+++ |..|+..... .........+... ..+......+.+++
T Consensus 204 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~~~~~li 267 (293)
T cd05053 204 EALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-------EELFKLLKEGYRM---------EKPQNCTQELYHLM 267 (293)
T ss_pred HHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-------HHHHHHHHcCCcC---------CCCCCCCHHHHHHH
Confidence 99988889999999999999999997 8888642211 1111211111111 11122234677899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++|||+.|+++.|+..
T Consensus 268 ~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 268 RDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHcccCcccCcCHHHHHHHHHHh
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.1e-22 Score=200.61 Aligned_cols=156 Identities=23% Similarity=0.374 Sum_probs=111.4
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
.....++.+++.++.+||..+++ ||||||+|||+++++.+||+|||+++....... ......|+..|+|||
T Consensus 168 ~~~~~i~~qi~~aL~~LH~~~iv-------HrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE 238 (353)
T PLN00034 168 QFLADVARQILSGIAYLHRRHIV-------HRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPE 238 (353)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEe-------ecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCccccCcc
Confidence 34556888899999999988776 999999999999999999999999986543221 122357899999999
Q ss_pred hhhh-----CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 347 YAME-----GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 347 ~~~~-----~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
++.. ...+.++|||||||++|||++|+.||...... ........ ....... ..+......+.
T Consensus 239 ~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~---~~~~~~~~-~~~~~~~---------~~~~~~~~~l~ 305 (353)
T PLN00034 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG---DWASLMCA-ICMSQPP---------EAPATASREFR 305 (353)
T ss_pred ccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---cHHHHHHH-HhccCCC---------CCCCccCHHHH
Confidence 8743 22356899999999999999999998622211 11111111 1001000 01112234577
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
+++.+||+.||++||++.||+++
T Consensus 306 ~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 306 HFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999874
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-22 Score=212.98 Aligned_cols=163 Identities=15% Similarity=0.161 Sum_probs=109.9
Q ss_pred CcchhhhHhHHHHHHHHHhh-eeeEEeEEeeeccccccccccccCCC----------------CceEeccCcceecCCCC
Q 011196 266 SKRWITIAEAASAIIVFLLS-TSFLWCIIRRRNKRVRASNVLLDHEM----------------NPKISDFGMARIFGGNQ 328 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~iHrDlKp~NILl~~~~----------------~~kl~DfGla~~~~~~~ 328 (491)
......++.+++.++.|||. .+++ ||||||+|||++.++ .+||+|||.+.....
T Consensus 230 ~~~~~~i~~qi~~aL~yLH~~~gIi-------HrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-- 300 (467)
T PTZ00284 230 HRHLAQIIFQTGVALDYFHTELHLM-------HTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-- 300 (467)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCCee-------cCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc--
Confidence 34456677788888888886 3555 999999999998765 489999998754221
Q ss_pred cccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHh-------hc----
Q 011196 329 SEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLW-------CE---- 397 (491)
Q Consensus 329 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~-------~~---- 397 (491)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+.... ..
T Consensus 301 ---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~g~~p~~~~~~~~~ 374 (467)
T PTZ00284 301 ---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN---LEHLHLMEKTLGRLPSEWAGRCGT 374 (467)
T ss_pred ---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHcCCCCHHHHhhccc
Confidence 12346789999999999999999999999999999999999999864321 11111111100 00
Q ss_pred CCcccc----------ccch-----hcCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 398 GHAAEL----------MDSV-----VKQS--CDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 398 ~~~~~~----------~d~~-----l~~~--~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
....++ .++. .... ........+.+|+.+||+.||++|||++|+++
T Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 375 EEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred hhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 000000 0000 0000 00011245678999999999999999999986
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.5e-23 Score=205.18 Aligned_cols=169 Identities=20% Similarity=0.240 Sum_probs=114.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCc-ccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQS-EANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... ........|+..|+|
T Consensus 102 ~~~~~~i~~qi~~aL~~LH~~~iv-------H~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~a 174 (338)
T cd07859 102 PEHHQFFLYQLLRALKYIHTANVF-------HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174 (338)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCC
Confidence 455667888999999999998777 999999999999999999999999976432221 112234578999999
Q ss_pred hhhhhh--CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHH-----------hhcCCccccccchhcC-
Q 011196 345 PEYAME--GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKL-----------WCEGHAAELMDSVVKQ- 410 (491)
Q Consensus 345 PE~~~~--~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~d~~l~~- 410 (491)
||++.+ ..++.++|||||||+++||++|+.||..... ......+... +......+.+......
T Consensus 175 PE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 251 (338)
T cd07859 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---VHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQ 251 (338)
T ss_pred HHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccC
Confidence 999876 5789999999999999999999999753221 1111111110 0000000000000000
Q ss_pred CCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 411 SCD-----QAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 411 ~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..+ ......+.+++.+||+.||++||+++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 252 PVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 0112346789999999999999999998864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=195.63 Aligned_cols=174 Identities=20% Similarity=0.217 Sum_probs=121.4
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|+.++.+.... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 71 ~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~iv-------H~dlkp~Nill~~~~~~kL~Dfg~a 143 (316)
T cd05592 71 LFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGII-------YRDLKLDNVLLDKDGHIKIADFGMC 143 (316)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEE-------eCCCCHHHeEECCCCCEEEccCcCC
Confidence 45666666555432221 11223445666788899999999987776 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+...... .......||..|+|||++.+..++.++|||||||++|||++|+.||.... ...... ......
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~---~~~~~~----~i~~~~-- 212 (316)
T cd05592 144 KENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED---EDELFD----SILNDR-- 212 (316)
T ss_pred eECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC---HHHHHH----HHHcCC--
Confidence 7643222 22234678999999999998889999999999999999999999975321 111111 111111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMS-SVAV 443 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl~ 443 (491)
+. .+......+.+++.+||+.||++||++. ++++
T Consensus 213 ----~~----~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 213 ----PH----FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred ----CC----CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 00 1111223456788999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.5e-22 Score=189.78 Aligned_cols=181 Identities=26% Similarity=0.296 Sum_probs=122.6
Q ss_pred eeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.+++|+.+........ +.......+.++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+
T Consensus 68 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~-------H~dl~p~nil~~~~~~~kl~dfg~ 140 (252)
T cd05084 68 IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCI-------HRDLAARNCLVTEKNVLKISDFGM 140 (252)
T ss_pred eEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc-------ccccchheEEEcCCCcEEECcccc
Confidence 345556665544332221 1223445667788888999999987766 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
+.................+..|+|||.+.++.++.++||||||+++||+++ |..|+..... .. .........
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~~----~~~~~~~~~ 213 (252)
T cd05084 141 SREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---QQ----TREAIEQGV 213 (252)
T ss_pred CcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---HH----HHHHHHcCC
Confidence 875432211111111123456999999988889999999999999999998 8877642211 11 111111111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.. ..+......+.+++.+||+.||++||++.+|+++|+.
T Consensus 214 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 214 RL---------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CC---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 00 1111223467789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.9e-22 Score=197.68 Aligned_cols=176 Identities=18% Similarity=0.261 Sum_probs=122.7
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|+.++.+.... ...........++.+++.++.++|..+++ ||||||+|||++.++.+||+|||++
T Consensus 71 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iv-------HrDlkp~Nili~~~~~~kl~Dfg~~ 143 (327)
T cd05617 71 LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGII-------YRDLKLDNVLLDADGHIKLTDYGMC 143 (327)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee-------ccCCCHHHEEEeCCCCEEEeccccc
Confidence 45556666554432211 11233455667888899999999988777 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...............+.........
T Consensus 144 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (327)
T cd05617 144 KEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR 221 (327)
T ss_pred eeccCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC
Confidence 75322111 1234578999999999999899999999999999999999999986443333333333333333222111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTM 438 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 438 (491)
.+......+.+++.+||+.||++|+++
T Consensus 222 ----------~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 222 ----------IPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred ----------CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 111112345678999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-22 Score=196.34 Aligned_cols=160 Identities=21% Similarity=0.339 Sum_probs=117.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..+++ ||||||+|||+++++.+||+|||+++...............++..|++|
T Consensus 111 ~~~~~~~~~~i~~~l~~lH~~~i~-------H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~p 183 (272)
T cd05075 111 TQMLVKFMTDIASGMEYLSSKSFI-------HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183 (272)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------ccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCH
Confidence 444567788888999999987666 9999999999999999999999999876433221112223456789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|+..+..++.++||||||+++||+++ |+.||... .... .+.....+..... +......+.+++
T Consensus 184 e~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~~----~~~~~~~~~~~~~---------~~~~~~~~~~li 247 (272)
T cd05075 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV---ENSE----IYDYLRQGNRLKQ---------PPDCLDGLYSLM 247 (272)
T ss_pred HHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC---CHHH----HHHHHHcCCCCCC---------CCCCCHHHHHHH
Confidence 99998889999999999999999999 78886431 1111 2222222221111 111223467899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++|||+.+|++.|+..
T Consensus 248 ~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 248 SSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-22 Score=200.97 Aligned_cols=180 Identities=16% Similarity=0.169 Sum_probs=124.2
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv-------H~dlkp~Nil~~~~~~~kL~Dfg~a 148 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYI-------HRDLKPENFLIDASGHIKLTDFGLS 148 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------ccCCCHHHEEECCCCCEEEEeCcCC
Confidence 455666665554433221 1223445566778888999999987776 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+.... ......|++.|+|||++.+..++.++|||||||++|||++|..||..... ......+ ..+... .
T Consensus 149 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i-~~~~~~-~- 217 (333)
T cd05600 149 KGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---NETWENL-KYWKET-L- 217 (333)
T ss_pred ccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH---HHHHHHH-Hhcccc-c-
Confidence 76533 22345789999999999988999999999999999999999999753211 1111111 111100 0
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..+... .........+.+++.+||+.+|++||++.+++++
T Consensus 218 --~~~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 218 --QRPVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred --cCCCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 001000 0001123456788899999999999999999876
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-22 Score=196.18 Aligned_cols=165 Identities=19% Similarity=0.201 Sum_probs=115.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..+++ ||||||+|||++.++.+||+|||+++....... .....|+..|+||
T Consensus 107 ~~~~~~~~~qi~~al~~lH~~~iv-------H~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aP 176 (288)
T cd07863 107 AETIKDLMRQFLRGLDFLHANCIV-------HRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAP 176 (288)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEECCCCCEEECccCccccccCccc---CCCccccccccCc
Confidence 455677888999999999988777 999999999999999999999999986543221 2234678999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC---Cccc-------cccchhc---CCC
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG---HAAE-------LMDSVVK---QSC 412 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~-------~~d~~l~---~~~ 412 (491)
|++.+..++.++||||+||+++||++|++||.... .......+....... .+.. ...+... ...
T Consensus 177 E~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (288)
T cd07863 177 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS---EADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSV 253 (288)
T ss_pred hHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC---HHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHh
Confidence 99998889999999999999999999999874321 111222222111100 0000 0000000 000
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 413 DQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 413 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
..+....+.+++.+||+.||++|||+.|++.
T Consensus 254 ~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 254 VPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0112345678999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.3e-22 Score=197.32 Aligned_cols=181 Identities=18% Similarity=0.265 Sum_probs=124.6
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|+.++...... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 71 ~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv-------H~dlkp~Nili~~~~~~kL~Dfg~~ 143 (329)
T cd05588 71 LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGII-------YRDLKLDNVLLDAEGHIKLTDYGMC 143 (329)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------ecCCCHHHeEECCCCCEEECcCccc
Confidence 35566666554432221 11233455667888899999999988777 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCC--cccHHHHHHHHhhcCC
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEH--GPSLLAYIWKLWCEGH 399 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~ 399 (491)
+...... .......||..|+|||++.+..++.++|||||||++|||++|+.||....... ......+.........
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (329)
T cd05588 144 KEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ 221 (329)
T ss_pred cccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC
Confidence 7432111 12234678999999999999889999999999999999999999986433222 1112222222222221
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCC------HHHHHH
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT------MSSVAV 443 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs------~~evl~ 443 (491)
.. .+......+.+++.+||+.||++||+ +.++++
T Consensus 222 ~~----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 222 IR----------IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CC----------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 10 11112234677999999999999997 566664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-22 Score=196.00 Aligned_cols=158 Identities=27% Similarity=0.355 Sum_probs=113.2
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC---CceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM---NPKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
...+.++.+++.++.+||..+++ ||||||+||+++.++ .+||+|||+++................+..|+
T Consensus 116 ~~~~~~~~qi~~~l~~LH~~~iv-------H~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 188 (277)
T cd05036 116 KDLLFCARDVAKGCKYLEENHFI-------HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEe-------ecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhC
Confidence 44566788888999999987766 999999999998754 58999999998653322211122223356799
Q ss_pred hhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHH
Q 011196 344 APEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 344 aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
|||++.+..++.++|||||||++|||++ |..||... ........ ....... ..+......+.+
T Consensus 189 aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~---~~~~~~~~----~~~~~~~---------~~~~~~~~~~~~ 252 (277)
T cd05036 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR---TNQEVMEF----VTGGGRL---------DPPKGCPGPVYR 252 (277)
T ss_pred CHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHH----HHcCCcC---------CCCCCCCHHHHH
Confidence 9999998899999999999999999997 88886422 11112211 1111111 111122345778
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhhc
Q 011196 423 IGLLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
++.+||+.||++||++.+|++.|+.
T Consensus 253 ~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 253 IMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHHHHcCCCcccCcCHHHHHHHhhC
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-22 Score=204.86 Aligned_cols=195 Identities=19% Similarity=0.230 Sum_probs=135.8
Q ss_pred cchhHHHHHHhhccccccCCCCCcEEEceecc----eeeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhh
Q 011196 211 SDCNVCLNSAVAQIPTCSKGKLGARIFCASCS----IRYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLS 285 (491)
Q Consensus 211 ~dC~~Cl~~~~~~~~~~~~~~~~g~i~~~~C~----lry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~ 285 (491)
-+|..|=..+...+.. .+- -+-...|+ --|.++.|-.++++..... ......+..-.+..++.+++|||.
T Consensus 412 Ve~~~~EkrI~~la~~-HPF----L~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~ 486 (694)
T KOG0694|consen 412 VESLMCEKRIFELANR-HPF----LVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHE 486 (694)
T ss_pred HHHHHHHHHHHHHhcc-CCe----EeecccccccCCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHh
Confidence 3566666666666552 221 11112222 2345566666666433322 223344555567788888999988
Q ss_pred eeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHH
Q 011196 286 TSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVV 365 (491)
Q Consensus 286 ~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvv 365 (491)
.+++ +||||.+|||||.+|++||+|||+++.--. ....+.+++||+.|||||++.+..|+..+|-|+|||+
T Consensus 487 ~~II-------YRDlKLdNiLLD~eGh~kiADFGlcKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVL 557 (694)
T KOG0694|consen 487 NGII-------YRDLKLDNLLLDTEGHVKIADFGLCKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVL 557 (694)
T ss_pred cCce-------eeecchhheEEcccCcEEecccccccccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHH
Confidence 8877 999999999999999999999999986432 2235667999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcC--CCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 011196 366 LLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQ--SCDQAELLKYIHIGLLCVQEDPMDRPTM 438 (491)
Q Consensus 366 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 438 (491)
+|||+.|+.||... +..++ +|..+.+ .++.-...+.+.|+.++|..||++|.-+
T Consensus 558 lyeML~Gq~PF~gd---dEee~----------------FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 558 LYEMLVGESPFPGD---DEEEV----------------FDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHcCCCCCCCC---CHHHH----------------HHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 99999999997532 22222 2222211 1233344567789999999999999876
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.7e-22 Score=195.03 Aligned_cols=167 Identities=14% Similarity=0.156 Sum_probs=112.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... ......|+..|+||
T Consensus 102 ~~~~~~~~~qi~~al~~lH~~~iv-------H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aP 172 (303)
T cd07869 102 PENVKLFLFQLLRGLSYIHQRYIL-------HRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPP 172 (303)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCCh
Confidence 345667788999999999988777 999999999999999999999999875432221 12235678999999
Q ss_pred hhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC---cccc-----ccch-hc--CCCC
Q 011196 346 EYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH---AAEL-----MDSV-VK--QSCD 413 (491)
Q Consensus 346 E~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-----~d~~-l~--~~~~ 413 (491)
|++.+ ..++.++||||+||++|||++|+.||.... +....+........... +... .++. .. ....
T Consensus 173 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (303)
T cd07869 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK--DIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKN 250 (303)
T ss_pred HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc--cHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCcc
Confidence 99875 457889999999999999999999986422 11112222211111100 0000 0000 00 0000
Q ss_pred H-------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 414 Q-------AELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 414 ~-------~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
. .....+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 251 LRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0 01134668999999999999999998875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-22 Score=198.07 Aligned_cols=161 Identities=25% Similarity=0.334 Sum_probs=118.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+|||+++++.+||+|||+++...............++..|+||
T Consensus 126 ~~~~~~i~~~i~~~l~~LH~~~iv-------H~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ap 198 (290)
T cd05045 126 MGDLISFAWQISRGMQYLAEMKLV-------HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAI 198 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------hhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCH
Confidence 445667788889999999987766 9999999999999999999999999765332222222233456789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||++++||++ |..||.... ....+......... ..+......+.+++
T Consensus 199 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~~~~~~i 262 (290)
T cd05045 199 ESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-------PERLFNLLKTGYRM---------ERPENCSEEMYNLM 262 (290)
T ss_pred HHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-------HHHHHHHHhCCCCC---------CCCCCCCHHHHHHH
Confidence 99988889999999999999999998 888864221 11222222221111 11112234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
.+||+.||++||++.|+++.|++..
T Consensus 263 ~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 263 LTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHHccCCcccCCCHHHHHHHHHHHH
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=203.93 Aligned_cols=173 Identities=17% Similarity=0.172 Sum_probs=116.3
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............||..|+|
T Consensus 258 ~~~~~~~i~~qi~~aL~yLH~~gIv-------HrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~A 330 (461)
T PHA03211 258 GLAQVTAVARQLLSAIDYIHGEGII-------HRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNA 330 (461)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEE-------ECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcC
Confidence 3556677888899999999988776 999999999999999999999999986543322222224578999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCcc-CCCcccHHHHHHHHhhcCC-----ccccccchh----------
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYH-LEHGPSLLAYIWKLWCEGH-----AAELMDSVV---------- 408 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~~-----~~~~~d~~l---------- 408 (491)
||++.+..++.++|||||||++|||++|..++.... ..........+.+...... ........+
T Consensus 331 PE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 410 (461)
T PHA03211 331 PEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAAR 410 (461)
T ss_pred HHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhc
Confidence 999999899999999999999999999876642211 1111111111111111110 000000000
Q ss_pred --cCCC---CH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 409 --KQSC---DQ----AELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 409 --~~~~---~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.... .. .....+.+|+.+||+.||++|||+.|++++
T Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 411 NRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred ccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 00 111246779999999999999999999875
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=190.48 Aligned_cols=159 Identities=26% Similarity=0.416 Sum_probs=117.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..++. ||||||+||+++.++.+||+|||+++...............++..|+||
T Consensus 118 ~~~~~~~~~~i~~~l~~lH~~~i~-------H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 190 (277)
T cd05032 118 LQKFIQMAAEIADGMAYLAAKKFV-------HRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------ccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCH
Confidence 345566778888889999987666 9999999999999999999999998765433322222334567889999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|.+.++.++.++||||||+++||+++ |..|+... ..... .+....+...... ......+.+++
T Consensus 191 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~---~~~~~----~~~~~~~~~~~~~---------~~~~~~~~~li 254 (277)
T cd05032 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL---SNEEV----LKFVIDGGHLDLP---------ENCPDKLLELM 254 (277)
T ss_pred HHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC---CHHHH----HHHHhcCCCCCCC---------CCCCHHHHHHH
Confidence 99988889999999999999999998 88886421 11111 1222222211111 11234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhc
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.+||+.+|++|||+.++++.|++
T Consensus 255 ~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 255 RMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHHcCCChhhCCCHHHHHHHhcC
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.86 E-value=8e-22 Score=197.73 Aligned_cols=175 Identities=17% Similarity=0.174 Sum_probs=122.0
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 70 ~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv-------HrDikp~NIll~~~~~~kL~DfG~~ 142 (328)
T cd05593 70 LCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIV-------YRDLKLENLMLDKDGHIKITDFGLC 142 (328)
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE-------ecccCHHHeEECCCCcEEEecCcCC
Confidence 445566665544322221 1223445666788889999999987776 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..... ........
T Consensus 143 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~---~~~~~----~~~~~~~~- 212 (328)
T cd05593 143 KEGITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLF----ELILMEDI- 212 (328)
T ss_pred ccCCCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC---HHHHH----HHhccCCc-
Confidence 7532211 11233578999999999998889999999999999999999999974321 11111 11111100
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAVM 444 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 444 (491)
. .+......+.+++.+||+.||++|| ++.|++++
T Consensus 213 -----~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 213 -----K----FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -----c----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0 1111223466788999999999997 88988865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-22 Score=193.57 Aligned_cols=158 Identities=25% Similarity=0.394 Sum_probs=116.4
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++.......... .....++..|+||
T Consensus 102 ~~~~~~~~~~l~~~l~~LH~~~i~-------H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aP 173 (261)
T cd05072 102 LPKLIDFSAQIAEGMAYIERKNYI-------HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA-REGAKFPIKWTAP 173 (261)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------ccccchhhEEecCCCcEEECCCccceecCCCceec-cCCCccceecCCH
Confidence 345566788889999999987766 99999999999999999999999998764432211 2223456789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.++.++.++||||||+++|||++ |+.||... ........ ....... + ... .....+.+++
T Consensus 174 E~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~---~~~~~~~~----~~~~~~~----~-~~~----~~~~~~~~li 237 (261)
T cd05072 174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM---SNSDVMSA----LQRGYRM----P-RME----NCPDELYDIM 237 (261)
T ss_pred HHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC---CHHHHHHH----HHcCCCC----C-CCC----CCCHHHHHHH
Confidence 99988889999999999999999998 88887421 11111111 1111110 0 001 1223567899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhc
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.+||+.+|++||+++++.++|+.
T Consensus 238 ~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 238 KTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHccCCcccCcCHHHHHHHHhc
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-22 Score=204.14 Aligned_cols=166 Identities=20% Similarity=0.193 Sum_probs=115.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...... ......|+..|+||
T Consensus 118 ~~~~~~~~~qi~~aL~~LH~~giv-------HrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aP 187 (355)
T cd07874 118 HERMSYLLYQMLCGIKHLHSAGII-------HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAP 187 (355)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------cCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCH
Confidence 445566788889999999987766 99999999999999999999999998653321 12235789999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHh------------------hcC--Cccccc-
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLW------------------CEG--HAAELM- 404 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~------------------~~~--~~~~~~- 404 (491)
|++.+..++.++|||||||++|||++|+.||..... ........... ... ....+.
T Consensus 188 E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (355)
T cd07874 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTF 264 (355)
T ss_pred HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccc
Confidence 999988899999999999999999999999753221 11111111100 000 000000
Q ss_pred -----cchhc--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 405 -----DSVVK--QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 405 -----d~~l~--~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
+.... ..........+.+++.+||+.||++|||+.|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 265 PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000 00111123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-21 Score=188.05 Aligned_cols=164 Identities=21% Similarity=0.297 Sum_probs=115.3
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhh
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY 347 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 347 (491)
....++.+++.++.++|..+++ ||||||+|||++.++.+||+|||+++.+.............++..|++||+
T Consensus 131 ~~~~~~~~i~~al~~lH~~~i~-------H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~ 203 (296)
T cd05095 131 TLIFMATQIASGMKYLSSLNFV-------HRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWES 203 (296)
T ss_pred HHHHHHHHHHHHHHHHHHCCee-------cccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHH
Confidence 4566788888899999988777 999999999999999999999999976533222222223344678999999
Q ss_pred hhhCCCCcccceeehhHHHHHHHh--CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 348 AMEGIFSVKSDVFSFGVVLLEIIS--GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 348 ~~~~~~s~~sDVwS~Gvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
...+.++.++||||||+++|||++ |..|+.... ...........+........ .+ .+......+.+++.
T Consensus 204 ~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~li~ 274 (296)
T cd05095 204 ILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS---DEQVIENTGEFFRDQGRQVY-LP-----KPALCPDSLYKLML 274 (296)
T ss_pred HhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC---hHHHHHHHHHHHhhcccccc-CC-----CCCCCCHHHHHHHH
Confidence 988899999999999999999998 556653221 11122111111111110000 01 01112356778999
Q ss_pred HcccCCCCCCCCHHHHHHHhhc
Q 011196 426 LCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L~~ 447 (491)
+||+.||++||++.+|++.|+.
T Consensus 275 ~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 275 SCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHcCCCcccCCCHHHHHHHHhC
Confidence 9999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.5e-22 Score=200.36 Aligned_cols=166 Identities=18% Similarity=0.163 Sum_probs=115.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...... ......|+..|+||
T Consensus 125 ~~~~~~~~~qi~~aL~~LH~~~iv-------H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aP 194 (364)
T cd07875 125 HERMSYLLYQMLCGIKHLHSAGII-------HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAP 194 (364)
T ss_pred HHHHHHHHHHHHHHHHHHhhCCee-------cCCCCHHHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCH
Confidence 445566788888999999987776 99999999999999999999999997653322 12235789999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc------------------CC--c-----
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE------------------GH--A----- 400 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------------------~~--~----- 400 (491)
|++.+..++.++|||||||++|||++|+.||..... ......+...... .. .
T Consensus 195 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (364)
T cd07875 195 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSF 271 (364)
T ss_pred HHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCCh
Confidence 999998999999999999999999999999854321 1111111110000 00 0
Q ss_pred cccccchhc---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 401 AELMDSVVK---QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 401 ~~~~d~~l~---~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.++....+. ..........+.+++.+||+.||++|||+.|++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 272 EKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 00011122456789999999999999999998874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-22 Score=199.73 Aligned_cols=150 Identities=23% Similarity=0.325 Sum_probs=109.0
Q ss_pred hHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhhhC
Q 011196 272 IAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEG 351 (491)
Q Consensus 272 ~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 351 (491)
+-+++..++.++|..+++ |-||||.|+|+-. |.+||+|||.+..+..+.........+||+-||+||.+...
T Consensus 465 ywkqML~aV~~IH~~gIV-------HSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~ 536 (677)
T KOG0596|consen 465 YWKQMLLAVKTIHQHGIV-------HSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDM 536 (677)
T ss_pred HHHHHHHHHHHHHHhcee-------ecCCCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhc
Confidence 445666666666666555 9999999999874 67999999999988777666666678999999999998632
Q ss_pred -----------CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCH-HHHHH
Q 011196 352 -----------IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQ-AELLK 419 (491)
Q Consensus 352 -----------~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~-~~~~~ 419 (491)
+.+.++||||+|||||+|+.|+.||+.+. +..... ..+.+|...-+++. ....+
T Consensus 537 ~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~aKl---------~aI~~P~~~Iefp~~~~~~~ 602 (677)
T KOG0596|consen 537 SSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIAKL---------HAITDPNHEIEFPDIPENDE 602 (677)
T ss_pred cccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHHHH---------HhhcCCCccccccCCCCchH
Confidence 25789999999999999999999975321 111111 22233322111111 11122
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 011196 420 YIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 420 ~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
++++++.||+.||++||++.|+++
T Consensus 603 li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 603 LIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHHHHHHHhcCcccCCCcHHHhc
Confidence 889999999999999999988765
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-22 Score=194.18 Aligned_cols=181 Identities=20% Similarity=0.285 Sum_probs=125.6
Q ss_pred eeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 245 YELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
|.++.|+.+........ ..........++.+++.++.+||..+++ ||||||+||++++++.+||+|||++
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~-------H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV-------HRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcc-------cCCCCcceEEEcCCCCEEECccchh
Confidence 45566665544322211 1223445667788888899999987766 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
+...............++..|+|||.+.+..++.++||||||++++|+++ |..||... .... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~---~~~~----~~~~~~~~~~ 226 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM---SNQD----VIKAVEDGYR 226 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC---CHHH----HHHHHHcCCC
Confidence 87642222111222344678999999988889999999999999999998 88886321 1111 1121111111
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.. .+......+.+++.+||+.+|++||++.||+++|++.
T Consensus 227 ~~---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 LP---------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 10 0112234577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-21 Score=186.41 Aligned_cols=159 Identities=29% Similarity=0.384 Sum_probs=119.5
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..++. ||||||+||+++.++.+||+|||.+................++..|+|
T Consensus 103 ~~~~~~~~~~~l~~al~~lH~~~i~-------H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 175 (262)
T cd00192 103 SLKDLLSFAIQIAKGMEYLASKKFV-------HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175 (262)
T ss_pred CHHHHHHHHHHHHHHHHHHHcCCcc-------cCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccC
Confidence 4556777888888999999987766 999999999999999999999999987654432222334567889999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||.+....++.++||||+|++++||++ |..||... .... .+.....+... ..+.....++.++
T Consensus 176 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~~~~----~~~~~~~~~~~---------~~~~~~~~~~~~l 239 (262)
T cd00192 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL---SNEE----VLEYLRKGYRL---------PKPEYCPDELYEL 239 (262)
T ss_pred HHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC---CHHH----HHHHHHcCCCC---------CCCccCChHHHHH
Confidence 999988889999999999999999999 58887533 1111 11222211111 1111223567789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhh
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~ 446 (491)
+.+||+.||++||++.|+++.|+
T Consensus 240 i~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 240 MLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHccCCcccCcCHHHHHHhhC
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-21 Score=194.49 Aligned_cols=125 Identities=22% Similarity=0.289 Sum_probs=93.5
Q ss_pred eeeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 243 IRYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
..|.++.|+.++....... ..........++.+++.++.++|... +++||||||+|||++.++.+||+|||+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~------~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 150 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH------QIMHRDVKPSNILVNSRGEIKLCDFGV 150 (331)
T ss_pred EEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC------CEEcCCCChhhEEEcCCCcEEEccCcc
Confidence 3456667766554432221 11223344566777788888887642 234999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCC
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSG 377 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~ 377 (491)
+....... .....|+..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 151 ~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 151 SGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred cccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 87653221 223568999999999998889999999999999999999999975
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-21 Score=190.49 Aligned_cols=179 Identities=20% Similarity=0.189 Sum_probs=124.2
Q ss_pred eeeecccccCCCCcccc------CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEec
Q 011196 244 RYELYRFLVDTPTVTVT------APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISD 317 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~D 317 (491)
.|.++.|+.++...... ...........++.+++.++.++|..+++ ||||||+||+++.++.+||+|
T Consensus 68 ~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~-------H~dlkp~Nili~~~~~~~l~d 140 (280)
T cd05608 68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII-------YRDLKPENVLLDNDGNVRISD 140 (280)
T ss_pred EEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCHHHEEECCCCCEEEee
Confidence 45666666655432111 11223455667788899999999987766 999999999999999999999
Q ss_pred cCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 318 FGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 318 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
||++......... .....|++.|+|||++.+..++.++||||||+++|||++|+.||....... ...........
T Consensus 141 fg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~ 215 (280)
T cd05608 141 LGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELKQRILN 215 (280)
T ss_pred CccceecCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch---hHHHHHHhhcc
Confidence 9999766443221 223578999999999999999999999999999999999999975322111 11111111111
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAVM 444 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 444 (491)
.. . ..+......+.+++.+||+.||++|| ++++++++
T Consensus 216 ~~--------~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 216 DS--------V--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cC--------C--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 00 0 11122334567889999999999999 67777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-22 Score=191.46 Aligned_cols=161 Identities=32% Similarity=0.427 Sum_probs=118.3
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCccc-ccCceeecCCCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEA-NTNRVVGTYGYM 343 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~ 343 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++......... ......++..|+
T Consensus 93 ~~~~~~~~~~qi~~~l~~lh~~~i~-------H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~ 165 (257)
T cd05060 93 PVSDLKELAHQVAMGMAYLESKHFV-------HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY 165 (257)
T ss_pred CHHHHHHHHHHHHHHHHHHhhcCee-------ccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcccccccc
Confidence 3455677888889999999987766 99999999999999999999999998664332211 111223456799
Q ss_pred hhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHH
Q 011196 344 APEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 344 aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
|||.+.+..++.++||||||+++||+++ |..||... ........+ ....... .+......+.+
T Consensus 166 aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~---~~~~~~~~~----~~~~~~~---------~~~~~~~~l~~ 229 (257)
T cd05060 166 APECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM---KGAEVIAML----ESGERLP---------RPEECPQEIYS 229 (257)
T ss_pred CHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC---CHHHHHHHH----HcCCcCC---------CCCCCCHHHHH
Confidence 9999988889999999999999999998 89987432 112222221 1111111 11112245678
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 423 IGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
++.+||+.||++||++.+|++.|++.
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 99999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.1e-22 Score=184.02 Aligned_cols=164 Identities=20% Similarity=0.227 Sum_probs=120.2
Q ss_pred eeeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 243 IRYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.-|.+.+|-.++.+...+- ...+.....-.+.+++.++.|||+..++ +|||||+|||||.+|.+||.|||+
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~ii-------YRDLKPENiLlD~~G~iKitDFGF 190 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDII-------YRDLKPENLLLDQNGHIKITDFGF 190 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCee-------eccCChHHeeeccCCcEEEEeccc
Confidence 3456667766666544432 1333445556788889999999999988 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
++.... .+-+.+||+.|+|||++....++.++|-|+|||++|||+.|.+||...+. .. +.+.+.++..
T Consensus 191 AK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~----iY~KI~~~~v 258 (355)
T KOG0616|consen 191 AKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQ----IYEKILEGKV 258 (355)
T ss_pred eEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HH----HHHHHHhCcc
Confidence 987633 24568999999999999999999999999999999999999999754322 11 2222222211
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCC
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDR 435 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~R 435 (491)
. +|.--...+.+|+.+.|+.|-.+|
T Consensus 259 ~----------fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 K----------FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred c----------CCcccCHHHHHHHHHHHhhhhHhh
Confidence 1 111122235567778888888888
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.3e-22 Score=197.82 Aligned_cols=175 Identities=18% Similarity=0.214 Sum_probs=122.2
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|+.++...... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 71 ~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv-------HrDikp~Nill~~~~~~kL~Dfg~~ 143 (321)
T cd05591 71 LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVI-------YRDLKLDNILLDAEGHCKLADFGMC 143 (321)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee-------ccCCCHHHeEECCCCCEEEeecccc
Confidence 35566666554432221 11223445566788889999999988777 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||.... ...... ....+..
T Consensus 144 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~~~~----~i~~~~~- 213 (321)
T cd05591 144 KEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFE----SILHDDV- 213 (321)
T ss_pred eecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC---HHHHHH----HHHcCCC-
Confidence 75432221 1234578999999999998889999999999999999999999975322 111111 1111110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-------TMSSVAVM 444 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-------s~~evl~~ 444 (491)
.. +......+.+++.+||+.||++|| ++.+++++
T Consensus 214 --~~-------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 --LY-------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --CC-------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 00 111123467789999999999999 78887754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-21 Score=188.95 Aligned_cols=159 Identities=25% Similarity=0.311 Sum_probs=113.2
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc--cccCceeecCCCCh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE--ANTNRVVGTYGYMA 344 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~a 344 (491)
.....++.+++.++.++|..+++ ||||||+|||++.++.+||+|||+++........ .......++..|+|
T Consensus 98 ~~~~~~~~~i~~~l~~lH~~~i~-------H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~a 170 (262)
T cd05058 98 KDLIGFGLQVAKGMEYLASKKFV-------HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170 (262)
T ss_pred HHHHHHHHHHHHHHHHHHhCCcc-------ccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccC
Confidence 34566777888999999987666 9999999999999999999999999754322111 11112345678999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCC-CCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGK-KSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..++.++||||||+++|||++|. +|+.. .......... . .+.... .+......+.++
T Consensus 171 PE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~---~~~~~~~~~~---~-~~~~~~---------~~~~~~~~~~~l 234 (262)
T cd05058 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VDSFDITVYL---L-QGRRLL---------QPEYCPDPLYEV 234 (262)
T ss_pred hhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHHH---h-cCCCCC---------CCCcCCHHHHHH
Confidence 99998888999999999999999999954 45431 1111111111 1 111000 011112357789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+.+||+.+|++||++.+|++.|++.
T Consensus 235 i~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred HHHHcCCChhhCCCHHHHHHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-21 Score=195.10 Aligned_cols=105 Identities=22% Similarity=0.358 Sum_probs=85.4
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccc----cCCCCceEeccCcceecCCCCc-ccccCceeecCC
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLL----DHEMNPKISDFGMARIFGGNQS-EANTNRVVGTYG 341 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl----~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~ 341 (491)
.....++.+++.++.+||..+++ ||||||+|||+ +.++.+||+|||+++....... ........||..
T Consensus 108 ~~~~~i~~qi~~aL~~lH~~~iv-------H~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~ 180 (317)
T cd07867 108 SMVKSLLYQILDGIHYLHANWVL-------HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180 (317)
T ss_pred HHHHHHHHHHHHHHHHHHhCCEE-------cCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceeccc
Confidence 34567788899999999988776 99999999999 5567899999999987644322 122234678999
Q ss_pred CChhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCC
Q 011196 342 YMAPEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGF 378 (491)
Q Consensus 342 y~aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~ 378 (491)
|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 181 y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 9999998764 578999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-22 Score=202.66 Aligned_cols=166 Identities=19% Similarity=0.161 Sum_probs=114.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...... ......||..|+||
T Consensus 122 ~~~~~~~~~qi~~~L~~LH~~~iv-------HrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aP 191 (359)
T cd07876 122 HERMSYLLYQMLCGIKHLHSAGII-------HRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAP 191 (359)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------cCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCc
Confidence 445566788889999999987776 99999999999999999999999997543221 12235789999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHh-------------------hcC-C-----c
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLW-------------------CEG-H-----A 400 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~-------------------~~~-~-----~ 400 (491)
|++.+..++.++||||||+++|||++|+.||..... ........+.. ... . .
T Consensus 192 E~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (359)
T cd07876 192 EVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH---IDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISF 268 (359)
T ss_pred hhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcch
Confidence 999988999999999999999999999999863321 11111111100 000 0 0
Q ss_pred cccccchhcC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 401 AELMDSVVKQ---SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 401 ~~~~d~~l~~---~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.+........ .........+.+++.+||+.||++|||+.|++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 269 EELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred hhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000 0011112456789999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.3e-22 Score=197.24 Aligned_cols=182 Identities=23% Similarity=0.332 Sum_probs=126.7
Q ss_pred eeeecccccCCCCccccCC----CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 244 RYELYRFLVDTPTVTVTAP----NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
.|.++.|+..+........ .........++.+++.++.++|..+++ |+||||+|||++.++.+||+|||
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~iv-------H~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCI-------HRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCee-------hhhhccceEEEcCCCeEEECCCc
Confidence 4555666655543322211 123456677888899999999987766 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
+++...............++..|+|||.+.+..++.++||||||+++||+++ |..|+..... . .........+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~---~---~~~~~~~~~~ 260 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV---D---SKFYKLIKEG 260 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc---h---HHHHHHHHcC
Confidence 9986543322212223445778999999998889999999999999999998 8888643211 1 1111111111
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.... .+.....++.+++.+||+.+|++||++.||++.|++
T Consensus 261 ~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 261 YRMA---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CcCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 1000 011112457789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.3e-22 Score=194.27 Aligned_cols=159 Identities=26% Similarity=0.364 Sum_probs=115.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..++. ||||||+|||+++++.+||+|||++................+++.|+||
T Consensus 121 ~~~~~~~~~qi~~al~~LH~~~i~-------H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 193 (280)
T cd05092 121 LGQMLAIASQIASGMVYLASLHFV-------HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP 193 (280)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------cccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCH
Confidence 445667788888999999987766 9999999999999999999999999765433222222234457789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++|||||||++|||++ |..||.... ........ ..+..... +......+.+++
T Consensus 194 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~----~~~~~~~~---------~~~~~~~~~~li 257 (280)
T cd05092 194 ESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS---NTEAIECI----TQGRELER---------PRTCPPEVYAIM 257 (280)
T ss_pred HHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC---HHHHHHHH----HcCccCCC---------CCCCCHHHHHHH
Confidence 99998889999999999999999998 888864211 11111111 11111110 111123466899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhc
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.+||+.||++||++.||++.|+.
T Consensus 258 ~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 258 QGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHccCChhhCCCHHHHHHHHhC
Confidence 99999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-21 Score=186.15 Aligned_cols=181 Identities=24% Similarity=0.277 Sum_probs=121.4
Q ss_pred eeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.++.++.+.+...... ..........++.+++.++.++|..+++ ||||||+||+++.++.+||+|||+
T Consensus 67 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~-------h~di~p~nili~~~~~~~l~d~g~ 139 (251)
T cd05041 67 IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCI-------HRDLAARNCLVGENNVLKISDFGM 139 (251)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEe-------hhhcCcceEEEcCCCcEEEeeccc
Confidence 455556655444322211 1122334456666777888888887766 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
++...............++..|+|||.+.++.++.++||||||++++|+++ |..|+..... .... .......
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~---~~~~----~~~~~~~ 212 (251)
T cd05041 140 SREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN---QQTR----ERIESGY 212 (251)
T ss_pred cccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH---HHHH----HHHhcCC
Confidence 976542221111112233567999999988889999999999999999999 7777643211 1111 1111110
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.. ..+......+.+++.+||+.+|++||++.||++.|+.
T Consensus 213 --~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 213 --RM-------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred --CC-------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 00 0111223467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-22 Score=191.43 Aligned_cols=160 Identities=24% Similarity=0.351 Sum_probs=116.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCccc-ccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEA-NTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~a 344 (491)
......++.+++.++.++|..+++ ||||||+|||++.++.+||+|||+++......... ......++..|+|
T Consensus 94 ~~~~~~~~~~i~~~l~~lH~~~i~-------H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 166 (257)
T cd05115 94 VSNVVELMHQVSMGMKYLEGKNFV-------HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYA 166 (257)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCee-------ecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCC
Confidence 455667888889999999987766 99999999999999999999999997654332211 1111223568999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++....++.++||||||+++||+++ |..||.... ... +......+... ..+......+.++
T Consensus 167 PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~----~~~~~~~~~~~---------~~~~~~~~~l~~l 230 (257)
T cd05115 167 PECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK---GPE----VMSFIEQGKRL---------DCPAECPPEMYAL 230 (257)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC---HHH----HHHHHHCCCCC---------CCCCCCCHHHHHH
Confidence 999988889999999999999999996 998864321 111 11112222111 1112233456789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+.+||+.||++||++.+|.+.|+..
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHcCCChhhCcCHHHHHHHHhhh
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-22 Score=197.80 Aligned_cols=169 Identities=21% Similarity=0.260 Sum_probs=118.6
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|+.++...... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 71 ~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~iv-------H~dlkp~NIli~~~~~~kL~DfG~~ 143 (320)
T cd05590 71 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGII-------YRDLKLDNVLLDHEGHCKLADFGMC 143 (320)
T ss_pred EEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------eCCCCHHHeEECCCCcEEEeeCCCC
Confidence 35566666554432211 11223445566788889999999987776 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+....... ......|++.|+|||++.+..++.++|||||||++|||++|+.||.... ... .......+...
T Consensus 144 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~----~~~~i~~~~~~ 214 (320)
T cd05590 144 KEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDD----LFEAILNDEVV 214 (320)
T ss_pred eecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHH----HHHHHhcCCCC
Confidence 75422211 2234578999999999998889999999999999999999999975321 111 11112111110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTM 438 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 438 (491)
.+......+.+++.+||+.||++||++
T Consensus 215 ----------~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 ----------YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred ----------CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 011122346778999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.4e-22 Score=197.50 Aligned_cols=169 Identities=21% Similarity=0.254 Sum_probs=119.4
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv-------HrDlkp~Nill~~~~~~kL~DfG~~ 148 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGII-------YRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEE-------ecCCCHHHeEECCCCcEEEccCCCc
Confidence 455666665554432211 1223455667888899999999987776 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ .....
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i----~~~~~- 218 (323)
T cd05616 149 KENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSI----MEHNV- 218 (323)
T ss_pred eecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC---HHHHHHHH----HhCCC-
Confidence 75432211 2234578999999999999999999999999999999999999975321 11222211 11111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTM 438 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 438 (491)
.++......+.+++.+||+.||++|++.
T Consensus 219 ---------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ---------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0111223456789999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-22 Score=199.00 Aligned_cols=222 Identities=18% Similarity=0.194 Sum_probs=152.9
Q ss_pred CccEEEEEecCCCCCccchhHHHHHHhhc---cccccCCCCCc--EEEceecceeeeecccccCCCCccccCC----CCC
Q 011196 195 FDTLQTTVHCIPDLSKSDCNVCLNSAVAQ---IPTCSKGKLGA--RIFCASCSIRYELYRFLVDTPTVTVTAP----NKT 265 (491)
Q Consensus 195 ~~~vyglaQC~~Dls~~dC~~Cl~~~~~~---~~~~~~~~~~g--~i~~~~C~lry~~~~f~~~~~~~~~~~~----~~~ 265 (491)
.++.|.|.+=.-+--..-|++ .|..+ +.++-+=.+-+ .+|...-.+-+.+..|.+++.+...... ...
T Consensus 28 ~~~~~vlK~I~l~~~t~~~r~---~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~ 104 (426)
T KOG0589|consen 28 DDKLYVLKKINLEKLTEPERR---SAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFP 104 (426)
T ss_pred CCceEEEEEEeccccCchhhH---HHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhcccc
Confidence 456888887776655555665 33222 22221111111 1222333345667788887776444321 122
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
.++...+..++..++.++|...++ |||||+.||++..+..+||+|||+++.+..... .....+||+.||.|
T Consensus 105 E~~i~~~~~Q~~~av~ylH~~~iL-------HRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~--~a~tvvGTp~YmcP 175 (426)
T KOG0589|consen 105 EERILKWFVQILLAVNYLHENRVL-------HRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS--LASTVVGTPYYMCP 175 (426)
T ss_pred HHHHHHHHHHHHHHHHHHHhhhhh-------cccchhhhhhccccCceeecchhhhhhcCCchh--hhheecCCCcccCH
Confidence 455666777777778888776666 999999999999999999999999998865442 34457999999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|.+.+.+|+.|+|||||||++|||.+-+++|...+ ...+...+.+. ... ..+.....++..++.
T Consensus 176 Eil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~---m~~Li~ki~~~--------~~~-----Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 176 EILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN---MSELILKINRG--------LYS-----PLPSMYSSELRSLVK 239 (426)
T ss_pred HHhCCCCCCccCcchhhcchHHHHHhcccccCccc---hHHHHHHHhhc--------cCC-----CCCccccHHHHHHHH
Confidence 99999999999999999999999999999975332 22233322211 112 223344556777899
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 011196 426 LCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~ 444 (491)
.|++.+|+.||++.+++.+
T Consensus 240 ~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHhhcCCccCCCHHHHhhC
Confidence 9999999999999999875
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.9e-22 Score=189.95 Aligned_cols=158 Identities=26% Similarity=0.464 Sum_probs=116.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||++++++.+||+|||++......... ......++..|+||
T Consensus 101 ~~~~~~~~~~l~~al~~lH~~~i~-------H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aP 172 (260)
T cd05070 101 LPNLVDMAAQVAAGMAYIERMNYI-------HRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAP 172 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------cCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccCh
Confidence 445677888888999999988766 9999999999999999999999999865432211 11123456689999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||++++|+++ |..||... ........ +...... ..+......+.+++
T Consensus 173 E~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~---~~~~~~~~----~~~~~~~---------~~~~~~~~~~~~li 236 (260)
T cd05070 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---NNREVLEQ----VERGYRM---------PCPQDCPISLHELM 236 (260)
T ss_pred HHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC---CHHHHHHH----HHcCCCC---------CCCCcCCHHHHHHH
Confidence 99988889999999999999999999 88886432 11111111 1111100 11112234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhc
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.+||+.||++|||+.++.+.|+.
T Consensus 237 ~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 237 LQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHcccCcccCcCHHHHHHHHhc
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.7e-22 Score=195.41 Aligned_cols=159 Identities=26% Similarity=0.403 Sum_probs=116.4
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhh
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY 347 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 347 (491)
....++.+++.++.++|..+++ ||||||+|||++.++.+||+|||+++...............++..|+|||.
T Consensus 120 ~~~~~~~~l~~~l~~lH~~~i~-------H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~ 192 (288)
T cd05061 120 EMIQMAAEIADGMAYLNAKKFV-------HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES 192 (288)
T ss_pred HHHHHHHHHHHHHHHHHhCCCc-------CCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHH
Confidence 4456777888889999987766 999999999999999999999999876543222222223345678999999
Q ss_pred hhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHH
Q 011196 348 AMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLL 426 (491)
Q Consensus 348 ~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~ 426 (491)
+.++.++.++||||||++++||++ |..||... ....... ....+.... .+......+.+++.+
T Consensus 193 ~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~---~~~~~~~----~~~~~~~~~---------~~~~~~~~~~~li~~ 256 (288)
T cd05061 193 LKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL---SNEQVLK----FVMDGGYLD---------QPDNCPERVTDLMRM 256 (288)
T ss_pred hccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHH----HHHcCCCCC---------CCCCCCHHHHHHHHH
Confidence 998889999999999999999998 67776421 1111111 111111111 111223467789999
Q ss_pred cccCCCCCCCCHHHHHHHhhcCC
Q 011196 427 CVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 427 cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
||+.||++||++.++++.|++..
T Consensus 257 ~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 257 CWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HcCCChhHCcCHHHHHHHHHhhc
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.4e-22 Score=190.57 Aligned_cols=158 Identities=29% Similarity=0.442 Sum_probs=115.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..+++ ||||||+||+++.++.+||+|||+++......... ......+..|+||
T Consensus 102 ~~~~~~~~~~i~~~l~~lH~~~i~-------H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aP 173 (261)
T cd05068 102 LPQLIDMAAQVASGMAYLEAQNYI-------HRDLAARNVLVGENNICKVADFGLARVIKEDIYEA-REGAKFPIKWTAP 173 (261)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------eccCCcceEEEcCCCCEEECCcceEEEccCCcccc-cCCCcCceeccCc
Confidence 445567777888888888887766 99999999999999999999999998765322111 1112234579999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||++++|+++ |+.||... ...... ......... ..+......+.+++
T Consensus 174 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~----~~~~~~~~~---------~~~~~~~~~~~~li 237 (261)
T cd05068 174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM---TNAEVL----QQVDQGYRM---------PCPPGCPKELYDIM 237 (261)
T ss_pred cccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC---CHHHHH----HHHHcCCCC---------CCCCcCCHHHHHHH
Confidence 99988889999999999999999999 88886422 111111 111111100 01112234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhc
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.+||+.+|++||++.++++.|+.
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHhhcCcccCCCHHHHHHHHhc
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=161.88 Aligned_cols=101 Identities=38% Similarity=0.583 Sum_probs=76.7
Q ss_pred eEeec---cCCC-CChHHHHHHHHHHHHHHHHHhhcc-CcccceeeeccCCCccEEEEEecCCCCCccchhHHHHHHhhc
Q 011196 149 LCVKN---ENYT-TEPDKLAQILNQTFNDEIRNAASS-DSKYAAQTINISSFDTLQTTVHCIPDLSKSDCNVCLNSAVAQ 223 (491)
Q Consensus 149 ~~~~~---~~~~-~~~~~f~~~~~~ll~~l~~~a~~~-~~~~a~~~~~~~~~~~vyglaQC~~Dls~~dC~~Cl~~~~~~ 223 (491)
|..|+ .+++ ++...|++++..||.+|+.+|+.+ ..+|++++. ..+.++||||+||++||++.||..||+.++..
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~ 79 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVAN 79 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCC
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHH
Confidence 34566 3344 455569999999999999998644 579999987 46788999999999999999999999999999
Q ss_pred cccccCCCCCcEEEceecceeeeeccc
Q 011196 224 IPTCSKGKLGARIFCASCSIRYELYRF 250 (491)
Q Consensus 224 ~~~~~~~~~~g~i~~~~C~lry~~~~f 250 (491)
++.+|+.++||+|++++|++||+.|+|
T Consensus 80 ~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 80 ISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHHhCCCCceEEEECCCEEEEEECCCC
Confidence 999999999999999999999999987
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-21 Score=197.89 Aligned_cols=180 Identities=18% Similarity=0.225 Sum_probs=123.0
Q ss_pred eeeecccccCCCCccccCC--CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTAP--NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.+++|+.++........ .........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~gii-------H~Dlkp~NIll~~~~~~kL~Dfg~~ 148 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFI-------HRDIKPDNILIDADGHIKLADFGLC 148 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee-------ccCCCHHHeEECCCCCEEeecCCCC
Confidence 3455566655443322211 223445566788899999999997777 9999999999999999999999999
Q ss_pred eecCCCC---------------------------cccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCC
Q 011196 322 RIFGGNQ---------------------------SEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKK 374 (491)
Q Consensus 322 ~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~ 374 (491)
+...... .........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence 7654332 0012234578999999999999999999999999999999999999
Q ss_pred CCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 011196 375 SSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT-MSSVAVM 444 (491)
Q Consensus 375 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~evl~~ 444 (491)
||.... .............. ...+. .......+.+++.+|++ ||++||+ +.+++++
T Consensus 229 Pf~~~~------~~~~~~~i~~~~~~--~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 229 PFYSDT------LQETYNKIINWKES--LRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCC------HHHHHHHHhccCCc--ccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 975322 11111111110000 00000 00023446678889997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.8e-22 Score=196.64 Aligned_cols=175 Identities=18% Similarity=0.189 Sum_probs=120.8
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|+.++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv-------H~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (323)
T cd05584 75 LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGII-------YRDLKPENILLDAQGHVKLTDFGLC 147 (323)
T ss_pred EEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHeEECCCCCEEEeeCcCC
Confidence 455556665443322211 1112334455677888999999988777 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||.... . ...... ...+..
T Consensus 148 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~---~---~~~~~~-~~~~~~- 217 (323)
T cd05584 148 KESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN---R---KKTIDK-ILKGKL- 217 (323)
T ss_pred eecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC---H---HHHHHH-HHcCCC-
Confidence 75432221 1233578999999999998889999999999999999999999975321 1 111111 111111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAVM 444 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 444 (491)
. .+......+.+++.+||+.||++|| ++.+++++
T Consensus 218 ~---------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 N---------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred C---------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 0 1111223467899999999999999 78887763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.4e-22 Score=194.99 Aligned_cols=167 Identities=23% Similarity=0.321 Sum_probs=115.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCccc-ccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEA-NTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||..+++ ||||||+||++++++.+||+|||+++......... ......++..|+|
T Consensus 107 ~~~~~~~~~~l~~aL~~LH~~~i~-------H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 179 (284)
T cd05081 107 HRKLLLYASQICKGMEYLGSKRYV-------HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCce-------eccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeC
Confidence 455667788889999999988777 99999999999999999999999998764332211 1111223456999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCC------c---ccHHHHHHHHhhcCCccccccchhcCCCCHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEH------G---PSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 415 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~------~---~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 415 (491)
||++.+..++.++||||||++++||++|..++....... . .............. .....+..
T Consensus 180 PE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~ 250 (284)
T cd05081 180 PESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN---------GRLPAPPG 250 (284)
T ss_pred HHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC---------CcCCCCCC
Confidence 999988889999999999999999999876643211000 0 00000000111000 00011112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 416 ELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 416 ~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
....+.+++.+||+.+|++|||+.||++.|+..
T Consensus 251 ~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 251 CPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 234577899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.3e-22 Score=190.03 Aligned_cols=154 Identities=23% Similarity=0.306 Sum_probs=114.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.++|..++. ||||||+||++++++.+||+|||+++....... ...++..|+||
T Consensus 101 ~~~~~~~~~~i~~~l~~lH~~~i~-------H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~y~aP 168 (256)
T cd05082 101 GDCLLKFSLDVCEAMEYLEANNFV-------HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAP 168 (256)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEe-------ccccchheEEEcCCCcEEecCCccceeccccCC-----CCccceeecCH
Confidence 445667788888999999988776 999999999999999999999999875432221 22345679999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++|||++ |+.|+.... ..... .....+.... .+......+.+++
T Consensus 169 E~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~---~~~~~----~~~~~~~~~~---------~~~~~~~~~~~li 232 (256)
T cd05082 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVV----PRVEKGYKMD---------APDGCPPVVYDVM 232 (256)
T ss_pred HHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC---HHHHH----HHHhcCCCCC---------CCCCCCHHHHHHH
Confidence 99988889999999999999999998 888864211 11111 1111111111 1112234567899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhc
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.+||+.+|++||++.++++.|+.
T Consensus 233 ~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 233 KQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHhcCChhhCcCHHHHHHHHhc
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.7e-22 Score=202.00 Aligned_cols=162 Identities=22% Similarity=0.335 Sum_probs=119.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............++..|+||
T Consensus 236 ~~~~~~~~~qi~~aL~~LH~~~iv-------H~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP 308 (400)
T cd05105 236 TLDLLSFTYQVARGMEFLASKNCV-------HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAP 308 (400)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------CCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceECh
Confidence 344566788888999999987766 9999999999999999999999999865443322223334567889999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++|||++ |..||...... . ..+.....+... ..+......+.+++
T Consensus 309 E~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~----~~~~~~~~~~~~---------~~~~~~~~~l~~li 373 (400)
T cd05105 309 ESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--S----TFYNKIKSGYRM---------AKPDHATQEVYDIM 373 (400)
T ss_pred hhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--H----HHHHHHhcCCCC---------CCCccCCHHHHHHH
Confidence 99998889999999999999999997 88886532111 1 111111111111 01112234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
.+||+.||++||++.+|.++|+...
T Consensus 374 ~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 374 VKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHCccCHhHCcCHHHHHHHHHHHc
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.6e-22 Score=195.95 Aligned_cols=159 Identities=25% Similarity=0.323 Sum_probs=117.2
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
.....++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++...............++..|+|||
T Consensus 137 ~~~~~~~~qi~~al~~LH~~giv-------H~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE 209 (304)
T cd05101 137 KDLVSCTYQVARGMEYLASQKCI-------HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPE 209 (304)
T ss_pred HHHHHHHHHHHHHHHHHHHCCee-------ecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCch
Confidence 34566778889999999987776 99999999999999999999999998765433222222334567899999
Q ss_pred hhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
++.+..++.++||||||+++||+++ |..|+... . . .........+.... .+......+.+++.
T Consensus 210 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---~---~-~~~~~~~~~~~~~~---------~~~~~~~~~~~li~ 273 (304)
T cd05101 210 ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI---P---V-EELFKLLKEGHRMD---------KPANCTNELYMMMR 273 (304)
T ss_pred hhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC---C---H-HHHHHHHHcCCcCC---------CCCCCCHHHHHHHH
Confidence 9988889999999999999999998 67775321 1 1 11222222221111 11122345777999
Q ss_pred HcccCCCCCCCCHHHHHHHhhcC
Q 011196 426 LCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+||+.+|++||++.||++.|+..
T Consensus 274 ~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 274 DCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred HHcccChhhCCCHHHHHHHHHHH
Confidence 99999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=196.53 Aligned_cols=173 Identities=20% Similarity=0.223 Sum_probs=123.1
Q ss_pred eeeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 243 IRYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
..|.++.|..++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv-------HrDLkp~NILl~~~~~ikL~DFG~ 177 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIV-------YRDLKPENLLLDKDGFIKMTDFGF 177 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------ccCCCHHHEEECCCCCEEEecCCC
Confidence 4556666665554432221 1222344566788889999999988777 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.... .. ........+..
T Consensus 178 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~----~~~~~i~~~~~ 245 (340)
T PTZ00426 178 AKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE---PL----LIYQKILEGII 245 (340)
T ss_pred CeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC---HH----HHHHHHhcCCC
Confidence 9865322 224578999999999998889999999999999999999999975321 11 11111111111
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAVM 444 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 444 (491)
. ++......+.+++.+||+.||++|+ ++++++++
T Consensus 246 ~----------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 Y----------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred C----------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 0111123456789999999999995 89988775
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.3e-22 Score=190.50 Aligned_cols=179 Identities=22% Similarity=0.317 Sum_probs=123.1
Q ss_pred eeeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.+++|..+....... ...........++.+++.++.+||..++. ||||||+||+++.++.+||+|||+
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~-------H~dl~p~ni~i~~~~~~kl~dfg~ 146 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI-------HRDLAARNCLVGEDNVVKVSDFGL 146 (256)
T ss_pred eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcc-------cccccHhhEEECCCCcEEECCccc
Confidence 44555555444332221 11223445677888899999999988777 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
++......... .....++..|+|||++.+..++.++||||||+++||+++ |+.||..... .... .......
T Consensus 147 ~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~----~~~~~~~ 218 (256)
T cd05059 147 ARYVLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVV----ESVSAGY 218 (256)
T ss_pred ceecccccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHH----HHHHcCC
Confidence 97654322111 111223457999999998889999999999999999998 7888753221 1111 1111111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 446 (491)
.. ..+......+.+++.+||+.+|++||++.|+++.|.
T Consensus 219 ~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 219 RL---------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred cC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 00 011112345778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.4e-22 Score=194.09 Aligned_cols=172 Identities=18% Similarity=0.193 Sum_probs=121.1
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|+.++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~-------H~dlkp~NIli~~~~~~kl~Dfg~~ 148 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIV-------YRDLKPENILLDKEGHIKLTDFGFA 148 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee-------ecCCCHHHeEECCCCCEEEEecCcc
Confidence 455566665544322211 1122444566788889999999988777 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+..... .....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..... .....+..
T Consensus 149 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~----~~i~~~~~- 215 (291)
T cd05612 149 KKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN---PFGIY----EKILAGKL- 215 (291)
T ss_pred hhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHH----HHHHhCCc-
Confidence 765321 123568999999999988889999999999999999999999975321 11111 11111111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT-----MSSVAVM 444 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 444 (491)
..+......+.+++.+||+.||++||+ +.+++++
T Consensus 216 ---------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 ---------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011111234678999999999999995 8877755
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=8e-22 Score=197.40 Aligned_cols=174 Identities=17% Similarity=0.177 Sum_probs=119.8
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.+..|..++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 71 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~gii-------HrDlkp~Nili~~~~~~kl~DfG~a 143 (325)
T cd05602 71 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIV-------YRDLKPENILLDSQGHIVLTDFGLC 143 (325)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------ecCCCHHHeEECCCCCEEEccCCCC
Confidence 345556655544322221 1122344556778899999999988777 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+....... ......|++.|+|||++.+..++.++|||||||++|||++|+.||.... .......+ .....
T Consensus 144 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i----~~~~~- 213 (325)
T cd05602 144 KENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNI----LNKPL- 213 (325)
T ss_pred cccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC---HHHHHHHH----HhCCc-
Confidence 75422211 2234578999999999999899999999999999999999999975321 11111111 11110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
. . .......+.+++.+||+.||++||++.+.+.
T Consensus 214 ~-----~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 214 Q-----L----KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred C-----C----CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 0 0 1111234667888999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-21 Score=197.01 Aligned_cols=101 Identities=20% Similarity=0.294 Sum_probs=84.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...... ......||..|+||
T Consensus 156 ~~~~~~i~~qi~~aL~~LH~~~iv-------HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aP 225 (357)
T PHA03209 156 IDQALIIEKQILEGLRYLHAQRII-------HRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAP 225 (357)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHEEECCCCCEEEecCccccccccCc---ccccccccccccCC
Confidence 455677888999999999998776 99999999999999999999999987532211 12235689999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCC
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSS 376 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~ 376 (491)
|++.+..++.++|||||||++|||+++..++
T Consensus 226 E~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 226 EVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred eecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 9999989999999999999999999866553
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.9e-22 Score=197.27 Aligned_cols=170 Identities=18% Similarity=0.193 Sum_probs=119.1
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|+.++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 71 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~giv-------H~dikp~NIll~~~~~~kl~Dfg~~ 143 (323)
T cd05575 71 LYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNII-------YRDLKPENILLDSQGHVVLTDFGLC 143 (323)
T ss_pred EEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------eCCCCHHHeEECCCCcEEEeccCCC
Confidence 355666666554422211 1122344556788899999999988777 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||.... .... .........
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~----~~~i~~~~~- 213 (323)
T cd05575 144 KEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---TAEM----YDNILNKPL- 213 (323)
T ss_pred cccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC---HHHH----HHHHHcCCC-
Confidence 7532211 12234578999999999998899999999999999999999999975321 1111 111111110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMS 439 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 439 (491)
. +.. .....+.+++.+||+.||++||++.
T Consensus 214 ~-----~~~----~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 R-----LKP----NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C-----CCC----CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0 111 1134567899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=196.51 Aligned_cols=149 Identities=20% Similarity=0.178 Sum_probs=111.0
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
.....+..+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...... ....|++.|+|||
T Consensus 118 ~~~~~~~~qi~~aL~~LH~~~iv-------H~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE 185 (329)
T PTZ00263 118 DVAKFYHAELVLAFEYLHSKDII-------YRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPE 185 (329)
T ss_pred HHHHHHHHHHHHHHHHHHHCCee-------ecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----ceecCChhhcCHH
Confidence 34455677888999999988777 99999999999999999999999998654321 2357899999999
Q ss_pred hhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHH
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLL 426 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~ 426 (491)
++.+..++.++|||||||++|||++|+.||.... . ...++....+... .+.....++.+++.+
T Consensus 186 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~----~~~~~~i~~~~~~----------~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT---P----FRIYEKILAGRLK----------FPNWFDGRARDLVKG 248 (329)
T ss_pred HHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC---H----HHHHHHHhcCCcC----------CCCCCCHHHHHHHHH
Confidence 9998889999999999999999999999974211 1 1111222222110 011112346679999
Q ss_pred cccCCCCCCCC-----HHHHHHH
Q 011196 427 CVQEDPMDRPT-----MSSVAVM 444 (491)
Q Consensus 427 cl~~dP~~RPs-----~~evl~~ 444 (491)
||+.||++||+ +.+++.+
T Consensus 249 ~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 249 LLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999997 6777644
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-21 Score=196.43 Aligned_cols=160 Identities=27% Similarity=0.347 Sum_probs=117.3
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
.....++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............++..|+|||
T Consensus 134 ~~~~~~~~qi~~al~~LH~~giv-------H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 206 (334)
T cd05100 134 KDLVSCAYQVARGMEYLASQKCI-------HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPE 206 (334)
T ss_pred HHHHHHHHHHHHHHHHHHHCCee-------ccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHH
Confidence 34566788888999999987776 99999999999999999999999998654332222222233456799999
Q ss_pred hhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
++.+..++.++||||||+++|||++ |..||.... . .........+...+. +......+.+++.
T Consensus 207 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~-~~~~~~~~~~~~~~~---------~~~~~~~l~~li~ 270 (334)
T cd05100 207 ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------V-EELFKLLKEGHRMDK---------PANCTHELYMIMR 270 (334)
T ss_pred HhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC------H-HHHHHHHHcCCCCCC---------CCCCCHHHHHHHH
Confidence 9998889999999999999999998 777764221 1 111222222211111 1122345778999
Q ss_pred HcccCCCCCCCCHHHHHHHhhcCC
Q 011196 426 LCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
+||+.+|++||++.|+++.|+...
T Consensus 271 ~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 271 ECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHcccChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-21 Score=198.88 Aligned_cols=168 Identities=19% Similarity=0.225 Sum_probs=115.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++........ ......++..|+||
T Consensus 102 ~~~~~~~~~qi~~aL~~LH~~~iv-------H~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aP 173 (372)
T cd07853 102 SDHVKVFLYQILRGLKYLHSAGIL-------HRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-HMTQEVVTQYYRAP 173 (372)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------CCCCChHHEEECCCCCEEeccccceeecccCccc-cCCCCCcCCCcCCH
Confidence 445667788899999999988777 9999999999999999999999999865432221 12234678899999
Q ss_pred hhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcccc---------------cc-chh
Q 011196 346 EYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAEL---------------MD-SVV 408 (491)
Q Consensus 346 E~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~d-~~l 408 (491)
|++.+. .++.++|||||||+++||++|+.||..... ......+..........++ .. +..
T Consensus 174 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (372)
T cd07853 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP---IQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSL 250 (372)
T ss_pred HHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCch
Confidence 998874 478999999999999999999999754321 1111111111110000000 00 000
Q ss_pred c--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 409 K--QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 409 ~--~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
. ..........+.+++.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 251 PVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 00111123457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.1e-22 Score=198.14 Aligned_cols=175 Identities=17% Similarity=0.190 Sum_probs=121.7
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 70 ~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv-------H~Dlkp~NIll~~~~~~kL~Dfg~~ 142 (323)
T cd05595 70 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV-------YRDIKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------ecCCCHHHEEEcCCCCEEecccHHh
Confidence 345566665554322111 1223455667788899999999988776 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+....... ......|++.|+|||++.+..++.++|||||||++|||++|+.||.... .......+ .....
T Consensus 143 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~~----~~~~~- 212 (323)
T cd05595 143 KEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELI----LMEEI- 212 (323)
T ss_pred ccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHH----hcCCC-
Confidence 75322111 1223578999999999998899999999999999999999999974321 11111111 11110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAVM 444 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 444 (491)
. .+......+.+++.+||+.||++|| ++.+++++
T Consensus 213 ~---------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 213 R---------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred C---------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 0 1111223466788999999999998 88887753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.8e-22 Score=196.38 Aligned_cols=174 Identities=21% Similarity=0.204 Sum_probs=120.0
Q ss_pred eeeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 243 IRYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
..|.++.|+.++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+
T Consensus 70 ~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv-------HrDlkp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05620 70 HLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGII-------YRDLKLDNVMLDRDGHIKIADFGM 142 (316)
T ss_pred EEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------ecCCCHHHeEECCCCCEEeCccCC
Confidence 3455666665544322211 1222344556778889999999988777 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
++...... .......|+..|+|||++.+..++.++||||||+++|||++|+.||.... ...+ ++......
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~---~~~~----~~~~~~~~- 212 (316)
T cd05620 143 CKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---EDEL----FESIRVDT- 212 (316)
T ss_pred CeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHH----HHHHHhCC-
Confidence 87432111 12234578999999999999899999999999999999999999975321 1111 11111111
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMS-SVA 442 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl 442 (491)
+.+ +......+.+++.+||+.||++||++. ++.
T Consensus 213 -----~~~----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 213 -----PHY----PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -----CCC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 000 111123466788999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.6e-22 Score=189.84 Aligned_cols=158 Identities=23% Similarity=0.336 Sum_probs=116.0
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.....+.++.+++.++.+||..+++ |+||||+||+++.++.+||+|||.++........ ......++..|++
T Consensus 98 ~~~~~~~~~~~i~~~l~~lH~~~i~-------H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~ 169 (256)
T cd05113 98 QPSQLLEMCKDVCEGMAYLESKQFI-------HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSP 169 (256)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCee-------ccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCCCccChhhCC
Confidence 3455677888999999999988777 9999999999999999999999998765432211 1112345678999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..++.++||||||+++|||++ |..||..... .... .....+..... +......+.++
T Consensus 170 pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~----~~~~~~~~~~~---------~~~~~~~~~~l 233 (256)
T cd05113 170 PEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETV----EKVSQGLRLYR---------PHLASEKVYAI 233 (256)
T ss_pred HHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHH----HHHhcCCCCCC---------CCCCCHHHHHH
Confidence 999988889999999999999999998 8888643221 1111 11111111100 01123457789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhh
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~ 446 (491)
+.+||+.||++||++.+|++.|+
T Consensus 234 i~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 234 MYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHcCCCcccCCCHHHHHHhhC
Confidence 99999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=189.18 Aligned_cols=157 Identities=26% Similarity=0.415 Sum_probs=116.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..++. ||||||+||+++.++.+||+|||++......... .....++..|++|
T Consensus 103 ~~~~~~~~~~i~~al~~lH~~~i~-------h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~P 173 (261)
T cd05148 103 VASLIDMACQVAEGMAYLEEQNSI-------HRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--SSDKKIPYKWTAP 173 (261)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------ccccCcceEEEcCCceEEEccccchhhcCCcccc--ccCCCCceEecCH
Confidence 445566778888889999987766 9999999999999999999999999765432211 1123456789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|.+.+..++.++||||||+++++|++ |+.|+.... ......... .+... ..+......+.+++
T Consensus 174 E~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~~----~~~~~---------~~~~~~~~~~~~~i 237 (261)
T cd05148 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQIT----AGYRM---------PCPAKCPQEIYKIM 237 (261)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHH----hCCcC---------CCCCCCCHHHHHHH
Confidence 99988889999999999999999998 788864321 111222111 11100 11112234567899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhc
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.+||+.||++|||+.++++.|++
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 238 LECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHcCCCchhCcCHHHHHHHHhc
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-21 Score=193.44 Aligned_cols=175 Identities=19% Similarity=0.182 Sum_probs=122.1
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|+.++...... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 71 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~iv-------H~dlkp~Nill~~~~~~kl~Dfg~~ 143 (318)
T cd05570 71 LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGII-------YRDLKLDNVLLDSEGHIKIADFGMC 143 (318)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeE-------ccCCCHHHeEECCCCcEEecccCCC
Confidence 34555665544332111 11223455667788889999999988777 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+....... ......|+..|+|||++.+..++.++|||||||++|||++|+.||.... ... ...........
T Consensus 144 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~----~~~~i~~~~~~ 214 (318)
T cd05570 144 KEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDE----LFQSILEDEVR 214 (318)
T ss_pred eecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHH----HHHHHHcCCCC
Confidence 75322111 2234578999999999999999999999999999999999999975321 111 11111111110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTM-----SSVAVM 444 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~~ 444 (491)
.+......+.+++.+||+.||++||++ .++++.
T Consensus 215 ----------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 ----------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ----------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 111122356789999999999999999 877653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.3e-22 Score=197.30 Aligned_cols=173 Identities=17% Similarity=0.180 Sum_probs=119.6
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|+.++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~giv-------H~Dlkp~NIll~~~~~~kL~DfG~~ 143 (325)
T cd05604 71 LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV-------YRDLKPENILLDSQGHVVLTDFGLC 143 (325)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee-------ecCCCHHHeEECCCCCEEEeecCCc
Confidence 345556655444322211 1223445666788899999999988777 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+...... .......|+..|+|||++.+..++.++|||||||++|||++|+.||.... ...+. ........
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~----~~~~~~~~- 213 (325)
T cd05604 144 KEGIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD---VAEMY----DNILHKPL- 213 (325)
T ss_pred ccCCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC---HHHHH----HHHHcCCc-
Confidence 7532211 12234578999999999999899999999999999999999999974321 11111 11111110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVA 442 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl 442 (491)
.+ .. .....+.+++.+|++.||++||++++.+
T Consensus 214 -~~----~~----~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 214 -VL----RP----GASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred -cC----CC----CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 00 11 1223466789999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-21 Score=189.32 Aligned_cols=180 Identities=21% Similarity=0.196 Sum_probs=122.7
Q ss_pred eeeecccccCCCCcccc----CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 244 RYELYRFLVDTPTVTVT----APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
.|.++.|+.++...... ...........++.+++.++.++|..+++ ||||||+||+++.++.+||+|||
T Consensus 68 ~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv-------H~dikp~Nili~~~~~~~l~Dfg 140 (277)
T cd05607 68 LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV-------YRDMKPENVLLDDQGNCRLSDLG 140 (277)
T ss_pred EEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEE-------EccCChHhEEEcCCCCEEEeece
Confidence 45566666554432111 11122445566778889999999988777 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
++........ .....|+..|+|||++.+..++.++||||+||++|||++|+.||........ .. .+........
T Consensus 141 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~-~~~~~~~~~~ 214 (277)
T cd05607 141 LAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KE-ELKRRTLEDE 214 (277)
T ss_pred eeeecCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HH-HHHHHhhccc
Confidence 9876543221 1234688999999999988899999999999999999999999754322111 11 1111111111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 445 (491)
... ... .....+.+++.+||+.||++||+++|+++.+
T Consensus 215 ~~~-----~~~----~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 215 VKF-----EHQ----NFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccc-----ccc----cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 100 001 1123467899999999999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-21 Score=195.34 Aligned_cols=175 Identities=18% Similarity=0.195 Sum_probs=120.8
Q ss_pred eeeecccccCCCCcccc-CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 244 RYELYRFLVDTPTVTVT-APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.|.++.|..++...... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++
T Consensus 77 ~~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iv-------Hrdlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIV-------YRDLKLDNLLLDTEGFVKIADFGLCK 149 (324)
T ss_pred EEEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE-------ecCCCHHHeEECCCCcEEeCcccCCc
Confidence 34555565544332221 11233455667888889999999988776 99999999999999999999999987
Q ss_pred ecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccc
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAE 402 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (491)
...... .......|+..|+|||++.+..++.++|||||||++|||++|+.||.... ...... ........
T Consensus 150 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~---~~~~~~----~i~~~~~~- 219 (324)
T cd05589 150 EGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD---EEEVFD----SIVNDEVR- 219 (324)
T ss_pred cCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC---HHHHHH----HHHhCCCC-
Confidence 532211 12234678999999999998889999999999999999999999975321 111111 11111110
Q ss_pred cccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 011196 403 LMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAVM 444 (491)
Q Consensus 403 ~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 444 (491)
.+......+.+++.+||+.||++|| ++.+++++
T Consensus 220 ---------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 220 ---------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ---------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1111223466799999999999999 56666553
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.9e-22 Score=191.88 Aligned_cols=157 Identities=23% Similarity=0.309 Sum_probs=113.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.++|..+++ ||||||+|||+++++.+||+|||++....... .......+..|+||
T Consensus 111 ~~~~~~~~~~i~~al~~lH~~~i~-------H~dikp~nili~~~~~~kl~dfgl~~~~~~~~---~~~~~~~~~~y~ap 180 (270)
T cd05047 111 SQQLLHFAADVARGMDYLSQKQFI-------HRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAI 180 (270)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEe-------ecccccceEEEcCCCeEEECCCCCccccchhh---hccCCCCccccCCh
Confidence 344566788888899999987766 99999999999999999999999986322111 11112235679999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++....++.++||||||++++||++ |..||.... ... .......+...+ .+......+.+++
T Consensus 181 E~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~---~~~----~~~~~~~~~~~~---------~~~~~~~~~~~li 244 (270)
T cd05047 181 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAE----LYEKLPQGYRLE---------KPLNCDDEVYDLM 244 (270)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC---HHH----HHHHHhCCCCCC---------CCCcCCHHHHHHH
Confidence 99988889999999999999999997 888874211 111 111111111111 0111223567899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||.+||++.++++.|+..
T Consensus 245 ~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 245 RQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred HHHcccChhhCCCHHHHHHHHHHh
Confidence 999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.9e-22 Score=198.96 Aligned_cols=175 Identities=16% Similarity=0.175 Sum_probs=120.4
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhh-eeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLS-TSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.++.|..++....... ..........++.+++.++.+||. .+++ ||||||+|||++.++.+||+|||+
T Consensus 70 ~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~iv-------HrDikp~NIll~~~~~~kL~Dfg~ 142 (325)
T cd05594 70 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV-------YRDLKLENLMLDKDGHIKITDFGL 142 (325)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEE-------ecCCCCCeEEECCCCCEEEecCCC
Confidence 455566665544322211 122344566677888888899886 4555 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
++....... ......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ..... .......
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~----~i~~~~~ 213 (325)
T cd05594 143 CKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFE----LILMEEI 213 (325)
T ss_pred CeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHH----HHhcCCC
Confidence 875432211 12235689999999999988999999999999999999999999753211 11111 1111110
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAVM 444 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 444 (491)
. .+......+.+++.+||+.||++|+ ++.+++++
T Consensus 214 -~---------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 -R---------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -C---------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0 0111123466788999999999996 89998765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-22 Score=197.06 Aligned_cols=159 Identities=23% Similarity=0.335 Sum_probs=113.7
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
.....++.+++.++.++|..+++ ||||||+|||+++++.+||+|||++........ ......+..|+|||
T Consensus 119 ~~~~~i~~qi~~al~~lH~~~iv-------H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE 188 (297)
T cd05089 119 QQLLQFASDVATGMQYLSEKQFI-------HRDLAARNVLVGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIE 188 (297)
T ss_pred HHHHHHHHHHHHHHHHHHHCCcc-------cCcCCcceEEECCCCeEEECCcCCCccccceec---cCCCCcCccccCch
Confidence 34566777888889999987666 999999999999999999999999864321111 11122345799999
Q ss_pred hhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
++....++.++||||||++++||++ |..||.... ..+ .......+.... .+......+.+|+.
T Consensus 189 ~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~---~~~----~~~~~~~~~~~~---------~~~~~~~~~~~li~ 252 (297)
T cd05089 189 SLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT---CAE----LYEKLPQGYRME---------KPRNCDDEVYELMR 252 (297)
T ss_pred hhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHH----HHHHHhcCCCCC---------CCCCCCHHHHHHHH
Confidence 9988889999999999999999997 988874221 111 111111111110 11112245678999
Q ss_pred HcccCCCCCCCCHHHHHHHhhcCCCC
Q 011196 426 LCVQEDPMDRPTMSSVAVMLASDIVT 451 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L~~~~~~ 451 (491)
+||+.+|.+||++.++++.|+.....
T Consensus 253 ~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 253 QCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999999998866543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-21 Score=186.93 Aligned_cols=161 Identities=20% Similarity=0.296 Sum_probs=118.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..++. |+||||+||+++.++.++|+|||++......... .....|+..|+||
T Consensus 105 ~~~~~~~~~~i~~~l~~LH~~~i~-------H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~ap 175 (267)
T cd08229 105 EKTVWKYFVQLCSALEHMHSRRVM-------HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSP 175 (267)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccccCCcCccCH
Confidence 445667788899999999988777 9999999999999999999999998765432221 1234678899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|++.+..++.++||||||+++|||++|..||..... .... ......... .+... .......+.+++.
T Consensus 176 e~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~-~~~~~~~~~-----~~~~~---~~~~~~~~~~li~ 242 (267)
T cd08229 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYS-LCKKIEQCD-----YPPLP---SDHYSEELRQLVN 242 (267)
T ss_pred HHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHH-HhhhhhcCC-----CCCCC---cccccHHHHHHHH
Confidence 999888899999999999999999999999742111 1111 111111111 01000 1122345778899
Q ss_pred HcccCCCCCCCCHHHHHHHhhcC
Q 011196 426 LCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+||+.||++|||+.+|++.+++.
T Consensus 243 ~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 243 MCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HhcCCCcccCCCHHHHHHHHhhh
Confidence 99999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.5e-22 Score=192.64 Aligned_cols=159 Identities=26% Similarity=0.425 Sum_probs=114.4
Q ss_pred CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
........++.+++.++.+||...++ |+||+++||+++.++.+||+|||+.................+...|+
T Consensus 100 ~~~~~~~~i~~~i~~~l~~Lh~~~ii-------H~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (259)
T PF07714_consen 100 LSEQQRLSIAIQIAEALSYLHSNNII-------HGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYL 172 (259)
T ss_dssp SBHHHHHHHHHHHHHHHHHHHHTTEE-------EST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS
T ss_pred cccccccccccccccccccccccccc-------ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 34566788899999999999998777 99999999999999999999999998763332222233345678899
Q ss_pred hhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHH
Q 011196 344 APEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 344 aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
|||.+....++.++||||||+++||+++ |+.|+... ...... ....++..... +......+.+
T Consensus 173 aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~----~~~~~~~~~~~---------~~~~~~~~~~ 236 (259)
T PF07714_consen 173 APEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEII----EKLKQGQRLPI---------PDNCPKDIYS 236 (259)
T ss_dssp -HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHH----HHHHTTEETTS---------BTTSBHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccc---cccccc----cccccccccee---------ccchhHHHHH
Confidence 9999999999999999999999999999 67775422 111222 22222221111 1112344678
Q ss_pred HHHHcccCCCCCCCCHHHHHHHh
Q 011196 423 IGLLCVQEDPMDRPTMSSVAVML 445 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~~L 445 (491)
++..||+.||++||++.+|++.|
T Consensus 237 li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 237 LIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHhcC
Confidence 99999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.7e-21 Score=183.25 Aligned_cols=176 Identities=21% Similarity=0.251 Sum_probs=124.1
Q ss_pred eeeecccccCCCCccccC----CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 244 RYELYRFLVDTPTVTVTA----PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
.|.+++|+.+........ ..........++.+++.++.++|..++. |+||||+||+++.++.+||+|||
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~-------h~dl~~~nili~~~~~~~l~df~ 146 (256)
T cd08529 74 LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL-------HRDIKSLNLFLDAYDNVKIGDLG 146 (256)
T ss_pred EEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCcceEEEeCCCCEEEcccc
Confidence 355666665544322211 1122345566788888999999987766 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
+++........ .....|+..|+|||+..+..++.++||||||++++||++|+.||.... ... .......+.
T Consensus 147 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~----~~~~~~~~~ 217 (256)
T cd08529 147 VAKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGA----LILKIIRGV 217 (256)
T ss_pred cceeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHH----HHHHHHcCC
Confidence 99876543221 223467889999999998889999999999999999999999975322 111 111111111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
... .+......+.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 FPP---------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCC---------CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111 111223457789999999999999999998864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=196.08 Aligned_cols=169 Identities=22% Similarity=0.255 Sum_probs=118.2
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|+.++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv-------H~dlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGII-------YRDLKLDNVMLDAEGHIKIADFGMC 148 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------ecCCCHHHeEEcCCCCEEEeecCcc
Confidence 456667766554422211 1223445566788889999999987776 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+....... ......|+..|+|||++.+..++.++|||||||++|||++|+.||.... .......+ .....
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i----~~~~~- 218 (324)
T cd05587 149 KENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQSI----MEHNV- 218 (324)
T ss_pred eecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHH----HcCCC-
Confidence 75322111 1223578999999999999889999999999999999999999975321 11111111 11110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTM 438 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 438 (491)
..+......+.+++.+||+.||++|++.
T Consensus 219 ---------~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 ---------SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---------CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0111112346788999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.7e-21 Score=186.23 Aligned_cols=161 Identities=19% Similarity=0.300 Sum_probs=111.9
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
.....++.+++.++.++|..+++ ||||||+||+++.++.+||+|||+++...............++..|+|||
T Consensus 100 ~~~~~~~~qi~~al~~lH~~~i~-------H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 172 (269)
T cd05087 100 TTLQRMACEIALGLLHLHKNNFI-------HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172 (269)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEe-------ccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHh
Confidence 34456778888999999988776 99999999999999999999999987543332222223345678899999
Q ss_pred hhhhC-------CCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHH
Q 011196 347 YAMEG-------IFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELL 418 (491)
Q Consensus 347 ~~~~~-------~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 418 (491)
++.+. .++.++||||||+++|||++ |+.||..... ........ .+......++.+.... ..
T Consensus 173 ~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~~~~~~----~~~~~~~~~~~~~~~~----~~ 241 (269)
T cd05087 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD---EQVLTYTV----REQQLKLPKPRLKLPL----SD 241 (269)
T ss_pred HhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHh----hcccCCCCCCccCCCC----Ch
Confidence 98642 35789999999999999996 9999753221 11111111 1111122222222111 22
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 011196 419 KYIHIGLLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 419 ~~~~l~~~cl~~dP~~RPs~~evl~~L~ 446 (491)
.+.+++.+|| .+|++|||+.||+..|+
T Consensus 242 ~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 242 RWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 3566888999 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-21 Score=204.90 Aligned_cols=165 Identities=15% Similarity=0.156 Sum_probs=111.4
Q ss_pred hhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhh
Q 011196 269 WITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYA 348 (491)
Q Consensus 269 ~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 348 (491)
...++.+++.++.|||..+++ ||||||+|||++.++.+||+|||+++.+...... ......|+..|+|||++
T Consensus 269 ~~~i~~ql~~aL~yLH~~gIi-------HrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~ 340 (501)
T PHA03210 269 TRAIMKQLLCAVEYIHDKKLI-------HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEIL 340 (501)
T ss_pred HHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhh
Confidence 456788888999999987776 9999999999999999999999999876543221 12235789999999999
Q ss_pred hhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh--cCCcc-------------------ccccch
Q 011196 349 MEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC--EGHAA-------------------ELMDSV 407 (491)
Q Consensus 349 ~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~-------------------~~~d~~ 407 (491)
.+..++.++|||||||++|||++|..++...........+..+..... ..... ..+.+.
T Consensus 341 ~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~ 420 (501)
T PHA03210 341 AGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPL 420 (501)
T ss_pred cCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhH
Confidence 998999999999999999999998754321111111111111111110 00000 000001
Q ss_pred hcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 408 VKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 408 l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
+... .....+.+++.+||+.||++|||+.|++.+
T Consensus 421 ~~~~---~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 421 IRNL---GLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHhc---CCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1000 011235667889999999999999999863
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-21 Score=194.95 Aligned_cols=160 Identities=25% Similarity=0.338 Sum_probs=116.4
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
.....++.+++.++.++|..+++ ||||||+|||++.++.+||+|||+++...............++..|+|||
T Consensus 134 ~~~~~~~~qi~~aL~~lH~~gi~-------H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 206 (314)
T cd05099 134 KDLVSCAYQVARGMEYLESRRCI-------HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPE 206 (314)
T ss_pred HHHHHHHHHHHHHHHHHHHCCee-------eccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHH
Confidence 34566788889999999987776 99999999999999999999999998654322211122223456799999
Q ss_pred hhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
++.++.++.++||||||+++||+++ |..||.... ... .......+...+ .+......+.+++.
T Consensus 207 ~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~---~~~----~~~~~~~~~~~~---------~~~~~~~~l~~li~ 270 (314)
T cd05099 207 ALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---VEE----LFKLLREGHRMD---------KPSNCTHELYMLMR 270 (314)
T ss_pred HHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC---HHH----HHHHHHcCCCCC---------CCCCCCHHHHHHHH
Confidence 9988889999999999999999999 788864221 111 111111211111 11122345668999
Q ss_pred HcccCCCCCCCCHHHHHHHhhcCC
Q 011196 426 LCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
+||+.||++||++.++++.|+...
T Consensus 271 ~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 271 ECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHcCCCcccCcCHHHHHHHHHHHH
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=188.76 Aligned_cols=159 Identities=28% Similarity=0.410 Sum_probs=117.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc-cccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE-ANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~a 344 (491)
......++.+++.++.++|..++. ||||||+||+++.++.+||+|||+++........ .......++..|++
T Consensus 96 ~~~~~~~~~qi~~~L~~lH~~~i~-------H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~ 168 (257)
T cd05040 96 ISTLCDYAVQIANGMRYLESKRFI-------HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA 168 (257)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------ccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecC
Confidence 445666778889999999988776 9999999999999999999999999876442211 11223456788999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..++.++||||||++++||++ |+.|+.... ..+....... ..... ..+......+.++
T Consensus 169 pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~---~~~~~---------~~~~~~~~~~~~l 233 (257)
T cd05040 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS---GSQILKKIDK---EGERL---------ERPEACPQDIYNV 233 (257)
T ss_pred HHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHh---cCCcC---------CCCccCCHHHHHH
Confidence 999988889999999999999999998 999974221 1111111111 11100 0111223457789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhh
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~ 446 (491)
+.+||+.+|++||++.+|++.|.
T Consensus 234 i~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 234 MLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHCCCCcccCCCHHHHHHHhc
Confidence 99999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.8e-22 Score=196.16 Aligned_cols=159 Identities=27% Similarity=0.332 Sum_probs=115.3
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
...+.++.+++.++.++|..+++ ||||||+||+++.++.+||+|||+++...............++..|+|||
T Consensus 140 ~~~~~~~~qi~~aL~~lH~~gi~-------H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 212 (307)
T cd05098 140 KDLVSCAYQVARGMEYLASKKCI-------HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 212 (307)
T ss_pred HHHHHHHHHHHHHHHHHHHCCcc-------cccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChH
Confidence 34556788888889999987766 99999999999999999999999987654322111122223456899999
Q ss_pred hhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
++.+..++.++||||||+++|||++ |..|+.... . .............+ .+......+.+++.
T Consensus 213 ~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------~-~~~~~~~~~~~~~~---------~~~~~~~~~~~li~ 276 (307)
T cd05098 213 ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------V-EELFKLLKEGHRMD---------KPSNCTNELYMMMR 276 (307)
T ss_pred HhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------H-HHHHHHHHcCCCCC---------CCCcCCHHHHHHHH
Confidence 9988889999999999999999998 778864211 1 11111111111111 11122345677999
Q ss_pred HcccCCCCCCCCHHHHHHHhhcC
Q 011196 426 LCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+||+.+|++||++.+|++.|+..
T Consensus 277 ~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 277 DCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HHcccChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-21 Score=187.51 Aligned_cols=158 Identities=26% Similarity=0.450 Sum_probs=116.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..+++ ||||||+||++++++.+||+|||+++........ ......++..|++|
T Consensus 101 ~~~~~~~~~~l~~al~~lH~~~i~-------H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~P 172 (260)
T cd05069 101 LPQLVDMAAQIADGMAYIERMNYI-------HRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAP 172 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEe-------ecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCH
Confidence 344567788888888999887766 9999999999999999999999999865432211 11223456789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|+..+..++.++||||||+++||+++ |..|+... ...... .....+... ..+......+.+++
T Consensus 173 e~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~----~~~~~~~~~---------~~~~~~~~~~~~li 236 (260)
T cd05069 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---VNREVL----EQVERGYRM---------PCPQGCPESLHELM 236 (260)
T ss_pred HHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC---CHHHHH----HHHHcCCCC---------CCCcccCHHHHHHH
Confidence 99988889999999999999999999 88886421 111111 111111100 01112234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhc
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.+||+.||++||++.+|++.|+.
T Consensus 237 ~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 237 KLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHccCCcccCcCHHHHHHHHhc
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=194.11 Aligned_cols=157 Identities=24% Similarity=0.304 Sum_probs=112.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...... ......++..|+||
T Consensus 123 ~~~~~~~~~qi~~al~~LH~~gi~-------H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aP 192 (303)
T cd05088 123 SQQLLHFAADVARGMDYLSQKQFI-------HRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAI 192 (303)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------ccccchheEEecCCCcEEeCccccCcccchhh---hcccCCCcccccCH
Confidence 345567788888889999987766 99999999999999999999999986432111 11112335679999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||++++|+++ |..||..... .... .....+...+ .+......+.+++
T Consensus 193 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~----~~~~~~~~~~---------~~~~~~~~~~~li 256 (303)
T cd05088 193 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELY----EKLPQGYRLE---------KPLNCDDEVYDLM 256 (303)
T ss_pred HHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HHHH----HHHhcCCcCC---------CCCCCCHHHHHHH
Confidence 99988889999999999999999998 9988742211 1111 1111110000 0111123467899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.+|++||++.++++.|+..
T Consensus 257 ~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 257 RQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=191.75 Aligned_cols=160 Identities=21% Similarity=0.261 Sum_probs=117.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||++++++.+||+|||+++.+.............++..|+||
T Consensus 116 ~~~~~~i~~~i~~~l~~LH~~~i~-------H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~ap 188 (280)
T cd05043 116 TQQLVHMAIQIACGMSYLHKRGVI-------HKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188 (280)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEe-------ecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCH
Confidence 445667788888999999987766 9999999999999999999999999865433222112223456789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++||+++ |+.||... ....+ ......+.... . .......+.+++
T Consensus 189 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---~~~~~----~~~~~~~~~~~--~-------~~~~~~~~~~li 252 (280)
T cd05043 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI---DPFEM----AAYLKDGYRLA--Q-------PINCPDELFAVM 252 (280)
T ss_pred HHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC---CHHHH----HHHHHcCCCCC--C-------CCcCCHHHHHHH
Confidence 99988889999999999999999998 99987432 11111 11111111000 0 111123567899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++||++.+|++.|+..
T Consensus 253 ~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 253 ACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred HHHcCCChhhCCCHHHHHHHHHHH
Confidence 999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-21 Score=195.02 Aligned_cols=170 Identities=16% Similarity=0.166 Sum_probs=118.0
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iv-------H~Dlkp~NIll~~~~~~kl~Dfg~~ 143 (321)
T cd05603 71 LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNII-------YRDLKPENILLDSQGHVVLTDFGLC 143 (321)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------eccCCHHHeEECCCCCEEEccCCCC
Confidence 455666665544322111 1122344556778899999999987776 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||.... ...... ...... .
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~----~i~~~~-~ 213 (321)
T cd05603 144 KEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---VSQMYD----NILHKP-L 213 (321)
T ss_pred ccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC---HHHHHH----HHhcCC-C
Confidence 7532211 12234578999999999998889999999999999999999999974321 111111 111111 0
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMS 439 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 439 (491)
..+......+.+++.+||+.||++||++.
T Consensus 214 ---------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 ---------QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 01112234567899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.7e-21 Score=186.07 Aligned_cols=182 Identities=19% Similarity=0.229 Sum_probs=125.3
Q ss_pred eeeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 243 IRYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
..|.++.|..++....... ........+.++.+++.++.+||..+++ ||||||+|||++.++.+|++|||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~ii-------H~dikp~nili~~~~~~~l~dfg 152 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYV-------HKGLAAHKVLVNSDLVCKISGFR 152 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEe-------eccccHhhEEEcCCCcEEECCCc
Confidence 3455666666554432221 1223455677888889999999987776 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
.......... .......++..|+|||++.++.++.++||||||+++||+++ |..||.... ...... ....+
T Consensus 153 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~---~~~~~~----~~~~~ 224 (266)
T cd05064 153 RLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS---GQDVIK----AVEDG 224 (266)
T ss_pred ccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC---HHHHHH----HHHCC
Confidence 8764322111 11112334678999999999999999999999999999775 999974321 111111 11111
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
... ..+......+.+++..||+.+|++||++.+|++.|++.
T Consensus 225 ~~~---------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 FRL---------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCC---------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 111 11112234567799999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=6e-22 Score=197.67 Aligned_cols=171 Identities=20% Similarity=0.230 Sum_probs=120.1
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|+.++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~-------H~dlkp~Nil~~~~~~~kL~Dfg~~ 145 (318)
T cd05582 73 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII-------YRDLKPENILLDEEGHIKLTDFGLS 145 (318)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEe-------cCCCCHHHeEECCCCcEEEeeccCC
Confidence 345556665544322211 1233556677888999999999998777 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||.... .......+ .....
T Consensus 146 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~---~~~~~~~i----~~~~~- 215 (318)
T cd05582 146 KESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD---RKETMTMI----LKAKL- 215 (318)
T ss_pred cccCCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC---HHHHHHHH----HcCCC-
Confidence 76533211 2224578999999999988889999999999999999999999975321 11111111 11111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSS 440 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e 440 (491)
..+......+.+++.+||+.||++||++.+
T Consensus 216 ---------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 ---------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ---------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 011112234667889999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.7e-21 Score=185.53 Aligned_cols=161 Identities=20% Similarity=0.287 Sum_probs=119.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..++. ||||||+||+++.++.++|+|||++......... .....++..|+||
T Consensus 105 ~~~~~~~~~~l~~~l~~lh~~~i~-------h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~ap 175 (267)
T cd08224 105 ERTIWKYFVQLCSALEHMHSKRIM-------HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSP 175 (267)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEe-------cCCcChhhEEECCCCcEEEeccceeeeccCCCcc--cceecCCccccCH
Confidence 455677888899999999988777 9999999999999999999999998765432211 2234678899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|++.+..++.++||||||+++||+++|+.|+.... ..... .......+...... .......+.+++.
T Consensus 176 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~-~~~~~~~~~~~~~~--------~~~~~~~~~~~i~ 242 (267)
T cd08224 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYS-LCKKIEKCDYPPLP--------ADHYSEELRDLVS 242 (267)
T ss_pred HHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHH-HHhhhhcCCCCCCC--------hhhcCHHHHHHHH
Confidence 99988889999999999999999999999964221 11111 11111111111110 1122345678999
Q ss_pred HcccCCCCCCCCHHHHHHHhhcC
Q 011196 426 LCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+||+.+|++||++.+|+++|++.
T Consensus 243 ~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 243 RCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HHcCCCcccCCCHHHHHHHHHHh
Confidence 99999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-21 Score=197.69 Aligned_cols=101 Identities=20% Similarity=0.265 Sum_probs=84.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC--CceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM--NPKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
-.....++.+++.++.+||.++++ |.||||+||||.+-. .+||+|||.+........ ..+-+..|+
T Consensus 288 l~~ir~~~~Qil~~L~~L~~l~II-------HcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYR 355 (586)
T KOG0667|consen 288 LPLVRKFAQQILTALLFLHELGII-------HCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYR 355 (586)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------eccCChhheeeccCCcCceeEEecccccccCCcce-----eeeeccccc
Confidence 345667888888999999888777 999999999997643 689999999986533221 456788999
Q ss_pred hhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCC
Q 011196 344 APEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGF 378 (491)
Q Consensus 344 aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~ 378 (491)
|||++.+.+|+.+.||||||||+.||++|.+-|..
T Consensus 356 APEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 356 APEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 99999999999999999999999999999776653
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=194.12 Aligned_cols=160 Identities=23% Similarity=0.315 Sum_probs=116.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++...............++..|++|
T Consensus 108 ~~~~~~~~~qi~~~L~~LH~~~iv-------H~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~P 180 (303)
T cd05110 108 SQLLLNWCVQIAKGMMYLEERRLV-------HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180 (303)
T ss_pred HHHHHHHHHHHHHHHHHHhhcCee-------ccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCH
Confidence 344567788888999999887666 9999999999999999999999999876433322222233456789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++||+++ |+.|+.... ... .......+.... .+......+.+++
T Consensus 181 E~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~----~~~~~~~~~~~~---------~~~~~~~~~~~li 244 (303)
T cd05110 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TRE----IPDLLEKGERLP---------QPPICTIDVYMVM 244 (303)
T ss_pred HHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHH----HHHHHHCCCCCC---------CCCCCCHHHHHHH
Confidence 99988889999999999999999997 888864221 111 111111111110 0111224567889
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
..||..+|++||++.++++.|+..
T Consensus 245 ~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 245 VKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.6e-21 Score=187.50 Aligned_cols=160 Identities=23% Similarity=0.356 Sum_probs=115.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..+++ |+||||+|||++.++.+||+|||++....... .....|+..|+||
T Consensus 94 ~~~~~~~~~qi~~~l~~lH~~~i~-------H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aP 162 (279)
T cd06619 94 EHVLGRIAVAVVKGLTYLWSLKIL-------HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAP 162 (279)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEe-------eCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCChhhcCc
Confidence 334556888889999999988777 99999999999999999999999997653321 2235788999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|++.+..++.++||||||+++|||++|+.||........................... ... ....++.+++.
T Consensus 163 E~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~----~~~~~~~~li~ 234 (279)
T cd06619 163 ERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL----PVG----QFSEKFVHFIT 234 (279)
T ss_pred eeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC----CCC----cCCHHHHHHHH
Confidence 9999888999999999999999999999997543222111111111111111111111 011 11234678899
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 011196 426 LCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~ 444 (491)
+||+.||++||+++|++++
T Consensus 235 ~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 235 QCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHhhCChhhCCCHHHHhcC
Confidence 9999999999999998864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.7e-21 Score=217.60 Aligned_cols=193 Identities=20% Similarity=0.364 Sum_probs=140.8
Q ss_pred eeeecccccCCCCccccCCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCccee
Q 011196 244 RYELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARI 323 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~ 323 (491)
.|.+++|..++....... ...+..+..++.+++.++.|+|.. +..+++||||||+||+++.++.+++. ||....
T Consensus 758 ~~lv~Ey~~~g~L~~~l~-~l~~~~~~~i~~~ia~~L~yLH~~----~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR-NLSWERRRKIAIGIAKALRFLHCR----CSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred CEEEEeCCCCCcHHHHHh-cCCHHHHHHHHHHHHHHHHHhccC----CCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 456677766554433221 233556677888899999999842 24556699999999999999888875 665543
Q ss_pred cCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcccc
Q 011196 324 FGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAEL 403 (491)
Q Consensus 324 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (491)
... .....|+..|+|||++.+..++.++|||||||++|||++|+.|++... ........+............+
T Consensus 832 ~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 904 (968)
T PLN00113 832 LCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMW 904 (968)
T ss_pred ccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhhe
Confidence 211 112367899999999999899999999999999999999999974322 2234455555544444445556
Q ss_pred ccchhcC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 404 MDSVVKQ--SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 404 ~d~~l~~--~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
+|+.+.. ..+.++..++.+++.+||+.||++||+|+||++.|+...
T Consensus 905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 6666533 345677788999999999999999999999999998764
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-21 Score=188.72 Aligned_cols=157 Identities=22% Similarity=0.346 Sum_probs=114.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.++|..++. ||||||+||+++.++.+||+|||.++........ ......++..|+||
T Consensus 99 ~~~~~~~~~~i~~~l~~lH~~~i~-------H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aP 170 (256)
T cd05114 99 KDMLLSMCQDVCEGMEYLERNSFI-------HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPP 170 (256)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------ccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCCCchhhCCh
Confidence 344567788888999999987776 9999999999999999999999998765332221 11123456689999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++||+++ |+.||... ........+ ..+... ..+ ......+.+++
T Consensus 171 E~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~---~~~~~~~~i----~~~~~~--~~~-------~~~~~~~~~li 234 (256)
T cd05114 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK---SNYEVVEMI----SRGFRL--YRP-------KLASMTVYEVM 234 (256)
T ss_pred hhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHH----HCCCCC--CCC-------CCCCHHHHHHH
Confidence 99988889999999999999999999 88886422 111222222 111110 011 11124577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhh
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~ 446 (491)
.+||+.||++||++.++++.|.
T Consensus 235 ~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 235 YSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HHHccCCcccCcCHHHHHHhhC
Confidence 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.8e-22 Score=198.55 Aligned_cols=164 Identities=18% Similarity=0.226 Sum_probs=113.8
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++..... .....|+..|+|
T Consensus 116 ~~~~~~~i~~qi~~aL~~LH~~~iv-------Hrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~a 183 (343)
T cd07878 116 SDEHVQFLIYQLLRGLKYIHSAGII-------HRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRA 183 (343)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCee-------cccCChhhEEECCCCCEEEcCCccceecCCC-----cCCccccccccC
Confidence 3455677888999999999988777 9999999999999999999999999865332 223568999999
Q ss_pred hhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccch--------hc--CCCC
Q 011196 345 PEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSV--------VK--QSCD 413 (491)
Q Consensus 345 PE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~--------l~--~~~~ 413 (491)
||++.+ ..++.++|||||||+++||++|+.||..... ............. ...+..... +. ...+
T Consensus 184 PE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (343)
T cd07878 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY---IDQLKRIMEVVGT-PSPEVLKKISSEHARKYIQSLPHMP 259 (343)
T ss_pred chHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHhCC-CCHHHHHhcchhhHHHHhhcccccc
Confidence 999876 4688999999999999999999999753211 1111111111100 000000000 00 0000
Q ss_pred H--------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 414 Q--------AELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 414 ~--------~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
. .....+.+++.+||+.||++|||+.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 260 QQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred chhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 011246789999999999999999998854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-21 Score=195.83 Aligned_cols=171 Identities=25% Similarity=0.330 Sum_probs=130.4
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.|||...++ |||+||.|||++..+.+|++|||+++.+..+.. ......||+.||||
T Consensus 99 Ee~v~~~a~~LVsaL~yLhs~ril-------hrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~--vltsikGtPlYmAP 169 (808)
T KOG0597|consen 99 EEQVRAIAYDLVSALYYLHSNRIL-------HRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS--VLTSIKGTPLYMAP 169 (808)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCcc-------cccCCcceeeecCCCceeechhhhhhhcccCce--eeeeccCcccccCH
Confidence 556777888999999999998888 999999999999999999999999998765332 34467899999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|+..+++|+..+|+||+||++||++.|++||.... +.+.+ +.+.. |+.. .+......++.++.
T Consensus 170 Elv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv-~~I~~-------d~v~---~p~~~S~~f~nfl~ 232 (808)
T KOG0597|consen 170 ELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLV-KSILK-------DPVK---PPSTASSSFVNFLQ 232 (808)
T ss_pred HHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHH-HHHhc-------CCCC---CcccccHHHHHHHH
Confidence 99999999999999999999999999999974211 11111 11111 1111 12233456778888
Q ss_pred HcccCCCCCCCCHHHHHHH--hhcCCCCCCCCCCCCeee
Q 011196 426 LCVQEDPMDRPTMSSVAVM--LASDIVTLPKPTQPAFSV 462 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~--L~~~~~~~~~p~~p~~~~ 462 (491)
..|++||.+|.+-.+++.+ .++.......|..|++.-
T Consensus 233 gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~s 271 (808)
T KOG0597|consen 233 GLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDS 271 (808)
T ss_pred HHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccC
Confidence 9999999999998888764 344445556677777753
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=191.62 Aligned_cols=167 Identities=24% Similarity=0.331 Sum_probs=118.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc-cccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE-ANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||..++. ||||||+||+++.++.+||+|||++......... .......++..|++
T Consensus 108 ~~~~~~~~~~l~~aL~~lH~~~i~-------H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (284)
T cd05038 108 LKRLLLFSSQICKGMDYLGSQRYI-------HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccC
Confidence 455667888888999999987776 9999999999999999999999999876532221 11112344567999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcc--------cHHHHHHHHhhcCCccccccchhcCCCCHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGP--------SLLAYIWKLWCEGHAAELMDSVVKQSCDQAE 416 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 416 (491)
||.+.+..++.++||||||++++||++|..|+......... .............. ....+...
T Consensus 181 Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~ 251 (284)
T cd05038 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE---------RLPRPPSC 251 (284)
T ss_pred cHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC---------cCCCCccC
Confidence 99998888999999999999999999999886432111100 01111111111111 01111222
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 417 LLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 417 ~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
..++.+++.+||+.+|++||++.||+++|++.
T Consensus 252 ~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 252 PDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 35678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-21 Score=189.16 Aligned_cols=181 Identities=20% Similarity=0.309 Sum_probs=124.3
Q ss_pred eeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 245 YELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
|.+++|+.+........ ..........++.+++.++.++|..+++ ||||||+||+++.++.+||+|||++
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~-------H~dlkp~Nili~~~~~~kl~dfg~~ 154 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV-------HRDLAARNILVNSNLECKVSDFGLS 154 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee-------ccccchhhEEEcCCCcEEECCCccc
Confidence 45556665444322211 1123445667788888999999988777 9999999999999999999999999
Q ss_pred eecCCCCccccc-CceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 322 RIFGGNQSEANT-NRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 322 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
............ .....+..|++||++....++.++||||||+++||+++ |+.|+.... ... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~---~~~----~~~~i~~~~ 227 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS---NHE----VMKAINDGF 227 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC---HHH----HHHHHhcCC
Confidence 765432221111 11123457999999988889999999999999999997 999974321 111 112221111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.. + ...+....+.+++.+||+.+|++||++.+|++.|++.
T Consensus 228 ~~----~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 RL----P-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CC----C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 0 1112234577899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.8e-21 Score=184.10 Aligned_cols=157 Identities=19% Similarity=0.234 Sum_probs=114.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccc-cCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEAN-TNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~-~~~~~gt~~y~a 344 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++.......... .....|+..|+|
T Consensus 103 ~~~~~~~~~~l~~~l~~lH~~~i~-------H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 175 (263)
T cd06625 103 ETVTRKYTRQILEGVEYLHSNMIV-------HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175 (263)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccC
Confidence 445567788889999999988777 999999999999999999999999976543221111 123457889999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||++.+..++.++||||||+++||+++|+.||... +............... ..+......+.+++
T Consensus 176 PE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~------~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~li 240 (263)
T cd06625 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF------EAMAAIFKIATQPTNP---------QLPSHVSPDARNFL 240 (263)
T ss_pred cceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc------chHHHHHHHhccCCCC---------CCCccCCHHHHHHH
Confidence 99999888999999999999999999999996421 1111111111111111 11112233467789
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 011196 425 LLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~ 444 (491)
.+||+.+|++||++.+++++
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHhhcCcccCCCHHHHhhC
Confidence 99999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-21 Score=187.68 Aligned_cols=159 Identities=26% Similarity=0.393 Sum_probs=115.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC-----CceEeccCcceecCCCCcccccCceeecC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM-----NPKISDFGMARIFGGNQSEANTNRVVGTY 340 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~-----~~kl~DfGla~~~~~~~~~~~~~~~~gt~ 340 (491)
......++.+++.++.++|..+++ |+||||+||+++.+. .+||+|||+++...............++.
T Consensus 105 ~~~~~~~~~~l~~~l~~lH~~~i~-------H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 177 (269)
T cd05044 105 LKELLDICLDVAKGCVYLEQMHFI-------HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177 (269)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------cCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCc
Confidence 345667788888888999887766 999999999999877 89999999997654332222222334567
Q ss_pred CCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHH
Q 011196 341 GYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLK 419 (491)
Q Consensus 341 ~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 419 (491)
.|+|||++.++.++.++||||||+++|||++ |+.||.... ..+....+ ..+... ..+......
T Consensus 178 ~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~---~~~~~~~~----~~~~~~---------~~~~~~~~~ 241 (269)
T cd05044 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN---NQEVLQHV----TAGGRL---------QKPENCPDK 241 (269)
T ss_pred cccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC---HHHHHHHH----hcCCcc---------CCcccchHH
Confidence 8999999999999999999999999999998 998864221 11111111 111101 011122345
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 011196 420 YIHIGLLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 420 ~~~l~~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
+.+++.+||+.+|++||++.+|++.|++
T Consensus 242 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 242 IYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 6789999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-21 Score=193.81 Aligned_cols=179 Identities=17% Similarity=0.225 Sum_probs=120.8
Q ss_pred eeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.+++|+.++.+..... ..........++.+++.++.++|..+++ ||||||+|||++.++.+||+|||+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~-------H~Dlkp~NIll~~~~~~kL~Dfg~ 148 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYV-------HRDIKPENVLIDRTGHIKLADFGS 148 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------cccCchHheEECCCCCEEeccCCC
Confidence 456666665554433221 1222344556777888999999988777 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhh------hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHH
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAM------EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKL 394 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 394 (491)
+......... ......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ..... ..
T Consensus 149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~---~i 221 (330)
T cd05601 149 AARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---AKTYN---NI 221 (330)
T ss_pred CeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---HHHHH---HH
Confidence 9876443222 122346899999999987 45678999999999999999999999753211 11111 11
Q ss_pred hhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 395 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 395 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..........+ .......+.+++.+||+ ||++||++.+++.+
T Consensus 222 ~~~~~~~~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 222 MNFQRFLKFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HcCCCccCCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 11111111100 01122346678888997 99999999998853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-21 Score=186.95 Aligned_cols=159 Identities=23% Similarity=0.409 Sum_probs=116.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..+++ ||||||+||++++++.+||+|||.++........ ......++..|++|
T Consensus 101 ~~~~~~~~~~l~~aL~~lH~~~i~-------H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~P 172 (262)
T cd05071 101 LPQLVDMAAQIASGMAYVERMNYV-------HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAP 172 (262)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------ccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCH
Confidence 345567788888888999887766 9999999999999999999999999866432211 11223456789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|+..+..++.++||||||+++||+++ |..||... ...... ......... ..+.+....+.+++
T Consensus 173 E~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~---~~~~~~----~~~~~~~~~---------~~~~~~~~~l~~li 236 (262)
T cd05071 173 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVL----DQVERGYRM---------PCPPECPESLHDLM 236 (262)
T ss_pred hHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---ChHHHH----HHHhcCCCC---------CCccccCHHHHHHH
Confidence 99988889999999999999999999 77776421 111111 111111100 11122345677899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++||++.++++.|+..
T Consensus 237 ~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 237 CQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHccCCcccCCCHHHHHHHHHHh
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.4e-21 Score=184.17 Aligned_cols=159 Identities=17% Similarity=0.278 Sum_probs=109.0
Q ss_pred hhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhh
Q 011196 269 WITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYA 348 (491)
Q Consensus 269 ~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 348 (491)
...++.+++.++.++|...++ ||||||+|||++.++.+||+|||++................++..|+|||++
T Consensus 101 ~~~~~~~i~~al~~lH~~~i~-------H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 173 (268)
T cd05086 101 LQRMACEIAAGVTHMHKHNFL-------HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173 (268)
T ss_pred HHHHHHHHHHHHHHHHHCCee-------ccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhc
Confidence 456677888899999987766 9999999999999999999999998643221111122235678899999987
Q ss_pred hh-------CCCCcccceeehhHHHHHHHhC-CCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHH
Q 011196 349 ME-------GIFSVKSDVFSFGVVLLEIISG-KKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKY 420 (491)
Q Consensus 349 ~~-------~~~s~~sDVwS~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 420 (491)
.. ..++.++||||||+++|||+++ ..|+... ........+. .+....+.++.+...++ .++
T Consensus 174 ~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~---~~~~~~~~~~----~~~~~~~~~~~~~~~~~----~~~ 242 (268)
T cd05086 174 GEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL---SDREVLNHVI----KDQQVKLFKPQLELPYS----ERW 242 (268)
T ss_pred ccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHH----hhcccccCCCccCCCCc----HHH
Confidence 53 2357899999999999999975 5565321 1112222221 12222333333332222 345
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHhh
Q 011196 421 IHIGLLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 421 ~~l~~~cl~~dP~~RPs~~evl~~L~ 446 (491)
.+++..|| .+|++||++++|++.|.
T Consensus 243 ~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 243 YEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 66888899 67999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-21 Score=193.96 Aligned_cols=174 Identities=20% Similarity=0.218 Sum_probs=120.3
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|+.++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 71 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~iv-------Hrdikp~Nil~~~~~~~kl~Dfg~~ 143 (316)
T cd05619 71 LFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV-------YRDLKLDNILLDTDGHIKIADFGMC 143 (316)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeE-------eCCCCHHHEEECCCCCEEEccCCcc
Confidence 345566665554432221 1222344566788888999999987766 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+....... ......||..|+|||++.+..++.++|||||||++|||++|+.||.... ...+... .....
T Consensus 144 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~----i~~~~-- 212 (316)
T cd05619 144 KENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD---EEELFQS----IRMDN-- 212 (316)
T ss_pred eECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC---HHHHHHH----HHhCC--
Confidence 75322111 2234578999999999998889999999999999999999999975321 1111111 11111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMS-SVAV 443 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl~ 443 (491)
+.. +......+.+++.+||+.||++||++. ++.+
T Consensus 213 ----~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 213 ----PCY----PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ----CCC----CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 000 111123456788999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-21 Score=188.72 Aligned_cols=159 Identities=25% Similarity=0.379 Sum_probs=116.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.++|..+++ ||||||+||+++.++.+||+|||+++................+..|+||
T Consensus 129 ~~~~~~~~~~i~~aL~~lH~~~i~-------H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 201 (288)
T cd05050 129 CTEQLCIAKQVAAGMAYLSERKFV-------HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP 201 (288)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCH
Confidence 344567888889999999987766 9999999999999999999999998765433222112223346779999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++|||||||++|||++ |..|+..... .........+.... .+.....++.+++
T Consensus 202 E~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~l~~li 265 (288)
T cd05050 202 ESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-------EEVIYYVRDGNVLS---------CPDNCPLELYNLM 265 (288)
T ss_pred HHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHhcCCCCC---------CCCCCCHHHHHHH
Confidence 99988889999999999999999997 7777532111 11112222222111 1112234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhc
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.+||+.||++||++.|+++.|++
T Consensus 266 ~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 266 RLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHcccCcccCCCHHHHHHHhhC
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-21 Score=193.51 Aligned_cols=166 Identities=16% Similarity=0.181 Sum_probs=112.4
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... ......++..|+||
T Consensus 103 ~~~~~~~~~qi~~aL~~lH~~~iv-------H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aP 173 (309)
T cd07872 103 MHNVKIFLYQILRGLAYCHRRKVL-------HRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPP 173 (309)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHEEECCCCCEEECccccceecCCCcc--ccccccccccccCC
Confidence 344566778888999999987766 999999999999999999999999976433221 12234678999999
Q ss_pred hhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC---Cccccc------c---chhcC--
Q 011196 346 EYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG---HAAELM------D---SVVKQ-- 410 (491)
Q Consensus 346 E~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~------d---~~l~~-- 410 (491)
|++.+ ..++.++||||||++++||++|+.||...... +....+....... .+..+. + +....
T Consensus 174 E~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (309)
T cd07872 174 DVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE---DELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQP 250 (309)
T ss_pred HHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCc
Confidence 99865 45889999999999999999999997543221 1111111111100 000000 0 00000
Q ss_pred --CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 411 --SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 411 --~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.........+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 251 LINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000011234678999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=182.96 Aligned_cols=160 Identities=18% Similarity=0.246 Sum_probs=109.0
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhh
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY 347 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 347 (491)
....++.+++.++.++|..+++ ||||||+|||++.++.+||+|||+++...............++..|+|||+
T Consensus 101 ~~~~~~~qi~~~l~~lH~~~iv-------H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 173 (269)
T cd05042 101 VLQRMACEVASGLLWLHQADFI-------HSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173 (269)
T ss_pred HHHHHHHHHHHHHHHHHhcCEe-------cccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHH
Confidence 3456778888999999987766 999999999999999999999999865432221111223345678999999
Q ss_pred hhh-------CCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHH
Q 011196 348 AME-------GIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLK 419 (491)
Q Consensus 348 ~~~-------~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 419 (491)
+.. ..++.++||||||+++|||++ |..||.... ........ .. .....+.++.+... ....
T Consensus 174 ~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~---~~~~~~~~---~~-~~~~~~~~~~~~~~----~~~~ 242 (269)
T cd05042 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS---DEQVLKQV---VR-EQDIKLPKPQLDLK----YSDR 242 (269)
T ss_pred HhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC---HHHHHHHH---hh-ccCccCCCCccccc----CCHH
Confidence 753 346789999999999999999 677764221 11111111 11 11112222222222 2234
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhh
Q 011196 420 YIHIGLLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 420 ~~~l~~~cl~~dP~~RPs~~evl~~L~ 446 (491)
+.+++..|| .||++||++++|++.|.
T Consensus 243 ~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 243 WYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 456778888 59999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=181.41 Aligned_cols=154 Identities=19% Similarity=0.321 Sum_probs=116.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.++|..+++ ||||||+||+++.++.++|+|||++........ ......++..|+||
T Consensus 101 ~~~~~~~~~~l~~~l~~lH~~~i~-------H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aP 171 (257)
T cd08223 101 ENQVVEWFVQIAMALQYLHEKHIL-------HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSP 171 (257)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------ccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCccCh
Confidence 455667888888999999988777 999999999999999999999999987643222 22345678899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|++.+..++.++||||||++++|+++|+.|+.... ........ ..+.... .+......+.+++.
T Consensus 172 E~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~-~~~~~~~---------~~~~~~~~~~~li~ 235 (257)
T cd08223 172 ELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRI-IEGKLPP---------MPKDYSPELGELIA 235 (257)
T ss_pred hHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHH-HhcCCCC---------CccccCHHHHHHHH
Confidence 99998889999999999999999999999864211 11111111 1121111 11223345778999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 011196 426 LCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~ 444 (491)
+||+.||++||++.+++++
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 236 TMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHhccCcccCCCHHHHhcC
Confidence 9999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-21 Score=190.15 Aligned_cols=188 Identities=20% Similarity=0.259 Sum_probs=125.0
Q ss_pred eeecccccCCCCccccCC---CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 245 YELYRFLVDTPTVTVTAP---NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
|.++.|..+......... .........++.+++.++.++|..+++ ||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~-------H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYV-------HRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCee-------ecccchheEEEcCCCCEEECCCccc
Confidence 455556554443222111 123445567788888999999987766 9999999999999999999999999
Q ss_pred eecCCCCcc-cccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccC--------CCcccHHHHHH
Q 011196 322 RIFGGNQSE-ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHL--------EHGPSLLAYIW 392 (491)
Q Consensus 322 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~--------~~~~~~~~~~~ 392 (491)
+........ .......++..|+|||++.+..++.++||||||++++|+++++.|...... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 865432221 112234567789999999888899999999999999999998765321100 00000111111
Q ss_pred HHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 393 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 393 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.....+... ..+......+.+|+.+||+.||++||++.++++.|+..
T Consensus 237 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111111 11112335678899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-21 Score=189.56 Aligned_cols=177 Identities=20% Similarity=0.316 Sum_probs=123.3
Q ss_pred eeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 244 RYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.|.++.|..+........ ..........++.+++.++.++|..++. ||||||+||+++.++.+||+|||++.
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~-------H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI-------HRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred EEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCHHHEEEcCCCCEEECccccch
Confidence 455666665544332221 1223456677888889999999988777 99999999999999999999999987
Q ss_pred ecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccc
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAE 402 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (491)
........ .....|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ............ ..
T Consensus 165 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~------~~~~~~~~~~~~-~~ 235 (296)
T cd06654 165 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGT-PE 235 (296)
T ss_pred hccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH------HHhHHHHhcCCC-CC
Confidence 65332211 1234678899999999888889999999999999999999999742211 111111111111 00
Q ss_pred cccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 403 LMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 403 ~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
+ ..+......+.+++.+||+.||++||++.++++
T Consensus 236 ~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 236 L-------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred C-------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0 011122345677999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-21 Score=192.64 Aligned_cols=179 Identities=16% Similarity=0.196 Sum_probs=118.8
Q ss_pred eeeecccccCCCCccccCC--CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTAP--NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
-|.++.|..++++..++.. ..........+.+.+.+|..+|..+++ ||||||+|+|||..|++||+||||+
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyI-------HRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYI-------HRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcc-------cccCChhheeecCCCCEeecccccc
Confidence 4566777777776555432 222333344555666778889998888 9999999999999999999999998
Q ss_pred eecCCC---------------------Cccc------c------------------cCceeecCCCChhhhhhhCCCCcc
Q 011196 322 RIFGGN---------------------QSEA------N------------------TNRVVGTYGYMAPEYAMEGIFSVK 356 (491)
Q Consensus 322 ~~~~~~---------------------~~~~------~------------------~~~~~gt~~y~aPE~~~~~~~s~~ 356 (491)
..+... .... . ....+||+-|||||++.+..|+..
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~ 368 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE 368 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence 532110 0000 0 012489999999999999999999
Q ss_pred cceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 011196 357 SDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP 436 (491)
Q Consensus 357 sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP 436 (491)
.|.||+|||+|||+.|-+||..... ...|+.+.... ..+......+...+..+||.+|+. ||++|-
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp-------~~T~rkI~nwr------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETP-------QETYRKIVNWR------ETLKFPEEVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHHh------hhccCCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence 9999999999999999999753221 12222221111 000001111112445678888887 999997
Q ss_pred C---HHHHHH
Q 011196 437 T---MSSVAV 443 (491)
Q Consensus 437 s---~~evl~ 443 (491)
- +.||.+
T Consensus 435 G~~G~~EIK~ 444 (550)
T KOG0605|consen 435 GSKGAEEIKK 444 (550)
T ss_pred CcccHHHHhc
Confidence 5 555544
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-21 Score=188.14 Aligned_cols=176 Identities=19% Similarity=0.277 Sum_probs=119.9
Q ss_pred eeeecccccCCCCccccCC----CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 244 RYELYRFLVDTPTVTVTAP----NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
.|.++.+..++........ .........++.+++.++.+||..+++ ||||||+||++++++.+||+|||
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~iv-------h~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVI-------HRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCc-------cCCCCHHHEEECCCCCEEEccCC
Confidence 4566666655443322211 112334556788889999999987666 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhh-----hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHH
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAM-----EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKL 394 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 394 (491)
++........ ......|+..|+|||++. +..++.++|||||||++|||++|+.|+..... .......
T Consensus 157 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~------~~~~~~~ 228 (272)
T cd06637 157 VSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALFLI 228 (272)
T ss_pred Cceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH------HHHHHHH
Confidence 9976533221 223467899999999986 33578899999999999999999999742211 1111111
Q ss_pred hhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 395 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 395 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.. ....... .. .....+.+++.+||+.||.+||++.++++
T Consensus 229 ~~-~~~~~~~----~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PR-NPAPRLK----SK----KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hc-CCCCCCC----CC----CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11 1111111 11 11235678999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.5e-21 Score=185.31 Aligned_cols=158 Identities=26% Similarity=0.434 Sum_probs=116.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.++|+|||++......... ......++..|+||
T Consensus 101 ~~~~~~i~~~i~~al~~LH~~~i~-------H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~p 172 (260)
T cd05067 101 INKLIDMAAQIAEGMAFIERKNYI-------HRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAP 172 (260)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCee-------cccccHHhEEEcCCCCEEEccCcceeecCCCCcc-cccCCcccccccCH
Confidence 345666788888999999887766 9999999999999999999999999765422211 11223456789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++....++.++||||||++++|+++ |+.||.... ...... ......... .+.....++.+++
T Consensus 173 e~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~----~~~~~~~~~---------~~~~~~~~~~~li 236 (260)
T cd05067 173 EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT---NPEVIQ----NLERGYRMP---------RPDNCPEELYELM 236 (260)
T ss_pred HHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC---hHHHHH----HHHcCCCCC---------CCCCCCHHHHHHH
Confidence 99988889999999999999999998 999975321 111111 111111111 1111224577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhc
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.+||+.+|++||++++++..|+.
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 237 RLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHccCChhhCCCHHHHHHHhhc
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-21 Score=194.30 Aligned_cols=162 Identities=25% Similarity=0.357 Sum_probs=117.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..+++ ||||||+|||++.++.+||+|||++................++..|+||
T Consensus 178 ~~~~~~~~~qi~~al~~lH~~~i~-------H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 250 (343)
T cd05103 178 LEDLICYSFQVAKGMEFLASRKCI-------HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 250 (343)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECc
Confidence 344566788888899999887776 9999999999999999999999999765332222222233456789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|.+.+..++.++||||||+++||+++ |..|+...... .. .......+..... +......+.+++
T Consensus 251 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~----~~~~~~~~~~~~~---------~~~~~~~~~~~~ 315 (343)
T cd05103 251 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EE----FCRRLKEGTRMRA---------PDYTTPEMYQTM 315 (343)
T ss_pred HHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HH----HHHHHhccCCCCC---------CCCCCHHHHHHH
Confidence 99988889999999999999999997 88886532111 11 1111111111111 001123467889
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
..||+.||++||++.||+++|+...
T Consensus 316 ~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 316 LDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.1e-21 Score=186.16 Aligned_cols=160 Identities=20% Similarity=0.288 Sum_probs=118.3
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
.....++.+++.++.+||..+++ |+||||+||+++.++.++|+|||++........ ......|+..|+|||
T Consensus 106 ~~~~~~~~~i~~~l~~LH~~~i~-------H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE 176 (267)
T cd08228 106 RTVWKYFVQLCSAVEHMHSRRVM-------HRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPE 176 (267)
T ss_pred HHHHHHHHHHHHHHHHHhhCCee-------CCCCCHHHEEEcCCCCEEECccccceeccchhH--HHhcCCCCccccChh
Confidence 44567788888899999887776 999999999999999999999999887643322 112346788999999
Q ss_pred hhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHH
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLL 426 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~ 426 (491)
.+.+..++.++||||||+++|||++|+.|+.... ....... ........... ........+.+++.+
T Consensus 177 ~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~----~~~~~~~-~~~~~~~~~~~--------~~~~~~~~~~~li~~ 243 (267)
T cd08228 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLFSLC-QKIEQCDYPPL--------PTEHYSEKLRELVSM 243 (267)
T ss_pred hhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc----ccHHHHH-HHHhcCCCCCC--------ChhhcCHHHHHHHHH
Confidence 9988889999999999999999999999964211 1111111 11111111110 111233557789999
Q ss_pred cccCCCCCCCCHHHHHHHhhcC
Q 011196 427 CVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 427 cl~~dP~~RPs~~evl~~L~~~ 448 (491)
||+.+|++||++.+|++.|+..
T Consensus 244 cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 244 CIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HCCCCcccCcCHHHHHHHHHHh
Confidence 9999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-21 Score=187.84 Aligned_cols=155 Identities=28% Similarity=0.324 Sum_probs=115.9
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.++|..++. ||||||+||+++.++.+||+|||+++....... ...++..|+|
T Consensus 100 ~~~~~~~~~~qi~~~l~~lh~~~i~-------H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~a 167 (256)
T cd05039 100 TLAQQLGFALDVCEGMEYLEEKNFV-------HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTA 167 (256)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcc-------chhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccC
Confidence 3456677888899999999987777 999999999999999999999999986532221 2234668999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++..+.++.++||||||++++|+++ |..||.... ...+ ......+...+. +......+.++
T Consensus 168 pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~----~~~~~~~~~~~~---------~~~~~~~~~~l 231 (256)
T cd05039 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDV----VPHVEKGYRMEA---------PEGCPPEVYKV 231 (256)
T ss_pred chhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC---HHHH----HHHHhcCCCCCC---------ccCCCHHHHHH
Confidence 999988889999999999999999997 888864321 1111 111111111111 11123457789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhc
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
+.+||+.+|++||++.|++++|++
T Consensus 232 i~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 232 MKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHhccChhhCcCHHHHHHHHhc
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-21 Score=185.04 Aligned_cols=155 Identities=23% Similarity=0.321 Sum_probs=114.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..+++ ||||||+||+++.++.+||+|||+++...... .....+..|+||
T Consensus 99 ~~~~~~~~~qi~~al~~lH~~~~~-------H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~p 166 (254)
T cd05083 99 VIQLLQFSLDVAEGMEYLESKKLV-------HRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAP 166 (254)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------ccccCcceEEEcCCCcEEECCCccceeccccC-----CCCCCCceecCH
Confidence 344566788888999999987777 99999999999999999999999987543211 112335679999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.++.++.++||||||++++||++ |+.||..... ... ......+...+ .+......+.+++
T Consensus 167 e~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~----~~~~~~~~~~~---------~~~~~~~~~~~li 230 (254)
T cd05083 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---KEV----KECVEKGYRME---------PPEGCPADVYVLM 230 (254)
T ss_pred HHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---HHH----HHHHhCCCCCC---------CCCcCCHHHHHHH
Confidence 99988889999999999999999998 8888643211 111 11111111111 0112234567899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.+|++||++.+|++.|+++
T Consensus 231 ~~~l~~~p~~Rp~~~~l~~~l~~~ 254 (254)
T cd05083 231 TSCWETEPKKRPSFHKLREKLEKE 254 (254)
T ss_pred HHHcCCChhhCcCHHHHHHHHccC
Confidence 999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=171.17 Aligned_cols=151 Identities=14% Similarity=0.144 Sum_probs=108.4
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..+ ||+|||++.++.+|+ ||+++...... ..|++.|+||
T Consensus 16 ~~~~~~i~~qi~~~L~~lH~~~-------------kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~~g~~~y~aP 73 (176)
T smart00750 16 EEEIWAVCLQCLRALRELHRQA-------------KSGNILLTWDGLLKL--DGSVAFKTPEQ-------SRVDPYFMAP 73 (176)
T ss_pred HHHHHHHHHHHHHHHHHHHhcC-------------CcccEeEcCccceee--ccceEeecccc-------CCCcccccCh
Confidence 4566778888888888887632 999999999999999 99998654321 2578999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHH---HHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAEL---LKYIH 422 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~---~~~~~ 422 (491)
|++.+..++.++|||||||++|||++|+.|+.... .................... ....... ..+.+
T Consensus 74 E~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 143 (176)
T smart00750 74 EVIQGQSYTEKADIYSLGITLYEALDYELPYNEER--ELSAILEILLNGMPADDPRD--------RSNLESVSAARSFAD 143 (176)
T ss_pred HHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc--hhcHHHHHHHHHhccCCccc--------cccHHHHHhhhhHHH
Confidence 99999999999999999999999999999974221 11111222211111110000 0011111 25788
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 423 IGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
++.+||+.||++||++.|+++++...
T Consensus 144 ~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 144 FMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHHhcccccccCHHHHHHHHHHH
Confidence 99999999999999999999988643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.3e-21 Score=190.98 Aligned_cols=169 Identities=22% Similarity=0.329 Sum_probs=134.8
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
...+..++..+++.+++||.++.++ ||||.+.|+|+|.++++||+|||+++.+-.+......++.+-+++|||
T Consensus 635 ~t~~~vsi~tqiasgmaYLes~nfV-------Hrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwma 707 (807)
T KOG1094|consen 635 ETAPGVSICTQIASGMAYLESLNFV-------HRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMA 707 (807)
T ss_pred ccchhHHHHHHHHHHHHHHHhhchh-------hccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehh
Confidence 3556777999999999999999999 999999999999999999999999997766666666677888999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh--CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS--GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
||.+.-+++++++|||+||+++||+++ ...|+.. ..+.+..+........+.....+ ..+.-+...+.+
T Consensus 708 wEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~---lt~e~vven~~~~~~~~~~~~~l------~~P~~cp~~lye 778 (807)
T KOG1094|consen 708 WESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQ---LTDEQVVENAGEFFRDQGRQVVL------SRPPACPQGLYE 778 (807)
T ss_pred HHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhh---hhHHHHHHhhhhhcCCCCcceec------cCCCcCcHHHHH
Confidence 999999999999999999999999875 6777542 22233333333333333222221 224455667889
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 423 IGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
++++||..|-++||+++++...|+...
T Consensus 779 lml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 779 LMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred HHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 999999999999999999999998753
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-21 Score=195.92 Aligned_cols=175 Identities=15% Similarity=0.183 Sum_probs=118.4
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++...... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 71 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~iv-------HrDlkp~Nili~~~~~~kl~Dfg~a 143 (330)
T cd05586 71 LYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV-------YRDLKPENILLDATGHIALCDFGLS 143 (330)
T ss_pred EEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------eccCCHHHeEECCCCCEEEecCCcC
Confidence 34555555544332211 11223455667888899999999988777 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
+....... ......||..|+|||++.+. .++.++|||||||++|||++|+.||.... . ...+.....+..
T Consensus 144 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~---~----~~~~~~i~~~~~ 214 (330)
T cd05586 144 KANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---T----QQMYRNIAFGKV 214 (330)
T ss_pred cCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC---H----HHHHHHHHcCCC
Confidence 75322221 12345789999999998765 47899999999999999999999974321 1 111122221111
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP----TMSSVAV 443 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP----s~~evl~ 443 (491)
.+.. ... ...+.+++.+||+.||++|| ++.++++
T Consensus 215 -~~~~----~~~----~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 215 -RFPK----NVL----SDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -CCCC----ccC----CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0100 111 23456788999999999998 4555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.9e-21 Score=186.99 Aligned_cols=159 Identities=18% Similarity=0.312 Sum_probs=116.6
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
.....++.+++.++.++|..+++ ||||||+||+++.++.+||+|||+++...............++..|++||
T Consensus 113 ~~~~~~~~~i~~~l~~lH~~~i~-------H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 185 (273)
T cd05074 113 QTLVRFMIDIASGMEYLSSKNFI-------HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALE 185 (273)
T ss_pred HHHHHHHHHHHHHHHHHHhCCEe-------ecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHh
Confidence 34566788888889999987766 99999999999999999999999998654332222222334567899999
Q ss_pred hhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
.+.+..++.++||||||+++|||++ |+.|+... ....+... ........ .+......+.+++.
T Consensus 186 ~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~---~~~~~~~~----~~~~~~~~---------~~~~~~~~~~~l~~ 249 (273)
T cd05074 186 SLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV---ENSEIYNY----LIKGNRLK---------QPPDCLEDVYELMC 249 (273)
T ss_pred HHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC---CHHHHHHH----HHcCCcCC---------CCCCCCHHHHHHHH
Confidence 9988889999999999999999999 77876422 11111111 11111110 01122346788999
Q ss_pred HcccCCCCCCCCHHHHHHHhhcC
Q 011196 426 LCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+||+.+|++||++.++++.|++.
T Consensus 250 ~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 250 QCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHcCCChhhCcCHHHHHHHHHhh
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=183.52 Aligned_cols=178 Identities=19% Similarity=0.183 Sum_probs=124.1
Q ss_pred eeeecccccCCCCcccc----CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 244 RYELYRFLVDTPTVTVT----APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
.|.++.|+.++...... ...........++.+++.++.+||..+++ ||||||+||++++++.++|+|||
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv-------H~dlkp~Nil~~~~~~~~l~Dfg 147 (285)
T cd05605 75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIV-------YRDLKPENILLDDYGHIRISDLG 147 (285)
T ss_pred EEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcE-------ecCCCHHHEEECCCCCEEEeeCC
Confidence 45566666554432211 11223445667788899999999998777 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
++........ .....|+..|+|||++.+..++.++||||+|+++||+++|+.||..... ......+.......
T Consensus 148 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~---~~~~~~~~~~~~~~- 220 (285)
T cd05605 148 LAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE---KVKREEVERRVKED- 220 (285)
T ss_pred CceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch---hhHHHHHHHHhhhc-
Confidence 9986543222 1234689999999999988899999999999999999999999753221 11111111111111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAVM 444 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 444 (491)
. ...+......+.+++.+||+.||++|| ++.+++++
T Consensus 221 ~---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 Q---------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred c---------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0 011122234567899999999999999 88888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-21 Score=191.77 Aligned_cols=169 Identities=21% Similarity=0.264 Sum_probs=119.0
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~iv-------HrDikp~Nill~~~~~ikL~Dfg~~ 148 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGII-------YRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee-------ccCCCHHHeEECCCCCEEEeccccc
Confidence 456666666554322211 1223456677888899999999987766 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+....... ......|+..|+|||++.+..++.++|||||||++|||++|+.||.... .......+. ....
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~----~~~~- 218 (323)
T cd05615 149 KEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED---EDELFQSIM----EHNV- 218 (323)
T ss_pred cccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHH----hCCC-
Confidence 75432211 1223568999999999998889999999999999999999999975321 111221111 1111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTM 438 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 438 (491)
..+......+.+++.+||+.||++|++.
T Consensus 219 ---------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ---------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111122346778999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-21 Score=192.91 Aligned_cols=125 Identities=22% Similarity=0.287 Sum_probs=91.7
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++.+..... ..........+..+++.++.+||... +++||||||+|||++.++.+||+|||++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~------~ivH~dlkp~Nili~~~~~~kL~Dfg~~ 151 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH------KIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC------CEEecCCChhhEEEcCCCCEEEeeCCcc
Confidence 345555555444322211 11223445567777888888888632 2349999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCC
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGF 378 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~ 378 (491)
....... .....|+..|+|||++.+..++.++|||||||++||+++|+.||..
T Consensus 152 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 152 GQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred hhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 7543221 2234688999999999888899999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-21 Score=186.95 Aligned_cols=156 Identities=21% Similarity=0.301 Sum_probs=113.7
Q ss_pred CcchhhhHhHHHHHHHHHhh-eeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLS-TSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
....+.++.+++.++.+||. .++. |+||||+||+++.++.+||+|||++....... ......|+..|++
T Consensus 112 ~~~~~~~~~~l~~~l~~lh~~~~i~-------H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~ 181 (269)
T cd08528 112 EERIWNIFVQMVLALRYLHKEKRIV-------HRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSC 181 (269)
T ss_pred HHHHHHHHHHHHHHHHHhccCCcee-------ecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcC
Confidence 34456677778888888874 3444 99999999999999999999999998654332 2234567889999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||++.+..++.++||||||+++||+++|+.|+... . ...... .......... ... .....+.+++
T Consensus 182 Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~---~---~~~~~~-~~~~~~~~~~----~~~----~~~~~l~~li 246 (269)
T cd08528 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST---N---MLSLAT-KIVEAVYEPL----PEG----MYSEDVTDVI 246 (269)
T ss_pred hhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc---C---HHHHHH-HHhhccCCcC----Ccc----cCCHHHHHHH
Confidence 99999888999999999999999999999996421 1 111111 1111111111 011 1124567889
Q ss_pred HHcccCCCCCCCCHHHHHHHhh
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~ 446 (491)
.+||+.||++||++.||.++++
T Consensus 247 ~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 247 TSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHCCCCCccCCCHHHHHHHhc
Confidence 9999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=190.51 Aligned_cols=181 Identities=18% Similarity=0.235 Sum_probs=122.0
Q ss_pred eeeeecccccCCCCccccCC-CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 243 IRYELYRFLVDTPTVTVTAP-NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
..|.++.|+.++.+...... .........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv-------HrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFI-------HRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCee-------ccCCCHHHEEEcCCCCEEEEeccce
Confidence 45666677665544332211 122334455677888999999987776 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhC----CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEG----IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
+....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+ ...
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i---~~~ 262 (370)
T cd05596 190 MKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKI---MDH 262 (370)
T ss_pred eeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH---HHHHHHH---HcC
Confidence 86543221 112345789999999998653 478999999999999999999999753211 1111111 111
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMD--RPTMSSVAVM 444 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~ 444 (491)
.......+ .......+.+++.+||+.+|++ ||++.|++++
T Consensus 263 ~~~~~~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 263 KNSLTFPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCcCCCCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 10000000 0112345667889999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-21 Score=187.52 Aligned_cols=160 Identities=25% Similarity=0.368 Sum_probs=115.2
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ |+||||+||+++.++.++|+|||.+..... .........++..|+|
T Consensus 96 ~~~~~~~~~~qi~~~L~~Lh~~~i~-------H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~~~y~a 166 (260)
T PF00069_consen 96 SEEEILKIAYQILEALAYLHSKGIV-------HRDIKPENILLDENGEVKLIDFGSSVKLSE--NNENFNPFVGTPEYMA 166 (260)
T ss_dssp BHHHHHHHHHHHHHHHHHHHHTTEE-------ESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSEBSSSSSSGGGSC
T ss_pred ccccccccccccccccccccccccc-------cccccccccccccccccccccccccccccc--cccccccccccccccc
Confidence 3456677888999999999998888 999999999999999999999999976411 1122334567889999
Q ss_pred hhhhh-hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAM-EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~-~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++. +..++.++||||+|+++++|++|..|+... ...+............ ....... .......+.++
T Consensus 167 PE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~---~~~~~~~~~~~~~~~~----~~~~~~~---~~~~~~~l~~l 236 (260)
T PF00069_consen 167 PEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES---NSDDQLEIIEKILKRP----LPSSSQQ---SREKSEELRDL 236 (260)
T ss_dssp HHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS---SHHHHHHHHHHHHHTH----HHHHTTS---HTTSHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccc---cchhhhhhhhhccccc----ccccccc---cchhHHHHHHH
Confidence 99998 778999999999999999999999997533 1111111111111000 0000000 00012567889
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 011196 424 GLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~ 443 (491)
+.+||+.||++||++.++++
T Consensus 237 i~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 237 IKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 99999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=184.99 Aligned_cols=177 Identities=19% Similarity=0.193 Sum_probs=120.8
Q ss_pred eeeecccccCCCCcccc----CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 244 RYELYRFLVDTPTVTVT----APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
.|.++.|+.+....... ...........++.+++.++.++|..+++ ||||||+||+++.++.++|+|||
T Consensus 75 ~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ii-------H~dikp~Nil~~~~~~~~l~Dfg 147 (285)
T cd05630 75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV-------YRDLKPENILLDDHGHIRISDLG 147 (285)
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEE-------eCCCCHHHEEECCCCCEEEeecc
Confidence 45555565544432211 11123445666788888999999987776 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
++........ .....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ............
T Consensus 148 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~---~~~~~~~~~~~~- 220 (285)
T cd05630 148 LAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI---KREEVERLVKEV- 220 (285)
T ss_pred ceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc---hHHHHHhhhhhh-
Confidence 9876543222 123468999999999998889999999999999999999999975322111 011111110000
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT-----MSSVAV 443 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~ 443 (491)
. ..... .....+.+++.+||+.||++||+ +.|+++
T Consensus 221 -~----~~~~~----~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 221 -Q----EEYSE----KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -h----hhcCc----cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0 00111 11234667899999999999999 778776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-20 Score=179.08 Aligned_cols=179 Identities=23% Similarity=0.272 Sum_probs=121.9
Q ss_pred eeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.++.|+.+.+...... ..........+..++..++.++|..+++ ||||||+||+++.++.+||+|||+
T Consensus 67 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~-------H~dl~p~nili~~~~~~~l~d~g~ 139 (250)
T cd05085 67 IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI-------HRDLAARNCLVGENNVLKISDFGM 139 (250)
T ss_pred cEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee-------ecccChheEEEcCCCeEEECCCcc
Confidence 445556655544332221 1122344566677788888888877666 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
+......... ......++..|+|||++.++.++.++||||||+++||+++ |..||.... ..... .......
T Consensus 140 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~---~~~~~----~~~~~~~ 211 (250)
T cd05085 140 SRQEDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT---NQQAR----EQVEKGY 211 (250)
T ss_pred ceeccccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC---HHHHH----HHHHcCC
Confidence 8754332211 1112234567999999988889999999999999999998 888874321 11111 1111111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 446 (491)
... .+......+.+++.+||+.+|++||++.|+++.|.
T Consensus 212 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 212 RMS---------CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 111 11122346778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-21 Score=193.65 Aligned_cols=173 Identities=20% Similarity=0.214 Sum_probs=116.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCccc-ccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEA-NTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++.......... ......|+..|+|
T Consensus 105 ~~~~~~i~~ql~~aL~~LH~~~iv-------H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 177 (336)
T cd07849 105 NDHIQYFLYQILRGLKYIHSANVL-------HRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177 (336)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------ccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccC
Confidence 445566788888999999988776 99999999999999999999999997654322111 1223567899999
Q ss_pred hhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC---ccccccch----h-----cCC
Q 011196 345 PEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH---AAELMDSV----V-----KQS 411 (491)
Q Consensus 345 PE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d~~----l-----~~~ 411 (491)
||++.+ ..++.++||||||++++||++|+.||..... ............... ...+.+.. + ...
T Consensus 178 PE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (336)
T cd07849 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY---LHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPK 254 (336)
T ss_pred hHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCc
Confidence 998765 4588999999999999999999999753221 111111111111100 00000000 0 000
Q ss_pred CC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcC
Q 011196 412 CD-----QAELLKYIHIGLLCVQEDPMDRPTMSSVAVM--LASD 448 (491)
Q Consensus 412 ~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 448 (491)
.+ .....++.+++.+||+.||++||++.|++++ ++..
T Consensus 255 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 255 VPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred ccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00 1123457789999999999999999999987 5544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.2e-21 Score=172.44 Aligned_cols=182 Identities=16% Similarity=0.199 Sum_probs=118.3
Q ss_pred eecceeeeecccccCCCCccccCCC--CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC---CCc
Q 011196 239 ASCSIRYELYRFLVDTPTVTVTAPN--KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE---MNP 313 (491)
Q Consensus 239 ~~C~lry~~~~f~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~---~~~ 313 (491)
.+-.++|.++.+..+.......-.. -+.-......+++..++.|.|..+++ |||+||+|+|+... --+
T Consensus 80 ~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~Iv-------HRDvkP~nllLASK~~~A~v 152 (355)
T KOG0033|consen 80 QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIV-------HRDLKPENLLLASKAKGAAV 152 (355)
T ss_pred cccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCce-------eccCChhheeeeeccCCCce
Confidence 3456788888777655432110000 00111122334455555555555444 99999999999543 348
Q ss_pred eEeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHH
Q 011196 314 KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWK 393 (491)
Q Consensus 314 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 393 (491)
||+|||++..... ......+.||++||+||++...+|+..+|||+.||+|+-++.|..||-. +....+. +
T Consensus 153 KL~~FGvAi~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rly----e 222 (355)
T KOG0033|consen 153 KLADFGLAIEVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLY----E 222 (355)
T ss_pred eecccceEEEeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHH----H
Confidence 9999999998763 2334568999999999999999999999999999999999999999742 2222222 2
Q ss_pred HhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 394 LWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 394 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+..+... +++...... .+...+|+.+||..||++|.|+.|.+.
T Consensus 223 ~I~~g~yd--~~~~~w~~i----s~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 223 QIKAGAYD--YPSPEWDTV----TPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHhccccC--CCCcccCcC----CHHHHHHHHHHhccChhhhccHHHHhC
Confidence 22222211 111111111 223456888999999999999988764
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-20 Score=179.73 Aligned_cols=176 Identities=18% Similarity=0.231 Sum_probs=123.2
Q ss_pred eeeecccccCCCCccccC----CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 244 RYELYRFLVDTPTVTVTA----PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
.|.+++|..+........ ........+.++.+++.++.++|..++. |+||||+||++++++.++|+|||
T Consensus 73 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~-------H~dl~p~nili~~~~~~~l~dfg 145 (255)
T cd08219 73 LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVL-------HRDIKSKNIFLTQNGKVKLGDFG 145 (255)
T ss_pred EEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcc-------cCCCCcceEEECCCCcEEEcccC
Confidence 455666665444322211 1123445567788888899999987777 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
++........ ......|+..|+|||++.+..++.++|+||||+++++|++|..||... .......... .+.
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~------~~~~~~~~~~-~~~ 216 (255)
T cd08219 146 SARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN------SWKNLILKVC-QGS 216 (255)
T ss_pred cceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC------CHHHHHHHHh-cCC
Confidence 9976643222 122356888999999998888999999999999999999999997521 1111111111 111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
...+ +......+.+++.+||+.||++||++.+|+..
T Consensus 217 ~~~~---------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 YKPL---------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCC---------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1111 11122346688999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.3e-21 Score=199.91 Aligned_cols=178 Identities=16% Similarity=0.094 Sum_probs=128.4
Q ss_pred ecccccCCCCccc----cCCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 247 LYRFLVDTPTVTV----TAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 247 ~~~f~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
++.|..++.+... +.-.......+.|..+++.+++.||.+ ..++||||||-+||||..+++.||||||-+.
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-----~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-----KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred ehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-----CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 3455554444322 122345677889999999999999974 4556799999999999999999999999986
Q ss_pred ecCCCC-c-ccc-----cCceeecCCCChhhhhh---hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHH
Q 011196 323 IFGGNQ-S-EAN-----TNRVVGTYGYMAPEYAM---EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIW 392 (491)
Q Consensus 323 ~~~~~~-~-~~~-----~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 392 (491)
..-..- . ... .-...-|+.|++||++. +.++++|+|||+|||+||-|.....||+..
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s------------- 261 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES------------- 261 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC-------------
Confidence 422111 0 000 00123489999999885 567999999999999999999999997521
Q ss_pred HHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 393 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 393 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
....|++....-........++.+||..||+.||.+||++-+|+..+...
T Consensus 262 ------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 262 ------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 12223333332222345677888899999999999999999999888554
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-20 Score=183.84 Aligned_cols=184 Identities=19% Similarity=0.237 Sum_probs=127.2
Q ss_pred eeeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 243 IRYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
..+.++.|+..+....... ..........++.+++.++.+||..+++ ||||||+||+++.++.+||+|||
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~-------H~di~p~nil~~~~~~~kL~dfg 154 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLV-------HRDLAARNVLVKTPQHVKITDFG 154 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEE-------ecccCcceEEEcCCCeEEECCCc
Confidence 3445555655444332221 1223456677888899999999987766 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
+++...............++..|++||.+....++.++|+||||++++|+++ |+.||..... .++.. ....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~----~~~~~ 227 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VEIPD----LLEKG 227 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HHHHH----HHhCC
Confidence 9987643322211112223568999999988889999999999999999998 9999753221 11111 11111
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
... ..+......+.+++.+||..||++||++.++++.|+...
T Consensus 228 ~~~---------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 228 ERL---------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred CCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 110 011112235677889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.4e-21 Score=183.73 Aligned_cols=150 Identities=21% Similarity=0.306 Sum_probs=110.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC-------CceEeccCcceecCCCCcccccCceee
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM-------NPKISDFGMARIFGGNQSEANTNRVVG 338 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~-------~~kl~DfGla~~~~~~~~~~~~~~~~g 338 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++ .+||+|||++..... .....+
T Consensus 100 ~~~~~~~~~~i~~~l~~LH~~~i~-------H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~ 166 (259)
T cd05037 100 LHWKLDVAKQLASALHYLEDKKLV-------HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVE 166 (259)
T ss_pred HHHHHHHHHHHHHHHHHHhhCCee-------cccCccceEEEecCccccCCceeEEeCCCCccccccc------cccccc
Confidence 445667788999999999987766 999999999999887 799999999976533 112346
Q ss_pred cCCCChhhhhhhC--CCCcccceeehhHHHHHHHhC-CCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHH
Q 011196 339 TYGYMAPEYAMEG--IFSVKSDVFSFGVVLLEIISG-KKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 415 (491)
Q Consensus 339 t~~y~aPE~~~~~--~~s~~sDVwS~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 415 (491)
+..|+|||++.+. .++.++||||||+++||+++| ..|+...... ... ..+..... . +..
T Consensus 167 ~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~~----~~~~~~~~--~---------~~~ 228 (259)
T cd05037 167 RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EKE----RFYQDQHR--L---------PMP 228 (259)
T ss_pred CCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hHH----HHHhcCCC--C---------CCC
Confidence 6789999999876 789999999999999999994 6665432211 111 11111100 0 000
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 011196 416 ELLKYIHIGLLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 416 ~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 446 (491)
....+.+++.+||+.+|++||++.+|++.|+
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1156778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-20 Score=184.43 Aligned_cols=178 Identities=21% Similarity=0.302 Sum_probs=127.2
Q ss_pred ceeeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 242 SIRYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 242 ~lry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
...|.+++|+.++....... .+........++.+++.++.++|..++. |+||||+||+++.++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~iv-------H~dl~p~Nil~~~~~~~~l~dfg~ 147 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI-------HRDIKAANVLLSEQGDVKLADFGV 147 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc-------CcCCChhhEEEcCCCCEEEccccc
Confidence 34677777776655433222 1223445566778888888999877666 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
+........ ......++..|+|||++.+..++.++|+||||+++|||++|+.|+...... ... .. .....
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~---~~-~~~~~- 217 (277)
T cd06640 148 AGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM---RVL---FL-IPKNN- 217 (277)
T ss_pred ceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH---hHh---hh-hhcCC-
Confidence 976643321 122346788999999998888999999999999999999999997432111 000 00 00110
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
...........+.+++.+||+.+|++||++.+++..
T Consensus 218 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 --------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 112233445667889999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.9e-21 Score=183.39 Aligned_cols=157 Identities=25% Similarity=0.345 Sum_probs=112.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++......... .....++..|+||
T Consensus 99 ~~~~~~~~~~l~~~l~~lH~~~i~-------h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~~aP 170 (256)
T cd05112 99 QETLLGMCLDVCEGMAYLESSNVI-------HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSP 170 (256)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------ccccccceEEEcCCCeEEECCCcceeecccCcccc-cCCCccchhhcCH
Confidence 344556677778888888887766 99999999999999999999999987654322111 1122346789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.++.++.++||||||+++||+++ |..|+.... ....... ...+. ....+. .....+.+|+
T Consensus 171 e~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~----~~~~~--~~~~~~-------~~~~~~~~l~ 234 (256)
T cd05112 171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS---NSEVVET----INAGF--RLYKPR-------LASQSVYELM 234 (256)
T ss_pred hHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHH----HhCCC--CCCCCC-------CCCHHHHHHH
Confidence 99988889999999999999999998 888864211 1111111 11110 011111 1124577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhh
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~ 446 (491)
.+||+.+|++||++.++++.|+
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 235 QHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHcccChhhCCCHHHHHHhhC
Confidence 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-20 Score=189.73 Aligned_cols=166 Identities=21% Similarity=0.212 Sum_probs=116.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++....... .....++..|+||
T Consensus 117 ~~~~~~~~~ql~~aL~~LH~~gi~-------H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aP 186 (353)
T cd07850 117 HERMSYLLYQMLCGIKHLHSAGII-------HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAP 186 (353)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------eCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCH
Confidence 445566788889999999998777 999999999999999999999999986543221 2234678899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHh------------------hcCC-------c
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLW------------------CEGH-------A 400 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~------------------~~~~-------~ 400 (491)
|.+.+..++.++||||||+++++|++|+.||..... ......+.... .... .
T Consensus 187 E~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (353)
T cd07850 187 EVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH---IDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSF 263 (353)
T ss_pred HHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcch
Confidence 999998999999999999999999999999753221 11111111100 0000 0
Q ss_pred cccccchh----cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 401 AELMDSVV----KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 401 ~~~~d~~l----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.++..... ....+......+.+++.+||+.||++||++.|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 264 EELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01111100 000011234557789999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.3e-21 Score=191.05 Aligned_cols=183 Identities=23% Similarity=0.345 Sum_probs=122.7
Q ss_pred EEEceecceeee----ecccccCCCCccccCCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC
Q 011196 235 RIFCASCSIRYE----LYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE 310 (491)
Q Consensus 235 ~i~~~~C~lry~----~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~ 310 (491)
.|-+-+||+|-- ++.|.-+.. ..+... .++.+...++.+.....|+++.++|.+.+ ||||||+.|||+.+.
T Consensus 88 tieYkgCyLre~TaWLVMEYClGSA-sDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~~-IHRDiKAGNILLse~ 162 (948)
T KOG0577|consen 88 TIEYKGCYLREHTAWLVMEYCLGSA-SDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHNR-IHRDIKAGNILLSEP 162 (948)
T ss_pred cccccceeeccchHHHHHHHHhccH-HHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhhH-HhhhccccceEecCC
Confidence 467888999853 455544332 111110 22334445555555555555555533333 399999999999999
Q ss_pred CCceEeccCcceecCCCCcccccCceeecCCCChhhhhh---hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccH
Q 011196 311 MNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM---EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSL 387 (491)
Q Consensus 311 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~ 387 (491)
|.+||+|||.+.+... ...++||++|||||++. .|+|+-++||||+||+..|+.-.++|.. +. +.
T Consensus 163 g~VKLaDFGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF--nM----NA 230 (948)
T KOG0577|consen 163 GLVKLADFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF--NM----NA 230 (948)
T ss_pred CeeeeccccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc--Cc----hH
Confidence 9999999999876532 44689999999999986 6899999999999999999999999943 22 22
Q ss_pred HHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 388 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 388 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
....+. +..... |.+. ..+=...+..++..||++-|.+|||..+++.
T Consensus 231 MSALYH-IAQNes-----PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 231 MSALYH-IAQNES-----PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHH-HHhcCC-----CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 222221 111211 1111 1122345667888999999999999988654
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.5e-21 Score=185.24 Aligned_cols=178 Identities=21% Similarity=0.326 Sum_probs=125.5
Q ss_pred ceeeeecccccCCCCccccCC-CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 242 SIRYELYRFLVDTPTVTVTAP-NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 242 ~lry~~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
...|.+++|+........... .........++.+++.++.++|..+++ ||||||+||++++++.++|+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~-------h~dl~p~ni~i~~~~~~~l~d~g~ 144 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKI-------HRDIKAANILLSEEGDVKLADFGV 144 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcc-------cCCCCHHHEEECCCCCEEEccccc
Confidence 345666666665544322221 234556677788888888888887766 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
++....... ......++..|++||++.+..++.++||||||+++|||++|+.|+.... ....... ......
T Consensus 145 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~---~~~~~~~----~~~~~~ 215 (274)
T cd06609 145 SGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH---PMRVLFL----IPKNNP 215 (274)
T ss_pred ceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc---hHHHHHH----hhhcCC
Confidence 987654321 1223567889999999998889999999999999999999999975322 1111111 111111
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
..+.+ . .....+.+++.+||+.||++||+++++++
T Consensus 216 ~~~~~-----~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 216 PSLEG-----N---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCcc-----c---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11111 1 02234677899999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.82 E-value=4e-21 Score=197.40 Aligned_cols=160 Identities=22% Similarity=0.281 Sum_probs=115.8
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
.....++.+++.++.+||..+++ ||||||+|||+++++.+||+|||+++...............++..|++||
T Consensus 239 ~~~~~~~~qi~~aL~~LH~~~iv-------Hrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 311 (401)
T cd05107 239 MDLVGFSYQVANGMEFLASKNCV-------HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPE 311 (401)
T ss_pred HHHHHHHHHHHHHHHHHhcCCcC-------cccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChH
Confidence 34556677888888888876655 99999999999999999999999998654322222222345678899999
Q ss_pred hhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
++.+..++.++||||||+++|||++ |..||..... . .........+... ..+......+.+|+.
T Consensus 312 ~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~---~---~~~~~~~~~~~~~---------~~p~~~~~~l~~li~ 376 (401)
T cd05107 312 SIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM---N---EQFYNAIKRGYRM---------AKPAHASDEIYEIMQ 376 (401)
T ss_pred HhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc---h---HHHHHHHHcCCCC---------CCCCCCCHHHHHHHH
Confidence 9998889999999999999999998 8888643211 1 1111111111100 011112345778999
Q ss_pred HcccCCCCCCCCHHHHHHHhhcC
Q 011196 426 LCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+||+.+|++||+++||++.|+..
T Consensus 377 ~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 377 KCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHcCCChhHCcCHHHHHHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.8e-21 Score=184.23 Aligned_cols=150 Identities=21% Similarity=0.278 Sum_probs=107.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC-------ceEeccCcceecCCCCcccccCceee
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN-------PKISDFGMARIFGGNQSEANTNRVVG 338 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~-------~kl~DfGla~~~~~~~~~~~~~~~~g 338 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++. +|++|||++...... ....+
T Consensus 104 ~~~~~~i~~qi~~~l~~lH~~~iv-------H~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~ 170 (262)
T cd05077 104 TPWKFKVAKQLASALSYLEDKDLV-------HGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVE 170 (262)
T ss_pred HHHHHHHHHHHHHHHHHhhhCCeE-------CCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccc
Confidence 445667888999999999987766 9999999999987654 899999998654321 12456
Q ss_pred cCCCChhhhhh-hCCCCcccceeehhHHHHHHH-hCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHH
Q 011196 339 TYGYMAPEYAM-EGIFSVKSDVFSFGVVLLEII-SGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAE 416 (491)
Q Consensus 339 t~~y~aPE~~~-~~~~s~~sDVwS~Gvvl~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 416 (491)
+..|+|||++. +..++.++||||||+++|||+ .|..|+...... ......... . .... ..
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~-~-~~~~---------~~ 232 (262)
T cd05077 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-------EKERFYEGQ-C-MLVT---------PS 232 (262)
T ss_pred cccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-------HHHHHHhcC-c-cCCC---------CC
Confidence 88899999887 456889999999999999998 477775421111 111111111 0 0100 11
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 011196 417 LLKYIHIGLLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 417 ~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 446 (491)
...+.+|+.+||+.||++||++.+|++.++
T Consensus 233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 233 CKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 235678999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.7e-21 Score=185.19 Aligned_cols=176 Identities=22% Similarity=0.330 Sum_probs=122.9
Q ss_pred eeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 244 RYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.|.++.|..+........ ..........++.+++.++.++|..+++ |+||||+||++++++.+||+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~iv-------H~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06642 77 LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI-------HRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred eEEEEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCee-------ccCCChheEEEeCCCCEEEccccccc
Confidence 455666655444322221 1223445667788888889999877666 99999999999999999999999997
Q ss_pred ecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccc
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAE 402 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (491)
....... ......|+..|+|||++.+..++.++||||||++++|+++|+.|+...... ... . ......
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~---~-~~~~~~--- 217 (277)
T cd06642 150 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---RVL---F-LIPKNS--- 217 (277)
T ss_pred cccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---hHH---h-hhhcCC---
Confidence 6543221 122346788999999998888999999999999999999999996422111 111 0 011111
Q ss_pred cccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 403 LMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 403 ~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.+. ........+.+++.+||+.+|++||++.+|+++
T Consensus 218 --~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 --PPT----LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred --CCC----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 111 112233457789999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-20 Score=193.55 Aligned_cols=181 Identities=16% Similarity=0.230 Sum_probs=116.4
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++.+..... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~giv-------HrDlKp~Nili~~~~~~kL~DFGl~ 148 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI-------HRDIKPDNILIDLDGHIKLTDFGLC 148 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCee-------ecCCcHHHEEECCCCCEEEeeCcCC
Confidence 455566665554332221 1122344555677888899999988777 9999999999999999999999997
Q ss_pred eecCCCCc---------------------------------------------ccccCceeecCCCChhhhhhhCCCCcc
Q 011196 322 RIFGGNQS---------------------------------------------EANTNRVVGTYGYMAPEYAMEGIFSVK 356 (491)
Q Consensus 322 ~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~ 356 (491)
+.+..... ........||..|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (381)
T cd05626 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228 (381)
T ss_pred cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc
Confidence 54311000 000123579999999999998889999
Q ss_pred cceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHH--cccCCCCC
Q 011196 357 SDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLL--CVQEDPMD 434 (491)
Q Consensus 357 sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~--cl~~dP~~ 434 (491)
+|||||||++|||++|+.||..... .... ...........+. + ....+ ..+.+++.+ |+..+|..
T Consensus 229 ~DiwSlG~il~elltG~~Pf~~~~~---~~~~---~~i~~~~~~~~~~-~--~~~~s----~~~~dli~~ll~~~~~~~~ 295 (381)
T cd05626 229 CDWWSVGVILFEMLVGQPPFLAPTP---TETQ---LKVINWENTLHIP-P--QVKLS----PEAVDLITKLCCSAEERLG 295 (381)
T ss_pred cceeehhhHHHHHHhCCCCCcCCCH---HHHH---HHHHccccccCCC-C--CCCCC----HHHHHHHHHHccCcccccC
Confidence 9999999999999999999753221 1111 1111100000000 0 00112 234456655 56677777
Q ss_pred CCCHHHHHHH
Q 011196 435 RPTMSSVAVM 444 (491)
Q Consensus 435 RPs~~evl~~ 444 (491)
||++.+++.+
T Consensus 296 R~~~~~~l~h 305 (381)
T cd05626 296 RNGADDIKAH 305 (381)
T ss_pred CCCHHHHhcC
Confidence 9999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-20 Score=192.76 Aligned_cols=150 Identities=24% Similarity=0.395 Sum_probs=114.2
Q ss_pred hhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC-CCCceEeccCcceecCCCCcccccCceeecCCCChhhhhh
Q 011196 271 TIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH-EMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM 349 (491)
Q Consensus 271 ~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 349 (491)
-...++..++.|||...++ |||||-+|||++- .|.+||+|||.++.+..- ...+.++.||..|||||++.
T Consensus 679 fYtkQILeGLkYLHen~IV-------HRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETFTGTLQYMAPEvID 749 (1226)
T KOG4279|consen 679 FYTKQILEGLKYLHENKIV-------HRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVID 749 (1226)
T ss_pred HHHHHHHHHhhhhhhccee-------eccccCCcEEEeeccceEEecccccchhhccC--CccccccccchhhhChHhhc
Confidence 3456777788888777666 9999999999975 589999999999876432 23456789999999999999
Q ss_pred hCC--CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHc
Q 011196 350 EGI--FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLC 427 (491)
Q Consensus 350 ~~~--~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~c 427 (491)
.|+ |+.++|||||||++.||.||++||-. ....+. .+++-+..+ .-.+.+.+...+...++++|
T Consensus 750 qG~RGYG~aADIWS~GCT~vEMATGrPPF~E--lgspqA------AMFkVGmyK------vHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 750 QGPRGYGKAADIWSFGCTMVEMATGRPPFVE--LGSPQA------AMFKVGMYK------VHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred cCCcCCCchhhhhhccceeEeeccCCCCeee--cCChhH------hhhhhccee------cCCCCcHHHHHHHHHHHHHH
Confidence 876 88999999999999999999999642 221111 111111111 11235666677888899999
Q ss_pred ccCCCCCCCCHHHHHH
Q 011196 428 VQEDPMDRPTMSSVAV 443 (491)
Q Consensus 428 l~~dP~~RPs~~evl~ 443 (491)
+.+||.+||++.++++
T Consensus 816 Fepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cCCCcccCccHHHhcc
Confidence 9999999999999875
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-20 Score=207.18 Aligned_cols=181 Identities=17% Similarity=0.178 Sum_probs=121.3
Q ss_pred eeeecccccCCCCccccC------CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC-------
Q 011196 244 RYELYRFLVDTPTVTVTA------PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE------- 310 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~------- 310 (491)
.|.++.|...+.+..... ........+.++.+++.++.+||.........+|+||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 355566665544432211 1223455667888899999999986533334567799999999999642
Q ss_pred ----------CCceEeccCcceecCCCCcccccCceeecCCCChhhhhhh--CCCCcccceeehhHHHHHHHhCCCCCCC
Q 011196 311 ----------MNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME--GIFSVKSDVFSFGVVLLEIISGKKSSGF 378 (491)
Q Consensus 311 ----------~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvvl~elltG~~p~~~ 378 (491)
..+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 348999999998654322 1234578999999999864 4588999999999999999999999752
Q ss_pred ccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 379 YHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.. ... .......... .+. .. .....+.+|+..||+.+|++||++.|++.
T Consensus 246 ~~-----~~~-qli~~lk~~p--~lp----i~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 AN-----NFS-QLISELKRGP--DLP----IK----GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CC-----cHH-HHHHHHhcCC--CCC----cC----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 11 111 1111111111 000 00 11245678999999999999999999983
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.2e-21 Score=183.61 Aligned_cols=158 Identities=25% Similarity=0.435 Sum_probs=115.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..++. ||||||+||+++.++.+||+|||.+......... ......++..|++|
T Consensus 101 ~~~~~~~~~~l~~aL~~lH~~~i~-------H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~P 172 (260)
T cd05073 101 LPKLIDFSAQIAEGMAFIEQRNYI-------HRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAP 172 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------ccccCcceEEEcCCCcEEECCCcceeeccCCCcc-cccCCcccccccCH
Confidence 345566788889999999987666 9999999999999999999999999765432221 12223456789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++..+.++.++|+||||++++|+++ |+.||... ....+. .....+..... .......+.+++
T Consensus 173 E~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~---~~~~~~----~~~~~~~~~~~---------~~~~~~~~~~~i 236 (260)
T cd05073 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM---SNPEVI----RALERGYRMPR---------PENCPEELYNIM 236 (260)
T ss_pred hHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC---CHHHHH----HHHhCCCCCCC---------cccCCHHHHHHH
Confidence 99988889999999999999999998 88886421 111111 11111111111 112234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhc
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.+||+.+|++||++.++++.|+.
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 237 MRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHcccCcccCcCHHHHHHHHhc
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.1e-21 Score=185.38 Aligned_cols=160 Identities=22% Similarity=0.344 Sum_probs=113.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccc-cCcee--ecCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEAN-TNRVV--GTYGY 342 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~-~~~~~--gt~~y 342 (491)
......++.+++.++.++|..+++ ||||||+||+++.++.+||+|||+++.......... ..... .+..|
T Consensus 105 ~~~~~~i~~~l~~al~~lH~~g~~-------H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y 177 (269)
T cd05065 105 VIQLVGMLRGIAAGMKYLSEMNYV-------HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177 (269)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEe-------ecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceee
Confidence 344566778888889999987776 999999999999999999999999876543222111 11111 13579
Q ss_pred ChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 343 MAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 343 ~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
++||++.+..++.++||||||+++||+++ |..||.... .......+ .... .. ..+.+....+.
T Consensus 178 ~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~---~~~~~~~i----~~~~--~~-------~~~~~~~~~~~ 241 (269)
T cd05065 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---NQDVINAI----EQDY--RL-------PPPMDCPTALH 241 (269)
T ss_pred cCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC---HHHHHHHH----HcCC--cC-------CCcccCCHHHH
Confidence 99999998899999999999999999886 888864221 11111111 1110 00 01112234467
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+++.+||+.+|++||++.+|+..|++.
T Consensus 242 ~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 242 QLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.5e-22 Score=203.51 Aligned_cols=180 Identities=20% Similarity=0.313 Sum_probs=132.0
Q ss_pred ecccccCCCCccccCCCC---CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCccee
Q 011196 247 LYRFLVDTPTVTVTAPNK---TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARI 323 (491)
Q Consensus 247 ~~~f~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~ 323 (491)
+..|.+++++..-+-.+. ...+..-++..|+.++.||...+++ ||||.++|||++.+..+|++|||+++.
T Consensus 708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YV-------HRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYV-------HRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCch-------hhhhhhhheeeccceEEEeccccceee
Confidence 445666555432222221 2334556778889999999999999 999999999999999999999999998
Q ss_pred cCCCCccc-ccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 324 FGGNQSEA-NTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 324 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+.++.... .+..-.=.++|.|||.+...+|+.++|||||||++||.++ |.+|+- +..+++.+..+
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW---dmSNQdVIkaI---------- 847 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW---DMSNQDVIKAI---------- 847 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc---ccchHHHHHHH----------
Confidence 75544221 1111222579999999999999999999999999999887 888842 11222222222
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
+...+-..+.+++..+.+||+.|||+|-.+||.+.||+.+|.+..
T Consensus 848 ---e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 848 ---EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred ---HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 222222345567788999999999999999999999999998763
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-20 Score=185.13 Aligned_cols=178 Identities=17% Similarity=0.259 Sum_probs=123.3
Q ss_pred eeeecccccCCCCcccc-CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 244 RYELYRFLVDTPTVTVT-APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.|.++.|+.+....... ...........++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++.
T Consensus 94 ~~lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~iv-------H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVI-------HRDIKSDSILLTSDGRIKLSDFGFCA 166 (292)
T ss_pred EEEEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEe-------ecCCCHHHEEEcCCCCEEEccCcchh
Confidence 46666666655432222 11223455667788888899999988766 99999999999999999999999987
Q ss_pred ecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccc
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAE 402 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (491)
....... ......|+..|+|||++.+..++.++||||||++++|+++|+.||... ........ ....
T Consensus 167 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~---~~~~~~~~----~~~~---- 233 (292)
T cd06658 167 QVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE---PPLQAMRR----IRDN---- 233 (292)
T ss_pred hcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHH----HHhc----
Confidence 5533221 223357889999999998888999999999999999999999997421 11111111 1111
Q ss_pred cccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 403 LMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 403 ~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..+.+... ......+.+++.+||+.||++|||+.++++.
T Consensus 234 -~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 234 -LPPRVKDS--HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -CCCccccc--cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 01111110 0112345678889999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-20 Score=184.36 Aligned_cols=158 Identities=25% Similarity=0.392 Sum_probs=111.2
Q ss_pred CcchhhhHhHHHHHHHHHhhe-eeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLST-SFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.++|.. +++ ||||||+||+++.++.+||+|||+++....... .....|+..|+|
T Consensus 106 ~~~~~~i~~~i~~~l~~lh~~~~i~-------H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~a 175 (288)
T cd06616 106 EEILGKIAVATVKALNYLKEELKII-------HRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMA 175 (288)
T ss_pred HHHHHHHHHHHHHHHHHHhhcCCee-------ccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccC
Confidence 344556777777788888753 444 999999999999999999999999876533221 122357889999
Q ss_pred hhhhhhC---CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 345 PEYAMEG---IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 345 PE~~~~~---~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
||++.+. .++.++||||||+++|||++|+.||.... .......+... +... .+...........+.
T Consensus 176 PE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~l~ 244 (288)
T cd06616 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GDPP-----ILSNSEEREFSPSFV 244 (288)
T ss_pred HHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CCCC-----cCCCcCCCccCHHHH
Confidence 9998766 58899999999999999999999975332 11122211111 1111 111111122344677
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
+++.+||+.||++||++.+|+++
T Consensus 245 ~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 245 NFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999998864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-20 Score=181.06 Aligned_cols=155 Identities=23% Similarity=0.334 Sum_probs=113.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..+++ ||||+|+||+++.++.+||+|||++........ ......++..|++|
T Consensus 98 ~~~~~~~~~~l~~~l~~lh~~~i~-------H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~P 168 (256)
T cd06612 98 EEEIAAILYQTLKGLEYLHSNKKI-------HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAP 168 (256)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCH
Confidence 455667788888899999988776 999999999999999999999999986543321 12234578899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|++.+..++.++||||||+++|||++|+.|+....... .. ........ +.. ..+......+.+++.
T Consensus 169 E~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~------~~-~~~~~~~~-----~~~--~~~~~~~~~~~~~i~ 234 (256)
T cd06612 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR------AI-FMIPNKPP-----PTL--SDPEKWSPEFNDFVK 234 (256)
T ss_pred HHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh------hh-hhhccCCC-----CCC--CchhhcCHHHHHHHH
Confidence 99988889999999999999999999999975321111 00 00000000 000 011122345778999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 011196 426 LCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~ 443 (491)
+||+.||++||++.||++
T Consensus 235 ~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHhcChhhCcCHHHHhc
Confidence 999999999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.4e-21 Score=194.19 Aligned_cols=156 Identities=24% Similarity=0.392 Sum_probs=122.9
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhh
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY 347 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 347 (491)
..+.++.+|..++.||....++ ||||..+|.|+.++..+||+|||+++++..+....+.+ ..-.+.|.|||.
T Consensus 366 vLlyMAtQIsSaMeYLEkknFI-------HRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG-AKFPIKWTAPEs 437 (1157)
T KOG4278|consen 366 VLLYMATQISSAMEYLEKKNFI-------HRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPES 437 (1157)
T ss_pred HHHHHHHHHHHHHHHHHHhhhh-------hhhhhhhhccccccceEEeeccchhhhhcCCceecccC-ccCcccccCccc
Confidence 3456788889999999988888 99999999999999999999999999987654433222 233678999999
Q ss_pred hhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHH
Q 011196 348 AMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLL 426 (491)
Q Consensus 348 ~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~ 426 (491)
+....|+.|+|||+|||+||||.| |..|+.... +..++... ....+.+.++.+..++.+||+.
T Consensus 438 LAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-------lSqVY~LL---------EkgyRM~~PeGCPpkVYeLMra 501 (1157)
T KOG4278|consen 438 LAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYGLL---------EKGYRMDGPEGCPPKVYELMRA 501 (1157)
T ss_pred ccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-------HHHHHHHH---------hccccccCCCCCCHHHHHHHHH
Confidence 999999999999999999999998 777764322 22233322 2333344556677889999999
Q ss_pred cccCCCCCCCCHHHHHHHhhc
Q 011196 427 CVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 427 cl~~dP~~RPs~~evl~~L~~ 447 (491)
||+++|.+||++.|+-+.++.
T Consensus 502 CW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 502 CWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred HhcCCcccCccHHHHHHHHHH
Confidence 999999999999998877743
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.4e-20 Score=187.51 Aligned_cols=181 Identities=16% Similarity=0.212 Sum_probs=119.5
Q ss_pred eeeeecccccCCCCccccCC-CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 243 IRYELYRFLVDTPTVTVTAP-NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
..|.++.|..++.+...... .........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~Iv-------HrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLI-------HRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeE-------ecCCCHHHEEECCCCCEEEEecccc
Confidence 45666666665544332211 122344556778888999999987776 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhC----CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEG----IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
+....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ...... .....
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~---~~~~~~---~i~~~ 262 (370)
T cd05621 190 MKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS---LVGTYS---KIMDH 262 (370)
T ss_pred eecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC---HHHHHH---HHHhC
Confidence 87643221 122345789999999999754 37889999999999999999999975321 111111 11111
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMD--RPTMSSVAVM 444 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~ 444 (491)
.....+.+ .......+.+++..|++.++++ ||++.|++++
T Consensus 263 ~~~~~~p~-------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KNSLNFPE-------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CcccCCCC-------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11111100 0111233556777888755543 8899998876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.8e-21 Score=183.59 Aligned_cols=158 Identities=25% Similarity=0.415 Sum_probs=115.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..+++ |+||||+||+++.++.+||+|||+++........ ......++..|+||
T Consensus 102 ~~~~~~~~~~i~~al~~lh~~~i~-------h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~P 173 (261)
T cd05034 102 LPQLVDMAAQIAEGMAYLESRNYI-------HRDLAARNILVGENLVCKIADFGLARLIEDDEYT-AREGAKFPIKWTAP 173 (261)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------cCCcchheEEEcCCCCEEECccccceeccchhhh-hhhccCCCccccCH
Confidence 445567788888889999987776 9999999999999999999999999866432111 11122345689999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|.+.+..++.++||||||++++|+++ |+.||... ......... ..+... ..+......+.+++
T Consensus 174 E~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~---~~~~~~~~~----~~~~~~---------~~~~~~~~~~~~~i 237 (261)
T cd05034 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM---TNREVLEQV----ERGYRM---------PRPPNCPEELYDLM 237 (261)
T ss_pred HHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHH----HcCCCC---------CCCCCCCHHHHHHH
Confidence 99998889999999999999999998 88886421 111122211 111000 00111134577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhc
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.+||+.+|++||++.++++.|+.
T Consensus 238 ~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 238 LQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHcccCcccCCCHHHHHHHHhc
Confidence 99999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.5e-20 Score=189.48 Aligned_cols=181 Identities=17% Similarity=0.183 Sum_probs=119.9
Q ss_pred eeeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 243 IRYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
..|.+..|+.++.+..... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+
T Consensus 75 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iv-------H~Dlkp~NIl~~~~~~~kl~Dfg~ 147 (364)
T cd05599 75 YLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYI-------HRDIKPDNLLLDAKGHIKLSDFGL 147 (364)
T ss_pred eEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------eccCCHHHeEECCCCCEEEeeccc
Confidence 3455666665554332221 1223455667888899999999988777 999999999999999999999999
Q ss_pred ceecCCCCccc------------------------------------ccCceeecCCCChhhhhhhCCCCcccceeehhH
Q 011196 321 ARIFGGNQSEA------------------------------------NTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGV 364 (491)
Q Consensus 321 a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gv 364 (491)
++.+....... ......||+.|+|||++.+..++.++|||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 227 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence 87543211100 001246899999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHH
Q 011196 365 VLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT---MSSV 441 (491)
Q Consensus 365 vl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs---~~ev 441 (491)
+++||++|..||..... ......+ ............ ... ...+.+++.+|+. +|.+|++ +.|+
T Consensus 228 il~el~~G~~Pf~~~~~---~~~~~~i---~~~~~~~~~~~~---~~~----s~~~~~li~~ll~-~p~~R~~~~~~~~l 293 (364)
T cd05599 228 IMYEMLVGYPPFCSDNP---QETYRKI---INWKETLQFPDE---VPL----SPEAKDLIKRLCC-EAERRLGNNGVNEI 293 (364)
T ss_pred HHHHhhcCCCCCCCCCH---HHHHHHH---HcCCCccCCCCC---CCC----CHHHHHHHHHHcc-CHhhcCCCCCHHHH
Confidence 99999999999753211 1111111 110000000000 011 2345567788886 9999998 8887
Q ss_pred HHH
Q 011196 442 AVM 444 (491)
Q Consensus 442 l~~ 444 (491)
+++
T Consensus 294 l~h 296 (364)
T cd05599 294 KSH 296 (364)
T ss_pred hcC
Confidence 663
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-20 Score=184.03 Aligned_cols=152 Identities=22% Similarity=0.239 Sum_probs=111.7
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
..++..-.+.+++.++.+||...++ .||+||+|||+|++|+++|+|+|++..+..++... ..+||.+|||
T Consensus 285 ~e~ra~FYAAEi~cGLehlH~~~iV-------YRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~---~rvGT~GYMA 354 (591)
T KOG0986|consen 285 DEQRARFYAAEIICGLEHLHRRRIV-------YRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR---GRVGTVGYMA 354 (591)
T ss_pred chHHHHHHHHHHHhhHHHHHhccee-------eccCChhheeeccCCCeEeeccceEEecCCCCccc---cccCcccccC
Confidence 3555666677777788888877776 99999999999999999999999999887665533 3489999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||++.++.|+...|-||+||++|||+.|+.||.-...... .+.+-++.... ..+++..-.++..+|.
T Consensus 355 PEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---~eEvdrr~~~~----------~~ey~~kFS~eakslc 421 (591)
T KOG0986|consen 355 PEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---REEVDRRTLED----------PEEYSDKFSEEAKSLC 421 (591)
T ss_pred HHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh---HHHHHHHHhcc----------hhhcccccCHHHHHHH
Confidence 9999999999999999999999999999999753221111 11111111110 0122233334556677
Q ss_pred HHcccCCCCCCCCHH
Q 011196 425 LLCVQEDPMDRPTMS 439 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~ 439 (491)
...|++||++|...+
T Consensus 422 ~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 422 EGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHccCHHHhccCC
Confidence 789999999997544
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.82 E-value=7e-21 Score=184.81 Aligned_cols=160 Identities=22% Similarity=0.341 Sum_probs=116.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccc-cCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEAN-TNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~-~~~~~gt~~y~a 344 (491)
......++.+++.++.++|..+++ ||||||+|||++.++.+||+|||+++.......... .....++..|++
T Consensus 105 ~~~~~~i~~~i~~~l~~lH~~~i~-------h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~ 177 (267)
T cd05066 105 VIQLVGMLRGIASGMKYLSDMGYV-------HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 177 (267)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEe-------ehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecC
Confidence 345667788888999999988776 999999999999999999999999987643322111 111233567999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..++.++|+||||++++|+++ |..||..... ...... ...+.. . + .+......+.++
T Consensus 178 pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~~----~~~~~~--~--~-----~~~~~~~~~~~l 241 (267)
T cd05066 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIKA----IEEGYR--L--P-----APMDCPAALHQL 241 (267)
T ss_pred HhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHHH----HhCCCc--C--C-----CCCCCCHHHHHH
Confidence 999998889999999999999999886 9988643211 111111 111110 0 0 011123456789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+.+||+.+|++||++.++++.|++.
T Consensus 242 i~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 242 MLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHcccCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-20 Score=186.27 Aligned_cols=172 Identities=18% Similarity=0.195 Sum_probs=115.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC----CCCceEeccCcceecCCCCc-ccccCceeecC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH----EMNPKISDFGMARIFGGNQS-EANTNRVVGTY 340 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~----~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~ 340 (491)
....+.++.+++.++.+||..+++ ||||||+||+++. ++.+||+|||++........ ........++.
T Consensus 107 ~~~~~~i~~qi~~~l~~lH~~~i~-------h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 179 (316)
T cd07842 107 PSMVKSLLWQILNGVHYLHSNWVL-------HRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEe-------eCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccc
Confidence 344566888899999999988776 9999999999999 89999999999986543322 11223456788
Q ss_pred CCChhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcc------cHHHHHHHHhhcC------------Ccc
Q 011196 341 GYMAPEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGP------SLLAYIWKLWCEG------------HAA 401 (491)
Q Consensus 341 ~y~aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~------~~~~~~~~~~~~~------------~~~ 401 (491)
.|+|||++.+. .++.++||||||++++||++|+.||......... .....+...+... ...
T Consensus 180 ~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (316)
T cd07842 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYD 259 (316)
T ss_pred cccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccch
Confidence 99999988764 4789999999999999999999998643332200 0011111111000 000
Q ss_pred ccccchhcCCCC---------H--HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 402 ELMDSVVKQSCD---------Q--AELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 402 ~~~d~~l~~~~~---------~--~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
...+.......+ . ....++.+++.+||+.||++|||+.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 260 TLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred hhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000000000 0 223457889999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-20 Score=183.21 Aligned_cols=167 Identities=17% Similarity=0.162 Sum_probs=112.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..++. ||||||+||+++.++.+||+|||+++........ .....++..|+||
T Consensus 98 ~~~~~~~~~qi~~al~~LH~~~i~-------H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aP 168 (284)
T cd07839 98 PEIVKSFMFQLLKGLAFCHSHNVL-------HRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPP 168 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEe-------cCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--cCCCccccCCcCh
Confidence 445667888999999999988776 9999999999999999999999999765432211 1234568899999
Q ss_pred hhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc------cccccch----hcC----
Q 011196 346 EYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA------AELMDSV----VKQ---- 410 (491)
Q Consensus 346 E~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~d~~----l~~---- 410 (491)
|++.+.. ++.++||||||+++|||++|..|+.. ..........+.+....... .+..+.. ...
T Consensus 169 E~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (284)
T cd07839 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSL 246 (284)
T ss_pred HHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC--CCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchh
Confidence 9987654 78999999999999999999988531 12211222222111110000 0000000 000
Q ss_pred -CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 411 -SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 411 -~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.........+.+++.+||+.||++|||+.+++.
T Consensus 247 ~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 247 VNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000112345678999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.3e-21 Score=187.78 Aligned_cols=166 Identities=14% Similarity=0.152 Sum_probs=111.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++........ ......++..|+||
T Consensus 103 ~~~~~~~~~qi~~aL~~lH~~~i~-------H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~P 173 (301)
T cd07873 103 MHNVKLFLFQLLRGLNYCHRRKVL-------HRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPP 173 (301)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------CCCCCHHHEEECCCCcEEECcCcchhccCCCCC--cccccceeecccCc
Confidence 345666778888999999988777 999999999999999999999999875432221 11234568899999
Q ss_pred hhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh---cCCcccccc---------chhcCC-
Q 011196 346 EYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC---EGHAAELMD---------SVVKQS- 411 (491)
Q Consensus 346 E~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d---------~~l~~~- 411 (491)
|++.+. .++.++||||||+++|||++|+.||..... ......+..... ...+..+.. +.....
T Consensus 174 E~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (301)
T cd07873 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV---EEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADC 250 (301)
T ss_pred HHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCChhhchhhhccccccccccCcccccc
Confidence 998754 478899999999999999999999753321 111111111110 000111000 000000
Q ss_pred ---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 412 ---CDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 412 ---~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
........+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 251 LHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00011234668999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.9e-20 Score=180.37 Aligned_cols=177 Identities=18% Similarity=0.272 Sum_probs=120.7
Q ss_pred eeeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.++.|..++...... ..+........++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+
T Consensus 77 ~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~-------H~dlkp~nili~~~~~~kl~dfg~ 149 (282)
T cd06643 77 LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKII-------HRDLKAGNILFTLDGDIKLADFGV 149 (282)
T ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee-------ecCCCcccEEEccCCCEEEccccc
Confidence 45566666544432211 12233456677888999999999998777 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhh-----hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHh
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAM-----EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLW 395 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 395 (491)
+........ ......++..|+|||++. +..++.++|||||||++|||++|+.||.... . ........
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~---~~~~~~~~ 221 (282)
T cd06643 150 SAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN---P---MRVLLKIA 221 (282)
T ss_pred ccccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC---H---HHHHHHHh
Confidence 875432211 122356889999999984 3457889999999999999999999975322 1 11111111
Q ss_pred hcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 396 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 396 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
......+..+ ......+.+++.+||+.||.+||++.++++
T Consensus 222 -~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 222 -KSEPPTLAQP-------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -hcCCCCCCCc-------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111111 111235678999999999999999988764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.8e-21 Score=185.86 Aligned_cols=167 Identities=18% Similarity=0.210 Sum_probs=116.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ |+||||+||++++++.+||+|||++......... ......++..|+||
T Consensus 99 ~~~~~~~~~~i~~~l~~LH~~~i~-------H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~P 170 (288)
T cd07833 99 PDAVRSYIWQLLQAIAYCHSHNII-------HRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAP 170 (288)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCC
Confidence 455667788889999999987766 9999999999999999999999999876543321 22235678899999
Q ss_pred hhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh-----------cC------Cccccccch
Q 011196 346 EYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC-----------EG------HAAELMDSV 407 (491)
Q Consensus 346 E~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----------~~------~~~~~~d~~ 407 (491)
|++.+. .++.++||||||+++||+++|+.||...... +........+. .. ...+..++.
T Consensus 171 E~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
T cd07833 171 ELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI---DQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPE 247 (288)
T ss_pred chhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcH
Confidence 999887 7899999999999999999999987532211 11111111000 00 000000000
Q ss_pred -hcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 408 -VKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 408 -l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
....++......+.+++.+||+.+|++||+++++++
T Consensus 248 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 248 SLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000111122466788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-20 Score=192.95 Aligned_cols=128 Identities=19% Similarity=0.311 Sum_probs=94.0
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++.+..... ..........++.+++.++.++|..+++ ||||||+|||++.++.+||+|||++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~iv-------HrDlKp~NILl~~~g~~kL~DFGla 148 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFI-------HRDIKPDNILIDRDGHIKLTDFGLC 148 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEECCCCCEEEeECCCC
Confidence 355566665554332221 1122344556677888899999988777 9999999999999999999999997
Q ss_pred eecCCCC---------------------------------------------cccccCceeecCCCChhhhhhhCCCCcc
Q 011196 322 RIFGGNQ---------------------------------------------SEANTNRVVGTYGYMAPEYAMEGIFSVK 356 (491)
Q Consensus 322 ~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~ 356 (491)
+.+.... .........||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (382)
T cd05625 149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 228 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe
Confidence 5321000 0000123468999999999998899999
Q ss_pred cceeehhHHHHHHHhCCCCCCC
Q 011196 357 SDVFSFGVVLLEIISGKKSSGF 378 (491)
Q Consensus 357 sDVwS~Gvvl~elltG~~p~~~ 378 (491)
+|||||||++|||++|+.||..
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~ 250 (382)
T cd05625 229 CDWWSVGVILYEMLVGQPPFLA 250 (382)
T ss_pred eeEEechHHHHHHHhCCCCCCC
Confidence 9999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-20 Score=181.70 Aligned_cols=155 Identities=19% Similarity=0.259 Sum_probs=108.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCc-ccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQS-EANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++....... ........++..|+|
T Consensus 105 ~~~~~~~~~qi~~~l~~LH~~~i~-------H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 177 (266)
T cd06651 105 ESVTRKYTRQILEGMSYLHSNMIV-------HRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177 (266)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------eCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccC
Confidence 445556788899999999987766 999999999999999999999999875532111 111223457889999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||++.+..++.++||||||+++||+++|+.||... .....+........ .+ ..+......+.+++
T Consensus 178 PE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~------~~~~~~~~~~~~~~-----~~----~~~~~~~~~~~~li 242 (266)
T cd06651 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY------EAMAAIFKIATQPT-----NP----QLPSHISEHARDFL 242 (266)
T ss_pred HHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc------chHHHHHHHhcCCC-----CC----CCchhcCHHHHHHH
Confidence 99998888999999999999999999999997522 11111111111111 11 11111122233444
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 011196 425 LLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~ 443 (491)
+||..+|++||+++||++
T Consensus 243 -~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 243 -GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -HHhcCChhhCcCHHHHhc
Confidence 688899999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.82 E-value=4e-20 Score=182.69 Aligned_cols=178 Identities=17% Similarity=0.289 Sum_probs=122.5
Q ss_pred eeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 244 RYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.|.++.|+.+........ ..........++.+++.++.++|..+++ ||||||+||+++.++.+||+|||++.
T Consensus 93 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iv-------H~dl~p~Nill~~~~~~kL~dfg~~~ 165 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVI-------HRDIKSDSILLTLDGRVKLSDFGFCA 165 (297)
T ss_pred EEEEEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHeEEccCCcEEEeechhHh
Confidence 345555655443322211 1223455667888888899999987776 99999999999999999999999987
Q ss_pred ecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccc
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAE 402 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (491)
....... ......|+..|+|||++.+..++.++||||||++++||++|+.||.... . ...... ........
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~---~---~~~~~~-~~~~~~~~ 236 (297)
T cd06659 166 QISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS---P---VQAMKR-LRDSPPPK 236 (297)
T ss_pred hcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---H---HHHHHH-HhccCCCC
Confidence 5543221 1223568899999999988889999999999999999999999974211 1 111111 11111000
Q ss_pred cccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 403 LMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 403 ~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
... .......+.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~-------~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 237 LKN-------AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccc-------cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 01112346678999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.3e-20 Score=187.18 Aligned_cols=127 Identities=24% Similarity=0.331 Sum_probs=95.8
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++.+..... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~giv-------HrDlKp~NILi~~~~~vkL~DFGla 148 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFI-------HRDIKPDNLLLDSKGHVKLSDFGLC 148 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE-------ecCCCHHHeEECCCCCEEEeeccCc
Confidence 455666665544332221 1223445666778888899999887776 9999999999999999999999998
Q ss_pred eecCCCCcc---------------------------------cccCceeecCCCChhhhhhhCCCCcccceeehhHHHHH
Q 011196 322 RIFGGNQSE---------------------------------ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLE 368 (491)
Q Consensus 322 ~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~e 368 (491)
+........ .......||+.|+|||++.+..++.++|||||||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 228 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHH
Confidence 754321100 00123579999999999998889999999999999999
Q ss_pred HHhCCCCCC
Q 011196 369 IISGKKSSG 377 (491)
Q Consensus 369 lltG~~p~~ 377 (491)
|++|+.||.
T Consensus 229 ll~G~~Pf~ 237 (363)
T cd05628 229 MLIGYPPFC 237 (363)
T ss_pred HHhCCCCCC
Confidence 999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-20 Score=181.60 Aligned_cols=159 Identities=21% Similarity=0.205 Sum_probs=116.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.++|..+ +...+++|+||||+||+++.++.+||+|||++......... .....++..|++|
T Consensus 104 ~~~~~~~~~~i~~~l~~lH~~~--~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~p 179 (265)
T cd08217 104 EEFIWRILTQLLLALYECHNRS--DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSP 179 (265)
T ss_pred HHHHHHHHHHHHHHHHHHhcCc--cccCcceecCCCHHHEEEecCCCEEEecccccccccCCccc--ccccccCCCccCh
Confidence 4456677888888889998332 12334449999999999999999999999999876543321 2234688999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|++.+..++.++|+||||+++++|++|+.|+.... ...+ ......+... ..+......+.+++.
T Consensus 180 E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~----~~~~~~~~~~---------~~~~~~~~~~~~l~~ 243 (265)
T cd08217 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQL----ASKIKEGKFR---------RIPYRYSSELNEVIK 243 (265)
T ss_pred hhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHH----HHHHhcCCCC---------CCccccCHHHHHHHH
Confidence 99988889999999999999999999999975322 1111 1111222111 112223356778999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 011196 426 LCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~ 444 (491)
+||+.+|++||++.+|+++
T Consensus 244 ~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 244 SMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHccCCcccCCCHHHHhhC
Confidence 9999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-20 Score=181.23 Aligned_cols=150 Identities=21% Similarity=0.266 Sum_probs=107.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC--------ceEeccCcceecCCCCcccccCcee
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN--------PKISDFGMARIFGGNQSEANTNRVV 337 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~--------~kl~DfGla~~~~~~~~~~~~~~~~ 337 (491)
....+.++.+++.++.++|..+++ ||||||+||+++.++. +|++|||++..... .....
T Consensus 99 ~~~~~~~~~qi~~~l~~lH~~~ii-------H~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~ 165 (258)
T cd05078 99 ISWKLEVAKQLAWALHFLEDKGLT-------HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP------KEILL 165 (258)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------cCCCccceEEEecccccccCCCceEEecccccccccCC------chhcc
Confidence 344556788888899999987776 9999999999987765 58999998864422 12245
Q ss_pred ecCCCChhhhhhhC-CCCcccceeehhHHHHHHHhCC-CCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHH
Q 011196 338 GTYGYMAPEYAMEG-IFSVKSDVFSFGVVLLEIISGK-KSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 415 (491)
Q Consensus 338 gt~~y~aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 415 (491)
++..|+|||++.+. .++.++||||||+++||+++|. .|+... +.. .... ... .. . ..+..
T Consensus 166 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~---~~~---~~~~-~~~-~~-~---------~~~~~ 227 (258)
T cd05078 166 ERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL---DSQ---KKLQ-FYE-DR-H---------QLPAP 227 (258)
T ss_pred ccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc---cHH---HHHH-HHH-cc-c---------cCCCC
Confidence 78899999999864 4789999999999999999985 443211 111 1010 000 00 0 11111
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 011196 416 ELLKYIHIGLLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 416 ~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 446 (491)
...++.+++.+||+.||++|||++++++.|+
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 228 KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 2245678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-20 Score=182.01 Aligned_cols=181 Identities=16% Similarity=0.265 Sum_probs=120.3
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.+..|+..+...... ...........++.+++.++.++|..+++ ||||||+||+++.++.+||+|||++
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~-------H~dl~p~nill~~~~~~~l~dfg~~ 153 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKM-------HRDIKGANILLTDNGDVKLADFGVA 153 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------ccCCCHHHEEECCCCCEEECcCccc
Confidence 34555665544432221 11223445666788888899999987766 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhh---hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAM---EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
........ ......|+..|+|||.+. ...++.++||||||++++||++|+.|+........ .. .+...
T Consensus 154 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~------~~-~~~~~ 224 (267)
T cd06646 154 AKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LF-LMSKS 224 (267)
T ss_pred eeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh------he-eeecC
Confidence 86543221 122346788999999884 34578899999999999999999999642211100 00 00000
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 445 (491)
. ...+.... .......+.+++.+||+.||++||++++|++.|
T Consensus 225 ~---~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 225 N---FQPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C---CCCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 00111100 011224567899999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-20 Score=183.80 Aligned_cols=177 Identities=19% Similarity=0.323 Sum_probs=122.0
Q ss_pred eeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 244 RYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.|.++.|..+........ ..........+..+++.++.+||..++. ||||||+||+++.++.+||+|||++.
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~-------H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVI-------HRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred EEEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCHHHEEECCCCCEEEccCccch
Confidence 455555555443322211 1233556677888888899999988776 99999999999999999999999987
Q ss_pred ecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccc
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAE 402 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (491)
........ .....++..|+|||.+.+..++.++||||||+++|++++|+.||..... ........... ...
T Consensus 164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~------~~~~~~~~~~~-~~~ 234 (296)
T cd06655 164 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNG-TPE 234 (296)
T ss_pred hccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcC-Ccc
Confidence 65433221 2234678899999999888899999999999999999999999743211 11111111111 111
Q ss_pred cccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 403 LMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 403 ~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
... +......+.+++.+||+.||++||++.+|+.
T Consensus 235 ~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 LQN-------PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCC-------cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 100 1112234667899999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-20 Score=184.37 Aligned_cols=177 Identities=19% Similarity=0.299 Sum_probs=121.2
Q ss_pred eeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 244 RYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.|.++.|..+........ ..........++.+++.++.+||..++. ||||||+|||++.++.+||+|||++.
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~-------H~dL~p~Nili~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVI-------HRDIKSDNILLGMDGSVKLTDFGFCA 163 (297)
T ss_pred EEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCHHHEEECCCCCEEECcCccce
Confidence 345555555444322211 1223445667788888899999987766 99999999999999999999999987
Q ss_pred ecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccc
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAE 402 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (491)
........ .....++..|++||.+.+..++.++||||||+++|++++|..||....... . .. .....+ ...
T Consensus 164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~--~-~~---~~~~~~-~~~ 234 (297)
T cd06656 164 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--A-LY---LIATNG-TPE 234 (297)
T ss_pred EccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch--h-ee---eeccCC-CCC
Confidence 65433221 223467889999999998889999999999999999999999974321111 0 00 000000 000
Q ss_pred cccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 403 LMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 403 ~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
. ..+......+.+++.+||+.||++||++.+|++
T Consensus 235 ~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 L-------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred C-------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 011122234567889999999999999998887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.9e-20 Score=173.29 Aligned_cols=173 Identities=20% Similarity=0.233 Sum_probs=119.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC----CCceEeccCcceecCCCCcc-cccCceeecC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE----MNPKISDFGMARIFGGNQSE-ANTNRVVGTY 340 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~----~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~ 340 (491)
..-.++++.++..++.|||+.-++ ||||||.|||+..+ |.+||+|||+++.+.+.-.. ......+-|.
T Consensus 131 ~~mvKsilwQil~Gv~YLH~NWvl-------HRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTi 203 (438)
T KOG0666|consen 131 RSMVKSILWQILDGVHYLHSNWVL-------HRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTI 203 (438)
T ss_pred HHHHHHHHHHHHhhhHHHhhhhee-------eccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEE
Confidence 345678999999999999999888 99999999999777 89999999999988654322 2334567799
Q ss_pred CCChhhhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCC---cc---cHHHHHHHHhh---cCCcccccc-----
Q 011196 341 GYMAPEYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEH---GP---SLLAYIWKLWC---EGHAAELMD----- 405 (491)
Q Consensus 341 ~y~aPE~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~---~~---~~~~~~~~~~~---~~~~~~~~d----- 405 (491)
+|+|||.+.+.. |+.+.|||+.|||+.||++-++.|......- .+ +.+..+.+... +..|+.+..
T Consensus 204 WYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q 283 (438)
T KOG0666|consen 204 WYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQ 283 (438)
T ss_pred EecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchH
Confidence 999999999865 8999999999999999999887765432211 11 12222322221 112221110
Q ss_pred ----chhcCCCCH---H--------HHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 011196 406 ----SVVKQSCDQ---A--------ELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445 (491)
Q Consensus 406 ----~~l~~~~~~---~--------~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 445 (491)
.......+. . ....-++|..++|+.||.+|.|+++.++..
T Consensus 284 ~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 284 TLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 000000000 0 011256788899999999999999987753
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.2e-20 Score=180.39 Aligned_cols=180 Identities=19% Similarity=0.237 Sum_probs=121.2
Q ss_pred eeeeecccccCCCCccccC------CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEe
Q 011196 243 IRYELYRFLVDTPTVTVTA------PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKIS 316 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~ 316 (491)
..|.++.|..+........ ..........++.+++.++.+||...++ ||||||+||+++.++.+||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~-------H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTI-------HRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCcc-------ccCCCHHhEEECCCCCEEEc
Confidence 3556666665554432211 1122334556778888889999987776 99999999999999999999
Q ss_pred ccCcceecCCCCcccccCceeecCCCChhhhhhh-----CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHH
Q 011196 317 DFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME-----GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYI 391 (491)
Q Consensus 317 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 391 (491)
|||+++....... ......|+..|+|||++.. ..++.++||||||+++|||++|+.|+...... ...
T Consensus 167 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~------~~~ 238 (286)
T cd06638 167 DFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM------RAL 238 (286)
T ss_pred cCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh------HHH
Confidence 9999986543221 1223468999999999853 44788999999999999999999997532111 111
Q ss_pred HHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 011196 392 WKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445 (491)
Q Consensus 392 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 445 (491)
.. ..........++. .....+.+++.+||+.||++||++.||++.+
T Consensus 239 ~~-~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 FK-IPRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hh-ccccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11 1111111111110 1123467899999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=180.28 Aligned_cols=187 Identities=21% Similarity=0.277 Sum_probs=121.2
Q ss_pred eeeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhh-eeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 243 IRYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLS-TSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
..|.++.|..+........ ..........++.+++.++.+||. ..++ ||||||+|||++.++.+||+|||
T Consensus 73 ~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~-------H~dl~p~nil~~~~~~~~l~dfg 145 (308)
T cd06615 73 EISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIM-------HRDVKPSNILVNSRGEIKLCDFG 145 (308)
T ss_pred EEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEE-------ECCCChHHEEEecCCcEEEccCC
Confidence 3455666665544332221 122344556778888888999886 3555 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc-C
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE-G 398 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~ 398 (491)
++...... ......|+..|+|||++.+..++.++||||||++++|+++|+.|+...... . ....+..... .
T Consensus 146 ~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~-~~~~~~~~~~~~ 217 (308)
T cd06615 146 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---E-LEAMFGRPVSEG 217 (308)
T ss_pred Cccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---h-HHHhhcCccccc
Confidence 98754322 122356889999999998888999999999999999999999997532211 1 1111100000 0
Q ss_pred Cc--------------------cccccchhcC---CCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 399 HA--------------------AELMDSVVKQ---SCD-QAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 399 ~~--------------------~~~~d~~l~~---~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.. .+..+..... ..+ ......+.+++.+||+.||++||++.||++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 218 EAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0000000000 000 0122347789999999999999999998865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-20 Score=182.82 Aligned_cols=159 Identities=23% Similarity=0.287 Sum_probs=116.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..+++ ||||||+||+++.++.+||+|||+++......... .....++..|+||
T Consensus 106 ~~~~~~~~~~l~~~l~~lH~~~~~-------H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aP 177 (270)
T cd05056 106 LASLILYSYQLSTALAYLESKRFV-------HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAP 177 (270)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------ccccChheEEEecCCCeEEccCceeeeccccccee-cCCCCccccccCh
Confidence 445566788888999999987766 99999999999999999999999998664432211 1122345689999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|.+....++.++||||||++++|+++ |..||.... ....... ...+.... .+......+.+++
T Consensus 178 E~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~---~~~~~~~----~~~~~~~~---------~~~~~~~~~~~li 241 (270)
T cd05056 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK---NNDVIGR----IENGERLP---------MPPNCPPTLYSLM 241 (270)
T ss_pred hhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHH----HHcCCcCC---------CCCCCCHHHHHHH
Confidence 99988889999999999999999986 999974321 1111111 11111111 0112234577789
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||..+|++||++.++++.|++.
T Consensus 242 ~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 242 TKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-20 Score=183.53 Aligned_cols=177 Identities=18% Similarity=0.284 Sum_probs=119.0
Q ss_pred eeeeecccccCCCCccccCC----CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEecc
Q 011196 243 IRYELYRFLVDTPTVTVTAP----NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDF 318 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~Df 318 (491)
..|.+++|...+........ .........++.+++.++.+||..+++ ||||||+||++++++.+||+||
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~iv-------H~dl~~~nili~~~~~~~l~df 165 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVI-------HRDIKGQNVLLTENAEVKLVDF 165 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCHHHEEECCCCCEEEeeC
Confidence 44566666654433222211 112333456777888899999987766 9999999999999999999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhh-----hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHH
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAM-----EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWK 393 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 393 (491)
|++........ ......|+..|+|||.+. ...++.++||||||+++|||++|..||..... ......
T Consensus 166 g~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~------~~~~~~ 237 (282)
T cd06636 166 GVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP------MRALFL 237 (282)
T ss_pred cchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH------Hhhhhh
Confidence 99875532211 223456889999999876 34578899999999999999999999743211 011111
Q ss_pred HhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 394 LWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 394 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.. ......+ ... .....+.+++.+||+.||++||++.||++
T Consensus 238 ~~-~~~~~~~----~~~----~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 IP-RNPPPKL----KSK----KWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred Hh-hCCCCCC----ccc----ccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 0000000 011 12235778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.8e-20 Score=187.96 Aligned_cols=156 Identities=17% Similarity=0.293 Sum_probs=109.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
..+...+.+++..++.|||... |||||||+.|||+..+|.++|+|||++-... ........++||++||||
T Consensus 129 E~QIqvvc~q~ldALn~LHs~~-------iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRDsFIGTPYWMAP 199 (1187)
T KOG0579|consen 129 EDQIQVVCYQVLDALNWLHSQN-------IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRDSFIGTPYWMAP 199 (1187)
T ss_pred hHHHHHHHHHHHHHHHHHhhcc-------hhhhhccccceEEEecCcEeeecccccccch--hHHhhhccccCCcccccc
Confidence 3344445555556666666554 4499999999999999999999999985432 222233458999999999
Q ss_pred hhhh-----hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHH
Q 011196 346 EYAM-----EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKY 420 (491)
Q Consensus 346 E~~~-----~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 420 (491)
|+.+ ..+|+.++||||||++|.||..+.+|-.. ...+. +.-.+.....+.++.|.-. ...+
T Consensus 200 EVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe---lnpMR----VllKiaKSePPTLlqPS~W-------s~~F 265 (1187)
T KOG0579|consen 200 EVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE---LNPMR----VLLKIAKSEPPTLLQPSHW-------SRSF 265 (1187)
T ss_pred hheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc---cchHH----HHHHHhhcCCCcccCcchh-------hhHH
Confidence 9876 46799999999999999999999999421 11111 1112223333444444322 2346
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 011196 421 IHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 421 ~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
-+++.+||..||..||++.+++++
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhC
Confidence 678899999999999999988753
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.2e-20 Score=184.30 Aligned_cols=168 Identities=19% Similarity=0.171 Sum_probs=114.4
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++......... .....++..|+|
T Consensus 106 ~~~~~~~~~~qi~~~l~~lH~~~i~-------H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~a 176 (309)
T cd07845 106 SESQVKCLMLQLLRGLQYLHENFII-------HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRA 176 (309)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCcccccccccC
Confidence 3456677888999999999998877 9999999999999999999999999876433211 122345788999
Q ss_pred hhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC---Ccc-----------ccccchhc
Q 011196 345 PEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG---HAA-----------ELMDSVVK 409 (491)
Q Consensus 345 PE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~-----------~~~d~~l~ 409 (491)
||.+.+ ..++.++||||+|+++|||++|+.||.... .......+....... .+. ........
T Consensus 177 PE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (309)
T cd07845 177 PELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS---EIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYN 253 (309)
T ss_pred hhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCC
Confidence 999875 457899999999999999999999975321 122222221111100 000 00000000
Q ss_pred C--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 410 Q--SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 410 ~--~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
. .........+.+++.+||+.||++|||+.|++.+
T Consensus 254 ~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 254 NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred chHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0000113456789999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.7e-20 Score=180.53 Aligned_cols=176 Identities=18% Similarity=0.179 Sum_probs=121.7
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.+++|+.++....... ..........++.+++.++.++|..+++ ||||||+|||+++++.+||+|||++
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~iv-------H~dikp~Nil~~~~~~~~l~dfg~~ 144 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV-------YRDLKPANILLDEHGHVRISDLGLA 144 (279)
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcC-------CCCCCHHHEEECCCCCEEEccCCcc
Confidence 345666665554322211 1233455667888889999999987766 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
....... .....|+..|+|||.+.+ ..++.++||||||++++||++|..||........ .........
T Consensus 145 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~--- 213 (279)
T cd05633 145 CDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLT--- 213 (279)
T ss_pred eeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH----HHHHHHhhc---
Confidence 7553322 123468999999999864 4588999999999999999999999753322111 111111100
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAVM 444 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 444 (491)
... ..+......+.+++.+||+.||++|| +++|++++
T Consensus 214 ---~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 214 ---VNV----ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---CCc----CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 001 11122234567788999999999999 59988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-20 Score=184.07 Aligned_cols=168 Identities=20% Similarity=0.226 Sum_probs=114.8
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++........ ......++..|+|
T Consensus 98 ~~~~~~~~~~ql~~~l~~LH~~~i~-------H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~a 168 (286)
T cd07847 98 PEHLIKKIIWQTLQAVNFCHKHNCI-------HRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRA 168 (286)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCce-------ecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCC
Confidence 3455677888899999999997777 999999999999999999999999987644322 1223457889999
Q ss_pred hhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHH-----------hhcCCc-cccccchhcCC
Q 011196 345 PEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKL-----------WCEGHA-AELMDSVVKQS 411 (491)
Q Consensus 345 PE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~-~~~~d~~l~~~ 411 (491)
||++.+ ..++.++||||||+++|||++|+.||...... +........ +..... .....+.....
T Consensus 169 PE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (286)
T cd07847 169 PELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV---DQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETR 245 (286)
T ss_pred HHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChHHhhhcccccccccccCCCcccc
Confidence 999876 45789999999999999999999997532211 111111110 000000 00000000000
Q ss_pred CCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 412 CDQ-----AELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 412 ~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.+. .....+.+++.+||+.||++||++.|++.+
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 246 EPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 010 113457789999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-20 Score=190.68 Aligned_cols=144 Identities=17% Similarity=0.183 Sum_probs=109.3
Q ss_pred hhHhHHHHHHHHHhheeeEEeEEeeeccccccccccc-cCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhh
Q 011196 271 TIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLL-DHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM 349 (491)
Q Consensus 271 ~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl-~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 349 (491)
.|+.+++.++.+||..+++ ||||||+|||+ +..++++|+|||.++..... ....+-|..|.|||++.
T Consensus 419 ~w~~~lv~Av~~LH~~gvv-------hRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~ 486 (612)
T KOG0603|consen 419 QWAAELVSAVDYLHEQGVV-------HRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLA 486 (612)
T ss_pred HHHHHHHHHHHHHHhcCee-------ecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhc
Confidence 4677778888888887777 99999999999 58899999999999876543 11224478999999999
Q ss_pred hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHccc
Q 011196 350 EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQ 429 (491)
Q Consensus 350 ~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~ 429 (491)
...++.++|+||||++||+|++|+.|+...... ..+......+... ........+|+.+||+
T Consensus 487 ~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s------------~~vS~~AKdLl~~LL~ 548 (612)
T KOG0603|consen 487 IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFS------------ECVSDEAKDLLQQLLQ 548 (612)
T ss_pred cCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCccc------------cccCHHHHHHHHHhcc
Confidence 889999999999999999999999997532221 2222222222222 2223345568889999
Q ss_pred CCCCCCCCHHHHHHH
Q 011196 430 EDPMDRPTMSSVAVM 444 (491)
Q Consensus 430 ~dP~~RPs~~evl~~ 444 (491)
.||.+||+|.++..+
T Consensus 549 ~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 549 VDPALRLGADEIGAH 563 (612)
T ss_pred CChhhCcChhhhccC
Confidence 999999999998753
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-20 Score=180.02 Aligned_cols=155 Identities=24% Similarity=0.364 Sum_probs=115.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..++. |+||||+||++++++.+||+|||++........ ......|+..|+||
T Consensus 100 ~~~~~~~~~~l~~~l~~lh~~~i~-------h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ap 170 (256)
T cd08221 100 EEMVLWYLFQIVSAVSYIHKAGIL-------HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSP 170 (256)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------ccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCH
Confidence 445567778888888999888776 999999999999999999999999987644332 22345688999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|++.+..++.++||||||+++|||++|..||... . ........ ..+..... +......+.+++.
T Consensus 171 e~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~---~~~~~~~~-~~~~~~~~---------~~~~~~~~~~~i~ 234 (256)
T cd08221 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT---N---PLNLVVKI-VQGNYTPV---------VSVYSSELISLVH 234 (256)
T ss_pred hhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC---C---HHHHHHHH-HcCCCCCC---------ccccCHHHHHHHH
Confidence 9998888899999999999999999999997421 1 11111111 11221111 1122345677899
Q ss_pred HcccCCCCCCCCHHHHHHHh
Q 011196 426 LCVQEDPMDRPTMSSVAVML 445 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L 445 (491)
+||+.+|++||++.++++++
T Consensus 235 ~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 235 SLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHcccCcccCCCHHHHhhCc
Confidence 99999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-20 Score=186.14 Aligned_cols=169 Identities=16% Similarity=0.168 Sum_probs=113.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc--cccCceeecCCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE--ANTNRVVGTYGYM 343 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~ 343 (491)
......++.+++.++.+||..+++ |+||||+||+++.++.+||+|||++......... .......++..|+
T Consensus 118 ~~~~~~i~~qi~~al~~lH~~~i~-------H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~ 190 (310)
T cd07865 118 LSEIKKVMKMLLNGLYYIHRNKIL-------HRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190 (310)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------ccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCcccc
Confidence 455667888899999999987766 9999999999999999999999999765432211 1122346788999
Q ss_pred hhhhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh---cCCcccc-----ccc--------
Q 011196 344 APEYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC---EGHAAEL-----MDS-------- 406 (491)
Q Consensus 344 aPE~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-----~d~-------- 406 (491)
|||++.+.. ++.++||||||++++||++|..|+..... ......+..... ....... .+.
T Consensus 191 aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (310)
T cd07865 191 PPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE---QHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQK 267 (310)
T ss_pred CcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccc
Confidence 999887644 78899999999999999999998753221 111111111110 0000000 000
Q ss_pred -hhcCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 407 -VVKQS-CDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 407 -~l~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..... .+..+...+.+++.+||+.||++||++.|++++
T Consensus 268 ~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 268 RKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000 000112345689999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=184.82 Aligned_cols=166 Identities=19% Similarity=0.181 Sum_probs=111.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++........ ......++..|+||
T Consensus 100 ~~~~~~~~~qi~~~L~~lH~~~i~-------H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aP 170 (285)
T cd07861 100 AELVKSYLYQILQGILFCHSRRVL-------HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAP 170 (285)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------ecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cccCCcccccccCh
Confidence 445667888999999999988776 999999999999999999999999976543221 11224568899999
Q ss_pred hhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc---CC-------------ccccccchh
Q 011196 346 EYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE---GH-------------AAELMDSVV 408 (491)
Q Consensus 346 E~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~-------------~~~~~d~~l 408 (491)
|++.+. .++.++||||||++++||++|+.|+..... ..........+.. .. ........+
T Consensus 171 E~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (285)
T cd07861 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE---IDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSL 247 (285)
T ss_pred HHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchh
Confidence 998754 478899999999999999999998753211 0111000000000 00 000000000
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 409 KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.. .......++.+++.+||+.||++|||+.+|+++
T Consensus 248 ~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 248 RS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00 000112356689999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.1e-20 Score=179.25 Aligned_cols=179 Identities=16% Similarity=0.242 Sum_probs=119.1
Q ss_pred eeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 245 YELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
|.+.+|..++...... ...........++.+++.++.++|..++. |+||||+||+++.++.+||+|||++.
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~-------H~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKM-------HRDIKGANILLTDNGHVKLADFGVSA 154 (267)
T ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHEEECCCCCEEECcceeee
Confidence 4455555444432221 11223455667788888999999988776 99999999999999999999999987
Q ss_pred ecCCCCcccccCceeecCCCChhhhhh---hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAM---EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
...... .......|+..|+|||++. .+.++.++|||||||++|||++|..|+.... ... ..........
T Consensus 155 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~--~~~----~~~~~~~~~~ 226 (267)
T cd06645 155 QITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH--PMR----ALFLMTKSNF 226 (267)
T ss_pred EccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc--chh----hHHhhhccCC
Confidence 654321 1223457899999999974 4558899999999999999999999864221 111 1111111110
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
........ ..+ ...+.+++.+||+.||++||++.+|+++
T Consensus 227 ~~~~~~~~--~~~----~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 227 QPPKLKDK--MKW----SNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCccccc--CCC----CHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00000000 011 1246678999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.8e-20 Score=187.31 Aligned_cols=181 Identities=17% Similarity=0.224 Sum_probs=117.0
Q ss_pred eeeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 243 IRYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
..|.++.|..++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~giv-------HrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 75 YLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFI-------HRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred eeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCee-------ccCCCHHHEEECCCCCEEEeeccc
Confidence 3456666665554432221 1122334455777888999999988777 999999999999999999999999
Q ss_pred ceecCCCCcc------------c---------------------------------ccCceeecCCCChhhhhhhCCCCc
Q 011196 321 ARIFGGNQSE------------A---------------------------------NTNRVVGTYGYMAPEYAMEGIFSV 355 (491)
Q Consensus 321 a~~~~~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ 355 (491)
++.+...... . ......||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 8633210000 0 001246899999999999888999
Q ss_pred ccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCC
Q 011196 356 KSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDR 435 (491)
Q Consensus 356 ~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~R 435 (491)
++|||||||++|||++|..||.... .......+.. +. ....+.+. ......+.+++.+|++ +|.+|
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~-~~--~~~~~p~~-------~~~s~~~~dli~~lL~-~~~~r 293 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSEN---SHETYRKIIN-WR--ETLYFPDD-------IHLSVEAEDLIRRLIT-NAENR 293 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCC---HHHHHHHHHc-cC--CccCCCCC-------CCCCHHHHHHHHHHhc-CHhhc
Confidence 9999999999999999999975321 1111111111 10 00001000 0112345678888887 67665
Q ss_pred ---CCHHHHHHH
Q 011196 436 ---PTMSSVAVM 444 (491)
Q Consensus 436 ---Ps~~evl~~ 444 (491)
+++.|++.+
T Consensus 294 ~~r~~~~~~l~h 305 (377)
T cd05629 294 LGRGGAHEIKSH 305 (377)
T ss_pred CCCCCHHHHhcC
Confidence 588888775
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-20 Score=183.23 Aligned_cols=166 Identities=19% Similarity=0.188 Sum_probs=115.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..++. |+||||+||+++.++.+||+|||.+........ ......++..|++|
T Consensus 97 ~~~~~~~~~~i~~~l~~LH~~~i~-------H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~P 167 (283)
T cd05118 97 ESLIKSYLYQLLQGLAFCHSHGIL-------HRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAP 167 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------ecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cccCccCcccccCc
Confidence 455677888899999999987776 999999999999999999999999987654331 11224578889999
Q ss_pred hhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC---Ccccccc-----------ch--h
Q 011196 346 EYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG---HAAELMD-----------SV--V 408 (491)
Q Consensus 346 E~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d-----------~~--l 408 (491)
|.+.+. .++.++||||||++++++++|+.||...+ ..+............ .+....+ .. .
T Consensus 168 E~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (283)
T cd05118 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS---EIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMP 244 (283)
T ss_pred HHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccC
Confidence 998876 68899999999999999999998874322 111111111111110 0000000 00 0
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 409 KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
...........+.+++.+||+.||.+||++++++.
T Consensus 245 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 245 LPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00011123456789999999999999999999886
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=184.81 Aligned_cols=182 Identities=18% Similarity=0.240 Sum_probs=118.5
Q ss_pred eeeeecccccCCCCccccCC-CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 243 IRYELYRFLVDTPTVTVTAP-NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
..|.+..|..++.+...... .........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv-------HrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI-------HRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEE-------eCCCCHHHEEECCCCCEEEEeCCce
Confidence 34556666655544322211 122334455677888889999987777 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhC----CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEG----IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...........
T Consensus 190 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~ 262 (371)
T cd05622 190 MKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKIMNH 262 (371)
T ss_pred eEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC------HHHHHHHHHcC
Confidence 876432211 12345799999999998753 37899999999999999999999975321 11111111111
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHh
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMD--RPTMSSVAVML 445 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~L 445 (491)
.......+ .......+.+++.+|++.++.+ ||++.|++++.
T Consensus 263 ~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 263 KNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11111111 0112234566788899844433 78999988864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.81 E-value=4e-20 Score=181.56 Aligned_cols=157 Identities=22% Similarity=0.226 Sum_probs=113.4
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++........ .....|+..|+|
T Consensus 100 ~~~~~~~~~~ql~~~l~~lH~~~ii-------H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~a 169 (285)
T cd05632 100 EEERALFYAAEILCGLEDLHRENTV-------YRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMA 169 (285)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCee-------ecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCCcCccC
Confidence 3455677888899999999988776 999999999999999999999999976533221 123468999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||++.+..++.++|+||||+++||+++|..||..... ......+........ . .. .......+.+|+
T Consensus 170 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~---~~~~~~~~~~~~~~~-~-----~~----~~~~~~~~~~li 236 (285)
T cd05632 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE---KVKREEVDRRVLETE-E-----VY----SAKFSEEAKSIC 236 (285)
T ss_pred hHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhhhccc-c-----cc----CccCCHHHHHHH
Confidence 9999888899999999999999999999999753211 111111111111110 0 01 111123456788
Q ss_pred HHcccCCCCCCCC-----HHHHHHH
Q 011196 425 LLCVQEDPMDRPT-----MSSVAVM 444 (491)
Q Consensus 425 ~~cl~~dP~~RPs-----~~evl~~ 444 (491)
.+||+.||++||+ +.+++.+
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcC
Confidence 9999999999999 6676653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-21 Score=179.68 Aligned_cols=143 Identities=22% Similarity=0.332 Sum_probs=101.6
Q ss_pred eEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhhh--CCCCcccceeehhHH
Q 011196 288 FLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME--GIFSVKSDVFSFGVV 365 (491)
Q Consensus 288 ~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvv 365 (491)
++....+|||||+||+|||++..|.+||+|||.+-.+...-. .+.-.|...|||||-+.. ..|+.++||||+|++
T Consensus 182 yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGIT 258 (361)
T KOG1006|consen 182 YLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGIT 258 (361)
T ss_pred HHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcce
Confidence 333445667999999999999999999999999865532221 223478899999998863 348999999999999
Q ss_pred HHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 366 LLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 366 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
|+|+.||..|+..+.. ..+++.. ...+..+.+..+.- ..+....+..++..|+.+|-.+||...++.+
T Consensus 259 L~EvAtG~fPyr~w~s-----vfeql~~-Vv~gdpp~l~~~~~----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 259 LYEVATGNFPYRKWDS-----VFEQLCQ-VVIGDPPILLFDKE----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred EeeeecCCCCcchHHH-----HHHHHHH-HHcCCCCeecCccc----ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 9999999999753322 2333222 23333333322211 1123456778889999999999999988765
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.3e-20 Score=181.51 Aligned_cols=168 Identities=18% Similarity=0.181 Sum_probs=115.3
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.....+.++.+++.++.+||..+++ |+||||+||+++.++.+||+|||+++........ .....++..|+|
T Consensus 100 ~~~~~~~~~~qi~~al~~lH~~~i~-------H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~a 170 (298)
T cd07841 100 TPADIKSYMLMTLRGLEYLHSNWIL-------HRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRA 170 (298)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCee-------ecCCChhhEEEcCCCCEEEccceeeeeccCCCcc--ccccccceeeeC
Confidence 3555677888999999999998877 9999999999999999999999999876443221 122356788999
Q ss_pred hhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC---------CccccccchhcCCCC-
Q 011196 345 PEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG---------HAAELMDSVVKQSCD- 413 (491)
Q Consensus 345 PE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~d~~l~~~~~- 413 (491)
||.+.+ ..++.++||||||++++|+++|.++|... ................ ..............+
T Consensus 171 PE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
T cd07841 171 PELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD---SDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPL 247 (298)
T ss_pred HHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC---ccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcch
Confidence 998865 45789999999999999999997765422 1112222221111000 000010000000111
Q ss_pred ----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 414 ----QAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 414 ----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
......+.+++.+||+.||++||++.||+++
T Consensus 248 ~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 248 KQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1224567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-20 Score=183.02 Aligned_cols=178 Identities=19% Similarity=0.250 Sum_probs=120.9
Q ss_pred eeeecccccCCCCcccc------CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEec
Q 011196 244 RYELYRFLVDTPTVTVT------APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISD 317 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~D 317 (491)
.|.+++|+.+++..... .........+.++.+++.++.++|..+++ ||||||+||+++.++.+||+|
T Consensus 99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv-------H~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRII-------HRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee-------ccCCCHHHEEEcCCCCEEEee
Confidence 45666666654432211 11223445666788888888999887666 999999999999999999999
Q ss_pred cCcceecCCCCcccccCceeecCCCChhhhhhhCC-----CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHH
Q 011196 318 FGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI-----FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIW 392 (491)
Q Consensus 318 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 392 (491)
||++......... .....|+..|+|||++.... ++.++||||||+++|||++|+.|+.... ......
T Consensus 172 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~------~~~~~~ 243 (291)
T cd06639 172 FGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH------PVKTLF 243 (291)
T ss_pred cccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc------HHHHHH
Confidence 9998765432211 12346788999999986433 6789999999999999999999974221 111111
Q ss_pred HHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 393 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 393 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
. +.......+.+ +.+....+.+++.+||+.||++||++.|++++
T Consensus 244 ~-~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 K-IPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H-HhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 11111111111 11222357789999999999999999998864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=177.52 Aligned_cols=185 Identities=22% Similarity=0.304 Sum_probs=123.7
Q ss_pred ceeeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 242 SIRYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 242 ~lry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
..+|.+++|+.++....... ..........++.+++.++.+||.. .+++||||||+||+++.++.++|+|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~------~~i~H~dl~p~nil~~~~~~~~l~d~g 149 (284)
T cd06620 76 NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV------HRIMHRDIKPSNILVNSRGQIKLCDFG 149 (284)
T ss_pred CEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHh------cCeeccCCCHHHEEECCCCcEEEccCC
Confidence 34567777776554422211 1122344556677777778888752 224599999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCc-----ccHHHHHHHH
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHG-----PSLLAYIWKL 394 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~-----~~~~~~~~~~ 394 (491)
++....... .....|+..|+|||++.++.++.++||||||++++|+++|+.||........ ..........
T Consensus 150 l~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd06620 150 VSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI 225 (284)
T ss_pred cccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH
Confidence 986542221 2235689999999999888899999999999999999999999864332211 1111111111
Q ss_pred hhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 011196 395 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445 (491)
Q Consensus 395 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 445 (491)
.. ..... +. ..+....+.+++.+||+.||++||++.||+++.
T Consensus 226 ~~-~~~~~-----~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 226 VQ-EPPPR-----LP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hh-ccCCC-----CC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11 11000 00 011234577899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=191.69 Aligned_cols=153 Identities=20% Similarity=0.279 Sum_probs=115.3
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC-CCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE-MNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~-~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
+..+.+..++..++.|||. ++.+|||||||-+||+|+.+ |.+||+|+|||....... ....+||+.||||
T Consensus 143 kaik~W~RQILkGL~yLHs-----~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~----aksvIGTPEFMAP 213 (632)
T KOG0584|consen 143 KAIKSWCRQILKGLVYLHS-----QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH----AKSVIGTPEFMAP 213 (632)
T ss_pred HHHHHHHHHHHHHhhhhhc-----CCCCccccccccceEEEcCCcCceeecchhHHHHhhccc----cceeccCccccCh
Confidence 3456788888888888888 67789999999999999876 889999999998764332 3347899999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|+.. ..|+..+||||||+.++||+|+.-|+.-.. + ...+++....|.-+.-+... .. .++.+|+.
T Consensus 214 EmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--n----~AQIYKKV~SGiKP~sl~kV-----~d---Pevr~fIe 278 (632)
T KOG0584|consen 214 EMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT--N----PAQIYKKVTSGIKPAALSKV-----KD---PEVREFIE 278 (632)
T ss_pred HHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC--C----HHHHHHHHHcCCCHHHhhcc-----CC---HHHHHHHH
Confidence 9986 679999999999999999999999964221 1 12333444444333222221 11 23456788
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 011196 426 LCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~ 444 (491)
+|+.. .++|||+.|+++.
T Consensus 279 kCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 279 KCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHhcC-chhccCHHHHhhC
Confidence 99999 9999999998863
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.1e-20 Score=178.86 Aligned_cols=157 Identities=24% Similarity=0.353 Sum_probs=112.7
Q ss_pred CcchhhhHhHHHHHHHHHhh-eeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLS-TSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.++|. .+++ |+||||+||+++.++.+||+|||.+......... ...++..|++
T Consensus 99 ~~~~~~~~~~l~~~l~~lH~~~~i~-------H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~y~~ 167 (265)
T cd06605 99 ERILGKIAVAVLKGLTYLHEKHKII-------HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK----TFVGTSSYMA 167 (265)
T ss_pred HHHHHHHHHHHHHHHHHHcCCCCee-------cCCCCHHHEEECCCCCEEEeecccchhhHHHHhh----cccCChhccC
Confidence 34455677788888888888 6666 9999999999999999999999998755322111 1567889999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHH-HHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA-ELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~~~~l 423 (491)
||++.+..++.++||||||++++++++|+.|+...... .......... ........+ +.. ....+.++
T Consensus 168 PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~-~~~~~~~~~---------~~~~~~~~~~~l 236 (265)
T cd06605 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQY-IVNEPPPRL---------PSGKFSPDFQDF 236 (265)
T ss_pred HHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHH-HhcCCCCCC---------ChhhcCHHHHHH
Confidence 99998888999999999999999999999997533211 1112222211 111111111 111 23346788
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 011196 424 GLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~ 444 (491)
+.+||..||++||++.+++.+
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 237 VNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHcCCCchhCcCHHHHhhC
Confidence 999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.8e-20 Score=179.18 Aligned_cols=154 Identities=19% Similarity=0.326 Sum_probs=114.4
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..++. |+||+|+||+++.++.++|+|||++......... .....|+..|+||
T Consensus 100 ~~~~~~~~~~l~~~l~~lh~~~i~-------h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p 170 (256)
T cd08218 100 EDQILDWFVQICLALKHVHDRKIL-------HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--ARTCIGTPYYLSP 170 (256)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEe-------cCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--hhhccCCccccCH
Confidence 344566788889999999987766 9999999999999999999999999765432221 2234678899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|++.+..++.++|+||||++++|+++|+.|+... +......... .+.... .+......+.+++.
T Consensus 171 e~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~------~~~~~~~~~~-~~~~~~---------~~~~~~~~~~~li~ 234 (256)
T cd08218 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG------NMKNLVLKII-RGSYPP---------VSSHYSYDLRNLVS 234 (256)
T ss_pred HHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC------CHHHHHHHHh-cCCCCC---------CcccCCHHHHHHHH
Confidence 9998888999999999999999999999996421 1111121111 111111 11122345778999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 011196 426 LCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~ 444 (491)
+||+.+|++||++.+|+++
T Consensus 235 ~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 235 QLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHhhCChhhCcCHHHHhhC
Confidence 9999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.4e-20 Score=183.75 Aligned_cols=128 Identities=13% Similarity=0.195 Sum_probs=91.4
Q ss_pred eeeecccccCCCCccccC----CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 244 RYELYRFLVDTPTVTVTA----PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
.|.+++|+..+....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+++.||+
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ii-------H~dlkp~Nil~~~~~~~~l~~~~ 146 (327)
T cd08227 74 LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYV-------HRSVKASHILISVDGKVYLSGLR 146 (327)
T ss_pred EEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEe-------cCCCChhhEEEecCCcEEEcccc
Confidence 345556655444322211 1123455667888899999999988776 99999999999999999999998
Q ss_pred cceecCCCCc-c----cccCceeecCCCChhhhhhh--CCCCcccceeehhHHHHHHHhCCCCCCC
Q 011196 320 MARIFGGNQS-E----ANTNRVVGTYGYMAPEYAME--GIFSVKSDVFSFGVVLLEIISGKKSSGF 378 (491)
Q Consensus 320 la~~~~~~~~-~----~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvvl~elltG~~p~~~ 378 (491)
.......... . .......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 147 SNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred hhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 6543321110 0 01112346778999999976 3588999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.9e-20 Score=183.51 Aligned_cols=179 Identities=13% Similarity=0.127 Sum_probs=121.9
Q ss_pred eeeeecccccCCCCccccCC----CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEecc
Q 011196 243 IRYELYRFLVDTPTVTVTAP----NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDF 318 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~Df 318 (491)
..|.++.|..+......... .........++.+++.++.+||..+++ ||||||+||+++.++.++|+||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~-------H~dlkp~Nili~~~~~~~l~df 147 (316)
T cd05574 75 YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV-------YRDLKPENILLHESGHIMLSDF 147 (316)
T ss_pred EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCee-------ccCCChHHeEEcCCCCEEEeec
Confidence 44566666655544332211 122344556778899999999988777 9999999999999999999999
Q ss_pred CcceecCCCCcc---------------------------cccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh
Q 011196 319 GMARIFGGNQSE---------------------------ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS 371 (491)
Q Consensus 319 Gla~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt 371 (491)
|++......... .......|+..|+|||++.+..++.++||||||+++|+|++
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~ 227 (316)
T cd05574 148 DLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227 (316)
T ss_pred chhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhh
Confidence 998754321110 01123468889999999998889999999999999999999
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 011196 372 GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT----MSSVAV 443 (491)
Q Consensus 372 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs----~~evl~ 443 (491)
|+.||..... .... .... .... ...........+.+++.+||+.||++||+ +.|++.
T Consensus 228 g~~pf~~~~~---~~~~---~~~~-~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 228 GTTPFKGSNR---DETF---SNIL-KKEV--------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCCCCCch---HHHH---HHHh-cCCc--------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 9999753211 1111 1111 1100 00001113356778999999999999999 666666
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.1e-20 Score=177.07 Aligned_cols=155 Identities=21% Similarity=0.311 Sum_probs=113.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc----cccCceeecCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE----ANTNRVVGTYG 341 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~----~~~~~~~gt~~ 341 (491)
......++.+++.++.++|..+++ ||||||+||++++++.+||+|||+++........ .......|+..
T Consensus 105 ~~~~~~~~~~l~~~l~~lH~~~iv-------H~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (267)
T cd06628 105 ETLVRNFVRQILKGLNYLHNRGII-------HRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177 (267)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCcc-------cccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcC
Confidence 344556788888999999988776 9999999999999999999999999866422111 11123457889
Q ss_pred CChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 342 YMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 342 y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
|+|||.+.+..++.++||||||+++|||++|+.||.... . ...+.... .. ..+ ..+......+.
T Consensus 178 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~---~~~~~~~~-~~-----~~~----~~~~~~~~~~~ 241 (267)
T cd06628 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT---Q---LQAIFKIG-EN-----ASP----EIPSNISSEAI 241 (267)
T ss_pred ccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc---H---HHHHHHHh-cc-----CCC----cCCcccCHHHH
Confidence 999999988889999999999999999999999975321 1 11111111 11 011 11112234567
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~ 443 (491)
+++.+||+.||++||++.||++
T Consensus 242 ~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 242 DFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhh
Confidence 7889999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=192.70 Aligned_cols=180 Identities=16% Similarity=0.212 Sum_probs=115.6
Q ss_pred eeeecccccCCCCccccCC--CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTAP--NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++.+...... .........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv-------HrDlkp~Nill~~~~~ikL~DFG~a 148 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFI-------HRDIKPDNILIDRDGHIKLTDFGLC 148 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------eCCCCHHHEEECCCCCEEEEeCCCC
Confidence 3455566655544332211 122334455677888999999988777 9999999999999999999999997
Q ss_pred eecCCCC-----------------------------------------cccccCceeecCCCChhhhhhhCCCCccccee
Q 011196 322 RIFGGNQ-----------------------------------------SEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360 (491)
Q Consensus 322 ~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVw 360 (491)
..+.... .........||+.|+|||++.+..++.++|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 228 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 228 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeee
Confidence 5321000 00011235799999999999988899999999
Q ss_pred ehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC---C
Q 011196 361 SFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP---T 437 (491)
Q Consensus 361 S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP---s 437 (491)
||||++|||++|+.||..... ......+ ..+... ..+ +. .... ...+.+++.+|+ .+|++|+ +
T Consensus 229 SlGvilyell~G~~Pf~~~~~---~~~~~~i-~~~~~~--~~~--~~-~~~~----s~~~~~li~~l~-~~p~~R~~~~t 294 (376)
T cd05598 229 SVGVILYEMLVGQPPFLADTP---AETQLKV-INWETT--LHI--PS-QAKL----SREASDLILRLC-CGAEDRLGKNG 294 (376)
T ss_pred eccceeeehhhCCCCCCCCCH---HHHHHHH-hccCcc--ccC--CC-CCCC----CHHHHHHHHHHh-cCHhhcCCCCC
Confidence 999999999999999753221 1111111 111100 000 00 0111 223455666665 5999999 8
Q ss_pred HHHHHHH
Q 011196 438 MSSVAVM 444 (491)
Q Consensus 438 ~~evl~~ 444 (491)
+.|++++
T Consensus 295 ~~ell~h 301 (376)
T cd05598 295 ADEIKAH 301 (376)
T ss_pred HHHHhCC
Confidence 8887765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.8e-20 Score=179.24 Aligned_cols=178 Identities=18% Similarity=0.283 Sum_probs=120.0
Q ss_pred eeeeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 243 IRYELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
..|.++.|+.+....... ...........++.+++.++.++|..+++ ||||||+||+++.++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~-------H~dlkp~Nili~~~~~~kl~dfg 155 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKII-------HRDLKAGNVLLTLDGDIKLADFG 155 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCee-------ecCCCcceEEEcCCCCEEEccCc
Confidence 345566666555432211 11223455667788888888888887766 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhh-----hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHH
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAM-----EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKL 394 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 394 (491)
++........ ......++..|+|||++. ...++.++||||||+++|||++|..|+..... ......
T Consensus 156 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~- 226 (292)
T cd06644 156 VSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLK- 226 (292)
T ss_pred cceecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHH-
Confidence 9875432211 122356788999999985 34478899999999999999999999743221 111111
Q ss_pred hhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 395 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 395 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
........... +......+.+++.+||+.||++||++.++++
T Consensus 227 ~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 227 IAKSEPPTLSQ-------PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HhcCCCccCCC-------CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11111111111 1122235678999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-20 Score=181.12 Aligned_cols=166 Identities=19% Similarity=0.244 Sum_probs=116.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC--------------------CCCceEeccCcceecC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH--------------------EMNPKISDFGMARIFG 325 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~--------------------~~~~kl~DfGla~~~~ 325 (491)
......+..|+...+.+||...+. |-||||+|||+.. +..+||+|||.+....
T Consensus 191 i~~ir~m~~QL~~sv~fLh~~kl~-------HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~ 263 (415)
T KOG0671|consen 191 IDHIRHMGYQLLESVAFLHDLKLT-------HTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH 263 (415)
T ss_pred hHHHHHHHHHHHHHHHHHHhccee-------ecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceec
Confidence 344566788888888888888887 9999999999832 2357999999998643
Q ss_pred CCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHH------------
Q 011196 326 GNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWK------------ 393 (491)
Q Consensus 326 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~------------ 393 (491)
... ...+.|..|+|||++.+..|+.+.||||+||||.|+.+|...|......+...+.+.+..
T Consensus 264 e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~ 338 (415)
T KOG0671|consen 264 EHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRK 338 (415)
T ss_pred cCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhh
Confidence 322 346789999999999999999999999999999999999988764432221122222211
Q ss_pred --HhhcCCc--ccc---------cc---ch-hcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 394 --LWCEGHA--AEL---------MD---SV-VKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 394 --~~~~~~~--~~~---------~d---~~-l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+..+.+ .+. .+ +. ........+..++++|+.+||..||.+|+|++|++.
T Consensus 339 ~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 339 EKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 1111100 000 00 00 011223466778999999999999999999999875
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-19 Score=179.69 Aligned_cols=170 Identities=17% Similarity=0.213 Sum_probs=112.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCc-----ccccCceeecC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQS-----EANTNRVVGTY 340 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~-----~~~~~~~~gt~ 340 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||.+........ ........++.
T Consensus 100 ~~~~~~~~~~l~~~L~~LH~~~iv-------H~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (314)
T cd08216 100 ELAIAFILKDVLNALDYIHSKGFI-------HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172 (314)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------cCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccc
Confidence 344566788899999999988776 999999999999999999999998875432111 11122345677
Q ss_pred CCChhhhhhhC--CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHh----hcC-------Cccc----c
Q 011196 341 GYMAPEYAMEG--IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLW----CEG-------HAAE----L 403 (491)
Q Consensus 341 ~y~aPE~~~~~--~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~----~~~-------~~~~----~ 403 (491)
.|+|||++... .++.++||||||+++|||++|+.||..... .....+...... ... .... .
T Consensus 173 ~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T cd08216 173 PWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA--TQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250 (314)
T ss_pred cccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence 89999998763 478999999999999999999999753211 111111110000 000 0000 0
Q ss_pred ccchh----cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 404 MDSVV----KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 404 ~d~~l----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.++.. ...........+.+++.+||+.||++|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 001112223467789999999999999999998864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-20 Score=180.32 Aligned_cols=172 Identities=20% Similarity=0.234 Sum_probs=115.7
Q ss_pred eeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC-------Cc
Q 011196 244 RYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM-------NP 313 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~-------~~ 313 (491)
.|.++.|..++....... ..........++.+++.++.++|..+++ ||||||+|||++..+ .+
T Consensus 91 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ii-------H~dlkp~Nill~~~~~~~~~~~~~ 163 (274)
T cd05076 91 NIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLV-------HGNVCAKNILLARLGLAEGTSPFI 163 (274)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCcc-------CCCCCcccEEEeccCcccCcccee
Confidence 345566665554322211 1122445667888899999999987666 999999999997654 37
Q ss_pred eEeccCcceecCCCCcccccCceeecCCCChhhhhhh-CCCCcccceeehhHHHHHHH-hCCCCCCCccCCCcccHHHHH
Q 011196 314 KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME-GIFSVKSDVFSFGVVLLEII-SGKKSSGFYHLEHGPSLLAYI 391 (491)
Q Consensus 314 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvvl~ell-tG~~p~~~~~~~~~~~~~~~~ 391 (491)
|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.|+...... .... .
T Consensus 164 kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~-~ 233 (274)
T cd05076 164 KLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS---EKER-F 233 (274)
T ss_pred eecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH---HHHH-H
Confidence 99999987643221 12356788999998875 45889999999999999995 688886432111 1111 1
Q ss_pred HHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 011196 392 WKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 392 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 446 (491)
.. ..... +......+.+++.+||+.+|++||++.+|++.|+
T Consensus 234 ~~--~~~~~------------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 234 YE--KKHRL------------PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH--hccCC------------CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 00 00000 0111234678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.5e-20 Score=183.74 Aligned_cols=181 Identities=14% Similarity=0.181 Sum_probs=116.8
Q ss_pred eeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.++.|+.++....... ..........++.+++.++.++|..+++ ||||||+|||++.++.+||+|||+
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ii-------HrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYV-------HRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------ecCCCHHHEEECCCCCEEEeecch
Confidence 456666666555433321 1122334556778888899999988777 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhh-----hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHh
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAM-----EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLW 395 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 395 (491)
++........ ......||+.|+|||++. .+.++.++|||||||++|||++|+.||... ..........
T Consensus 149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~------~~~~~~~~i~ 221 (332)
T cd05623 149 CLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE------SLVETYGKIM 221 (332)
T ss_pred heecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC------CHHHHHHHHh
Confidence 8765332221 122357899999999986 345889999999999999999999997522 1111111111
Q ss_pred hcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCC--CCCCCHHHHHHH
Q 011196 396 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDP--MDRPTMSSVAVM 444 (491)
Q Consensus 396 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP--~~RPs~~evl~~ 444 (491)
.......+ +.. .......+.+++.+|+..++ ..|+++.|++++
T Consensus 222 ~~~~~~~~--p~~----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 222 NHKERFQF--PAQ----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCccccC--CCc----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11110000 000 01112345567777775544 346888888766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-20 Score=182.13 Aligned_cols=168 Identities=21% Similarity=0.215 Sum_probs=113.8
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.....+.++.+++.++.+||..++. |+||||+||++++++.+||+|||++........ ......++..|+|
T Consensus 98 ~~~~~~~~~~~i~~~l~~LH~~~i~-------h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~a 168 (286)
T cd07846 98 DESRVRKYLFQILRGIEFCHSHNII-------HRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRA 168 (286)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcc-------ccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccCcccceeeccC
Confidence 3556677888899999999987766 999999999999999999999999886543321 1223567889999
Q ss_pred hhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC--Cccc----------cccchhcCC
Q 011196 345 PEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG--HAAE----------LMDSVVKQS 411 (491)
Q Consensus 345 PE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~----------~~d~~l~~~ 411 (491)
||++.+ ..++.++||||||+++|||++|++||.... ..............- ...+ ...+.....
T Consensus 169 PE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (286)
T cd07846 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS---DIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEI 245 (286)
T ss_pred cHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc---hHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCc
Confidence 999875 347889999999999999999998874221 111111111100000 0000 000000000
Q ss_pred -----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 412 -----CDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 412 -----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
........+.+++.+||+.+|++||++.++++.
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 246 EPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred chHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 011223557889999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=174.29 Aligned_cols=157 Identities=29% Similarity=0.418 Sum_probs=114.4
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.++|..++. ||||||+||+++.++.+||+|||+++........... ...++..|++
T Consensus 101 ~~~~~~~~~~ql~~~l~~lh~~~~~-------h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~ 172 (258)
T smart00219 101 SLSDLLSFALQIARGMEYLESKNFI-------HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMA 172 (258)
T ss_pred CHHHHHHHHHHHHHHHHHHhcCCee-------ecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccC
Confidence 3455667788888888888887766 9999999999999999999999999876543222211 2236789999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||.+.+..++.++||||+|++++||++ |..|+.. .......... ........ +.....++.++
T Consensus 173 Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~---~~~~~~~~~~----~~~~~~~~---------~~~~~~~~~~~ 236 (258)
T smart00219 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG---MSNEEVLEYL----KKGYRLPK---------PENCPPEIYKL 236 (258)
T ss_pred hHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHH----hcCCCCCC---------CCcCCHHHHHH
Confidence 999988889999999999999999998 7777542 1111222211 11111111 11123457789
Q ss_pred HHHcccCCCCCCCCHHHHHHHh
Q 011196 424 GLLCVQEDPMDRPTMSSVAVML 445 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L 445 (491)
+.+||+.||++|||+.|+++.|
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHCcCChhhCcCHHHHHhhC
Confidence 9999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-20 Score=186.69 Aligned_cols=166 Identities=20% Similarity=0.199 Sum_probs=115.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++....... ......++..|+||
T Consensus 107 ~~~~~~i~~qi~~aL~~LH~~~i~-------H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~y~aP 177 (337)
T cd07858 107 DDHCQYFLYQLLRGLKYIHSANVL-------HRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYRAP 177 (337)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEe-------cCCCCHHHEEEcCCCCEEECcCccccccCCCcc--cccccccccCccCh
Confidence 445667888888999999988776 999999999999999999999999986543221 12234678899999
Q ss_pred hhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc-----------CCccccc-------cc
Q 011196 346 EYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE-----------GHAAELM-------DS 406 (491)
Q Consensus 346 E~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~-------d~ 406 (491)
|.+.. ..++.++||||||+++++|++|+.||..... ............. ....+.+ ++
T Consensus 178 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (337)
T cd07858 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY---VHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQ 254 (337)
T ss_pred HHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCccccc
Confidence 99875 4688999999999999999999999753211 1111111111110 0000000 00
Q ss_pred hhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 407 VVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 407 ~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.... ........+.+++.+||+.||++||++.+++++
T Consensus 255 ~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 255 SFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000 011223557889999999999999999999877
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-20 Score=182.11 Aligned_cols=168 Identities=19% Similarity=0.220 Sum_probs=115.3
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.....+.++.+++.++.+||..++. |+||||+||++++++.+||+|||++.......... .....++..|+|
T Consensus 98 ~~~~~~~i~~~i~~al~~LH~~~~~-------h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~ 169 (287)
T cd07840 98 TESQIKCYMKQLLEGLQYLHSNGIL-------HRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD-YTNRVITLWYRP 169 (287)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCce-------eccCcHHHeEEcCCCCEEEccccceeeccCCCccc-ccccccccccCC
Confidence 3455677888899999999987776 99999999999999999999999998764433211 122356788999
Q ss_pred hhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC---Ccccc--------------ccc
Q 011196 345 PEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG---HAAEL--------------MDS 406 (491)
Q Consensus 345 PE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--------------~d~ 406 (491)
||.+.+ ..++.++||||||+++|||++|+.|+.... .......+....... .+... ...
T Consensus 170 PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (287)
T cd07840 170 PELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST---ELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKR 246 (287)
T ss_pred ceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCchhhccccccchhhhhccccccchh
Confidence 998765 457899999999999999999999975322 112222221111110 00000 000
Q ss_pred hhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 407 VVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 407 ~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+.......+...+.+++.+||+.||++||++.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 247 RLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred HHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0111111112456789999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.9e-20 Score=178.23 Aligned_cols=160 Identities=22% Similarity=0.353 Sum_probs=115.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCccc--ccCceeecCCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEA--NTNRVVGTYGYM 343 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~ 343 (491)
......+..+++.++.+||..++. ||||||+||++++++.+||+|||++.......... ......|+..|+
T Consensus 101 ~~~~~~~~~ql~~al~~lh~~~i~-------h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~ 173 (267)
T cd06610 101 EAIIATVLKEVLKGLEYLHSNGQI-------HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173 (267)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhc
Confidence 445667788888999999988777 99999999999999999999999987664432221 223356889999
Q ss_pred hhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCC-CHHHHHHHH
Q 011196 344 APEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC-DQAELLKYI 421 (491)
Q Consensus 344 aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~~ 421 (491)
+||++... .++.++|+||||++++||++|+.||...... .. ........ .. .+.... .......+.
T Consensus 174 ~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~---~~~~~~~~-~~-----~~~~~~~~~~~~~~~~ 241 (267)
T cd06610 174 APEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KV---LMLTLQND-PP-----SLETGADYKKYSKSFR 241 (267)
T ss_pred ChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hh---HHHHhcCC-CC-----CcCCccccccccHHHH
Confidence 99999877 7899999999999999999999997532211 11 11111111 00 111000 012234567
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
+++.+||+.||++||++.+|+++
T Consensus 242 ~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 242 KMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred HHHHHHcCCChhhCcCHHHHhhC
Confidence 89999999999999999998863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.9e-20 Score=181.40 Aligned_cols=168 Identities=20% Similarity=0.199 Sum_probs=116.4
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++....... ......++..|+|
T Consensus 104 ~~~~~~~i~~qi~~aL~~LH~~~i~-------H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~a 174 (293)
T cd07843 104 LQSEVKCLMLQLLSGVAHLHDNWIL-------HRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRA 174 (293)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCee-------eccCCHHHEEECCCCcEEEeecCceeeccCCcc--ccccccccccccC
Confidence 3556677888999999999998777 999999999999999999999999987654321 1223456889999
Q ss_pred hhhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh-----------c------CCccccccc
Q 011196 345 PEYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC-----------E------GHAAELMDS 406 (491)
Q Consensus 345 PE~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----------~------~~~~~~~d~ 406 (491)
||.+.+.. ++.++||||||++++||++|..||..... ......+...+. . .........
T Consensus 175 PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (293)
T cd07843 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE---IDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYN 251 (293)
T ss_pred chhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCchHHHHHhhccchhcccccccccch
Confidence 99987644 68899999999999999999999753321 111111111110 0 000011111
Q ss_pred hhcCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 407 VVKQSCDQA-ELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 407 ~l~~~~~~~-~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.+...++.. ....+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 252 QLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111112211 24456789999999999999999998863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=181.28 Aligned_cols=182 Identities=15% Similarity=0.189 Sum_probs=117.5
Q ss_pred eeeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 243 IRYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
..|.++.|..++.+..... ..........++.+++.++.++|..+++ ||||||+|||++.++.+||+|||
T Consensus 75 ~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~ii-------HrDlkp~Nill~~~~~~kl~DfG 147 (331)
T cd05624 75 YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYV-------HRDIKPDNVLLDMNGHIRLADFG 147 (331)
T ss_pred EEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee-------eccCchHHEEEcCCCCEEEEecc
Confidence 3456666666554433321 1122344556677888889999887777 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhh-----CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHH
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAME-----GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKL 394 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 394 (491)
+++........ ......|++.|+|||++.+ +.++.++||||||+++|||++|+.||.... ........
T Consensus 148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~------~~~~~~~i 220 (331)
T cd05624 148 SCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKI 220 (331)
T ss_pred ceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC------HHHHHHHH
Confidence 99866433221 1223568999999999875 467889999999999999999999974221 11111111
Q ss_pred hhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 011196 395 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMD--RPTMSSVAVM 444 (491)
Q Consensus 395 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~ 444 (491)
........+ .+.. ......+.+++.+|+..++++ |+++++++++
T Consensus 221 ~~~~~~~~~-p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 221 MNHEERFQF-PSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HcCCCcccC-CCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111110000 0100 011234666778888765544 4678877754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=175.90 Aligned_cols=160 Identities=23% Similarity=0.301 Sum_probs=113.1
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
.....++.+++.++.++|..+++ ||||||+||+++.++.+||+|||+++...............|+..|++||
T Consensus 108 ~~~~~~~~qi~~~l~~lH~~~i~-------H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE 180 (272)
T cd06629 108 QLVRFFTEQVLEGLAYLHSKGIL-------HRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180 (272)
T ss_pred HHHHHHHHHHHHHHHHHhhCCee-------ecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHH
Confidence 34556778888889999987766 99999999999999999999999997654322222223356788999999
Q ss_pred hhhhCC--CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 347 YAMEGI--FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 347 ~~~~~~--~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
++.... ++.++|+||||+++||+++|..|+... ................. +... ........+.+++
T Consensus 181 ~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~------~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~li 249 (272)
T cd06629 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE------EAIAAMFKLGNKRSAPP-IPPD----VSMNLSPVALDFL 249 (272)
T ss_pred HhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc------chHHHHHHhhccccCCc-CCcc----ccccCCHHHHHHH
Confidence 987654 789999999999999999999997421 11111222111111111 1111 1112234577789
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 011196 425 LLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~ 444 (491)
.+||+.+|++||++.+|+++
T Consensus 250 ~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 250 NACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHhcCChhhCCCHHHHhhC
Confidence 99999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-20 Score=187.34 Aligned_cols=169 Identities=20% Similarity=0.206 Sum_probs=114.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc---cccCceeecCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE---ANTNRVVGTYGY 342 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~---~~~~~~~gt~~y 342 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++......... .......|+..|
T Consensus 106 ~~~~~~i~~qi~~~L~~LH~~~i~-------H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y 178 (337)
T cd07852 106 DVHKRYIMYQLLKALKYIHSGNVI-------HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178 (337)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccc
Confidence 445566788889999999988777 9999999999999999999999999865432221 122345688999
Q ss_pred Chhhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHh-----------hcCCccccccchhcC
Q 011196 343 MAPEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLW-----------CEGHAAELMDSVVKQ 410 (491)
Q Consensus 343 ~aPE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~d~~l~~ 410 (491)
+|||++.+ ..++.++||||||+++|||++|+.||...... .......... ......++++.....
T Consensus 179 ~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (337)
T cd07852 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL---NQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSR 255 (337)
T ss_pred cCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccc
Confidence 99998765 45788999999999999999999997532211 1111111110 000000011000000
Q ss_pred ------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 411 ------SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 411 ------~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.........+.+++.+||+.||++|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 256 PRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred cccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000123457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-20 Score=207.76 Aligned_cols=154 Identities=17% Similarity=0.174 Sum_probs=105.4
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC-------------------CCCceEeccCcceecCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH-------------------EMNPKISDFGMARIFGG 326 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~-------------------~~~~kl~DfGla~~~~~ 326 (491)
....+.++.+++.++.|+|..+++ ||||||+||||+. ++.+|++|||+++....
T Consensus 79 ~~~~~~i~~qi~~al~~lH~~gIv-------HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~ 151 (793)
T PLN00181 79 AFECFHVFRQIVEIVNAAHSQGIV-------VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEI 151 (793)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------eccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccccc
Confidence 456777888999999999988777 9999999999954 44567777777654211
Q ss_pred CCc--------c------cccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHH
Q 011196 327 NQS--------E------ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIW 392 (491)
Q Consensus 327 ~~~--------~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 392 (491)
... . .......||+.|||||++.+..++.++|||||||++|||++|..|+... .......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~-----~~~~~~~- 225 (793)
T PLN00181 152 LSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK-----SRTMSSL- 225 (793)
T ss_pred ccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH-----HHHHHHH-
Confidence 000 0 0011245788999999999999999999999999999999988774210 0111111
Q ss_pred HHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 393 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 393 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
... ...+.. .....+...++.+||+.||++||++.||+++
T Consensus 226 ---~~~----~~~~~~-----~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 226 ---RHR----VLPPQI-----LLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred ---HHh----hcChhh-----hhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 000 011110 1112334577889999999999999999763
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-19 Score=175.25 Aligned_cols=157 Identities=17% Similarity=0.282 Sum_probs=113.4
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..++. |+||||+||+++.++.+||+|||++........ ......++..|++|
T Consensus 100 ~~~~~~~~~ql~~~l~~lh~~~i~-------h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~P 170 (262)
T cd06613 100 ELQIAYVCRETLKGLAYLHETGKI-------HRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAP 170 (262)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCce-------ecCCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCc
Confidence 455667888888889999887766 999999999999999999999999876543221 12235678899999
Q ss_pred hhhhhC---CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHH
Q 011196 346 EYAMEG---IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 346 E~~~~~---~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
|.+.+. .++.++||||||+++|||++|+.|+..... ........... ...+.+ .........+.+
T Consensus 171 e~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~------~~~~~~~~~~~----~~~~~~--~~~~~~~~~~~~ 238 (262)
T cd06613 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP------MRALFLISKSN----FPPPKL--KDKEKWSPVFHD 238 (262)
T ss_pred hhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcc----CCCccc--cchhhhhHHHHH
Confidence 998776 788999999999999999999999743211 01111111110 000111 011223456788
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 011196 423 IGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~ 443 (491)
++.+||+.||.+||++.+|+.
T Consensus 239 li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 239 FIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHcCCChhhCCCHHHHhc
Confidence 999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-19 Score=173.25 Aligned_cols=156 Identities=22% Similarity=0.366 Sum_probs=114.2
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.++|..++. |+||||+||++++++.+||+|||.+........ .....++..|++
T Consensus 96 ~~~~~~~i~~~i~~~l~~lh~~~i~-------h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~ 165 (253)
T cd05122 96 TESQIAYVCKELLKGLEYLHSNGII-------HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMA 165 (253)
T ss_pred CHHHHHHHHHHHHHHHHHhhcCCEe-------cCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccC
Confidence 3455666778888888888887766 999999999999999999999999976644322 234578899999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||++.+..++.++||||||++++++++|+.|+..... ...... ............ ......+.+++
T Consensus 166 PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~~~~~~-------~~~~~~~~~~i 231 (253)
T cd05122 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP------MKALFK-IATNGPPGLRNP-------EKWSDEFKDFL 231 (253)
T ss_pred HHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch------HHHHHH-HHhcCCCCcCcc-------cccCHHHHHHH
Confidence 9999888889999999999999999999999753211 111111 111111111111 00134577889
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 011196 425 LLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~ 444 (491)
.+||+.||++||++.+++++
T Consensus 232 ~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 232 KKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHccCChhhCCCHHHHhcC
Confidence 99999999999999998863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-19 Score=180.33 Aligned_cols=168 Identities=20% Similarity=0.220 Sum_probs=114.6
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc---------cccCc
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE---------ANTNR 335 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~---------~~~~~ 335 (491)
.......++.+++.++.+||..++. ||||||+||++++++.+||+|||+++........ .....
T Consensus 113 ~~~~~~~i~~~l~~al~~lH~~~i~-------H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (311)
T cd07866 113 TESQIKCYMLQLLEGINYLHENHIL-------HRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185 (311)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCccccccccc
Confidence 3556677888999999999988777 9999999999999999999999999765332211 11123
Q ss_pred eeecCCCChhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC---------ccccc-
Q 011196 336 VVGTYGYMAPEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH---------AAELM- 404 (491)
Q Consensus 336 ~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~- 404 (491)
..++..|+|||.+.+. .++.++||||||++++||++|++||..... ......++....... .....
T Consensus 186 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (311)
T cd07866 186 LVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD---IDQLHLIFKLCGTPTEETWPGWRSLPGCEG 262 (311)
T ss_pred ceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChhhchhhhhcccccc
Confidence 4678889999988754 478999999999999999999999753221 222222222211100 00000
Q ss_pred -------cchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 405 -------DSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 405 -------d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+.+... .......+.+++.+||+.||++|||+.|++.
T Consensus 263 ~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 263 VHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred cccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000 0011245778999999999999999998875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-20 Score=190.67 Aligned_cols=225 Identities=22% Similarity=0.249 Sum_probs=150.1
Q ss_pred CCCccEEEEEecCCCCCcc-chhHHHHHHhhccccccC--CCCCcEEEceecceeeeecccccCCCCccccCC----CCC
Q 011196 193 SSFDTLQTTVHCIPDLSKS-DCNVCLNSAVAQIPTCSK--GKLGARIFCASCSIRYELYRFLVDTPTVTVTAP----NKT 265 (491)
Q Consensus 193 ~~~~~vyglaQC~~Dls~~-dC~~Cl~~~~~~~~~~~~--~~~~g~i~~~~C~lry~~~~f~~~~~~~~~~~~----~~~ 265 (491)
.+...|-..+.|-+|-+.. .=..-|+++...+.-.-. -+.-|.|+...=.|.+|+.+. ++++.-+.. ..-
T Consensus 134 psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELapl---GSLldrLrka~~~~ll 210 (1039)
T KOG0199|consen 134 PSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAPL---GSLLDRLRKAKKAILL 210 (1039)
T ss_pred CCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhccc---chHHHHHhhcccccee
Confidence 4567899999999885544 445555555554432221 122334433333333333221 111111100 000
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCc-ccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQS-EANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~a 344 (491)
-...-..+.+++.+++||....++ ||||-.+|+|+-....+||+|||+.+.++.+.. +.......-...|.|
T Consensus 211 v~~Lcdya~QiA~aM~YLeskrlv-------HRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCa 283 (1039)
T KOG0199|consen 211 VSRLCDYAMQIAKAMQYLESKRLV-------HRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCA 283 (1039)
T ss_pred HHHHHHHHHHHHHHHHHHhhhhhh-------hhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccC
Confidence 122335688999999999988777 999999999999999999999999998865543 233334445678999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||.+....|+.++|||+|||++|||++ |+.||....... +.+ .+|..-+-.-+..+.+++.++
T Consensus 284 PEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-------IL~---------~iD~~erLpRPk~csedIY~i 347 (1039)
T KOG0199|consen 284 PESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-------ILK---------NIDAGERLPRPKYCSEDIYQI 347 (1039)
T ss_pred HhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-------HHH---------hccccccCCCCCCChHHHHHH
Confidence 999999999999999999999999998 778875432211 111 122111112345677889999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 011196 424 GLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~ 443 (491)
++.||..+|++||++..|.+
T Consensus 348 mk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 348 MKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred HHHhccCCccccccHHHHHH
Confidence 99999999999999999973
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.8e-20 Score=185.32 Aligned_cols=127 Identities=23% Similarity=0.330 Sum_probs=96.2
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++.+..... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~giv-------HrDLkp~NIli~~~~~vkL~DfG~~ 148 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFI-------HRDIKPDNLLLDAKGHVKLSDFGLC 148 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------ccCCCHHHEEECCCCCEEEeeccCC
Confidence 455666665554333221 1223445666788888999999988777 9999999999999999999999998
Q ss_pred eecCCCCcc---------------------------------cccCceeecCCCChhhhhhhCCCCcccceeehhHHHHH
Q 011196 322 RIFGGNQSE---------------------------------ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLE 368 (491)
Q Consensus 322 ~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~e 368 (491)
+........ .......||+.|+|||++.+..++.++|||||||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilye 228 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeee
Confidence 754221100 00113478999999999999899999999999999999
Q ss_pred HHhCCCCCC
Q 011196 369 IISGKKSSG 377 (491)
Q Consensus 369 lltG~~p~~ 377 (491)
|++|+.||.
T Consensus 229 l~tG~~Pf~ 237 (360)
T cd05627 229 MLIGYPPFC 237 (360)
T ss_pred cccCCCCCC
Confidence 999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-19 Score=172.87 Aligned_cols=180 Identities=19% Similarity=0.300 Sum_probs=126.3
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.+++++.+........ ..........++.+++.++.+||..++. |+||+|+||+++.++.+||+|||.+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-------h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIV-------HRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------ccCCCHHHEEEcCCCCEEEcccccE
Confidence 344555554443222211 1234556677888888999999987766 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
................++..|++||.+.+...+.++||||||++++++++|..||.... ......+.........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~ 223 (260)
T cd06606 149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPP 223 (260)
T ss_pred EecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCc
Confidence 87654432111223567889999999988889999999999999999999999975433 2222222222111111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
. .+......+.+++.+||+.||++||++.+++..
T Consensus 224 ~---------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 E---------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred C---------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1 112224567788999999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.9e-20 Score=176.12 Aligned_cols=179 Identities=21% Similarity=0.305 Sum_probs=126.1
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhh-eeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLS-TSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.++.|+.+.+...... ..........++.+++.++.++|. .+++ ||||||+||+++.++.++|+|||+
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~-------H~~l~~~ni~~~~~~~~~l~df~~ 146 (264)
T cd06623 74 ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHII-------HRDIKPSNLLINSKGEVKIADFGI 146 (264)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCc-------cCCCCHHHEEECCCCCEEEccCcc
Confidence 445555655444332221 223345567788889999999998 7777 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
+......... .....++..|+|||.+.+..++.++||||||+++||+++|+.|+.............. ......
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~----~~~~~~ 220 (264)
T cd06623 147 SKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA----ICDGPP 220 (264)
T ss_pred ceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH----HhcCCC
Confidence 9876433322 1245688999999999888899999999999999999999999754322111111111 111111
Q ss_pred cccccchhcCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 401 AELMDSVVKQSCDQA-ELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~-~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.. .+.. ....+.+++.+||+.+|++||++.+++++
T Consensus 221 ~~---------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PS---------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CC---------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 1111 23457789999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.4e-20 Score=199.59 Aligned_cols=163 Identities=26% Similarity=0.337 Sum_probs=123.8
Q ss_pred CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCccccc-CceeecCCC
Q 011196 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANT-NRVVGTYGY 342 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~-~~~~gt~~y 342 (491)
........++.|++.++.||.....+ ||||-.+|||+.++..+||+|||+++........... ....-...|
T Consensus 415 L~~~dLlsfa~QIa~GMe~L~~~~~v-------HRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kW 487 (609)
T KOG0200|consen 415 LTTKDLLSFAYQIANGMEYLASVPCV-------HRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKW 487 (609)
T ss_pred cCHHHHHHHHHHHHHHHHHHhhCCcc-------chhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceee
Confidence 34567888999999999999988777 9999999999999999999999999965443333211 110124569
Q ss_pred ChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 343 MAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 343 ~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
||||.+....|+.++|||||||++|||++ |..|+.. ......+++..+++... +.+..+..++.
T Consensus 488 mApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~------~~~~~~l~~~l~~G~r~---------~~P~~c~~eiY 552 (609)
T KOG0200|consen 488 MAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG------IPPTEELLEFLKEGNRM---------EQPEHCSDEIY 552 (609)
T ss_pred cCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC------CCcHHHHHHHHhcCCCC---------CCCCCCCHHHH
Confidence 99999999999999999999999999998 7777642 11112223333333221 22334456678
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+||+.||+.+|++||++.++++.++..
T Consensus 553 ~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 553 DLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 899999999999999999999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.9e-20 Score=168.03 Aligned_cols=170 Identities=16% Similarity=0.197 Sum_probs=112.7
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCc--ccccCceeecCCCChh
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQS--EANTNRVVGTYGYMAP 345 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aP 345 (491)
...+....+..++.++|...++ |||+|+.|+||+.++.+||+|||+++.+..... ....+..+-|.+|++|
T Consensus 125 ~Ikk~Mk~Lm~GL~~iHr~kil-------HRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrpp 197 (376)
T KOG0669|consen 125 EIKKVMKGLMNGLYYIHRNKIL-------HRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPP 197 (376)
T ss_pred HHHHHHHHHHHHHHHHHHhhHH-------hhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCH
Confidence 3445566667777777777666 999999999999999999999999987643222 2223345669999999
Q ss_pred hhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCC-----CC------
Q 011196 346 EYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQS-----CD------ 413 (491)
Q Consensus 346 E~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-----~~------ 413 (491)
|.+.+. .|+++.|||.-||++.||.+|.+.+......+...++......+..+.|++...-.+... .+
T Consensus 198 EllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rk 277 (376)
T KOG0669|consen 198 ELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRK 277 (376)
T ss_pred HHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhh
Confidence 999875 599999999999999999999987653222222222222222222222222211000000 00
Q ss_pred -HHHH------HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 414 -QAEL------LKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 414 -~~~~------~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.+.. ....+|+.+++..||.+|+++.+++.+
T Consensus 278 v~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 278 VKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred hhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 0111 135678889999999999999998764
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=177.73 Aligned_cols=154 Identities=23% Similarity=0.330 Sum_probs=108.8
Q ss_pred CcchhhhHhHHHHHHHHHhh-eeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLS-TSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||. .+++ ||||||+||+++.++.+||+|||++....... .....++..|+|
T Consensus 101 ~~~~~~~~~~i~~~l~~LH~~~~i~-------H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~a 169 (286)
T cd06622 101 EDVLRRITYAVVKGLKFLKEEHNII-------HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMA 169 (286)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCCEe-------eCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccCccC
Confidence 44556777788888888875 3555 99999999999999999999999987653221 122457889999
Q ss_pred hhhhhhCC------CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHH
Q 011196 345 PEYAMEGI------FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELL 418 (491)
Q Consensus 345 PE~~~~~~------~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 418 (491)
||++.+.. ++.++|||||||++||+++|+.||.... ........ .....+.... .+.....
T Consensus 170 PE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~~-~~~~~~~~~~---------~~~~~~~ 236 (286)
T cd06622 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET---YANIFAQL-SAIVDGDPPT---------LPSGYSD 236 (286)
T ss_pred cchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc---hhhHHHHH-HHHhhcCCCC---------CCcccCH
Confidence 99985443 5789999999999999999999975321 11111111 1111111111 1222334
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 419 KYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 419 ~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+.+++.+||+.+|++||++.+++.
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 237 DAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHHHHcccCcccCCCHHHHhc
Confidence 5677999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.3e-20 Score=179.26 Aligned_cols=160 Identities=20% Similarity=0.284 Sum_probs=116.3
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......+..+++.++.+||..++. ||||||+||+++.++.+||+|||+++...... ........++..|++
T Consensus 115 ~~~~~~~~~~~l~~~l~~LH~~~i~-------H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~ 186 (275)
T cd05046 115 STKQKVALCTQIALGMDHLSNARFV-------HRDLAARNCLVSSQREVKVSLLSLSKDVYNSE-YYKLRNALIPLRWLA 186 (275)
T ss_pred CHHHHHHHHHHHHHHHHHhhhcCcc-------cCcCccceEEEeCCCcEEEcccccccccCccc-ccccCCceeEEeecC
Confidence 3556677888899999999988777 99999999999999999999999987543221 112223466778999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||.+.+..++.++||||||++++|+++ |..||.... .... ......+..... .+......+.++
T Consensus 187 PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~---~~~~----~~~~~~~~~~~~--------~~~~~~~~l~~~ 251 (275)
T cd05046 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS---DEEV----LNRLQAGKLELP--------VPEGCPSRLYKL 251 (275)
T ss_pred hhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc---hHHH----HHHHHcCCcCCC--------CCCCCCHHHHHH
Confidence 999988888999999999999999998 677763211 1111 111111111110 011122457789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhc
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
+.+||+.||++||++.|++..|++
T Consensus 252 i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 252 MTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred HHHHcCCCcccCCCHHHHHHHhcC
Confidence 999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=196.01 Aligned_cols=154 Identities=21% Similarity=0.323 Sum_probs=109.7
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecC----------------CCCccc
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFG----------------GNQSEA 331 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~----------------~~~~~~ 331 (491)
..+.+..+++.++.|+|..+++ ||||||.||+++++..+||+|||++.... ......
T Consensus 698 ~~wrLFreIlEGLaYIH~~giI-------HRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~ 770 (1351)
T KOG1035|consen 698 EAWRLFREILEGLAYIHDQGII-------HRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDG 770 (1351)
T ss_pred HHHHHHHHHHHHHHHHHhCcee-------eccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCc
Confidence 3456778888999999998877 99999999999999999999999998621 011112
Q ss_pred ccCceeecCCCChhhhhhhC---CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchh
Q 011196 332 NTNRVVGTYGYMAPEYAMEG---IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVV 408 (491)
Q Consensus 332 ~~~~~~gt~~y~aPE~~~~~---~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 408 (491)
..+..+||.-|+|||++.+. +|+.|+||||+|||++||+.- |+. .++... +....+.+.++.-
T Consensus 771 ~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~T-----sMERa~-iL~~LR~g~iP~~----- 836 (1351)
T KOG1035|consen 771 DLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGT-----SMERAS-ILTNLRKGSIPEP----- 836 (1351)
T ss_pred ccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCc-----hHHHHH-HHHhcccCCCCCC-----
Confidence 33467999999999999764 499999999999999999853 221 111111 2222233333322
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 409 KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
..+..++...-.+++.++++.||.+||||.|++.
T Consensus 837 -~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 837 -ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred -cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 1122233334456889999999999999988764
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.9e-20 Score=177.88 Aligned_cols=176 Identities=19% Similarity=0.336 Sum_probs=121.6
Q ss_pred eeeecccccCCCCccccCC-CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 244 RYELYRFLVDTPTVTVTAP-NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.|.++.|+.+.+....... .........++.+++.++.++|..++. |+||||+||+++.++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~-------H~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVI-------HRDIKAANILVTNTGNVKLCDFGVAA 149 (277)
T ss_pred EEEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcc-------cCCcCHHHEEEcCCCCEEEccCCcee
Confidence 3455666655443222111 223455667788888999999988777 99999999999999999999999998
Q ss_pred ecCCCCcccccCceeecCCCChhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
....... ......|+..|+|||++.++ .++.++||||||+++|+|++|..||..... ..... ......
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~------~~~~~-~~~~~~-- 218 (277)
T cd06917 150 LLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA------FRAMM-LIPKSK-- 218 (277)
T ss_pred ecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh------hhhhh-ccccCC--
Confidence 7654332 12235688899999998754 468899999999999999999999753211 11110 000111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+.+... .....+.+++.+||+.||++||++.+++.
T Consensus 219 ---~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 ---PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ---CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111111 12345678999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=179.72 Aligned_cols=126 Identities=21% Similarity=0.323 Sum_probs=95.1
Q ss_pred eeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.+..|+.++.+..... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv-------H~dlkp~Nill~~~~~~kl~Dfg~ 148 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYV-------HRDIKPDNVLLDKNGHIRLADFGS 148 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE-------ECCCCHHHEEECCCCCEEEEECCc
Confidence 456666665554433221 1223445566788889999999988777 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhh-----CCCCcccceeehhHHHHHHHhCCCCCC
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAME-----GIFSVKSDVFSFGVVLLEIISGKKSSG 377 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvvl~elltG~~p~~ 377 (491)
+......... ......||+.|+|||++.. +.++.++|||||||++|||++|+.||.
T Consensus 149 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 149 CLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred eeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 8765432221 1223468999999999873 457889999999999999999999974
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=175.57 Aligned_cols=165 Identities=19% Similarity=0.215 Sum_probs=115.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ |+||||+||+++.++.+||+|||++........ .....++..|+||
T Consensus 106 ~~~~~~~~~~i~~al~~LH~~~i~-------h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~P 175 (287)
T cd07838 106 PETIKDLMRQLLRGVDFLHSHRIV-------HRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAP 175 (287)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------eccCChhhEEEccCCCEEEeccCcceeccCCcc---cccccccccccCh
Confidence 455677888899999999988776 999999999999999999999999987643322 1223578899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccc----------cccchhc---CCC
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAE----------LMDSVVK---QSC 412 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~d~~l~---~~~ 412 (491)
|++.+..++.++||||||++++||++|.+|+.... .......+........... ....... ...
T Consensus 176 E~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T cd07838 176 EVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS---EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSF 252 (287)
T ss_pred HHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC---hHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhh
Confidence 99998889999999999999999999988865322 1122222211111000000 0000000 001
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 413 DQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 413 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
..+....+.+++.+||+.||++||++.+++.
T Consensus 253 ~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 253 VPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 1122356678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=178.64 Aligned_cols=167 Identities=16% Similarity=0.155 Sum_probs=111.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++........ .....++..|+||
T Consensus 102 ~~~~~~~~~qi~~~L~~lH~~~i~-------H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aP 172 (291)
T cd07870 102 PYNVRLFMFQLLRGLAYIHGQHIL-------HRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPP 172 (291)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------cCCCChHHEEEcCCCcEEEeccccccccCCCCCC--CCCccccccccCC
Confidence 344556777888888999887666 9999999999999999999999998754332211 1234568899999
Q ss_pred hhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC---------ccccccchh----cCC
Q 011196 346 EYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH---------AAELMDSVV----KQS 411 (491)
Q Consensus 346 E~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~d~~l----~~~ 411 (491)
|++.+. .++.++||||||+++|||++|+.||..... ....+...|..+.... ......... ...
T Consensus 173 E~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (291)
T cd07870 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQ 250 (291)
T ss_pred ceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcc
Confidence 998754 478899999999999999999999753221 1222222222111100 000000000 000
Q ss_pred C-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 412 C-----DQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 412 ~-----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
. .......+.+++.+|++.||++|||+.|++.
T Consensus 251 ~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 251 LRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0 0011245667899999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-20 Score=202.19 Aligned_cols=154 Identities=22% Similarity=0.295 Sum_probs=110.3
Q ss_pred HhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCc--ccccCceeecCCCChhhhhhh
Q 011196 273 AEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQS--EANTNRVVGTYGYMAPEYAME 350 (491)
Q Consensus 273 ~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~ 350 (491)
..+++.++.+||..+++ ||||||.||+++.+|.+|++|||.+..+..+.. ........||+.|||||++.+
T Consensus 1340 t~qll~gla~LH~~gIV-------HRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~ 1412 (1509)
T KOG4645|consen 1340 TKQLLEGLAYLHEHGIV-------HRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITG 1412 (1509)
T ss_pred HHHHHHHHHHHHhcCce-------ecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcc
Confidence 34566677777776666 999999999999999999999999987654321 112234689999999999986
Q ss_pred CC---CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHc
Q 011196 351 GI---FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLC 427 (491)
Q Consensus 351 ~~---~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~c 427 (491)
.. ..-+.||||+|||++||+||++||..++ ++-.+. -+...+..+.+ |..-..+-.+++..|
T Consensus 1413 t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d--ne~aIM----y~V~~gh~Pq~---------P~~ls~~g~dFle~C 1477 (1509)
T KOG4645|consen 1413 TKGKGHGGAADIWSLGCVVLEMATGKRPWAELD--NEWAIM----YHVAAGHKPQI---------PERLSSEGRDFLEHC 1477 (1509)
T ss_pred cccCCCCcchhhhcccceEEEeecCCCchhhcc--chhHHH----hHHhccCCCCC---------chhhhHhHHHHHHHH
Confidence 43 5678999999999999999999986332 211111 12222333322 222333455688899
Q ss_pred ccCCCCCCCCHHHHHHHhhcC
Q 011196 428 VQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 428 l~~dP~~RPs~~evl~~L~~~ 448 (491)
|+.||++|+++.|+++.--.+
T Consensus 1478 l~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1478 LEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred HhcCchhhhHHHHHHHhhccc
Confidence 999999999999888764433
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.3e-20 Score=177.74 Aligned_cols=179 Identities=16% Similarity=0.146 Sum_probs=125.5
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.+++|+.+........ ..........++.+++.++.++|..+++ ||||||+||+++.++.+||+|||++
T Consensus 72 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~-------H~dl~p~nil~~~~~~~~l~dfg~~ 144 (260)
T cd05611 72 LYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGII-------HRDIKPENLLIDQTGHLKLTDFGLS 144 (260)
T ss_pred EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHeEECCCCcEEEeecccc
Confidence 456666666554332221 1223455667888999999999998777 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+.... .....++..|++||.+.+..++.++||||||++++|+++|..||.... .. ..+.........
T Consensus 145 ~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~----~~~~~~~~~~~~ 211 (260)
T cd05611 145 RNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET---PD----AVFDNILSRRIN 211 (260)
T ss_pred eeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC---HH----HHHHHHHhcccC
Confidence 75432 123457889999999988888999999999999999999999974221 11 111111111110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.... ........+.+++.+||+.||++||++.++.+.|+..
T Consensus 212 --~~~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~ 252 (260)
T cd05611 212 --WPEE----VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252 (260)
T ss_pred --CCCc----ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence 0000 1111234577899999999999999888777777664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-19 Score=192.90 Aligned_cols=160 Identities=16% Similarity=0.118 Sum_probs=101.8
Q ss_pred hhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC-CCCceEeccCcceecCCCCcccccCceeecCCCChhhhh
Q 011196 270 ITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH-EMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYA 348 (491)
Q Consensus 270 ~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 348 (491)
..++.+++.++.++|..+++ ||||||+|||++. ++.+||+|||+++.+...... ......+++.|+|||.+
T Consensus 258 ~~i~~qll~aL~yLH~~gIi-------HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~ 329 (566)
T PLN03225 258 QTIMRQILFALDGLHSTGIV-------HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQY 329 (566)
T ss_pred HHHHHHHHHHHHHHHHCCEE-------eCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHh
Confidence 35677778888888887666 9999999999986 578999999999865433222 22346789999999976
Q ss_pred hhC----------------------CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC----ccc
Q 011196 349 MEG----------------------IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH----AAE 402 (491)
Q Consensus 349 ~~~----------------------~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 402 (491)
... .++.++|||||||++|||+++..+++. .+..........+. +..
T Consensus 330 ~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~ 402 (566)
T PLN03225 330 IMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS-------NLIQFNRQLKRNDYDLVAWRK 402 (566)
T ss_pred hccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch-------HHHHHHHHHHhcCCcHHHHHH
Confidence 422 234567999999999999987655321 11111000000000 000
Q ss_pred cccch----hcCCC--CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 403 LMDSV----VKQSC--DQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 403 ~~d~~----l~~~~--~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
...+. +...+ .........+|+.+||+.||++|||+.|++++
T Consensus 403 ~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 403 LVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred hhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 00000 00000 00111234579999999999999999998874
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.4e-20 Score=177.55 Aligned_cols=175 Identities=16% Similarity=0.167 Sum_probs=122.5
Q ss_pred eeeeecccccCCCCccccCC--CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC-CceEeccC
Q 011196 243 IRYELYRFLVDTPTVTVTAP--NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM-NPKISDFG 319 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~-~~kl~DfG 319 (491)
..|.++.|+.+..+...... .........++.+++.++.++|..+++ ||||||+||+++.++ .++|+|||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~-------H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNII-------HNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCee-------eCCCCHHHEEEeCCCCeEEEecCc
Confidence 34566667665544322211 234556677888899999999988776 999999999999998 99999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
+++...... ...++..|+|||++.+..++.++||||||++++||++|+.||...... ...... ..... ...
T Consensus 156 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~-~~~~~-~~~ 226 (267)
T PHA03390 156 LCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLES-LLKRQ-QKK 226 (267)
T ss_pred cceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHH-HHHhh-ccc
Confidence 987654321 235788999999999888999999999999999999999997622111 111111 11111 110
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT-MSSVAV 443 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~evl~ 443 (491)
... .......+.+++.+||+.||.+||+ ++|+++
T Consensus 227 -~~~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 -LPF---------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -CCc---------ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000 1122345678889999999999996 588774
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-19 Score=178.15 Aligned_cols=190 Identities=14% Similarity=0.159 Sum_probs=123.4
Q ss_pred eeeeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 243 IRYELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
..|.+++|. +....... ...........++.+++.++.++|..++. |+||||+||+++.++.++|+|||
T Consensus 73 ~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~-------H~dl~p~ni~~~~~~~~~l~dfg 144 (286)
T cd07832 73 GFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIM-------HRDLKPANLLISADGVLKIADFG 144 (286)
T ss_pred eeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee-------cCCcCHHHEEEcCCCcEEEeeee
Confidence 345666666 44332211 11223455677888899999999987776 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
++........ .......|+..|+|||++.+. .++.++||||+|++++||++|.+++... ........+.......
T Consensus 145 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~---~~~~~~~~~~~~~~~~ 220 (286)
T cd07832 145 LARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE---NDIEQLAIVFRTLGTP 220 (286)
T ss_pred ecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC---CHHHHHHHHHHHcCCC
Confidence 9986644321 112234678899999998654 4689999999999999999997775421 1122222222211110
Q ss_pred C---c---------cccccch----hcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 399 H---A---------AELMDSV----VKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 399 ~---~---------~~~~d~~----l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
. + ..+..+. .......+....+.+++.+||+.||++||++++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 221 NEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0 0000000 0000001123567889999999999999999998864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.6e-20 Score=178.02 Aligned_cols=155 Identities=21% Similarity=0.307 Sum_probs=110.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..++. |+||+|+||+++.++.+||+|||++........ ......|+..|+||
T Consensus 112 ~~~~~~~~~ql~~al~~lH~~~i~-------H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aP 182 (275)
T cd06608 112 EEWIAYILRETLRGLAYLHENKVI-------HRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAP 182 (275)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCcc-------cCCCCHHHEEEccCCeEEECCCccceecccchh--hhcCccccccccCH
Confidence 444566778888888888887766 999999999999999999999999876543222 12235688999999
Q ss_pred hhhhh-----CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHH
Q 011196 346 EYAME-----GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKY 420 (491)
Q Consensus 346 E~~~~-----~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 420 (491)
|++.. ..++.++||||||++++|+++|+.||.... ...... . ........+. .+......+
T Consensus 183 E~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~---~-~~~~~~~~~~-------~~~~~~~~~ 248 (275)
T cd06608 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH---PMRALF---K-IPRNPPPTLK-------SPENWSKKF 248 (275)
T ss_pred hHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc---hHHHHH---H-hhccCCCCCC-------chhhcCHHH
Confidence 98853 246789999999999999999999974221 111111 1 1111111111 111233457
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 011196 421 IHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 421 ~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+++.+||..||++|||+.++++
T Consensus 249 ~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 249 NDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHHHHHhhcChhhCcCHHHHhc
Confidence 78999999999999999999886
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-19 Score=177.46 Aligned_cols=175 Identities=18% Similarity=0.171 Sum_probs=121.0
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|+.++....... ..........++.+++.++.++|..+++ ||||||+||+++.++.+||+|||++
T Consensus 72 ~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~-------H~di~p~nili~~~~~~kl~dfg~~ 144 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV-------YRDLKPANILLDEHGHVRISDLGLA 144 (278)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEE-------cCCCCHHHEEECCCCCEEEccCcCc
Confidence 345555655444322211 1223456677888888999999987766 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
....... .....|+..|+|||++.++ .++.++||||+|++++||++|+.||.......... ........
T Consensus 145 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~-- 214 (278)
T cd05606 145 CDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTM-- 214 (278)
T ss_pred cccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhcc--
Confidence 7553322 1234689999999999755 58999999999999999999999975432211111 11111100
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAV 443 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~ 443 (491)
+.. .+......+.+++.+||+.||++|| ++.++++
T Consensus 215 ----~~~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 215 ----AVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ----CCC----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 011 1111234577888999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-19 Score=179.07 Aligned_cols=178 Identities=18% Similarity=0.289 Sum_probs=123.5
Q ss_pred eeeecccccCCCCccccCC-CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 244 RYELYRFLVDTPTVTVTAP-NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.|.++.|..+......... .........++.+++.++.+||..++. ||||||+||+++.++.+||+|||++.
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~-------H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI-------HRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred EEEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEe-------eccCCHHHEEEcCCCCEEEccCccee
Confidence 4566666655543322211 223445667788888889999988777 99999999999999999999999987
Q ss_pred ecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccc
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAE 402 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (491)
....... ......|+..|++||.+..+.++.++||||||+++||+++|+.||....... ........+. ..
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~------~~~~~~~~~~-~~ 234 (293)
T cd06647 164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNGT-PE 234 (293)
T ss_pred ccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh------heeehhcCCC-CC
Confidence 6543322 1223467889999999988889999999999999999999999975322111 1111111110 00
Q ss_pred cccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 403 LMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 403 ~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
...+......+.+++.+||+.+|++||++.+++.+
T Consensus 235 -------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 -------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111223356679999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-19 Score=176.73 Aligned_cols=155 Identities=22% Similarity=0.313 Sum_probs=109.5
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC-CCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH-EMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
.....+..+++.++.+||..+++ ||||||+||+++. ++.+||+|||++........ ......|+..|+||
T Consensus 108 ~~~~~~~~qi~~al~~lH~~~i~-------h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aP 178 (268)
T cd06624 108 QTIIFYTKQILEGLKYLHDNQIV-------HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAP 178 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEe-------ecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccCh
Confidence 34455677888999999987777 9999999999986 67899999999876543222 12234578899999
Q ss_pred hhhhhCC--CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 346 EYAMEGI--FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 346 E~~~~~~--~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
|++.+.. ++.++||||||+++||+++|+.|+...... ....+....... .+ ..+......+.++
T Consensus 179 E~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~-----~~----~~~~~~~~~~~~l 244 (268)
T cd06624 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP-----QAAMFKVGMFKI-----HP----EIPESLSAEAKNF 244 (268)
T ss_pred hhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh-----hhhHhhhhhhcc-----CC----CCCcccCHHHHHH
Confidence 9987644 788999999999999999999997432111 011111100000 00 1122223456788
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 011196 424 GLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~ 444 (491)
+.+||+.+|++||++.|++++
T Consensus 245 i~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 245 ILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHcCCCchhCCCHHHHHhC
Confidence 999999999999999998864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.4e-20 Score=181.19 Aligned_cols=184 Identities=22% Similarity=0.238 Sum_probs=127.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeE--EeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFL--WCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~--~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
+...-.++.-++.++++||.-.-. |++..|+|||||++|||+..++++.|+|||++..+........+...+||.+||
T Consensus 306 w~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYM 385 (534)
T KOG3653|consen 306 WNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYM 385 (534)
T ss_pred HHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhc
Confidence 445567888899999999875443 455678899999999999999999999999999887776666666789999999
Q ss_pred hhhhhhhCC-CC-----cccceeehhHHHHHHHhCCCCCCCccCCC----------cccHHHHHHHHhhc-CCccccccc
Q 011196 344 APEYAMEGI-FS-----VKSDVFSFGVVLLEIISGKKSSGFYHLEH----------GPSLLAYIWKLWCE-GHAAELMDS 406 (491)
Q Consensus 344 aPE~~~~~~-~s-----~~sDVwS~Gvvl~elltG~~p~~~~~~~~----------~~~~~~~~~~~~~~-~~~~~~~d~ 406 (491)
|||++.+.. +. .+.||||+|.|+|||+++..-..-....+ ...-++..+..... ..-+.+.+.
T Consensus 386 APEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~ 465 (534)
T KOG3653|consen 386 APEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDA 465 (534)
T ss_pred CHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhh
Confidence 999997642 22 46999999999999998654321100000 00011111111111 111122222
Q ss_pred hhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCC
Q 011196 407 VVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLP 453 (491)
Q Consensus 407 ~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 453 (491)
.... ..+.-+.+.+..||+.||+.|.|+.-|.+++.......+
T Consensus 466 W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 466 WRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred hhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 2211 234456678889999999999999999999988754433
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-19 Score=169.00 Aligned_cols=161 Identities=17% Similarity=0.174 Sum_probs=116.2
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC---CCceEeccCcceecCCCCcccccCceeecCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE---MNPKISDFGMARIFGGNQSEANTNRVVGTYG 341 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~---~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 341 (491)
..+....|..++..+++|||...+. ||||||+|+|.... -.+||+|||+++.-.... .....+-|+.
T Consensus 159 TErea~eI~~qI~~Av~~lH~~nIA-------HRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~---~L~TPc~TPy 228 (400)
T KOG0604|consen 159 TEREASEIMKQIGLAVRYLHSMNIA-------HRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG---DLMTPCFTPY 228 (400)
T ss_pred hHHHHHHHHHHHHHHHHHHHhcchh-------hccCChhheeeecCCCCcceEecccccccccCCCc---cccCCccccc
Confidence 3556677888999999999999999 99999999999654 468999999998653322 2233566999
Q ss_pred CChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 342 YMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 342 y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
|.|||++...+|+...|+||+||++|-|++|.+||...+... +..-....+..+. .++.++ + -....+...
T Consensus 229 YvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gq-y~FP~p----E-Ws~VSe~aK 299 (400)
T KOG0604|consen 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQ-YEFPEP----E-WSCVSEAAK 299 (400)
T ss_pred ccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccC-ccCCCh----h-HhHHHHHHH
Confidence 999999998899999999999999999999999975443321 1111111111111 111111 0 012234556
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
++++.+|..+|.+|.|+.+++++
T Consensus 300 dlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 300 DLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HHHHHHhcCCchhheeHHHhhcC
Confidence 78999999999999999998753
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-19 Score=175.13 Aligned_cols=153 Identities=21% Similarity=0.283 Sum_probs=113.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..++. |+||||+||+++.++.+||+|||++....... ......|+..|++|
T Consensus 101 ~~~~~~~~~~i~~~l~~lH~~~i~-------H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~p 170 (258)
T cd06632 101 EPVIRLYTRQILLGLEYLHDRNTV-------HRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAP 170 (258)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCH
Confidence 445566788888999999988777 99999999999999999999999987654332 12235678899999
Q ss_pred hhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|.+.... ++.++|+||||+++|++++|+.||.... .....+..........+ +......+.+++
T Consensus 171 e~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li 235 (258)
T cd06632 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE------GVAAVFKIGRSKELPPI---------PDHLSDEAKDFI 235 (258)
T ss_pred HHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc------HHHHHHHHHhcccCCCc---------CCCcCHHHHHHH
Confidence 9987766 8999999999999999999999975322 11122221111111111 111224466789
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 011196 425 LLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~ 443 (491)
.+||+.+|++||++.+++.
T Consensus 236 ~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 236 LKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHhhcCcccCcCHHHHhc
Confidence 9999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=7e-20 Score=179.82 Aligned_cols=155 Identities=19% Similarity=0.274 Sum_probs=113.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..++. ||||||+||+++.++.+||+|||++........ ......|+..|+||
T Consensus 114 ~~~~~~~~~ql~~~l~~lH~~~i~-------H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aP 184 (285)
T cd06648 114 EEQIATVCLAVLKALSFLHAQGVI-------HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAP 184 (285)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccCCccccCH
Confidence 445567888888999999988777 999999999999999999999998875533221 12234688999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|.+.+..++.++||||||++++||++|+.||... +....... ......... .. .......+.+++.
T Consensus 185 E~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~---~~~~~~~~----~~~~~~~~~-----~~--~~~~~~~l~~li~ 250 (285)
T cd06648 185 EVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE---PPLQAMKR----IRDNLPPKL-----KN--LHKVSPRLRSFLD 250 (285)
T ss_pred HHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC---CHHHHHHH----HHhcCCCCC-----cc--cccCCHHHHHHHH
Confidence 9998888999999999999999999999996421 11111111 111111111 10 1112345788999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 011196 426 LCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~ 443 (491)
+||+.+|++||++.++++
T Consensus 251 ~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 251 RMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHcccChhhCcCHHHHcc
Confidence 999999999999998885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.1e-20 Score=180.25 Aligned_cols=165 Identities=16% Similarity=0.150 Sum_probs=111.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC-CCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH-EMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||..+++ ||||||+||+++. ++.+||+|||+++....... ......+++.|+|
T Consensus 109 ~~~~~~~~~qi~~~L~~LH~~~i~-------H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~a 179 (295)
T cd07837 109 AKTIKSFMYQLLKGVAHCHKHGVM-------HRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK--SYTHEIVTLWYRA 179 (295)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------ecCCChHHEEEecCCCeEEEeecccceecCCCcc--ccCCcccccCCCC
Confidence 445667788899999999988776 9999999999998 88999999999876532211 1122356788999
Q ss_pred hhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC---cccc------------ccchh
Q 011196 345 PEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH---AAEL------------MDSVV 408 (491)
Q Consensus 345 PE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~------------~d~~l 408 (491)
||++.+ ..++.++||||||+++|||++|..||.... .......+........ +... ....+
T Consensus 180 PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (295)
T cd07837 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS---ELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDL 256 (295)
T ss_pred hHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhH
Confidence 999875 457899999999999999999999875321 1111111111111000 0000 00000
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 409 KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
. .........+.+++.+||+.||++||++.|++.
T Consensus 257 ~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 257 S-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred H-HhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 000112345778999999999999999998875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.4e-20 Score=173.77 Aligned_cols=203 Identities=17% Similarity=0.243 Sum_probs=134.5
Q ss_pred HHHHhhccc--cccCCCCCcEEEceeccee----eeecccccCCCCccc---cCCCCCCcchhhhHhHHHHHHHHHhhee
Q 011196 217 LNSAVAQIP--TCSKGKLGARIFCASCSIR----YELYRFLVDTPTVTV---TAPNKTSKRWITIAEAASAIIVFLLSTS 287 (491)
Q Consensus 217 l~~~~~~~~--~~~~~~~~g~i~~~~C~lr----y~~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 287 (491)
|+.++.+|. +.|...- .|.+.+-|+. |.++.|...++.... .-.+...+...+++.....+++|||-+.
T Consensus 72 LQEIIKEISIMQQC~S~y--VVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~ 149 (502)
T KOG0574|consen 72 LQEIIKEISIMQQCKSKY--VVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK 149 (502)
T ss_pred HHHHHHHHHHHHHcCCch--hhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH
Confidence 667776654 4554322 2222222222 334445444433222 1223334555667777778888888765
Q ss_pred eEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHH
Q 011196 288 FLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLL 367 (491)
Q Consensus 288 ~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ 367 (491)
-+ |||||+.|||++.+|.+||+|||++-.+...- ...+...||+.|||||++.+-.|+.++||||+|++..
T Consensus 150 KI-------HRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaI 220 (502)
T KOG0574|consen 150 KI-------HRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAI 220 (502)
T ss_pred HH-------HhhcccccEEEcccchhhhhhccccchhhhhH--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhh
Confidence 44 99999999999999999999999997654322 2234579999999999999999999999999999999
Q ss_pred HHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 368 EIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 368 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
||..|++|+...+..... .++.....+.+ .-++.=..++-++++.||-++|++|-|+.+++++
T Consensus 221 EMAEG~PPYsDIHPMRAI-------FMIPT~PPPTF-------~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 221 EMAEGRPPYSDIHPMRAI-------FMIPTKPPPTF-------KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhhcCCCCccccccccee-------EeccCCCCCCC-------CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 999999997654332210 00111111111 1123334567789999999999999999887764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-20 Score=191.68 Aligned_cols=184 Identities=24% Similarity=0.262 Sum_probs=127.8
Q ss_pred ecccccCCCCccccCCC---CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCccee
Q 011196 247 LYRFLVDTPTVTVTAPN---KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARI 323 (491)
Q Consensus 247 ~~~f~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~ 323 (491)
+..+-.++++...+... .+..+.+....+++.++.|||....+ ||||-++|+|+..++.+||+|||+++.
T Consensus 239 vmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~I-------HRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 239 VMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCI-------HRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCc-------chhHhHHHheecCCCeEEeCccccccC
Confidence 44555555443333222 22456677888999999999998887 999999999999999999999999875
Q ss_pred cCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccc
Q 011196 324 FGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAE 402 (491)
Q Consensus 324 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (491)
-.... .......-+..|+|||.+..+.|+.++|||||||++||+++ |..|+.... ......++. .++...
T Consensus 312 ~~~~~--~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~---~~~v~~kI~---~~~~r~- 382 (474)
T KOG0194|consen 312 GSQYV--MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK---NYEVKAKIV---KNGYRM- 382 (474)
T ss_pred Cccee--eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC---HHHHHHHHH---hcCccC-
Confidence 43111 11111234679999999999999999999999999999998 777854221 111222111 111111
Q ss_pred cccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCCC
Q 011196 403 LMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPK 454 (491)
Q Consensus 403 ~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 454 (491)
..+......+..++.+||..||++||+|.++.+.|+........
T Consensus 383 --------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 383 --------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred --------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 11112334455677799999999999999999999887555443
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.3e-20 Score=184.37 Aligned_cols=169 Identities=18% Similarity=0.246 Sum_probs=114.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc--cccCceeecCCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE--ANTNRVVGTYGYM 343 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~ 343 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++........ .......|+..|+
T Consensus 106 ~~~~~~i~~qi~~aL~~LH~~~iv-------H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~ 178 (334)
T cd07855 106 EEHIRYFLYQLLRGLKYIHSANVI-------HRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178 (334)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHEEEcCCCcEEecccccceeecccCcCCCccccccccccccc
Confidence 455667888889999999987776 9999999999999999999999999765432211 1112357889999
Q ss_pred hhhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh-----------cCCccccccchh-cC
Q 011196 344 APEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC-----------EGHAAELMDSVV-KQ 410 (491)
Q Consensus 344 aPE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~d~~l-~~ 410 (491)
+||.+.+ ..++.++||||||+++|||++|+.||...... .....+..... .....+..+... ..
T Consensus 179 ~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~---~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (334)
T cd07855 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV---HQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQ 255 (334)
T ss_pred ChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH---HHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCC
Confidence 9999866 45889999999999999999999997532211 11111111000 000000000000 00
Q ss_pred CCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 411 SCD-----QAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 411 ~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..+ ......+.+++.+||+.+|++||++.+++.+
T Consensus 256 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 256 PVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred CCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 011 1124567889999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-19 Score=175.07 Aligned_cols=157 Identities=21% Similarity=0.270 Sum_probs=112.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCC----cccccCceeecCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQ----SEANTNRVVGTYG 341 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~----~~~~~~~~~gt~~ 341 (491)
......++.+++.++.++|..++. |+||||+||+++.++.+||+|||++....... .........|+..
T Consensus 101 ~~~~~~~~~qi~~~l~~lH~~~i~-------H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (265)
T cd06631 101 EPVFCKYTKQILDGVAYLHNNCVV-------HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173 (265)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------cCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCcc
Confidence 455566778888999999987776 99999999999999999999999987543211 1111223467889
Q ss_pred CChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 342 YMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 342 y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
|+|||++.+..++.++||||||++++|+++|+.||..... ................ +. ......+.
T Consensus 174 ~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~-----~~----~~~~~~~~ 239 (265)
T cd06631 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-----LAAMFYIGAHRGLMPR-----LP----DSFSAAAI 239 (265)
T ss_pred ccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-----HHHHHHhhhccCCCCC-----CC----CCCCHHHH
Confidence 9999999888899999999999999999999999753211 1110000000011111 11 11234467
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~ 443 (491)
+++.+||+.+|++||++.|+++
T Consensus 240 ~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 240 DFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHhcCCcccCCCHHHHhc
Confidence 7899999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-19 Score=198.60 Aligned_cols=160 Identities=19% Similarity=0.254 Sum_probs=112.7
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCc----------------cc
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQS----------------EA 331 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~----------------~~ 331 (491)
..+.++.+++.++.++|..+++ ||||||+|||++.++.+||+|||+++....... ..
T Consensus 114 ~iL~I~~QIa~AL~yLHs~GII-------HRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t 186 (932)
T PRK13184 114 AFLSIFHKICATIEYVHSKGVL-------HRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186 (932)
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-------ccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccc
Confidence 4566788889999999987766 999999999999999999999999986521110 01
Q ss_pred ccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCC
Q 011196 332 NTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQS 411 (491)
Q Consensus 332 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 411 (491)
......||+.|+|||++.+..++.++|||||||+++||++|+.||..... .... .. .. +.++....
T Consensus 187 ~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~---~ki~---~~----~~---i~~P~~~~- 252 (932)
T PRK13184 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG---RKIS---YR----DV---ILSPIEVA- 252 (932)
T ss_pred cCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch---hhhh---hh----hh---ccChhhcc-
Confidence 11235799999999999998999999999999999999999999753111 1110 00 00 00000000
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhcC
Q 011196 412 CDQAELLKYIHIGLLCVQEDPMDRP-TMSSVAVMLASD 448 (491)
Q Consensus 412 ~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~~ 448 (491)
...+....+.+++.+||+.||++|| +++++++.|+..
T Consensus 253 p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 253 PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0011223466789999999999996 566677766554
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7e-20 Score=185.05 Aligned_cols=155 Identities=22% Similarity=0.328 Sum_probs=122.6
Q ss_pred hhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhh
Q 011196 269 WITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYA 348 (491)
Q Consensus 269 ~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 348 (491)
......++..++.||++..++ ||||..+|||+....-+||+|||+++.+......... ...-++.|||||.+
T Consensus 493 L~ly~~Qi~talaYLeSkrfV-------HRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESI 564 (974)
T KOG4257|consen 493 LTLYCYQICTALAYLESKRFV-------HRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESI 564 (974)
T ss_pred HHHHHHHHHHHHHHHHhhchh-------hhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCcccc
Confidence 445677888999999998888 9999999999999999999999999987655443322 34457789999999
Q ss_pred hhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHc
Q 011196 349 MEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLC 427 (491)
Q Consensus 349 ~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~c 427 (491)
.-.+|+.++|||-|||.+||++. |..||......+ .--.+...-+-..++.++..+..|+.+|
T Consensus 565 NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI~~iEnGeRlP~P~nCPp~LYslmskc 628 (974)
T KOG4257|consen 565 NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VIGHIENGERLPCPPNCPPALYSLMSKC 628 (974)
T ss_pred chhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eEEEecCCCCCCCCCCCChHHHHHHHHH
Confidence 99999999999999999999986 899976432211 1111222223345667778899999999
Q ss_pred ccCCCCCCCCHHHHHHHhhc
Q 011196 428 VQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 428 l~~dP~~RPs~~evl~~L~~ 447 (491)
|.+||.+||.+.|+...|+.
T Consensus 629 WayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 629 WAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred hccCcccCCcHHHHHHHHHH
Confidence 99999999999999888743
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-19 Score=176.45 Aligned_cols=165 Identities=18% Similarity=0.164 Sum_probs=112.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..++. ||||||+||+++. +.+||+|||+++........ ....++..|+||
T Consensus 99 ~~~~~~~~~qi~~~L~~LH~~~i~-------H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aP 167 (282)
T cd07831 99 EKRVKSYMYQLLKSLDHMHRNGIF-------HRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---TEYISTRWYRAP 167 (282)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCce-------ecccCHHHEEEcC-CCeEEEecccccccccCCCc---CCCCCCcccCCh
Confidence 455677888889999999987766 9999999999999 99999999999865432221 224578899999
Q ss_pred hhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHH-----------hhcCCccccccchhcC---
Q 011196 346 EYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKL-----------WCEGHAAELMDSVVKQ--- 410 (491)
Q Consensus 346 E~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~d~~l~~--- 410 (491)
|++.. +.++.++|||||||++|||++|..||..... .+........ ...........+....
T Consensus 168 E~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (282)
T cd07831 168 ECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE---LDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGL 244 (282)
T ss_pred hHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH---HHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccH
Confidence 98754 4578899999999999999999999753221 1111111111 1111000000000000
Q ss_pred -CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 411 -SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 411 -~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.........+.+++.+||+.||++||++.++++.
T Consensus 245 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 245 RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0011234678899999999999999999998863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-19 Score=176.11 Aligned_cols=156 Identities=17% Similarity=0.206 Sum_probs=111.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCc-ccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQS-EANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.++|..+++ |+||||+||+++.++.+||+|||+++....... ........|+..|+|
T Consensus 105 ~~~~~~~~~~l~~~l~~lH~~~i~-------H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 177 (265)
T cd06652 105 ENVTRKYTRQILEGVSYLHSNMIV-------HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177 (265)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEe-------cCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccC
Confidence 344566788888999999988766 999999999999999999999999875432111 111223457889999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||.+.+..++.++||||||+++||+++|+.||... .............. . ...+......+.+++
T Consensus 178 PE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~------~~~~~~~~~~~~~~-----~----~~~~~~~~~~~~~~i 242 (265)
T cd06652 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF------EAMAAIFKIATQPT-----N----PVLPPHVSDHCRDFL 242 (265)
T ss_pred hhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc------chHHHHHHHhcCCC-----C----CCCchhhCHHHHHHH
Confidence 99998888999999999999999999999997422 11111111111110 0 112233344566788
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 011196 425 LLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~ 444 (491)
.+||. +|++||+++||+++
T Consensus 243 ~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 243 KRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHhc-ChhhCCCHHHHhcC
Confidence 88885 99999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-19 Score=171.89 Aligned_cols=153 Identities=25% Similarity=0.384 Sum_probs=111.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC-CCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE-MNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~-~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.++|..+++ |+||||+||+++.+ +.+||+|||++........ .....++..|+|
T Consensus 100 ~~~~~~~~~~i~~~l~~lh~~~i~-------h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~a 169 (256)
T cd08220 100 EDTILHFFVQILLALHHVHTKLIL-------HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYIS 169 (256)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---ccccccCCcccC
Confidence 445567778888889999988777 99999999999865 4579999999987643322 223567889999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||.+.+..++.++||||||+++|++++|+.|+.... ........ .......+. ......+.+++
T Consensus 170 PE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~---~~~~~~~~----~~~~~~~~~---------~~~~~~l~~li 233 (256)
T cd08220 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN---LPALVLKI----MSGTFAPIS---------DRYSPDLRQLI 233 (256)
T ss_pred chhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc---hHHHHHHH----HhcCCCCCC---------CCcCHHHHHHH
Confidence 999988888999999999999999999999964321 11111111 111111111 11233467899
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 011196 425 LLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~ 444 (491)
.+||+.||++||++.|++++
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHccCChhhCCCHHHHhhC
Confidence 99999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.8e-20 Score=178.93 Aligned_cols=176 Identities=20% Similarity=0.311 Sum_probs=123.5
Q ss_pred eeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 244 RYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.|.++.|..++....... ..........++.+++.++.++|..++. |+||||+||+++.++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~-------h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 77 LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI-------HRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred EEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCee-------cCCCCHHhEEECCCCCEEEeecccce
Confidence 456666665544333222 2233555667788888888888877666 99999999999999999999999987
Q ss_pred ecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccc
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAE 402 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (491)
....... ......++..|++||++.+..++.++|+||||+++||+++|..|+..... ...... .......
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~- 219 (277)
T cd06641 150 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP------MKVLFL-IPKNNPP- 219 (277)
T ss_pred ecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch------HHHHHH-HhcCCCC-
Confidence 6543221 11234678899999999888889999999999999999999999743211 111111 1111111
Q ss_pred cccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 403 LMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 403 ~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
. .+......+.+++.+||+.+|++||++.+++++
T Consensus 220 ----~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 ----T----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----C----CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1 111223456778999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.8e-19 Score=173.33 Aligned_cols=162 Identities=24% Similarity=0.289 Sum_probs=115.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..++. |+||+|+||+++.++.+||+|||++........ ....++..|++|
T Consensus 104 ~~~~~~i~~~i~~~L~~lH~~~i~-------H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~p 172 (287)
T cd06621 104 EKVLGKIAESVLKGLSYLHSRKII-------HRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAP 172 (287)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCHHHEEEecCCeEEEeecccccccccccc----ccccCCccccCH
Confidence 445667888899999999988777 999999999999999999999999875432211 134568899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|.+.+..++.++||||||+++|||++|+.|+....... ....+. ...........+.+.. .. ...-...+.+++.
T Consensus 173 E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~li~ 247 (287)
T cd06621 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIEL-LSYIVNMPNPELKDEP-GN--GIKWSEEFKDFIK 247 (287)
T ss_pred HHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHH-HHHHhcCCchhhccCC-CC--CCchHHHHHHHHH
Confidence 99988889999999999999999999999976432211 111111 1111111111111110 00 0112345778999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 011196 426 LCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~ 443 (491)
+||+.||++|||+.||++
T Consensus 248 ~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 248 QCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHcCCCcccCCCHHHHHh
Confidence 999999999999999887
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=5e-20 Score=185.80 Aligned_cols=168 Identities=17% Similarity=0.193 Sum_probs=113.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++..... .....++..|+||
T Consensus 116 ~~~~~~~~~qi~~aL~~LH~~~i~-------H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aP 183 (342)
T cd07879 116 EDKVQYLVYQMLCGLKYIHSAGII-------HRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAP 183 (342)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccCh
Confidence 445566778888899999987766 9999999999999999999999998754221 1234678899999
Q ss_pred hhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh-----------cCCcccccc---chhcC
Q 011196 346 EYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC-----------EGHAAELMD---SVVKQ 410 (491)
Q Consensus 346 E~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~d---~~l~~ 410 (491)
|++.+ ..++.++||||||+++|||++|+.||..... .......+.... ........+ .....
T Consensus 184 E~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (342)
T cd07879 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRK 260 (342)
T ss_pred hhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccc
Confidence 99876 4588999999999999999999999753211 111111111100 000000000 00000
Q ss_pred CC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcC
Q 011196 411 SC---DQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM--LASD 448 (491)
Q Consensus 411 ~~---~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 448 (491)
.. .......+.+++.+||+.||++||++.+++.+ ++..
T Consensus 261 ~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 261 DFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred hHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00 00112356789999999999999999999854 5544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.1e-20 Score=184.90 Aligned_cols=167 Identities=20% Similarity=0.243 Sum_probs=112.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc--cccCceeecCCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE--ANTNRVVGTYGYM 343 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~ 343 (491)
....+.++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++........ .......|+..|+
T Consensus 104 ~~~~~~~~~qi~~aL~~LH~~giv-------H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~ 176 (332)
T cd07857 104 DAHFQSFIYQILCGLKYIHSANVL-------HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYR 176 (332)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------cCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCcccc
Confidence 455667888899999999988776 9999999999999999999999999865432211 1123457899999
Q ss_pred hhhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHH-----------hhcCCcccccc------
Q 011196 344 APEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKL-----------WCEGHAAELMD------ 405 (491)
Q Consensus 344 aPE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~d------ 405 (491)
|||++.+ ..++.++||||+|++++++++|+.||..... .......... +..........
T Consensus 177 aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (332)
T cd07857 177 APEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY---VDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIP 253 (332)
T ss_pred CcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH---HHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccC
Confidence 9998866 4588999999999999999999998753221 1111111110 00000000000
Q ss_pred -chhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 406 -SVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 406 -~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
..+. .........+.+++.+||+.||++||++.+++.
T Consensus 254 ~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 254 KKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 000011345778999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.5e-19 Score=173.59 Aligned_cols=159 Identities=23% Similarity=0.343 Sum_probs=114.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC-CceEeccCcceecCCCCcc--cccCceeecCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM-NPKISDFGMARIFGGNQSE--ANTNRVVGTYGY 342 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~-~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y 342 (491)
......++.+++.++.+||..+++ ||||||+||+++.++ .+||+|||.+......... .......|+..|
T Consensus 102 ~~~~~~~~~ql~~al~~LH~~~i~-------H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (268)
T cd06630 102 EAVIINYTEQLLRGLSYLHENQII-------HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccce
Confidence 445567788899999999988777 999999999998776 5899999998766433111 112235678899
Q ss_pred ChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHH
Q 011196 343 MAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 343 ~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
+|||.+.+..++.++||||+|++++++++|..||...... .............. ....+......+.+
T Consensus 175 ~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~ 242 (268)
T cd06630 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS---NHLALIFKIASATT---------APSIPEHLSPGLRD 242 (268)
T ss_pred eCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc---chHHHHHHHhccCC---------CCCCchhhCHHHHH
Confidence 9999998888999999999999999999999997532221 11111211111111 11222233456778
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 011196 423 IGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~ 443 (491)
++.+||+.+|++||++.++++
T Consensus 243 ~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 243 VTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHcCCCcccCcCHHHHhc
Confidence 999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-19 Score=174.53 Aligned_cols=163 Identities=20% Similarity=0.232 Sum_probs=117.8
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCc------ccccCceee
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQS------EANTNRVVG 338 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~------~~~~~~~~g 338 (491)
.......++.+++.++.++|..+++ |+||+|+||+++.++.+||+|||++........ ........+
T Consensus 91 ~~~~~~~i~~qi~~~L~~lH~~~i~-------H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (265)
T cd05579 91 DEDVARIYIAEIVLALEYLHSNGII-------HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163 (265)
T ss_pred CHHHHHHHHHHHHHHHHHHHHcCee-------cCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCccc
Confidence 3455667888999999999988777 999999999999999999999999875433211 112233567
Q ss_pred cCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHH
Q 011196 339 TYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELL 418 (491)
Q Consensus 339 t~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 418 (491)
+..|++||.......+.++||||||++++|+++|..||.... . ...... ...+... . + .......
T Consensus 164 ~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~---~~~~~~-~~~~~~~-~--~-----~~~~~~~ 228 (265)
T cd05579 164 TPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET---P---EEIFQN-ILNGKIE-W--P-----EDVEVSD 228 (265)
T ss_pred CccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---H---HHHHHH-HhcCCcC-C--C-----ccccCCH
Confidence 889999999988888999999999999999999999975321 1 111111 1111100 0 0 0000134
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 419 KYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 419 ~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
.+.+++.+||+.+|++||++.++.+.|+..+
T Consensus 229 ~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~ 259 (265)
T cd05579 229 EAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259 (265)
T ss_pred HHHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence 5678999999999999999988887777654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.6e-19 Score=176.60 Aligned_cols=156 Identities=22% Similarity=0.350 Sum_probs=110.0
Q ss_pred CcchhhhHhHHHHHHHHHhh-eeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLS-TSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.++|. .+++ ||||||+||+++.++.+||+|||++......... ....++..|+|
T Consensus 113 ~~~~~~i~~~i~~~l~~lH~~~~i~-------H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~a 182 (296)
T cd06618 113 EDILGKMTVAIVKALHYLKEKHGVI-------HRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMA 182 (296)
T ss_pred HHHHHHHHHHHHHHHHHHHhhCCEe-------cCCCcHHHEEEcCCCCEEECccccchhccCCCcc---cCCCCCccccC
Confidence 34456788888999999986 3555 9999999999999999999999998765432221 12356788999
Q ss_pred hhhhhhC----CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHH
Q 011196 345 PEYAMEG----IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKY 420 (491)
Q Consensus 345 PE~~~~~----~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 420 (491)
||++.+. .++.++||||||+++|||++|+.||.... .. .+....... .....+... .....++
T Consensus 183 PE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~---~~~~~~~~~-~~~~~~~~~-------~~~~~~l 249 (296)
T cd06618 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK--TE---FEVLTKILQ-EEPPSLPPN-------EGFSPDF 249 (296)
T ss_pred HhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch--hH---HHHHHHHhc-CCCCCCCCC-------CCCCHHH
Confidence 9998754 37889999999999999999999975321 11 111111111 111111000 0122457
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 011196 421 IHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 421 ~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.+++.+||+.||++||++.+++++
T Consensus 250 ~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 250 CSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHHHccCChhhCCCHHHHhcC
Confidence 789999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-19 Score=176.09 Aligned_cols=167 Identities=14% Similarity=0.152 Sum_probs=111.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++........ .....++..|+||
T Consensus 102 ~~~~~~~~~ql~~al~~lH~~~i~-------H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aP 172 (291)
T cd07844 102 MHNVRLFLFQLLRGLAYCHQRRVL-------HRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPP 172 (291)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cccCCHHHEEEcCCCCEEECccccccccCCCCcc--ccccccccccCCc
Confidence 345566777888899999987776 9999999999999999999999998754221111 1123467889999
Q ss_pred hhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC---cccc--------------ccch
Q 011196 346 EYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH---AAEL--------------MDSV 407 (491)
Q Consensus 346 E~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--------------~d~~ 407 (491)
|++.+ ..++.++||||+|+++|||++|+.||..... ........+....... +... ....
T Consensus 173 E~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (291)
T cd07844 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRP 250 (291)
T ss_pred HHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChh
Confidence 99875 4588999999999999999999999753221 1112222222111100 0000 0000
Q ss_pred hcCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 408 VKQSC-DQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 408 l~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
+.... .......+.+++.+||+.||++||++.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 251 LINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 0011245678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-19 Score=178.07 Aligned_cols=168 Identities=19% Similarity=0.185 Sum_probs=112.3
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||+|+||+++.++.+||+|||+++........ .....++..|+|
T Consensus 97 ~~~~~~~~~~~i~~~L~~lH~~~~~-------H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~a 167 (283)
T cd07835 97 DPPLIKSYLYQLLQGIAYCHSHRVL-------HRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRA 167 (283)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCee-------CCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCCCC
Confidence 3455677888899999999987766 9999999999999999999999999765332211 122356889999
Q ss_pred hhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC---------Cccccccchhc-----
Q 011196 345 PEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG---------HAAELMDSVVK----- 409 (491)
Q Consensus 345 PE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~d~~l~----- 409 (491)
||++.+. .++.++||||||+++|||++|+.||..... ......+.+..... ...+.......
T Consensus 168 PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (283)
T cd07835 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE---IDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQD 244 (283)
T ss_pred CceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccc
Confidence 9988664 478899999999999999999999753211 11111111110000 00000000000
Q ss_pred -CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 410 -QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 410 -~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..........+.+++.+||+.||++||+++|++++
T Consensus 245 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 245 LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00011112457789999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-19 Score=180.44 Aligned_cols=185 Identities=14% Similarity=0.135 Sum_probs=122.6
Q ss_pred eeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 245 YELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
|.+++|..+........ ..........++.+++.++.++|..+++ ||||||+||+++.++.+||+|||+++
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~-------H~dl~p~NIll~~~~~~~l~dfg~~~ 149 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIV-------HRDLKPDNLLITSMGHIKLTDFGLSK 149 (305)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------ccCCchHHEEECCCCCEEEeeCCCcc
Confidence 45556655443322211 1122334455677888899999987766 99999999999999999999999986
Q ss_pred ecCCCC-------------cccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHH
Q 011196 323 IFGGNQ-------------SEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLA 389 (491)
Q Consensus 323 ~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 389 (491)
...... .........++..|+|||++.+..++.++||||||+++||+++|..||... ....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~---~~~~--- 223 (305)
T cd05609 150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD---TPEE--- 223 (305)
T ss_pred ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHH---
Confidence 421100 000111245788999999998888999999999999999999999997421 1111
Q ss_pred HHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 011196 390 YIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIV 450 (491)
Q Consensus 390 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 450 (491)
.......+.. ..+.... .....+.+++.+||+.||++||++.++.+.|+..+.
T Consensus 224 -~~~~~~~~~~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 224 -LFGQVISDDI---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred -HHHHHHhccc---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 1111111111 0111111 122346789999999999999998888888887643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.78 E-value=4e-19 Score=171.67 Aligned_cols=158 Identities=23% Similarity=0.369 Sum_probs=112.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccc--cCceeecCCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEAN--TNRVVGTYGYM 343 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~--~~~~~gt~~y~ 343 (491)
......++.+++.++.+||..++. |+||||+||++++++.+||+|||++........... .....++..|+
T Consensus 98 ~~~~~~i~~~i~~~l~~lh~~~i~-------H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T cd06626 98 EHVIRVYTLQLLEGLAYLHSHGIV-------HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM 170 (264)
T ss_pred hHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCcc
Confidence 455666788889999999988777 999999999999999999999999987643322111 11246788999
Q ss_pred hhhhhhhCC---CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHH
Q 011196 344 APEYAMEGI---FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKY 420 (491)
Q Consensus 344 aPE~~~~~~---~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 420 (491)
+||++.+.. ++.++||||||++++|+++|+.||.... .. ........ ......+ .. .......+
T Consensus 171 ~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~--~~---~~~~~~~~-~~~~~~~-----~~--~~~~~~~~ 237 (264)
T cd06626 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD--NE---FQIMFHVG-AGHKPPI-----PD--SLQLSPEG 237 (264)
T ss_pred ChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc--ch---HHHHHHHh-cCCCCCC-----Cc--ccccCHHH
Confidence 999998766 8899999999999999999999975322 11 11111111 1111111 00 00113345
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 011196 421 IHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 421 ~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+++.+||+.+|++||++.+++.
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhc
Confidence 67889999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-19 Score=176.28 Aligned_cols=154 Identities=21% Similarity=0.326 Sum_probs=109.6
Q ss_pred CcchhhhHhHHHHHHHHHhhe-eeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLST-SFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.++|.. .++ ||||||+||+++.++.+||+|||++........ .....|+..|+|
T Consensus 102 ~~~~~~~~~qi~~~l~~lH~~~~i~-------h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~a 171 (283)
T cd06617 102 EDILGKIAVSIVKALEYLHSKLSVI-------HRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA---KTIDAGCKPYMA 171 (283)
T ss_pred HHHHHHHHHHHHHHHHHHhhcCCee-------cCCCCHHHEEECCCCCEEEeecccccccccccc---cccccCCccccC
Confidence 445567788888888999874 555 999999999999999999999999876532211 122467889999
Q ss_pred hhhhhh----CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHH
Q 011196 345 PEYAME----GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKY 420 (491)
Q Consensus 345 PE~~~~----~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 420 (491)
||++.+ ..++.++|+||||+++|||++|+.|+.... . .......... +....+.. . .....+
T Consensus 172 PE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~---~~~~~~~~~~-~~~~~~~~----~----~~~~~l 237 (283)
T cd06617 172 PERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK--T---PFQQLKQVVE-EPSPQLPA----E----KFSPEF 237 (283)
T ss_pred hhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc--c---CHHHHHHHHh-cCCCCCCc----c----ccCHHH
Confidence 998864 446889999999999999999999974211 1 1111111111 11111110 1 112356
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 011196 421 IHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 421 ~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+++.+||+.+|++||++.+|++
T Consensus 238 ~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 238 QDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 78999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-19 Score=173.14 Aligned_cols=177 Identities=17% Similarity=0.210 Sum_probs=121.3
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.+++|..+........ ..........++.+++.++.++|..+++ |+||||+||+++.++.+||+|||++
T Consensus 68 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~-------h~dl~~~nilv~~~~~~~l~df~~~ 140 (262)
T cd05572 68 IYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGII-------YRDLKPENLLLDSNGYVKLVDFGFA 140 (262)
T ss_pred cEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcc-------cCCCCHHHEEEcCCCCEEEeeCCcc
Confidence 455566665444322221 1223445566777888888889887766 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+...... ......++..|++||.+.+..++.++|+||||+++||+++|..|+..... +...............
T Consensus 141 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~ 213 (262)
T cd05572 141 KKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDILKGNGKL 213 (262)
T ss_pred cccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHhccCCCC
Confidence 8664432 12234678899999999888899999999999999999999999754321 1111111111001000
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT-----MSSVAV 443 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~ 443 (491)
..+......+.+++.+||+.||++||+ +.|+++
T Consensus 214 ---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 214 ---------EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ---------CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 111112345778999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.5e-19 Score=174.10 Aligned_cols=186 Identities=17% Similarity=0.185 Sum_probs=124.7
Q ss_pred eeeeecccccCCCCccccCC--CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 243 IRYELYRFLVDTPTVTVTAP--NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
..|.++.|..++........ .........++.+++.++.+||..+++ ||||||+||+++.++.++|+|||+
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~-------H~dl~p~nil~~~~~~~~l~dfg~ 151 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGII-------YRDIKLENILLDSEGHVVLTDFGL 151 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCee-------ccCCCHHHeEECCCCCEEEEECcc
Confidence 34556666654433222111 122344556677888899999987776 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCC--CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI--FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
++........ ......|+..|++||.+.+.. .+.++||||||++++||++|..||...... .......+.....
T Consensus 152 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~ 227 (288)
T cd05583 152 SKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ---NSQSEISRRILKS 227 (288)
T ss_pred cccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc---chHHHHHHHHHcc
Confidence 8765432211 122346788999999987655 788999999999999999999997532111 1111111111111
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
. +. .+......+.+++.+||+.||++|||+.++.+.|+...
T Consensus 228 ~------~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 228 K------PP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred C------CC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 0 00 11112234667899999999999999999988887753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-19 Score=177.97 Aligned_cols=167 Identities=19% Similarity=0.242 Sum_probs=114.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++++||..+++ ||||||+||++++++.+||+|||++......... ......++..|++|
T Consensus 115 ~~~~~~i~~qi~~aL~~LH~~~i~-------H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~P 186 (302)
T cd07864 115 EDHIKSFMKQLLEGLNYCHKKNFL-------HRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPP 186 (302)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccCh
Confidence 455677888999999999988777 9999999999999999999999999865433221 11223567889999
Q ss_pred hhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC---cccccc--------------ch
Q 011196 346 EYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH---AAELMD--------------SV 407 (491)
Q Consensus 346 E~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d--------------~~ 407 (491)
|.+.+. .++.++||||||++++||++|+.||... ........+........ +.++.. ..
T Consensus 187 E~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (302)
T cd07864 187 ELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN---QELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRR 263 (302)
T ss_pred HHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCChhhcccccccccccccccccccccc
Confidence 988653 4788999999999999999999987532 22222222222111110 011100 00
Q ss_pred hcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 408 VKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 408 l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
...... .....+.+++.+||+.||++||++.++++.
T Consensus 264 ~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 264 LREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 113457889999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-19 Score=176.09 Aligned_cols=166 Identities=19% Similarity=0.203 Sum_probs=113.1
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.....+.++.+++.++.+||..++. |+||||+||+++.++.++|+|||++........ .....++..|+|
T Consensus 97 ~~~~~~~~~~~l~~~l~~Lh~~~i~-------H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~a 166 (283)
T cd07830 97 SESVIRSIIYQILQGLAHIHKHGFF-------HRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRA 166 (283)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcc-------cCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccccC
Confidence 3455677888888999999987766 999999999999999999999999986543222 123467889999
Q ss_pred hhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc-------------CCcc----ccccc
Q 011196 345 PEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE-------------GHAA----ELMDS 406 (491)
Q Consensus 345 PE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-------------~~~~----~~~d~ 406 (491)
||++.+ ..++.++|+||||++++||++|+.||...... ............ .... .....
T Consensus 167 PE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T cd07830 167 PEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI---DQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPT 243 (283)
T ss_pred ceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH---HHHHHHHHhcCCCChhhhhhHhhhhccccccccccccc
Confidence 998754 45789999999999999999999887533211 111111000000 0000 00000
Q ss_pred hhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 407 VVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 407 ~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.+.... ......+.+++.+||+.||++||+++|++.+
T Consensus 244 ~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 244 SLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000 0113567889999999999999999998763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.2e-19 Score=177.90 Aligned_cols=148 Identities=16% Similarity=0.242 Sum_probs=114.6
Q ss_pred hhhhHhHHHHHHHHHhheeeEEeEEeeecccccccccccc-CCCCceEeccCcceecCCCCcccccCceeecCCCChhhh
Q 011196 269 WITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLD-HEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY 347 (491)
Q Consensus 269 ~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 347 (491)
......++..+|.|.|.+..+ ||||||+||.+- .-|-+||.|||++..+..++ .....+|+..|-|||+
T Consensus 120 a~kYF~QI~~AI~YCHqLHVV-------HRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~---kL~TsCGSLAYSAPEI 189 (864)
T KOG4717|consen 120 AKKYFAQIVHAISYCHQLHVV-------HRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK---KLTTSCGSLAYSAPEI 189 (864)
T ss_pred HHHHHHHHHHHHHHHhhhhhh-------cccCCcceeEEeeecCceEeeeccccccCCCcc---hhhcccchhhccCchh
Confidence 445666777778888777666 999999998765 45889999999998765443 3446799999999999
Q ss_pred hhhCCCC-cccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHH
Q 011196 348 AMEGIFS-VKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLL 426 (491)
Q Consensus 348 ~~~~~~s-~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~ 426 (491)
+.+..|+ +++||||+|||||-+++|+.||..-++. +.+..++|-.. ..+.-...+|.+|+..
T Consensus 190 LLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---------------ETLTmImDCKY--tvPshvS~eCrdLI~s 252 (864)
T KOG4717|consen 190 LLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---------------ETLTMIMDCKY--TVPSHVSKECRDLIQS 252 (864)
T ss_pred hhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---------------hhhhhhhcccc--cCchhhhHHHHHHHHH
Confidence 9999997 5899999999999999999997532211 12223344332 2344556778999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 011196 427 CVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 427 cl~~dP~~RPs~~evl~ 443 (491)
||+.||++|.+.+||+.
T Consensus 253 MLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 253 MLVRDPKKRASLEEIVS 269 (864)
T ss_pred HHhcCchhhccHHHHhc
Confidence 99999999999999875
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-19 Score=175.06 Aligned_cols=155 Identities=25% Similarity=0.282 Sum_probs=111.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..++. ||||||+||+++.++.+||+|||++....... ......++..|++|
T Consensus 94 ~~~~~~~~~ql~~~l~~lH~~~i~-------H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~P 163 (277)
T cd05577 94 EARAIFYAAQIICGLEHLHQRRIV-------YRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAP 163 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------cCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCCCCcCCH
Confidence 445566778888999999987776 99999999999999999999999987653321 12234578899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|++.++.++.++||||||+++++|++|+.||........ .......... .. . ..+......+.+++.
T Consensus 164 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~-~~-----~----~~~~~~~~~~~~li~ 230 (277)
T cd05577 164 EVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE---KEELKRRTLE-MA-----V----EYPDKFSPEAKDLCE 230 (277)
T ss_pred HHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc---HHHHHhcccc-cc-----c----cCCccCCHHHHHHHH
Confidence 999888899999999999999999999999754322111 1111111000 00 0 111112345678999
Q ss_pred HcccCCCCCCC-----CHHHHHH
Q 011196 426 LCVQEDPMDRP-----TMSSVAV 443 (491)
Q Consensus 426 ~cl~~dP~~RP-----s~~evl~ 443 (491)
+||+.||++|| ++.+++.
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 231 ALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHccCChhHccCCCcccHHHHHh
Confidence 99999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.5e-19 Score=175.33 Aligned_cols=152 Identities=24% Similarity=0.360 Sum_probs=111.6
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.++|..+++ ||||||+||++++++.+||+|||++...... ....++..|+|
T Consensus 113 ~~~~~~~~~~ql~~~L~~LH~~~i~-------H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~a 179 (307)
T cd06607 113 QEVEIAAICHGALQGLAYLHSHERI-------HRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMA 179 (307)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCce-------ecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccC
Confidence 3455667788899999999988776 9999999999999999999999998754322 23457889999
Q ss_pred hhhhh---hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 345 PEYAM---EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 345 PE~~~---~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
||++. ...++.++||||||+++|||++|+.|+.... ......... ......+ ........+.
T Consensus 180 PE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~------~~~~~~~~~-~~~~~~~--------~~~~~~~~~~ 244 (307)
T cd06607 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIA-QNDSPTL--------SSNDWSDYFR 244 (307)
T ss_pred ceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc------HHHHHHHHh-cCCCCCC--------CchhhCHHHH
Confidence 99874 3568899999999999999999999964211 111111111 1111111 0112234577
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
+++.+||+.||++||++.+|+.+
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcC
Confidence 89999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.5e-19 Score=172.64 Aligned_cols=178 Identities=19% Similarity=0.273 Sum_probs=120.8
Q ss_pred eeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.+++|+.++....... ..........++.+++.++.+||..+++ |+||||+||+++.++.+||+|||+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~-------h~dl~p~nili~~~~~~~l~d~g~ 149 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVI-------HRDLKAGNILLTLDGDVKLADFGV 149 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------cCCCChhhEEECCCCCEEEccCcc
Confidence 355566665544322211 1223456677888999999999988776 999999999999999999999998
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhh-----CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHh
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAME-----GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLW 395 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 395 (491)
+........ ......++..|++||++.. ..++.++||||||+++|||++|+.||.... . .... ..+
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~---~---~~~~-~~~ 220 (280)
T cd06611 150 SAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN---P---MRVL-LKI 220 (280)
T ss_pred chhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC---H---HHHH-HHH
Confidence 865432211 1223568899999999853 346789999999999999999999975321 1 1111 111
Q ss_pred hcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 396 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 396 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.......+.. +......+.+++.+||+.+|++||++.+|++.
T Consensus 221 ~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 221 LKSEPPTLDQ-------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred hcCCCCCcCC-------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1111111100 11112346678999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-19 Score=174.14 Aligned_cols=178 Identities=15% Similarity=0.162 Sum_probs=124.7
Q ss_pred eeecccccCCCCccccCCCC----CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 245 YELYRFLVDTPTVTVTAPNK----TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
+.++.|..++....++...+ +.....-.+..+..++.|||.++++ .|||||+||||.++|++-|+||.+
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGiv-------YRDLKPENILvredGHIMLsDFDL 225 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIV-------YRDLKPENILVREDGHIMLSDFDL 225 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhcee-------eccCCcceeEEecCCcEEeeeccc
Confidence 34455655555544432222 2333444677788889999999999 999999999999999999999999
Q ss_pred ceecCC---------------------------------C-Cc--------------------ccccCceeecCCCChhh
Q 011196 321 ARIFGG---------------------------------N-QS--------------------EANTNRVVGTYGYMAPE 346 (491)
Q Consensus 321 a~~~~~---------------------------------~-~~--------------------~~~~~~~~gt~~y~aPE 346 (491)
+..... . .. ......++||-.|+|||
T Consensus 226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE 305 (459)
T KOG0610|consen 226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE 305 (459)
T ss_pred cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence 753210 0 00 01122478999999999
Q ss_pred hhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHH
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLL 426 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~ 426 (491)
++.+..++.++|-|.|||++|||+.|..||....... .+.+++-+.+.-.........+.+||.+
T Consensus 306 vI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~ 370 (459)
T KOG0610|consen 306 VIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPLKFPEEPEVSSAAKDLIRK 370 (459)
T ss_pred eeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCCcCCCCCcchhHHHHHHHH
Confidence 9999999999999999999999999999986433221 1122222222211122344567789999
Q ss_pred cccCCCCCCCC----HHHHHHH
Q 011196 427 CVQEDPMDRPT----MSSVAVM 444 (491)
Q Consensus 427 cl~~dP~~RPs----~~evl~~ 444 (491)
.|.+||++|.. +.||.++
T Consensus 371 LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 371 LLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HhccChhhhhccccchHHhhcC
Confidence 99999999998 7777654
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-19 Score=181.98 Aligned_cols=169 Identities=20% Similarity=0.214 Sum_probs=117.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCc-ccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQS-EANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||..++. ||||||+|||++.++.++|+|||++........ ........++..|+|
T Consensus 102 ~~~~~~i~~~l~~~l~~LH~~gi~-------H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 174 (330)
T cd07834 102 DDHIQYFLYQILRGLKYLHSANVI-------HRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174 (330)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCC
Confidence 445666888899999999998877 999999999999999999999999987644321 011233567889999
Q ss_pred hhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh-----------cCCccccccchh-cCC
Q 011196 345 PEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC-----------EGHAAELMDSVV-KQS 411 (491)
Q Consensus 345 PE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~d~~l-~~~ 411 (491)
||++.+. .++.++||||||+++++|++|+.||..... ......+..... .....+.+.... ...
T Consensus 175 PE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (330)
T cd07834 175 PELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY---IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPK 251 (330)
T ss_pred ceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCc
Confidence 9999887 789999999999999999999999754321 111111111110 000000000000 000
Q ss_pred -----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 412 -----CDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 412 -----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
........+.+++.+||+.+|++||++.+++.+
T Consensus 252 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 252 KPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred chhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011123457789999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.1e-19 Score=178.42 Aligned_cols=168 Identities=17% Similarity=0.183 Sum_probs=109.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC-CCCceEeccCcceecCCCCccc-ccCceeecCCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH-EMNPKISDFGMARIFGGNQSEA-NTNRVVGTYGYM 343 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~-~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~ 343 (491)
......++.+++.++.+||..+++ ||||||+||+++. ++.+||+|||+++......... ......++..|+
T Consensus 113 ~~~~~~~~~qi~~aL~~LH~~giv-------H~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 185 (342)
T cd07854 113 EEHARLFMYQLLRGLKYIHSANVL-------HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185 (342)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------cCCCCHHHEEEcCCCceEEECCcccceecCCcccccccccccccccccc
Confidence 455667888899999999988766 9999999999974 5578999999997653322111 112235788999
Q ss_pred hhhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh-----------cCCccccccchhcCC
Q 011196 344 APEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC-----------EGHAAELMDSVVKQS 411 (491)
Q Consensus 344 aPE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~d~~l~~~ 411 (491)
|||++.+ ..++.++|||||||++|||++|+.||...... ........... ...............
T Consensus 186 aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (342)
T cd07854 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL---EQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPR 262 (342)
T ss_pred CHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccC
Confidence 9998765 45788999999999999999999997532211 00000000000 000000000000000
Q ss_pred CC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 412 CD-----QAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 412 ~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+ .....++.+++.+||+.||++||++.|++.
T Consensus 263 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 263 RPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00 011245678999999999999999999884
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-19 Score=175.65 Aligned_cols=166 Identities=18% Similarity=0.163 Sum_probs=110.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++........ ......++..|+||
T Consensus 99 ~~~~~~~~~~i~~~l~~lh~~~i~-------H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aP 169 (284)
T cd07860 99 LPLIKSYLFQLLQGLAFCHSHRVL-------HRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 169 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHEEECCCCCEEEeeccchhhcccCcc--ccccccccccccCC
Confidence 344566788888999999987766 999999999999999999999999876543221 11223567889999
Q ss_pred hhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC----------------ccccccchh
Q 011196 346 EYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH----------------AAELMDSVV 408 (491)
Q Consensus 346 E~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~d~~l 408 (491)
|++.+.. ++.++||||||++++||++|+.||.... .........+...... ........+
T Consensus 170 E~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (284)
T cd07860 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS---EIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDF 246 (284)
T ss_pred eEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCH
Confidence 9887644 5889999999999999999999975321 1111111111110000 000000000
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 409 KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.. ........+.+++.+||+.||++||++++++++
T Consensus 247 ~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 247 SK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00 000112345689999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.5e-19 Score=160.34 Aligned_cols=151 Identities=19% Similarity=0.225 Sum_probs=116.4
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
.....+...+++.++.|+|...++ ||||||+|+|++..+..||+|||-+...+.+. ....+||..|.+|
T Consensus 123 e~~~a~Yi~q~A~Al~y~h~k~VI-------hRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k----R~tlcgt~dyl~p 191 (281)
T KOG0580|consen 123 EQRAATYIKQLANALLYCHLKRVI-------HRDIKPENLLLGSAGELKIADFGWSVHAPSNK----RKTLCGTLDYLPP 191 (281)
T ss_pred ccchhHHHHHHHHHHHHhccCCcc-------cCCCCHHHhccCCCCCeeccCCCceeecCCCC----ceeeecccccCCH
Confidence 455667888899998888887666 99999999999999999999999997654322 3357899999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|...+..++..+|+|++|++.+|++.|.+||.... ..+....+.+ - ++.+| ........+++.
T Consensus 192 Emv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k----~---~~~~p-------~~is~~a~dlI~ 254 (281)
T KOG0580|consen 192 EMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRK----V---DLKFP-------STISGGAADLIS 254 (281)
T ss_pred hhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHH----c---cccCC-------cccChhHHHHHH
Confidence 99999999999999999999999999999986432 1122222211 1 11122 122234567888
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 011196 426 LCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~ 444 (491)
+|+..+|.+|.+..|++++
T Consensus 255 ~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 255 RLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHhccCccccccHHHHhhh
Confidence 9999999999999998864
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.9e-19 Score=176.85 Aligned_cols=170 Identities=18% Similarity=0.237 Sum_probs=110.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc-----cccCceeecC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE-----ANTNRVVGTY 340 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~ 340 (491)
......++.+++.++.++|..+++ ||||||+|||++.++.+|+.||+........... .......++.
T Consensus 100 ~~~~~~~~~qi~~aL~~lH~~~iv-------HrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (328)
T cd08226 100 EALIGNILFGALRGLNYLHQNGYI-------HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVL 172 (328)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCcc
Confidence 334456788888899999987766 9999999999999999999999865432211100 0011123456
Q ss_pred CCChhhhhhhC--CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHH----------------H-------h
Q 011196 341 GYMAPEYAMEG--IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWK----------------L-------W 395 (491)
Q Consensus 341 ~y~aPE~~~~~--~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~----------------~-------~ 395 (491)
.|++||++.+. .++.++||||||++++||++|+.||...... ......... . +
T Consensus 173 ~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (328)
T cd08226 173 PWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGV 250 (328)
T ss_pred CccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccccchhhhhhccchhhh
Confidence 79999999764 4789999999999999999999997532210 000000000 0 0
Q ss_pred h---------cCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 396 C---------EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 396 ~---------~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
. ......+.+..+...........+.+++.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 251 DSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 000001111111112223345678899999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.4e-19 Score=170.04 Aligned_cols=154 Identities=21% Similarity=0.311 Sum_probs=112.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC-CceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM-NPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.++|..++. |+||||+||++++++ .+||+|||.+......... .....|+..|+|
T Consensus 100 ~~~~~~~~~~l~~~l~~lh~~~i~-------H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~a 170 (257)
T cd08225 100 EDQILSWFVQISLGLKHIHDRKIL-------HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL--AYTCVGTPYYLS 170 (257)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------cccCCHHHEEEcCCCCeEEecccccchhccCCccc--ccccCCCccccC
Confidence 455677788889999999988777 999999999999885 4699999998765432221 122457889999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||+..+..++.++|+||||++++|+++|+.|+.... ......... .+..... .......+.+++
T Consensus 171 pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~-~~~~~~~---------~~~~~~~~~~~i 234 (257)
T cd08225 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKIC-QGYFAPI---------SPNFSRDLRSLI 234 (257)
T ss_pred HHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHh-cccCCCC---------CCCCCHHHHHHH
Confidence 999988889999999999999999999999974221 112222211 1111111 111223577889
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 011196 425 LLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~ 444 (491)
.+||+.+|++||++.||+++
T Consensus 235 ~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 235 SQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHhccChhhCcCHHHHhhC
Confidence 99999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-19 Score=173.59 Aligned_cols=152 Identities=21% Similarity=0.205 Sum_probs=114.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..++. |+||||+||++++++.+||+|||++....... .....++..|++|
T Consensus 102 ~~~~~~~~~~l~~al~~lh~~~i~-------h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~----~~~~~~~~~~~~P 170 (256)
T cd08530 102 EQEIWRIFIQLLRGLQALHEQKIL-------HRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGTPHYMAP 170 (256)
T ss_pred HHHHHHHHHHHHHHHHHHhhCCcc-------cCCCCcceEEEecCCcEEEeeccchhhhccCC----cccccCCccccCH
Confidence 345567788888999999988776 99999999999999999999999998764431 1224578899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|.+.+..++.++|+||||++++|+++|+.||.... ...+. .....+.... .+......+.+++.
T Consensus 171 e~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~---~~~~~----~~~~~~~~~~---------~~~~~~~~~~~li~ 234 (256)
T cd08530 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS---MQDLR----YKVQRGKYPP---------IPPIYSQDLQNFIR 234 (256)
T ss_pred HHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHH----HHHhcCCCCC---------CchhhCHHHHHHHH
Confidence 99988889999999999999999999999975322 11111 1111111111 12233455788999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 011196 426 LCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~ 444 (491)
+||+.+|++||++.++++.
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 235 SMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHcCCCcccCCCHHHHhcC
Confidence 9999999999999998864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-19 Score=178.86 Aligned_cols=177 Identities=22% Similarity=0.326 Sum_probs=120.0
Q ss_pred ceeeeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEecc
Q 011196 242 SIRYELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDF 318 (491)
Q Consensus 242 ~lry~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~Df 318 (491)
...|.+++|..+ ...... ..+........++.+++.++.++|..++. ||||||+||+++.++.+||+||
T Consensus 98 ~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~-------H~dL~p~Nil~~~~~~~kl~df 169 (317)
T cd06635 98 HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI-------HRDIKAGNILLTEPGQVKLADF 169 (317)
T ss_pred CeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCcccEEECCCCCEEEecC
Confidence 345566666643 221111 11123445566778888889999987766 9999999999999999999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhh---hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHh
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAM---EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLW 395 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 395 (491)
|++..... .....|+..|+|||++. .+.++.++||||||+++|||++|+.|+... .. ...... +
T Consensus 170 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~---~~---~~~~~~-~ 236 (317)
T cd06635 170 GSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NA---MSALYH-I 236 (317)
T ss_pred CCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc---cH---HHHHHH-H
Confidence 99865432 12346788999999984 456889999999999999999999996421 11 111111 1
Q ss_pred hcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 011196 396 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 396 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
........ ........+.+++.+||+.+|++||++.+|++.+-.
T Consensus 237 ~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 237 AQNESPTL--------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred HhccCCCC--------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 11111000 011122346779999999999999999999976544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.8e-19 Score=170.85 Aligned_cols=175 Identities=20% Similarity=0.193 Sum_probs=121.5
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.+++|+.+........ .+........++.+++.++.+||..+++ |+||||+||++++++.++|+|||++
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~-------h~dl~~~nil~~~~~~~~l~d~~~~ 147 (258)
T cd05578 75 MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGII-------HRDIKPDNILLDEQGHVHITDFNIA 147 (258)
T ss_pred EEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCee-------ccCCCHHHeEEcCCCCEEEeecccc
Confidence 445555655443321111 1233455667788889999999988777 9999999999999999999999998
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
........ .....|+..|++||.+.+..++.++|+||||++++++++|..|+...... ............ .
T Consensus 148 ~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~--~ 218 (258)
T cd05578 148 TKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQETA--D 218 (258)
T ss_pred cccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhccc--c
Confidence 76543321 22346788999999998888999999999999999999999997643321 111111111110 0
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTM--SSVA 442 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~--~evl 442 (491)
...+......+.+++.+||+.||++||++ +|++
T Consensus 219 --------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 --------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 01111223567789999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-19 Score=179.19 Aligned_cols=150 Identities=18% Similarity=0.252 Sum_probs=113.4
Q ss_pred hhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhh
Q 011196 270 ITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM 349 (491)
Q Consensus 270 ~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 349 (491)
.-+..-+..++.|||..+++ .|||||+|.++|.+|.+||.|||+++.+..+. .+.+++||+.|.|||++.
T Consensus 523 rF~~acv~EAfeYLH~k~iI-------YRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---KTwTFcGTpEYVAPEIIL 592 (732)
T KOG0614|consen 523 RFYVACVLEAFEYLHRKGII-------YRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---KTWTFCGTPEYVAPEIIL 592 (732)
T ss_pred hhhHHHHHHHHHHHHhcCce-------eccCChhheeeccCCceEEeehhhHHHhccCC---ceeeecCCcccccchhhh
Confidence 34556677888899988887 99999999999999999999999999886544 456799999999999999
Q ss_pred hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHccc
Q 011196 350 EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQ 429 (491)
Q Consensus 350 ~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~ 429 (491)
...++.++|.|++|++++|+++|.+||...+.....++ +.+.... ..+|........+++++...
T Consensus 593 nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~---ILkGid~------------i~~Pr~I~k~a~~Lik~LCr 657 (732)
T KOG0614|consen 593 NKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL---ILKGIDK------------IEFPRRITKTATDLIKKLCR 657 (732)
T ss_pred ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH---HHhhhhh------------hhcccccchhHHHHHHHHHh
Confidence 99999999999999999999999999864433222222 2111111 11222333445678888888
Q ss_pred CCCCCCCC-----HHHHHHH
Q 011196 430 EDPMDRPT-----MSSVAVM 444 (491)
Q Consensus 430 ~dP~~RPs-----~~evl~~ 444 (491)
.+|.+|.. +.+|-.+
T Consensus 658 ~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 658 DNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred cCcHhhhccccCChHHHHhh
Confidence 99999976 5555543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-19 Score=180.01 Aligned_cols=156 Identities=20% Similarity=0.205 Sum_probs=116.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC----CCceEeccCcceecCCCCcccccCceeecCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE----MNPKISDFGMARIFGGNQSEANTNRVVGTYG 341 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~----~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 341 (491)
......++.+++.++.++|..+++ ||||||+|+|+... +.+|++|||++..... .......+||+.
T Consensus 134 E~da~~~~~~il~av~~lH~~gvv-------HrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~ 203 (382)
T KOG0032|consen 134 ERDAAGIIRQILEAVKYLHSLGVV-------HRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPE 203 (382)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCce-------eccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCcc
Confidence 455667888889999999998777 99999999999644 4799999999998765 223445799999
Q ss_pred CChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 342 YMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 342 y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
|+|||++....|+..+||||+|+++|.|++|.+||...... .... ....+.+ ++.+ +.-........
T Consensus 204 y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~---~~~~----~i~~~~~-~f~~-----~~w~~is~~ak 270 (382)
T KOG0032|consen 204 YVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF---EIFL----AILRGDF-DFTS-----EPWDDISESAK 270 (382)
T ss_pred ccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh---HHHH----HHHcCCC-CCCC-----CCccccCHHHH
Confidence 99999999999999999999999999999999997532211 1111 1112221 1111 11112234456
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
+++..++..||.+|+++.+++++
T Consensus 271 d~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 271 DFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHhcccCcccCCCHHHHhcC
Confidence 78889999999999999999984
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.9e-19 Score=168.12 Aligned_cols=154 Identities=21% Similarity=0.337 Sum_probs=116.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..++. |+||||+||+++.++.+||+|||++........ ......|+..|+||
T Consensus 102 ~~~~~~i~~~i~~~l~~lh~~~~~-------H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~p 172 (258)
T cd08215 102 EEQILDWFVQLCLALKYLHSRKIL-------HRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSP 172 (258)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEe-------cccCChHHeEEcCCCcEEECCccceeecccCcc--eecceeeeecccCh
Confidence 455677888889999999998887 999999999999999999999999987644331 22335788899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|...+..++.++||||+|+++++|++|+.|+.... ... ............+ +......+.+++.
T Consensus 173 e~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~-~~~~~~~~~~~~~---------~~~~~~~~~~~i~ 236 (258)
T cd08215 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLE-LALKILKGQYPPI---------PSQYSSELRNLVS 236 (258)
T ss_pred hHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHH-HHHHHhcCCCCCC---------CCCCCHHHHHHHH
Confidence 99988889999999999999999999999964322 111 1111112111111 1122245678999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 011196 426 LCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~ 444 (491)
+||+.+|++||++.+++++
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 237 SLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHcCCChhhCcCHHHHhcC
Confidence 9999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.7e-19 Score=174.07 Aligned_cols=177 Identities=16% Similarity=0.261 Sum_probs=120.6
Q ss_pred eeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 244 RYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.|.++.|..+........ ..........++.+++.++.++|..+++ |+||||+||+++.++.++|+|||++.
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~giv-------H~dl~p~Nilv~~~~~~~l~dfg~~~ 164 (292)
T cd06657 92 LWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVI-------HRDIKSDSILLTHDGRVKLSDFGFCA 164 (292)
T ss_pred EEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHEEECCCCCEEEcccccce
Confidence 445556655544322221 1223445566778888889999987766 99999999999999999999999987
Q ss_pred ecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccc
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAE 402 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (491)
....... ......|+..|++||++.+..++.++|+||||++++|+++|..||... ......... .... ..
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~---~~~~~~~~~----~~~~-~~ 234 (292)
T cd06657 165 QVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMI----RDNL-PP 234 (292)
T ss_pred ecccccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHH----HhhC-Cc
Confidence 6543221 122356788999999998888899999999999999999999997421 111111111 1110 00
Q ss_pred cccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 403 LMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 403 ~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+.. + ......+.+++.+||+.||.+||++.++++
T Consensus 235 ~~~~-~-----~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 235 KLKN-L-----HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCC-c-----ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0000 0 011234567889999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=170.01 Aligned_cols=165 Identities=20% Similarity=0.198 Sum_probs=113.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||++++++.+||+|||+++....... ......++..|+||
T Consensus 97 ~~~~~~~~~~i~~~l~~LH~~~i~-------H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aP 167 (282)
T cd07829 97 PNLIKSIMYQLLRGLAYCHSHRIL-------HRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAP 167 (282)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------cCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCCh
Confidence 455677888888999999987766 999999999999999999999999986643322 11223457789999
Q ss_pred hhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHH-----------HhhcCC-----ccccccchh
Q 011196 346 EYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWK-----------LWCEGH-----AAELMDSVV 408 (491)
Q Consensus 346 E~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~-----~~~~~d~~l 408 (491)
|.+.+. .++.++||||||++++|+++|+.||.... .......+.. .+..-. .........
T Consensus 168 E~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (282)
T cd07829 168 EILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS---EIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDL 244 (282)
T ss_pred HHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccch
Confidence 998776 78899999999999999999998874322 1111111111 111100 000000000
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 409 KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
....+ .....+.+++.+||+.||++||++.+++.
T Consensus 245 ~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 245 EKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000 11346788999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-18 Score=171.88 Aligned_cols=171 Identities=19% Similarity=0.213 Sum_probs=119.3
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..+....... ...........++.+++.++.++|..+++ ||||||+||+++.++.+||+|||++
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~-------H~dl~p~nili~~~~~~kl~dfg~~ 148 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIV-------YRDLKPENLLLDSDGYIKITDFGFA 148 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEe-------cCCCCHHHEEECCCCCEEEeeCCCc
Confidence 45556666544432221 11223445556778888899999987776 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+..... .....|++.|++||.+.+...+.++||||||+++++|++|+.||.... . .........+...
T Consensus 149 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~----~~~~~~~~~~~~~ 216 (290)
T cd05580 149 KRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---P----IQIYEKILEGKVR 216 (290)
T ss_pred cccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---H----HHHHHHHhcCCcc
Confidence 865433 223467899999999988888999999999999999999999975322 1 1111111111110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAV 443 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~ 443 (491)
.+......+.+++.+||+.||++|+ +++|+++
T Consensus 217 ----------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 ----------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1111134566788999999999999 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.6e-19 Score=174.56 Aligned_cols=178 Identities=19% Similarity=0.295 Sum_probs=122.2
Q ss_pred eeeeecccccCCCCccccCC---CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 243 IRYELYRFLVDTPTVTVTAP---NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
..|.++.|..+......... .........++.+++.++.++|..++. |+||||+||+++.++.+||+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~-------H~dl~p~ni~i~~~~~~~l~d~~ 161 (286)
T cd06614 89 ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI-------HRDIKSDNILLSKDGSVKLADFG 161 (286)
T ss_pred EEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCee-------eCCCChhhEEEcCCCCEEECccc
Confidence 34556666654443322211 233455667888888999999987777 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
++........ ......++..|++||++.+..++.++||||||+++|++++|+.|+..... ...... .....
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~------~~~~~~-~~~~~ 232 (286)
T cd06614 162 FAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP------LRALFL-ITTKG 232 (286)
T ss_pred hhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HHhcC
Confidence 9865433221 11224578899999999888899999999999999999999999642211 111111 11111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
...... .......+.+++.+||+.+|.+||++.+|++
T Consensus 233 ~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 233 IPPLKN-------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCCCcc-------hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111110 1112245678999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-19 Score=170.20 Aligned_cols=162 Identities=14% Similarity=0.073 Sum_probs=112.8
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.+..|..++....... ..........++.+++.++.++|..+++ ||||||+||+++.++.++++|||.+
T Consensus 60 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~-------H~dlkp~Nil~~~~~~~~l~df~~~ 132 (237)
T cd05576 60 VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIV-------CRDLNPNNILLDDRGHIQLTYFSRW 132 (237)
T ss_pred EEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCee-------ccCCCHHHEEEcCCCCEEEecccch
Confidence 445556665554322211 1223445667788888999999987777 9999999999999999999999987
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
....... ....++..|+|||.+.+..++.++||||+|++++|+++|..|+...... .....
T Consensus 133 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~~~-- 193 (237)
T cd05576 133 SEVEDSC-----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INTHT-- 193 (237)
T ss_pred hcccccc-----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------ccccc--
Confidence 6553321 1234567799999998888899999999999999999999875321100 00000
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTM 438 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 438 (491)
.+ ..+......+.+++.+||+.||++||++
T Consensus 194 ~~-------~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 194 TL-------NIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cc-------CCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 00 0111122346678999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.8e-19 Score=178.67 Aligned_cols=169 Identities=19% Similarity=0.201 Sum_probs=114.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCC------------ccccc
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQ------------SEANT 333 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~------------~~~~~ 333 (491)
......++.+++.++.+||..++. ||||||+||+++.++.+||+|||+++...... .....
T Consensus 118 ~~~~~~~~~ql~~aL~~LH~~~i~-------H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (335)
T PTZ00024 118 ESQVKCILLQILNGLNVLHKWYFM-------HRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190 (335)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccc
Confidence 455667888889999999987776 99999999999999999999999998654111 01111
Q ss_pred CceeecCCCChhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC---ccccc-----
Q 011196 334 NRVVGTYGYMAPEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH---AAELM----- 404 (491)
Q Consensus 334 ~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~----- 404 (491)
....++..|+|||++.+. .++.++||||||++++||++|+.||.... .......+........ +....
T Consensus 191 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 267 (335)
T PTZ00024 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN---EIDQLGRIFELLGTPNEDNWPQAKKLPLY 267 (335)
T ss_pred cccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCchhhCcchhhcccc
Confidence 223567889999998764 46899999999999999999999975332 2222222222211111 00000
Q ss_pred -------cchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 011196 405 -------DSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445 (491)
Q Consensus 405 -------d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 445 (491)
.+.... ........+.+++.+||+.+|++||++.|++.+-
T Consensus 268 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 268 TEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred cccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 000000 0011234577899999999999999999998743
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-18 Score=176.09 Aligned_cols=164 Identities=20% Similarity=0.225 Sum_probs=112.5
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.++|..+++ ||||||+||+++.++.+||+|||++...... .....++..|+|
T Consensus 116 ~~~~~~~~~~ql~~aL~~LH~~gi~-------H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~a 183 (343)
T cd07851 116 SDDHIQFLVYQILRGLKYIHSAGII-------HRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 183 (343)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccC
Confidence 3455667888889999999988776 9999999999999999999999999765332 123456888999
Q ss_pred hhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHH-----------hhcCCccccccchhcC--
Q 011196 345 PEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKL-----------WCEGHAAELMDSVVKQ-- 410 (491)
Q Consensus 345 PE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~d~~l~~-- 410 (491)
||.+.+. .++.++||||||++++|+++|+.||..... ......+... +........+......
T Consensus 184 PE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (343)
T cd07851 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH---IDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPK 260 (343)
T ss_pred HHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCC
Confidence 9998653 578899999999999999999999753211 1111111111 0000000000000000
Q ss_pred -CC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 411 -SC---DQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 411 -~~---~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+ .......+.+++.+||+.||++|||+.||++
T Consensus 261 ~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 261 KDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00 0011346788999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.2e-19 Score=175.13 Aligned_cols=153 Identities=25% Similarity=0.340 Sum_probs=110.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..+++ ||||||+||+++.++.+||+|||++...... ....++..|+||
T Consensus 114 ~~~~~~~~~~l~~~l~~LH~~~i~-------H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aP 180 (308)
T cd06634 114 EVEIAAVTHGALQGLAYLHSHNMI-------HRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAP 180 (308)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------cCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccCH
Confidence 445566777888888999987766 9999999999999999999999998765322 234578899999
Q ss_pred hhhh---hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHH
Q 011196 346 EYAM---EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 346 E~~~---~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
|++. .+.++.++||||||+++|||++|..|+..... . ..... .......... .......+.+
T Consensus 181 E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~---~~~~~-~~~~~~~~~~--------~~~~~~~~~~ 245 (308)
T cd06634 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---M---SALYH-IAQNESPALQ--------SGHWSEYFRN 245 (308)
T ss_pred HHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH---H---HHHHH-HhhcCCCCcC--------cccccHHHHH
Confidence 9985 35678899999999999999999999642211 1 11111 1111111110 1122234667
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhh
Q 011196 423 IGLLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~~L~ 446 (491)
++.+||+.+|++||++.+|+....
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCcc
Confidence 899999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-18 Score=166.22 Aligned_cols=175 Identities=19% Similarity=0.267 Sum_probs=121.4
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.+++|..+........ ..........++.+++.++.++|..++. ||||||+||+++.++.+||+|||++
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~-------H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 74 LYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVI-------HRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred EEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcc-------cCCCCHHHEEECCCCCEEEeccccc
Confidence 344555554443322111 1223455667788888888888887776 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
......... .....++..|++||...+...+.++|||++|++++++++|..|+.... .....+.... ....
T Consensus 147 ~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~------~~~~~~~~~~-~~~~ 217 (254)
T cd06627 147 TKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN------PMAALFRIVQ-DDHP 217 (254)
T ss_pred eecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhc-cCCC
Confidence 876543321 223567889999999988778899999999999999999999975321 1111222111 1111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
. .+......+.+++.+||+.+|++||++.+++.
T Consensus 218 ~---------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 P---------LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C---------CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 11112345668899999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-18 Score=171.97 Aligned_cols=164 Identities=20% Similarity=0.198 Sum_probs=108.6
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC-CCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH-EMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
....++.+++.++.+||..+++ ||||||+||+++. ++.+||+|||++........ ......++..|++||
T Consensus 103 ~~~~~~~qi~~aL~~LH~~~i~-------H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE 173 (294)
T PLN00009 103 LIKTYLYQILRGIAYCHSHRVL-------HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPE 173 (294)
T ss_pred HHHHHHHHHHHHHHHHHhCCee-------CCCCCcceEEEECCCCEEEEcccccccccCCCcc--ccccCceeecccCHH
Confidence 3446777888899999987766 9999999999985 45689999999976533211 112345688999999
Q ss_pred hhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC---c------cccccchh--cC----
Q 011196 347 YAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH---A------AELMDSVV--KQ---- 410 (491)
Q Consensus 347 ~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~------~~~~d~~l--~~---- 410 (491)
++.+. .++.++||||||+++|+|++|+.||.... ..+............. + .+...... ..
T Consensus 174 ~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (294)
T PLN00009 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS---EIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLA 250 (294)
T ss_pred HHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHH
Confidence 98764 57899999999999999999999975321 1111111111111100 0 00000000 00
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 411 SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 411 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
........++.+++.+|++.||++||++.++++
T Consensus 251 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 251 TVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred HhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001112244678999999999999999999986
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.4e-19 Score=173.49 Aligned_cols=166 Identities=20% Similarity=0.223 Sum_probs=112.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..++. ||||||+||++++++.+||+|||++........ ......++..|++|
T Consensus 99 ~~~~~~~~~qi~~~l~~lH~~~i~-------h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~P 169 (284)
T cd07836 99 PNTVKSFTYQLLKGIAFCHENRVL-------HRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAP 169 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------eCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccCh
Confidence 445667788888999999988777 999999999999999999999999975533211 11224568899999
Q ss_pred hhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC---c------cccccchhc------
Q 011196 346 EYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH---A------AELMDSVVK------ 409 (491)
Q Consensus 346 E~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~------~~~~d~~l~------ 409 (491)
|++.+. .++.++||||||+++||+++|+.||.... ..+......+...... + .........
T Consensus 170 E~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (284)
T cd07836 170 DVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN---NEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDL 246 (284)
T ss_pred HHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHH
Confidence 998764 46889999999999999999999975322 1122222211111000 0 000000000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 410 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
..........+.+++.+||+.||.+||++.++++
T Consensus 247 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 247 QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0011122345778999999999999999999885
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-19 Score=186.56 Aligned_cols=153 Identities=22% Similarity=0.321 Sum_probs=113.2
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC---C--CCceEeccCcceecCCCCc-ccccCceeecCC
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH---E--MNPKISDFGMARIFGGNQS-EANTNRVVGTYG 341 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~---~--~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~ 341 (491)
..+.+..+++.++++||.+.++ ||||||.||||+. + ..++|+|||+++....++. ........||.+
T Consensus 607 ~~~~~l~q~~~GlaHLHsl~iV-------HRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~G 679 (903)
T KOG1027|consen 607 DPISVLSQIASGLAHLHSLKIV-------HRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSG 679 (903)
T ss_pred cHHHHHHHHHHHHHHHHhcccc-------cccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCccc
Confidence 4567788899999999999888 9999999999976 3 4689999999998765543 334456789999
Q ss_pred CChhhhhhhCCCCcccceeehhHHHHHHHhC-CCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHH
Q 011196 342 YMAPEYAMEGIFSVKSDVFSFGVVLLEIISG-KKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKY 420 (491)
Q Consensus 342 y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 420 (491)
|+|||++.+..-+.++||||+||++|..++| ..||+.....+ .+++ -.+..+..+ .+ .+ ++ ..
T Consensus 680 W~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl------~~~~~L~~L-~~-----~~-d~--eA 743 (903)
T KOG1027|consen 680 WQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANIL------TGNYTLVHL-EP-----LP-DC--EA 743 (903)
T ss_pred ccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhh------cCccceeee-cc-----Cc-hH--HH
Confidence 9999999998888899999999999999986 88876321111 0000 001111111 11 11 11 45
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 011196 421 IHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 421 ~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+|+.+|++.+|..||++.+|+.
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHhC
Confidence 67888999999999999999875
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.2e-18 Score=172.73 Aligned_cols=162 Identities=18% Similarity=0.186 Sum_probs=111.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++...... .....++..|++|
T Consensus 117 ~~~~~~i~~qi~~al~~LH~~gi~-------H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aP 184 (343)
T cd07880 117 EDRIQFLVYQMLKGLKYIHAAGII-------HRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAP 184 (343)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccCH
Confidence 455667888899999999988776 9999999999999999999999998765322 1234568899999
Q ss_pred hhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHH-----------HhhcCCccccc-------cc
Q 011196 346 EYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWK-----------LWCEGHAAELM-------DS 406 (491)
Q Consensus 346 E~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~-------d~ 406 (491)
|++.+ ..++.++|+||||++++++++|+.||..... ......... .+......... ..
T Consensus 185 E~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (343)
T cd07880 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH---LDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKK 261 (343)
T ss_pred HHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcc
Confidence 99876 4578999999999999999999999753211 111111100 00000000000 00
Q ss_pred hhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 407 VVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 407 ~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+. .........+.+++.+|++.||++|||+.+++.
T Consensus 262 ~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 262 DFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000112234678999999999999999999884
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.3e-19 Score=180.05 Aligned_cols=163 Identities=19% Similarity=0.208 Sum_probs=111.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..+++ ||||||+||+++.++.+||+|||+++..... .....++..|+||
T Consensus 119 ~~~~~~i~~qi~~aL~~LH~~~iv-------H~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aP 186 (345)
T cd07877 119 DDHVQFLIYQILRGLKYIHSADII-------HRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 186 (345)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------ecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCH
Confidence 445666788889999999988776 9999999999999999999999998754321 1234678899999
Q ss_pred hhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccc---------------cchhc
Q 011196 346 EYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELM---------------DSVVK 409 (491)
Q Consensus 346 E~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------d~~l~ 409 (491)
|.+.+ ..++.++||||||++++||++|+.||..... ......+..... ....++. +....
T Consensus 187 E~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (345)
T cd07877 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVG-TPGAELLKKISSESARNYIQSLTQMPK 262 (345)
T ss_pred HHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhC-CCCHHHHhhcccHhHHHHHHHhcccCC
Confidence 99866 4688999999999999999999999743211 111111111000 0000000 00000
Q ss_pred CCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 410 QSC---DQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 410 ~~~---~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..+ .......+.+++.+|++.||++||++.+++.+
T Consensus 263 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 263 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred cchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 00113356789999999999999999988765
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.1e-19 Score=163.05 Aligned_cols=177 Identities=18% Similarity=0.224 Sum_probs=118.1
Q ss_pred CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
.+....+.+.+++..++.|||..+++ ||||||.|.|++.+-..||+|||+++.....+... .+..+-|..|+
T Consensus 153 Ls~DHvKVFlYQILRGLKYLHsA~IL-------HRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h-MTqEVVTQYYR 224 (449)
T KOG0664|consen 153 LTPDHVKVFVYQILRGLKYLHTANIL-------HRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN-MTHEVVTQYYR 224 (449)
T ss_pred CCcchhhhhHHHHHhhhHHHhhcchh-------hccCCCccEEeccCceEEecccccccccchhhhhh-hHHHHHHHHhc
Confidence 34555667889999999999999998 99999999999999999999999999765443332 33455688999
Q ss_pred hhhhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHH--------HHHhhcCCccccccchhc-----
Q 011196 344 APEYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYI--------WKLWCEGHAAELMDSVVK----- 409 (491)
Q Consensus 344 aPE~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~d~~l~----- 409 (491)
|||++++.. |+..+||||.||++.|++..+-.|.....-+..+++... .+.-.++.-..+++...+
T Consensus 225 APEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~ 304 (449)
T KOG0664|consen 225 APELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQ 304 (449)
T ss_pred cHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCcc
Confidence 999999864 899999999999999999887665432221111111111 111111111111111100
Q ss_pred ----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 410 ----QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 410 ----~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
-..+...-.+-+.+..+++..||++|.+..+.+.++-.+
T Consensus 305 vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 305 RLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred ceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 001111122344566778999999999999888776433
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.75 E-value=3e-18 Score=166.07 Aligned_cols=155 Identities=19% Similarity=0.206 Sum_probs=111.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCc-ccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQS-EANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||..++. |+||||+||+++.++.++|+|||+++....... ........++..|+|
T Consensus 105 ~~~~~~~~~~i~~al~~LH~~~i~-------H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 177 (264)
T cd06653 105 ENVTRRYTRQILQGVSYLHSNMIV-------HRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177 (264)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEe-------cCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccC
Confidence 445566788889999999988777 999999999999999999999999986532111 111123567889999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||++.+..++.++|+||||++++|+++|+.||... .....+......... + ..+......+.+++
T Consensus 178 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~~-----~----~~p~~~~~~~~~~i 242 (264)
T cd06653 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY------EAMAAIFKIATQPTK-----P----MLPDGVSDACRDFL 242 (264)
T ss_pred HhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc------CHHHHHHHHHcCCCC-----C----CCCcccCHHHHHHH
Confidence 99998888899999999999999999999997522 111111111111111 1 11222234566788
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 011196 425 LLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~ 443 (491)
.+||+ +|.+||++.+++.
T Consensus 243 ~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 243 KQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHhc-CcccCccHHHHhc
Confidence 89999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.7e-19 Score=169.67 Aligned_cols=152 Identities=17% Similarity=0.257 Sum_probs=115.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......+..++..++.|.|....+ |||||.+|||+|.++++||+|||++..+.... ...+++|++-|.+|
T Consensus 152 ErEaRhfFRQIvSAVhYCHknrVv-------HRDLKLENILLD~N~NiKIADFGLSNly~~~k---fLqTFCGSPLYASP 221 (668)
T KOG0611|consen 152 EREARHFFRQIVSAVHYCHKNRVV-------HRDLKLENILLDQNNNIKIADFGLSNLYADKK---FLQTFCGSPLYASP 221 (668)
T ss_pred HHHHHHHHHHHHHHHHHHhhccce-------ecccchhheeecCCCCeeeeccchhhhhcccc---HHHHhcCCcccCCc
Confidence 444566777888888877766555 99999999999999999999999998764432 34568999999999
Q ss_pred hhhhhCCCC-cccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFS-VKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s-~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+.+|. +.+|.||+||+||-++.|..||+.+... ...+.+..+...+--.| ....-|+
T Consensus 222 EIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQIs~GaYrEP~~P-----------SdA~gLI 283 (668)
T KOG0611|consen 222 EIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQISRGAYREPETP-----------SDASGLI 283 (668)
T ss_pred cccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHHhhcccccCCCCC-----------chHHHHH
Confidence 999998874 7899999999999999999998754321 12223333333222111 1223478
Q ss_pred HHcccCCCCCCCCHHHHHHHh
Q 011196 425 LLCVQEDPMDRPTMSSVAVML 445 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L 445 (491)
.+||..||++|-|+.+|..+-
T Consensus 284 RwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 284 RWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHHHhcCcccchhHHHHhhhh
Confidence 899999999999999998765
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-18 Score=170.06 Aligned_cols=157 Identities=18% Similarity=0.245 Sum_probs=109.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++........ ......|+..|++|
T Consensus 104 ~~~~~~~~~qi~~al~~lH~~~i~-------H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aP 175 (290)
T cd05613 104 EQEVQIYSGEIVLALEHLHKLGII-------YRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAP 175 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------ccCCCHHHeEECCCCCEEEeeCccceeccccccc-ccccccCCcccCCh
Confidence 445556667888889999987776 9999999999999999999999999865432211 12235688899999
Q ss_pred hhhhhC--CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 346 EYAMEG--IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 346 E~~~~~--~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
|++... .++.++||||||+++|+|++|..|+...... .............. + ..+......+.++
T Consensus 176 E~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~-------~----~~~~~~~~~~~~l 242 (290)
T cd05613 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE-------P----PYPQEMSALAKDI 242 (290)
T ss_pred hhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC-------C----CCCccCCHHHHHH
Confidence 998753 4678999999999999999999997532211 11111111111110 0 0111122356678
Q ss_pred HHHcccCCCCCCC-----CHHHHHH
Q 011196 424 GLLCVQEDPMDRP-----TMSSVAV 443 (491)
Q Consensus 424 ~~~cl~~dP~~RP-----s~~evl~ 443 (491)
+.+||+.||++|| ++.+++.
T Consensus 243 l~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 243 IQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 9999999999997 5666554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.1e-18 Score=170.56 Aligned_cols=151 Identities=24% Similarity=0.362 Sum_probs=108.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++..... .....|+..|+||
T Consensus 120 ~~~~~~~~~qi~~al~~LH~~gi~-------H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aP 186 (313)
T cd06633 120 EVEIAAITHGALQGLAYLHSHNMI-------HRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAP 186 (313)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------cCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccCh
Confidence 345566778888999999988777 999999999999999999999998864321 2235678899999
Q ss_pred hhhh---hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHH
Q 011196 346 EYAM---EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 346 E~~~---~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
|++. .+.++.++||||||+++|||++|..|+.... . .......... ....... ... ...+.+
T Consensus 187 E~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~---~---~~~~~~~~~~-~~~~~~~----~~~----~~~l~~ 251 (313)
T cd06633 187 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---A---MSALYHIAQN-DSPTLQS----NEW----TDSFRG 251 (313)
T ss_pred hhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---h---HHHHHHHHhc-CCCCCCc----ccc----CHHHHH
Confidence 9984 4568899999999999999999999964221 1 1111111111 1111111 111 234667
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 011196 423 IGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~~ 444 (491)
++.+||+.+|++||++.+++..
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 8999999999999999988753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.1e-18 Score=166.84 Aligned_cols=175 Identities=21% Similarity=0.252 Sum_probs=121.8
Q ss_pred eeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 245 YELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
|.++.++.+........ ..........++.+++.++.+||..++. |+||||+||+++.++.++|+|||++.
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~-------H~dl~~~ni~i~~~~~~~l~df~~~~ 150 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGII-------HRDLKPENILLDKDMHIKITDFGTAK 150 (280)
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee-------ecCCCHHHeEECCCCCEEecCCcccc
Confidence 44555554444322221 1233556677888899999999987777 99999999999999999999999998
Q ss_pred ecCCCCcc------------------cccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCc
Q 011196 323 IFGGNQSE------------------ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHG 384 (491)
Q Consensus 323 ~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~ 384 (491)
........ .......++..|++||......++.++||||||++++++++|+.|+.... .
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~ 227 (280)
T cd05581 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN---E 227 (280)
T ss_pred ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc---H
Confidence 65432211 12233567889999999988888999999999999999999999975322 1
Q ss_pred ccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 011196 385 PSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTM----SSVAV 443 (491)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~----~evl~ 443 (491)
....... . ... ...+......+.+++.+||+.||++||++ ++++.
T Consensus 228 ~~~~~~~---~-~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 YLTFQKI---L-KLE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHH---H-hcC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111111 1 100 01111223457789999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.3e-18 Score=161.30 Aligned_cols=177 Identities=20% Similarity=0.237 Sum_probs=122.2
Q ss_pred eeeecccccCCCCccccCCC--CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTAPN--KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.+.+++|+............ ........+..+++.++.++|..++. |+||+|+||+++.++.++|+|||.+
T Consensus 62 ~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~-------h~~i~~~ni~~~~~~~~~l~d~~~~ 134 (244)
T smart00220 62 LYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGII-------HRDLKPENILLDEDGHVKLADFGLA 134 (244)
T ss_pred EEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCee-------cCCcCHHHeEECCCCcEEEccccce
Confidence 44555565554332221111 23445666777888888889887766 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
....... ......++..|++||.+.+..++.++|||+||++++++++|..|+... .+. .............
T Consensus 135 ~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~--~~~----~~~~~~~~~~~~~ 205 (244)
T smart00220 135 RQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD--DQL----LELFKKIGKPKPP 205 (244)
T ss_pred eeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcH----HHHHHHHhccCCC
Confidence 8765432 222356788999999998888999999999999999999999986432 111 1111111111111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.... .......+.+++.+||..+|++||++.++++
T Consensus 206 ~~~~-------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 206 FPPP-------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred Cccc-------cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0000 0002345778999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.5e-19 Score=169.22 Aligned_cols=157 Identities=20% Similarity=0.267 Sum_probs=116.4
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhh
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY 347 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 347 (491)
+...++.+++.++.+||..+++ |.||..+|.+||+...+||+|-.+++.+-..+.+.-....-.+..||+||.
T Consensus 397 qlV~masQla~am~hlh~~~Vi-------HkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEa 469 (563)
T KOG1024|consen 397 QLVLMASQLAMAMEHLHNHGVI-------HKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEA 469 (563)
T ss_pred HHHHHHHHHHHHHHHHHhcCcc-------cchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHH
Confidence 3445566777777777776666 999999999999999999999999987544443333333344778999999
Q ss_pred hhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHH
Q 011196 348 AMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLL 426 (491)
Q Consensus 348 ~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~ 426 (491)
+....|+..+||||||+++|||+| |+.|+...+. .++ ....+++. .+ ..+.+++.++..+|.-
T Consensus 470 l~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP---fEm----~~ylkdGy--Rl-------aQP~NCPDeLf~vMac 533 (563)
T KOG1024|consen 470 LQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP---FEM----EHYLKDGY--RL-------AQPFNCPDELFTVMAC 533 (563)
T ss_pred HhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH---HHH----HHHHhccc--ee-------cCCCCCcHHHHHHHHH
Confidence 999999999999999999999998 8888532111 111 11122221 11 1234556678899999
Q ss_pred cccCCCCCCCCHHHHHHHhhc
Q 011196 427 CVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 427 cl~~dP~~RPs~~evl~~L~~ 447 (491)
||..+|++||+++|++..|.+
T Consensus 534 CWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 534 CWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHhcCcccCCCHHHHHHHHHH
Confidence 999999999999999998875
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.1e-18 Score=164.07 Aligned_cols=171 Identities=21% Similarity=0.257 Sum_probs=119.0
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.+++++.+........ ..........++.+++.++.++|..++. |+||||+||+++.++.++|+|||++
T Consensus 68 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~-------H~~l~p~ni~~~~~~~~~l~d~~~~ 140 (250)
T cd05123 68 LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII-------YRDLKPENILLDADGHIKLTDFGLA 140 (250)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce-------ecCCCcceEEEcCCCcEEEeecCcc
Confidence 345555554443322211 1223455667788899999999988777 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
........ ......++..|++||...+...+.++|+||||+++||+++|+.||..... ......+ .....
T Consensus 141 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~----~~~~~- 210 (250)
T cd05123 141 KELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKI----LKDPL- 210 (250)
T ss_pred eecccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH----hcCCC-
Confidence 76543321 12335678899999999888889999999999999999999999743211 1111111 11100
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSS 440 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e 440 (491)
..+......+.+++.+||..||++||++.+
T Consensus 211 ---------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 211 ---------RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ---------CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111111345678999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-18 Score=173.33 Aligned_cols=165 Identities=19% Similarity=0.246 Sum_probs=109.9
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhh
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY 347 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 347 (491)
....++.+++.++.+||..+++ ||||||+||++++++.+||+|||.+...... .....++..|++||+
T Consensus 109 ~~~~~~~ql~~aL~~LH~~~ii-------H~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~ 176 (328)
T cd07856 109 FIQYFLYQILRGLKYVHSAGVV-------HRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEI 176 (328)
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-------cCCCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCcee
Confidence 3455777888889999987766 9999999999999999999999998754321 123456888999998
Q ss_pred hhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHH--------HHHHHHhhcCCccccccchh-cCCCCH---
Q 011196 348 AME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLL--------AYIWKLWCEGHAAELMDSVV-KQSCDQ--- 414 (491)
Q Consensus 348 ~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~d~~l-~~~~~~--- 414 (491)
+.+ ..++.++||||||++++|+++|+.||............ ...+.....+...++..... ....+.
T Consensus 177 ~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (328)
T cd07856 177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEK 256 (328)
T ss_pred eeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHH
Confidence 766 46889999999999999999999997532211000000 00011111111111110000 001111
Q ss_pred --HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 415 --AELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 415 --~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.....+.+++.+||+.+|++||++.+++..
T Consensus 257 ~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 257 FKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 112467789999999999999999988654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.6e-18 Score=164.15 Aligned_cols=153 Identities=22% Similarity=0.290 Sum_probs=111.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.++|..++. |+||||+||+++. +.+||+|||+++....... ......|+..|++|
T Consensus 105 ~~~~~~~~~~l~~~l~~lH~~~i~-------h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~p 174 (260)
T cd08222 105 ENQVCEWFIQLLLGVHYMHQRRIL-------HRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSP 174 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHHcCcc-------ccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccCH
Confidence 445567788888889999987776 9999999999985 5699999999976543222 12234578899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|...+..++.++|+||||+++|++++|..|+... .......... .+... ..+......+.+++.
T Consensus 175 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~------~~~~~~~~~~-~~~~~---------~~~~~~~~~~~~li~ 238 (260)
T cd08222 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ------NFLSVVLRIV-EGPTP---------SLPETYSRQLNSIMQ 238 (260)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHHHHH-cCCCC---------CCcchhcHHHHHHHH
Confidence 9998888899999999999999999999996421 1111111111 11111 112233346778999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 011196 426 LCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~ 444 (491)
+||+.||++||++.|+++.
T Consensus 239 ~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHhcCChhhCcCHHHHhhC
Confidence 9999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.1e-19 Score=158.49 Aligned_cols=92 Identities=28% Similarity=0.400 Sum_probs=72.5
Q ss_pred hheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhhh----CCCCcccce
Q 011196 284 LSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME----GIFSVKSDV 359 (491)
Q Consensus 284 ~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDV 359 (491)
|++.++|....+||||+||+||||+.+|.+|++|||.+-.+.+.-.. +.-.|...|||||.+.. ..|+.++||
T Consensus 159 ~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDv 235 (282)
T KOG0984|consen 159 HALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDV 235 (282)
T ss_pred HHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhh
Confidence 34444444455679999999999999999999999999766433221 12457889999998863 368999999
Q ss_pred eehhHHHHHHHhCCCCCCC
Q 011196 360 FSFGVVLLEIISGKKSSGF 378 (491)
Q Consensus 360 wS~Gvvl~elltG~~p~~~ 378 (491)
||+|+.+.||.+++.|++.
T Consensus 236 WSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 236 WSLGITMIEMAILRFPYES 254 (282)
T ss_pred hhhhhhhhhhhhccccccc
Confidence 9999999999999999754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.9e-18 Score=161.68 Aligned_cols=103 Identities=24% Similarity=0.281 Sum_probs=89.2
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
...+...+..+...++.++|..++. ||||||+||++..+..+||.|||+++..... -..+..+.+..|+|
T Consensus 116 DH~tis~i~yq~~~~ik~lhs~~Ii-------hRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyra 185 (369)
T KOG0665|consen 116 DHETISYILYQMLCGIKHLHSAGII-------HRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRA 185 (369)
T ss_pred chHHHHHHHHHHHHHHHHHHhccee-------ecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccC
Confidence 3566777889999999999999888 9999999999999999999999999864322 12334677899999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCC
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSG 377 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~ 377 (491)
||++.+..+.+.+||||+||++.||+.|+.-|.
T Consensus 186 pevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 186 PEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred chheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 999999889999999999999999999987654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.3e-18 Score=164.87 Aligned_cols=142 Identities=25% Similarity=0.315 Sum_probs=105.4
Q ss_pred hhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhh
Q 011196 270 ITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM 349 (491)
Q Consensus 270 ~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 349 (491)
.-.+..++.++.+||..+++ .||||.+|||+|.+|++||.|||+++.--- ....+.+++||+.|+|||++.
T Consensus 453 vFYAaEiaigLFFLh~kgIi-------YRDLKLDNvmLd~eGHiKi~DFGmcKEni~--~~~TTkTFCGTPdYiAPEIi~ 523 (683)
T KOG0696|consen 453 VFYAAEIAIGLFFLHSKGII-------YRDLKLDNVMLDSEGHIKIADFGMCKENIF--DGVTTKTFCGTPDYIAPEIIA 523 (683)
T ss_pred hhhhHHHHHHhhhhhcCCee-------eeeccccceEeccCCceEeeeccccccccc--CCcceeeecCCCcccccceEE
Confidence 34566677777777777766 999999999999999999999999975321 223355689999999999999
Q ss_pred hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHccc
Q 011196 350 EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQ 429 (491)
Q Consensus 350 ~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~ 429 (491)
..+|+.++|-|||||+||||+.|++||+. ++..++...+.++ . -.++..-..+...|....+.
T Consensus 524 YqPYgksvDWWa~GVLLyEmlaGQpPFdG---eDE~elF~aI~eh----n----------vsyPKslSkEAv~ickg~lt 586 (683)
T KOG0696|consen 524 YQPYGKSVDWWAFGVLLYEMLAGQPPFDG---EDEDELFQAIMEH----N----------VSYPKSLSKEAVAICKGLLT 586 (683)
T ss_pred ecccccchhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHHc----c----------CcCcccccHHHHHHHHHHhh
Confidence 99999999999999999999999999753 3333333333221 1 11223333445567777888
Q ss_pred CCCCCCCC
Q 011196 430 EDPMDRPT 437 (491)
Q Consensus 430 ~dP~~RPs 437 (491)
+.|.+|..
T Consensus 587 K~P~kRLG 594 (683)
T KOG0696|consen 587 KHPGKRLG 594 (683)
T ss_pred cCCccccC
Confidence 89998853
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.7e-18 Score=181.71 Aligned_cols=128 Identities=21% Similarity=0.375 Sum_probs=102.1
Q ss_pred ceeeeecccccCCCCccccCCCC-CCcchh-hhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 242 SIRYELYRFLVDTPTVTVTAPNK-TSKRWI-TIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 242 ~lry~~~~f~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
..-|.++.||.+++++.+.+.-. -..+|- -....++.++.-+|.++++ ||||||+|||||..|++||+|||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyV-------HRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYV-------HRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccce-------eccCCcceeEecccCcEeeccch
Confidence 44578889999998877754322 122332 2355566778889999999 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhh-----CCCCcccceeehhHHHHHHHhCCCCCC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAME-----GIFSVKSDVFSFGVVLLEIISGKKSSG 377 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvvl~elltG~~p~~ 377 (491)
.+-.+..+... .....+|||.|.+||++.. +.|+...|-||+||++|||+.|..||.
T Consensus 221 sClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 221 SCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred hHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 99877644332 2345799999999999962 569999999999999999999999975
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-18 Score=178.10 Aligned_cols=161 Identities=22% Similarity=0.296 Sum_probs=127.4
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
.+..+.+..+|+.++.||+....+ ||||-.+|||+..-..+||.|||+++....+..+-......-.+.|||-
T Consensus 797 sq~lLnw~~QIAkgM~YLe~qrlV-------HrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmal 869 (1177)
T KOG1025|consen 797 SQDLLNWCYQIAKGMKYLEEQRLV-------HRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMAL 869 (1177)
T ss_pred HHHHHHHHHHHHHHHHHHHhcchh-------hhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHH
Confidence 456678899999999999965555 9999999999999999999999999988766555444445557789999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|.+....|+.++|||||||++||++| |..|++....++..++ +....+-+.++.+...+..++
T Consensus 870 e~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl----------------le~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 870 ESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL----------------LEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred HHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH----------------HhccccCCCCCCccHHHHHHH
Confidence 99999999999999999999999998 8888654333322211 111112234566677888899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
.+||..|++.||+++++...+.+..
T Consensus 934 vkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred HHHhccCcccCccHHHHHHHHHHHh
Confidence 9999999999999999998887654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.7e-18 Score=164.59 Aligned_cols=177 Identities=20% Similarity=0.235 Sum_probs=119.5
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEe-eeccccccccccccCCCCceEeccCcceecCCCCc--ccccCceeecCCCC
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIR-RRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQS--EANTNRVVGTYGYM 343 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~-~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~ 343 (491)
...+.++.-++.++++||.-.+--..++ |.|||||+.|||+..++.+-|+|+|++....+... ....+..+||.+||
T Consensus 308 ~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYM 387 (513)
T KOG2052|consen 308 EGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYM 387 (513)
T ss_pred HHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeecc
Confidence 3455667777888888887655544343 45999999999999999999999999987654422 22344579999999
Q ss_pred hhhhhhhCC----CC--cccceeehhHHHHHHHhC----------CCCCCCccCCCcccHHHHHHHHhhcCCccccccch
Q 011196 344 APEYAMEGI----FS--VKSDVFSFGVVLLEIISG----------KKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSV 407 (491)
Q Consensus 344 aPE~~~~~~----~s--~~sDVwS~Gvvl~elltG----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 407 (491)
|||++.+.- |. ..+||||||.|+||+.-+ +.||.. ..+.+.-.+...+...-.. +.|.
T Consensus 388 APEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd--~Vp~DPs~eeMrkVVCv~~----~RP~ 461 (513)
T KOG2052|consen 388 APEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD--VVPSDPSFEEMRKVVCVQK----LRPN 461 (513)
T ss_pred ChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc--CCCCCCCHHHHhcceeecc----cCCC
Confidence 999997532 22 469999999999999853 234321 1111111111111111111 1222
Q ss_pred hcCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 408 VKQS-CDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 408 l~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
+... ...+.+..+.+||+.||..||..|-|+-.|.+.|.+..
T Consensus 462 ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 462 IPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 2211 23356777889999999999999999999999888775
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-17 Score=170.06 Aligned_cols=148 Identities=21% Similarity=0.257 Sum_probs=116.1
Q ss_pred hhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhh
Q 011196 269 WITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYA 348 (491)
Q Consensus 269 ~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 348 (491)
......++..+++|+|...++ |||||++||||+.++++||+|||++..+.... .....+|++.|.|||+.
T Consensus 157 ar~~F~q~vsaveYcH~k~iv-------HrdLk~eNilL~~~mnikIaDfgfS~~~~~~~---~lqt~cgsppyAaPEl~ 226 (596)
T KOG0586|consen 157 ARAKFRQIVSAVEYCHSKNIV-------HRDLKAENILLDENMNIKIADFGFSTFFDYGL---MLQTFCGSPPYAAPELF 226 (596)
T ss_pred hhhhhHHHHHHHHHHhhccee-------ccccchhhcccccccceeeeccccceeecccc---cccccCCCCCccChHhh
Confidence 344566788889999998888 99999999999999999999999999876432 23457999999999999
Q ss_pred hhCCCC-cccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCC--CCHHHHHHHHHHHH
Q 011196 349 MEGIFS-VKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQS--CDQAELLKYIHIGL 425 (491)
Q Consensus 349 ~~~~~s-~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~~~~l~~ 425 (491)
.+.+|. +++|+||+|+++|-|+.|..||+... ++++-++.+... .+.....+|-+++.
T Consensus 227 ~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-------------------lk~Lr~rvl~gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 227 NGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-------------------LKELRPRVLRGKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cCcccCCcceehhhhhhhheeeeecccccCCcc-------------------cccccchheeeeecccceeechhHHHHH
Confidence 988764 78999999999999999999976322 222223333221 22223345778999
Q ss_pred HcccCCCCCCCCHHHHHHHh
Q 011196 426 LCVQEDPMDRPTMSSVAVML 445 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L 445 (491)
++|-.+|.+|++++++.+.-
T Consensus 288 k~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred HhhccCccccCCHHHhhhhc
Confidence 99999999999999988653
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.4e-17 Score=155.48 Aligned_cols=97 Identities=25% Similarity=0.377 Sum_probs=81.2
Q ss_pred HhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhhhCC
Q 011196 273 AEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI 352 (491)
Q Consensus 273 ~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 352 (491)
-..++.++.|||+..++ .||||.+|.|+|.+|++||.|||+++.--. ....+..++||+.|+|||++...-
T Consensus 274 GaEIvsAL~YLHs~~iv-------YRDlKLENLlLDkDGHIKitDFGLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnD 344 (516)
T KOG0690|consen 274 GAEIVSALGYLHSRNIV-------YRDLKLENLLLDKDGHIKITDFGLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDND 344 (516)
T ss_pred hHHHHHHhhhhhhCCee-------eeechhhhheeccCCceEeeecccchhccc--ccceeccccCChhhcCchhhcccc
Confidence 33455666777766666 999999999999999999999999985322 222345689999999999999999
Q ss_pred CCcccceeehhHHHHHHHhCCCCCCC
Q 011196 353 FSVKSDVFSFGVVLLEIISGKKSSGF 378 (491)
Q Consensus 353 ~s~~sDVwS~Gvvl~elltG~~p~~~ 378 (491)
|+..+|-|.+||++|||++|+.||..
T Consensus 345 YgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 345 YGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred ccceeehhhhhHHHHHHHhccCcccc
Confidence 99999999999999999999999753
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.5e-17 Score=173.01 Aligned_cols=180 Identities=19% Similarity=0.236 Sum_probs=117.5
Q ss_pred eeecccccCCCCccccCCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceec
Q 011196 245 YELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIF 324 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~ 324 (491)
|.|+.|..+++...+.---. ..++....++......|.++.++ |..++||||||-.|||++.++.+||.|||++...
T Consensus 97 WLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HL-H~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHL-HNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred EEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHH-hhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 45667766665433321111 23333333333333334444444 3334459999999999999999999999999877
Q ss_pred CCCCcccccCceeecCCCChhhhhhhC-----CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 325 GGNQSEANTNRVVGTYGYMAPEYAMEG-----IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 325 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
.... ....+.+||+.|||||++.-. -|+..+|+||+|++..||--|.+|+...+... +.-.+...-
T Consensus 174 dsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-------aLF~IpRNP 244 (953)
T KOG0587|consen 174 DSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFLIPRNP 244 (953)
T ss_pred eccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------hhccCCCCC
Confidence 5433 334568999999999998643 37889999999999999999999964332211 011111111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+.+. .+..=..++.+++..||.+|-++||++.++++
T Consensus 245 PPkLk-------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 245 PPKLK-------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred Ccccc-------chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11111 23344567889999999999999999877654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.7e-17 Score=164.89 Aligned_cols=102 Identities=23% Similarity=0.255 Sum_probs=84.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC-CceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM-NPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.+.....++++..++.+|--++++ |.||||.|||+++.. .+||||||.+.....+... ...-+..|.|
T Consensus 535 ikaVRsYaqQLflALklLK~c~vl-------HaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit----PYLVSRFYRa 603 (752)
T KOG0670|consen 535 IKAVRSYAQQLFLALKLLKKCGVL-------HADIKPDNILVNESKNILKLCDFGSASFASENEIT----PYLVSRFYRA 603 (752)
T ss_pred ehHHHHHHHHHHHHHHHHHhcCee-------ecccCccceEeccCcceeeeccCcccccccccccc----HHHHHHhccC
Confidence 344566788888888888888888 999999999999874 5799999999876544322 2334678999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCC
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGF 378 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~ 378 (491)
||++.+.+|+...|+||.||.|||+.||+--|..
T Consensus 604 PEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 604 PEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred cceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 9999999999999999999999999999977653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.6e-16 Score=161.24 Aligned_cols=129 Identities=19% Similarity=0.312 Sum_probs=92.4
Q ss_pred eeeecccccCCCCccccCCCC--C-CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVTAPNK--T-SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
-|.++.|..++++..++..-. . .-.++. +..+..++...|-.+++ ||||||+|||||.+|++||.||||
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFY-IAEltcAiesVHkmGFI-------HRDiKPDNILIDrdGHIKLTDFGL 775 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFY-IAELTCAIESVHKMGFI-------HRDIKPDNILIDRDGHIKLTDFGL 775 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhccCHHHHHHHH-HHHHHHHHHHHHhccce-------ecccCccceEEccCCceeeeeccc
Confidence 345566666666654432111 0 112232 33455667778888888 999999999999999999999999
Q ss_pred ceecCC---------CCc-------------------------------ccccCceeecCCCChhhhhhhCCCCccccee
Q 011196 321 ARIFGG---------NQS-------------------------------EANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360 (491)
Q Consensus 321 a~~~~~---------~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVw 360 (491)
+.-+.. +.. .......+||.-|+|||++....++...|-|
T Consensus 776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww 855 (1034)
T KOG0608|consen 776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW 855 (1034)
T ss_pred cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence 864321 000 0001236899999999999999999999999
Q ss_pred ehhHHHHHHHhCCCCCCCcc
Q 011196 361 SFGVVLLEIISGKKSSGFYH 380 (491)
Q Consensus 361 S~Gvvl~elltG~~p~~~~~ 380 (491)
|.||||+||+.|+.||....
T Consensus 856 s~gvil~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 856 SVGVILYEMLVGQPPFLADT 875 (1034)
T ss_pred HhhHHHHHHhhCCCCccCCC
Confidence 99999999999999985433
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-16 Score=174.59 Aligned_cols=94 Identities=17% Similarity=0.197 Sum_probs=65.6
Q ss_pred eecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHH
Q 011196 337 VGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAE 416 (491)
Q Consensus 337 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 416 (491)
+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+ .. .... .+.. ....
T Consensus 541 vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~~---~~~~~~~~i---l~-~~~~---~p~~----~~~~ 606 (669)
T cd05610 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDE---TPQQVFQNI---LN-RDIP---WPEG----EEKL 606 (669)
T ss_pred eeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHH---Hh-cCCC---CCcc----cccC
Confidence 5689999999999988999999999999999999999997431 111111111 11 1100 0000 1112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 417 LLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 417 ~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
...+.+++.+||..||++||++.|++++
T Consensus 607 ~~~~~~~l~~lL~~dP~~R~ta~e~l~h 634 (669)
T cd05610 607 SVNAQNAIEILLTMDPTKRAGLKELKQH 634 (669)
T ss_pred CHHHHHHHHHHcccChhHCcCHHHHHhC
Confidence 2346678889999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.2e-16 Score=162.92 Aligned_cols=160 Identities=18% Similarity=0.255 Sum_probs=112.2
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC--CC--CceEeccCcceecCCCCcccccCceeecC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH--EM--NPKISDFGMARIFGGNQSEANTNRVVGTY 340 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~--~~--~~kl~DfGla~~~~~~~~~~~~~~~~gt~ 340 (491)
+...++.++..+..++.+||..+++ ||||||.||++-. +| .-||+|||.|+....+. ....+.||.
T Consensus 118 pE~e~l~lL~d~~~al~~LrEn~Iv-------HRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~ 187 (732)
T KOG4250|consen 118 PESEFLDLLSDLVSALRHLRENGIV-------HRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTE 187 (732)
T ss_pred CHHHHHHHHHHHHHHHHHHHHcCce-------eccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCch
Confidence 3667888999999999999988887 9999999999843 23 35999999999886655 344689999
Q ss_pred CCChhhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC--Cccccccchh---------
Q 011196 341 GYMAPEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG--HAAELMDSVV--------- 408 (491)
Q Consensus 341 ~y~aPE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~~l--------- 408 (491)
.|.+||++.. +.|+..+|.|||||++||.+||..||--+.... +.....|...... ...-..++..
T Consensus 188 ~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk--~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~ 265 (732)
T KOG4250|consen 188 EYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK--NNKEIMWHIITKKPSGVAIGAQEEENGPVEWSST 265 (732)
T ss_pred hhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc--ccchhhhhhhccCCCceeEeeecccCCceeeecc
Confidence 9999999984 889999999999999999999999975443332 2222222222111 0000001100
Q ss_pred ---cCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 011196 409 ---KQSCDQAELLKYIHIGLLCVQEDPMDRP 436 (491)
Q Consensus 409 ---~~~~~~~~~~~~~~l~~~cl~~dP~~RP 436 (491)
..........++-.+.-.+|..+|++|.
T Consensus 266 lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 266 LPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 0112233445566677778888999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.1e-16 Score=142.58 Aligned_cols=163 Identities=17% Similarity=0.230 Sum_probs=111.5
Q ss_pred hhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC-CCceEeccCcceecCCCCcccccCceeecCCCChhhh
Q 011196 269 WITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE-MNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY 347 (491)
Q Consensus 269 ~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~-~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 347 (491)
..-...++..++.+.|+.++. |||+||.|++||.. ..++|+|+|++.+...++... ..+.+..|..||.
T Consensus 134 IryY~~elLkALdyCHS~GIm-------HRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn---VRVASRyfKGPEL 203 (338)
T KOG0668|consen 134 IRYYIYELLKALDYCHSMGIM-------HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---VRVASRYFKGPEL 203 (338)
T ss_pred HHHHHHHHHHHHhHHHhcCcc-------cccCCcceeeechhhceeeeeecchHhhcCCCceee---eeeehhhcCCchh
Confidence 344566777788888888887 99999999999976 568999999998875544432 3466788999999
Q ss_pred hhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC---------------CccccccchhcC-
Q 011196 348 AMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG---------------HAAELMDSVVKQ- 410 (491)
Q Consensus 348 ~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~d~~l~~- 410 (491)
+..- .|+.+-|+|||||++.+|+..+.|| ++..++.+.+-.+-+..... ...+++....+.
T Consensus 204 LVdy~~YDYSLD~WS~GcmlA~miFrkepF--FhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~ 281 (338)
T KOG0668|consen 204 LVDYQMYDYSLDMWSLGCMLASMIFRKEPF--FHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKP 281 (338)
T ss_pred eeechhccccHHHHHHHHHHHHHHhccCcc--cCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhcccccc
Confidence 9864 4899999999999999999999996 44444333322222211111 111111111110
Q ss_pred -------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 411 -------SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 411 -------~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
+...-...+.++++.+.|..|.++|+|++|.+.
T Consensus 282 w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 282 WSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 000011245778888999999999999999775
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-16 Score=155.41 Aligned_cols=160 Identities=21% Similarity=0.266 Sum_probs=108.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC---CCceEeccCcceecCCCCcc-----cccCcee
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE---MNPKISDFGMARIFGGNQSE-----ANTNRVV 337 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~---~~~kl~DfGla~~~~~~~~~-----~~~~~~~ 337 (491)
.+...+|+.+++.++.||... ..+|||-||||.|||+... |.+||.|||+++++..+... ..+....
T Consensus 567 EKEARSIiMQiVnAL~YLNEi-----kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgA 641 (775)
T KOG1151|consen 567 EKEARSIIMQIVNALKYLNEI-----KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGA 641 (775)
T ss_pred HHHHHHHHHHHHHHHHHHhcc-----CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccC
Confidence 455667777888888887653 4568899999999999654 67999999999998654432 2345678
Q ss_pred ecCCCChhhhhhhC----CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCC
Q 011196 338 GTYGYMAPEYAMEG----IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCD 413 (491)
Q Consensus 338 gt~~y~aPE~~~~~----~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 413 (491)
||.+|++||.+.-+ +++.|+||||+|||+|..+.|+.||+... ..++++++- ...+.....--..| ..
T Consensus 642 GTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq--sQQdILqeN-TIlkAtEVqFP~KP-----vV 713 (775)
T KOG1151|consen 642 GTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ--SQQDILQEN-TILKATEVQFPPKP-----VV 713 (775)
T ss_pred ceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch--hHHHHHhhh-chhcceeccCCCCC-----cc
Confidence 99999999988754 47899999999999999999999986321 111222111 01111111100111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 011196 414 QAELLKYIHIGLLCVQEDPMDRPTMSSV 441 (491)
Q Consensus 414 ~~~~~~~~~l~~~cl~~dP~~RPs~~ev 441 (491)
.. +...++.+||++.-++|....++
T Consensus 714 ss---eAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 714 SS---EAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred CH---HHHHHHHHHHHhhhhhhhhHHHH
Confidence 12 23457789999999999885553
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.1e-17 Score=162.35 Aligned_cols=147 Identities=22% Similarity=0.240 Sum_probs=107.2
Q ss_pred hhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC---CCceEeccCcceecCCCCcccccCceeecCCCChhhh
Q 011196 271 TIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE---MNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY 347 (491)
Q Consensus 271 ~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~---~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 347 (491)
-++.++..++.+||..+++ |.||||+|||+... -.+||+|||+++++++..-. ...+||+.|+|||+
T Consensus 668 FlvtQIL~ALr~LH~knIv-------HCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR---rsVVGTPAYLaPEV 737 (888)
T KOG4236|consen 668 FLVTQILVALRYLHFKNIV-------HCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR---RSVVGTPAYLAPEV 737 (888)
T ss_pred HHHHHHHHHHHHhhhccee-------eccCCchheeeccCCCCCceeeccccceeecchhhhh---hhhcCCccccCHHH
Confidence 3455666677777776666 99999999999654 46899999999998765432 34689999999999
Q ss_pred hhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHc
Q 011196 348 AMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLC 427 (491)
Q Consensus 348 ~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~c 427 (491)
+....|+..-|+||.|+|+|--++|..||. .+++..+.++.+..++....|.+ .....++++...
T Consensus 738 LrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQNAaFMyPp~PW~e-------------is~~AidlIn~L 802 (888)
T KOG4236|consen 738 LRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQNAAFMYPPNPWSE-------------ISPEAIDLINNL 802 (888)
T ss_pred HhhccccccccceeeeEEEEEEecccccCC--CccchhHHhhccccccCCCchhh-------------cCHHHHHHHHHH
Confidence 999999999999999999999999999964 23332223332222222222222 223456788888
Q ss_pred ccCCCCCCCCHHHHH
Q 011196 428 VQEDPMDRPTMSSVA 442 (491)
Q Consensus 428 l~~dP~~RPs~~evl 442 (491)
||..=.+|-|..+-+
T Consensus 803 LqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 803 LQVKMRKRYSVDKSL 817 (888)
T ss_pred HHHHHHHhcchHhhc
Confidence 888888888876654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.3e-16 Score=146.85 Aligned_cols=147 Identities=22% Similarity=0.367 Sum_probs=107.7
Q ss_pred hHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhhhC
Q 011196 272 IAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEG 351 (491)
Q Consensus 272 ~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 351 (491)
....+..++.+||..+++ .||||..|+|+|.+|++||.|+|+++.--. ....+.+++||+.|.|||++.+.
T Consensus 356 ys~ei~lal~flh~rgii-------yrdlkldnvlldaeghikltdygmcke~l~--~gd~tstfcgtpnyiapeilrge 426 (593)
T KOG0695|consen 356 YSAEICLALNFLHERGII-------YRDLKLDNVLLDAEGHIKLTDYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGE 426 (593)
T ss_pred hhHHHHHHHHHHhhcCee-------eeeccccceEEccCCceeecccchhhcCCC--CCcccccccCCCcccchhhhccc
Confidence 455666778888887777 999999999999999999999999985322 22335578999999999999999
Q ss_pred CCCcccceeehhHHHHHHHhCCCCCCCccCCC-cccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccC
Q 011196 352 IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEH-GPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQE 430 (491)
Q Consensus 352 ~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~ 430 (491)
.|...+|-|++|++++||+.|+.||+.....+ +++..++..+.+-+..+ ..+..-..+.-.+.+.-|++
T Consensus 427 eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi----------riprslsvkas~vlkgflnk 496 (593)
T KOG0695|consen 427 EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI----------RIPRSLSVKASHVLKGFLNK 496 (593)
T ss_pred ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc----------cccceeehhhHHHHHHhhcC
Confidence 99999999999999999999999998654332 23334444333222211 01112222334567778999
Q ss_pred CCCCCCC
Q 011196 431 DPMDRPT 437 (491)
Q Consensus 431 dP~~RPs 437 (491)
||++|..
T Consensus 497 dp~erlg 503 (593)
T KOG0695|consen 497 DPKERLG 503 (593)
T ss_pred CcHHhcC
Confidence 9999853
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.2e-16 Score=135.12 Aligned_cols=161 Identities=17% Similarity=0.181 Sum_probs=103.5
Q ss_pred hhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhhh
Q 011196 271 TIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME 350 (491)
Q Consensus 271 ~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 350 (491)
++.-++..++.+.|+.. +.|||+||.|.||+.+|..|++|||+++.++-.... ....+-|.+|++|.++.+
T Consensus 105 sfmlqllrgl~fchshn-------vlhrdlkpqnllin~ngelkladfglarafgipvrc--ysaevvtlwyrppdvlfg 175 (292)
T KOG0662|consen 105 SFMLQLLRGLGFCHSHN-------VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFG 175 (292)
T ss_pred HHHHHHHhhhhhhhhhh-------hhhccCCcceEEeccCCcEEecccchhhhcCCceEe--eeceeeeeeccCcceeee
Confidence 33444444444444443 349999999999999999999999999987644321 223456899999999988
Q ss_pred CC-CCcccceeehhHHHHHHHhCCCC-CCCccCCCcccHHHHHHHHhh---cCCcccc---ccchhcCCCCH-----HHH
Q 011196 351 GI-FSVKSDVFSFGVVLLEIISGKKS-SGFYHLEHGPSLLAYIWKLWC---EGHAAEL---MDSVVKQSCDQ-----AEL 417 (491)
Q Consensus 351 ~~-~s~~sDVwS~Gvvl~elltG~~p-~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---~d~~l~~~~~~-----~~~ 417 (491)
.+ |++..|+||-||++.|+.....| |. ..+..+.+..+.+... ++.++.+ .|-.....++. ..+
T Consensus 176 akly~tsidmwsagcifaelanagrplfp---g~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqiv 252 (292)
T KOG0662|consen 176 AKLYSTSIDMWSAGCIFAELANAGRPLFP---GNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIV 252 (292)
T ss_pred eehhccchHhhhcchHHHHHhhcCCCCCC---CCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHh
Confidence 65 89999999999999999875444 33 2333333333333222 2222222 12111111221 111
Q ss_pred ----HHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 418 ----LKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 418 ----~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+-.++..+.+.-+|..|.++++.++
T Consensus 253 p~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 253 PKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred hhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 12346778889999999999988765
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.4e-16 Score=160.27 Aligned_cols=160 Identities=13% Similarity=0.071 Sum_probs=101.2
Q ss_pred hhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhh
Q 011196 269 WITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYA 348 (491)
Q Consensus 269 ~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 348 (491)
...++.+++.++.++|..+++ ||||||+|||++.++.+||+|||+++........ ......+++.|++||.+
T Consensus 311 ~~~i~~ql~~aL~~lH~~~iv-------HrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 311 IKGVMRQVLTGLRKLHRIGIV-------HRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEEL 382 (507)
T ss_pred HHHHHHHHHHHHHHHHHCCee-------cCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhhh
Confidence 445667777888888876655 9999999999999999999999999765332211 11122347899999987
Q ss_pred hhCC--------------------C--CcccceeehhHHHHHHHhCCC-CCCCccCCC----cccHHHHHHHHhhcCCcc
Q 011196 349 MEGI--------------------F--SVKSDVFSFGVVLLEIISGKK-SSGFYHLEH----GPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 349 ~~~~--------------------~--s~~sDVwS~Gvvl~elltG~~-p~~~~~~~~----~~~~~~~~~~~~~~~~~~ 401 (491)
.... + ..+.||||+||+++||++|.. |+....... ........|+.+......
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 5422 1 234799999999999999875 543211100 001111123332222111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCC---CCCCCHHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDP---MDRPTMSSVAVM 444 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP---~~RPs~~evl~~ 444 (491)
- ...........+++.++|..+| .+|+|++|++++
T Consensus 463 ~--------~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 463 F--------SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred c--------ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0 0011122345678888888765 789999998753
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.1e-15 Score=144.15 Aligned_cols=160 Identities=17% Similarity=0.197 Sum_probs=109.8
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC---ceEeccCcceecCCCCc-----ccccCceee
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN---PKISDFGMARIFGGNQS-----EANTNRVVG 338 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~---~kl~DfGla~~~~~~~~-----~~~~~~~~g 338 (491)
.....+...++.++.+||..++. ||||||+|||-..... +||+||.+...+..... .......+|
T Consensus 176 ~EAs~vvkdia~aLdFlH~kgIA-------HRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvG 248 (463)
T KOG0607|consen 176 REASRVVKDIASALDFLHTKGIA-------HRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVG 248 (463)
T ss_pred HHHHHHHHHHHHHHHHHhhcCcc-------cccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCccc
Confidence 34556778889999999998888 9999999999876543 79999988764422211 122234688
Q ss_pred cCCCChhhhhhh-----CCCCcccceeehhHHHHHHHhCCCCCCCccCCCc--------ccHHHHHHHHhhcCCcccccc
Q 011196 339 TYGYMAPEYAME-----GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHG--------PSLLAYIWKLWCEGHAAELMD 405 (491)
Q Consensus 339 t~~y~aPE~~~~-----~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~d 405 (491)
+..|||||+..- ..|+.+.|.||+|||+|-|++|.+||...-..+- ..=.....+.+.++..
T Consensus 249 SAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkY----- 323 (463)
T KOG0607|consen 249 SAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKY----- 323 (463)
T ss_pred chhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCC-----
Confidence 899999998752 3489999999999999999999999865332221 1111122222222221
Q ss_pred chhcCCCCHHH----HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 406 SVVKQSCDQAE----LLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 406 ~~l~~~~~~~~----~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
+++..+ ..+..+++.+.+..|+.+|.++.+++.
T Consensus 324 -----eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 324 -----EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred -----cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 122222 223446777888899999999988876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.3e-15 Score=137.72 Aligned_cols=124 Identities=28% Similarity=0.492 Sum_probs=102.6
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC-CCCceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH-EMNPKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
.......+...++.++.++|..+++ |+||+|.||+++. ++.++|+|||.+........ ......+...|+
T Consensus 90 ~~~~~~~~~~~l~~~l~~lh~~~~~-------H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ 160 (215)
T cd00180 90 SEDEILRILLQILEGLEYLHSNGII-------HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYM 160 (215)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCee-------ccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCcc
Confidence 3455667788888889999988777 9999999999999 89999999999986643321 122345688899
Q ss_pred hhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHH
Q 011196 344 APEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 344 aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
+||..... ..+.+.|+|++|++++++ ..+.+
T Consensus 161 ~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------~~~~~ 192 (215)
T cd00180 161 APEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------PELKD 192 (215)
T ss_pred ChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------HHHHH
Confidence 99999877 788999999999999998 45677
Q ss_pred HHHHcccCCCCCCCCHHHHHHHh
Q 011196 423 IGLLCVQEDPMDRPTMSSVAVML 445 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~~L 445 (491)
++..|++.||++||++.++++.+
T Consensus 193 ~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 193 LIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHhhCCcccCcCHHHHhhCC
Confidence 88999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.4e-15 Score=140.61 Aligned_cols=163 Identities=17% Similarity=0.251 Sum_probs=113.2
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeecccccccccccc--CCCCceEeccCcceecCCCCcccccCceeecCCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLD--HEMNPKISDFGMARIFGGNQSEANTNRVVGTYGY 342 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~--~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 342 (491)
+....+.+..+++.++.++|...++ |||||.+||||- +...+||+|||+.+..+.... ....+..|
T Consensus 119 gE~~~K~v~~ql~SAi~fMHsknlV-------HRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~-----~~~~~~~y 186 (378)
T KOG1345|consen 119 GEANTKKVFAQLLSAIEFMHSKNLV-------HRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK-----YLEYVNNY 186 (378)
T ss_pred cHHHHHHHHHHHHHHHHHhhccchh-------hcccccceEEEecCCccEEEeeecccccccCceeh-----hhhhhccc
Confidence 3556678899999999999998888 999999999993 335799999999876543221 22346679
Q ss_pred ChhhhhhhC-----CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHH
Q 011196 343 MAPEYAMEG-----IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAEL 417 (491)
Q Consensus 343 ~aPE~~~~~-----~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 417 (491)
.+||..... +..+.+|||.||++++.+++|..||.--.. ++.-.+-|..|..+....+.+.. ..+.
T Consensus 187 ~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~---~d~~Y~~~~~w~~rk~~~~P~~F--~~fs---- 257 (378)
T KOG1345|consen 187 HAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI---MDKPYWEWEQWLKRKNPALPKKF--NPFS---- 257 (378)
T ss_pred CCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc---cCchHHHHHHHhcccCccCchhh--cccC----
Confidence 999987532 357889999999999999999999873222 23334445556555544332222 1122
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 418 LKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 418 ~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+.+++.++-+..+|++|=-..++.++....
T Consensus 258 ~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 258 EKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred HHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 2355667789999999995555555555433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.4e-15 Score=158.50 Aligned_cols=161 Identities=18% Similarity=0.187 Sum_probs=117.3
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc--cccCceeecCCCChh
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE--ANTNRVVGTYGYMAP 345 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aP 345 (491)
..--...++..++.|+|..++. |||+|++|+++..++.+||+|||.+..+...... .......|+..|+||
T Consensus 421 e~~c~fKqL~~Gv~y~h~~Gia-------hrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~ap 493 (601)
T KOG0590|consen 421 EADCFFKQLLRGVKYLHSMGLA-------HRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAP 493 (601)
T ss_pred hhhHHHHHHHHHHHHHHhcCce-------eccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCc
Confidence 3445677888889999999999 9999999999999999999999999866433332 344568899999999
Q ss_pred hhhhhCCCCc-ccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSV-KSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~-~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..|++ ..||||.|+++..|++|+.||..-...+... .+.. ......+.... .........+...++
T Consensus 494 E~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~~~-----~~~~~~~~~~~--~~~~~~lp~~~~~~~ 565 (601)
T KOG0590|consen 494 EVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KTNN-----YSDQRNIFEGP--NRLLSLLPRETRIII 565 (601)
T ss_pred ccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hhhc-----cccccccccCh--HHHHHhchhhHHHHH
Confidence 9999999986 6999999999999999999987544333221 0000 00000010000 001112334566788
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 011196 425 LLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~ 443 (491)
.++|+.||.+|.|+++|++
T Consensus 566 ~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 566 YRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHccCChhheecHHHHhh
Confidence 9999999999999999985
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.6e-14 Score=139.83 Aligned_cols=165 Identities=19% Similarity=0.289 Sum_probs=102.3
Q ss_pred hhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC-CCceEeccCcceecCCCC--------------c------
Q 011196 271 TIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE-MNPKISDFGMARIFGGNQ--------------S------ 329 (491)
Q Consensus 271 ~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~-~~~kl~DfGla~~~~~~~--------------~------ 329 (491)
.....+..++.++|..+++ ||||||+|+|.+.. +.-.|.|||++......+ .
T Consensus 136 ~Yl~~ll~Al~~~h~~GIv-------HRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~ 208 (418)
T KOG1167|consen 136 WYLRNLLKALAHLHKNGIV-------HRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDV 208 (418)
T ss_pred HHHHHHHHHhhhhhccCcc-------ccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcc
Confidence 3444555566666665555 99999999999876 456899999997211000 0
Q ss_pred ----------------------ccccCceeecCCCChhhhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCccc
Q 011196 330 ----------------------EANTNRVVGTYGYMAPEYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPS 386 (491)
Q Consensus 330 ----------------------~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~ 386 (491)
........||++|+|||++...+ .++++||||.|+|++-+++++.||. ...++...
T Consensus 209 ~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf-~a~dd~~a 287 (418)
T KOG1167|consen 209 HCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFF-KAKDDADA 287 (418)
T ss_pred cccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccc-cCccccch
Confidence 00011257999999999998754 6889999999999999999999963 22222223
Q ss_pred HHHHHHH-----------------HhhcCC---cccc------cc-chhcC-CC--------CHHHHHHHHHHHHHcccC
Q 011196 387 LLAYIWK-----------------LWCEGH---AAEL------MD-SVVKQ-SC--------DQAELLKYIHIGLLCVQE 430 (491)
Q Consensus 387 ~~~~~~~-----------------~~~~~~---~~~~------~d-~~l~~-~~--------~~~~~~~~~~l~~~cl~~ 430 (491)
+.+.+.. .|.... ..++ ++ +.+.. +. .......++++..+|+..
T Consensus 288 l~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~ 367 (418)
T KOG1167|consen 288 LAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLEL 367 (418)
T ss_pred HHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccC
Confidence 3222210 111000 0000 00 00000 00 001123678999999999
Q ss_pred CCCCCCCHHHHHH
Q 011196 431 DPMDRPTMSSVAV 443 (491)
Q Consensus 431 dP~~RPs~~evl~ 443 (491)
||.+|.|+++.++
T Consensus 368 np~kRitAEeALk 380 (418)
T KOG1167|consen 368 NPQKRITAEDALK 380 (418)
T ss_pred ChhhcccHHHHhc
Confidence 9999999998775
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=9.9e-14 Score=142.19 Aligned_cols=147 Identities=20% Similarity=0.285 Sum_probs=99.4
Q ss_pred hHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhh---h
Q 011196 274 EAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM---E 350 (491)
Q Consensus 274 ~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~ 350 (491)
.....++.|+|+.+-. |||||-.|||+++.+.+|+.|||.+-.++.. ......+.||+.|||||+.. .
T Consensus 119 Retl~gl~ylhs~gk~-------hRdiKGanilltd~gDvklaDfgvsaqitat--i~KrksfiGtpywmapEvaaverk 189 (829)
T KOG0576|consen 119 RETLQGLKYLHSQGKI-------HRDIKGANILLTDEGDVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERK 189 (829)
T ss_pred hhhhccchhhhcCCcc-------cccccccceeecccCceeecccCchhhhhhh--hhhhhcccCCccccchhHHHHHhc
Confidence 3344455555555444 9999999999999999999999998765432 22334589999999999875 4
Q ss_pred CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC--CccccccchhcCCCCHHHHHHHHHHHHHcc
Q 011196 351 GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG--HAAELMDSVVKQSCDQAELLKYIHIGLLCV 428 (491)
Q Consensus 351 ~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl 428 (491)
+.|..+.|||+.|+...|+---++|.. +.... .+..+.... ....+.|+. .-...+-++++.++
T Consensus 190 ggynqlcdiwa~gitAiel~eLqpplf--dlhpm-----r~l~LmTkS~~qpp~lkDk~-------kws~~fh~fvK~al 255 (829)
T KOG0576|consen 190 GGYNQLCDIWALGITAIELGELQPPLF--DLHPM-----RALFLMTKSGFQPPTLKDKT-------KWSEFFHNFVKGAL 255 (829)
T ss_pred ccccccccccccccchhhhhhcCCccc--ccchH-----HHHHHhhccCCCCCcccCCc-------cchHHHHHHHHHHh
Confidence 679999999999999999987777732 11111 111111111 111111221 11234557888999
Q ss_pred cCCCCCCCCHHHHHH
Q 011196 429 QEDPMDRPTMSSVAV 443 (491)
Q Consensus 429 ~~dP~~RPs~~evl~ 443 (491)
-++|++||++..++.
T Consensus 256 tknpKkRptaeklL~ 270 (829)
T KOG0576|consen 256 TKNPKKRPTAEKLLQ 270 (829)
T ss_pred cCCCccCCChhhhee
Confidence 999999999987654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.2e-12 Score=134.04 Aligned_cols=167 Identities=17% Similarity=0.300 Sum_probs=115.7
Q ss_pred hhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhh
Q 011196 270 ITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM 349 (491)
Q Consensus 270 ~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 349 (491)
..+...++.++.|+|...+. .|+.++++|.++|..+.+||.|||+.................-..-|.|||.+.
T Consensus 51 ~s~~rdi~~Gl~ylh~s~i~------~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr 124 (484)
T KOG1023|consen 51 LSFIRDISKGLAYLHNSPIG------YHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLR 124 (484)
T ss_pred HHHHHHHHHHHHHHhcCcce------eeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhc
Confidence 35677888899999877664 299999999999999999999999987664211111111122345799999987
Q ss_pred hC-------CCCcccceeehhHHHHHHHhCCCCCCCccCCCcc-cHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 350 EG-------IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGP-SLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 350 ~~-------~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
.. ..+.+.||||||++++|+++.+.||+........ ++...+.. .....+.|.+.... +....++
T Consensus 125 ~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~ 197 (484)
T KOG1023|consen 125 GALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELL 197 (484)
T ss_pred ccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHH
Confidence 53 1467899999999999999999998754333222 22322222 12222333332111 2233688
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
.++..||..+|++||++++|-..++...
T Consensus 198 ~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 198 LLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred HHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 8999999999999999999988887664
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.7e-13 Score=137.95 Aligned_cols=130 Identities=21% Similarity=0.293 Sum_probs=89.8
Q ss_pred EeeeccccccccccccCCCCceEeccCcceecCCCC----cccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHH
Q 011196 293 IRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQ----SEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLE 368 (491)
Q Consensus 293 ~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~e 368 (491)
++.+|||+||.||....+..+||+|||+........ .....+...||..||+||.+.+.+|+.|+|||+||++++|
T Consensus 375 k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~E 454 (516)
T KOG1033|consen 375 KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAE 454 (516)
T ss_pred ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHH
Confidence 455699999999999999999999999987665443 1123345789999999999999999999999999999999
Q ss_pred HHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 011196 369 IIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSV 441 (491)
Q Consensus 369 llt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev 441 (491)
++. -...+. -.....-+..+.++ +....+++. =..+.++++...|.+||++.++
T Consensus 455 L~~~f~T~~e----------r~~t~~d~r~g~ip----~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 455 LLIQFSTQFE----------RIATLTDIRDGIIP----PEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHHHhccHHH----------HHHhhhhhhcCCCC----hHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence 987 222211 00011112222222 111112222 2357788999999999955443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.35 E-value=9.4e-13 Score=126.99 Aligned_cols=133 Identities=17% Similarity=0.244 Sum_probs=87.1
Q ss_pred hhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhh
Q 011196 270 ITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM 349 (491)
Q Consensus 270 ~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 349 (491)
..+..+++..++.+|..+++ |+||||+|++++.+|.++|+||+.....+..... ...+..|.+||...
T Consensus 148 l~lT~Q~I~lvA~Lh~~GlV-------Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~ 215 (288)
T PF14531_consen 148 LSLTVQMIRLVANLHSYGLV-------HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELES 215 (288)
T ss_dssp HHHHHHHHHHHHHHHHTTEE-------EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHH
T ss_pred HHHHHHHHHHHHHHhhcceE-------ecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhh
Confidence 34445667778888988888 9999999999999999999999887654322111 12357799999875
Q ss_pred hC--------CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 350 EG--------IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 350 ~~--------~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
.. .++.+.|.|++|+++|.|.++..||+.......... .-..+. +..+.+.
T Consensus 216 ~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~ 274 (288)
T PF14531_consen 216 CAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQ 274 (288)
T ss_dssp HHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG--------------------GGTTSS----HHHH
T ss_pred hhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc--------------------cchhcC-CcCHHHH
Confidence 42 478899999999999999999999864432221111 112233 4455677
Q ss_pred HHHHHcccCCCCCC
Q 011196 422 HIGLLCVQEDPMDR 435 (491)
Q Consensus 422 ~l~~~cl~~dP~~R 435 (491)
.|+..+|+.||.+|
T Consensus 275 ~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 275 FLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHT-SSGGGS
T ss_pred HHHHHHccCCcccC
Confidence 78999999999988
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-12 Score=122.65 Aligned_cols=104 Identities=24% Similarity=0.355 Sum_probs=84.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......+..+++.++.++|..++. |+||+|+||+++.++.++|+|||.+......... ......++..|++|
T Consensus 97 ~~~~~~~~~~l~~~l~~lh~~~i~-------h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~p 168 (225)
T smart00221 97 EEEARFYLRQILEALEYLHSLGIV-------HRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAP 168 (225)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccceeccCCcCCH
Confidence 444566777788888888887666 9999999999999999999999999876543211 22345678899999
Q ss_pred hhh-hhCCCCcccceeehhHHHHHHHhCCCCCC
Q 011196 346 EYA-MEGIFSVKSDVFSFGVVLLEIISGKKSSG 377 (491)
Q Consensus 346 E~~-~~~~~s~~sDVwS~Gvvl~elltG~~p~~ 377 (491)
|.+ ....++.++|||+||++++||++|+.||.
T Consensus 169 e~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 169 EVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred hHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 998 56678889999999999999999999973
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=5.7e-13 Score=134.66 Aligned_cols=100 Identities=23% Similarity=0.325 Sum_probs=80.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.|..|++.++.+||..+++ |||||-+|+.++.+|-+||+|||.+....++. -..++||..|.||
T Consensus 669 E~eAk~IFkQV~agi~hlh~~~iv-------hrdikdenvivd~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aap 737 (772)
T KOG1152|consen 669 EPEAKLIFKQVVAGIKHLHDQGIV-------HRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAP 737 (772)
T ss_pred hHHHHHHHHHHHhccccccccCce-------ecccccccEEEecCCeEEEeeccchhhhcCCC----cceeeeeccccch
Confidence 334455666666666666666555 99999999999999999999999987553322 2358999999999
Q ss_pred hhhhhCCC-CcccceeehhHHHHHHHhCCCCC
Q 011196 346 EYAMEGIF-SVKSDVFSFGVVLLEIISGKKSS 376 (491)
Q Consensus 346 E~~~~~~~-s~~sDVwS~Gvvl~elltG~~p~ 376 (491)
|++.+.+| ...-|||++|+++|-++....|+
T Consensus 738 evl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 738 EVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred hhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 99998886 56799999999999999888775
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.24 E-value=4e-11 Score=117.67 Aligned_cols=168 Identities=24% Similarity=0.292 Sum_probs=112.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC-CceEeccCcceecCCCCccc----ccCceeecC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM-NPKISDFGMARIFGGNQSEA----NTNRVVGTY 340 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~-~~kl~DfGla~~~~~~~~~~----~~~~~~gt~ 340 (491)
......+..++..++.++|..+++ |||+||+||+++... .+++.|||.++......... ......|+.
T Consensus 100 ~~~~~~~~~~~~~~l~~~H~~~~~-------hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~ 172 (384)
T COG0515 100 ESEALFILAQILSALEYLHSKGII-------HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172 (384)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------ccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccccccccccccccc
Confidence 344556677777777788887755 999999999999988 69999999998654433221 234578999
Q ss_pred CCChhhhhhh---CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHH
Q 011196 341 GYMAPEYAME---GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAEL 417 (491)
Q Consensus 341 ~y~aPE~~~~---~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 417 (491)
.|++||.+.+ .......|+||+|+++++++.|..|+...... ......+........... .............
T Consensus 173 ~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 248 (384)
T COG0515 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTPSL-ASPLSPSNPELIS 248 (384)
T ss_pred ccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCccc-ccccCccccchhh
Confidence 9999999987 57889999999999999999999995433221 011112221111111100 0000000001223
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 418 LKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 418 ~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..+.+++..++..+|..|.+..+....
T Consensus 249 ~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 249 KAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 456678889999999999999887764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.5e-12 Score=126.09 Aligned_cols=129 Identities=20% Similarity=0.251 Sum_probs=88.4
Q ss_pred CCCceEeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCC---ccc
Q 011196 310 EMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEH---GPS 386 (491)
Q Consensus 310 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~---~~~ 386 (491)
+..+||+|||-+......-+ .-+-|..|++||++.+..|++.+||||++|+++||+||...|+-...+. +.+
T Consensus 390 di~vKIaDlGNACW~~khFT-----~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED 464 (590)
T KOG1290|consen 390 DIRVKIADLGNACWVHKHFT-----EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED 464 (590)
T ss_pred ceeEEEeeccchhhhhhhhc-----hhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence 45799999999875433222 2345888999999999999999999999999999999987765332221 222
Q ss_pred HHHHHHHHh--------hc-----------CCcccc-------ccchhc--CCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 011196 387 LLAYIWKLW--------CE-----------GHAAEL-------MDSVVK--QSCDQAELLKYIHIGLLCVQEDPMDRPTM 438 (491)
Q Consensus 387 ~~~~~~~~~--------~~-----------~~~~~~-------~d~~l~--~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 438 (491)
.+..+.+.. .. +.+..+ +...|. -.++.++..++.+++.-||+.+|++||||
T Consensus 465 HiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA 544 (590)
T KOG1290|consen 465 HIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTA 544 (590)
T ss_pred HHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccH
Confidence 222222111 11 111111 111121 14678889999999999999999999999
Q ss_pred HHHHH
Q 011196 439 SSVAV 443 (491)
Q Consensus 439 ~evl~ 443 (491)
.+.++
T Consensus 545 ~~cl~ 549 (590)
T KOG1290|consen 545 AQCLK 549 (590)
T ss_pred HHHhc
Confidence 88764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=8.2e-11 Score=117.66 Aligned_cols=168 Identities=20% Similarity=0.179 Sum_probs=115.6
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC-----CCceEeccCcce--ecCCCCc----cc-c
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE-----MNPKISDFGMAR--IFGGNQS----EA-N 332 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~-----~~~kl~DfGla~--~~~~~~~----~~-~ 332 (491)
+...+..++.++..++.++|..+++ ||||||.|+++... ..+.|.|||+++ ....... .. .
T Consensus 120 s~~T~l~ia~q~l~~l~~lH~~G~i-------HRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~ 192 (322)
T KOG1164|consen 120 SRKTVLRIAIQNLNALEDLHSKGFI-------HRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRP 192 (322)
T ss_pred CHhHHHHHHHHHHHHHHHHHhcCcc-------cCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCC
Confidence 3566788999999999999999999 99999999999865 358999999998 3221111 11 1
Q ss_pred -cCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCC
Q 011196 333 -TNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQS 411 (491)
Q Consensus 333 -~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 411 (491)
...+.||..|.++....+...+.+.|+||++-++.|++.|..||........ ........... .... ...
T Consensus 193 ~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~~~~~~~----~~~~--~~~ 263 (322)
T KOG1164|consen 193 QKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFEKDPRKL----LTDR--FGD 263 (322)
T ss_pred CccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHHHHhhhh----cccc--ccC
Confidence 2235699999999999999999999999999999999999999854332222 11111111111 0010 111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCC
Q 011196 412 CDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVT 451 (491)
Q Consensus 412 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 451 (491)
..+.+... +...+-..+..++|....+...|+.....
T Consensus 264 ~~~~~~~~---~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 264 LKPEEFAK---ILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred CChHHHHH---HHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 22233333 44444458899999999999887665433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.4e-12 Score=136.62 Aligned_cols=150 Identities=18% Similarity=0.204 Sum_probs=103.6
Q ss_pred HHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCC-------------CcccccCceeecCCCC
Q 011196 277 SAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGN-------------QSEANTNRVVGTYGYM 343 (491)
Q Consensus 277 ~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~-------------~~~~~~~~~~gt~~y~ 343 (491)
+..+.|+|..+++ |||+||+|.+|..-|++|+.|||+++..... ..+-...+.+||+.|+
T Consensus 153 vla~Eylh~ygiv-------hrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyi 225 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIV-------HRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYI 225 (1205)
T ss_pred hHHhHhhccCCee-------cCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCcccc
Confidence 6678888888888 9999999999999999999999999753110 0011123468999999
Q ss_pred hhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 344 APEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 344 aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
|||++....|...+|-|++|+|+||.+-|..||..... .+++..+... ...+.|- |+ .-..+..++
T Consensus 226 aPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp---eelfg~visd--~i~wpE~-de--------a~p~Ea~dl 291 (1205)
T KOG0606|consen 226 APEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISD--DIEWPEE-DE--------ALPPEAQDL 291 (1205)
T ss_pred ChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH---HHHHhhhhhh--hcccccc-Cc--------CCCHHHHHH
Confidence 99999999999999999999999999999999753211 1222222110 1111111 11 112334567
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhc
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
+.+.|+.+|..|--....+++-++
T Consensus 292 i~~LL~qnp~~Rlgt~ga~evk~h 315 (1205)
T KOG0606|consen 292 IEQLLRQNPLCRLGTGGALEVKQH 315 (1205)
T ss_pred HHHHHHhChHhhcccchhhhhhhc
Confidence 778999999999644444444433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.5e-11 Score=122.36 Aligned_cols=87 Identities=29% Similarity=0.385 Sum_probs=71.2
Q ss_pred HHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcc
Q 011196 277 SAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356 (491)
Q Consensus 277 ~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~ 356 (491)
+.++.++|.++++ |||+|++||+++.+|++|+.|||+++..-.... .+||..|||||++. .+...
T Consensus 107 aLald~lh~l~ii-------yrd~k~enilld~~Ghi~~tdfglske~v~~~~------~cgt~eymApEI~~--gh~~a 171 (612)
T KOG0603|consen 107 ALALDHLHKLGIA-------YRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSA 171 (612)
T ss_pred HHHHhhcchhHHH-------HhcccccceeecccCccccCCchhhhHhHhhhh------cccchhhhhhHhhh--ccCCc
Confidence 3344445555555 999999999999999999999999987533222 27899999999998 55788
Q ss_pred cceeehhHHHHHHHhCCCCCCC
Q 011196 357 SDVFSFGVVLLEIISGKKSSGF 378 (491)
Q Consensus 357 sDVwS~Gvvl~elltG~~p~~~ 378 (491)
+|-||||++.+||++|..||..
T Consensus 172 ~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 172 ADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ccchhhhhhHHHHhhCCCCCch
Confidence 9999999999999999999753
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=9e-11 Score=108.92 Aligned_cols=154 Identities=16% Similarity=0.168 Sum_probs=107.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEe--ccCcceecCCCCcccccCceeecCCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKIS--DFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
..+..+++-.++.++.+||.+.-..- .--|.+..++||++.+.+|+ |--++.+. . ...-.+.||
T Consensus 288 ~sqav~faldiargmaflhslep~ip-----r~~lns~hvmidedltarismad~kfsfqe--------~-gr~y~pawm 353 (448)
T KOG0195|consen 288 HSQAVRFALDIARGMAFLHSLEPMIP-----RFYLNSKHVMIDEDLTARISMADTKFSFQE--------V-GRAYSPAWM 353 (448)
T ss_pred cchHHHHHHHHHhhHHHHhhcchhhh-----hhhcccceEEecchhhhheecccceeeeec--------c-ccccCcccC
Confidence 44667788899999999998743311 22356778999999988775 43322211 1 123367899
Q ss_pred hhhhhhhCCCC---cccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHH
Q 011196 344 APEYAMEGIFS---VKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKY 420 (491)
Q Consensus 344 aPE~~~~~~~s---~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 420 (491)
+||.+...+-+ .++|+|||.+++||+.|...||......+.. .++.-+.++...++.....+
T Consensus 354 spealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialeglrv~ippgis~hm 418 (448)
T KOG0195|consen 354 SPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEGLRVHIPPGISRHM 418 (448)
T ss_pred CHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhccccccCCCCccHHH
Confidence 99999876633 5799999999999999999998654332211 11111223334445555667
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 421 IHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 421 ~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+++.-|+++||.+||.+..|+-.|++.
T Consensus 419 ~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 419 NKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred HHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 7899999999999999999999988864
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.6e-10 Score=111.16 Aligned_cols=156 Identities=18% Similarity=0.174 Sum_probs=96.6
Q ss_pred hhhhHhHHHHHHHHHhheeeEEeEEeeecccccccccccc--CCC--CceEeccCcceecCCCCc----ccccCceeecC
Q 011196 269 WITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLD--HEM--NPKISDFGMARIFGGNQS----EANTNRVVGTY 340 (491)
Q Consensus 269 ~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~--~~~--~~kl~DfGla~~~~~~~~----~~~~~~~~gt~ 340 (491)
..-++.++..++.+||..++. |||+|++|||+. ++. ...|+|||.+..-....- ....-...|.-
T Consensus 343 ~~~~laQlLEav~hL~~hgvA-------hRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa 415 (598)
T KOG4158|consen 343 GRVILAQLLEAVTHLHKHGVA-------HRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNA 415 (598)
T ss_pred HHHHHHHHHHHHHHHHHccch-------hhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcc
Confidence 334556666777777776666 999999999983 443 467899998753221100 01111235667
Q ss_pred CCChhhhhhhC--C---CC-cccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCH
Q 011196 341 GYMAPEYAMEG--I---FS-VKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQ 414 (491)
Q Consensus 341 ~y~aPE~~~~~--~---~s-~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 414 (491)
..||||+...- + .+ .|+|.|+.|.+.||+++...||.. +.+.. +.. +.+.+..++ .+. .
T Consensus 416 ~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~-rGem~--L~~---r~Yqe~qLP-----alp----~ 480 (598)
T KOG4158|consen 416 KLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK-RGEML--LDT---RTYQESQLP-----ALP----S 480 (598)
T ss_pred eecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc-cchhe--ech---hhhhhhhCC-----CCc----c
Confidence 78999998642 2 22 589999999999999999999743 11111 111 011111111 111 2
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 011196 415 AELLKYIHIGLLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 415 ~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 446 (491)
.....+.+++...|+.||++|++..-....|+
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 22234556788899999999999776655554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3e-10 Score=122.92 Aligned_cols=153 Identities=18% Similarity=0.198 Sum_probs=93.9
Q ss_pred HhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceec--CCCCccccc---CceeecCCCChhhh
Q 011196 273 AEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIF--GGNQSEANT---NRVVGTYGYMAPEY 347 (491)
Q Consensus 273 ~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~--~~~~~~~~~---~~~~gt~~y~aPE~ 347 (491)
+-++..++...|..++. |+|||.+||||..=.++.|.||.--+.. +.+....-+ .+...-..|.|||-
T Consensus 126 aFQLL~al~qcH~~gVc-------HGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPER 198 (1431)
T KOG1240|consen 126 AFQLLKALSQCHKLGVC-------HGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPER 198 (1431)
T ss_pred HHHHHHHHHHHHHcCcc-------ccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHh
Confidence 33445555555665555 9999999999998888999999776542 222111100 00111236999998
Q ss_pred hhhC----------C-CCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHH
Q 011196 348 AMEG----------I-FSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 415 (491)
Q Consensus 348 ~~~~----------~-~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 415 (491)
+... . .+++-||||+||++.|+++ |+++|... ++.. ++.+. .......+.. .+
T Consensus 199 Fv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~a-----Yr~~~-~~~~e~~Le~-Ie-- 263 (1431)
T KOG1240|consen 199 FVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLA-----YRSGN-ADDPEQLLEK-IE-- 263 (1431)
T ss_pred hhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHh-----HhccC-ccCHHHHHHh-Cc--
Confidence 7642 1 5788999999999999998 56665421 1111 11111 0000111110 00
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 416 ELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 416 ~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
-..+.++++.|++.||++|.++++.++--.+.
T Consensus 264 -d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 264 -DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred -CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 01345688999999999999999998874443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=9.5e-09 Score=103.46 Aligned_cols=105 Identities=13% Similarity=0.142 Sum_probs=72.0
Q ss_pred eeeecccccCCCCccccCCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeecccc-ccccccccCCCCceEeccCcce
Q 011196 244 RYELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRV-RASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDl-Kp~NILl~~~~~~kl~DfGla~ 322 (491)
.|.++.|..+..+. ...+ .....+..+++.++.++|..+++ |||| ||+|||++.++.+||+|||+++
T Consensus 93 ~~LVmE~~~G~~L~-~~~~----~~~~~~~~~i~~aL~~lH~~gIi-------HrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 93 DGLVRGWTEGVPLH-LARP----HGDPAWFRSAHRALRDLHRAGIT-------HNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred cEEEEEccCCCCHH-HhCc----cchHHHHHHHHHHHHHHHHCCCe-------eCCCCCcceEEEcCCCCEEEEECccce
Confidence 46667776654432 1111 11245677788899999988777 9999 9999999999999999999998
Q ss_pred ecCCCCcc------cccCceeecCCCChhhhhhhCC------CCccccee
Q 011196 323 IFGGNQSE------ANTNRVVGTYGYMAPEYAMEGI------FSVKSDVF 360 (491)
Q Consensus 323 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~------~s~~sDVw 360 (491)
.+...... .......+++.|++||++...+ .+...|-|
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 76433211 1113467788899999986432 33446666
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.6e-09 Score=114.48 Aligned_cols=153 Identities=21% Similarity=0.308 Sum_probs=102.4
Q ss_pred hHhHHHHHHHHHh-heeeEEeEEeeeccccccccccccCCC-CceEeccCcceecCC-CCcccccCceee-cCCCChhhh
Q 011196 272 IAEAASAIIVFLL-STSFLWCIIRRRNKRVRASNVLLDHEM-NPKISDFGMARIFGG-NQSEANTNRVVG-TYGYMAPEY 347 (491)
Q Consensus 272 ~~~~~~~~~~~l~-~~~~~~~~~~~iHrDlKp~NILl~~~~-~~kl~DfGla~~~~~-~~~~~~~~~~~g-t~~y~aPE~ 347 (491)
...+...++.++| ..++. ||||||+|.+++..+ ..|+.|||++..+.. ...........| ++.|+|||.
T Consensus 128 ~~~ql~s~l~~~H~~~~~~-------h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~ 200 (601)
T KOG0590|consen 128 YLPQLNSGLSYLHPENGVT-------HRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEH 200 (601)
T ss_pred hhhhhccCccccCcccccc-------cCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCccc
Confidence 4445555556666 44444 999999999999999 999999999987765 444444445677 999999999
Q ss_pred hhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHH
Q 011196 348 AMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLL 426 (491)
Q Consensus 348 ~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~ 426 (491)
..+.. .....|+||.|+++.-+++|..|+......... ... |.... ......... ......+++..+
T Consensus 201 ~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~-----~~~~~--~~~~~~~~~----~~~~~~~~~l~k 268 (601)
T KOG0590|consen 201 LSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSS-----WKSNK--GRFTQLPWN----SISDQAHDLLHK 268 (601)
T ss_pred ccchhhcCCCcccccccccccccccCCCCcccccccccc-cee-----ecccc--cccccCccc----cCChhhhhcccc
Confidence 98743 467899999999999999999998754433311 011 11110 000000011 111224456677
Q ss_pred cccCCCCCCCCHHHHHH
Q 011196 427 CVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 427 cl~~dP~~RPs~~evl~ 443 (491)
++..+|..|.+.+++..
T Consensus 269 ~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 269 ILKENPSNRLSIEELKL 285 (601)
T ss_pred cccCCchhccccccccc
Confidence 88899999999776543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=3.2e-08 Score=94.79 Aligned_cols=114 Identities=18% Similarity=0.256 Sum_probs=85.9
Q ss_pred hhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC-----CceEeccCcceecCCCCcc-----cccCceee
Q 011196 269 WITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM-----NPKISDFGMARIFGGNQSE-----ANTNRVVG 338 (491)
Q Consensus 269 ~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~-----~~kl~DfGla~~~~~~~~~-----~~~~~~~g 338 (491)
..-++.++..-++++|...++ .|||||+|+||..-+ .+.|+|||+++......+. .......|
T Consensus 126 V~miA~Qmi~rie~vH~k~LI-------YRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsG 198 (449)
T KOG1165|consen 126 VAMIAKQMITRIEYVHEKDLI-------YRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSG 198 (449)
T ss_pred HHHHHHHHHHHHHHHHhccee-------ecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcccccccccc
Confidence 334555555556666665555 999999999997543 4789999999987554432 23345789
Q ss_pred cCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHH
Q 011196 339 TYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLA 389 (491)
Q Consensus 339 t~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 389 (491)
|..||+-....+.+.+...|+=|+|-++...+-|..||............+
T Consensus 199 TARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe 249 (449)
T KOG1165|consen 199 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE 249 (449)
T ss_pred ceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH
Confidence 999999988888888999999999999999999999998665554443333
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.64 E-value=8.2e-08 Score=105.77 Aligned_cols=135 Identities=14% Similarity=0.098 Sum_probs=97.5
Q ss_pred CCcEEEceecceeeeecccccCCCCccccCCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC--
Q 011196 232 LGARIFCASCSIRYELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH-- 309 (491)
Q Consensus 232 ~~g~i~~~~C~lry~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~-- 309 (491)
..+-++...|.+.-+.++|..-....+ ......+.-.+.+..+++.++..||..+|+ |+||||+|.||..
T Consensus 760 ~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~II-------HgDiKPDNfll~~~~ 831 (974)
T KOG1166|consen 760 SSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGII-------HGDIKPDNFLLRREI 831 (974)
T ss_pred HHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhccee-------cccCCcceeEeeccc
Confidence 345666777777766666643322222 122233445666788888888889888777 9999999999943
Q ss_pred -----CCCceEeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCC
Q 011196 310 -----EMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKK 374 (491)
Q Consensus 310 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~ 374 (491)
...++|+|||-+-.+.--.....-...++|-.+-.+|+..+.+|+..+|.|.++.+++-|+.|+.
T Consensus 832 ~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 832 CADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred CCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 34589999999864422111222334678899999999999999999999999999999999874
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=4e-08 Score=90.23 Aligned_cols=164 Identities=15% Similarity=0.142 Sum_probs=108.7
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC---CceEeccCcceecCCCCc-----ccccCceee
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM---NPKISDFGMARIFGGNQS-----EANTNRVVG 338 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~---~~kl~DfGla~~~~~~~~-----~~~~~~~~g 338 (491)
+..+-.+.++..-+.++|..+++ ||||||+|+|..-+. .+.++|||+++.+.+..+ ........|
T Consensus 111 kTvLMLaDQml~RiEyvH~r~fi-------HRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltG 183 (341)
T KOG1163|consen 111 KTVLMLADQMLSRIEYVHLRNFI-------HRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTG 183 (341)
T ss_pred HhHHHHHHHHHHHHHHHHhhccc-------cccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccce
Confidence 44555677778888888888888 999999999997653 467999999987654332 223345789
Q ss_pred cCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHH
Q 011196 339 TYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELL 418 (491)
Q Consensus 339 t~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 418 (491)
|..|.+-....+...+...|+=|+|-++...--|..||.........+..+.+.+. ... ..-+.+...+|.+-.
T Consensus 184 TaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek----K~s-~~ie~LC~G~P~EF~- 257 (341)
T KOG1163|consen 184 TARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK----KMS-TPIEVLCKGFPAEFA- 257 (341)
T ss_pred eeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh----hcC-CCHHHHhCCCcHHHH-
Confidence 99999887777777788999999999999999999999765444333333322221 111 112233444554433
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 011196 419 KYIHIGLLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 419 ~~~~l~~~cl~~dP~~RPs~~evl~~L~ 446 (491)
-.+.-|-..--++-|...-+-++..
T Consensus 258 ---myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 258 ---MYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred ---HHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 2334466666666676554444443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.1e-08 Score=94.09 Aligned_cols=100 Identities=13% Similarity=0.162 Sum_probs=67.6
Q ss_pred eeeeecccccCCCCccccCCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 243 IRYELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
-.|.++.|.++.+........ .....++..++..+|..+++ |||+||+||+++.++ ++|+|||...
T Consensus 117 ~~~lvmEyi~G~tL~~~~~~~------~~~~~~i~~~l~~lH~~gi~-------H~Dikp~Nili~~~g-i~liDfg~~~ 182 (232)
T PRK10359 117 TYIMLIEYIEGVELNDMPEIS------EDVKAKIKASIESLHQHGMV-------SGDPHKGNFIVSKNG-LRIIDLSGKR 182 (232)
T ss_pred CeEEEEEEECCccHHHhhhcc------HHHHHHHHHHHHHHHHcCCc-------cCCCChHHEEEeCCC-EEEEECCCcc
Confidence 345566666655443221110 12345777778888888887 999999999999988 9999999886
Q ss_pred ecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHH
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEII 370 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ell 370 (491)
........ ..+..+..+..++|+|+||+.+....
T Consensus 183 ~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 183 CTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred cccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 54221110 11444556778999999999877654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.4e-07 Score=86.99 Aligned_cols=99 Identities=13% Similarity=0.120 Sum_probs=69.9
Q ss_pred hhHhHHHHHHHHHhheeeEEeEEeeecccc-ccccccccCCCCceEeccCcceecCCCCcc------cc-----cCceee
Q 011196 271 TIAEAASAIIVFLLSTSFLWCIIRRRNKRV-RASNVLLDHEMNPKISDFGMARIFGGNQSE------AN-----TNRVVG 338 (491)
Q Consensus 271 ~~~~~~~~~~~~l~~~~~~~~~~~~iHrDl-Kp~NILl~~~~~~kl~DfGla~~~~~~~~~------~~-----~~~~~g 338 (491)
.+..++..++.++|..+++ |||| ||+|||++.++.++|+|||++......... .. ......
T Consensus 95 ~~~~qi~~~L~~lH~~GIv-------HrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y 167 (218)
T PRK12274 95 AYFRAARRLLQQLHRCGVA-------HNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMY 167 (218)
T ss_pred HHHHHHHHHHHHHHHCcCc-------cCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhc
Confidence 4566777788888888777 9999 799999999999999999999865432210 00 111235
Q ss_pred cCCCChhhhhhhC-CCC-cccceeehhHHHHHHHhCCCCC
Q 011196 339 TYGYMAPEYAMEG-IFS-VKSDVFSFGVVLLEIISGKKSS 376 (491)
Q Consensus 339 t~~y~aPE~~~~~-~~s-~~sDVwS~Gvvl~elltG~~p~ 376 (491)
++.|+.|+-..-. ..+ ...+-++-|.-+|.++|+..+.
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 168 CPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred CCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 7778888754322 334 3445558899999999998773
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=98.28 E-value=9e-07 Score=81.45 Aligned_cols=53 Identities=15% Similarity=0.153 Sum_probs=44.7
Q ss_pred CcchhhhHhHHHHHHHHHhh-eeeEEeEEeeeccccccccccccCCCCceEeccCcceecCC
Q 011196 266 SKRWITIAEAASAIIVFLLS-TSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGG 326 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~ 326 (491)
......++.+++.++.++|. .+++ ||||||+|||++ ++.++|+|||++.....
T Consensus 116 ~~~~~~i~~~l~~~l~~lH~~~giv-------HrDlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 116 EEEAEELYEQVVEQMRRLYQEAGLV-------HGDLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred HHHHHHHHHHHHHHHHHHHHhCCEe-------cCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence 34567788888888888888 7777 999999999999 78999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=98.26 E-value=9.1e-07 Score=81.39 Aligned_cols=72 Identities=11% Similarity=0.069 Sum_probs=47.9
Q ss_pred eeecccccCCCCccc--cCCCCCCcchhhhHhHHHHHHHHH-hheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 245 YELYRFLVDTPTVTV--TAPNKTSKRWITIAEAASAIIVFL-LSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 245 y~~~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
|.++.|..+...... .....+......++.+++.++.++ |..+++ ||||||+|||++ ++.++|+|||++
T Consensus 93 ~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~gii-------HrDlkP~NIli~-~~~v~LiDFG~a 164 (190)
T cd05147 93 VLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLV-------HADLSEYNLLYH-DGKLYIIDVSQS 164 (190)
T ss_pred EEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcc-------cCCCCHHHEEEE-CCcEEEEEcccc
Confidence 456666655322111 111222344566677777777777 565666 999999999998 478999999999
Q ss_pred eec
Q 011196 322 RIF 324 (491)
Q Consensus 322 ~~~ 324 (491)
...
T Consensus 165 ~~~ 167 (190)
T cd05147 165 VEH 167 (190)
T ss_pred ccC
Confidence 754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.3e-06 Score=82.22 Aligned_cols=154 Identities=17% Similarity=0.177 Sum_probs=97.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCC--CCcccccCceeecCCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGG--NQSEANTNRVVGTYGYM 343 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~--~~~~~~~~~~~gt~~y~ 343 (491)
.+.|.++..++..++.|||+. ...++|+++.-+.|++..++-+|++--........ ......+....+-++|.
T Consensus 175 ~~~wkkw~tqIlsal~yLhs~-----~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~ 249 (458)
T KOG1266|consen 175 QKAWKKWCTQILSALSYLHSC-----DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFS 249 (458)
T ss_pred HHHHHHHHHHHHhhhhhhhcc-----CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccc
Confidence 567888999999999999984 45577999999999999999888864322211111 01111122335678899
Q ss_pred hhhhhhhCCCCcccceeehhHHHHHHHhCCCCCC-CccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHH
Q 011196 344 APEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSG-FYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 344 aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
+||+-..-+.+..+|||+||+..+||..+..-.. .........-...+ +..+-+..- ..
T Consensus 250 a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~--------i~~len~lq------------r~ 309 (458)
T KOG1266|consen 250 APESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV--------IIGLENGLQ------------RG 309 (458)
T ss_pred cCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh--------eeeccCccc------------cC
Confidence 9998777777889999999999999987654311 10000000000000 000111111 12
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 011196 423 IGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~~ 444 (491)
++.+|++..|..||+|++++.+
T Consensus 310 ~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 310 SITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred cCcccccCCCCCCcchhhhhcC
Confidence 4557999999999999987654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.13 E-value=6.3e-07 Score=94.03 Aligned_cols=146 Identities=17% Similarity=0.162 Sum_probs=92.5
Q ss_pred hheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCccc-------ccCceeecCCCChhhhhhhCCCCcc
Q 011196 284 LSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEA-------NTNRVVGTYGYMAPEYAMEGIFSVK 356 (491)
Q Consensus 284 ~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~s~~ 356 (491)
-++.++|.+.++||++|.|++|.++..+..||+.|+++.....+.... ...-.....-|.|||++.+...+.+
T Consensus 110 dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~~ 189 (700)
T KOG2137|consen 110 DGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTPA 189 (700)
T ss_pred chhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccccccc
Confidence 355667778888999999999999999999999999886544321111 0111233568999999998778899
Q ss_pred cceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCC
Q 011196 357 SDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDR 435 (491)
Q Consensus 357 sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~R 435 (491)
+|+||+|++++-+.. |+.-+...... +.+....... +.-.. .+..+...++.+=+.+++..++..|
T Consensus 190 sd~fSlG~li~~i~~~gk~i~~a~~~~-----~~~~~~~~~~----~~~~~----~~s~~~p~el~~~l~k~l~~~~~~r 256 (700)
T KOG2137|consen 190 SDVFSLGVLIYTIYNGGKSIIAANGGL-----LSYSFSRNLL----NAGAF----GYSNNLPSELRESLKKLLNGDSAVR 256 (700)
T ss_pred ccceeeeeEEEEEecCCcchhhccCCc-----chhhhhhccc----ccccc----cccccCcHHHHHHHHHHhcCCcccC
Confidence 999999999999984 44443322111 1111111000 00000 1111222334555667899999999
Q ss_pred CCHHHHH
Q 011196 436 PTMSSVA 442 (491)
Q Consensus 436 Ps~~evl 442 (491)
|++.++.
T Consensus 257 p~~~~l~ 263 (700)
T KOG2137|consen 257 PTLDLLL 263 (700)
T ss_pred cchhhhh
Confidence 9766544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=97.91 E-value=1.2e-05 Score=76.53 Aligned_cols=49 Identities=10% Similarity=0.095 Sum_probs=42.0
Q ss_pred chhhhHhHHHHHHHHHhhee-eEEeEEeeeccccccccccccCCCCceEeccCcceec
Q 011196 268 RWITIAEAASAIIVFLLSTS-FLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIF 324 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~-~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~ 324 (491)
....++.+++.++.++|..+ +. ||||||+||+++ ++.++|+|||.+...
T Consensus 149 ~~~~i~~qi~~~l~~LH~~g~ii-------H~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 149 EEFELYDDILEEMRKLYKEGELV-------HGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred HHHHHHHHHHHHHHHHHhcCCEE-------eCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 34567788888888998887 77 999999999999 788999999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.86 E-value=1.1e-05 Score=88.12 Aligned_cols=131 Identities=20% Similarity=0.267 Sum_probs=85.6
Q ss_pred eeccccccccccccCCCCceEeccCcceecCCC-------------------------Cc----ccccCceeecCCCChh
Q 011196 295 RRNKRVRASNVLLDHEMNPKISDFGMARIFGGN-------------------------QS----EANTNRVVGTYGYMAP 345 (491)
Q Consensus 295 ~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~-------------------------~~----~~~~~~~~gt~~y~aP 345 (491)
++|||+||.|+|+..++..++.|||.....+.. +. ........||+.|.+|
T Consensus 925 r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laP 1004 (1205)
T KOG0606|consen 925 RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAP 1004 (1205)
T ss_pred hhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCC
Confidence 449999999999999999999999844321100 00 0112346789999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|...+......+|.|++|++++|.++|.+||....... +.+.+.++.. +.. .-+.+...+..+++.
T Consensus 1005 e~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~-------~f~ni~~~~~-----~~p--~g~~~~s~~aq~~~~ 1070 (1205)
T KOG0606|consen 1005 EILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ-------IFENILNRDI-----PWP--EGPEEGSYEAQDLIN 1070 (1205)
T ss_pred cccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh-------hhhccccCCC-----CCC--CCccccChhhhhhhh
Confidence 99999999999999999999999999999975322111 1111111110 000 111122223445666
Q ss_pred HcccCCCCCCCCHH
Q 011196 426 LCVQEDPMDRPTMS 439 (491)
Q Consensus 426 ~cl~~dP~~RPs~~ 439 (491)
..+..+|.+|-.|.
T Consensus 1071 ~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1071 RLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhccCchhccCcc
Confidence 77788999997765
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=97.80 E-value=2.6e-05 Score=72.14 Aligned_cols=50 Identities=14% Similarity=0.086 Sum_probs=40.2
Q ss_pred hhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecC
Q 011196 269 WITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFG 325 (491)
Q Consensus 269 ~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~ 325 (491)
...++.++..++..+|..++. ||||||+||++++++.++|+|||.+....
T Consensus 127 ~~~~~~~i~~~l~~lh~~gi~-------H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 127 PEEVLDEILEEIVKAYKHGII-------HGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred HHHHHHHHHHHHHHHHHCCCC-------cCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 345666677777777776555 99999999999999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.78 E-value=8.7e-06 Score=84.29 Aligned_cols=135 Identities=21% Similarity=0.292 Sum_probs=87.1
Q ss_pred EeeeccccccccccccCC-CCceEeccCcceecCCCCcccc---cCceeecCCCChhhhhhhCCCCcccceeehhHHHHH
Q 011196 293 IRRRNKRVRASNVLLDHE-MNPKISDFGMARIFGGNQSEAN---TNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLE 368 (491)
Q Consensus 293 ~~~iHrDlKp~NILl~~~-~~~kl~DfGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~e 368 (491)
.+++|-|+||.||++..+ ...++.|||+...+....-... ..+..|...|++||... +.++...|+|++|.++.|
T Consensus 241 ~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~ 319 (524)
T KOG0601|consen 241 NNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILE 319 (524)
T ss_pred CcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHh
Confidence 344499999999999999 8899999999988765432211 11225677899999874 456889999999999999
Q ss_pred HHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 369 IISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 369 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
...+.......... .|....... +.++.... -..++-..+.++++.+|..|++.+.+..+
T Consensus 320 ~~l~~~~~~~g~~~--------~W~~~r~~~---ip~e~~~~-----~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 320 AILGSHLPSVGKNS--------SWSQLRQGY---IPLEFCEG-----GSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred hHhhcccccCCCCC--------Ccccccccc---CchhhhcC-----cchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 99886553211000 121111111 11111111 01122236778999999999998776543
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.77 E-value=2.8e-05 Score=53.55 Aligned_cols=44 Identities=39% Similarity=0.662 Sum_probs=34.6
Q ss_pred CCCCCCCCCCCCeeecccCCCccccCC-C--CCCccCceeecccCCC
Q 011196 448 DIVTLPKPTQPAFSVSRVASGQFVSHS-E--DHCSVNAITLSTMSPR 491 (491)
Q Consensus 448 ~~~~~~~p~~p~~~~~~~~~~~~~~~~-~--~~~s~~~~~~s~~~~r 491 (491)
+...||.|++|+|+..+...+..+++. . ..+|+|++|+|-+++|
T Consensus 2 e~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 2 ETATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred CcccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 456899999999999887544333333 3 5799999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=97.76 E-value=2.9e-05 Score=70.90 Aligned_cols=50 Identities=14% Similarity=0.122 Sum_probs=40.3
Q ss_pred cchhhhHhHHHHHHHHHhh-eeeEEeEEeeeccccccccccccCCCCceEeccCcceec
Q 011196 267 KRWITIAEAASAIIVFLLS-TSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIF 324 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~ 324 (491)
.....++.++..++..+|. .+++ ||||||+||+++ ++.++|+|||.+...
T Consensus 114 ~~~~~~~~~~~~~l~~lh~~~~iv-------H~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 114 EDPEELYDQILELMRKLYREAGLV-------HGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred ccHHHHHHHHHHHHHHHhhccCcC-------cCCCChhhEEEE-CCcEEEEECcccccc
Confidence 4455667777777777776 5555 999999999999 889999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.62 E-value=4e-05 Score=73.18 Aligned_cols=44 Identities=20% Similarity=0.275 Sum_probs=38.6
Q ss_pred HhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCccee
Q 011196 273 AEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARI 323 (491)
Q Consensus 273 ~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~ 323 (491)
..+++.++..+|..+++ ||||||.|||++.++.++|+|||.+..
T Consensus 148 ~~~i~~~l~~lH~~GI~-------HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 148 WQAIGQLIARFHDAGVY-------HADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHHHHHHHHHHCCCC-------CCCCCchhEEEcCCCCEEEEECCCccc
Confidence 45677788889988877 999999999999988999999998864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00064 Score=68.03 Aligned_cols=103 Identities=14% Similarity=0.158 Sum_probs=78.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
+.-.+.....++.+++-||..++. -+|+.++|+|+.+++.+.|.|-..-....++.. ....+|...|.+|
T Consensus 116 w~fllrvaRnlA~aFA~lH~~Gh~-------vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~---~~cpVg~~eftPP 185 (637)
T COG4248 116 WDFLLRVARNLASAFATLHEHGHV-------VGDVNQNSFLVSDDSKVVLVDSDSFQINANGTL---HLCPVGVSEFTPP 185 (637)
T ss_pred cHHHHHHHHHHHHHHHHHHhcCCc-------ccccCccceeeecCceEEEEcccceeeccCCce---EecccCccccCCH
Confidence 444567788888889999998887 899999999999999999998543332222221 2235788899999
Q ss_pred hhhh-----hCCCCcccceeehhHHHHHHHhC-CCCCCC
Q 011196 346 EYAM-----EGIFSVKSDVFSFGVVLLEIISG-KKSSGF 378 (491)
Q Consensus 346 E~~~-----~~~~s~~sDVwS~Gvvl~elltG-~~p~~~ 378 (491)
|.-. +..-+...|-|.+|+++++++.| +.|+..
T Consensus 186 ElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 186 ELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred HHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 9765 23346789999999999999886 888764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=7.8e-05 Score=69.45 Aligned_cols=48 Identities=19% Similarity=0.315 Sum_probs=40.9
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCccee
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARI 323 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~ 323 (491)
....++.+++..+.++|..++. |+|+||.|||++ ++.++|+|||.+..
T Consensus 96 ~~~~i~~~i~~~l~~lH~~~i~-------H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 96 EELELSREIGRLVGKLHSAGII-------HGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-------cCCCCcccEEEE-CCCEEEEECCcccC
Confidence 4566777888888888887766 999999999999 78899999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0001 Score=67.99 Aligned_cols=45 Identities=13% Similarity=0.315 Sum_probs=39.8
Q ss_pred hhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCccee
Q 011196 271 TIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARI 323 (491)
Q Consensus 271 ~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~ 323 (491)
.++.+++.++..+|..++. |+|+||.||+++ ++.+++.|||++..
T Consensus 94 ~~~~~i~~~l~~lH~~gi~-------H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 94 ELLREIGRLVGKLHKAGIV-------HGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred HHHHHHHHHHHHHHHCCee-------cCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 6777888888899988777 999999999999 78999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00011 Score=78.80 Aligned_cols=66 Identities=12% Similarity=0.224 Sum_probs=47.7
Q ss_pred eeeecccccCCCCccccCCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCccee
Q 011196 244 RYELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARI 323 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~ 323 (491)
.+.++.|..+.+..... .....++.+++.++.++|..+++ ||||||+|||+ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l------~~~~~~~~~i~~~L~~lH~~gii-------HrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVL------EGNPELVRKVGEIVAKLHKAGIV-------HGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHH------HHHHHHHHHHHHHHHHHHhCCCc-------cCCCChHHEEE-ECCcEEEEeCccccc
Confidence 34555665544432211 12345677888888999887766 99999999999 577899999999975
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00012 Score=76.01 Aligned_cols=130 Identities=18% Similarity=0.147 Sum_probs=79.7
Q ss_pred EEeeeccccccccccccCC-CCceEeccCcceecCCCCcccccCceeecCCCC--hhhhhhhCCCCcccceeehhHHHHH
Q 011196 292 IIRRRNKRVRASNVLLDHE-MNPKISDFGMARIFGGNQSEANTNRVVGTYGYM--APEYAMEGIFSVKSDVFSFGVVLLE 368 (491)
Q Consensus 292 ~~~~iHrDlKp~NILl~~~-~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~sDVwS~Gvvl~e 368 (491)
.+.++|+|+||+||++..+ +..+++|||....+.-... ...+..++. +++......+..+.|++|||.-+.|
T Consensus 384 s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e 458 (524)
T KOG0601|consen 384 SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDE 458 (524)
T ss_pred chhhhcccccccceeeccchhhhhccccccccccceecc-----cccccccccccchhhccccccccccccccccccccc
Confidence 3444499999999999886 7889999998864221111 122333444 4444455678899999999999999
Q ss_pred HHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 011196 369 IISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLA 446 (491)
Q Consensus 369 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 446 (491)
.+++..-.... .+ |.....+...... .....+..+...+...+++.||.+.++..+..
T Consensus 459 ~~~~~~ls~~~--~~--------~~~i~~~~~p~~~----------~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 459 AITGSPLSESG--VQ--------SLTIRSGDTPNLP----------GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred cccCcccCccc--cc--------ceeeecccccCCC----------chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 99887542110 00 1111111111111 11133444666788899999999887765544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0002 Score=74.47 Aligned_cols=83 Identities=14% Similarity=0.248 Sum_probs=54.4
Q ss_pred EEceecceeeeecccccCCCCccccCCCCCCcchhhhHhHHHH-HHHHHhheeeEEeEEeeeccccccccccccCCCCce
Q 011196 236 IFCASCSIRYELYRFLVDTPTVTVTAPNKTSKRWITIAEAASA-IIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPK 314 (491)
Q Consensus 236 i~~~~C~lry~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~k 314 (491)
++...|.-++.++.|..+.+................++..++. .+..+|..+++ |+|+||.||+++.++.++
T Consensus 225 v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~-------H~D~hPgNilv~~~g~i~ 297 (437)
T TIGR01982 225 VYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFF-------HADLHPGNIFVLKDGKII 297 (437)
T ss_pred EehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCce-------eCCCCcccEEECCCCcEE
Confidence 4445566678888888776654332111111123344444433 34556665555 999999999999999999
Q ss_pred EeccCcceecC
Q 011196 315 ISDFGMARIFG 325 (491)
Q Consensus 315 l~DfGla~~~~ 325 (491)
+.|||++..+.
T Consensus 298 liDfG~~~~l~ 308 (437)
T TIGR01982 298 ALDFGIVGRLS 308 (437)
T ss_pred EEeCCCeeECC
Confidence 99999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00022 Score=66.50 Aligned_cols=40 Identities=18% Similarity=0.278 Sum_probs=30.2
Q ss_pred HHHHHHHHHhheeeEEeEEeeeccccccccccccC----CCCceEeccCcc
Q 011196 275 AASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH----EMNPKISDFGMA 321 (491)
Q Consensus 275 ~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~----~~~~kl~DfGla 321 (491)
.+..++.++|..+++ ||||||+|||++. +..++|+||+.+
T Consensus 113 ~L~~l~~yLh~~~Iv-------hrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 113 LLKKLKRYLLDNRIV-------TMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHHHHHCCEe-------ecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 333444888887777 9999999999974 347999995444
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.00046 Score=59.67 Aligned_cols=53 Identities=19% Similarity=0.194 Sum_probs=40.4
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCccee
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARI 323 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~ 323 (491)
.....+...+...+..+|... ..+++|+|+||+||+++..+.+++.|||.+..
T Consensus 86 ~~~~~~~~~~~~~l~~lh~~~----~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 86 EEKEDIAEQLAELLAKLHQLP----LLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred HHHHHHHHHHHHHHHHHhCCC----ceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 344556667777777777642 13455999999999999988999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0015 Score=58.30 Aligned_cols=49 Identities=18% Similarity=0.148 Sum_probs=37.6
Q ss_pred hhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 271 TIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 271 ~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
....+++..+..||..... ...++|+|+||.||+++ ++.++++||+.+.
T Consensus 87 ~~~~~l~~~l~~LH~~~~~--~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 87 ENLEKIAKLLKKLHSSPLP--DLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred HHHHHHHHHHHHHhCCCCC--CceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 3556777888888886541 22345999999999999 5679999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.0033 Score=66.74 Aligned_cols=85 Identities=14% Similarity=0.255 Sum_probs=53.7
Q ss_pred EEEceecceeeeecccccCCCCccccCCCCCCcchhhhHhHHH-HHHHHHhheeeEEeEEeeeccccccccccccCCC--
Q 011196 235 RIFCASCSIRYELYRFLVDTPTVTVTAPNKTSKRWITIAEAAS-AIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM-- 311 (491)
Q Consensus 235 ~i~~~~C~lry~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~-- 311 (491)
.++-.-|.-++.+..|..+.+......-...+.+...+++..+ ..+..++..++. |+|+||.||+++.++
T Consensus 227 ~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~~Gff-------HaDpHPGNIlv~~~g~~ 299 (537)
T PRK04750 227 EVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFRDGFF-------HADMHPGNIFVSYDPPE 299 (537)
T ss_pred eeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCee-------eCCCChHHeEEecCCCC
Confidence 4555668888888888877665332111111222223333322 223334444555 999999999999888
Q ss_pred --CceEeccCcceecCC
Q 011196 312 --NPKISDFGMARIFGG 326 (491)
Q Consensus 312 --~~kl~DfGla~~~~~ 326 (491)
.+++.|||+...+..
T Consensus 300 ~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 300 NPRYIALDFGIVGSLNK 316 (537)
T ss_pred CCeEEEEecceEEECCH
Confidence 899999999976643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.011 Score=62.53 Aligned_cols=92 Identities=15% Similarity=0.172 Sum_probs=63.9
Q ss_pred HHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCccc
Q 011196 278 AIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKS 357 (491)
Q Consensus 278 ~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~s 357 (491)
.+.+.+.++.++|+..+++|++|.-..|++++.|..||++|.+......... ......--..|..|+.+.... -..
T Consensus 109 Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~ 184 (690)
T KOG1243|consen 109 GLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSI 184 (690)
T ss_pred HHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cch
Confidence 3445566777777788888999999999999999999999988764432111 011111223456666543222 346
Q ss_pred ceeehhHHHHHHHhCC
Q 011196 358 DVFSFGVVLLEIISGK 373 (491)
Q Consensus 358 DVwS~Gvvl~elltG~ 373 (491)
|.|-||++++|++.|.
T Consensus 185 D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 185 DSWGLGCLIEELFNGS 200 (690)
T ss_pred hhhhHHHHHHHHhCcc
Confidence 9999999999999983
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.0067 Score=55.82 Aligned_cols=47 Identities=9% Similarity=-0.024 Sum_probs=34.4
Q ss_pred hhhHhHHHHHHHHH-hheeeEEeEEeeeccccccccccccCCCCceEeccCcceec
Q 011196 270 ITIAEAASAIIVFL-LSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIF 324 (491)
Q Consensus 270 ~~~~~~~~~~~~~l-~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~ 324 (491)
..+..++...+..+ |..+++ |+||++.|||+++ +.+.|+|||.+...
T Consensus 127 ~~i~~~i~~~l~~l~H~~glV-------HGDLs~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 127 KNAYYQVLSMMKQLYKECNLV-------HADLSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred HHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEEEC-CcEEEEECCCceeC
Confidence 34455555555555 555555 9999999999974 67999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.01 Score=55.15 Aligned_cols=50 Identities=18% Similarity=0.237 Sum_probs=43.2
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC---CceEeccCccee
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM---NPKISDFGMARI 323 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~---~~kl~DfGla~~ 323 (491)
.....+...++..+.-||..++. |+|+++.|||++.+. .+.++||+.++.
T Consensus 118 ~~~~~ll~~l~~~i~~lH~~gi~-------H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 118 SQRRELLRALARLIAKLHDAGIY-------HGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hhHHHHHHHHHHHHHHHHHCcCC-------CCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 34567888888899999999998 999999999999887 789999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.014 Score=52.52 Aligned_cols=45 Identities=16% Similarity=0.292 Sum_probs=37.4
Q ss_pred hhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCccee
Q 011196 271 TIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARI 323 (491)
Q Consensus 271 ~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~ 323 (491)
.+...+...+.-||..+++ |+||.++||++..+. +.++|||++..
T Consensus 96 ~~~r~vG~~vg~lH~~giv-------HGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 96 DLLREVGRLVGKLHKAGIV-------HGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred HHHHHHHHHHHHHHhcCee-------cCCCccceEEEeCCc-EEEEECCcccc
Confidence 4666677777778888887 999999999998765 89999999974
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.011 Score=57.18 Aligned_cols=49 Identities=10% Similarity=0.149 Sum_probs=41.0
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC-------CCCceEeccCccee
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH-------EMNPKISDFGMARI 323 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~-------~~~~kl~DfGla~~ 323 (491)
....+...++..+..+|..++. |+|++++|||++. +..+.++||+.++.
T Consensus 139 ~~~~ll~~la~~i~~LH~~Gi~-------HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 139 LKRMLIKRVATMVRDMHAAGIN-------HRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHHHHHHHHHHHHHHCcCc-------cCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 3446777888889999999888 9999999999975 46789999998753
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.038 Score=49.80 Aligned_cols=47 Identities=26% Similarity=0.458 Sum_probs=37.3
Q ss_pred hhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC---ceEeccCccee
Q 011196 270 ITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN---PKISDFGMARI 323 (491)
Q Consensus 270 ~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~---~kl~DfGla~~ 323 (491)
......+...+.-||...+. |+||..+||++..++. +.++|||++..
T Consensus 116 ~~~~~~iG~~igklH~ndii-------HGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 116 AELARRIGELIGKLHDNDII-------HGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred HHHHHHHHHHHHHhhhCCee-------cccccccceEEecCCCcCceEEEeecchhc
Confidence 45667777777778877777 9999999999977654 47999999854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.028 Score=51.39 Aligned_cols=48 Identities=25% Similarity=0.250 Sum_probs=32.4
Q ss_pred hhhhHhHHHH-HHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceec
Q 011196 269 WITIAEAASA-IIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIF 324 (491)
Q Consensus 269 ~~~~~~~~~~-~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~ 324 (491)
...+...+.. ....+|..+++ |+||.+.|||++++ .+.|+|||.+...
T Consensus 108 ~~~~~~~il~~~~~~~~~~giv-------HGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 108 PKELLEEILEEIIKMLHKAGIV-------HGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp HHHHHHHHHHHHHHHHHCTTEE-------ESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred HHHHHHHHHHHHHHHHHhcCce-------ecCCChhhEEeecc-eEEEEecCcceec
Confidence 3444444444 34445676777 99999999999988 8999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=92.72 E-value=0.036 Score=56.62 Aligned_cols=36 Identities=17% Similarity=0.067 Sum_probs=25.3
Q ss_pred hhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC
Q 011196 269 WITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE 310 (491)
Q Consensus 269 ~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~ 310 (491)
.+.|..++..++.||| ..-+|||-||||+|||+...
T Consensus 189 VK~I~~qvL~GLdYLH------~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 189 VKEICRQVLTGLDYLH------RECGIIHTDLKPENVLLCST 224 (590)
T ss_pred HHHHHHHHHHHHHHHH------HhcCccccCCCcceeeeecc
Confidence 4456666666666655 44567799999999999654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=91.99 E-value=0.14 Score=47.79 Aligned_cols=44 Identities=23% Similarity=0.229 Sum_probs=36.0
Q ss_pred hHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCccee
Q 011196 272 IAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARI 323 (491)
Q Consensus 272 ~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~ 323 (491)
+...+...+..+|..+++ |+|..|.|+++.+++ +++.||+..+.
T Consensus 140 ~~~ki~~~ikqlH~~G~~-------HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 140 LAEKIVEAIKQLHKHGFY-------HGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred HHHHHHHHHHHHHHcCCc-------cCCCCcCcEEEECCc-EEEEECccccc
Confidence 445566778889999999 999999999999655 89999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.71 E-value=0.17 Score=47.01 Aligned_cols=51 Identities=10% Similarity=0.037 Sum_probs=42.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC--ceEeccCccee
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN--PKISDFGMARI 323 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~--~kl~DfGla~~ 323 (491)
...+..+...++.++.-+|..++. |+|+-+.||+++.++. ++++||.-++.
T Consensus 127 ~~~k~~il~~va~~ia~LH~~Gv~-------Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 127 DEVRQAMLKAVALAFKKMHSVNRQ-------HGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred hHHHHHHHHHHHHHHHHHHHCCCc-------CCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 344567888899999999999998 9999999999986666 89999986653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=90.26 E-value=1.3 Score=46.24 Aligned_cols=83 Identities=17% Similarity=0.300 Sum_probs=61.2
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
...+.++.++..++..+|..++. -+-|.+.+||++.+.+++|+..|.......+.. |
T Consensus 393 ~~lW~y~~QLtaaL~sIHssGLA-------ck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~----------------~ 449 (655)
T KOG3741|consen 393 EVLWSYISQLTAALYSIHSSGLA-------CKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT----------------E 449 (655)
T ss_pred HHHHHHHHHHHHHHHHHHhcCce-------eecccHhHeEeeCcceEEEecccceeeecCCCC----------------c
Confidence 44667788888899999999888 567889999999999999998887765433220 1
Q ss_pred hhhhCCCCcccceeehhHHHHHHHhCCCC
Q 011196 347 YAMEGIFSVKSDVFSFGVVLLEIISGKKS 375 (491)
Q Consensus 347 ~~~~~~~s~~sDVwS~Gvvl~elltG~~p 375 (491)
-+.+ ..+-|.=-||.+++.|.+|...
T Consensus 450 ~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 450 PLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred chhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 1111 1345777899999999999654
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=89.85 E-value=0.036 Score=64.19 Aligned_cols=79 Identities=16% Similarity=0.087 Sum_probs=64.6
Q ss_pred eccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCC
Q 011196 296 RNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKS 375 (491)
Q Consensus 296 iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p 375 (491)
+|+++|+-|.+|..+.++|++++|+.++...... ..+...+++.|+.|+...+-.++.++|+|..|+-+++.--|..+
T Consensus 1362 v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~ 1439 (2724)
T KOG1826|consen 1362 VSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAY 1439 (2724)
T ss_pred hhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHH
Confidence 5999999999999999999999999984332221 22346778889999999888899999999999999988777666
Q ss_pred C
Q 011196 376 S 376 (491)
Q Consensus 376 ~ 376 (491)
+
T Consensus 1440 f 1440 (2724)
T KOG1826|consen 1440 F 1440 (2724)
T ss_pred H
Confidence 4
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=89.17 E-value=0.19 Score=46.55 Aligned_cols=30 Identities=20% Similarity=0.160 Sum_probs=25.3
Q ss_pred EeeeccccccccccccC--CCCceEeccCcce
Q 011196 293 IRRRNKRVRASNVLLDH--EMNPKISDFGMAR 322 (491)
Q Consensus 293 ~~~iHrDlKp~NILl~~--~~~~kl~DfGla~ 322 (491)
..++|+|+++.||+++. ++.+.|+||+.+.
T Consensus 174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred cEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 44569999999999998 5668899998775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=86.92 E-value=0.57 Score=46.93 Aligned_cols=26 Identities=31% Similarity=0.625 Sum_probs=24.9
Q ss_pred ccccccccccccCCCCceEeccCccee
Q 011196 297 NKRVRASNVLLDHEMNPKISDFGMARI 323 (491)
Q Consensus 297 HrDlKp~NILl~~~~~~kl~DfGla~~ 323 (491)
|||+.-.||||+ +|++.|+||-+++.
T Consensus 345 hrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 345 HRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred cccccccceeee-cCceEEEEeeeeec
Confidence 999999999999 99999999999984
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=86.33 E-value=0.83 Score=48.46 Aligned_cols=83 Identities=16% Similarity=0.207 Sum_probs=54.8
Q ss_pred EceecceeeeecccccCCCCccccCCCCCCcchhhhHhHHH-HHHHHHhheeeEEeEEeeeccccccccccccCCCCceE
Q 011196 237 FCASCSIRYELYRFLVDTPTVTVTAPNKTSKRWITIAEAAS-AIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKI 315 (491)
Q Consensus 237 ~~~~C~lry~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl 315 (491)
+-.-|.-+-.+..+..+.+......-...+.....+++... ..+..+...++. |.|.+|.||+++.++.+.+
T Consensus 234 ~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~dgff-------HaDpHpGNi~v~~~g~i~~ 306 (517)
T COG0661 234 YWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDGFF-------HADPHPGNILVRSDGRIVL 306 (517)
T ss_pred ehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhcCcc-------ccCCCccceEEecCCcEEE
Confidence 33344555567777776666554322223344444555444 334455566777 9999999999999999999
Q ss_pred eccCcceecCC
Q 011196 316 SDFGMARIFGG 326 (491)
Q Consensus 316 ~DfGla~~~~~ 326 (491)
.|||+...+..
T Consensus 307 lDfGi~g~l~~ 317 (517)
T COG0661 307 LDFGIVGRLDP 317 (517)
T ss_pred EcCcceecCCH
Confidence 99999876543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=84.91 E-value=0.66 Score=45.87 Aligned_cols=30 Identities=23% Similarity=0.189 Sum_probs=25.8
Q ss_pred EeeeccccccccccccCCCCceEeccCcce
Q 011196 293 IRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 293 ~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
..++|+|+++.||+++.++...|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 456799999999999988767899998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=84.25 E-value=0.64 Score=43.23 Aligned_cols=30 Identities=23% Similarity=0.204 Sum_probs=19.3
Q ss_pred Eeeecccccccccccc-CCCCceEeccCcce
Q 011196 293 IRRRNKRVRASNVLLD-HEMNPKISDFGMAR 322 (491)
Q Consensus 293 ~~~iHrDlKp~NILl~-~~~~~kl~DfGla~ 322 (491)
..++|+|+.+.|||++ +++.+.|+||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cEEEEeccccccceeeeccceeEEEecccce
Confidence 3456999999999999 45555799998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=83.67 E-value=0.63 Score=49.70 Aligned_cols=72 Identities=21% Similarity=0.256 Sum_probs=57.3
Q ss_pred eccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCC
Q 011196 296 RNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKS 375 (491)
Q Consensus 296 iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p 375 (491)
+||| ||+..+ +..|..||+....+.... ......+++.+++||+...+.+..+.|+|+.|.--.++.-|.+|
T Consensus 358 ~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 358 VHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred cCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 4888 787765 568999999887665432 23457889999999999999999999999999877777766665
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=83.60 E-value=0.58 Score=44.23 Aligned_cols=30 Identities=17% Similarity=0.180 Sum_probs=24.8
Q ss_pred EeeeccccccccccccCCCCceEeccCcce
Q 011196 293 IRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 293 ~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
..++|+|+.+.||+++++....|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 346799999999999977656799999774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=83.47 E-value=1.9 Score=41.51 Aligned_cols=44 Identities=11% Similarity=0.131 Sum_probs=32.5
Q ss_pred hhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 271 TIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 271 ~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.+...+...+..+...+++ |+|+.+-||+++++|.+.++||--+
T Consensus 206 ~il~~il~~~~~~~~~GiV-------HGDlSefNIlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 206 EILDKILEEVRKAYRRGIV-------HGDLSEFNILVTEDGDIVVIDWPQA 249 (304)
T ss_pred HHHHHHHHHHHHHHHcCcc-------ccCCchheEEEecCCCEEEEeCccc
Confidence 3444444444444455555 9999999999999999999999644
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=83.06 E-value=0.56 Score=46.55 Aligned_cols=30 Identities=20% Similarity=0.132 Sum_probs=25.1
Q ss_pred EeeeccccccccccccCCCCceEeccCcce
Q 011196 293 IRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 293 ~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
..++|+|+++.||+++.+....|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 356799999999999976656899999774
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=82.45 E-value=0.73 Score=41.99 Aligned_cols=26 Identities=19% Similarity=0.208 Sum_probs=23.1
Q ss_pred eccccccccccccCCCCceEeccCcce
Q 011196 296 RNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 296 iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.|+|+.|.||++++++ ++|+||+.+.
T Consensus 80 ~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 80 LHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred ecCCCCCccEEEECCC-EEEEeCCccc
Confidence 3999999999998877 8999999874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=82.26 E-value=0.91 Score=42.73 Aligned_cols=29 Identities=14% Similarity=0.213 Sum_probs=24.8
Q ss_pred eeeccccccccccccC-CCCceEeccCcce
Q 011196 294 RRRNKRVRASNVLLDH-EMNPKISDFGMAR 322 (491)
Q Consensus 294 ~~iHrDlKp~NILl~~-~~~~kl~DfGla~ 322 (491)
..+|+|+.+.|||++. ++.+.++||..+.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 4569999999999998 5779999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=81.32 E-value=0.86 Score=44.82 Aligned_cols=29 Identities=21% Similarity=0.219 Sum_probs=24.8
Q ss_pred eeeccccccccccccCC----CCceEeccCcce
Q 011196 294 RRRNKRVRASNVLLDHE----MNPKISDFGMAR 322 (491)
Q Consensus 294 ~~iHrDlKp~NILl~~~----~~~kl~DfGla~ 322 (491)
...|+|+.+.|||++++ +.++++||..+.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 34599999999999974 789999998774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=80.67 E-value=0.85 Score=43.01 Aligned_cols=27 Identities=11% Similarity=0.026 Sum_probs=23.9
Q ss_pred eeccccccccccccCCCCceEeccCcce
Q 011196 295 RRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 295 ~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.+|+|+.|.||++++++ +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 35999999999999888 9999998774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=80.42 E-value=0.92 Score=43.04 Aligned_cols=30 Identities=13% Similarity=0.149 Sum_probs=25.3
Q ss_pred EeeeccccccccccccCCCCceEeccCcce
Q 011196 293 IRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 293 ~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
...+|+|+.|.|||++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 345599999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 491 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-20 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-20 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-14 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-13 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-12 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-05 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-05 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-05 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-05 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-05 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-05 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-04 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-04 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-04 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-04 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-04 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-04 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-04 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-04 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-61
Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 8/162 (4%)
Query: 291 CIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME 350
I R K ++N+LLD KISDFG+AR T+R+VGT YMAPE +
Sbjct: 153 HHIHRDIK---SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LR 208
Query: 351 GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA-AELMDSVVK 409
G + KSD++SFGVVLLEII+G + + LL ++ E + +D +
Sbjct: 209 GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLLDIKEEIEDEEKTIEDYIDKKMN 266
Query: 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVT 451
D + + C+ E RP + V +L +
Sbjct: 267 D-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 3e-59
Identities = 59/160 (36%), Positives = 88/160 (55%), Gaps = 6/160 (3%)
Query: 291 CIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME 350
II R V+A+N+LLD E + DFG+A++ + T V GT G++APEY
Sbjct: 154 KIIHRD---VKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLST 209
Query: 351 GIFSVKSDVFSFGVVLLEIISGKKSSGFYHL--EHGPSLLAYIWKLWCEGHAAELMDSVV 408
G S K+DVF +GV+LLE+I+G+++ L + LL ++ L E L+D +
Sbjct: 210 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL 269
Query: 409 KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448
+ + E+ + I + LLC Q PM+RP MS V ML D
Sbjct: 270 QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-47
Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 5/156 (3%)
Query: 291 CIIRRRNKRVRASNVLLDHEMNPKISDFGMARIF-GGNQSEANTNRVVGTYGYMAPEYAM 349
II R V++ N+LLD PKI+DFG+++ +Q+ +T V GT GY+ PEY +
Sbjct: 159 AIIHRD---VKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGTLGYIDPEYFI 214
Query: 350 EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK 409
+G + KSDV+SFGVVL E++ + + +L + + G +++D +
Sbjct: 215 KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA 274
Query: 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
L K+ + C+ DRP+M V L
Sbjct: 275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 9e-43
Identities = 35/162 (21%), Positives = 67/162 (41%), Gaps = 17/162 (10%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI-----FS 354
+++ NVLL + + I+DFG+A F +S +T+ VGT YMAPE I
Sbjct: 157 IKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAF 216
Query: 355 VKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQ---- 410
++ D+++ G+VL E+ S ++ E+ +L + ++ ++ + VV +
Sbjct: 217 LRIDMYAMGLVLWELASRCTAADGPVDEY---MLPFEEEIGQHPSLEDMQEVVVHKKKRP 273
Query: 411 ----SCDQAELLK-YIHIGLLCVQEDPMDRPTMSSVAVMLAS 447
+ + C D R + V +
Sbjct: 274 VLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 31/196 (15%), Positives = 63/196 (32%), Gaps = 27/196 (13%)
Query: 291 CIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGN------QSEANTNRVVGTYGYMA 344
I R + NVL+ ++ ISDFG++ GN + + VGT YMA
Sbjct: 140 AISHRDLN---SRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMA 196
Query: 345 PEYAMEGI-------FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397
PE + + D+++ G++ EI +A+ ++
Sbjct: 197 PEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE-SVPEYQMAFQTEVGNH 255
Query: 398 GHAAELMDSVVKQ----------SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLAS 447
++ V ++ + + C +D R T +A
Sbjct: 256 PTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315
Query: 448 DIVTLPKPTQPAFSVS 463
++ + + +
Sbjct: 316 LMMIWERNKSVSPTAH 331
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-22
Identities = 32/149 (21%), Positives = 68/149 (45%), Gaps = 14/149 (9%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE---YAMEGIFSVK 356
++++N+ L + KI DFG+A ++ G+ +MAPE +S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 357 SDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAE 416
SDV++FG+VL E+++G+ Y + + I + + +L S V+ +C +
Sbjct: 206 SDVYAFGIVLYELMTGQLP---Y--SNINNRDQIIEMVGRGSLSPDL--SKVRSNCPKR- 257
Query: 417 LLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
+ C+++ +RP+ + +
Sbjct: 258 ---MKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 42/185 (22%), Positives = 72/185 (38%), Gaps = 26/185 (14%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR------------VVGTYGYMAPEYA 348
+ N L+ N ++DFG+AR+ +++ R VVG +MAPE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 349 MEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVV 408
+ K DVFSFG+VL EII + P + + L G +D
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNA--DPDY--LPRTMDFG--LNVRGF----LDRYC 244
Query: 409 KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSVSRVASG 468
+C + + I + C DP RP+ + L + + L + ++ G
Sbjct: 245 PPNCPPS----FFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRG 300
Query: 469 QFVSH 473
+ ++
Sbjct: 301 FWETY 305
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-21
Identities = 34/153 (22%), Positives = 70/153 (45%), Gaps = 37/153 (24%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSF 362
N+L+D + K+ DFG++R+ + ++ GT +MAPE + + KSDV+SF
Sbjct: 168 PNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSF 225
Query: 363 GVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQ--------SCDQ 414
GV+L E+ + ++ P W + A+++ +V + + +
Sbjct: 226 GVILWELATLQQ----------P---------WGNLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 415 --AELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
A +++ C +P RP+ +++ +L
Sbjct: 267 QVAAIIEG------CWTNEPWKRPSFATIMDLL 293
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-20
Identities = 39/159 (24%), Positives = 65/159 (40%), Gaps = 24/159 (15%)
Query: 303 SNVLLDHEMN-PKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
N+LL KI DFG A + + G+ +MAPE +S K DVFS
Sbjct: 134 PNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFS 188
Query: 362 FGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQ--AELLK 419
+G++L E+I+ +K + E G +W + G L+ + + L+
Sbjct: 189 WGIILWEVITRRK---PFD-EIGGPAFRIMWAV-HNGTRPPLIK-----NLPKPIESLMT 238
Query: 420 YIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQP 458
C +DP RP+M + ++ + P +P
Sbjct: 239 ------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 36/169 (21%), Positives = 61/169 (36%), Gaps = 35/169 (20%)
Query: 303 SNVLLDHEMNPKISDFGMARIF--GGNQSEANTNRVVGTYGYMAPEYAMEGIFSV----- 355
N+L+ I+D G+A F N+ + N VGT YM PE ++ +
Sbjct: 171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQS 229
Query: 356 --KSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQ--- 410
+D++SFG++L E+ S G L Y + + ++ + V +
Sbjct: 230 YIMADMYSFGLILWEVARRCVSGG----IVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR 285
Query: 411 ----------SCDQ--AELLKYIHIGLLCVQEDPMDRPTMSSVAVMLAS 447
C + +L+ C +P R T V LA
Sbjct: 286 PSFPNRWSSDECLRQMGKLMTE------CWAHNPASRLTALRVKKTLAK 328
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 32/158 (20%), Positives = 61/158 (38%), Gaps = 32/158 (20%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR---VVGTYGYMAPE---------YAM 349
+ NV D I+DFG+ I G Q+ ++ G ++APE
Sbjct: 158 SKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEED 216
Query: 350 EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK 409
+ FS SDVF+ G + E+ + + + A IW++ + + +
Sbjct: 217 KLPFSKHSDVFALGTIWYELHAREWP---F---KTQPAEAIIWQM----GTGMKPN-LSQ 265
Query: 410 QSCDQ--AELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
+ +++L + C + +RPT + + ML
Sbjct: 266 IGMGKEISDILLF------CWAFEQEERPTFTKLMDML 297
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 34/150 (22%), Positives = 67/150 (44%), Gaps = 25/150 (16%)
Query: 303 SNVLLD-----HEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE--YAMEGIFSV 355
N+ L + K++DFG+++ S + + ++G + +MAPE A E ++
Sbjct: 153 PNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMAPETIGAEEESYTE 207
Query: 356 KSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 415
K+D +SF ++L I++G+ + E+ + +I + EG + + C
Sbjct: 208 KADTYSFAMILYTILTGEG---PFD-EYSYGKIKFINMIREEGLRPTI-----PEDCPP- 257
Query: 416 ELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
+ ++ LC DP RP S + L
Sbjct: 258 ---RLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 38/162 (23%), Positives = 67/162 (41%), Gaps = 47/162 (29%)
Query: 302 ASNVLLDHEMNP--------KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIF 353
+SN+L+ ++ KI+DFG+AR + + G Y +MAPE +F
Sbjct: 136 SSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPEVIRASMF 191
Query: 354 SVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQ--- 410
S SDV+S+GV+L E+++G+ P + + V
Sbjct: 192 SKGSDVWSYGVLLWELLTGEV----------P---------FRGIDGLAVAYGVAMNKLA 232
Query: 411 -----SCDQ--AELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
+C + A+L++ C DP RP+ +++ L
Sbjct: 233 LPIPSTCPEPFAKLMED------CWNPDPHSRPSFTNILDQL 268
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-19
Identities = 30/168 (17%), Positives = 62/168 (36%), Gaps = 50/168 (29%)
Query: 292 IIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEG 351
I R + +V++D +M +IS + F + + ++APE A++
Sbjct: 134 IPRHALN---SRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE-ALQK 182
Query: 352 ----IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSV 407
+D++SF V+L E+++ + P + + E+ V
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREV----------P---------FADLSNMEIGMKV 223
Query: 408 VKQ--------SCDQ--AELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
+ ++L+K +C+ EDP RP + +L
Sbjct: 224 ALEGLRPTIPPGISPHVSKLMK------ICMNEDPAKRPKFDMIVPIL 265
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 33/167 (19%), Positives = 61/167 (36%), Gaps = 31/167 (18%)
Query: 303 SNVLLDHEMNPKISDFGMARIF--GGNQSEANTNRVVGTYGYMAPEYAMEGIFSV----- 355
N+L+ I+D G+A + + N VGT YMAPE ++ ++
Sbjct: 176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFES 234
Query: 356 --KSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQ--- 410
++D+++ G+V EI G H L Y + + E+ V +Q
Sbjct: 235 FKRADIYAMGLVFWEIARRCSIGG----IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR 290
Query: 411 --------SCDQAELLKYIHIGLL--CVQEDPMDRPTMSSVAVMLAS 447
SC+ ++ ++ C + R T + L+
Sbjct: 291 PNIPNRWQSCEALRVMA----KIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 35/163 (21%), Positives = 57/163 (34%), Gaps = 23/163 (14%)
Query: 303 SNVLLDHEMNPKISDFGMARIF--GGNQSEANTNRVVGTYGYMAPE------YAMEGIFS 354
N+L+ I+D G+A + NQ + N VGT YMAPE
Sbjct: 142 KNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSY 201
Query: 355 VKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVV------ 408
+ D+++FG+VL E+ S+G + + + + E M VV
Sbjct: 202 KRVDIWAFGLVLWEVARRMVSNG----IVEDYKPPF-YDVVPNDPSFEDMRKVVCVDQQR 256
Query: 409 ----KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLAS 447
+ L + C ++P R T + L
Sbjct: 257 PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 7e-17
Identities = 27/149 (18%), Positives = 51/149 (34%), Gaps = 28/149 (18%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTN----------RVVGTYGYMAPEYAMEGI 352
SN+ + K+ DFG+ ++ E VGT YM+PE
Sbjct: 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN 252
Query: 353 FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 412
+S K D+FS G++L E++ + I L ++
Sbjct: 253 YSHKVDIFSLGLILFELLYSFSTQ---------MERVRIITDVRNLKFPLLFT---QKYP 300
Query: 413 DQAELLKYIHIGLLCVQEDPMDRPTMSSV 441
+ +++ + P +RP + +
Sbjct: 301 QEHMMVQ------DMLSPSPTERPEATDI 323
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 8e-17
Identities = 45/185 (24%), Positives = 72/185 (38%), Gaps = 48/185 (25%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG-----YMAPEYAMEGIFSV 355
A N+L++ E + KI+DFG+A++ ++ VV G + APE + IFS
Sbjct: 154 AARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAPESLSDNIFSR 209
Query: 356 KSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQ 414
+SDV+SFGVVL E+ + KS M +
Sbjct: 210 QSDVWSFGVVLYELFTYCDKS-------------------CSPSAEFLRMMGCERDVPAL 250
Query: 415 AELLKYIHIG-----------------LLCVQEDPMDRPTMSSVAVMLASDIVTLPKPT- 456
+ LL+ + G LC P DRP+ S++ L + + +
Sbjct: 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL-DMLWSGSRGCE 309
Query: 457 QPAFS 461
AF+
Sbjct: 310 THAFT 314
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 41/172 (23%), Positives = 65/172 (37%), Gaps = 27/172 (15%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG-----YMAPEYAMEGIFSV 355
A NVLLD++ KI DFG+A+ V G + APE E F
Sbjct: 161 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYAPECLKEYKFYY 216
Query: 356 KSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK----- 409
SDV+SFGV L E+++ S +A + L + + +
Sbjct: 217 ASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-----GQMTVLRLTELLERGERLP 271
Query: 410 --QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPA 459
C E+ Y H+ C + + RPT ++ +L + + P+
Sbjct: 272 RPDKCPA-EV--Y-HLMKNCWETEASFRPTFENLIPIL-KTVHEKYQGQAPS 318
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 31/158 (19%), Positives = 61/158 (38%), Gaps = 26/158 (16%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG-----YMAPEYAMEGIFSV 355
A NVL++ E KI DFG+ + ++ V + APE M+ F +
Sbjct: 153 AARNVLVESEHQVKIGDFGLTKAIETDKEYY----TVKDDRDSPVFWYAPECLMQSKFYI 208
Query: 356 KSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK------ 409
SDV+SFGV L E+++ S + ++ L++++ +
Sbjct: 209 ASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM----TVTRLVNTLKEGKRLPC 264
Query: 410 -QSCDQAELLKYIH-IGLLCVQEDPMDRPTMSSVAVML 445
+C ++ + C + P +R + ++
Sbjct: 265 PPNCPDE-----VYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 41/168 (24%), Positives = 58/168 (34%), Gaps = 42/168 (25%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
+ A N L+ + KISDFGM+R A+ + APE G +S +SDV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 360 FSFGVVLLEIIS-GKK-------SSGFYHLEHG-----PSLLAYIWKLWCEGHAAELMDS 406
+SFG++L E S G +E G P L C LM
Sbjct: 299 WSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPEL--------CPDAVFRLM-- 348
Query: 407 VVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPK 454
C +P RP+ S++ L I +
Sbjct: 349 ------------------EQCWAYEPGQRPSFSTIYQEL-QSIRKRHR 377
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 9e-16
Identities = 38/157 (24%), Positives = 62/157 (39%), Gaps = 23/157 (14%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG-----YMAPEYAMEGIFSV 355
N+L+++E KI DFG+ ++ ++ V G + APE E FSV
Sbjct: 141 ATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYAPESLTESKFSV 196
Query: 356 KSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK------ 409
SDV+SFGVVL E+ + + S E + L++ +
Sbjct: 197 ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM---IVFHLIELLKNNGRLPR 253
Query: 410 -QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
C E+ Y I C + RP+ +A+ +
Sbjct: 254 PDGC-PDEI--Y-MIMTECWNNNVNQRPSFRDLALRV 286
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 37/158 (23%), Positives = 61/158 (38%), Gaps = 25/158 (15%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG-----YMAPEYAMEGIFSV 355
N+L+++E KI DFG+ ++ ++ V G + APE E FSV
Sbjct: 172 ATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAPESLTESKFSV 227
Query: 356 KSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK------ 409
SDV+SFGVVL E+ + + S E + L++ +
Sbjct: 228 ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM---IVFHLIELLKNNGRLPR 284
Query: 410 -QSCDQAELLKYIH-IGLLCVQEDPMDRPTMSSVAVML 445
C I+ I C + RP+ +A+ +
Sbjct: 285 PDGCPDE-----IYMIMTECWNNNVNQRPSFRDLALRV 317
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 45/178 (25%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG------YMAPEYAMEGIFS 354
A NVL+D + K+SDFG++R+ + A T T G + APE FS
Sbjct: 178 AARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAPEAIAFRTFS 232
Query: 355 VKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK---- 409
SDV+SFGVV+ E+++ G++ P Y W + +++ SV +
Sbjct: 233 SASDVWSFGVVMWEVLAYGER----------P----Y-WNM----TNRDVISSVEEGYRL 273
Query: 410 ---QSCDQAELLKYIH-IGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSVS 463
C A +H + L C +D RP S + +L ++ P+ + +VS
Sbjct: 274 PAPMGCPHA-----LHQLMLDCWHKDRAQRPRFSQIVSVL-DALIRSPESLRATATVS 325
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 5e-15
Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 43/168 (25%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
RA+N+L+ + K++DFG+AR+ N+ A + APE A+ G F++KSDV+
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVW 448
Query: 361 SFGVVLLEIIS-GKK-------SSGFYHLEHG-----PSLLAYIWKLWCEGHAAELMDSV 407
SFG++L E+ + G+ +E G P C +LM
Sbjct: 449 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE--------CPESLHDLM--- 497
Query: 408 VKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKP 455
C +++P +RPT + L D T +P
Sbjct: 498 -----------------CQCWRKEPEERPTFEYLQAFL-EDYFTSTEP 527
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 38/139 (27%), Positives = 60/139 (43%), Gaps = 18/139 (12%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSF 362
+NV LD + N K+ DFG+ARI + S A T VGT YM+PE ++ KSD++S
Sbjct: 145 ANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 363 GVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422
G +L E+ + F S K+ EG + S + E++
Sbjct: 203 GCLLYELCALMPP--FT----AFSQKELAGKI-REGKFRRIPYRY---SDELNEIIT--- 249
Query: 423 IGLLCVQEDPMDRPTMSSV 441
+ RP++ +
Sbjct: 250 ---RMLNLKDYHRPSVEEI 265
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 30/170 (17%), Positives = 57/170 (33%), Gaps = 32/170 (18%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRV----------VGTYGYMAPEYAMEGI 352
SN+ + K+ DFG+ ++ E VGT YM+PE
Sbjct: 147 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206
Query: 353 FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 412
+S K D+FS G++L E++ F L ++
Sbjct: 207 YSHKVDIFSLGLILFELL-----YPFS----TQMERVRTLTDVRNLKFPPLFT---QKYP 254
Query: 413 DQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVT-LPKPTQPAFS 461
+ +++ + PM+RP ++ + + + L P +
Sbjct: 255 CEYVMVQ------DMLSPSPMERPEAINI---IENAVFEDLDFPGKTVLR 295
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 27/76 (35%), Positives = 43/76 (56%), Gaps = 12/76 (15%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTN-----RVVGTYGYMAPEYAMEGIFSV 355
A NVL+ KI+DFG+AR I + + TN + +MAPE + +++
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTH 238
Query: 356 KSDVFSFGVVLLEIIS 371
+SDV+SFGV++ EI +
Sbjct: 239 QSDVWSFGVLMWEIFT 254
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 44/171 (25%), Positives = 69/171 (40%), Gaps = 49/171 (28%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGT---YGYMAPEYAMEGIFSVKS 357
RA+N+L+ + KI+DFG+AR+ N+ A G + APE G F++KS
Sbjct: 311 RAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFTIKS 366
Query: 358 DVFSFGVVLLEIIS-GKK-------SSGFYHLEHG-----PSLLAYIWKLWCEGHAAELM 404
DV+SFG++L+EI++ G+ LE G P C +M
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN--------CPEELYNIM 418
Query: 405 DSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKP 455
+ C + P +RPT + +L D T +
Sbjct: 419 --------------------MRCWKNRPEERPTFEYIQSVL-DDFYTATES 448
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 43/168 (25%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
RA+N+L+ + K++DFG+AR+ N+ A + APE A+ G F++KSDV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVW 365
Query: 361 SFGVVLLEIIS-GKK-------SSGFYHLEHG-----PSLLAYIWKLWCEGHAAELMDSV 407
SFG++L E+ + G+ +E G P C +LM
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE--------CPESLHDLM--- 414
Query: 408 VKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKP 455
C +++P +RPT + L D T +P
Sbjct: 415 -----------------CQCWRKEPEERPTFEYLQAFL-EDYFTSTEP 444
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 40/158 (25%), Positives = 59/158 (37%), Gaps = 42/158 (26%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
A N L+ K++DFG++R+ G+ A+ + APE FS+KSDV+
Sbjct: 345 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVW 403
Query: 361 SFGVVLLEIIS-GKK-------SSGFYHLEHG-----PSLLAYIWKLWCEGHAAELMDSV 407
+FGV+L EI + G S + LE P C ELM
Sbjct: 404 AFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG--------CPEKVYELM--- 452
Query: 408 VKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
C Q +P DRP+ + +
Sbjct: 453 -----------------RACWQWNPSDRPSFAEIHQAF 473
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 35/165 (21%), Positives = 65/165 (39%), Gaps = 31/165 (18%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
V+ SN+L++ K+ DFG++ S AN+ VGT YM+PE +SV+SD+
Sbjct: 158 VKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VGTRSYMSPERLQGTHYSVQSDI 213
Query: 360 FSFGVVLLEIISGK-------------------KSSGFYHLEHGPSLLAYIWKLWCEGHA 400
+S G+ L+E+ G+ + + + K +
Sbjct: 214 WSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRP 273
Query: 401 A----ELMDSVVKQSCDQAELLKY----IHIGLLCVQEDPMDRPT 437
EL+D +V + + + C+ ++P +R
Sbjct: 274 PMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 318
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 27/76 (35%), Positives = 43/76 (56%), Gaps = 12/76 (15%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTN-----RVVGTYGYMAPEYAMEGIFSV 355
A NVL+ KI+DFG+AR I + + TN + +MAPE + +++
Sbjct: 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTH 284
Query: 356 KSDVFSFGVVLLEIIS 371
+SDV+SFGV++ EI +
Sbjct: 285 QSDVWSFGVLMWEIFT 300
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 29/78 (37%), Positives = 43/78 (55%), Gaps = 12/78 (15%)
Query: 300 VRASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTN-----RVVGTYGYMAPEYAMEGIF 353
V A NVLL + KI DFG+AR I + N + +MAPE + ++
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK------WMAPESIFDCVY 243
Query: 354 SVKSDVFSFGVVLLEIIS 371
+V+SDV+S+G++L EI S
Sbjct: 244 TVQSDVWSYGILLWEIFS 261
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 44/155 (28%), Positives = 66/155 (42%), Gaps = 28/155 (18%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTN-----RVVGTYGYMAPEYAMEGIFSV 355
A NVL+ H KI DFG+AR I + N + +MAPE EGI+++
Sbjct: 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK------WMAPESLFEGIYTI 253
Query: 356 KSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQ 414
KSDV+S+G++L EI S G + + + + I G MD +
Sbjct: 254 KSDVWSYGILLWEIFSLGV--NPYPGIPVDANFYKLI----QNGF---KMDQ--PFYATE 302
Query: 415 AELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449
E+ Y I C D RP+ ++ L +
Sbjct: 303 -EI--Y-IIMQSCWAFDSRKRPSFPNLTSFLGCQL 333
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 37/141 (26%), Positives = 63/141 (44%), Gaps = 17/141 (12%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
+NV + K+ D G+ R F + A++ +VGT YM+PE E ++ KSD++S
Sbjct: 164 PANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWS 221
Query: 362 FGVVLLEIISGKKSSGFY-HLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKY 420
G +L E+ + + FY + SL I + L S + +L+
Sbjct: 222 LGCLLYEMAALQSP--FYGDKMNLYSLCKKI----EQCDYPPLPSDHY--SEELRQLVN- 272
Query: 421 IHIGLLCVQEDPMDRPTMSSV 441
+C+ DP RP ++ V
Sbjct: 273 -----MCINPDPEKRPDVTYV 288
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 26/78 (33%), Positives = 40/78 (51%), Gaps = 12/78 (15%)
Query: 300 VRASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTN-----RVVGTYGYMAPEYAMEGIF 353
+ A N+LL H KI DFG+AR I + N + +MAPE ++
Sbjct: 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK------WMAPESIFNCVY 224
Query: 354 SVKSDVFSFGVVLLEIIS 371
+ +SDV+S+G+ L E+ S
Sbjct: 225 TFESDVWSYGIFLWELFS 242
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 24/76 (31%), Positives = 42/76 (55%), Gaps = 12/76 (15%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTN-----RVVGTYGYMAPEYAMEGIFSV 355
A N+L+ KISDFG++R ++ + + + +MA E + I++
Sbjct: 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTT 231
Query: 356 KSDVFSFGVVLLEIIS 371
+SDV+SFGV+L EI++
Sbjct: 232 QSDVWSFGVLLWEIVT 247
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 36/192 (18%), Positives = 71/192 (36%), Gaps = 54/192 (28%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTN-----RVVGTYGYMAPEYAMEGIFSV 355
A N +L +M ++DFG++R I+ G+ + ++A E + +++V
Sbjct: 165 ARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK------WLALESLADNLYTV 218
Query: 356 KSDVFSFGVVLLEIIS-------GKKSSG-FYHLEHG-----PSLLAYIWKLWCEGHAAE 402
SDV++FGV + EI++ G +++ + +L G P C +
Sbjct: 219 HSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPE--------CMEEVYD 270
Query: 403 LMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSV 462
LM C DP RP+ + + + L +I+ +
Sbjct: 271 LM--------------------YQCWSADPKQRPSFTCLRMEL-ENILGHLSVLSTSQDP 309
Query: 463 SRVASGQFVSHS 474
+ + H
Sbjct: 310 LYINIERAHHHH 321
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 29/76 (38%), Positives = 44/76 (57%), Gaps = 12/76 (15%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTN-----RVVGTYGYMAPEYAMEGIFSV 355
A NVL+ + KI+DFG+AR I + + TN + +MAPE + I++
Sbjct: 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK------WMAPEALFDRIYTH 272
Query: 356 KSDVFSFGVVLLEIIS 371
+SDV+SFGV+L EI +
Sbjct: 273 QSDVWSFGVLLWEIFT 288
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 11/76 (14%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTN-----RVVGTYGYMAPEYAMEGIFSV 355
A N L+ K++DFG++R+ G+ A+ + + APE FS+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAYNKFSI 191
Query: 356 KSDVFSFGVVLLEIIS 371
KSDV++FGV+L EI +
Sbjct: 192 KSDVWAFGVLLWEIAT 207
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 36/180 (20%), Positives = 67/180 (37%), Gaps = 57/180 (31%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG------YMAPEYAMEGIFS 354
A N+L++ + K+SDFG++R+ + T T G + APE F+
Sbjct: 174 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-----TSGGKIPIRWTAPEAISYRKFT 228
Query: 355 VKSDVFSFGVVLLEIIS-GKK--------------SSGFYHLEHGPSLLAYIWKLWCEGH 399
SDV+SFG+V+ E+++ G++ + G + L C
Sbjct: 229 SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPTPMD---------CPSA 278
Query: 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPA 459
+LM + C Q++ RP + + +L ++ P +
Sbjct: 279 IYQLM--------------------MQCWQQERARRPKFADIVSIL-DKLIRAPDSLKTL 317
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 27/76 (35%), Positives = 42/76 (55%), Gaps = 12/76 (15%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTN-----RVVGTYGYMAPEYAMEGIFSV 355
A N+LL + KI DFG+AR I+ + + +MAPE + ++++
Sbjct: 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK------WMAPETIFDRVYTI 229
Query: 356 KSDVFSFGVVLLEIIS 371
+SDV+SFGV+L EI S
Sbjct: 230 QSDVWSFGVLLWEIFS 245
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 35/157 (22%), Positives = 59/157 (37%), Gaps = 30/157 (19%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
+N+ L K+ DFG+ G G YMAPE ++G + +DVFS
Sbjct: 185 PANIFLGPRGRCKLGDFGLLVEL-GTAGAGEV--QEGDPRYMAPE-LLQGSYGTAADVFS 240
Query: 362 FGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421
G+ +LE+ + G W+ +G+ + + S + +L
Sbjct: 241 LGLTILEVACNME-----LPHGGEG-----WQQLRQGYLPPEFTAGL--SSELRSVLV-- 286
Query: 422 HIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQP 458
+ ++ DP R T A ++ LP QP
Sbjct: 287 ----MMLEPDPKLRAT--------AEALLALPVLRQP 311
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 29/74 (39%), Positives = 46/74 (62%), Gaps = 7/74 (9%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGT---YGYMAPEYAMEGIFSVKS 357
RA+N+L+ ++ KI+DFG+AR+ N+ A G + APE G F++KS
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAINYGTFTIKS 191
Query: 358 DVFSFGVVLLEIIS 371
DV+SFG++L EI++
Sbjct: 192 DVWSFGILLTEIVT 205
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 33/140 (23%), Positives = 61/140 (43%), Gaps = 18/140 (12%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
+ N+ L + ++ DFG+AR+ A +GT Y++PE ++ KSD+++
Sbjct: 153 SQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWA 210
Query: 362 FGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421
G VL E+ + K H S+ + K+ G + S D L+
Sbjct: 211 LGCVLYELCTLK------HAFEAGSMKNLVLKI-ISGSFPPVSLHY---SYDLRSLVS-- 258
Query: 422 HIGLLCVQEDPMDRPTMSSV 441
+ +P DRP+++S+
Sbjct: 259 ----QLFKRNPRDRPSVNSI 274
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 26/77 (33%), Positives = 37/77 (48%), Gaps = 11/77 (14%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG------YMAPEYAMEGIFS 354
A NVLL + KISDFG+++ +++ + APE FS
Sbjct: 144 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPECINYYKFS 198
Query: 355 VKSDVFSFGVVLLEIIS 371
KSDV+SFGV++ E S
Sbjct: 199 SKSDVWSFGVLMWEAFS 215
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 26/80 (32%), Positives = 45/80 (56%), Gaps = 11/80 (13%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG-----YMAPEYAMEGIFSV 355
A NVL+ + KI+DFG+A++ G + E + G +MA E + I++
Sbjct: 144 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALESILHRIYTH 198
Query: 356 KSDVFSFGVVLLEIIS-GKK 374
+SDV+S+GV + E+++ G K
Sbjct: 199 QSDVWSYGVTVWELMTFGSK 218
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 5e-14
Identities = 24/78 (30%), Positives = 33/78 (42%), Gaps = 6/78 (7%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGT---YGYMAPEYAMEGIFSVKS 357
A N+LL KI DFG+ R N + + APE FS S
Sbjct: 148 AARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLKTRTFSHAS 205
Query: 358 DVFSFGVVLLEIIS-GKK 374
D + FGV L E+ + G++
Sbjct: 206 DTWMFGVTLWEMFTYGQE 223
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 20/76 (26%), Positives = 40/76 (52%), Gaps = 12/76 (15%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTN-----RVVGTYGYMAPEYAMEGIFSV 355
A N +L +M ++DFG+++ I+ G+ + ++A E + +++
Sbjct: 175 ARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK------WIAIESLADRVYTS 228
Query: 356 KSDVFSFGVVLLEIIS 371
KSDV++FGV + EI +
Sbjct: 229 KSDVWAFGVTMWEIAT 244
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 12/76 (15%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTN-----RVVGTYGYMAPEYAMEGIFSV 355
N L+ M KI+DFG++R I+ + +A+ N R +M PE ++
Sbjct: 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR------WMPPESIFYNRYTT 255
Query: 356 KSDVFSFGVVLLEIIS 371
+SDV+++GVVL EI S
Sbjct: 256 ESDVWAYGVVLWEIFS 271
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 5/74 (6%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGT---YGYMAPEYAMEGIFSVKS 357
A N+L++ + K+SDFG+ R+ + A T R G + +PE F+ S
Sbjct: 174 AARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAIAYRKFTSAS 231
Query: 358 DVFSFGVVLLEIIS 371
DV+S+G+VL E++S
Sbjct: 232 DVWSYGIVLWEVMS 245
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 8e-14
Identities = 23/73 (31%), Positives = 36/73 (49%), Gaps = 2/73 (2%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTY--GYMAPEYAMEGIFSVKSD 358
A N +LD K++DFG+AR + + + A E F+ KSD
Sbjct: 151 AARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSD 210
Query: 359 VFSFGVVLLEIIS 371
V+SFGV+L E+++
Sbjct: 211 VWSFGVLLWELLT 223
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 29/73 (39%), Positives = 40/73 (54%), Gaps = 9/73 (12%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGY--MAPEYAMEGIFSVKSD 358
A NVL+ + K+SDFG+ + EA++ + G APE E FS KSD
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTKSD 368
Query: 359 VFSFGVVLLEIIS 371
V+SFG++L EI S
Sbjct: 369 VWSFGILLWEIYS 381
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 9e-14
Identities = 24/76 (31%), Positives = 40/76 (52%), Gaps = 11/76 (14%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTN-----RVVGTYGYMAPEYAMEGIFSV 355
A N L++ + K+SDFG++R ++ ++ R + PE M FS
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLMYSKFSS 200
Query: 356 KSDVFSFGVVLLEIIS 371
KSD+++FGV++ EI S
Sbjct: 201 KSDIWAFGVLMWEIYS 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 26/76 (34%), Positives = 39/76 (51%), Gaps = 10/76 (13%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG------YMAPEYAMEGIFSV 355
A N +LD + K++DFG+AR + V G +MA E F+
Sbjct: 156 ARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 211
Query: 356 KSDVFSFGVVLLEIIS 371
KSDV+SFGV+L E+++
Sbjct: 212 KSDVWSFGVLLWELMT 227
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 43/156 (27%), Positives = 68/156 (43%), Gaps = 42/156 (26%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG-----YMAPEYAMEGIFSVK 356
A N+L+ KI+DFG++R Q V T G +MA E +++
Sbjct: 170 ARNILVGENYVAKIADFGLSR----GQEVY----VKKTMGRLPVRWMAIESLNYSVYTTN 221
Query: 357 SDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK------- 409
SDV+S+GV+L EI+S L P +C AEL + + +
Sbjct: 222 SDVWSYGVLLWEIVS---------LGGTP---------YCGMTCAELYEKLPQGYRLEKP 263
Query: 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
+CD E+ Y + C +E P +RP+ + + V L
Sbjct: 264 LNCDD-EV--Y-DLMRQCWREKPYERPSFAQILVSL 295
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 27/76 (35%), Positives = 39/76 (51%), Gaps = 12/76 (15%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTN-----RVVGTYGYMAPEYAMEGIFSV 355
A N ++ + KI DFGM R I+ + R +M+PE +G+F+
Sbjct: 166 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR------WMSPESLKDGVFTT 219
Query: 356 KSDVFSFGVVLLEIIS 371
SDV+SFGVVL EI +
Sbjct: 220 YSDVWSFGVVLWEIAT 235
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 1e-13
Identities = 27/74 (36%), Positives = 39/74 (52%), Gaps = 7/74 (9%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGT---YGYMAPEYAMEGIFSVKS 357
A N L+ K+SDFGM R +Q ++T GT + +PE +S KS
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSSKS 186
Query: 358 DVFSFGVVLLEIIS 371
DV+SFGV++ E+ S
Sbjct: 187 DVWSFGVLMWEVFS 200
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 26/70 (37%), Positives = 39/70 (55%), Gaps = 1/70 (1%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363
N+L+D KI DFG+A+ S TN V+GT Y +PE A +D++S G
Sbjct: 141 NILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIG 199
Query: 364 VVLLEIISGK 373
+VL E++ G+
Sbjct: 200 IVLYEMLVGE 209
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 27/146 (18%), Positives = 51/146 (34%), Gaps = 36/146 (24%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
SN+ L KI DFG+ +++ R GT YM+PE + + D+++
Sbjct: 150 PSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYA 206
Query: 362 FGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQ------SCDQA 415
G++L E++ + F ++ + +
Sbjct: 207 LGLILAELLHVCD-TAFE--------------------TSKFFTDLRDGIISDIFDKKEK 245
Query: 416 ELLKYIHIGLLCVQEDPMDRPTMSSV 441
LL+ + + P DRP S +
Sbjct: 246 TLLQ------KLLSKKPEDRPNTSEI 265
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 40/170 (23%), Positives = 56/170 (32%), Gaps = 47/170 (27%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTY--GYMAPEYAMEGIFSVKSD 358
A NVL+ K+ DFG++R + G +MAPE F+ SD
Sbjct: 143 AARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRFTSASD 199
Query: 359 VFSFGVVLLEIIS-GKK-------SSGFYHLEHG-----PSLLAYIWKLWCEGHAAELMD 405
V+ FGV + EI+ G K + +E+G P C LM
Sbjct: 200 VWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN--------CPPTLYSLM- 250
Query: 406 SVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKP 455
C DP RP + + L S I+ K
Sbjct: 251 -------------------TKCWAYDPSRRPRFTELKAQL-STILEEEKA 280
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 40/172 (23%), Positives = 64/172 (37%), Gaps = 44/172 (25%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG------YMAPEYAMEGIFS 354
A NVLL + KISDFG+++ G + S + APE FS
Sbjct: 137 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPECINFRKFS 191
Query: 355 VKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK---- 409
+SDV+S+GV + E +S G+K P Y K+ E+M + +
Sbjct: 192 SRSDVWSYGVTMWEALSYGQK----------P----Y-KKM----KGPEVMAFIEQGKRM 232
Query: 410 ---QSCDQAELLKYIH-IGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQ 457
C ++ + C DRP +V + + +L +
Sbjct: 233 ECPPECPPE-----LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 2e-13
Identities = 26/74 (35%), Positives = 41/74 (55%), Gaps = 7/74 (9%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGT---YGYMAPEYAMEGIFSVKS 357
A N L+D ++ K+SDFGM R +Q ++ GT + APE +S KS
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKYSSKS 186
Query: 358 DVFSFGVVLLEIIS 371
DV++FG+++ E+ S
Sbjct: 187 DVWAFGILMWEVFS 200
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 29/76 (38%), Positives = 43/76 (56%), Gaps = 12/76 (15%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTN-----RVVGTYGYMAPEYAMEGIFSV 355
NVL+ ++N KISD G+ R ++ + + N R +MAPE M G FS+
Sbjct: 156 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR------WMAPEAIMYGKFSI 209
Query: 356 KSDVFSFGVVLLEIIS 371
SD++S+GVVL E+ S
Sbjct: 210 DSDIWSYGVVLWEVFS 225
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 24/75 (32%), Positives = 43/75 (57%), Gaps = 10/75 (13%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG-----YMAPEYAMEGIFSVK 356
A NVL+ + KI+DFG+A++ G + E + G +MA E + I++ +
Sbjct: 145 ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALESILHRIYTHQ 199
Query: 357 SDVFSFGVVLLEIIS 371
SDV+S+GV + E+++
Sbjct: 200 SDVWSYGVTVWELMT 214
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 27/75 (36%), Positives = 38/75 (50%), Gaps = 10/75 (13%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG-----YMAPEYAMEGIFSVK 356
N L+ + KI DFGM+R + + RV G +M PE + F+ +
Sbjct: 186 TRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRV-GGRTMLPIRWMPPESILYRKFTTE 240
Query: 357 SDVFSFGVVLLEIIS 371
SDV+SFGVVL EI +
Sbjct: 241 SDVWSFGVVLWEIFT 255
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 27/71 (38%), Positives = 42/71 (59%), Gaps = 2/71 (2%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
A N+LL + KI DFG+AR I+ + + +MAPE + +++++SDV+
Sbjct: 221 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-PLKWMAPETIFDRVYTIQSDVW 279
Query: 361 SFGVVLLEIIS 371
SFGV+L EI S
Sbjct: 280 SFGVLLWEIFS 290
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 33/153 (21%), Positives = 56/153 (36%), Gaps = 28/153 (18%)
Query: 302 ASNVLLDHEMNPKISDFGMARIF------------GGNQSEANTNRVVGTYGYMAPE-YA 348
N+ +D N KI DFG+A+ S N +GT Y+A E
Sbjct: 144 PMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD 203
Query: 349 MEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVV 408
G ++ K D++S G++ E+I Y G + I K D
Sbjct: 204 GTGHYNEKIDMYSLGIIFFEMI--------YPFSTGMERVN-ILKKLRSVSIEFPPDFDD 254
Query: 409 KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSV 441
+ + ++++ L + DP RP ++
Sbjct: 255 NKMKVEKKIIR------LLIDHDPNKRPGARTL 281
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 26/76 (34%), Positives = 40/76 (52%), Gaps = 10/76 (13%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG------YMAPEYAMEGIFSV 355
A N +LD + K++DFG+AR + + V G +MA E F+
Sbjct: 220 ARNCMLDEKFTVKVADFGLARDM----YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 275
Query: 356 KSDVFSFGVVLLEIIS 371
KSDV+SFGV+L E+++
Sbjct: 276 KSDVWSFGVLLWELMT 291
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 25/76 (32%), Positives = 38/76 (50%), Gaps = 12/76 (15%)
Query: 302 ASNVLLDHEMNPKISDFGMAR-IFGGNQSEANTN-----RVVGTYGYMAPEYAMEGIFSV 355
N L+ + KI DFGM+R ++ + + R +M PE M F+
Sbjct: 161 TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR------WMPPESIMYRKFTT 214
Query: 356 KSDVFSFGVVLLEIIS 371
+SDV+SFGV+L EI +
Sbjct: 215 ESDVWSFGVILWEIFT 230
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 40/171 (23%), Positives = 64/171 (37%), Gaps = 38/171 (22%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGT---YGYMAPEYAMEGIFSVKS 357
A NVLL + KISDFG+++ G + S + APE FS +S
Sbjct: 463 AARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFRKFSSRS 520
Query: 358 DVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK------- 409
DV+S+GV + E +S G+K P Y K+ E+M + +
Sbjct: 521 DVWSYGVTMWEALSYGQK----------P----Y-KKM----KGPEVMAFIEQGKRMECP 561
Query: 410 QSCDQAELLKYIH-IGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPA 459
C ++ + C DRP +V + + +L +
Sbjct: 562 PECPPE-----LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 20/76 (26%), Positives = 38/76 (50%), Gaps = 10/76 (13%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG-----YMAPEYAMEGIFSV 355
A NVLL +++DFG+A + + + + +MA E G ++
Sbjct: 142 AARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMALESIHFGKYTH 196
Query: 356 KSDVFSFGVVLLEIIS 371
+SDV+S+GV + E+++
Sbjct: 197 QSDVWSYGVTVWELMT 212
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 4e-13
Identities = 29/73 (39%), Positives = 40/73 (54%), Gaps = 9/73 (12%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGY--MAPEYAMEGIFSVKSD 358
A NVL+ + K+SDFG+ + EA++ + G APE E FS KSD
Sbjct: 144 AARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTKSD 196
Query: 359 VFSFGVVLLEIIS 371
V+SFG++L EI S
Sbjct: 197 VWSFGILLWEIYS 209
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 37/144 (25%), Positives = 66/144 (45%), Gaps = 22/144 (15%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE----YAMEGIFSV 355
++ SN+LLD N K+ DFG++ + ++ G YMAPE A + V
Sbjct: 152 IKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMAPERIDPSASRQGYDV 208
Query: 356 KSDVFSFGVVLLEIISGKKSSGF-YHLEHGP-SLLAYIWKLWCEGHAAELMDSVVKQSCD 413
+SDV+S G+ L E+ +G+ F Y + L + +G +L +S ++
Sbjct: 209 RSDVWSLGITLYELATGR----FPYPKWNSVFDQLTQV----VKGDPPQLSNSEEREFSP 260
Query: 414 QAELLKYIHIGLLCVQEDPMDRPT 437
+ +++ LC+ +D RP
Sbjct: 261 --SFINFVN---LCLTKDESKRPK 279
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 24/71 (33%), Positives = 40/71 (56%), Gaps = 1/71 (1%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSE-ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSF 362
N+++ K+ DFG+AR + + T V+GT Y++PE A +SDV+S
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 363 GVVLLEIISGK 373
G VL E+++G+
Sbjct: 206 GCVLYEVLTGE 216
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 8e-13
Identities = 20/74 (27%), Positives = 32/74 (43%), Gaps = 7/74 (9%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGT---YGYMAPEYAMEGIFSVKS 357
N+L+ K+ DFG++R + T +M+PE F+ S
Sbjct: 140 AVRNILVASPECVKLGDFGLSRYIEDED----YYKASVTRLPIKWMSPESINFRRFTTAS 195
Query: 358 DVFSFGVVLLEIIS 371
DV+ F V + EI+S
Sbjct: 196 DVWMFAVCMWEILS 209
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 20/71 (28%), Positives = 34/71 (47%), Gaps = 1/71 (1%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSF 362
N+L+ + + DFG+A + VGT YMAPE E + ++D+++
Sbjct: 163 ENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHATYRADIYAL 221
Query: 363 GVVLLEIISGK 373
VL E ++G
Sbjct: 222 TCVLYECLTGS 232
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 31/139 (22%), Positives = 60/139 (43%), Gaps = 20/139 (14%)
Query: 300 VRASNVLLDHEM-NPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSD 358
++ N+ + + KI D G+A + S A V+GT +MAPE E + D
Sbjct: 157 LKCDNIFITGPTGSVKIGDLGLATLK--RASFAKA--VIGTPEFMAPEMYEEK-YDESVD 211
Query: 359 VFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELL 418
V++FG+ +LE+ + + Y A I++ G D V + E++
Sbjct: 212 VYAFGMCMLEMATSEYP---YSECQNA---AQIYRRVTSGVKPASFDKV--AIPEVKEII 263
Query: 419 KYIHIGLLCVQEDPMDRPT 437
+ C++++ +R +
Sbjct: 264 E------GCIRQNKDERYS 276
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 23/78 (29%), Positives = 41/78 (52%), Gaps = 7/78 (8%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE----YAMEGIFSV 355
V+ SNVL++ K+ DFG++ + + + G YMAPE + +SV
Sbjct: 136 VKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AGCKPYMAPERINPELNQKGYSV 192
Query: 356 KSDVFSFGVVLLEIISGK 373
KSD++S G+ ++E+ +
Sbjct: 193 KSDIWSLGITMIELAILR 210
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 35/145 (24%), Positives = 64/145 (44%), Gaps = 25/145 (17%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-----YAMEGIFS 354
V+ SN+LLD K+ DFG++ ++++ +R G YMAPE + +
Sbjct: 151 VKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 355 VKSDVFSFGVVLLEIISGKKSSGF-YHLEHGP-SLLAYIWKLWCEGHAAELMDSVVKQSC 412
+++DV+S G+ L+E+ +G+ F Y +L + + L+ + S
Sbjct: 208 IRADVWSLGISLVELATGQ----FPYKNCKTDFEVLTKVLQ-----EEPPLLPGHMGFSG 258
Query: 413 DQAELLKYIHIGLLCVQEDPMDRPT 437
D +K C+ +D RP
Sbjct: 259 DFQSFVKD------CLTKDHRKRPK 277
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 17/71 (23%), Positives = 28/71 (39%), Gaps = 8/71 (11%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSF 362
N++L E K+ D G + GT G+ APE G +V +D+++
Sbjct: 211 ENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRTGP-TVATDIYTV 262
Query: 363 GVVLLEIISGK 373
G L +
Sbjct: 263 GRTLAALTLDL 273
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 33/78 (42%), Positives = 39/78 (50%), Gaps = 13/78 (16%)
Query: 302 ASNVLLD---HEMNPKISDFGMARIFGGNQSEANTNRVVGTYGY-----MAPEYAMEGIF 353
A N LL KI DFGMAR + A+ R G M PE MEGIF
Sbjct: 168 ARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK-GGCAMLPVKWMPPEAFMEGIF 222
Query: 354 SVKSDVFSFGVVLLEIIS 371
+ K+D +SFGV+L EI S
Sbjct: 223 TSKTDTWSFGVLLWEIFS 240
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 37/147 (25%), Positives = 56/147 (38%), Gaps = 26/147 (17%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-----------YAMEGI 352
N L+ + K+ DFG+A + + + VG YM PE +
Sbjct: 185 NFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSK 243
Query: 353 FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 412
S KSDV+S G +L + GK F + + S L I H E D
Sbjct: 244 ISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIID---PNHEIEFPDIP---EK 295
Query: 413 DQAELLKYIHIGLLCVQEDPMDRPTMS 439
D ++LK C++ DP R ++
Sbjct: 296 DLQDVLK------CCLKRDPKQRISIP 316
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 22/71 (30%), Positives = 34/71 (47%), Gaps = 1/71 (1%)
Query: 301 RASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
A NVL+ K+ DFG++R + + + +MAPE F+ SDV+
Sbjct: 518 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVW 576
Query: 361 SFGVVLLEIIS 371
FGV + EI+
Sbjct: 577 MFGVCMWEILM 587
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 33/78 (42%), Positives = 38/78 (48%), Gaps = 13/78 (16%)
Query: 302 ASNVLLD---HEMNPKISDFGMARIFGGNQSEANTNRVVGTYGY-----MAPEYAMEGIF 353
A N LL KI DFGMAR + A R G M PE MEGIF
Sbjct: 209 ARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRK-GGCAMLPVKWMPPEAFMEGIF 263
Query: 354 SVKSDVFSFGVVLLEIIS 371
+ K+D +SFGV+L EI S
Sbjct: 264 TSKTDTWSFGVLLWEIFS 281
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 19/146 (13%), Positives = 32/146 (21%), Gaps = 25/146 (17%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM--EGIFSVKSDVF 360
N+ + + + D G Y E+ F+ + +
Sbjct: 223 DNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAW 277
Query: 361 SFGVVLLEIISGK-----KSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 415
G+ + + + G PSL G L D V
Sbjct: 278 QLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFV-------K 330
Query: 416 ELLKYIHIGLLCVQEDPMDRPTMSSV 441
L+ L D R
Sbjct: 331 TLIG----RFLNF--DRRRRLLPLEA 350
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 38/147 (25%), Positives = 57/147 (38%), Gaps = 26/147 (17%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-----------YAMEGI 352
N L+ + K+ DFG+A + + + VGT YM PE +
Sbjct: 157 NFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSK 215
Query: 353 FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 412
S KSDV+S G +L + GK F + + S L I H E D
Sbjct: 216 ISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIID---PNHEIEFPDIP---EK 267
Query: 413 DQAELLKYIHIGLLCVQEDPMDRPTMS 439
D ++LK C++ DP R ++
Sbjct: 268 DLQDVLK------CCLKRDPKQRISIP 288
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 38/147 (25%), Positives = 58/147 (39%), Gaps = 26/147 (17%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-----------YAMEGI 352
N L+ + K+ DFG+A + + + VGT YM PE +
Sbjct: 138 NFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSK 196
Query: 353 FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 412
S KSDV+S G +L + GK + F + + S L I H E D
Sbjct: 197 ISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKLHAIID---PNHEIEFPDIP---EK 248
Query: 413 DQAELLKYIHIGLLCVQEDPMDRPTMS 439
D ++LK C++ DP R ++
Sbjct: 249 DLQDVLK------CCLKRDPKQRISIP 269
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 32/175 (18%), Positives = 48/175 (27%), Gaps = 68/175 (38%)
Query: 300 VRASNVLLDHEMNP--------KISDFGMARIFGGNQSEANTNRVVGTYGY-----MAPE 346
V A N+LL E + K+SD G++ + PE
Sbjct: 139 VCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------ILQERIPWVPPE 187
Query: 347 YAMEG-IFSVKSDVFSFGVVLLEIIS-GKK-------SSGFYHLEHG-----PSLLAYIW 392
++ +D +SFG L EI S G K E P
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPK------ 241
Query: 393 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLAS 447
E L+ C+ +P RP+ ++ L S
Sbjct: 242 --AAELA--NLI--------------------NNCMDYEPDHRPSFRAIIRDLNS 272
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 27/73 (36%), Positives = 40/73 (54%), Gaps = 9/73 (12%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI---FSVKSDVF 360
N+LLD + +ISD G+A F + + VGT+GYMAPE +G+ S D F
Sbjct: 322 NILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSA--DWF 375
Query: 361 SFGVVLLEIISGK 373
S G +L +++ G
Sbjct: 376 SLGCMLFKLLRGH 388
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 28/140 (20%), Positives = 55/140 (39%), Gaps = 18/140 (12%)
Query: 302 ASNVLLDHEMNP-KISDFGMARIF---GGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKS 357
A NVLL + + + DFG A G +S + + GT +MAPE M K
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 237
Query: 358 DVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAEL 417
D++S ++L +++G + L I + + + A+
Sbjct: 238 DIWSSCCMMLHMLNGCHP---WTQYFRGPLCLKIAS-----EPPPIREIPPSCAPLTAQA 289
Query: 418 LKYIHIGLLCVQEDPMDRPT 437
++ ++++P+ R +
Sbjct: 290 IQ------EGLRKEPVHRAS 303
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 9/76 (11%), Positives = 22/76 (28%), Gaps = 6/76 (7%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-----YAMEGIFSVKS 357
+++LD ++ F G + + R A + +
Sbjct: 240 VDIVLDQRGGVFLTGFEHLVRD-GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAF 298
Query: 358 DVFSFGVVLLEIISGK 373
D ++ G+ + I
Sbjct: 299 DTWTLGLAIYWIWCAD 314
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 37/140 (26%), Positives = 59/140 (42%), Gaps = 21/140 (15%)
Query: 302 ASNVLLD-HEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE---YAMEGIFSVKS 357
NVL++ + KISDFG ++ G T GT YMAPE G + +
Sbjct: 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRG-YGKAA 206
Query: 358 DVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAEL 417
D++S G ++E+ +GK FY L A ++K+ E+ +S+ S +
Sbjct: 207 DIWSLGCTIIEMATGKPP--FYELGEP---QAAMFKVGMFKVHPEIPESM---SAEAKAF 258
Query: 418 LKYIHIGLLCVQEDPMDRPT 437
+ C + DP R
Sbjct: 259 IL------KCFEPDPDKRAC 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 21/78 (26%), Positives = 36/78 (46%), Gaps = 9/78 (11%)
Query: 304 NVLL-----DHEMNPKISDFGMARIFGGNQSE-ANTNRVVGTYGYMAPEY---AMEGIFS 354
N+L+ ++ ISDFG+ + + + + V GT G++APE + +
Sbjct: 148 NILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPT 207
Query: 355 VKSDVFSFGVVLLEIISG 372
D+FS G V +IS
Sbjct: 208 YTVDIFSAGCVFYYVISE 225
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 29/148 (19%), Positives = 49/148 (33%), Gaps = 19/148 (12%)
Query: 304 NVLLD---HEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
N++L + KI D G A+ VGT Y+APE + ++V D +
Sbjct: 151 NIVLQPGPQRLIHKIIDLGYAKELD-QGELCTE--FVGTLQYLAPELLEQKKYTVTVDYW 207
Query: 361 SFGVVLLEIISGK-------KSSGFYHLEHGPSLLAYIWKLWCEGHA---AELMDSVVKQ 410
SFG + E I+G + ++ S + G + L
Sbjct: 208 SFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLS 267
Query: 411 SCDQAELLKYIHIGLLCVQEDPMDRPTM 438
+L +++ L R T
Sbjct: 268 GILAGKLERWLQCML---MWHQRQRGTD 292
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 4e-10
Identities = 22/70 (31%), Positives = 42/70 (60%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363
N+LL+ +M+ +I+DFG A++ +A N VGT Y++PE E SD+++ G
Sbjct: 160 NILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALG 219
Query: 364 VVLLEIISGK 373
++ ++++G
Sbjct: 220 CIIYQLVAGL 229
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 26/70 (37%), Positives = 38/70 (54%), Gaps = 2/70 (2%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363
NVLLD + N +ISD G+A Q++ GT G+MAPE + + D F+ G
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMAPELLLGEEYDFSVDYFALG 376
Query: 364 VVLLEIISGK 373
V L E+I+ +
Sbjct: 377 VTLYEMIAAR 386
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 25/70 (35%), Positives = 38/70 (54%), Gaps = 3/70 (4%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363
N+LLD + +ISD G+A Q+ VGT GYMAPE ++ D ++ G
Sbjct: 316 NILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALG 372
Query: 364 VVLLEIISGK 373
+L E+I+G+
Sbjct: 373 CLLYEMIAGQ 382
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 26/74 (35%), Positives = 41/74 (55%), Gaps = 5/74 (6%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE--YAMEGIFS-VKSDV 359
SN+L+ + + KI+DFG++ F G+ + + VGT +MAPE IFS DV
Sbjct: 166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKIFSGKALDV 223
Query: 360 FSFGVVLLEIISGK 373
++ GV L + G+
Sbjct: 224 WAMGVTLYCFVFGQ 237
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 11/82 (13%), Positives = 24/82 (29%), Gaps = 17/82 (20%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY-----------AMEG 351
+++LD ++ F G + G+ PE
Sbjct: 235 VDIVLDQRGGVFLTGFEHLVRDGARVV------SSVSRGFEPPELEARRATISYHRDRRT 288
Query: 352 IFSVKSDVFSFGVVLLEIISGK 373
+ + D ++ G+V+ I
Sbjct: 289 LMTFSFDAWALGLVIYWIWCAD 310
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 26/74 (35%), Positives = 43/74 (58%), Gaps = 2/74 (2%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
++A+NVLL K++DFG+A Q + NT VGT +MAPE + + K+D+
Sbjct: 145 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADI 202
Query: 360 FSFGVVLLEIISGK 373
+S G+ +E+ G+
Sbjct: 203 WSLGITAIELARGE 216
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 26/74 (35%), Positives = 46/74 (62%), Gaps = 2/74 (2%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
++A N+LL+ E + K++DFG+A ++ NT V+GT +MAPE E ++ +D+
Sbjct: 151 IKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADI 208
Query: 360 FSFGVVLLEIISGK 373
+S G+ +E+ GK
Sbjct: 209 WSLGITAIEMAEGK 222
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 29/75 (38%), Positives = 41/75 (54%), Gaps = 11/75 (14%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFS------VKS 357
N+LLD N KISDFG+A +F N E N++ GT Y+APE +
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-----LLKRREFHAEPV 189
Query: 358 DVFSFGVVLLEIISG 372
DV+S G+VL +++G
Sbjct: 190 DVWSCGIVLTAMLAG 204
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 24/73 (32%), Positives = 39/73 (53%), Gaps = 8/73 (10%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNR---VVGTYGYMAPEYAMEGIFSVKSDVF 360
N+LL MN KI+DFG+A Q + + + GT Y++PE A ++SDV+
Sbjct: 142 NLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVW 196
Query: 361 SFGVVLLEIISGK 373
S G + ++ G+
Sbjct: 197 SLGCMFYTLLIGR 209
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 29/75 (38%), Positives = 41/75 (54%), Gaps = 11/75 (14%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFS------VKS 357
N+LLD N KISDFG+A +F N E N++ GT Y+APE +
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-----LLKRREFHAEPV 189
Query: 358 DVFSFGVVLLEIISG 372
DV+S G+VL +++G
Sbjct: 190 DVWSCGIVLTAMLAG 204
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 28/156 (17%), Positives = 46/156 (29%), Gaps = 45/156 (28%)
Query: 302 ASNVLLDHEMNP-------------------KISDFGMARIFGGNQSEANTNRVVGTYGY 342
SN+ + P KI D G Q E G +
Sbjct: 143 PSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE------EGDSRF 196
Query: 343 MAPEYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401
+A E E K+D+F+ + ++ + L I +G
Sbjct: 197 LANEVLQENYTHLPKADIFALALTVVCAAGAE------PLPRNGDQWHEI----RQGRLP 246
Query: 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT 437
+ + S + ELLK + + DP RP+
Sbjct: 247 RIPQVL---SQEFTELLK------VMIHPDPERRPS 273
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 37/166 (22%), Positives = 53/166 (31%), Gaps = 46/166 (27%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMARIFGGNQS--EANTNRVVGTYGYMAPEYAMEGIFSV 355
R A + ISDFG+ + QS N N GT G+ APE E
Sbjct: 152 SRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQ 211
Query: 356 -------KSDVFSFGVVLLEIISGKK-------------SSGFYHLEHGPSLLAYIWKLW 395
D+FS G V I+S K G + L+
Sbjct: 212 TKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMK------CLHD 265
Query: 396 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSV 441
S++ ++ D L+ ++ DP+ RPT V
Sbjct: 266 ---------RSLIAEATD---LIS----QMIDH--DPLKRPTAMKV 293
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 24/74 (32%), Positives = 44/74 (59%), Gaps = 2/74 (2%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
+++ N+LL + + K++DFG QS+ +T +VGT +MAPE + K D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 360 FSFGVVLLEIISGK 373
+S G++ +E+I G+
Sbjct: 200 WSLGIMAIEMIEGE 213
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 21/78 (26%), Positives = 32/78 (41%), Gaps = 16/78 (20%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK------ 356
SN+L+D K+SDFG + + GTY +M PE FS +
Sbjct: 181 SNILMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPE-----FFSNESSYNGA 231
Query: 357 -SDVFSFGVVLLEIISGK 373
D++S G+ L +
Sbjct: 232 KVDIWSLGICLYVMFYNV 249
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 8e-09
Identities = 17/82 (20%), Positives = 34/82 (41%), Gaps = 15/82 (18%)
Query: 304 NVLL----DHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE--------YAMEG 351
N++ D + K++DFG AR ++ + + + GT Y+ P+ +
Sbjct: 142 NIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGTEEYLHPDMYERAVLRKDHQK 198
Query: 352 IFSVKSDVFSFGVVLLEIISGK 373
+ D++S GV +G
Sbjct: 199 KYGATVDLWSIGVTFYHAATGS 220
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 25/72 (34%), Positives = 40/72 (55%), Gaps = 7/72 (9%)
Query: 304 NVLL---DHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
N+LL + N +I DFG++ F ++ +GT Y+APE + G + K DV+
Sbjct: 156 NLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPE-VLHGTYDEKCDVW 211
Query: 361 SFGVVLLEIISG 372
S GV+L ++SG
Sbjct: 212 STGVILYILLSG 223
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 17/82 (20%), Positives = 33/82 (40%), Gaps = 15/82 (18%)
Query: 304 NVLL----DHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE--------YAMEG 351
N++ D + K++DFG AR + + + + GT Y+ P+ +
Sbjct: 142 NIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVS--LYGTEEYLHPDMYERAVLRKDHQK 198
Query: 352 IFSVKSDVFSFGVVLLEIISGK 373
+ D++S GV +G
Sbjct: 199 KYGATVDLWSIGVTFYHAATGS 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 23/74 (31%), Positives = 39/74 (52%), Gaps = 8/74 (10%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNR---VVGTYGYMAPEYAMEGIFSVKSDV 359
N+ L+ ++ KI DFG+A + E + R + GT Y+APE + S + DV
Sbjct: 170 GNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 224
Query: 360 FSFGVVLLEIISGK 373
+S G ++ ++ GK
Sbjct: 225 WSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 23/74 (31%), Positives = 39/74 (52%), Gaps = 8/74 (10%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNR---VVGTYGYMAPEYAMEGIFSVKSDV 359
N+ L+ ++ KI DFG+A + E + R + GT Y+APE + S + DV
Sbjct: 144 GNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 198
Query: 360 FSFGVVLLEIISGK 373
+S G ++ ++ GK
Sbjct: 199 WSIGCIMYTLLVGK 212
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 23/73 (31%), Positives = 39/73 (53%), Gaps = 7/73 (9%)
Query: 304 NVLL---DHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
N+LL + + KI DFG++ +F + +GT Y+APE + + K DV+
Sbjct: 166 NLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPE-VLRKKYDEKCDVW 221
Query: 361 SFGVVLLEIISGK 373
S GV+L +++G
Sbjct: 222 SIGVILFILLAGY 234
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 19/74 (25%), Positives = 44/74 (59%), Gaps = 2/74 (2%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
+++ ++LL + K+SDFG + + + +VGT +MAPE +++ + D+
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDI 224
Query: 360 FSFGVVLLEIISGK 373
+S G++++E++ G+
Sbjct: 225 WSLGIMVIEMVDGE 238
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 25/174 (14%), Positives = 48/174 (27%), Gaps = 36/174 (20%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANT-----NRVVGTYGYMAPEYAMEGI-- 352
V+AS++L+ + +S + V +++PE + +
Sbjct: 154 VKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQG 213
Query: 353 FSVKSDVFSFGVVLLEIISGKKSSGFYH--------LEHGPSLLAYIWKLWCEGHAAELM 404
+ KSD++S G+ E+ +G L L + E
Sbjct: 214 YDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPS 273
Query: 405 DSVVKQSCDQAELLKYIHIGL---------------------LCVQEDPMDRPT 437
SV + C+Q +P RP+
Sbjct: 274 RSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 23/72 (31%), Positives = 40/72 (55%), Gaps = 7/72 (9%)
Query: 304 NVLL---DHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
N+LL + +N KI DFG++ F + +GT Y+APE ++ ++ K DV+
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPE-VLKKKYNEKCDVW 231
Query: 361 SFGVVLLEIISG 372
S GV++ ++ G
Sbjct: 232 SCGVIMYILLCG 243
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 26/72 (36%), Positives = 40/72 (55%), Gaps = 7/72 (9%)
Query: 304 NVLL---DHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
N+LL + + + KI DFG++ F N +GT Y+APE + G + K DV+
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE-VLRGTYDEKCDVW 206
Query: 361 SFGVVLLEIISG 372
S GV+L ++SG
Sbjct: 207 SAGVILYILLSG 218
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 30/184 (16%), Positives = 56/184 (30%), Gaps = 48/184 (26%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNR----------VVGTYGYMAPE----YAM 349
N+LL ++ K+ DFG A + + + T Y PE Y+
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227
Query: 350 EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLA-----YIWKLWCEGHAAELM 404
I K D+++ G +L + + F + L Y
Sbjct: 228 FPI-GEKQDIWALGCILYLLCFRQ--HPFE----DGAKLRIVNGKYSIPPHD-------- 272
Query: 405 DSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSV----AVMLASDIVTLPKPTQPAF 460
Q L++ +Q +P +R +++ V + A+ V P
Sbjct: 273 ----TQYTVFHSLIRA------MLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELL 322
Query: 461 SVSR 464
+
Sbjct: 323 EQNG 326
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 21/69 (30%), Positives = 34/69 (49%), Gaps = 9/69 (13%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE------YAMEGIFSVKS 357
N+LLD +MN K++DFG + + V GT Y+APE + +
Sbjct: 154 NILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEV 210
Query: 358 DVFSFGVVL 366
D++S GV++
Sbjct: 211 DMWSTGVIM 219
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 19/76 (25%), Positives = 32/76 (42%), Gaps = 6/76 (7%)
Query: 304 NVLL--DHEMNPKISDFGMARIFGGNQSEANT--NRVVGTYGYMAPE--YAMEGIFSVKS 357
N L + K+ DFG+++ F + GT ++APE + K
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 358 DVFSFGVVLLEIISGK 373
D +S GV+L ++ G
Sbjct: 258 DAWSAGVLLHLLLMGA 273
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 24/76 (31%), Positives = 40/76 (52%), Gaps = 5/76 (6%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEAN---TNRVVGTYGYMAPEYAM-EGIFSVKS 357
A+NVL+ + K++DFG+AR F ++ TNRVV T Y PE + E +
Sbjct: 152 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPI 210
Query: 358 DVFSFGVVLLEIISGK 373
D++ G ++ E+ +
Sbjct: 211 DLWGAGCIMAEMWTRS 226
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 24/75 (32%), Positives = 37/75 (49%), Gaps = 10/75 (13%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE--YAMEGI---FSVKSD 358
N+LLD + I+DF +A + + GT YMAPE + +G F+V D
Sbjct: 145 NILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAV--D 199
Query: 359 VFSFGVVLLEIISGK 373
+S GV E++ G+
Sbjct: 200 WWSLGVTAYELLRGR 214
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 20/69 (28%), Positives = 33/69 (47%), Gaps = 9/69 (13%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE------YAMEGIFSVKS 357
N+LLD M ++SDFG + + + GT GY+APE + +
Sbjct: 230 NILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEV 286
Query: 358 DVFSFGVVL 366
D+++ GV+L
Sbjct: 287 DLWACGVIL 295
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 27/152 (17%), Positives = 45/152 (29%), Gaps = 53/152 (34%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKS------ 357
N+++ + K+ DFG A + GT Y APE +
Sbjct: 160 NIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGTIEYCAPE-----VLMGNPYRGPEL 211
Query: 358 DVFSFGVVLLEIISG--------KKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK 409
+++S GV L ++ + H P L+
Sbjct: 212 EMWSLGVTLYTLVFEENPFCELEETVEAAIHP---PYLV--------------------- 247
Query: 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSV 441
S + L+ GLL P R T+ +
Sbjct: 248 -SKELMSLVS----GLLQP--VPERRTTLEKL 272
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 6e-08
Identities = 23/79 (29%), Positives = 37/79 (46%), Gaps = 7/79 (8%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-----YAMEGIFS 354
++ NVLL K+ DFG++ NT +GT +MAPE + +
Sbjct: 155 IKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYD 212
Query: 355 VKSDVFSFGVVLLEIISGK 373
KSD++S G+ +E+ G
Sbjct: 213 FKSDLWSLGITAIEMAEGA 231
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 22/66 (33%), Positives = 30/66 (45%), Gaps = 5/66 (7%)
Query: 304 NVLLDHEMNP---KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
VLL + N K+ FG+A G + A VGT +MAPE + DV+
Sbjct: 160 CVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEVVKREPYGKPVDVW 217
Query: 361 SFGVVL 366
GV+L
Sbjct: 218 GCGVIL 223
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 8e-08
Identities = 23/73 (31%), Positives = 35/73 (47%), Gaps = 10/73 (13%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNR---VVGTYGYMAPEYAMEGIFSVKSDVF 360
N+LL KI+DFG + A ++R + GT Y+ PE + K D++
Sbjct: 139 NLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLW 191
Query: 361 SFGVVLLEIISGK 373
S GV+ E + GK
Sbjct: 192 SLGVLCYEFLVGK 204
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 26/76 (34%), Positives = 37/76 (48%), Gaps = 14/76 (18%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFS------VKS 357
N+LLD +MN KI+DFG + F + G Y APE +F +
Sbjct: 144 NLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPE-----LFQGKKYDGPEV 195
Query: 358 DVFSFGVVLLEIISGK 373
DV+S GV+L ++SG
Sbjct: 196 DVWSLGVILYTLVSGS 211
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 33/155 (21%), Positives = 51/155 (32%), Gaps = 38/155 (24%)
Query: 304 NVLLDHEMNPKISDFG---MARIFGGNQSEANTN----RVVGTYGYMAPE----YAMEGI 352
N+LL E P + D G A I +A T T Y APE + I
Sbjct: 164 NILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVI 223
Query: 353 FSVKSDVFSFGVVLLEIISGKKSSGF-YHLEHGPSLLA-----YIWKLWCEGHAAELMDS 406
++DV+S G VL ++ G+ + + G S+
Sbjct: 224 -DERTDVWSLGCVLYAMMFGE--GPYDMVFQKGDSVALAVQNQLSIPQSP---------- 270
Query: 407 VVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSV 441
+ S +LL + DP RP + +
Sbjct: 271 --RHSSALWQLLNS------MMTVDPHQRPHIPLL 297
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 20/72 (27%), Positives = 30/72 (41%), Gaps = 2/72 (2%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM--EGIFSVKSDVFS 361
N+LL KIS G+A ++ G+ + PE A + K D++S
Sbjct: 139 NLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWS 198
Query: 362 FGVVLLEIISGK 373
GV L I +G
Sbjct: 199 AGVTLYNITTGL 210
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 40/150 (26%), Positives = 68/150 (45%), Gaps = 27/150 (18%)
Query: 300 VRASNVLLDHEMNPKISDFGM-ARIFGGNQSEANTNR--VVGTYGYMAPEYAMEGI-FSV 355
V+A N+LL + + +I+DFG+ A + G N R VGT +MAPE + +
Sbjct: 147 VKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDF 206
Query: 356 KSDVFSFGVVLLEIISGKKSSGFYH--------LEHGPSLLAYIWKLWCEGHAAELMDSV 407
K+D++SFG+ +E+ +G Y L++ P L + + +
Sbjct: 207 KADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE---------TGVQDKEML 257
Query: 408 VKQSCDQAELLKYIHIGLLCVQEDPMDRPT 437
K +++ LC+Q+DP RPT
Sbjct: 258 KKYGKSFRKMIS------LCLQKDPEKRPT 281
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 18/70 (25%), Positives = 31/70 (44%), Gaps = 4/70 (5%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363
N+L+ ++ KI+DFG + + + GT Y+ PE K D++ G
Sbjct: 144 NLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAG 199
Query: 364 VVLLEIISGK 373
V+ E + G
Sbjct: 200 VLCYEFLVGM 209
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 24/66 (36%), Positives = 36/66 (54%), Gaps = 7/66 (10%)
Query: 304 NVLL---DHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
N+LL + + + KI DFG++ F N +GT Y+APE + G + K DV+
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE-VLRGTYDEKCDVW 206
Query: 361 SFGVVL 366
S GV+L
Sbjct: 207 SAGVIL 212
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 20/79 (25%), Positives = 43/79 (54%), Gaps = 7/79 (8%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-----YAMEGIFS 354
++A NVL+ E + +++DFG++ + ++ +GT +MAPE + +
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPYD 200
Query: 355 VKSDVFSFGVVLLEIISGK 373
K+D++S G+ L+E+ +
Sbjct: 201 YKADIWSLGITLIEMAQIE 219
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 5e-07
Identities = 22/66 (33%), Positives = 33/66 (50%), Gaps = 7/66 (10%)
Query: 304 NVLL---DHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
N+L KI DFG+A +F ++ + GT YMAPE + + K D++
Sbjct: 154 NILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPE-VFKRDVTFKCDIW 209
Query: 361 SFGVVL 366
S GVV+
Sbjct: 210 SAGVVM 215
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 6e-07
Identities = 19/66 (28%), Positives = 33/66 (50%), Gaps = 7/66 (10%)
Query: 304 NVLL---DHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
N L + K+ DFG+A F + VGT Y++P+ +EG++ + D +
Sbjct: 136 NFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQ-VLEGLYGPECDEW 191
Query: 361 SFGVVL 366
S GV++
Sbjct: 192 SAGVMM 197
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 28/77 (36%), Positives = 39/77 (50%), Gaps = 9/77 (11%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE---YAMEGIFSVK 356
V+A N+LL K+ DFG A + AN+ VGT +MAPE EG + K
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSA----SIMAPANS--FVGTPYWMAPEVILAMDEGQYDGK 233
Query: 357 SDVFSFGVVLLEIISGK 373
DV+S G+ +E+ K
Sbjct: 234 VDVWSLGITCIELAERK 250
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 19/66 (28%), Positives = 36/66 (54%), Gaps = 6/66 (9%)
Query: 304 NVLLDHEMNP---KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
N+LL + K++DFG+A +++ + GT GY++PE + +S D++
Sbjct: 158 NLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIW 214
Query: 361 SFGVVL 366
+ GV+L
Sbjct: 215 ACGVIL 220
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 26/78 (33%), Positives = 41/78 (52%), Gaps = 15/78 (19%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-------YAMEGIFSV 355
N+L++ + K++DFG+AR F G + T+ VV T Y AP+ Y S
Sbjct: 148 QNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLMGSKKY------ST 199
Query: 356 KSDVFSFGVVLLEIISGK 373
D++S G + E+I+GK
Sbjct: 200 SVDIWSIGCIFAEMITGK 217
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 20/66 (30%), Positives = 34/66 (51%), Gaps = 5/66 (7%)
Query: 304 NVLLDHEMNP---KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
N+LL ++ K++DFG+A G Q GT GY++PE + + D++
Sbjct: 140 NLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLW 197
Query: 361 SFGVVL 366
+ GV+L
Sbjct: 198 ACGVIL 203
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 22/71 (30%), Positives = 38/71 (53%), Gaps = 3/71 (4%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSF 362
N+L+ K++DFG+ARI+ + T+ VV T Y APE ++ ++ D++S
Sbjct: 149 QNILVTSSGQIKLADFGLARIYSFQMAL--TSVVV-TLWYRAPEVLLQSSYATPVDLWSV 205
Query: 363 GVVLLEIISGK 373
G + E+ K
Sbjct: 206 GCIFAEMFRRK 216
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 19/66 (28%), Positives = 36/66 (54%), Gaps = 6/66 (9%)
Query: 304 NVLLDHEMNP---KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
N+LL + K++DFG+A +++ + GT GY++PE + +S D++
Sbjct: 135 NLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIW 191
Query: 361 SFGVVL 366
+ GV+L
Sbjct: 192 ACGVIL 197
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 22/69 (31%), Positives = 33/69 (47%), Gaps = 9/69 (13%)
Query: 304 NVLL---DHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE---YAMEGIFSVKS 357
NVLL + + KI+DFG ++I G + GT Y+APE ++
Sbjct: 144 NVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAV 200
Query: 358 DVFSFGVVL 366
D +S GV+L
Sbjct: 201 DCWSLGVIL 209
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 22/69 (31%), Positives = 32/69 (46%), Gaps = 9/69 (13%)
Query: 304 NVLLDHEMNP---KISDFGMARIFGGNQSEANTNRVVGTYGYMAPE---YAMEGIFSVKS 357
NVLL + KI+DFG ++I G + GT Y+APE ++
Sbjct: 269 NVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAV 325
Query: 358 DVFSFGVVL 366
D +S GV+L
Sbjct: 326 DCWSLGVIL 334
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 22/71 (30%), Positives = 37/71 (52%), Gaps = 3/71 (4%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSF 362
N+L+ K++DFG+ARI+ + T VV T Y APE ++ ++ D++S
Sbjct: 149 ENILVTSGGTVKLADFGLARIYSYQMA--LTPVVV-TLWYRAPEVLLQSTYATPVDMWSV 205
Query: 363 GVVLLEIISGK 373
G + E+ K
Sbjct: 206 GCIFAEMFRRK 216
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 18/66 (27%), Positives = 31/66 (46%), Gaps = 7/66 (10%)
Query: 304 NVLL---DHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
N+L + I+DFG++++ + GT GY+APE + +S D +
Sbjct: 136 NLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCW 191
Query: 361 SFGVVL 366
S GV+
Sbjct: 192 SIGVIT 197
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 20/79 (25%), Positives = 35/79 (44%), Gaps = 15/79 (18%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-------YAMEGIFSV 355
N+L++ K+++FG+AR F G + VV T Y P+ Y S
Sbjct: 130 QNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFGAKLY------ST 181
Query: 356 KSDVFSFGVVLLEIISGKK 374
D++S G + E+ + +
Sbjct: 182 SIDMWSAGCIFAELANAGR 200
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 24/76 (31%), Positives = 40/76 (52%), Gaps = 4/76 (5%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363
N++LD + + KI+DFG+ + G + A GT Y+APE + + D + G
Sbjct: 279 NLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 336
Query: 364 VVLLEIISGKKSSGFY 379
VV+ E++ G+ FY
Sbjct: 337 VVMYEMMCGR--LPFY 350
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 21/68 (30%), Positives = 30/68 (44%), Gaps = 6/68 (8%)
Query: 303 SNVLL-DHEMNP---KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSD 358
SN+L D NP +I DFG A+ T T ++APE + D
Sbjct: 145 SNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAACD 202
Query: 359 VFSFGVVL 366
++S GV+L
Sbjct: 203 IWSLGVLL 210
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 17/67 (25%), Positives = 31/67 (46%), Gaps = 7/67 (10%)
Query: 304 NVLLDHEMNP----KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
N++L + P K+ DFG+A + GT ++APE +++D+
Sbjct: 145 NIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 360 FSFGVVL 366
+S GV+
Sbjct: 202 WSIGVIT 208
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 15/78 (19%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-------YAMEGIFSV 355
N+L++ K+ DFG+AR F G ++ VV T Y AP+ Y S
Sbjct: 137 QNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLWYRAPDVLMGSRTY------ST 188
Query: 356 KSDVFSFGVVLLEIISGK 373
D++S G +L E+I+GK
Sbjct: 189 SIDIWSCGCILAEMITGK 206
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 20/67 (29%), Positives = 30/67 (44%), Gaps = 5/67 (7%)
Query: 303 SNVLL---DHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
N+L + + KI DFG AR+ + T T Y APE + + D+
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQNGYDESCDL 192
Query: 360 FSFGVVL 366
+S GV+L
Sbjct: 193 WSLGVIL 199
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 26/78 (33%), Positives = 42/78 (53%), Gaps = 15/78 (19%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-------YAMEGIFSV 355
+N+LLD K++DFG+A+ F G+ + A T++VV T Y APE Y V
Sbjct: 141 NNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRWYRAPELLFGARMY------GV 192
Query: 356 KSDVFSFGVVLLEIISGK 373
D+++ G +L E++
Sbjct: 193 GVDMWAVGCILAELLLRV 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 17/53 (32%), Positives = 27/53 (50%), Gaps = 3/53 (5%)
Query: 314 KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVL 366
KI+DFG+++I V GT GY APE + + D++S G++
Sbjct: 191 KIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 20/78 (25%), Positives = 36/78 (46%), Gaps = 15/78 (19%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-------YAMEGIFSV 355
N+L++ K++DFG+AR ++ N VV T Y P+ Y S
Sbjct: 129 QNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPPDILLGSTDY------ST 180
Query: 356 KSDVFSFGVVLLEIISGK 373
+ D++ G + E+ +G+
Sbjct: 181 QIDMWGVGCIFYEMATGR 198
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 18/67 (26%), Positives = 30/67 (44%), Gaps = 7/67 (10%)
Query: 304 NVLLDHEMNP----KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
N++L P KI DFG+A + GT ++APE +++D+
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADM 200
Query: 360 FSFGVVL 366
+S GV+
Sbjct: 201 WSIGVIT 207
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 19/76 (25%), Positives = 33/76 (43%), Gaps = 8/76 (10%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-------YAMEGIFSVK 356
N+LLD + +++DFG + + VGT Y++PE G + +
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRAD-GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE 250
Query: 357 SDVFSFGVVLLEIISG 372
D ++ GV E+ G
Sbjct: 251 CDWWALGVFAYEMFYG 266
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 5e-06
Identities = 17/67 (25%), Positives = 31/67 (46%), Gaps = 7/67 (10%)
Query: 304 NVLLDHEMNP----KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
N++L + P K+ DFG+A + GT ++APE +++D+
Sbjct: 138 NIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADM 194
Query: 360 FSFGVVL 366
+S GV+
Sbjct: 195 WSIGVIT 201
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 47.1 bits (113), Expect = 5e-06
Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 15/78 (19%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-------YAMEGIFSV 355
N+L++ E KI+DFG+AR F G T+ +V T Y AP+ Y S
Sbjct: 129 QNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPDVLMGSKKY------ST 180
Query: 356 KSDVFSFGVVLLEIISGK 373
D++S G + E+++G
Sbjct: 181 TIDIWSVGCIFAEMVNGT 198
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 5e-06
Identities = 25/76 (32%), Positives = 44/76 (57%), Gaps = 4/76 (5%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363
N+LLD E + K++DFG+++ ++ +A + GT YMAPE + +D +SFG
Sbjct: 156 NILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGHTQSADWWSFG 213
Query: 364 VVLLEIISGKKSSGFY 379
V++ E+++G F
Sbjct: 214 VLMFEMLTGT--LPFQ 227
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 19/74 (25%), Positives = 37/74 (50%), Gaps = 6/74 (8%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-----YAMEGIFSVKSD 358
N+L+D + +++DFG + ++ VGT Y++PE +G + + D
Sbjct: 205 NILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECD 263
Query: 359 VFSFGVVLLEIISG 372
+S GV + E++ G
Sbjct: 264 WWSLGVCMYEMLYG 277
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 5e-06
Identities = 17/67 (25%), Positives = 31/67 (46%), Gaps = 7/67 (10%)
Query: 304 NVLLDHEMNP----KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
N++L + P K+ DFG+A + GT ++APE +++D+
Sbjct: 145 NIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 360 FSFGVVL 366
+S GV+
Sbjct: 202 WSIGVIT 208
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 24/76 (31%), Positives = 39/76 (51%), Gaps = 14/76 (18%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFS------VKS 357
N+LLD +N KI+DFG++ I T+ G+ Y APE + + +
Sbjct: 138 NLLLDDNLNVKIADFGLSNIMTDGN-FLKTS--CGSPNYAAPE-----VINGKLYAGPEV 189
Query: 358 DVFSFGVVLLEIISGK 373
DV+S G+VL ++ G+
Sbjct: 190 DVWSCGIVLYVMLVGR 205
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 6e-06
Identities = 21/76 (27%), Positives = 41/76 (53%), Gaps = 4/76 (5%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363
N++L+H+ + K++DFG+ + + + +T GT YMAPE M + D +S G
Sbjct: 151 NIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMRSGHNRAVDWWSLG 208
Query: 364 VVLLEIISGKKSSGFY 379
++ ++++G F
Sbjct: 209 ALMYDMLTGA--PPFT 222
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 7e-06
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 18/78 (23%)
Query: 304 NVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRVVGTYGYMAPE------YAMEGIFSV 355
NVLLD E + K++D+GM + + G+ T+ GT Y+APE Y FSV
Sbjct: 140 NVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYIAPEILRGEDYG----FSV 191
Query: 356 KSDVFSFGVVLLEIISGK 373
D ++ GV++ E+++G+
Sbjct: 192 --DWWALGVLMFEMMAGR 207
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 7e-06
Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 4/77 (5%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363
NVLLDHE + K++DFGM + N T GT Y+APE E ++ D ++ G
Sbjct: 154 NVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEILQEMLYGPAVDWWAMG 211
Query: 364 VVLLEIISGKKSSGFYH 380
V+L E++ G + F
Sbjct: 212 VLLYEMLCGH--APFEA 226
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 14/65 (21%), Positives = 27/65 (41%), Gaps = 5/65 (7%)
Query: 304 NVLLDHEMNP--KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
N++ + + KI DFG+A ++ T + APE +D+++
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWA 235
Query: 362 FGVVL 366
GV+
Sbjct: 236 IGVLG 240
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 7e-06
Identities = 25/76 (32%), Positives = 38/76 (50%), Gaps = 14/76 (18%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFS------VKS 357
NVLLD MN KI+DFG++ + + T G+ Y APE + S +
Sbjct: 141 NVLLDAHMNAKIADFGLSNMMSDGE-FLRT--SCGSPNYAAPE-----VISGRLYAGPEV 192
Query: 358 DVFSFGVVLLEIISGK 373
D++S GV+L ++ G
Sbjct: 193 DIWSCGVILYALLCGT 208
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 8e-06
Identities = 24/78 (30%), Positives = 39/78 (50%), Gaps = 8/78 (10%)
Query: 304 NVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
N++LD + + KI+DFG+ + I G GT Y+APE + + D +
Sbjct: 135 NLMLDKDGHIKITDFGLCKEGISDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWG 190
Query: 362 FGVVLLEIISGKKSSGFY 379
GVV+ E++ G+ FY
Sbjct: 191 LGVVMYEMMCGR--LPFY 206
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 22/77 (28%), Positives = 35/77 (45%), Gaps = 13/77 (16%)
Query: 303 SNVLLDHEMNP-KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKS---- 357
N+L++ + N K+ DFG A+ SE + + + Y APE +
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPEL----MLGATEYTPS 222
Query: 358 -DVFSFGVVLLEIISGK 373
D++S G V E+I GK
Sbjct: 223 IDLWSIGCVFGELILGK 239
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 19/65 (29%), Positives = 30/65 (46%), Gaps = 5/65 (7%)
Query: 304 NVLLDHEMNP--KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
N+L + KI DFG+AR + + GT ++APE S +D++S
Sbjct: 217 NILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWS 273
Query: 362 FGVVL 366
GV+
Sbjct: 274 VGVIA 278
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 23/82 (28%), Positives = 40/82 (48%), Gaps = 13/82 (15%)
Query: 304 NVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRVVGTYGYMAPEYAMEG----IFSVKS 357
N+LLD + ++DFG+++ + + GT YMAP+ G +V
Sbjct: 189 NILLDSNGHVVLTDFGLSKEFVADETER---AYDFCGTIEYMAPDIVRGGDSGHDKAV-- 243
Query: 358 DVFSFGVVLLEIISGKKSSGFY 379
D +S GV++ E+++G S F
Sbjct: 244 DWWSLGVLMYELLTGA--SPFT 263
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 16/65 (24%), Positives = 27/65 (41%), Gaps = 5/65 (7%)
Query: 304 NVLLDHEMNP--KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
N++ + KI +FG AR N + Y APE + S +D++S
Sbjct: 132 NIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWS 188
Query: 362 FGVVL 366
G ++
Sbjct: 189 LGTLV 193
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 29/78 (37%), Positives = 46/78 (58%), Gaps = 8/78 (10%)
Query: 304 NVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
N+LLD + + KI+DFGM + + G + TN GT Y+APE + ++ D +S
Sbjct: 148 NILLDKDGHIKIADFGMCKENMLGDAK----TNTFCGTPDYIAPEILLGQKYNHSVDWWS 203
Query: 362 FGVVLLEIISGKKSSGFY 379
FGV+L E++ G+ S F+
Sbjct: 204 FGVLLYEMLIGQ--SPFH 219
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 27/72 (37%), Positives = 41/72 (56%), Gaps = 6/72 (8%)
Query: 304 NVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
NV+LD E + KI+DFGM + I+ G T GT Y+APE + D ++
Sbjct: 151 NVMLDSEGHIKIADFGMCKENIWDGVT----TKTFCGTPDYIAPEIIAYQPYGKSVDWWA 206
Query: 362 FGVVLLEIISGK 373
FGV+L E+++G+
Sbjct: 207 FGVLLYEMLAGQ 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 23/72 (31%), Positives = 41/72 (56%), Gaps = 6/72 (8%)
Query: 304 NVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
NVLLD E + K++D+GM + + G+ T+ GT Y+APE + D ++
Sbjct: 183 NVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYIAPEILRGEDYGFSVDWWA 238
Query: 362 FGVVLLEIISGK 373
GV++ E+++G+
Sbjct: 239 LGVLMFEMMAGR 250
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 22/78 (28%), Positives = 33/78 (42%), Gaps = 15/78 (19%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-------YAMEGIFSV 355
N+L+ K+ DFG AR E + V T Y APE Y +V
Sbjct: 153 ENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWYRAPELLVGDVKYGK----AV 206
Query: 356 KSDVFSFGVVLLEIISGK 373
DV++ G ++ E+ G+
Sbjct: 207 --DVWAIGCLVTEMFMGE 222
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 28/78 (35%), Positives = 43/78 (55%), Gaps = 8/78 (10%)
Query: 304 NVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
NV+LD E + KI+DFGM + I+ G T GT Y+APE + D ++
Sbjct: 472 NVMLDSEGHIKIADFGMCKENIWDGVT----TKTFCGTPDYIAPEIIAYQPYGKSVDWWA 527
Query: 362 FGVVLLEIISGKKSSGFY 379
FGV+L E+++G+ + F
Sbjct: 528 FGVLLYEMLAGQ--APFE 543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 25/76 (32%), Positives = 39/76 (51%), Gaps = 14/76 (18%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFS------VKS 357
NVLLD MN KI+DFG++ + + T+ G+ Y APE + S +
Sbjct: 146 NVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPE-----VISGRLYAGPEV 197
Query: 358 DVFSFGVVLLEIISGK 373
D++S GV+L ++ G
Sbjct: 198 DIWSSGVILYALLCGT 213
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 26/145 (17%), Positives = 44/145 (30%), Gaps = 45/145 (31%)
Query: 304 NVLLDHE-MNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY-AMEGIFSVKSDVFS 361
N+L+D K+ DFG + GT Y PE+ + V+S
Sbjct: 179 NILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWS 234
Query: 362 FGVVLLEIISG--------KKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCD 413
G++L +++ G + G + S +
Sbjct: 235 LGILLYDMVCGDIPFEHDEEIIRGQVFF---RQRV----------------------SSE 269
Query: 414 QAELLKYIHIGLLCVQEDPMDRPTM 438
L++ L + P DRPT
Sbjct: 270 CQHLIR----WCLAL--RPSDRPTF 288
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 26/77 (33%), Positives = 38/77 (49%), Gaps = 13/77 (16%)
Query: 303 SNVLLDHEMNP-KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIF-----SVK 356
N+LLD + K+ DFG A+ + E N + + Y Y APE IF +
Sbjct: 185 QNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRAPEL----IFGATDYTSS 237
Query: 357 SDVFSFGVVLLEIISGK 373
DV+S G VL E++ G+
Sbjct: 238 IDVWSAGCVLAELLLGQ 254
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 23/77 (29%), Positives = 36/77 (46%), Gaps = 13/77 (16%)
Query: 303 SNVLLDHEMNP-KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKS---- 357
NVL++ K+ DFG A+ + SE N + Y Y APE IF +
Sbjct: 160 HNVLVNEADGTLKLCDFGSAKKL--SPSEPNVAYICSRY-YRAPEL----IFGNQHYTTA 212
Query: 358 -DVFSFGVVLLEIISGK 373
D++S G + E++ G+
Sbjct: 213 VDIWSVGCIFAEMMLGE 229
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 26/145 (17%), Positives = 48/145 (33%), Gaps = 45/145 (31%)
Query: 304 NVLLDHEMNP-KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY-AMEGIFSVKSDVFS 361
N+L+D K+ DFG + GT Y PE+ + ++ + V+S
Sbjct: 169 NILIDLRRGCAKLIDFGSGALLHD--EPYTD--FDGTRVYSPPEWISRHQYHALPATVWS 224
Query: 362 FGVVLLEIISG--------KKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCD 413
G++L +++ G + H P+ + S D
Sbjct: 225 LGILLYDMVCGDIPFERDQEILEAELHF---PAHV----------------------SPD 259
Query: 414 QAELLKYIHIGLLCVQEDPMDRPTM 438
L++ L P RP++
Sbjct: 260 CCALIR----RCLAP--KPSSRPSL 278
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 23/78 (29%), Positives = 38/78 (48%), Gaps = 8/78 (10%)
Query: 304 NVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
N+LLD + + ++DFG+ + I + T+ GT Y+APE + + D +
Sbjct: 169 NILLDSQGHIVLTDFGLCKENIEHNST----TSTFCGTPEYLAPEVLHKQPYDRTVDWWC 224
Query: 362 FGVVLLEIISGKKSSGFY 379
G VL E++ G FY
Sbjct: 225 LGAVLYEMLYGL--PPFY 240
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 22/83 (26%), Positives = 40/83 (48%), Gaps = 18/83 (21%)
Query: 303 SNVLLDHEMNP----KISDFGMARIFGG-NQSEANTNRVVGTYGYMAPE-------YAME 350
+N+L+ E KI+D G AR+F + A+ + VV T+ Y APE Y
Sbjct: 157 ANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHY--- 213
Query: 351 GIFSVKSDVFSFGVVLLEIISGK 373
+ D+++ G + E+++ +
Sbjct: 214 ---TKAIDIWAIGCIFAELLTSE 233
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 13/77 (16%)
Query: 303 SNVLLDHEMNP-KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIF-----SVK 356
N+LLD K+ DFG A+I E N + + Y Y APE IF +
Sbjct: 170 QNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY-YRAPEL----IFGATNYTTN 222
Query: 357 SDVFSFGVVLLEIISGK 373
D++S G V+ E++ G+
Sbjct: 223 IDIWSTGCVMAELMQGQ 239
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 9/77 (11%), Positives = 19/77 (24%)
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
+ D + D G + T G+ E ++ +
Sbjct: 206 GNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ 265
Query: 357 SDVFSFGVVLLEIISGK 373
D F + ++ G
Sbjct: 266 IDYFGVAATVYCMLFGT 282
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 23/71 (32%), Positives = 32/71 (45%), Gaps = 16/71 (22%)
Query: 304 NVLLDHE--MNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFS------V 355
N LLD KI DFG ++ + S+ + VGT Y+APE +
Sbjct: 146 NTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS--TVGTPAYIAPE-----VLLRQEYDGK 197
Query: 356 KSDVFSFGVVL 366
+DV+S GV L
Sbjct: 198 IADVWSCGVTL 208
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 22/73 (30%), Positives = 35/73 (47%), Gaps = 5/73 (6%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE----YAMEGIFSVKSDV 359
N+LLD + K++DFG + VGT Y++PE +G + + D
Sbjct: 198 NMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 256
Query: 360 FSFGVVLLEIISG 372
+S GV L E++ G
Sbjct: 257 WSVGVFLYEMLVG 269
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 3e-05
Identities = 24/78 (30%), Positives = 35/78 (44%), Gaps = 15/78 (19%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-------YAMEGIFSV 355
N+L+ K+ DFG AR+ G S+ + V T Y +PE Y V
Sbjct: 131 ENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWYRSPELLVGDTQYGP----PV 184
Query: 356 KSDVFSFGVVLLEIISGK 373
DV++ G V E++SG
Sbjct: 185 --DVWAIGCVFAELLSGV 200
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 19/66 (28%), Positives = 32/66 (48%), Gaps = 6/66 (9%)
Query: 304 NVLL---DHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
N+LL + KI DFGM+R G ++GT Y+APE + +D++
Sbjct: 161 NILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMW 217
Query: 361 SFGVVL 366
+ G++
Sbjct: 218 NIGIIA 223
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 36/169 (21%), Positives = 55/169 (32%), Gaps = 47/169 (27%)
Query: 304 NVLLDHEMNP---KISDFGMARIFGGNQSEANTNR-----VVGTYGYMAPE-----YAME 350
N+L +H KI DF + N + + G+ YMAPE
Sbjct: 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 351 GIFSVKSDVFSFGVV---LLEIISGKKSSG---FYHLEHGPSLLAYIWKLWCEGHAAELM 404
I+ + D++S GV+ LL SG F S + C L
Sbjct: 201 SIYDKRCDLWSLGVILYILL--------SGYPPFVG--RCGSDCGWDRGEACPACQNMLF 250
Query: 405 DSVVKQ------------SCDQAELLKYIHIGLLCVQEDPMDRPTMSSV 441
+S+ + SC +L+ LL D R + + V
Sbjct: 251 ESIQEGKYEFPDKDWAHISCAAKDLIS----KLLVR--DAKQRLSAAQV 293
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 16/65 (24%), Positives = 28/65 (43%), Gaps = 5/65 (7%)
Query: 304 NVLLDHEMNP--KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
N++ + + K+ DFG+ Q + GT + APE A +D++S
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWS 341
Query: 362 FGVVL 366
GV+
Sbjct: 342 VGVLS 346
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 17/66 (25%), Positives = 29/66 (43%), Gaps = 7/66 (10%)
Query: 304 NVLL---DHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVF 360
N+L + + K++DFG A+ N T Y+APE + D++
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMW 213
Query: 361 SFGVVL 366
S GV++
Sbjct: 214 SLGVIM 219
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 3/71 (4%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSF 362
SN+++ + KI DFG+AR G S T VV T Y APE + + D++S
Sbjct: 156 SNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSV 212
Query: 363 GVVLLEIISGK 373
G ++ E+I G
Sbjct: 213 GCIMGEMIKGG 223
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 20/82 (24%), Positives = 36/82 (43%), Gaps = 21/82 (25%)
Query: 303 SNVLLDHE-MNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE---------YAMEGI 352
NV++DHE ++ D+G+A + + RV Y + PE Y++
Sbjct: 159 HNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FKGPELLVDYQMYDYSL--- 212
Query: 353 FSVKSDVFSFGVVLLEIISGKK 374
D++S G +L +I K+
Sbjct: 213 -----DMWSLGCMLASMIFRKE 229
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 19/69 (27%), Positives = 37/69 (53%), Gaps = 5/69 (7%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363
N+L+D + +++DFG A+ G T + GT +APE + ++ D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALG 225
Query: 364 VVLLEIISG 372
V++ E+ +G
Sbjct: 226 VLIYEMAAG 234
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 24/71 (33%), Positives = 37/71 (52%), Gaps = 3/71 (4%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSF 362
SN+++ + KI DFG+AR G S T VV T Y APE + + D++S
Sbjct: 193 SNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSV 249
Query: 363 GVVLLEIISGK 373
G ++ E++ K
Sbjct: 250 GCIMGEMVRHK 260
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 9e-05
Identities = 25/75 (33%), Positives = 39/75 (52%), Gaps = 17/75 (22%)
Query: 304 NVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE------YAMEGIFSVKS 357
N+LLD + KI+DFG A+ T + GT Y+APE Y S+
Sbjct: 136 NILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNK----SI-- 184
Query: 358 DVFSFGVVLLEIISG 372
D +SFG+++ E+++G
Sbjct: 185 DWWSFGILIYEMLAG 199
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 13/65 (20%), Positives = 29/65 (44%), Gaps = 5/65 (7%)
Query: 309 HEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLE 368
++ KI+D G A + +E + T Y + E + ++ +D++S + E
Sbjct: 231 EKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFE 285
Query: 369 IISGK 373
+ +G
Sbjct: 286 LATGD 290
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 15/53 (28%), Positives = 25/53 (47%), Gaps = 3/53 (5%)
Query: 314 KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVL 366
K++DFG A+ + S T Y+APE + D++S GV++
Sbjct: 204 KLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 22/83 (26%), Positives = 32/83 (38%), Gaps = 20/83 (24%)
Query: 303 SNVLLDHEMNP-----KISDFGMARIFGGNQSEANTNRVVGTYGYMAPE-------YAME 350
N+LL KI DFG+AR F G T+ ++ T Y PE Y
Sbjct: 161 QNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII-TLWYRPPEILLGSRHY--- 215
Query: 351 GIFSVKSDVFSFGVVLLEIISGK 373
S D++S + E++
Sbjct: 216 ---STSVDIWSIACIWAEMLMKT 235
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 24/74 (32%), Positives = 39/74 (52%), Gaps = 4/74 (5%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEAN--TNRVVGTYGYMAPEYAME-GIFSVKSDV 359
SN+LL+ + KI DFG+AR+ + T V T Y APE + ++ D+
Sbjct: 157 SNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDI 215
Query: 360 FSFGVVLLEIISGK 373
+S G +L E++S +
Sbjct: 216 WSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 20/72 (27%), Positives = 37/72 (51%), Gaps = 6/72 (8%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME-GIFSVKSDVFS 361
SN+ ++ + KI DFG+AR + V T Y APE + ++ D++S
Sbjct: 161 SNLAVNEDCELKILDFGLARHTADEMTGY-----VATRWYRAPEIMLNWMHYNQTVDIWS 215
Query: 362 FGVVLLEIISGK 373
G ++ E+++G+
Sbjct: 216 VGCIMAELLTGR 227
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 20/72 (27%), Positives = 36/72 (50%), Gaps = 6/72 (8%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME-GIFSVKSDVFS 361
N+ ++ + KI DFG+AR + V T Y APE + ++ D++S
Sbjct: 155 GNLAVNEDCELKILDFGLARHADAEMTG-----YVVTRWYRAPEVILSWMHYNQTVDIWS 209
Query: 362 FGVVLLEIISGK 373
G ++ E+++GK
Sbjct: 210 VGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 21/72 (29%), Positives = 36/72 (50%), Gaps = 6/72 (8%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME-GIFSVKSDVFS 361
N+ ++ + KI DFG+AR + V T Y APE + ++ D++S
Sbjct: 157 GNLAVNEDCELKILDFGLARQADSEMTGY-----VVTRWYRAPEVILNWMRYTQTVDIWS 211
Query: 362 FGVVLLEIISGK 373
G ++ E+I+GK
Sbjct: 212 VGCIMAEMITGK 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 22/72 (30%), Positives = 33/72 (45%), Gaps = 4/72 (5%)
Query: 303 SNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME-GIFSVKSDVFS 361
N+LL + I DF +AR T+ V Y APE M+ F+ D++S
Sbjct: 163 GNILLADNNDITICDFNLAR--EDTADANKTHYVT-HRWYRAPELVMQFKGFTKLVDMWS 219
Query: 362 FGVVLLEIISGK 373
G V+ E+ + K
Sbjct: 220 AGCVMAEMFNRK 231
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 491 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.97 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.97 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.97 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.96 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.96 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.96 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.96 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.96 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.95 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.95 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.95 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.95 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.95 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.94 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.94 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.94 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.94 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.94 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.93 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.93 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.92 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.92 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.92 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.92 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.91 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.91 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.91 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.91 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.91 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.91 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.91 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.91 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.91 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.9 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.9 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.9 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.9 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.9 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.9 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.9 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.9 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.9 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.9 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.9 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.9 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.9 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.9 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.9 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.9 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.89 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.89 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.89 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.89 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.89 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.89 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.89 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.89 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.89 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.89 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.89 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.89 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.89 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.89 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.89 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.89 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.89 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.89 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.89 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.89 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.89 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.89 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.89 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.89 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.89 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.89 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.88 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.88 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.88 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.88 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.88 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.88 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.88 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.88 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.88 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.88 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.88 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.88 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.88 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.88 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.88 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.88 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.88 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.88 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.88 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.88 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.88 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.88 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.88 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.88 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.88 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.88 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.88 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.88 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.88 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.88 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.88 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.88 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.88 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.88 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.88 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.88 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.88 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.88 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.88 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.88 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.88 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.88 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.88 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.87 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.87 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.87 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.87 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.87 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.87 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.87 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.87 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.87 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.87 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.87 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.87 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.87 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.87 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.87 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.87 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.87 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.87 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.87 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.87 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.87 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.87 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.87 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.87 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.87 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.87 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.87 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.87 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.87 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.87 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.87 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.87 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.87 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.87 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.87 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.87 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.87 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.87 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.87 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.87 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.87 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.87 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.87 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.87 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.86 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.86 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.86 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.86 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.86 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.86 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.86 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.86 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.86 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.86 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.86 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.86 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.86 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.86 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.86 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.86 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.86 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.86 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.86 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.86 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.86 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.86 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.86 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.86 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.86 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.86 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.86 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.86 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.86 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.86 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.86 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.86 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.86 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.86 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.86 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.86 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.86 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.86 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.86 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.86 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.86 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.86 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.86 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.85 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.85 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.85 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.85 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.85 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.85 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.85 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.85 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.85 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.85 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.85 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.85 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.85 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.85 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.85 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.85 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.85 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.85 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.85 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.85 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.85 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.84 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.84 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.84 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.84 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.84 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.84 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.84 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.84 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.84 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.84 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.84 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.84 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.84 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.84 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.84 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.83 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.83 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.83 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.83 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.83 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.83 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.81 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.81 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.79 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.76 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.72 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.7 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.52 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.17 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 98.7 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 98.11 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 97.1 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 94.62 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 94.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 94.27 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 93.77 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 89.31 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 86.45 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 86.15 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 82.98 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 82.46 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 80.86 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 80.42 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 80.31 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 80.31 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=268.47 Aligned_cols=191 Identities=19% Similarity=0.280 Sum_probs=130.3
Q ss_pred eeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 245 YELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
|.++.|..++++.... ...........++.+++.++.|||..+++ ||||||+||||++++++||+|||++
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~Ii-------HRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNII-------HRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCB-------CSCCCSSSEEEETTEEEEECCCSSC
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------CCccCHHHEEECCCCcEEEeeccCc
Confidence 4556666665543322 12334567788999999999999987666 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhh---CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAME---GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
+...............||+.|||||++.+ ++|+.++|||||||++|||++|+.||.... ..... ......+
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~---~~~~~---~~~~~~~ 253 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN---NRDQI---IFMVGRG 253 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC---CHHHH---HHHHHTT
T ss_pred eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC---hHHHH---HHHHhcC
Confidence 87654333333445789999999999964 468999999999999999999999975321 11111 1112221
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCC
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLP 453 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 453 (491)
... +.+. ..+......+.+|+.+||+.||++|||+.||++.|+.....+|
T Consensus 254 ~~~----p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 254 YAS----PDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp CCC----CCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred CCC----CCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 111 1100 1112233457789999999999999999999998876544443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=269.29 Aligned_cols=160 Identities=25% Similarity=0.353 Sum_probs=125.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.|||...++ ||||||+||||++++++||+|||+++...............||+.||||
T Consensus 144 ~~~~~~i~~qia~gl~yLH~~~ii-------HRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAP 216 (308)
T 4gt4_A 144 PPDFVHLVAQIAAGMEYLSSHHVV-------HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP 216 (308)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCC-------CCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCH
Confidence 345677899999999999987766 9999999999999999999999999876544433344557899999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.++.++.++|||||||++|||+| |+.||.... ..++. .....+.... .+......+.+|+
T Consensus 217 E~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~---~~~~~----~~i~~~~~~~---------~p~~~~~~~~~li 280 (308)
T 4gt4_A 217 EAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVV----EMIRNRQVLP---------CPDDCPAWVYALM 280 (308)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC---HHHHH----HHHHTTCCCC---------CCTTCCHHHHHHH
T ss_pred HHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---HHHHH----HHHHcCCCCC---------CcccchHHHHHHH
Confidence 99999999999999999999999998 899975322 22222 2222222211 1222334577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++||||.||+++|+..
T Consensus 281 ~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 281 IECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHcCCChhHCcCHHHHHHHHHhc
Confidence 999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=268.39 Aligned_cols=183 Identities=22% Similarity=0.321 Sum_probs=137.1
Q ss_pred eeeecccccCCCCcccc---------------CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeecccccccccccc
Q 011196 244 RYELYRFLVDTPTVTVT---------------APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLD 308 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~ 308 (491)
.|.++.|..++++.... ....++.....++.+++.++.|||...++ ||||||+|||++
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ii-------HRDlKp~NILl~ 162 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFV-------HRDLATRNCLVG 162 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc-------cCccCHhhEEEC
Confidence 45666776666543221 11234566788999999999999987666 999999999999
Q ss_pred CCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccH
Q 011196 309 HEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSL 387 (491)
Q Consensus 309 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~ 387 (491)
.++.+||+|||+++...............||+.|||||++.++.|+.++|||||||++|||+| |+.||... ...++
T Consensus 163 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~---~~~~~ 239 (299)
T 4asz_A 163 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL---SNNEV 239 (299)
T ss_dssp GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS---CHHHH
T ss_pred CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---CHHHH
Confidence 999999999999987654443334445689999999999999999999999999999999998 89997532 12222
Q ss_pred HHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 388 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 388 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
... ...+.... .+.....++.+|+.+||+.||++|||++||+++|++..
T Consensus 240 ~~~----i~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 240 IEC----ITQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHH----HHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH----HHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 222 22222111 11222345778999999999999999999999998753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-32 Score=269.16 Aligned_cols=162 Identities=27% Similarity=0.356 Sum_probs=117.4
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.....+.++.+++.++.|||...++ ||||||+||||++++.+||+|||+++...............||+.|||
T Consensus 156 ~~~~~~~i~~qia~gl~yLH~~~ii-------HRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymA 228 (329)
T 4aoj_A 156 GLGQLLAVASQVAAGMVYLAGLHFV-------HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 228 (329)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCC
T ss_pred CHHHHHHHHHHHHHHHHHHhcCCee-------cccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccC
Confidence 3556778999999999999987666 999999999999999999999999987654443334445679999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..++.++|||||||++|||+| |+.||... ...+....+ ..+...+ .+.....++.+|
T Consensus 229 PE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~---~~~~~~~~i----~~g~~~~---------~p~~~~~~~~~l 292 (329)
T 4aoj_A 229 PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL---SNTEAIDCI----TQGRELE---------RPRACPPEVYAI 292 (329)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS---CHHHHHHHH----HHTCCCC---------CCTTCCHHHHHH
T ss_pred hhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC---CHHHHHHHH----HcCCCCC---------CcccccHHHHHH
Confidence 999999999999999999999999999 89997532 122222222 2221111 112223457789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
+.+||+.||++|||+.||+++|+...
T Consensus 293 i~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 293 MRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 99999999999999999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-31 Score=267.86 Aligned_cols=161 Identities=25% Similarity=0.344 Sum_probs=126.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.|||...++ ||||||+|||+++++.+||+|||+++...............||+.||||
T Consensus 184 ~~~~~~~~~qia~gl~yLH~~~ii-------HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAP 256 (353)
T 4ase_A 184 LEHLICYSFQVAKGMEFLASRKCI-------HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 256 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred HHHHHHHHHHHHHHHHhHhhCCee-------cCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCH
Confidence 445667888999999999987766 9999999999999999999999999977655544445567899999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..|+.++|||||||++|||+| |+.||..... .. .+......+..... +.....++.+++
T Consensus 257 E~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~---~~---~~~~~i~~g~~~~~---------p~~~~~~~~~li 321 (353)
T 4ase_A 257 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---DE---EFCRRLKEGTRMRA---------PDYTTPEMYQTM 321 (353)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---SH---HHHHHHHHTCCCCC---------CTTCCHHHHHHH
T ss_pred HHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH---HH---HHHHHHHcCCCCCC---------CccCCHHHHHHH
Confidence 99999999999999999999999998 8999753221 11 12222222221111 112234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++|||+.||+++|+..
T Consensus 322 ~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 322 LDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCcChhHCcCHHHHHHHHHHH
Confidence 999999999999999999998764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=255.06 Aligned_cols=201 Identities=17% Similarity=0.140 Sum_probs=136.7
Q ss_pred eeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhheeeEE-eEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLSTSFLW-CIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++++..... .+........++.+++.++.|||.....+ +..+++||||||+||||+.++++||+|||++
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 467788877666543321 23345567788889999999999763321 3456779999999999999999999999999
Q ss_pred eecCCCCcc--cccCceeecCCCChhhhhhhC------CCCcccceeehhHHHHHHHhCCCCCCCccCCCc--------c
Q 011196 322 RIFGGNQSE--ANTNRVVGTYGYMAPEYAMEG------IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHG--------P 385 (491)
Q Consensus 322 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~--------~ 385 (491)
+........ .......||+.|||||++.+. .++.++|||||||++|||++|.+|+........ .
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 876543322 123346899999999999754 467899999999999999999887653322111 1
Q ss_pred cHHHHHHHHhhcCCccccccchhcC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 386 SLLAYIWKLWCEGHAAELMDSVVKQ-SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
............... ++.+.. ..+.+....+.+|+.+||+.||++||||.||++.|+..
T Consensus 236 ~~~~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 112222222222211 111111 11234566788999999999999999999999999764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=257.65 Aligned_cols=187 Identities=18% Similarity=0.151 Sum_probs=133.2
Q ss_pred eeeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC-CceEeccC
Q 011196 243 IRYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM-NPKISDFG 319 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~-~~kl~DfG 319 (491)
..|.++.|..++++..... ..........++.+++.++.|||..+++ ||||||+||||+.++ .+||+|||
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~Ii-------HRDlKp~NILl~~~g~~vKl~DFG 196 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL-------HGDVKADNVLLSSDGSRAALCDFG 196 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEE-------CSCCCGGGEEECTTSCCEEECCCT
T ss_pred EEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCce-------ecccCHHHEEEeCCCCEEEEeeCC
Confidence 3466677776665533321 2234566778899999999999998777 999999999999987 59999999
Q ss_pred cceecCCCCcc---cccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh
Q 011196 320 MARIFGGNQSE---ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC 396 (491)
Q Consensus 320 la~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 396 (491)
+++.+...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ...+...+...
T Consensus 197 la~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~i~~~-- 271 (336)
T 4g3f_A 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF---RGPLCLKIASE-- 271 (336)
T ss_dssp TCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC---CSCCHHHHHHS--
T ss_pred CCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHHcC--
Confidence 99976543221 12234679999999999999999999999999999999999999985432 22233322211
Q ss_pred cCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 011196 397 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIV 450 (491)
Q Consensus 397 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 450 (491)
.....+ .+......+.+++.+||+.||++|||+.|+++.|.....
T Consensus 272 ~~~~~~---------~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 272 PPPIRE---------IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp CCGGGG---------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCchh---------cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 000011 111223456778999999999999999999998876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=245.54 Aligned_cols=176 Identities=17% Similarity=0.221 Sum_probs=124.5
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC-CCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH-EMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~-~~~~kl~DfGl 320 (491)
.|.++.|..++++..... ..........++.+++.++.|||..+ .+++||||||+||||+. ++.+||+|||+
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-----~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-----PPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-----SCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCEEecccChhheeEECCCCCEEEEeCcC
Confidence 366777777665533321 22334566778889999999999865 12349999999999984 78999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
++..... .....+||+.|||||++. ++|+.++|||||||++|||++|+.||.... . ...+......+..
T Consensus 179 a~~~~~~----~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~--~----~~~~~~~i~~~~~ 247 (290)
T 3fpq_A 179 ATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ--N----AAQIYRRVTSGVK 247 (290)
T ss_dssp GGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS--S----HHHHHHHHTTTCC
T ss_pred CEeCCCC----ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--c----HHHHHHHHHcCCC
Confidence 9864322 233468999999999885 569999999999999999999999974211 1 1222222322221
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
....+ ...+ .++.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~----~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 PASFD----KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CGGGG----GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCC----ccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 1122 24677899999999999999999886
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=250.30 Aligned_cols=178 Identities=17% Similarity=0.248 Sum_probs=129.3
Q ss_pred eeeeecccccCCCCcccc-CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 243 IRYELYRFLVDTPTVTVT-APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
..|.++.|..++.+.... ...........++.+++.++.|||..+++ ||||||+||||+.++.+||+|||++
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~Ii-------HRDlKp~NILl~~~g~vKl~DFGla 217 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI-------HRDIKSDSILLTHDGRVKLSDFGFC 217 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------cccCCHHHEEECCCCCEEEecCcCc
Confidence 345666666655433222 12234556777888999999999998877 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+.+..... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||... ........+ ......
T Consensus 218 ~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i----~~~~~~ 288 (346)
T 4fih_A 218 AQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMI----RDNLPP 288 (346)
T ss_dssp EECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHH----HHSSCC
T ss_pred eecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHH----HcCCCC
Confidence 87654332 234578999999999999999999999999999999999999997532 112222222 221111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+.. .......+.+|+.+||+.||++|||+.|+++
T Consensus 289 ~~~~-------~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 289 RLKN-------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CCSC-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCc-------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 0111235678999999999999999999876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-30 Score=251.53 Aligned_cols=175 Identities=17% Similarity=0.247 Sum_probs=130.3
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
-|.+..|..++++..... ..........++.+++.++.|||..+++ ||||||+|||++.++.+||+|||++
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~Ii-------HRDlKPeNILl~~~g~vKl~DFGla 179 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGII-------HRDLKPENILLNEDMHIQITDFGTA 179 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCc-------cCCCCHHHeEEcCCCCEEEEEcCCc
Confidence 455666666555433221 1233556677889999999999998887 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+.+............+||+.|||||++.+..|+.++||||+||++|||++|+.||... +...+...+ ..+..
T Consensus 180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i----~~~~~- 251 (311)
T 4aw0_A 180 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEGLIFAKI----IKLEY- 251 (311)
T ss_dssp EECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH----HHTCC-
T ss_pred eecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHH----HcCCC-
Confidence 9876544444455679999999999999999999999999999999999999997532 222222222 11111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVA 442 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl 442 (491)
++ .... ..++.+|+.+||+.||++|||++|++
T Consensus 252 ~~-----p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DF-----PEKF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CC-----CTTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CC-----Cccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11 1112 23467899999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-29 Score=252.52 Aligned_cols=176 Identities=17% Similarity=0.265 Sum_probs=129.7
Q ss_pred eeeeecccccCCCCccccC----CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEecc
Q 011196 243 IRYELYRFLVDTPTVTVTA----PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDF 318 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~Df 318 (491)
..|.+..|..++++..... ..........++.+++.++.|||..+++ ||||||+||||+.++.+||+||
T Consensus 97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~Ii-------HRDlKp~NILl~~~g~vKl~DF 169 (350)
T 4b9d_A 97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKIL-------HRDIKSQNIFLTKDGTVQLGDF 169 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCE-------ETTCCGGGEEECTTCCEEECST
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCee-------eccCCHHHEEECCCCCEEEccc
Confidence 3466777777666543321 1123455677899999999999998877 9999999999999999999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
|+++...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||... ....+.. .. ..+
T Consensus 170 Gla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~---~i-~~~ 240 (350)
T 4b9d_A 170 GIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNLVL---KI-ISG 240 (350)
T ss_dssp TEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHH---HH-HHT
T ss_pred ccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHH---HH-HcC
Confidence 9998754321 1223468999999999999999999999999999999999999998532 1122222 21 122
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
....+ ...+ ...+.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~-----~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 241 SFPPV-----SLHY----SYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCCC-----CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCC-----CccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 21111 1112 234678999999999999999999986
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=200.84 Aligned_cols=103 Identities=17% Similarity=0.381 Sum_probs=94.2
Q ss_pred cccccCCCCCCccCCCChHHHHHHHHHHHhhhhhcCCC-CccccccC-CCCCeEEEEEeccCCCChhhHHHHHHHHHHHH
Q 011196 36 EYQYKFCPRGTNNTASIIYIYNLSKLFNRKLHEEGGNS-LYRNASVG-DNPDKVYGLFLCRFDVSHQVCQNCIFDAIDIL 113 (491)
Q Consensus 36 ~~~~~~C~~~~~~~~~s~~~~nl~~ll~~l~~~~~~~~-~f~~~~~g-~~~~~vygl~~C~~d~~~~~C~~Cl~~a~~~~ 113 (491)
.++++.|++ ++|+++++|++||+.||+.|+++++.++ +|+++..| .++++||||+|||||+++++|..||+.|+.++
T Consensus 4 ~~v~~~Cn~-~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~ 82 (108)
T 3a2e_A 4 AFVSSACNT-QKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRI 82 (108)
T ss_dssp CEEEEEECS-SBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTH
T ss_pred ceeeeecCC-CccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHH
Confidence 688999976 7999999999999999999999886544 47777666 45699999999999999999999999999999
Q ss_pred HHhCCCCccEEEEccccEEEEccccc
Q 011196 114 VESCNGTKEATIWYDICMVCYSNKFF 139 (491)
Q Consensus 114 ~~~C~~~~~~~~~~~~C~~ry~~~~f 139 (491)
.++||+++||+||++.|+||||+++|
T Consensus 83 ~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 83 FSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHCCCCceEEEECCCEEEEEeCCcC
Confidence 99999999999999999999999998
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=250.88 Aligned_cols=179 Identities=16% Similarity=0.245 Sum_probs=130.4
Q ss_pred ceeeeecccccCCCCcccc-CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 242 SIRYELYRFLVDTPTVTVT-APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 242 ~lry~~~~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
...|.++.|..++.+.... ...........++.+++.++.|||..+++ ||||||+||||+.++.+||+|||+
T Consensus 221 ~~~~iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~Ii-------HRDiKp~NILl~~~g~vKl~DFGl 293 (423)
T 4fie_A 221 DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI-------HRDIKSDSILLTHDGRVKLSDFGF 293 (423)
T ss_dssp TEEEEEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSTTTEEECTTCCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCee-------cccCCHHHEEEcCCCCEEEecCcc
Confidence 3456677777665543322 12233556777888999999999998877 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
++.+..... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||... ........ ......
T Consensus 294 a~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~----i~~~~~ 364 (423)
T 4fie_A 294 CAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKM----IRDNLP 364 (423)
T ss_dssp CEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHH----HHHSCC
T ss_pred ceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHH----HHcCCC
Confidence 987654332 234578999999999999999999999999999999999999997521 11222222 211111
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
..+... ... ...+.+|+.+||+.||++|||+.|+++
T Consensus 365 ~~~~~~---~~~----s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 365 PRLKNL---HKV----SPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CCCSCT---TSS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccc---ccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111100 111 235678999999999999999999876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-29 Score=243.43 Aligned_cols=175 Identities=19% Similarity=0.229 Sum_probs=124.8
Q ss_pred eeeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 243 IRYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
..|.+..|..++++.... ...........++.+++.++.|+|..+++ ||||||+|||++.++.+||+|||+
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~Ii-------HRDlKp~NILl~~~g~vKl~DFGl 172 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII-------YRDLKPENILLDEEGHIKLTDFGL 172 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCC-------CSSCCGGGEEECTTSCEEEESSEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCc-------CCCCCHHHeEEcCCCCEEeccccc
Confidence 345666666665543322 12234556777888999999999998777 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
++....... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||... +...+...+. ....
T Consensus 173 a~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~----~~~~ 243 (304)
T 3ubd_A 173 SKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMIL----KAKL 243 (304)
T ss_dssp EEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH----HCCC
T ss_pred ceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc---CHHHHHHHHH----cCCC
Confidence 986543222 233478999999999999999999999999999999999999997532 2222222221 1111
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTM-----SSVAV 443 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~ 443 (491)
. .+......+.+|+.+||+.||++|||+ +|+++
T Consensus 244 ~----------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 G----------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp C----------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred C----------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 0 111122346789999999999999984 56654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-28 Score=237.82 Aligned_cols=152 Identities=19% Similarity=0.287 Sum_probs=108.4
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......+..+++.++.|+|..+++ ||||||+|||++.++++||+|||+++...... ......||+.|||
T Consensus 110 ~e~~~~~~~~qi~~al~ylH~~~Ii-------HRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~A 179 (275)
T 3hyh_A 110 SEQEARRFFQQIISAVEYCHRHKIV-------HRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAA 179 (275)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCTTTEEECTTCCEEECCSSCC------------------CTTSC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcc-------cccCChHHeEECCCCCEEEeecCCCeecCCCC---ccCCeeECcccCC
Confidence 3556778889999999999998777 99999999999999999999999998654322 2234689999999
Q ss_pred hhhhhhCCC-CcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIF-SVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~-s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..+ +.++||||+||++|||++|+.||... ....+. +....+... + .... ...+.+|
T Consensus 180 PE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~----~~i~~~~~~-~-----p~~~----s~~~~~l 242 (275)
T 3hyh_A 180 PEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLF----KNISNGVYT-L-----PKFL----SPGAAGL 242 (275)
T ss_dssp HHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHH----HHHHHTCCC-C-----CTTS----CHHHHHH
T ss_pred hhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHH----HHHHcCCCC-C-----CCCC----CHHHHHH
Confidence 999988776 57999999999999999999998531 111222 222222111 0 1112 2346779
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 011196 424 GLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~ 443 (491)
+.+||+.||++|||+.|+++
T Consensus 243 i~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 243 IKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHc
Confidence 99999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=233.43 Aligned_cols=176 Identities=26% Similarity=0.425 Sum_probs=148.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............||+.|+||
T Consensus 138 ~~~~~~i~~~i~~~l~~lH~~~iv-------H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 210 (321)
T 2qkw_B 138 WEQRLEICIGAARGLHYLHTRAII-------HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDP 210 (321)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCH
T ss_pred HHHHHHHHHHHHHHHHHhcCCCee-------cCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCH
Confidence 455677888999999999998777 9999999999999999999999999875433333333446789999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|++.++.++.++||||||+++|||++|+.||.............+.......+....++++.+......+....+.+++.
T Consensus 211 E~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (321)
T 2qkw_B 211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAV 290 (321)
T ss_dssp HHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHH
T ss_pred HHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHH
Confidence 99999999999999999999999999999987655555556666666666666777777777777778888999999999
Q ss_pred HcccCCCCCCCCHHHHHHHhhcC
Q 011196 426 LCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+||+.||++|||+.||++.|+..
T Consensus 291 ~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 291 KCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCcccCcCHHHHHHHHHHH
Confidence 99999999999999999999865
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.7e-28 Score=235.86 Aligned_cols=174 Identities=18% Similarity=0.248 Sum_probs=114.2
Q ss_pred eeecccccCCCCccccCCC-----CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 245 YELYRFLVDTPTVTVTAPN-----KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
|.+..|..++.+....... ......+.++.+++.++.|||..+++ ||||||+|||++.++.+||+|||
T Consensus 91 ~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~Ii-------HRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 91 YIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLM-------HRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp EEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEECTTCCEEECCCC
T ss_pred EEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCc-------cccCcHHHeEECCCCcEEEccCc
Confidence 5666676665543322111 11223456788999999999998777 99999999999999999999999
Q ss_pred cceecCCCCccc----------ccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHH
Q 011196 320 MARIFGGNQSEA----------NTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLA 389 (491)
Q Consensus 320 la~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 389 (491)
+++......... .....+||+.|||||++.+..|+.++|||||||++|||++ ||... .+..
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~~- 234 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MERV- 234 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHHH-
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHHH-
Confidence 998765432211 1234579999999999999999999999999999999996 54311 1111
Q ss_pred HHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 390 YIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 390 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
...........+... ........+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 RTLTDVRNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHhcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111112222211111 122234567899999999999999999886
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-26 Score=226.53 Aligned_cols=198 Identities=31% Similarity=0.524 Sum_probs=154.4
Q ss_pred eeeecccccCCCCccccC------CCCCCcchhhhHhHHHHHHHHHhhe---eeEEeEEeeeccccccccccccCCCCce
Q 011196 244 RYELYRFLVDTPTVTVTA------PNKTSKRWITIAEAASAIIVFLLST---SFLWCIIRRRNKRVRASNVLLDHEMNPK 314 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~~~iHrDlKp~NILl~~~~~~k 314 (491)
.|.+++|+.++....... ..........++.+++.++.+||.. +++ ||||||+|||++.++.+|
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iv-------H~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII-------HRDVKAANILLDEEFEAV 174 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEE-------CCCCSGGGEEECTTCCEE
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE-------eCCCchhhEEECCCCCEE
Confidence 345566665544322211 1123445677888999999999997 666 999999999999999999
Q ss_pred EeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCcc--CCCcccHHHHHH
Q 011196 315 ISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYH--LEHGPSLLAYIW 392 (491)
Q Consensus 315 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~--~~~~~~~~~~~~ 392 (491)
|+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .........+..
T Consensus 175 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp ECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred eccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 9999999876543322 2234568999999999999999999999999999999999999986432 223344555555
Q ss_pred HHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 393 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 393 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
..........+.+..+......+....+.+++.+||+.||++|||+.||+++|++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 556666677777777777888899999999999999999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-27 Score=237.90 Aligned_cols=127 Identities=18% Similarity=0.211 Sum_probs=96.6
Q ss_pred eeeeecccccCCCCccccCCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC-CCceEeccCcc
Q 011196 243 IRYELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE-MNPKISDFGMA 321 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~-~~~kl~DfGla 321 (491)
.-|.+..|..++...... ...+......++.+++.++.|+|..+++ ||||||+|||++.+ +.+||+|||++
T Consensus 94 ~~~lvmE~~~g~~L~~~~-~~l~~~~~~~~~~qll~al~ylH~~gIi-------HRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDIL-NSLSFQEVREYMLNLFKALKRIHQFGIV-------HRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEEECCCCCCHHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeCCCcccHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeE-------eCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 345566666555443332 2234556777888999999999998888 99999999999877 78999999999
Q ss_pred eecCCCCcc--------------------------cccCceeecCCCChhhhhhhCC-CCcccceeehhHHHHHHHhCCC
Q 011196 322 RIFGGNQSE--------------------------ANTNRVVGTYGYMAPEYAMEGI-FSVKSDVFSFGVVLLEIISGKK 374 (491)
Q Consensus 322 ~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvvl~elltG~~ 374 (491)
+........ ......+||+.|+|||++.+.+ ++.++||||+||+++||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 865432210 1122357999999999998764 8999999999999999999999
Q ss_pred CCC
Q 011196 375 SSG 377 (491)
Q Consensus 375 p~~ 377 (491)
||.
T Consensus 246 Pf~ 248 (361)
T 4f9c_A 246 PFY 248 (361)
T ss_dssp SSS
T ss_pred CCC
Confidence 974
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=234.78 Aligned_cols=169 Identities=18% Similarity=0.180 Sum_probs=118.4
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCC--cccccCceeecCCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQ--SEANTNRVVGTYGY 342 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~--~~~~~~~~~gt~~y 342 (491)
.......++.+++.++.|||..+++ ||||||+|||++.++.+||+|||+++.+.... ........+||+.|
T Consensus 156 ~~~~~~~~~~qil~al~ylH~~~ii-------HRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y 228 (398)
T 4b99_A 156 TLEHVRYFLYQLLRGLKYMHSAQVI-------HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 228 (398)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCB-------CCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTT
T ss_pred CHHHHHHHHHHHHHHHHHHHHCcCc-------CCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHh
Confidence 3456778899999999999998877 99999999999999999999999998764322 12233457899999
Q ss_pred ChhhhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcccc-----------ccchh-c
Q 011196 343 MAPEYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAEL-----------MDSVV-K 409 (491)
Q Consensus 343 ~aPE~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~d~~l-~ 409 (491)
||||++.+.. ++.++||||+||++|||++|+.||... .....+..+............ +.... .
T Consensus 229 ~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~---~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (398)
T 4b99_A 229 RAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK---NYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPR 305 (398)
T ss_dssp CCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS---SHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCC
T ss_pred cCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC---CHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCc
Confidence 9999988754 689999999999999999999998532 222233333222211110000 00000 0
Q ss_pred CCCCHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 410 QSCDQA-----ELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 410 ~~~~~~-----~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
...+.+ ....+++|+.+||+.||++|||+.|+++
T Consensus 306 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 306 QPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 001111 1235678999999999999999999876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=219.37 Aligned_cols=183 Identities=13% Similarity=0.121 Sum_probs=133.9
Q ss_pred CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC-----ceEeccCcceecCCCCcc-----ccc
Q 011196 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN-----PKISDFGMARIFGGNQSE-----ANT 333 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~-----~kl~DfGla~~~~~~~~~-----~~~ 333 (491)
........++.+++.++.+||..+++ ||||||+|||++.++. +||+|||+++........ ...
T Consensus 103 ~~~~~~~~i~~qi~~~l~~lH~~~iv-------H~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 175 (298)
T 1csn_A 103 FSVKTVAMAAKQMLARVQSIHEKSLV-------YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEE-------CCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEe-------cCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCc
Confidence 34566778899999999999998877 9999999999987765 999999999876543321 123
Q ss_pred CceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCC
Q 011196 334 NRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCD 413 (491)
Q Consensus 334 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 413 (491)
....||+.|+|||++.+..++.++||||||+++|||++|+.||..............+..........+ +....
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~- 249 (298)
T 1csn_A 176 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE-----LCAGF- 249 (298)
T ss_dssp CCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH-----HTTTS-
T ss_pred cCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH-----HHhhC-
Confidence 456799999999999998999999999999999999999999865443333333322222211111111 11112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCCCCCCCCeee
Q 011196 414 QAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSV 462 (491)
Q Consensus 414 ~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~~p~~~~ 462 (491)
...+.+++.+||+.||++||++.+|++.|+.....+.....-.|.|
T Consensus 250 ---~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 295 (298)
T 1csn_A 250 ---PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 295 (298)
T ss_dssp ---CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred ---cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence 2457789999999999999999999999998765554444444443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=221.53 Aligned_cols=201 Identities=19% Similarity=0.176 Sum_probs=136.7
Q ss_pred eeecccccCCCCcccc-CCCCCCcchhhhHhHHHHHHHHHhheee---EEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 245 YELYRFLVDTPTVTVT-APNKTSKRWITIAEAASAIIVFLLSTSF---LWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~---~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
|.++.|..++.+.... ...........++.+++.++.+||.... ..|..+++||||||+|||++.++.+||+|||+
T Consensus 98 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 4555666554432222 1223455677889999999999998611 11334666999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhh-----CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHH------
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAME-----GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLA------ 389 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~------ 389 (491)
++...............||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 987765444333445679999999999986 346678999999999999999999986533322211111
Q ss_pred ---HHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 390 ---YIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 390 ---~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
..............+..... .......+.+|+.+||+.||++|||+.||++.|+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQ---KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGG---SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhhhhhhhhcccCCCCcccccc---ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111111111111111111 124456688999999999999999999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-26 Score=242.75 Aligned_cols=177 Identities=18% Similarity=0.158 Sum_probs=128.5
Q ss_pred ceeeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 242 SIRYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 242 ~lry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
..-|.+..|..++.+..... ..........++.+++.++.|||..+++ ||||||+||||+.+|++||+|||
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIi-------HRDLKPeNILld~~G~vKL~DFG 337 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV-------YRDLKPANILLDEHGHVRISDLG 337 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEE-------CCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------ccCCchHHeEEeCCCCEEecccc
Confidence 34566777777666533321 2234556677888999999999998887 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
+++.+.... ....+||+.|||||++.+ ..|+.++|+||+||++|||++|+.||......+... +.......
T Consensus 338 lA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~----i~~~i~~~ 409 (689)
T 3v5w_A 338 LACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTM 409 (689)
T ss_dssp TCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH----HHHHHHHC
T ss_pred eeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH----HHHhhcCC
Confidence 998765433 334689999999999975 469999999999999999999999986433222111 11111111
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT-----MSSVAV 443 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~ 443 (491)
.. . ++......+.+|+.+||+.||++|++ +.||++
T Consensus 410 ~~-~---------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 AV-E---------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CC-C---------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CC-C---------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11 0 11111234678999999999999998 677764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-26 Score=229.96 Aligned_cols=161 Identities=20% Similarity=0.324 Sum_probs=120.6
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............+|..|+|
T Consensus 115 ~~~~~~~~~~qi~~~l~~LH~~~iv-------H~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a 187 (327)
T 3poz_A 115 GSQYLLNWCVQIAKGMNYLEDRRLV-------HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187 (327)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSC
T ss_pred CHHHHHHHHHHHHHHHHHHhhCCee-------CCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccC
Confidence 3456777889999999999988766 999999999999999999999999987655443333334566889999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..++.++||||||+++|||++ |+.||..... ..+...+ ..+... ..+......+.++
T Consensus 188 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~----~~~~~~---------~~~~~~~~~~~~l 251 (327)
T 3poz_A 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSIL----EKGERL---------PQPPICTIDVYMI 251 (327)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHH----HTTCCC---------CCCTTBCHHHHHH
T ss_pred hHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH---HHHHHHH----HcCCCC---------CCCccCCHHHHHH
Confidence 999999999999999999999999999 9999753321 2222111 111100 1111223457789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+.+||+.||++||++.||+++|+..
T Consensus 252 i~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 252 MVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp HHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCChhhCCCHHHHHHHHHHH
Confidence 9999999999999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-25 Score=214.74 Aligned_cols=182 Identities=16% Similarity=0.162 Sum_probs=134.2
Q ss_pred CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccc---cCCCCceEeccCcceecCCCCcc-----cccCc
Q 011196 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLL---DHEMNPKISDFGMARIFGGNQSE-----ANTNR 335 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl---~~~~~~kl~DfGla~~~~~~~~~-----~~~~~ 335 (491)
........++.+++.++.+||..+++ ||||||+|||+ +.++.+||+|||+++........ .....
T Consensus 102 ~~~~~~~~i~~qi~~~l~~lH~~~iv-------H~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 174 (296)
T 3uzp_A 102 FSLKTVLLLADQMISRIEYIHSKNFI-------HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 174 (296)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCee-------eCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccc
Confidence 34566778899999999999998877 99999999999 47889999999999876543321 11234
Q ss_pred eeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHH
Q 011196 336 VVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 415 (491)
Q Consensus 336 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 415 (491)
..||..|+|||++.+..++.++||||||+++|||++|+.||..............+......... +.+....+
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~-- 247 (296)
T 3uzp_A 175 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----EVLCKGYP-- 247 (296)
T ss_dssp CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----HHHTTTSC--
T ss_pred cccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-----HHHHhhCC--
Confidence 67899999999999999999999999999999999999998765444444444333222111110 11111222
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCCCCCCCCee
Q 011196 416 ELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFS 461 (491)
Q Consensus 416 ~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~~p~~~ 461 (491)
..+.+++.+||+.||++||++.+|++.|+........+..-.|.
T Consensus 248 --~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~d 291 (296)
T 3uzp_A 248 --SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 291 (296)
T ss_dssp --HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCG
T ss_pred --HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccc
Confidence 34778999999999999999999999999875554443333343
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-25 Score=215.30 Aligned_cols=173 Identities=17% Similarity=0.173 Sum_probs=131.0
Q ss_pred CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccc---cCCCCceEeccCcceecCCCCcc-----cccCc
Q 011196 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLL---DHEMNPKISDFGMARIFGGNQSE-----ANTNR 335 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl---~~~~~~kl~DfGla~~~~~~~~~-----~~~~~ 335 (491)
........++.+++.++.+||..+++ ||||||+|||+ +.++.+||+|||+++........ .....
T Consensus 102 ~~~~~~~~i~~qi~~~l~~LH~~~iv-------H~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~ 174 (296)
T 4hgt_A 102 FSLKTVLLLADQMISRIEYIHSKNFI-------HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 174 (296)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccc
Confidence 34566778899999999999998877 99999999999 78899999999999876543321 12234
Q ss_pred eeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHH
Q 011196 336 VVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 415 (491)
Q Consensus 336 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 415 (491)
..||..|+|||.+.+..++.++||||||+++|||++|+.||........................ +......+
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~-- 247 (296)
T 4hgt_A 175 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----EVLCKGYP-- 247 (296)
T ss_dssp CCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----HHHTTTSC--
T ss_pred cCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-----hhhhccCC--
Confidence 67899999999999999999999999999999999999998765444444444333222111111 11111122
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCC
Q 011196 416 ELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTL 452 (491)
Q Consensus 416 ~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 452 (491)
..+.+++.+||+.||++||++.+|++.|++.....
T Consensus 248 --~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 248 --SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp --HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 35778999999999999999999999998765443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.7e-25 Score=214.52 Aligned_cols=191 Identities=17% Similarity=0.216 Sum_probs=130.6
Q ss_pred eeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHh--------heeeEEeEEeeeccccccccccccCCCCce
Q 011196 244 RYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLL--------STSFLWCIIRRRNKRVRASNVLLDHEMNPK 314 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~--------~~~~~~~~~~~iHrDlKp~NILl~~~~~~k 314 (491)
.|.++.|..++....... ..........++.+++.++.+|| ..+++ ||||||+|||++.++.+|
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~iv-------H~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA-------HRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEE-------CSCCCGGGEEECTTSCEE
T ss_pred eEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCee-------cCCCChHhEEEcCCCCEE
Confidence 345556655544332221 22335567778889999999999 55555 999999999999999999
Q ss_pred EeccCcceecCCCCccc--ccCceeecCCCChhhhhhhC------CCCcccceeehhHHHHHHHhC----------CCCC
Q 011196 315 ISDFGMARIFGGNQSEA--NTNRVVGTYGYMAPEYAMEG------IFSVKSDVFSFGVVLLEIISG----------KKSS 376 (491)
Q Consensus 315 l~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwS~Gvvl~elltG----------~~p~ 376 (491)
|+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999998764433221 12335789999999999876 455799999999999999999 6665
Q ss_pred CCccCCCcccHHHHHHHHhhc-CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 011196 377 GFYHLEHGPSLLAYIWKLWCE-GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
...... ............. .....+... ..+......+.+++.+||+.||++|||+.||++.|++
T Consensus 234 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 234 YDVVPN--DPSFEDMRKVVCVDQQRPNIPNR----WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TTTSCS--SCCHHHHHHHHTTSCCCCCCCGG----GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccCCC--CcchhhhhHHHhccCCCCCCChh----hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 432211 1112222222211 111111111 1123456778899999999999999999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-25 Score=221.34 Aligned_cols=181 Identities=18% Similarity=0.227 Sum_probs=128.7
Q ss_pred eecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 246 ELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 246 ~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.++.|+.++.+..... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv-------H~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV-------HRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCC-------CSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCC-------CCccchheEEECCCCeEEECCCCccc
Confidence 4445555444332221 1233566778889999999999998777 99999999999999999999999998
Q ss_pred ecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
...............|+..|+|||++.++.++.++||||||+++|||++ |+.||..... ...... ...+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~----~~~~~~~ 236 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL---AEVPDL----LEKGERL 236 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT---THHHHH----HHTTCBC
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH---HHHHHH----HHcCCCC
Confidence 7755444333445678889999999999999999999999999999999 9999764321 112111 1111111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
... ......+.+++.+||+.||++||++.|+++.|+...
T Consensus 237 ~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 237 AQP---------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CCC---------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCC---------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 110 011123567889999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-25 Score=218.19 Aligned_cols=163 Identities=23% Similarity=0.364 Sum_probs=113.1
Q ss_pred CcchhhhHhHHHHHHHHHhhee--eEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTS--FLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
....+.++.+++.++.+||..+ ++ ||||||+|||++.++.+||+|||+++....... ......||+.|+
T Consensus 136 ~~~~~~i~~qi~~aL~~LH~~~~~iv-------H~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~ 206 (309)
T 3p86_A 136 ERRRLSMAYDVAKGMNYLHNRNPPIV-------HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWM 206 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHHTSSSCCC-------CTTCCGGGEEECTTCCEEECCCC-------------------CCTTS
T ss_pred HHHHHHHHHHHHHHHHHHHcCCCCEE-------CCCCChhhEEEeCCCcEEECCCCCCcccccccc--ccccCCCCcccc
Confidence 4456678889999999999877 66 999999999999999999999999976433221 223467899999
Q ss_pred hhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 344 APEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 344 aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
|||++.+..++.++||||||+++|||++|+.||.... .......+ .......+ .+......+.++
T Consensus 207 aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~---~~~~~~~~---~~~~~~~~---------~~~~~~~~l~~l 271 (309)
T 3p86_A 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN---PAQVVAAV---GFKCKRLE---------IPRNLNPQVAAI 271 (309)
T ss_dssp CHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC---HHHHHHHH---HHSCCCCC---------CCTTSCHHHHHH
T ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH---HhcCCCCC---------CCccCCHHHHHH
Confidence 9999999999999999999999999999999975321 11111111 11111111 111122356789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcCCCCC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASDIVTL 452 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 452 (491)
+.+||+.||++|||+.+|++.|+......
T Consensus 272 i~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 272 IEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 99999999999999999999999875443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.91 E-value=8.1e-25 Score=221.01 Aligned_cols=186 Identities=13% Similarity=0.160 Sum_probs=135.7
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeecccccccccccc--CCCCceEeccCcceecCCCCcc-----cccCcee
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLD--HEMNPKISDFGMARIFGGNQSE-----ANTNRVV 337 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~--~~~~~kl~DfGla~~~~~~~~~-----~~~~~~~ 337 (491)
.....+.++.+++.++.+||..+++ ||||||+|||++ .++.+||+|||+++.+...... .......
T Consensus 150 ~~~~~~~i~~qi~~~l~~lH~~~ii-------HrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~ 222 (364)
T 3op5_A 150 SRKTVLQLSLRILDILEYIHEHEYV-------HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHD 222 (364)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeE-------EecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccC
Confidence 4566788999999999999998777 999999999999 8899999999999876432211 1113356
Q ss_pred ecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHH
Q 011196 338 GTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAEL 417 (491)
Q Consensus 338 gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 417 (491)
||+.|+|||++.+..++.++||||||+++|||++|+.||.... ............. .....+++++.+... ...
T Consensus 223 gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~ 296 (364)
T 3op5_A 223 GTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL--KDPKYVRDSKIRY-RENIASLMDKCFPAA---NAP 296 (364)
T ss_dssp CCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT--TCHHHHHHHHHHH-HHCHHHHHHHHSCTT---CCC
T ss_pred CCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc--cCHHHHHHHHHHh-hhhHHHHHHHhcccc---cCH
Confidence 9999999999999899999999999999999999999986322 1222222222211 122333333332211 112
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCCCCCCCCeeec
Q 011196 418 LKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSVS 463 (491)
Q Consensus 418 ~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~~p~~~~~ 463 (491)
..+.+++..||+.||++||++.+|++.|+........+....+.|.
T Consensus 297 ~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 342 (364)
T 3op5_A 297 GEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLS 342 (364)
T ss_dssp HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-
T ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceE
Confidence 3567788999999999999999999999887666666555666553
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8e-25 Score=217.88 Aligned_cols=169 Identities=14% Similarity=0.139 Sum_probs=125.2
Q ss_pred CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC-----ceEeccCcceecCCCCccc-----cc
Q 011196 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN-----PKISDFGMARIFGGNQSEA-----NT 333 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~-----~kl~DfGla~~~~~~~~~~-----~~ 333 (491)
........++.+++.++.+||..+++ ||||||+|||++.++. +||+|||+++......... ..
T Consensus 102 ~~~~~~~~i~~qi~~~l~~LH~~~ii-------HrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~ 174 (330)
T 2izr_A 102 FSLKTVLMIAIQLISRMEYVHSKNLI-------YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174 (330)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCee-------ccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCcccccccc
Confidence 34566778899999999999998777 9999999999998887 9999999998764433211 12
Q ss_pred CceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCC
Q 011196 334 NRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCD 413 (491)
Q Consensus 334 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 413 (491)
....||+.|+|||++.+..++.++||||||+++|||++|+.||..............+........ .+.+....
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~~- 248 (330)
T 2izr_A 175 KSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP-----IEVLCENF- 248 (330)
T ss_dssp CCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-----HHHHTTTC-
T ss_pred CCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-----HHHHhccC-
Confidence 356899999999999999999999999999999999999999865433222222222211110000 01111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 414 QAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 414 ~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
..+.+++..||+.||++||++.+|++.|+...
T Consensus 249 ----p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 249 ----PEMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp ----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ----hHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 16778999999999999999999999997543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.2e-25 Score=223.05 Aligned_cols=160 Identities=24% Similarity=0.295 Sum_probs=123.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............+++.|+||
T Consensus 202 ~~~~~~i~~qi~~aL~~LH~~~iv-------HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 274 (370)
T 2psq_A 202 FKDLVSCTYQLARGMEYLASQKCI-------HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 274 (370)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------ccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECH
Confidence 445677888999999999998777 9999999999999999999999999876544333333345678899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++|||||||++|||++ |+.||.... ...+... ...+.... .+......+.+++
T Consensus 275 E~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~---~~~~~~~----~~~~~~~~---------~~~~~~~~l~~li 338 (370)
T 2psq_A 275 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VEELFKL----LKEGHRMD---------KPANCTNELYMMM 338 (370)
T ss_dssp HHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGGHHHH----HHTTCCCC---------CCTTSCHHHHHHH
T ss_pred hHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH----HhcCCCCC---------CCCCCCHHHHHHH
Confidence 99999999999999999999999999 999975322 2222221 11221111 1112234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++||++.|+++.|+..
T Consensus 339 ~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 339 RDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999865
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-24 Score=227.01 Aligned_cols=169 Identities=17% Similarity=0.209 Sum_probs=127.0
Q ss_pred CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccc---cCCCCceEeccCcceecCCCCcc-----cccCc
Q 011196 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLL---DHEMNPKISDFGMARIFGGNQSE-----ANTNR 335 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl---~~~~~~kl~DfGla~~~~~~~~~-----~~~~~ 335 (491)
......+.++.+++.++.+||..+++ ||||||+|||| +.++.+||+|||+++........ .....
T Consensus 100 l~~~~~~~i~~qi~~aL~yLH~~gIv-------HrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~ 172 (483)
T 3sv0_A 100 LSLKTVLMLADQMINRVEFVHSKSFL-------HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172 (483)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEe-------ecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccc
Confidence 34566778899999999999998877 99999999999 68899999999999876543321 12235
Q ss_pred eeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHH
Q 011196 336 VVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 415 (491)
Q Consensus 336 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 415 (491)
..||..|+|||++.+..++.++|||||||++|||++|+.||..............+......... .. +...++
T Consensus 173 ~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~----~~-l~~~~p-- 245 (483)
T 3sv0_A 173 LTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI----EA-LCRGYP-- 245 (483)
T ss_dssp CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH----HH-HHTTSC--
T ss_pred cCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH----HH-HhcCCc--
Confidence 68999999999999999999999999999999999999998654433322222222221111111 11 111222
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 416 ELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 416 ~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.++.+|+..||+.||++||++.+|+++|+..
T Consensus 246 --~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 246 --TEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp --HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred --HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 3577899999999999999999999988654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-24 Score=211.31 Aligned_cols=172 Identities=30% Similarity=0.409 Sum_probs=130.2
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++...............|++.|+|
T Consensus 131 ~~~~~~~i~~~i~~~l~~lH~~~i~-------H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~a 203 (307)
T 2nru_A 131 SWHMRCKIAQGAANGINFLHENHHI-------HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMA 203 (307)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCC
T ss_pred CHHHHHHHHHHHHHHHHHHhcCCee-------cCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCC
Confidence 3456677888999999999998777 999999999999999999999999987654333333344678999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh--cCCccccccchhcCCCCHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC--EGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
||.+.+ .++.++||||||+++|||++|..||.......... .+..... ...+.+.+++.+ ...+......+.+
T Consensus 204 PE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 278 (307)
T 2nru_A 204 PEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL---DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYS 278 (307)
T ss_dssp HHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT---HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHH
T ss_pred hHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH---HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHH
Confidence 998764 58899999999999999999999986543322211 1111111 122233333333 2345667788899
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 423 IGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
++.+||+.||++||++.+|+++|+..
T Consensus 279 li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 279 VASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 99999999999999999999999865
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.7e-25 Score=235.25 Aligned_cols=178 Identities=16% Similarity=0.181 Sum_probs=127.9
Q ss_pred eeeeecccccCCCCccccCC---CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC--CCceEec
Q 011196 243 IRYELYRFLVDTPTVTVTAP---NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE--MNPKISD 317 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~--~~~kl~D 317 (491)
..|.++.|..++.+...... .........++.+++.++.|||..+++ ||||||+|||++.+ +.+||+|
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~ii-------HRDlKp~Nill~~~~~~~vKl~D 300 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV-------HLDLKPENIMFTTKRSNELKLID 300 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEESSSSCCCEEECC
T ss_pred EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCee-------eccCChhhccccCCCCCCEEEee
Confidence 34566677766654332221 123455677888999999999998887 99999999999854 7899999
Q ss_pred cCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 318 FGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 318 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
||+++.+..... ....+||+.|||||++.+..|+.++||||+||++|||++|+.||... ........ ...
T Consensus 301 FG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~---~~~~~~~~----i~~ 370 (573)
T 3uto_A 301 FGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRN----VKS 370 (573)
T ss_dssp CSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHH----HHT
T ss_pred ccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHH----HHh
Confidence 999998754332 23468999999999999999999999999999999999999997532 11122221 111
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.... + ........+ ..+.+|+.+||+.||++|||+.|+++
T Consensus 371 ~~~~-~-~~~~~~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 371 CDWN-M-DDSAFSGIS----EDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TCCC-C-CSGGGTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCC-C-CcccccCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1110 1 111111122 34678899999999999999999887
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=8e-25 Score=215.77 Aligned_cols=183 Identities=21% Similarity=0.330 Sum_probs=128.8
Q ss_pred eeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 245 YELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
|.++.|..++...... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv-------H~dlkp~Nil~~~~~~~kl~Dfg~~ 155 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII-------HRDLNSHNCLVRENKNVVVADFGLA 155 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSTTSEEECTTSCEEECCCTTC
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcc-------CCCCCcCeEEECCCCCEEEeecccc
Confidence 4455555544432221 12233556778889999999999998877 9999999999999999999999999
Q ss_pred eecCCCCccc------------ccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcc--cH
Q 011196 322 RIFGGNQSEA------------NTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGP--SL 387 (491)
Q Consensus 322 ~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~--~~ 387 (491)
+......... ......||+.|+|||++.+..++.++||||||+++|||++|..|+......... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 235 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh
Confidence 8764332211 111457899999999999999999999999999999999999987543222111 11
Q ss_pred HHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 011196 388 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIV 450 (491)
Q Consensus 388 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 450 (491)
...... .. .+......+.+++.+||+.||++|||+.++++.|+....
T Consensus 236 ~~~~~~------------~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 236 VRGFLD------------RY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp HHHHHH------------HT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcccc------------cc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111111 00 111112346779999999999999999999999987643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.1e-25 Score=222.20 Aligned_cols=182 Identities=24% Similarity=0.274 Sum_probs=129.3
Q ss_pred eeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.++.|..++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv-------HrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI-------HRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECTTCCEEECCGGG
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcC-------CcccCHHHEEEcCCCcEEECcCCC
Confidence 355666665544322211 1223455677888999999999998877 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
++...............++..|+|||++.++.++.++||||||+++|||++ |..||.... ... .......+.
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~---~~~----~~~~~~~~~ 332 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS---NQQ----TREFVEKGG 332 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC---HHH----HHHHHHTTC
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHH----HHHHHHcCC
Confidence 986543322222223456788999999999999999999999999999998 898875321 111 111122221
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.. ..+......+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 333 ~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 333 RL---------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11 11111234567899999999999999999999999764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=9.1e-24 Score=211.68 Aligned_cols=173 Identities=12% Similarity=0.146 Sum_probs=124.8
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC--CceEeccCcceecCCCCcc-----cccCcee
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM--NPKISDFGMARIFGGNQSE-----ANTNRVV 337 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~ 337 (491)
.....+.++.+++.++.+||..+++ ||||||+|||++.++ .+||+|||+++.+...... .......
T Consensus 149 ~~~~~~~i~~qi~~aL~~LH~~~iv-------H~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~ 221 (345)
T 2v62_A 149 KKSTVLQLGIRMLDVLEYIHENEYV-------HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHN 221 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCee-------CCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccC
Confidence 3556778899999999999998777 999999999999887 9999999999876432211 1113457
Q ss_pred ecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHH
Q 011196 338 GTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAEL 417 (491)
Q Consensus 338 gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 417 (491)
||..|+|||++.+..++.++||||||+++|||++|+.||.... ................. ...+...... ....
T Consensus 222 gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~ 295 (345)
T 2v62_A 222 GTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL--KDPVAVQTAKTNLLDEL-PQSVLKWAPS---GSSC 295 (345)
T ss_dssp SCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT--TCHHHHHHHHHHHHHTT-THHHHHHSCT---TSCC
T ss_pred CCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc--cccHHHHHHHHhhcccc-cHHHHhhccc---cccH
Confidence 8999999999999899999999999999999999999975321 11111222211111111 1111111100 0122
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 011196 418 LKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIV 450 (491)
Q Consensus 418 ~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 450 (491)
..+.+++.+||+.||++||++.+|++.|+....
T Consensus 296 ~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 296 CEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 357789999999999999999999999998754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-25 Score=223.26 Aligned_cols=162 Identities=20% Similarity=0.315 Sum_probs=115.7
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............+|..|+|
T Consensus 115 ~~~~~~~i~~qi~~aL~~LH~~~iv-------H~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~a 187 (327)
T 3lzb_A 115 GSQYLLNWCVQIAKGMNYLEDRRLV-------HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187 (327)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSC
T ss_pred CHHHHHHHHHHHHHHHHHHhhCCCc-------CCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccC
Confidence 3455677888999999999988777 999999999999999999999999987654433333334556788999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..++.++||||||+++|||++ |+.||.... ...+...+ ..+... ..+......+.++
T Consensus 188 PE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~---~~~~~~~~----~~~~~~---------~~~~~~~~~l~~l 251 (327)
T 3lzb_A 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEISSIL----EKGERL---------PQPPICTIDVYMI 251 (327)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGGHHHHH----HTTCCC---------CCCTTBCHHHHHH
T ss_pred HHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC---HHHHHHHH----HcCCCC---------CCCccCCHHHHHH
Confidence 999999999999999999999999999 999975322 12222211 111111 0111123357789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
+.+||+.||++||++.|+++.|+...
T Consensus 252 i~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 252 MRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 99999999999999999999998764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-24 Score=216.21 Aligned_cols=196 Identities=15% Similarity=0.142 Sum_probs=129.0
Q ss_pred eeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhhe---------eeEEeEEeeeccccccccccccCCCCce
Q 011196 245 YELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLST---------SFLWCIIRRRNKRVRASNVLLDHEMNPK 314 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~---------~~~~~~~~~iHrDlKp~NILl~~~~~~k 314 (491)
|.+++|+.++.+..... ..........++.+++.++.+||.. +++ ||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~iv-------H~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAIS-------HRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEE-------CSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhcccccccccee-------ecccccceEEEcCCCcEE
Confidence 45666665554432221 1223445667888999999999987 555 999999999999999999
Q ss_pred EeccCcceecCCCCc------ccccCceeecCCCChhhhhhh-------CCCCcccceeehhHHHHHHHhCCCCCCCccC
Q 011196 315 ISDFGMARIFGGNQS------EANTNRVVGTYGYMAPEYAME-------GIFSVKSDVFSFGVVLLEIISGKKSSGFYHL 381 (491)
Q Consensus 315 l~DfGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~ 381 (491)
|+|||+++....... ........||+.|+|||++.+ ..++.++||||||+++|||++|..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987643221 111223468999999999976 4567899999999999999999777532221
Q ss_pred CCc-ccH----------HHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 382 EHG-PSL----------LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 382 ~~~-~~~----------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
... ... ................+.... .........+.+|+.+||+.||++|||+.||++.|+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 111 110 011111111111111111110 112235567889999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.8e-24 Score=209.24 Aligned_cols=177 Identities=20% Similarity=0.322 Sum_probs=126.6
Q ss_pred eeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 244 RYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.|.++.|+.++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++.
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~-------H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI-------HRDIKSDNILLGMDGSVKLTDFGFCA 164 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCce-------eCCCCHHHEEECCCCCEEEeeCCCce
Confidence 355566665544322221 1233556777888999999999998777 99999999999999999999999998
Q ss_pred ecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccc
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAE 402 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (491)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .............. .
T Consensus 165 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~~~~~~~-~ 235 (297)
T 3fxz_A 165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN------PLRALYLIATNGTP-E 235 (297)
T ss_dssp ECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHHCSC-C
T ss_pred ecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCC-C
Confidence 7654332 2234678999999999999999999999999999999999999974321 11111111111111 1
Q ss_pred cccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 403 LMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 403 ~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
... +......+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 LQN-------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CSC-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCC-------ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 101 1112234678999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=9.7e-24 Score=210.06 Aligned_cols=202 Identities=18% Similarity=0.198 Sum_probs=130.9
Q ss_pred eeeeecccccCCCCcccc-CCCCCCcchhhhHhHHHHHHHHHhheeeEE-eEEeeeccccccccccccCCCCceEeccCc
Q 011196 243 IRYELYRFLVDTPTVTVT-APNKTSKRWITIAEAASAIIVFLLSTSFLW-CIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
..|.++.|+.++.+.... ...........++.+++.++.+||...+.. +..+++||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 345666666554433222 122335566778889999999999872211 122445999999999999999999999999
Q ss_pred ceecCCCCccc--ccCceeecCCCChhhhhhhCCCCcc------cceeehhHHHHHHHhC----------CCCCCCccCC
Q 011196 321 ARIFGGNQSEA--NTNRVVGTYGYMAPEYAMEGIFSVK------SDVFSFGVVLLEIISG----------KKSSGFYHLE 382 (491)
Q Consensus 321 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~------sDVwS~Gvvl~elltG----------~~p~~~~~~~ 382 (491)
++......... ......||+.|+|||++.+.....+ +|||||||++|||++| +.||......
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 268 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence 98764432221 1224578999999999987766655 9999999999999999 4444322111
Q ss_pred CcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 383 HGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
........................ ...+....+.+|+.+||+.||++|||+.||++.|+...
T Consensus 269 --~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 269 --DPSYEDMREIVCIKKLRPSFPNRW---SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp --SCCHHHHHHHHTTSCCCCCCCGGG---GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCchhhhHHHHhhhccCccccccc---hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 111122222221111111111111 11255677889999999999999999999999998753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6e-24 Score=210.47 Aligned_cols=179 Identities=13% Similarity=0.152 Sum_probs=128.7
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccc----cCCCCceEeccCcceecCCCCcccccCceeecC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLL----DHEMNPKISDFGMARIFGGNQSEANTNRVVGTY 340 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl----~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~ 340 (491)
.....+.++.+++.++.+||..+++ ||||||+|||+ +.++.+||+|||+++....... .....||.
T Consensus 110 ~~~~~~~i~~qi~~~L~~LH~~~iv-------H~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~ 179 (319)
T 4euu_A 110 PESEFLIVLRDVVGGMNHLRENGIV-------HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTE 179 (319)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCCSCG
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEe-------cCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeecccCC
Confidence 3556777899999999999998877 99999999999 7778899999999987654332 22356899
Q ss_pred CCChhhhhh--------hCCCCcccceeehhHHHHHHHhCCCCCCCccCCC-cccHHHHHHHHhhcCCcccccc------
Q 011196 341 GYMAPEYAM--------EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEH-GPSLLAYIWKLWCEGHAAELMD------ 405 (491)
Q Consensus 341 ~y~aPE~~~--------~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d------ 405 (491)
.|+|||++. +..++.++|||||||++|||++|+.||....... .......+........+..+..
T Consensus 180 ~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 259 (319)
T 4euu_A 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPI 259 (319)
T ss_dssp GGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCE
T ss_pred CccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCcc
Confidence 999999987 4678999999999999999999999975433221 1222222222211111111100
Q ss_pred -----chhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCC
Q 011196 406 -----SVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLP 453 (491)
Q Consensus 406 -----~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 453 (491)
-.............+.+++.+||+.||++|||+.|+++..+.+...-.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~~ 312 (319)
T 4euu_A 260 DWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGN 312 (319)
T ss_dssp EEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC---
T ss_pred ccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcCC
Confidence 001123455667778899999999999999999999999988765443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=7.1e-24 Score=206.92 Aligned_cols=166 Identities=20% Similarity=0.356 Sum_probs=113.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............||+.|+||
T Consensus 119 ~~~~~~i~~qi~~~L~~lH~~~i~-------H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 191 (289)
T 3og7_A 119 MKKLIDIARQTARGMDYLHAKSII-------HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191 (289)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------cccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCc
Confidence 455677888999999999998777 9999999999999999999999999865432222233346789999999
Q ss_pred hhhh---hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHH
Q 011196 346 EYAM---EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 346 E~~~---~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
|++. +..++.++||||||+++|||++|+.||.... .... .......+........ ........+.+
T Consensus 192 E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~----~~~~~~~~~~~~~~~~-----~~~~~~~~l~~ 260 (289)
T 3og7_A 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQ----IIEMVGRGSLSPDLSK-----VRSNCPKRMKR 260 (289)
T ss_dssp HHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC--CHHH----HHHHHHHTSCCCCTTS-----SCTTSCHHHHH
T ss_pred hhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc--hHHH----HHHHhcccccCcchhh-----ccccCCHHHHH
Confidence 9986 5678899999999999999999999975321 1111 1222222221111111 11122345778
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 423 IGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
++.+||+.||++||++.++++.|+...
T Consensus 261 li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 261 LMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.6e-25 Score=223.23 Aligned_cols=169 Identities=26% Similarity=0.314 Sum_probs=128.1
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............+|..|+|
T Consensus 189 ~~~~~~~i~~qi~~aL~~LH~~~iv-------H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~a 261 (382)
T 3tt0_A 189 SSKDLVSCAYQVARGMEYLASKKCI-------HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 261 (382)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEe-------cCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeC
Confidence 3456778889999999999988776 999999999999999999999999987655443333444567889999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..++.++||||||++++||++ |..||.... . .........+..... +......+.++
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~---~----~~~~~~~~~~~~~~~---------~~~~~~~l~~l 325 (382)
T 3tt0_A 262 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---V----EELFKLLKEGHRMDK---------PSNCTNELYMM 325 (382)
T ss_dssp HHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---H----HHHHHHHHTTCCCCC---------CSSCCHHHHHH
T ss_pred HHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---H----HHHHHHHHcCCCCCC---------CccCCHHHHHH
Confidence 999999999999999999999999999 999875321 1 112222222221111 11122457789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcCCCCCCCCC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPT 456 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~ 456 (491)
+.+||+.||++|||+.||++.|+..........
T Consensus 326 i~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 326 MRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 999999999999999999999998754443333
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.9e-24 Score=174.00 Aligned_cols=106 Identities=25% Similarity=0.351 Sum_probs=97.3
Q ss_pred CCCceEeeccCCCCChHHHHHHHHHHHHHHHHHhhccCcccceeeeccCCCccEEEEEecCCCCCccchhHHHHHHhhcc
Q 011196 145 TSPFLCVKNENYTTEPDKLAQILNQTFNDEIRNAASSDSKYAAQTINISSFDTLQTTVHCIPDLSKSDCNVCLNSAVAQI 224 (491)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~f~~~~~~ll~~l~~~a~~~~~~~a~~~~~~~~~~~vyglaQC~~Dls~~dC~~Cl~~~~~~~ 224 (491)
+...+..|+..++++++.|+.+++.||..|..+|+.+..+|+++..+..+.++||||+||+|||++.||+.||+.++.++
T Consensus 3 t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~ 82 (108)
T 3a2e_A 3 TAFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRI 82 (108)
T ss_dssp CCEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTH
T ss_pred cceeeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHH
Confidence 34456789999999999999999999999999997777788888777667789999999999999999999999999999
Q ss_pred ccccCCCCCcEEEceecceeeeeccc
Q 011196 225 PTCSKGKLGARIFCASCSIRYELYRF 250 (491)
Q Consensus 225 ~~~~~~~~~g~i~~~~C~lry~~~~f 250 (491)
+++|++++||+|++++|++||+.++|
T Consensus 83 ~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 83 FSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHCCCCceEEEECCCEEEEEeCCcC
Confidence 99999999999999999999999987
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=7.2e-25 Score=219.25 Aligned_cols=165 Identities=26% Similarity=0.347 Sum_probs=124.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++................||+.|+||
T Consensus 171 ~~~~~~i~~qi~~aL~~LH~~~iv-------H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 243 (344)
T 1rjb_A 171 FEDLLCFAYQVAKGMEFLEFKSCV-------HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 243 (344)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCH
Confidence 345667888999999999998777 9999999999999999999999999876544433334456788999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++|||++ |..||..... .... ......+.... .+......+.+|+
T Consensus 244 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~---~~~~~~~~~~~---------~~~~~~~~l~~li 308 (344)
T 1rjb_A 244 ESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV---DANF---YKLIQNGFKMD---------QPFYATEEIYIIM 308 (344)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---SHHH---HHHHHTTCCCC---------CCTTCCHHHHHHH
T ss_pred HHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc---HHHH---HHHHhcCCCCC---------CCCCCCHHHHHHH
Confidence 99999999999999999999999998 9999753321 1111 11121211110 1111234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcCCCCC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASDIVTL 452 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~~~~~ 452 (491)
.+||+.||++|||+.||+++|+......
T Consensus 309 ~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 309 QSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 9999999999999999999999875443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.9e-24 Score=211.35 Aligned_cols=185 Identities=23% Similarity=0.317 Sum_probs=130.8
Q ss_pred ceeeeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEecc
Q 011196 242 SIRYELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDF 318 (491)
Q Consensus 242 ~lry~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~Df 318 (491)
...|.++.|+.++.+.... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv-------H~Dlkp~NIll~~~~~~kl~Df 195 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYV-------HRDLAARNVLVDSNLVCKVSDF 195 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECTTCCEEECCC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCee-------CCCCCcceEEECCCCCEEECCC
Confidence 3456667777655443322 12234556777888999999999998877 9999999999999999999999
Q ss_pred CcceecCCCCccc-ccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhh
Q 011196 319 GMARIFGGNQSEA-NTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWC 396 (491)
Q Consensus 319 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 396 (491)
|+++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.... ..... ....
T Consensus 196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~---~~~~~----~~~~ 268 (325)
T 3kul_A 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT---NRDVI----SSVE 268 (325)
T ss_dssp SSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHH----HHHH
T ss_pred CcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC---HHHHH----HHHH
Confidence 9998765432211 2223455778999999999999999999999999999999 999974321 11111 1111
Q ss_pred cCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 397 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 397 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
.+... ..+......+.+|+.+||+.||++||++.||++.|+...
T Consensus 269 ~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 269 EGYRL---------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCC---------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111 011122345778999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.8e-24 Score=213.81 Aligned_cols=161 Identities=25% Similarity=0.346 Sum_probs=122.4
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............||..|+||
T Consensus 192 ~~~~~~~~~ql~~aL~~LH~~~iv-------H~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 264 (359)
T 3vhe_A 192 LEHLICYSFQVAKGMEFLASRKCI-------HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264 (359)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------cCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeECh
Confidence 445677888999999999998776 9999999999999999999999999876544433344456789999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++|||++ |+.||..... .... ......+..... +......+.+++
T Consensus 265 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~---~~~~~~~~~~~~---------~~~~~~~l~~li 329 (359)
T 3vhe_A 265 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---DEEF---CRRLKEGTRMRA---------PDYTTPEMYQTM 329 (359)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---SHHH---HHHHHHTCCCCC---------CTTCCHHHHHHH
T ss_pred hhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch---hHHH---HHHHHcCCCCCC---------CCCCCHHHHHHH
Confidence 99999999999999999999999998 9999753221 1111 111222211111 111223467889
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++|||+.||+++|+..
T Consensus 330 ~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 330 LDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHccCChhhCCCHHHHHHHHHHH
Confidence 999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.6e-24 Score=212.03 Aligned_cols=180 Identities=23% Similarity=0.284 Sum_probs=126.4
Q ss_pred eeeecccccCCCCccccCC--CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTAP--NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++........ .........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~giv-------H~Dlkp~NIll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT-------HRDIKPENLLLDERDNLKISDFGLA 152 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------ccccchHHEEEeCCCCEEEEEeecc
Confidence 3455555554443333222 223456778889999999999998877 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCC-CcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIF-SVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
+...............||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... ..... +.....
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~---~~~~~~ 226 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSD---WKEKKT 226 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS---HHHHH---HHTTCT
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHH---Hhcccc
Confidence 87644333333345689999999999988775 778999999999999999999985432211 11111 111111
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
. ..+. . .....+.+|+.+||+.||++|||+.|++++
T Consensus 227 ~--~~~~--~----~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 227 Y--LNPW--K----KIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp T--STTG--G----GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c--CCcc--c----cCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 0000 0 112345679999999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-24 Score=224.70 Aligned_cols=187 Identities=20% Similarity=0.357 Sum_probs=128.5
Q ss_pred eeeecccccCCCCccccC----CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 244 RYELYRFLVDTPTVTVTA----PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
.|.++.|..++++..... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iv-------HrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV-------HRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEECGGGCEEECCCC
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCee-------CCCCChhhEEECCCCCEEECCCc
Confidence 345556665554432221 1233456677888999999999988776 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
+++....... .......++..|+|||++.++.++.++||||||+++|||++ |+.||.... ..... .....+
T Consensus 326 ~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~---~~~~~----~~i~~~ 397 (452)
T 1fmk_A 326 LARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVL----DQVERG 397 (452)
T ss_dssp TTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHH----HHHHTT
T ss_pred cceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC---HHHHH----HHHHcC
Confidence 9987643221 11223456788999999999999999999999999999999 898875321 11112 222222
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCCC
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPK 454 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 454 (491)
... ..+......+.+|+.+||+.||++|||+.+|++.|+......+.
T Consensus 398 ~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 398 YRM---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp CCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 111 11122234577899999999999999999999999988655443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.89 E-value=7.1e-25 Score=223.36 Aligned_cols=169 Identities=21% Similarity=0.222 Sum_probs=115.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCc----------------
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQS---------------- 329 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~---------------- 329 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++.......
T Consensus 108 ~~~~~~i~~qi~~~L~~LH~~~iv-------HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~ 180 (388)
T 3oz6_A 108 PVHKQYVVYQLIKVIKYLHSGGLL-------HRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180 (388)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC------
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEE-------eCCCCHHHeEEcCCCCEEecCCccccccccccccccccccccccccccc
Confidence 445566888999999999998877 999999999999999999999999987533110
Q ss_pred ---ccccCceeecCCCChhhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc----
Q 011196 330 ---EANTNRVVGTYGYMAPEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA---- 401 (491)
Q Consensus 330 ---~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 401 (491)
........||+.|+|||++.+ ..++.++|||||||+++||++|+.||.... .......+..........
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~p~~~~~~~ 257 (388)
T 3oz6_A 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS---TMNQLERIIGVIDFPSNEDVES 257 (388)
T ss_dssp ---------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCCHHHHHh
Confidence 111234579999999999987 578999999999999999999999975322 222222222211111000
Q ss_pred -------------------------ccccc---hh-cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 402 -------------------------ELMDS---VV-KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 402 -------------------------~~~d~---~l-~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..+.. .+ ...........+.+|+.+||+.||++|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 258 IQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp SCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 00000 00 000000112457789999999999999999998875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.4e-24 Score=221.94 Aligned_cols=168 Identities=17% Similarity=0.140 Sum_probs=115.3
Q ss_pred CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...... ......||+.|+
T Consensus 161 l~~~~~~~~~~qil~aL~~lH~~~ii-------HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~ 230 (464)
T 3ttj_A 161 LDHERMSYLLYQMLCGIKHLHSAGII-------HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYR 230 (464)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcc-------cCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCccccccc
Confidence 33556677889999999999998777 99999999999999999999999998764322 223468899999
Q ss_pred hhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC------------------------
Q 011196 344 APEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH------------------------ 399 (491)
Q Consensus 344 aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------------ 399 (491)
|||++.+..++.++|||||||+++||++|+.||.... ..+....+.+......
T Consensus 231 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~---~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (464)
T 3ttj_A 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD---YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL 307 (464)
T ss_dssp CHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCC
T ss_pred CHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCC
Confidence 9999999999999999999999999999999985322 1122222211111100
Q ss_pred -ccccccchhcCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 400 -AAELMDSVVKQSC---DQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 400 -~~~~~d~~l~~~~---~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
+.......+.... .......+.+|+.+||+.||++|||+.|++++
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 308 TFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000 01124568899999999999999999998864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.1e-24 Score=211.48 Aligned_cols=160 Identities=26% Similarity=0.342 Sum_probs=122.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............+++.|+||
T Consensus 149 ~~~~~~i~~qi~~~l~~lH~~~iv-------H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 221 (314)
T 2ivs_A 149 MGDLISFAWQISQGMQYLAEMKLV-------HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAI 221 (314)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCc-------ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccCh
Confidence 445677888999999999998777 9999999999999999999999999876554433333345678889999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|.+.+..++.++||||||+++|||++ |..||.... ...+.. ....+.... .+......+.+++
T Consensus 222 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---~~~~~~----~~~~~~~~~---------~~~~~~~~~~~li 285 (314)
T 2ivs_A 222 ESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP---PERLFN----LLKTGHRME---------RPDNCSEEMYRLM 285 (314)
T ss_dssp HHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGGHHH----HHHTTCCCC---------CCTTCCHHHHHHH
T ss_pred hhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHH----HhhcCCcCC---------CCccCCHHHHHHH
Confidence 99999999999999999999999999 999975322 122222 112221111 1112234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++||++.||++.|+..
T Consensus 286 ~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 286 LQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999865
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-25 Score=218.52 Aligned_cols=168 Identities=20% Similarity=0.275 Sum_probs=117.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc-cccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE-ANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++........ .......++..|+|
T Consensus 113 ~~~~~~~~~qi~~~l~~lH~~~iv-------H~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 185 (295)
T 3ugc_A 113 HIKLLQYTSQICKGMEYLGTKRYI-------HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185 (295)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCC
T ss_pred HHHHHHHHHHHHHHHHHHhcCCcc-------cCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeC
Confidence 455677888999999999988777 9999999999999999999999999876443221 11222346778999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccC---------CCcccHHHHHHHHhhcCCccccccchhcCCCCHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHL---------EHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 415 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 415 (491)
||.+.+..++.++||||||+++|||++|..|+..... .................... ..+..
T Consensus 186 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~ 256 (295)
T 3ugc_A 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL---------PRPDG 256 (295)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCC---------CCCTT
T ss_pred cHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcC---------CCCcC
Confidence 9999999999999999999999999999988653210 00001111111111111111 11222
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 416 ELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 416 ~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
....+.+++.+||+.||++|||+.||++.|+...
T Consensus 257 ~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 257 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 3345778999999999999999999999998653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.9e-24 Score=209.07 Aligned_cols=166 Identities=19% Similarity=0.203 Sum_probs=118.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... ......||+.|+||
T Consensus 118 ~~~~~~~~~qi~~~l~~LH~~~iv-------H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aP 188 (311)
T 3niz_A 118 DSQIKIYLYQLLRGVAHCHQHRIL-------HRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAP 188 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------cCCCchHhEEECCCCCEEEccCcCceecCCCcc--cccCCcccCCcCCH
Confidence 455677888999999999998877 999999999999999999999999987643322 12235789999999
Q ss_pred hhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc---cccccch------h--cCCCC
Q 011196 346 EYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA---AELMDSV------V--KQSCD 413 (491)
Q Consensus 346 E~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~d~~------l--~~~~~ 413 (491)
|++.+ ..++.++||||||++++||++|+.||...... .....+......... ....+.. . ....+
T Consensus 189 E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (311)
T 3niz_A 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD---DQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKP 265 (311)
T ss_dssp HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT---THHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCC
T ss_pred HHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCc
Confidence 99976 56899999999999999999999998643322 233333332221111 1100000 0 00000
Q ss_pred -----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 414 -----QAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 414 -----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.....++.+++.+||+.||++|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 266 WSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 011245778999999999999999999886
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-24 Score=213.53 Aligned_cols=166 Identities=17% Similarity=0.189 Sum_probs=119.3
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... .....||+.|+|
T Consensus 118 ~~~~~~~i~~qi~~al~~lH~~~iv-------H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~a 187 (308)
T 3g33_A 118 PAETIKDLMRQFLRGLDFLHANCIV-------HRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRA 187 (308)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCTTTEEECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCHHHEEEcCCCCEEEeeCccccccCCCcc---cCCccccccccC
Confidence 3556778899999999999998777 999999999999999999999999986543222 234578999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC---Cccccc---cchhc--CCCC---
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG---HAAELM---DSVVK--QSCD--- 413 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---d~~l~--~~~~--- 413 (491)
||++.+..++.++|||||||++|||++|+.||... ........+....... .+.... +.... ...+
T Consensus 188 PE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (308)
T 3g33_A 188 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN---SEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQS 264 (308)
T ss_dssp HHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS---SHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHH
T ss_pred chHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHH
Confidence 99999999999999999999999999999997532 2222222232222111 111000 00000 0000
Q ss_pred --HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 414 --QAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 414 --~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+....+.+++.+||+.||++|||+.|+++
T Consensus 265 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 265 VVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 112245678999999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-24 Score=218.04 Aligned_cols=154 Identities=9% Similarity=0.001 Sum_probs=111.5
Q ss_pred hhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhh
Q 011196 270 ITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM 349 (491)
Q Consensus 270 ~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 349 (491)
+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... ...+|+.|+|||++.
T Consensus 197 ~~i~~qi~~aL~~LH~~~iv-------HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~ 264 (371)
T 3q60_A 197 HILTAQLIRLAANLQSKGLV-------HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLN 264 (371)
T ss_dssp HHHHHHHHHHHHHHHHTTEE-------ETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHCCCc-------cCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhcc
Confidence 56678999999999998877 999999999999999999999999987643211 235679999999998
Q ss_pred h--CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHc
Q 011196 350 E--GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLC 427 (491)
Q Consensus 350 ~--~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~c 427 (491)
+ ..++.++|||||||++|||++|+.||.......... +........................+.+|+.+|
T Consensus 265 ~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 336 (371)
T 3q60_A 265 ASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF 336 (371)
T ss_dssp CSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHH
T ss_pred CCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHH
Confidence 7 679999999999999999999999986442221100 000000000000000000112234577899999
Q ss_pred ccCCCCCCCCHHHHHH
Q 011196 428 VQEDPMDRPTMSSVAV 443 (491)
Q Consensus 428 l~~dP~~RPs~~evl~ 443 (491)
|+.||++|||+.|+++
T Consensus 337 L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 337 LNFDRRRRLLPLEAME 352 (371)
T ss_dssp TCSSTTTCCCHHHHTT
T ss_pred cCCChhhCCCHHHHhc
Confidence 9999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.89 E-value=9.2e-24 Score=216.13 Aligned_cols=181 Identities=17% Similarity=0.167 Sum_probs=121.9
Q ss_pred eeeecccccCCCCccccC----CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC---CCCceEe
Q 011196 244 RYELYRFLVDTPTVTVTA----PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH---EMNPKIS 316 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~---~~~~kl~ 316 (491)
.|.++.|..++.+..... ..........++.+++.++.+||..+++ ||||||+|||++. ++.+||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv-------HrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA-------HRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------ccCcCcceEEEecCCCCccEEEE
Confidence 345556655444322221 1233556778899999999999998777 9999999999998 7889999
Q ss_pred ccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCc-ccHHHHHHHHh
Q 011196 317 DFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHG-PSLLAYIWKLW 395 (491)
Q Consensus 317 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~ 395 (491)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+.
T Consensus 207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~--- 280 (400)
T 1nxk_A 207 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR--- 280 (400)
T ss_dssp CCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---
T ss_pred ecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---
Confidence 999998654322 12346789999999999988999999999999999999999999864433221 11222221
Q ss_pred hcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 396 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 396 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.+... ...+. .... ...+.+|+.+||+.||++|||+.|++++
T Consensus 281 -~~~~~-~~~~~-~~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 281 -MGQYE-FPNPE-WSEV----SEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -HTCCC-CCTTT-TTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -cCccc-CCCcc-cccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11110 00000 0112 2356789999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.5e-24 Score=212.35 Aligned_cols=162 Identities=19% Similarity=0.353 Sum_probs=115.2
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............+++.|+|
T Consensus 135 ~~~~~~~i~~qi~~al~~LH~~~iv-------H~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~a 207 (323)
T 3qup_A 135 PLQTLVRFMVDIACGMEYLSSRNFI-------HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207 (323)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCC
T ss_pred CHHHHHHHHHHHHHHHHHHHcCCcc-------cCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccC
Confidence 3456778889999999999998777 999999999999999999999999987654433333334456788999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||.+.+..++.++||||||+++|||++ |+.||.... .......+ ..+.... .+......+.++
T Consensus 208 PE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~---~~~~~~~~----~~~~~~~---------~~~~~~~~l~~l 271 (323)
T 3qup_A 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE---NAEIYNYL----IGGNRLK---------QPPECMEEVYDL 271 (323)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGGHHHHH----HTTCCCC---------CCTTCCHHHHHH
T ss_pred chhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC---hHHHHHHH----hcCCCCC---------CCCccCHHHHHH
Confidence 999999999999999999999999999 898875322 22222221 1111111 111222457789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
+.+||+.||++|||+.++++.|+...
T Consensus 272 i~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 272 MYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999998764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=211.27 Aligned_cols=183 Identities=11% Similarity=0.114 Sum_probs=130.3
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC--CceEeccCcceecCCCCcc-----cccCcee
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM--NPKISDFGMARIFGGNQSE-----ANTNRVV 337 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~ 337 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++ .+||+|||+++........ .......
T Consensus 157 ~~~~~~~i~~qi~~~L~~LH~~~iv-------H~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~ 229 (352)
T 2jii_A 157 SERSVLQVACRLLDALEFLHENEYV-------HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHE 229 (352)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCB-------CSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcc-------CCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcccccccccccccc
Confidence 3556778899999999999998777 999999999999988 8999999999866432211 1123357
Q ss_pred ecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhc-CCCCHHH
Q 011196 338 GTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK-QSCDQAE 416 (491)
Q Consensus 338 gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~ 416 (491)
||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...........+.. ....+.+.... ...+
T Consensus 230 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--- 303 (352)
T 2jii_A 230 GDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP--NTEDIMKQKQKFVD-KPGPFVGPCGHWIRPS--- 303 (352)
T ss_dssp SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT--CHHHHHHHHHHHHH-SCCCEECTTSCEECCC---
T ss_pred CCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc--CHHHHHHHHHhccC-ChhhhhhhccccCCCc---
Confidence 89999999999998999999999999999999999999764321 11122222221111 11112111111 1122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCCCCCCCCee
Q 011196 417 LLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFS 461 (491)
Q Consensus 417 ~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~~p~~~ 461 (491)
..+.+++.+||+.||++||++.+|++.|+............++.
T Consensus 304 -~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~d 347 (352)
T 2jii_A 304 -ETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIG 347 (352)
T ss_dssp -HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCC
T ss_pred -HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCcccc
Confidence 44677899999999999999999999998876555444333343
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.6e-24 Score=210.89 Aligned_cols=162 Identities=24% Similarity=0.389 Sum_probs=123.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............+++.|+||
T Consensus 144 ~~~~~~~~~qi~~~l~~lH~~~i~-------H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 216 (313)
T 1t46_A 144 LEDLLSFSYQVAKGMAFLASKNCI-------HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216 (313)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------cCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeCh
Confidence 456677888999999999998777 9999999999999999999999999877554443334456788899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||++++||++ |+.||..... ....... ...... .. .+......+.+++
T Consensus 217 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~---~~~~~~-----~~----~~~~~~~~l~~li 281 (313)
T 1t46_A 217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---DSKFYKM---IKEGFR-----ML----SPEHAPAEMYDIM 281 (313)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---SHHHHHH---HHHTCC-----CC----CCTTSCHHHHHHH
T ss_pred HHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc---hhHHHHH---hccCCC-----CC----CcccCCHHHHHHH
Confidence 99999999999999999999999998 9998753221 1111111 111110 00 0111224577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
.+||+.||++|||+.|++++|++..
T Consensus 282 ~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 282 KTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHcCCCchhCcCHHHHHHHHHHHH
Confidence 9999999999999999999998753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=5.6e-24 Score=212.43 Aligned_cols=163 Identities=23% Similarity=0.321 Sum_probs=122.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............++..|+||
T Consensus 173 ~~~~~~i~~qi~~~l~~LH~~~iv-------H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 245 (343)
T 1luf_A 173 CAEQLCIARQVAAGMAYLSERKFV-------HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 245 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecCh
Confidence 455677888999999999988777 9999999999999999999999999865433222223345678899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++|||++ |..||.... . .........+..... +......+.+++
T Consensus 246 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---~----~~~~~~~~~~~~~~~---------~~~~~~~l~~li 309 (343)
T 1luf_A 246 ESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA---H----EEVIYYVRDGNILAC---------PENCPLELYNLM 309 (343)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---H----HHHHHHHHTTCCCCC---------CTTCCHHHHHHH
T ss_pred hhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC---h----HHHHHHHhCCCcCCC---------CCCCCHHHHHHH
Confidence 99999999999999999999999999 998975321 1 111222222222111 111224577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcCCCC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASDIVT 451 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~~~~ 451 (491)
.+||+.||++||++.+|+++|+.....
T Consensus 310 ~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 310 RLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred HHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 999999999999999999999987543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-24 Score=213.65 Aligned_cols=165 Identities=22% Similarity=0.365 Sum_probs=117.0
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............+++.|+|
T Consensus 145 ~~~~~~~i~~qi~~aL~~LH~~~iv-------H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 217 (313)
T 3brb_A 145 PLQTLLKFMVDIALGMEYLSNRNFL-------HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217 (313)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTTTCC-------CCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcc-------cCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccC
Confidence 3456778889999999999998776 999999999999999999999999987654332222334567889999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||.+.+..++.++||||||+++|||++ |..||.... ........ ..+..... +......+.++
T Consensus 218 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~----~~~~~~~~---------~~~~~~~l~~l 281 (313)
T 3brb_A 218 IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ---NHEMYDYL----LHGHRLKQ---------PEDCLDELYEI 281 (313)
T ss_dssp HHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGGHHHHH----HTTCCCCC---------BTTCCHHHHHH
T ss_pred chhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC---HHHHHHHH----HcCCCCCC---------CccccHHHHHH
Confidence 999999999999999999999999999 888865322 22222222 11111111 11122457789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcCCCCC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASDIVTL 452 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 452 (491)
+.+||+.||++||++.+++++|+.....+
T Consensus 282 i~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 282 MYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 99999999999999999999998765443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=209.21 Aligned_cols=200 Identities=17% Similarity=0.124 Sum_probs=129.8
Q ss_pred eeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhheeeEE-eEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLSTSFLW-CIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.+++|+..+.+..... ........+.++.+++.++.+||...... +..+++||||||+|||++.++.+||+|||++
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCc
Confidence 345556655444322211 12334566778888999999999211110 1233449999999999999999999999999
Q ss_pred eecCCCCccc--ccCceeecCCCChhhhhhhC------CCCcccceeehhHHHHHHHhC----------CCCCCCccCCC
Q 011196 322 RIFGGNQSEA--NTNRVVGTYGYMAPEYAMEG------IFSVKSDVFSFGVVLLEIISG----------KKSSGFYHLEH 383 (491)
Q Consensus 322 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwS~Gvvl~elltG----------~~p~~~~~~~~ 383 (491)
+......... ......||..|+|||++.+. .++.++||||||+++|||++| ..||.....
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~-- 272 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP-- 272 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC--
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc--
Confidence 8765433211 22345789999999999765 234789999999999999999 556532211
Q ss_pred cccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 384 GPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
....................+.... ...+....+.+|+.+||+.||++|||+.||+++|+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccHHHHHHHHHHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 1111222222222221111111110 1235566788999999999999999999999999865
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-24 Score=224.95 Aligned_cols=183 Identities=22% Similarity=0.401 Sum_probs=130.3
Q ss_pred eeecccccCCCCccccCC----CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 245 YELYRFLVDTPTVTVTAP----NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
|.++.|..++.+...... .........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv-------HrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI-------HRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCC-------CSSCSGGGEEECTTCCEEECSTTG
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc-------CCCCCHHHEEECCCCcEEEeeCCC
Confidence 455566655544322211 122345667888999999999988776 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
++....... .......++..|+|||++..+.++.++||||||+++|||++ |+.||... ........+ ..+.
T Consensus 331 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~---~~~~~~~~i----~~~~ 402 (454)
T 1qcf_A 331 ARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM---SNPEVIRAL----ERGY 402 (454)
T ss_dssp GGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHHHHH----HHTC
T ss_pred ceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC---CHHHHHHHH----HcCC
Confidence 987643211 11122346788999999999999999999999999999999 99997532 112222221 1111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCC
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVT 451 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 451 (491)
.. ..+......+.+|+.+||+.||++|||+.+|++.|+.....
T Consensus 403 ~~---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 403 RM---------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CC---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 00 11112234577899999999999999999999999987543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=206.41 Aligned_cols=172 Identities=23% Similarity=0.331 Sum_probs=118.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC-ceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN-PKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~-~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
....+.++.+++.++.+||... .++++||||||+|||++.++. +||+|||++...... .....||..|+|
T Consensus 101 ~~~~~~~~~qi~~~l~~LH~~~----~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~a 171 (307)
T 2eva_A 101 AAHAMSWCLQCSQGVAYLHSMQ----PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMA 171 (307)
T ss_dssp HHHHHHHHHHHHHHHHHHHTCS----SSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSC
T ss_pred HHHHHHHHHHHHHHHHHHHhCC----CCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEC
Confidence 3455667788889999999821 123449999999999998886 799999999755322 123468999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||++.+..++.++||||||+++|||++|+.||..... ......+... .+..... ....+ ..+.+++
T Consensus 172 PE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~-~~~~~~~-----~~~~~----~~l~~li 237 (307)
T 2eva_A 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG----PAFRIMWAVH-NGTRPPL-----IKNLP----KPIESLM 237 (307)
T ss_dssp HHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS----SHHHHHHHHH-TTCCCCC-----BTTCC----HHHHHHH
T ss_pred hhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc----cHHHHHHHHh-cCCCCCc-----ccccC----HHHHHHH
Confidence 9999988999999999999999999999999753221 1112222221 1111111 11222 3467799
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcCCCCCCCCCCCCe
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAF 460 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~~p~~ 460 (491)
.+||+.||++|||+.+++++|+.....++.+..|..
T Consensus 238 ~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~ 273 (307)
T 2eva_A 238 TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273 (307)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCC
T ss_pred HHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccc
Confidence 999999999999999999999987666655544443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.8e-23 Score=205.13 Aligned_cols=179 Identities=18% Similarity=0.300 Sum_probs=128.0
Q ss_pred eeeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 243 IRYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
..|.++.|..++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 116 ~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~iv-------H~Dlkp~NIll~~~~~~kl~Dfg~~ 188 (321)
T 2c30_A 116 ELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVI-------HRDIKSDSILLTLDGRVKLSDFGFC 188 (321)
T ss_dssp EEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHEEECCCCcEEEeeeeee
Confidence 3456666665554332222 1234556778888999999999998777 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..... .........
T Consensus 189 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~---~~~~~----~~~~~~~~~ 259 (321)
T 2c30_A 189 AQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS---PVQAM----KRLRDSPPP 259 (321)
T ss_dssp EECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHH----HHHHHSSCC
T ss_pred eecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHH----HHHhcCCCC
Confidence 87654322 1234678999999999999999999999999999999999999975321 11111 111111111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..... ......+.+++.+||+.||++|||+.|++++
T Consensus 260 ~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 260 KLKNS-------HKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp CCTTG-------GGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcCcc-------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11110 1112346778999999999999999999873
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.89 E-value=5e-24 Score=224.11 Aligned_cols=182 Identities=21% Similarity=0.302 Sum_probs=131.4
Q ss_pred eeeecccccCCCCccccC----CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 244 RYELYRFLVDTPTVTVTA----PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
.|.++.|..++.+..... ........+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv-------HrDlkp~NIll~~~~~~kl~DFG 363 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI-------HRNLAARNCLVGENHLVKVADFG 363 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECGGGCEEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcc-------cCCCChhhEEECCCCcEEEeecc
Confidence 455666665554332221 1223445667888999999999998777 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
+++........ ......++..|+|||++....++.++||||||+++|||++ |..||.... .......+ ..+
T Consensus 364 ~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~---~~~~~~~~----~~~ 435 (495)
T 1opk_A 364 LSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELL----EKD 435 (495)
T ss_dssp CEECCTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGGHHHHH----HTT
T ss_pred cceeccCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----HcC
Confidence 99876433221 2223456788999999999999999999999999999999 888875322 12222211 111
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
.. ...+......+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 436 ~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 436 YR---------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CC---------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11 1111222345778999999999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=204.87 Aligned_cols=168 Identities=15% Similarity=0.158 Sum_probs=119.4
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... ......||..|+|
T Consensus 99 ~~~~~~~~~~ql~~~l~~lH~~~iv-------H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~a 169 (292)
T 3o0g_A 99 DPEIVKSFLFQLLKGLGFCHSRNVL-------HRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRP 169 (292)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--CCCSCCSCGGGCC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEEcCCCCEEEeecccceecCCccc--cccCCccccCCcC
Confidence 3556777889999999999998877 999999999999999999999999987643322 2234578999999
Q ss_pred hhhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc---cccc------------chh
Q 011196 345 PEYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA---ELMD------------SVV 408 (491)
Q Consensus 345 PE~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~d------------~~l 408 (491)
||++.+.. ++.++||||||++++||++|..|+. ...........+.+........ .... ...
T Consensus 170 PE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~--~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T 3o0g_A 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF--PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS 247 (292)
T ss_dssp HHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC--CCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCC
T ss_pred hHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc--CCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcc
Confidence 99998766 8999999999999999999888842 2223333333333322211110 0000 000
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 409 KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
...........+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00011122345678999999999999999999886
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.6e-24 Score=205.83 Aligned_cols=158 Identities=21% Similarity=0.360 Sum_probs=116.6
Q ss_pred CCcchhhhHhHHHHHHHHHhhee--eEEeEEeeeccccccccccccCCCC-----ceEeccCcceecCCCCcccccCcee
Q 011196 265 TSKRWITIAEAASAIIVFLLSTS--FLWCIIRRRNKRVRASNVLLDHEMN-----PKISDFGMARIFGGNQSEANTNRVV 337 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~~iHrDlKp~NILl~~~~~-----~kl~DfGla~~~~~~~~~~~~~~~~ 337 (491)
.......++.+++.++.+||..+ ++ ||||||+|||++.++. +||+|||+++..... .....
T Consensus 120 ~~~~~~~~~~~l~~~l~~lH~~~~~iv-------H~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~ 187 (287)
T 4f0f_A 120 KWSVKLRLMLDIALGIEYMQNQNPPIV-------HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLL 187 (287)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTSSSCCB-------CSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC-----EECCC
T ss_pred cHHHHHHHHHHHHHHHHHHHhCCCCee-------cCCCCcceEEEeccCCCCceeEEeCCCCcccccccc-----ccccC
Confidence 34556778889999999999877 66 9999999999987776 999999999754321 22357
Q ss_pred ecCCCChhhhhh--hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHH
Q 011196 338 GTYGYMAPEYAM--EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 415 (491)
Q Consensus 338 gt~~y~aPE~~~--~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 415 (491)
|++.|+|||++. ...++.++||||||+++|||++|+.||...... ................ .+..
T Consensus 188 g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~---------~~~~ 254 (287)
T 4f0f_A 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG----KIKFINMIREEGLRPT---------IPED 254 (287)
T ss_dssp CCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC----HHHHHHHHHHSCCCCC---------CCTT
T ss_pred CCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc----HHHHHHHHhccCCCCC---------CCcc
Confidence 899999999984 455789999999999999999999998543221 1111111111111111 1112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 011196 416 ELLKYIHIGLLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 416 ~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
....+.+++.+||+.||++|||+.|+++.|++
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 255 CPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 23457789999999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-23 Score=209.39 Aligned_cols=157 Identities=18% Similarity=0.257 Sum_probs=109.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++ ++.+||+|||+++...............||+.|+||
T Consensus 107 ~~~~~~i~~qi~~al~~lH~~~ii-------HrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP 178 (343)
T 3dbq_A 107 PWERKSYWKNMLEAVHTIHQHGIV-------HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCH
Confidence 445677888999999999988776 999999999997 577999999999876544333333456799999999
Q ss_pred hhhhh-----------CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCH
Q 011196 346 EYAME-----------GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQ 414 (491)
Q Consensus 346 E~~~~-----------~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 414 (491)
|++.+ ..++.++|||||||++|||++|+.||... ................. ..+.
T Consensus 179 E~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~~~~~~~~~~---------~~~~ 244 (343)
T 3dbq_A 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----INQISKLHAIIDPNHEI---------EFPD 244 (343)
T ss_dssp HHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC-----CSHHHHHHHHHCTTSCC---------CCCC
T ss_pred HHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh-----hhHHHHHHHHhcCCccc---------CCcc
Confidence 99975 67899999999999999999999997521 11122222222111111 1111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 415 AELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 415 ~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.....+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 112346789999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=6.2e-23 Score=203.12 Aligned_cols=161 Identities=22% Similarity=0.364 Sum_probs=122.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............+++.|+||
T Consensus 137 ~~~~~~i~~qi~~~l~~lH~~~i~-------H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 209 (322)
T 1p4o_A 137 LSKMIQMAGEIADGMAYLNANKFV-------HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCB-------CSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCc-------cCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccCh
Confidence 455667888999999999998777 9999999999999999999999999865443332333345778899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++|||++ |..||.... ... .......+..... +......+.+++
T Consensus 210 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~----~~~~~~~~~~~~~---------~~~~~~~l~~li 273 (322)
T 1p4o_A 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQ----VLRFVMEGGLLDK---------PDNCPDMLFELM 273 (322)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HHH----HHHHHHTTCCCCC---------CTTCCHHHHHHH
T ss_pred hhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC---HHH----HHHHHHcCCcCCC---------CCCCCHHHHHHH
Confidence 99999999999999999999999999 788864321 111 1222222221111 111224467899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
.+||+.||++|||+.|+++.|+...
T Consensus 274 ~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 274 RMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHcCCCcccCcCHHHHHHHHHHhh
Confidence 9999999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=7.6e-24 Score=210.44 Aligned_cols=194 Identities=23% Similarity=0.269 Sum_probs=133.4
Q ss_pred eeeeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 243 IRYELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
..|.+++|+.++...... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv-------H~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCV-------HRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEEEETTEEEECCGG
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCcc-------CCCCChhhEEECCCCCEEEcccc
Confidence 345566666554432221 11233556777888999999999998777 99999999999999999999999
Q ss_pred cceecCCCCcc-cccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCC--------CcccHHHH
Q 011196 320 MARIFGGNQSE-ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLE--------HGPSLLAY 390 (491)
Q Consensus 320 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~--------~~~~~~~~ 390 (491)
+++........ .......|+..|+|||++.+..++.++||||||++++||++|..|+...... ........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence 99876543322 1223356788899999999999999999999999999999999986432110 01111111
Q ss_pred HHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCC
Q 011196 391 IWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTL 452 (491)
Q Consensus 391 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 452 (491)
.......+.. ...+......+.+|+.+||+.||++|||+.|++++|+......
T Consensus 253 ~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 253 LLELLEEGQR---------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHHhhcccC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1121111111 1112223345778999999999999999999999999876544
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.2e-23 Score=204.82 Aligned_cols=177 Identities=24% Similarity=0.273 Sum_probs=114.7
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCC---cccccCceeecCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQ---SEANTNRVVGTYG 341 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~---~~~~~~~~~gt~~ 341 (491)
.......++.+++.++.+||..+++ ||||||+|||++ ++.+||+|||+++...... .........|+..
T Consensus 128 ~~~~~~~i~~qi~~al~~lH~~~i~-------H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~ 199 (319)
T 2y4i_B 128 DVNKTRQIAQEIVKGMGYLHAKGIL-------HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199 (319)
T ss_dssp CSHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGG
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcc-------ccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCccc
Confidence 4566778899999999999998777 999999999998 6799999999987543211 1112223468999
Q ss_pred CChhhhhhh---------CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCC
Q 011196 342 YMAPEYAME---------GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 412 (491)
Q Consensus 342 y~aPE~~~~---------~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 412 (491)
|+|||++.+ ..++.++||||||+++|||++|+.||.... . ....+. ...+........ ..
T Consensus 200 y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~---~~~~~~-~~~~~~~~~~~~----~~ 268 (319)
T 2y4i_B 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP---A---EAIIWQ-MGTGMKPNLSQI----GM 268 (319)
T ss_dssp TSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC---H---HHHHHH-HHTTCCCCCCCS----SC
T ss_pred ccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC---H---HHHHHH-hccCCCCCCCcC----CC
Confidence 999999874 347899999999999999999999975321 1 111111 122211111111 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCCCCCCCCeeecc
Q 011196 413 DQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSVSR 464 (491)
Q Consensus 413 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~~p~~~~~~ 464 (491)
+ ..+.+++.+||+.||++|||+.+++++|+.........+.|..+|..
T Consensus 269 ~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~~ 316 (319)
T 2y4i_B 269 G----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS 316 (319)
T ss_dssp C----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------------
T ss_pred C----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccccc
Confidence 1 23667999999999999999999999999997777777777777654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.3e-24 Score=212.86 Aligned_cols=151 Identities=19% Similarity=0.254 Sum_probs=112.5
Q ss_pred CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++........ .....||+.|+
T Consensus 154 l~~~~~~~i~~qi~~aL~~LH~~~iv-------H~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~ 223 (311)
T 3p1a_A 154 LPEAQVWGYLRDTLLALAHLHSQGLV-------HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYM 223 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEe-------cCCCCHHHEEECCCCCEEEccceeeeecccCCC---CcccCCCcccc
Confidence 34566778899999999999998776 999999999999999999999999987643322 22356899999
Q ss_pred hhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 344 APEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 344 aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
|||++.+ .++.++||||||+++|||++|..++... ..+.....+.. .+...... ...+.++
T Consensus 224 aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~----~~~~~~~~----~~~l~~l 284 (311)
T 3p1a_A 224 APELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYL----PPEFTAGL----SSELRSV 284 (311)
T ss_dssp CGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCC----CHHHHTTS----CHHHHHH
T ss_pred CHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCC----CcccccCC----CHHHHHH
Confidence 9998865 7999999999999999999997664311 11222222211 11111112 2457789
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 011196 424 GLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~ 443 (491)
+.+||+.||++|||+.|+++
T Consensus 285 i~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 285 LVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHcCCChhhCcCHHHHHh
Confidence 99999999999999999886
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.5e-24 Score=213.28 Aligned_cols=161 Identities=26% Similarity=0.372 Sum_probs=122.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............|+..|+||
T Consensus 163 ~~~~~~~~~qi~~~l~~lH~~~iv-------H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 235 (333)
T 2i1m_A 163 TRDLLHFSSQVAQGMAFLASKNCI-------HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAP 235 (333)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCH
T ss_pred HHHHHHHHHHHHHHHHHHhcCCcc-------cCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCH
Confidence 456677888999999999998777 9999999999999999999999999876544333334456778899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++|||++ |..||..... ..... .....+... ..+......+.+++
T Consensus 236 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~---~~~~~~~~~---------~~~~~~~~~l~~li 300 (333)
T 2i1m_A 236 ESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV---NSKFY---KLVKDGYQM---------AQPAFAPKNIYSIM 300 (333)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS---SHHHH---HHHHHTCCC---------CCCTTCCHHHHHHH
T ss_pred HHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch---hHHHH---HHHhcCCCC---------CCCCCCCHHHHHHH
Confidence 99999999999999999999999998 8888753221 11111 111111100 00111124567899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++|||+.||+++|+..
T Consensus 301 ~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 301 QACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhccChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-24 Score=219.14 Aligned_cols=182 Identities=20% Similarity=0.305 Sum_probs=118.1
Q ss_pred eeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.++.|..++.+..... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv-------H~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV-------HRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEECTTCCEEECCC--
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCee-------CCCCCcceEEEcCCCCEEECcCcc
Confidence 345556665544322221 1233456677889999999999988776 999999999999999999999999
Q ss_pred ceecCCCCccc-ccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 321 ARIFGGNQSEA-NTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 321 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
++......... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..... .....+
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~---~~~~~----~~i~~~ 266 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS---NQDVI----KAVDEG 266 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC---HHHHH----HHHHTT
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC---HHHHH----HHHHcC
Confidence 98765432211 1222345778999999999999999999999999999998 999974321 11111 111111
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
. ....+......+.+++.+||+.||++||++.+|+++|+..
T Consensus 267 ~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 267 Y---------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp E---------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 1 0111112334577899999999999999999999999765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.8e-24 Score=218.84 Aligned_cols=161 Identities=27% Similarity=0.326 Sum_probs=119.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC---CceEeccCcceecCCCCcccccCceeecCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM---NPKISDFGMARIFGGNQSEANTNRVVGTYGY 342 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 342 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++ .+||+|||+++...............||+.|
T Consensus 180 ~~~~~~i~~qi~~aL~~LH~~~iv-------HrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y 252 (367)
T 3l9p_A 180 MLDLLHVARDIACGCQYLEENHFI-------HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252 (367)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGG
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------CCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccE
Confidence 445677888999999999998777 999999999999554 5999999999865332222233345678999
Q ss_pred ChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 343 MAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 343 ~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
+|||++.+..++.++|||||||++|||++ |..||... ...... .....+..... +......+.
T Consensus 253 ~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~---~~~~~~----~~i~~~~~~~~---------~~~~~~~l~ 316 (367)
T 3l9p_A 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVL----EFVTSGGRMDP---------PKNCPGPVY 316 (367)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHH----HHHHTTCCCCC---------CTTCCHHHH
T ss_pred ECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---CHHHHH----HHHHcCCCCCC---------CccCCHHHH
Confidence 99999999999999999999999999998 99987532 111111 22222211111 111223477
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
+|+.+||+.||++||++.+|++.|+...
T Consensus 317 ~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 317 RIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 8999999999999999999999997653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.2e-24 Score=218.79 Aligned_cols=157 Identities=18% Similarity=0.261 Sum_probs=110.4
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++ ++.+||+|||+++...............||+.|+||
T Consensus 154 ~~~~~~i~~qi~~aL~~lH~~~iv-------HrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP 225 (390)
T 2zmd_A 154 PWERKSYWKNMLEAVHTIHQHGIV-------HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225 (390)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTTCC-------CCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------ecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccCh
Confidence 335667888999999999998776 999999999996 578999999999876543333233456799999999
Q ss_pred hhhhh-----------CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCH
Q 011196 346 EYAME-----------GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQ 414 (491)
Q Consensus 346 E~~~~-----------~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 414 (491)
|++.+ ..++.++|||||||++|||++|+.||.... ................. .+.
T Consensus 226 E~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~~~~~~~~~~~---------~~~ 291 (390)
T 2zmd_A 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNHEIE---------FPD 291 (390)
T ss_dssp HHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CHHHHHHHHHCTTSCCC---------CCC
T ss_pred HHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-----HHHHHHHHHhCccccCC---------CCc
Confidence 99875 368899999999999999999999975321 11122222221111111 111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 415 AELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 415 ~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.....+.+|+.+||+.||++||++.|++++
T Consensus 292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 112356789999999999999999999865
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.88 E-value=5.4e-24 Score=211.98 Aligned_cols=174 Identities=19% Similarity=0.225 Sum_probs=124.8
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++...... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~iv-------HrDlkp~NIll~~~~~~kl~DFG~a 161 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV-------HRDLKAENLLLDADMNIKIADFGFS 161 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEECTTSCEEECSTTCC
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEe-------ccCCCHHHEEEcCCCCEEEeeccCc
Confidence 35555665544432221 12233556777888999999999988777 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCC-cccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFS-VKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
+....... .....||+.|+|||++.+..+. .++||||+||++|||++|+.||.... ...+.. ....+..
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~----~i~~~~~ 231 (328)
T 3fe3_A 162 NEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---LKELRE----RVLRGKY 231 (328)
T ss_dssp GGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH----HHHHCCC
T ss_pred eecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC---HHHHHH----HHHhCCC
Confidence 86643322 2345789999999999988775 79999999999999999999975321 111111 1111111
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
. .+......+.+++.+||+.||++|||+.|++++
T Consensus 232 ~----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 R----------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp C----------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred C----------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 111122346789999999999999999998864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.2e-24 Score=212.45 Aligned_cols=164 Identities=14% Similarity=0.146 Sum_probs=105.8
Q ss_pred CCcchhhhHhHHHHHHHHHhhee--eEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCccc----------c
Q 011196 265 TSKRWITIAEAASAIIVFLLSTS--FLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEA----------N 332 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~----------~ 332 (491)
.......++.+++.++.+||..+ ++ ||||||+|||++.++.+||+|||+++......... .
T Consensus 134 ~~~~~~~i~~qi~~~l~~LH~~~~~iv-------H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 206 (337)
T 3ll6_A 134 SCDTVLKIFYQTCRAVQHMHRQKPPII-------HRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206 (337)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTSSSCCB-------CCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC--------------
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCEE-------EccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchh
Confidence 35567788899999999999877 66 99999999999999999999999998764332211 1
Q ss_pred cCceeecCCCChhhhh---hhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhc
Q 011196 333 TNRVVGTYGYMAPEYA---MEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK 409 (491)
Q Consensus 333 ~~~~~gt~~y~aPE~~---~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 409 (491)
.....||+.|+|||++ .+..++.++||||||+++|||++|+.||....... ... .... ....
T Consensus 207 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~-----~~~~----~~~~ 271 (337)
T 3ll6_A 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR------IVN-----GKYS----IPPH 271 (337)
T ss_dssp -----------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------------CC----CCTT
T ss_pred hccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH------hhc-----Cccc----CCcc
Confidence 1134689999999998 56678999999999999999999999975321110 000 0000 0000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCCC
Q 011196 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPK 454 (491)
Q Consensus 410 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 454 (491)
.. ....+.+|+.+||+.||++||++.|+++.|+......+.
T Consensus 272 ~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 272 DT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp CC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred cc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 01 112356789999999999999999999999887554443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-23 Score=213.04 Aligned_cols=177 Identities=17% Similarity=0.248 Sum_probs=123.8
Q ss_pred eeeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 243 IRYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
..|.++.|..++.+.... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~giv-------HrDLKp~NILl~~~g~ikL~DFGl 199 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGII-------YRDLKLDNVLLDSEGHIKLTDYGM 199 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCB-------CCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEE-------eccCCHHHEEECCCCCEEEeecce
Confidence 345666776655432221 12233556677888999999999998777 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCc--ccHHHHHHHHhhcC
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHG--PSLLAYIWKLWCEG 398 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~ 398 (491)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..............
T Consensus 200 a~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~ 277 (396)
T 4dc2_A 200 CKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277 (396)
T ss_dssp CBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC
T ss_pred eeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc
Confidence 98532222 223457899999999999999999999999999999999999999864322111 11122222222221
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTM 438 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 438 (491)
.. .++......+.+|+.+||+.||++||++
T Consensus 278 ~~----------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 278 QI----------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CC----------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred cc----------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11 0111122356789999999999999996
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.9e-23 Score=203.29 Aligned_cols=187 Identities=19% Similarity=0.268 Sum_probs=127.3
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.+++|..+....... ..+........++.+++.++.++|..+++ ||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~-------H~Dlkp~Nil~~~~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIV-------HRDIKPQNILIDSNKTLKIFDFGIA 158 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEECTTSCEEECCCSSS
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCHHHEEECCCCCEEEEeCCCc
Confidence 34555665554432221 11233556777888999999999988777 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||... ............. ..
T Consensus 159 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~------~~~~~~~~~~~~~-~~ 230 (294)
T 4eqm_A 159 KALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE------TAVSIAIKHIQDS-VP 230 (294)
T ss_dssp TTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS------CHHHHHHHHHSSC-CC
T ss_pred cccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHhhcc-CC
Confidence 86543221 2233457899999999999999999999999999999999999997532 1122222222221 11
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhcCCC
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-TMSSVAVMLASDIV 450 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~ 450 (491)
.. ........ ...+.+++.+||+.||++|| +++++.+.|+....
T Consensus 231 ~~-~~~~~~~~----~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 231 NV-TTDVRKDI----PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp CH-HHHSCTTS----CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred Cc-chhcccCC----CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 11 11111122 24567799999999999998 99999999987743
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.88 E-value=4.8e-24 Score=212.60 Aligned_cols=161 Identities=25% Similarity=0.315 Sum_probs=122.4
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............+++.|+||
T Consensus 156 ~~~~~~i~~qi~~aL~~LH~~~iv-------H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 228 (334)
T 2pvf_A 156 FKDLVSCTYQLARGMEYLASQKCI-------HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228 (334)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------CCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeCh
Confidence 345677888999999999998777 9999999999999999999999999876554333333345678889999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++|||++ |+.||.... ...+. .....+.... .+......+.+++
T Consensus 229 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~----~~~~~~~~~~---------~~~~~~~~l~~li 292 (334)
T 2pvf_A 229 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VEELF----KLLKEGHRMD---------KPANCTNELYMMM 292 (334)
T ss_dssp HHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHH----HHHHHTCCCC---------CCTTCCHHHHHHH
T ss_pred HHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC---HHHHH----HHHhcCCCCC---------CCccCCHHHHHHH
Confidence 99999899999999999999999999 999875321 11111 1122221111 1111224577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
.+||+.||++||++.|+++.|+...
T Consensus 293 ~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 293 RDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999998763
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.88 E-value=6.6e-24 Score=215.14 Aligned_cols=185 Identities=23% Similarity=0.317 Sum_probs=121.2
Q ss_pred eeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 245 YELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
|.+++|..++.+..... ........+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv-------HrDlkp~NIll~~~~~~kL~DFG~a 239 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV-------HRDLAARNCMLDEKFTVKVADFGLA 239 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEECTTCCEEECCC---
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEe-------cCccchheEEECCCCCEEEeecccc
Confidence 45556655544322221 1233455677888999999999998777 9999999999999999999999999
Q ss_pred eecCCCCcc--cccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 322 RIFGGNQSE--ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 322 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
+........ .......+++.|+|||++.+..++.++||||||+++|||++ |.+||.... .......+. .+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~---~~~~~~~~~----~~ 312 (373)
T 3c1x_A 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLL----QG 312 (373)
T ss_dssp ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---SSCHHHHHH----TT
T ss_pred ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC---HHHHHHHHH----cC
Confidence 865432211 11223456788999999999999999999999999999999 666654322 222222221 11
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCC
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTL 452 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 452 (491)
... .. +......+.+++.+||+.||++||++.|+++.|+.....+
T Consensus 313 ~~~--~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 313 RRL--LQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp CCC--CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCC--CC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 110 00 1112235778999999999999999999999998875444
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.88 E-value=6.5e-24 Score=207.60 Aligned_cols=186 Identities=21% Similarity=0.266 Sum_probs=128.8
Q ss_pred eeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 245 YELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
|.++.++.++...... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~-------H~dikp~Nili~~~~~~kl~Dfg~~ 171 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFV-------HRDLAARNCMLDESFTVKVADFGLA 171 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEECTTCCEEECCTTSS
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcc-------cCCCCcceEEEcCCCcEEeCcCCCc
Confidence 4455555444332221 12233455677888999999999998777 9999999999999999999999999
Q ss_pred eecCCCCc--ccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 322 RIFGGNQS--EANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 322 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
+....... ........++..|+|||.+.+..++.++||||||+++|||++|..|+. ............. ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~--~~~~~~~~~~~~~----~~~ 245 (298)
T 3pls_A 172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY--RHIDPFDLTHFLA----QGR 245 (298)
T ss_dssp CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT--TTSCGGGHHHHHH----TTC
T ss_pred ccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC--ccCCHHHHHHHhh----cCC
Confidence 86543221 112233567889999999999999999999999999999999666532 1222222222221 111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCC
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTL 452 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 452 (491)
... .+......+.+++.+||+.||++|||+.++++.|+.....+
T Consensus 246 ~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 246 RLP---------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp CCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCC---------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 100 01111235778999999999999999999999998764433
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=8.2e-23 Score=200.20 Aligned_cols=176 Identities=18% Similarity=0.257 Sum_probs=123.4
Q ss_pred eeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 244 RYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.|.++.|..++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++
T Consensus 113 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv-------H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 185 (298)
T 2zv2_A 113 LYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKII-------HRDIKPSNLLVGEDGHIKIADFGVSN 185 (298)
T ss_dssp EEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCee-------ccCCCHHHEEECCCCCEEEecCCCcc
Confidence 355566665544433221 1233556777888999999999998777 99999999999999999999999998
Q ss_pred ecCCCCcccccCceeecCCCChhhhhhhCC---CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGI---FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
........ .....||+.|+|||++.+.. .+.++||||||+++|||++|+.||.... ... .........
T Consensus 186 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~-~~~~~~~~~ 256 (298)
T 2zv2_A 186 EFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER------IMC-LHSKIKSQA 256 (298)
T ss_dssp ECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS------HHH-HHHHHHHCC
T ss_pred cccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc------HHH-HHHHHhccc
Confidence 76543221 23357899999999997655 3778999999999999999999974321 111 111111111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.. ..+ .... ...+.+++.+||+.||++||++.|+++
T Consensus 257 ~~-~~~---~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 257 LE-FPD---QPDI----AEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CC-CCS---SSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CC-CCC---cccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 11 000 0112 234678999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-23 Score=218.40 Aligned_cols=177 Identities=23% Similarity=0.295 Sum_probs=128.3
Q ss_pred eeeecccccCCCCccccC---C-CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 244 RYELYRFLVDTPTVTVTA---P-NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
.|.++.|..++.+..... . .......+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv-------HrDlkp~Nill~~~~~~kl~DfG 334 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV-------HRDLAARNVLVSEDNVAKVSDFG 334 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCCGGGEEECTTSCEEECCCT
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCee-------CCCCCHhhEEECCCCCEEEeeCC
Confidence 456667766554432221 1 123455677889999999999998777 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
+++...... ....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+ ..+
T Consensus 335 ~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i----~~~ 402 (450)
T 1k9a_A 335 LTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV----EKG 402 (450)
T ss_dssp TCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT---TTHHHHH----HTT
T ss_pred Ccccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcC
Confidence 998643221 12356889999999999999999999999999999998 9999754322 2222222 122
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
... ..+......+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 403 ~~~---------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 403 YKM---------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 11122234577899999999999999999999999764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.4e-23 Score=201.91 Aligned_cols=178 Identities=18% Similarity=0.236 Sum_probs=129.4
Q ss_pred eeeecccccCCCCcccc----CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 244 RYELYRFLVDTPTVTVT----APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
.|.+++|+..+...... .........+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~-------H~dlkp~Nil~~~~~~~kl~Dfg 167 (284)
T 2a19_B 95 LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLI-------NRDLKPSNIFLVDTKQVKIGDFG 167 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEEEETTEEEECCCT
T ss_pred EEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCee-------eccCCHHHEEEcCCCCEEECcch
Confidence 45555665554432221 12233455677888999999999998777 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
+++....... .....|++.|+|||++.+..++.++||||||+++|||++|..|+.. ....+.....+.
T Consensus 168 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~~~~~~~~~ 235 (284)
T 2a19_B 168 LVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKFFTDLRDGI 235 (284)
T ss_dssp TCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHHHHHHHTTC
T ss_pred hheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHHHHHhhccc
Confidence 9987654332 2235689999999999998899999999999999999999888421 111122222222
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCC
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTL 452 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 452 (491)
.. ..++ ..+.+++.+||+.||++||++.|++++|+......
T Consensus 236 ~~--------~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 236 IS--------DIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp CC--------TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred cc--------ccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 11 1122 23567899999999999999999999998765443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.88 E-value=3e-23 Score=200.17 Aligned_cols=160 Identities=24% Similarity=0.352 Sum_probs=112.5
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC--------CCCceEeccCcceecCCCCcccccCce
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH--------EMNPKISDFGMARIFGGNQSEANTNRV 336 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~--------~~~~kl~DfGla~~~~~~~~~~~~~~~ 336 (491)
.......++.+++.++.+||..+.. +++||||||+|||++. ++.+||+|||+++....... ...
T Consensus 103 ~~~~~~~i~~~l~~~l~~lH~~~~~----~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~ 174 (271)
T 3dtc_A 103 PPDILVNWAVQIARGMNYLHDEAIV----PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSA 174 (271)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHSSSS----CCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----------------
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCCC----ceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc----cCC
Confidence 3455677888999999999987621 2349999999999986 67899999999986543222 235
Q ss_pred eecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHH
Q 011196 337 VGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAE 416 (491)
Q Consensus 337 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 416 (491)
.|++.|+|||.+.+..++.++||||||++++||++|+.||.... ................ .+...
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~---------~~~~~ 239 (271)
T 3dtc_A 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID------GLAVAYGVAMNKLALP---------IPSTC 239 (271)
T ss_dssp -CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC------HHHHHHHHHTSCCCCC---------CCTTC
T ss_pred CCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHhhhcCCCCCC---------CCccc
Confidence 68999999999999999999999999999999999999975321 1111111111111111 11122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 011196 417 LLKYIHIGLLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 417 ~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
...+.+++.+||+.||++|||+.|++++|+.
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 2457789999999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-23 Score=207.81 Aligned_cols=166 Identities=20% Similarity=0.220 Sum_probs=116.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... ......||+.|+||
T Consensus 107 ~~~~~~~~~qi~~aL~~lH~~~iv-------H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aP 177 (317)
T 2pmi_A 107 LNLVKYFQWQLLQGLAFCHENKIL-------HRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAP 177 (317)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEECTTCCEEECCCSSCEETTSCCC--CCCCCCSCCTTCCH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------eCCCChHHeEEcCCCCEEECcCccceecCCCcc--cCCCCcccccccCc
Confidence 445666788999999999998777 999999999999999999999999987643222 12235789999999
Q ss_pred hhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC---Ccccc-----------------c
Q 011196 346 EYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG---HAAEL-----------------M 404 (491)
Q Consensus 346 E~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-----------------~ 404 (491)
|++.+. .++.++|||||||++|||++|+.||.... .......+....... .+... +
T Consensus 178 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (317)
T 2pmi_A 178 DVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN---DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDL 254 (317)
T ss_dssp HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCS
T ss_pred hHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhH
Confidence 999764 58999999999999999999999975322 222222222221110 00000 0
Q ss_pred cchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 405 DSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 405 d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
...+...........+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 255 RQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp HHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000000111235778999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.2e-23 Score=208.45 Aligned_cols=176 Identities=9% Similarity=0.030 Sum_probs=126.4
Q ss_pred eeecccccCCCCcccc-------CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC--------
Q 011196 245 YELYRFLVDTPTVTVT-------APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH-------- 309 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~-------- 309 (491)
|.++.|+.++.+.... .........+.++.+++.++.+||..+++ ||||||+|||++.
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~iv-------HrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEII-------HGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEE-------CCCCSGGGEEECGGGTCC---
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCee-------cCCCCHHHEEecccccCcccc
Confidence 4566666555443222 11233556778899999999999998777 9999999999998
Q ss_pred ---CCCceEeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCccc
Q 011196 310 ---EMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPS 386 (491)
Q Consensus 310 ---~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~ 386 (491)
++.+||+|||+++.+.............||..|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 89999999999986543222223344679999999999999999999999999999999999999974221110
Q ss_pred HHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHhhcC
Q 011196 387 LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDR-PTMSSVAVMLASD 448 (491)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~R-Ps~~evl~~L~~~ 448 (491)
. .+..........+ .+.+++..|++.+|.+| |+++++.+.|+..
T Consensus 293 --------------~-~~~~~~~~~~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 --------------C-KPEGLFRRLPHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp --------------E-EECSCCTTCSSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred --------------e-eechhccccCcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0 0111111111222 34467789999999999 6788888877765
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.1e-25 Score=218.21 Aligned_cols=192 Identities=20% Similarity=0.227 Sum_probs=132.1
Q ss_pred eeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 244 RYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.|.++.|+..+.+..... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~iv-------H~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYI-------HRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCcc-------CCCCchheEEEcCCCCEEECCccccc
Confidence 345555554443322221 1233556777889999999999998877 99999999999999999999999998
Q ss_pred ecCCCCcc-cccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCC--------CcccHHHHHHH
Q 011196 323 IFGGNQSE-ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLE--------HGPSLLAYIWK 393 (491)
Q Consensus 323 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~--------~~~~~~~~~~~ 393 (491)
........ .......++..|+|||++.+..++.++||||||++++||++|..||...... ...........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 77543321 1223356788899999999999999999999999999999999997532110 00000011111
Q ss_pred HhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCC
Q 011196 394 LWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVT 451 (491)
Q Consensus 394 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 451 (491)
....+. ....+......+.+|+.+||+.||++|||+.|+++.|+.....
T Consensus 263 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 263 LLERGE---------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhccc---------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 111111 1111222335678899999999999999999999999876433
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=5.4e-24 Score=206.39 Aligned_cols=162 Identities=26% Similarity=0.437 Sum_probs=121.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++........ ......++..|+||
T Consensus 108 ~~~~~~i~~qi~~~l~~lH~~~i~-------H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aP 179 (279)
T 1qpc_A 108 INKLLDMAAQIAEGMAFIEERNYI-------HRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAP 179 (279)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------ccCCCHhhEEEcCCCCEEECCCcccccccCcccc-cccCCCCccCccCh
Confidence 455677888999999999998877 9999999999999999999999999876543221 22234567899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.++.++.++||||||++++||++ |+.||.... ..... .....+... .. +......+.+++
T Consensus 180 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~----~~~~~~~~~-----~~----~~~~~~~l~~li 243 (279)
T 1qpc_A 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---NPEVI----QNLERGYRM-----VR----PDNCPEELYQLM 243 (279)
T ss_dssp HHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHH----HHHHTTCCC-----CC----CTTCCHHHHHHH
T ss_pred hhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC---HHHHH----HHHhcccCC-----CC----cccccHHHHHHH
Confidence 99998899999999999999999999 888875321 11111 111111111 00 111224577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcCCCC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASDIVT 451 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~~~~ 451 (491)
.+||+.||++|||+.++++.|+.....
T Consensus 244 ~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 244 RLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 999999999999999999999876433
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=3e-23 Score=203.05 Aligned_cols=186 Identities=22% Similarity=0.306 Sum_probs=128.1
Q ss_pred eeeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.+++|+.++...... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~-------H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV-------HRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEECTTCCEEECSCGG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCcc-------CCCCchheEEECCCCCEEECcccc
Confidence 34555666554432222 12233456677888999999999998777 999999999999999999999999
Q ss_pred ceecCCCCcc--cccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCC-CCCCCccCCCcccHHHHHHHHhhc
Q 011196 321 ARIFGGNQSE--ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGK-KSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 321 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
++........ .......+|+.|+|||.+.+..++.++||||||++++||++|. +|+... .......... .
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~----~ 247 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTFDITVYLL----Q 247 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS---CTTTHHHHHH----T
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC---CHHHHHHHHh----c
Confidence 9866433211 1222356778899999999999999999999999999999954 454322 2222222221 1
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCC
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTL 452 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 452 (491)
+.... . .... ...+.+++.+||+.||++||++.|+++.|+.....+
T Consensus 248 ~~~~~--~---~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 248 GRRLL--Q---PEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp TCCCC--C---CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CCCCC--C---CccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11000 0 0111 234778999999999999999999999998764443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.9e-23 Score=202.50 Aligned_cols=166 Identities=21% Similarity=0.237 Sum_probs=113.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... ......||+.|+||
T Consensus 99 ~~~~~~~~~qi~~~l~~lH~~~i~-------H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aP 169 (288)
T 1ob3_A 99 SVTAKSFLLQLLNGIAYCHDRRVL-------HRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAP 169 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHEEEcCCCCEEEeECccccccCcccc--ccccccccccccCc
Confidence 455677888999999999998777 999999999999999999999999986543221 12235789999999
Q ss_pred hhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC---cccc-----ccchhc-------
Q 011196 346 EYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH---AAEL-----MDSVVK------- 409 (491)
Q Consensus 346 E~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-----~d~~l~------- 409 (491)
|++.+. .++.++||||||+++|||++|+.||.... .......+.+...... +... .++...
T Consensus 170 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
T 1ob3_A 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS---EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPW 246 (288)
T ss_dssp HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCG
T ss_pred hheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccH
Confidence 999764 58999999999999999999999975322 2222222322221111 1000 000000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 410 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
..........+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 247 ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000112345678999999999999999999876
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6.8e-24 Score=206.00 Aligned_cols=160 Identities=20% Similarity=0.287 Sum_probs=117.5
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++........ ......++..|+|
T Consensus 111 ~~~~~~~~~~~i~~~l~~lH~~~i~-------H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~a 182 (281)
T 3cc6_A 111 KVLTLVLYSLQICKAMAYLESINCV-------HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMS 182 (281)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcc-------cCCCccceEEECCCCcEEeCccCCCccccccccc-ccccCCCCcceeC
Confidence 3455667888999999999988777 9999999999999999999999999865433221 1223456788999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..++.++||||||+++|||++ |+.||.... .......... +..... +......+.++
T Consensus 183 PE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~---~~~~~~~~~~----~~~~~~---------~~~~~~~l~~l 246 (281)
T 3cc6_A 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE---NKDVIGVLEK----GDRLPK---------PDLCPPVLYTL 246 (281)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---GGGHHHHHHH----TCCCCC---------CTTCCHHHHHH
T ss_pred chhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC---hHHHHHHHhc----CCCCCC---------CCCCCHHHHHH
Confidence 999999999999999999999999998 999975322 2222222211 111100 11112346789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+.+||+.||++||++.|+++.|+..
T Consensus 247 i~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 247 MTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHccCCchhCcCHHHHHHHHHHH
Confidence 9999999999999999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-23 Score=209.84 Aligned_cols=175 Identities=17% Similarity=0.186 Sum_probs=124.7
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++.+.... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv-------HrDlkp~NIll~~~g~vkL~DFG~a 152 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV-------YRDIKLENLMLDKDGHIKITDFGLC 152 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCB-------CCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee-------cCcCCHHHEEECCCCCEEEeeccch
Confidence 34556666554432221 11223455667888999999999988777 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||... ....+...+ ......
T Consensus 153 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i----~~~~~~ 223 (337)
T 1o6l_A 153 KEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELI----LMEEIR 223 (337)
T ss_dssp BCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH----HHCCCC
T ss_pred hhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC---CHHHHHHHH----HcCCCC
Confidence 86432221 233568999999999999989999999999999999999999997421 111111111 111110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAVM 444 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 444 (491)
++......+.+++.+||+.||++|| ++.||+++
T Consensus 224 ----------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 ----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1111223467789999999999999 89998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=3.8e-23 Score=203.87 Aligned_cols=161 Identities=25% Similarity=0.356 Sum_probs=122.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++...............||+.|+||
T Consensus 147 ~~~~~~~~~qi~~al~~lH~~~i~-------H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 219 (316)
T 2xir_A 147 LEHLICYSFQVAKGMEFLASRKCI-------HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 219 (316)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------cccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCc
Confidence 345667788899999999988776 9999999999999999999999999876544433334456789999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++|||++ |..||...... .. .......+..... +......+.+++
T Consensus 220 E~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~----~~~~~~~~~~~~~---------~~~~~~~l~~li 284 (316)
T 2xir_A 220 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EE----FCRRLKEGTRMRA---------PDYTTPEMYQTM 284 (316)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HH----HHHHHHHTCCCCC---------CTTCCHHHHHHH
T ss_pred hhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh--HH----HHHHhccCccCCC---------CCCCCHHHHHHH
Confidence 99999999999999999999999998 99997532211 11 1111212211111 111123567889
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++|||+.||+++|+..
T Consensus 285 ~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 285 LDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999865
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.3e-23 Score=203.05 Aligned_cols=189 Identities=21% Similarity=0.258 Sum_probs=131.7
Q ss_pred eeeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.+++|+.+++..... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~-------H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYV-------HRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcc-------cCCCchheEEEcCCCCEEECcccc
Confidence 34556666554432221 12233556677888999999999998877 999999999999999999999999
Q ss_pred ceecCCCCcc-cccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCcc--------CCCcccHHHHH
Q 011196 321 ARIFGGNQSE-ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYH--------LEHGPSLLAYI 391 (491)
Q Consensus 321 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~--------~~~~~~~~~~~ 391 (491)
++........ .......||..|+|||++.+..++.++||||||+++|||++|..|+.... ...........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 9876543321 22233567888999999999999999999999999999999998843210 01111111111
Q ss_pred HHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 392 WKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 392 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
......+... ..+......+.+++.+||+.||++|||+.++++.|+..
T Consensus 253 ~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 253 VNTLKEGKRL---------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhccCCC---------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1222111111 11222234577899999999999999999999999863
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.3e-24 Score=205.18 Aligned_cols=161 Identities=25% Similarity=0.357 Sum_probs=120.9
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++......... .....++..|+|
T Consensus 102 ~~~~~~~i~~qi~~~l~~lH~~~i~-------H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~a 173 (268)
T 3sxs_A 102 EPSQLLEMCYDVCEGMAFLESHQFI-------HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS-SVGTKFPVKWSA 173 (268)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------ESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE-CCSCCCCGGGCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCee-------cCCcCcceEEECCCCCEEEccCccceecchhhhhc-ccCCCcCcccCC
Confidence 3456677888999999999998877 99999999999999999999999998765433222 223456778999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||.+.+..++.++||||||++++||++ |+.||.... ..... .....+... ..+ ... ...+.++
T Consensus 174 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~----~~~~~~~~~--~~~---~~~----~~~l~~l 237 (268)
T 3sxs_A 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT---NSEVV----LKVSQGHRL--YRP---HLA----SDTIYQI 237 (268)
T ss_dssp HHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHH----HHHHTTCCC--CCC---TTS----CHHHHHH
T ss_pred HHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC---hHHHH----HHHHcCCCC--CCC---CcC----hHHHHHH
Confidence 999999899999999999999999999 999975322 11111 111111110 011 111 2346789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
+.+||+.||++|||+.|+++.|+...
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 238 MYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 99999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.9e-24 Score=206.39 Aligned_cols=180 Identities=22% Similarity=0.276 Sum_probs=127.0
Q ss_pred eeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 245 YELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
|.+++|+.++...... ...........++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~-------H~dikp~Nil~~~~~~~kl~Dfg~~ 153 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI-------HRDLAARNCLVGENQVIKVSDFGMT 153 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEECGGGCEEECCTTGG
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCee-------cCCcchheEEEcCCCCEEecccccc
Confidence 4455555544332221 11233456677888999999999988777 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
+....... .......++..|+|||++.+..++.++||||+|++++||++ |+.||... ...... .....+..
T Consensus 154 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~---~~~~~~----~~~~~~~~ 225 (269)
T 4hcu_A 154 RFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVV----EDISTGFR 225 (269)
T ss_dssp GGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHH----HHHHTTCC
T ss_pred cccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC---CHHHHH----HHHhcCcc
Confidence 86543221 11223456778999999999999999999999999999999 89887532 111111 11111110
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
. .. +......+.+++.+||+.||++||++.|++++|++.
T Consensus 226 ~--~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 226 L--YK-------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp C--CC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C--CC-------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 0 00 111123467899999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4e-23 Score=210.24 Aligned_cols=166 Identities=18% Similarity=0.174 Sum_probs=121.4
Q ss_pred CcchhhhHhHHHHHHHHHhhe-eeEEeEEeeeccccccccccccCCC---------------------------------
Q 011196 266 SKRWITIAEAASAIIVFLLST-SFLWCIIRRRNKRVRASNVLLDHEM--------------------------------- 311 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~iHrDlKp~NILl~~~~--------------------------------- 311 (491)
....+.++.+++.++.+||.. +++ ||||||+|||++.++
T Consensus 145 ~~~~~~i~~qi~~aL~~lH~~~giv-------HrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (397)
T 1wak_A 145 LPCVKKIIQQVLQGLDYLHTKCRII-------HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217 (397)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCEE-------CCCCSGGGEEECCCHHHHHHHHHHHC---------------------C
T ss_pred HHHHHHHHHHHHHHHHHHHHhCCEe-------cCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccc
Confidence 456777889999999999987 777 999999999998765
Q ss_pred ----------------CceEeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCC
Q 011196 312 ----------------NPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKS 375 (491)
Q Consensus 312 ----------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p 375 (491)
.+||+|||+++..... .....||..|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 218 ~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 292 (397)
T 1wak_A 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292 (397)
T ss_dssp CTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCC
Confidence 7999999999876432 2235789999999999999999999999999999999999999
Q ss_pred CCCccCCCcccH---HHHHHHHhhc--------CC-----------cccccc-------ch--hcCCCCHHHHHHHHHHH
Q 011196 376 SGFYHLEHGPSL---LAYIWKLWCE--------GH-----------AAELMD-------SV--VKQSCDQAELLKYIHIG 424 (491)
Q Consensus 376 ~~~~~~~~~~~~---~~~~~~~~~~--------~~-----------~~~~~d-------~~--l~~~~~~~~~~~~~~l~ 424 (491)
|........... ...+...... +. ...+.+ .. -....+.+....+.+|+
T Consensus 293 f~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 372 (397)
T 1wak_A 293 FEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFL 372 (397)
T ss_dssp CCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHH
T ss_pred CCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHH
Confidence 865443332211 1111111110 00 000000 00 01124566777899999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 011196 425 LLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~ 443 (491)
.+||+.||++|||+.|+++
T Consensus 373 ~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 373 LPMLELIPEKRATAAECLR 391 (397)
T ss_dssp GGGGCSSGGGSCCHHHHHT
T ss_pred HHHhccChhhcCCHHHHhh
Confidence 9999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=7.6e-24 Score=205.74 Aligned_cols=159 Identities=24% Similarity=0.307 Sum_probs=110.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++........ ......+++.|+||
T Consensus 115 ~~~~~~~~~qi~~~l~~lH~~~i~-------H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aP 186 (281)
T 1mp8_A 115 LASLILYAYQLSTALAYLESKRFV-------HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAP 186 (281)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEEEETTEEEECC--------------------CCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------cccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCcccccCh
Confidence 455677888999999999988776 9999999999999999999999999876433221 12234567889999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++||||||+++|||++ |..||.... .......+ ..+.... .+......+.+++
T Consensus 187 E~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~---~~~~~~~i----~~~~~~~---------~~~~~~~~l~~li 250 (281)
T 1mp8_A 187 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---NNDVIGRI----ENGERLP---------MPPNCPPTLYSLM 250 (281)
T ss_dssp HHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGGHHHHH----HTTCCCC---------CCTTCCHHHHHHH
T ss_pred hhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC---HHHHHHHH----HcCCCCC---------CCCCCCHHHHHHH
Confidence 99999999999999999999999996 888975322 22222222 1111111 1112234567899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++||++.|+++.|+..
T Consensus 251 ~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 251 TKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-23 Score=207.34 Aligned_cols=185 Identities=17% Similarity=0.166 Sum_probs=109.5
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC---CceEecc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM---NPKISDF 318 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~---~~kl~Df 318 (491)
.|.++.|..++...... ...........++.+++.++.+||..+++ ||||||+|||++.++ .+||+||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iv-------H~Dlkp~NIll~~~~~~~~~kl~Df 153 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVV-------HRDLKPENLLFTDENDNLEIKIIDF 153 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEEEC----CEEEECCC
T ss_pred EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCe-------ecCCCHHHEEEecCCCcccEEEecc
Confidence 35566666554432221 12234556778899999999999998777 999999999998765 7999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
|+++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||..................+..+
T Consensus 154 g~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~ 231 (325)
T 3kn6_A 154 GFARLKPPDNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG 231 (325)
T ss_dssp TTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT
T ss_pred ccceecCCCCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC
Confidence 999865433221 234578999999999999999999999999999999999999986543322222222233333332
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.... ..+. .. .....+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~-~~~~-~~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 232 DFSF-EGEA-WK----NVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CCCC-CSHH-HH----TSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCC-Cccc-cc----CCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 2110 0000 00 11345778999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-23 Score=209.16 Aligned_cols=178 Identities=15% Similarity=0.202 Sum_probs=126.1
Q ss_pred eeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC--CCCceEecc
Q 011196 244 RYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH--EMNPKISDF 318 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~--~~~~kl~Df 318 (491)
.|.++.|+.++....... ..........++.+++.++.+||..+++ ||||||+|||++. ++.+||+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~giv-------H~Dlkp~NIl~~~~~~~~~kl~Df 148 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG-------HFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEESSSSCCCEEECCC
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCC-------cCCCCHHHEEEccCCCCCEEEEEC
Confidence 345555655443322221 1233556778899999999999998877 9999999999987 789999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
|+++....... .....||+.|+|||++.+..++.++||||||+++|||++|..||... ........+ ...
T Consensus 149 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i----~~~ 218 (321)
T 1tki_A 149 GQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENI----MNA 218 (321)
T ss_dssp TTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHH----HHT
T ss_pred CCCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC---CHHHHHHHH----HcC
Confidence 99987654322 23467899999999999888999999999999999999999997532 111122211 111
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
... .+....... ...+.+++.+||+.||++|||+.|++++
T Consensus 219 ~~~--~~~~~~~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 219 EYT--FDEEAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCC--CCHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCC--CChhhhccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111 011111112 2356789999999999999999999873
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-23 Score=213.02 Aligned_cols=166 Identities=17% Similarity=0.169 Sum_probs=117.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeecccccccccccc-CCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLD-HEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||..+++ ||||||+|||++ .++.+||+|||+++....... .....||+.|+|
T Consensus 140 ~~~~~~~~~qi~~aL~~LH~~~iv-------HrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~a 209 (394)
T 4e7w_A 140 MLLIKLYMYQLLRSLAYIHSIGIC-------HRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRA 209 (394)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------CCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccC
Confidence 445667888999999999998877 999999999999 789999999999987643332 223578999999
Q ss_pred hhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC---------------Cccccccchh
Q 011196 345 PEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG---------------HAAELMDSVV 408 (491)
Q Consensus 345 PE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~d~~l 408 (491)
||++.+. .++.++|||||||++|||++|+.||.... ....+..+.+..... ....+.....
T Consensus 210 PE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (394)
T 4e7w_A 210 PELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES---GIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPF 286 (394)
T ss_dssp HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCH
T ss_pred HHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcH
Confidence 9999765 58999999999999999999999975322 122222222211111 0111100000
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 409 KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
...+.......+.+|+.+||+.||++|||+.|++++
T Consensus 287 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 287 SKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000111123467889999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.9e-23 Score=204.93 Aligned_cols=176 Identities=19% Similarity=0.226 Sum_probs=122.3
Q ss_pred eeeecccccCCCCccccCCCC-----CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEecc
Q 011196 244 RYELYRFLVDTPTVTVTAPNK-----TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDF 318 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~Df 318 (491)
.|.++.|..++.......... .....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+||
T Consensus 136 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv-------H~Dlkp~NIll~~~~~~kL~Df 208 (332)
T 3qd2_B 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM-------HRDLKPSNIFFTMDDVVKVGDF 208 (332)
T ss_dssp EEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCee-------ecCCCcccEEEeCCCCEEEeec
Confidence 456666666554433221111 1223567888999999999998777 9999999999999999999999
Q ss_pred CcceecCCCCcc----------cccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHH
Q 011196 319 GMARIFGGNQSE----------ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLL 388 (491)
Q Consensus 319 Gla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~ 388 (491)
|+++........ .......||+.|+|||++.+..++.++||||||+++|||++|..|+. ..
T Consensus 209 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~- 279 (332)
T 3qd2_B 209 GLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ER- 279 (332)
T ss_dssp TTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HH-
T ss_pred CcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HH-
Confidence 999876543211 12234579999999999999999999999999999999999876621 01
Q ss_pred HHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 389 AYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 389 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
............... .......+.+++.+||+.||++|||+.|++++
T Consensus 280 ~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 280 VRIITDVRNLKFPLL---------FTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHTTCCCHH---------HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhhccCCCcc---------cccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 111111111111111 11223456789999999999999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.8e-23 Score=204.91 Aligned_cols=183 Identities=21% Similarity=0.315 Sum_probs=118.2
Q ss_pred eeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 245 YELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
|.++.|+.+....... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv-------H~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGII-------HRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCC-------cCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 5566665543332221 12233556777888999999999998777 99999999999999999999999998
Q ss_pred ecCCCCc-ccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 323 IFGGNQS-EANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 323 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
....... ........||+.|+|||++.+..++.++||||||+++|||++|+.||... ......+.........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~------~~~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD------SPVSVAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHhcCCCCC
Confidence 6643322 12233467899999999999999999999999999999999999997432 1122222222222111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH-HHhhc
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVA-VMLAS 447 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl-~~L~~ 447 (491)
........ ...+.+++.+||+.||++||++.+++ ..|..
T Consensus 239 ---~~~~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 239 ---PSARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp ---HHHHSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---cccccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 01111112 23467789999999999999766554 44443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-23 Score=212.56 Aligned_cols=143 Identities=13% Similarity=0.108 Sum_probs=109.6
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhh
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPE 346 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 346 (491)
...+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++.... ......| +.|+|||
T Consensus 206 ~~~~~i~~qi~~aL~~LH~~~iv-------HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE 272 (377)
T 3byv_A 206 HARLQLTLQVIRLLASLHHYGLV-------HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPE 272 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEE-------CSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHH
T ss_pred HHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChh
Confidence 44556888999999999998777 999999999999999999999999986432 1223567 9999999
Q ss_pred hhhhC-----------CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHH
Q 011196 347 YAMEG-----------IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 415 (491)
Q Consensus 347 ~~~~~-----------~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 415 (491)
++.+. .++.++|||||||++|||++|+.||........ ...+... ....+
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~---------------~~~~~~~--~~~~~-- 333 (377)
T 3byv_A 273 LEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG---------------SEWIFRS--CKNIP-- 333 (377)
T ss_dssp HHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CC---------------SGGGGSS--CCCCC--
T ss_pred hhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccc---------------hhhhhhh--ccCCC--
Confidence 99987 899999999999999999999999753221111 0111110 01222
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 416 ELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 416 ~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
..+.+|+.+||+.||++||++.|+++
T Consensus 334 --~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 334 --QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp --HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred --HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 34677999999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.6e-23 Score=208.49 Aligned_cols=176 Identities=18% Similarity=0.268 Sum_probs=121.6
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++.+.... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv-------HrDlkp~NIll~~~g~~kL~DFG~a 157 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGII-------YRDLKLDNVLLDSEGHIKLTDYGMC 157 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCB-------CCCCCGGGEEECTTSCEEECCGGGC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCce-------ecCCCHHHEEECCCCCEEEEecccc
Confidence 35556666554432221 11233455677888999999999998777 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcc--cHHHHHHHHhhcCC
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGP--SLLAYIWKLWCEGH 399 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~ 399 (491)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..............
T Consensus 158 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~ 235 (345)
T 3a8x_A 158 KEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 235 (345)
T ss_dssp BCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC
T ss_pred ccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC
Confidence 8543222 1233468999999999999989999999999999999999999998643221111 11122222222221
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTM 438 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 438 (491)
.. .+......+.+++.+||+.||++||++
T Consensus 236 ~~----------~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 IR----------IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CC----------CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CC----------CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 10 111122356779999999999999996
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=5.7e-24 Score=213.97 Aligned_cols=174 Identities=21% Similarity=0.243 Sum_probs=121.1
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++.+.... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~giv-------HrDlkp~NILl~~~g~ikL~DFG~a 171 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGII-------YRDLKLDNVLLDHEGHCKLADFGMC 171 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCB-------CCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCc-------ccCCCHHHEEECCCCCEEEccccce
Confidence 45666666655432221 12233556677888999999999998777 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+...+ ..+...
T Consensus 172 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i----~~~~~~ 242 (353)
T 3txo_A 172 KEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE---NEDDLFEAI----LNDEVV 242 (353)
T ss_dssp BCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH----HHCCCC
T ss_pred eecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC---CHHHHHHHH----HcCCCC
Confidence 8543222 2233468999999999999989999999999999999999999997532 111222211 111110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTM------SSVAV 443 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~------~evl~ 443 (491)
++......+.+++.+||+.||++||++ .|+++
T Consensus 243 ----------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 ----------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ----------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111122346778999999999999998 66665
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=9.5e-24 Score=227.47 Aligned_cols=183 Identities=23% Similarity=0.301 Sum_probs=128.8
Q ss_pred eeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.++.|..++.+..... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ii-------HrDlkp~NILl~~~~~vkL~DFGl 482 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV-------HRNLAARNVLLVNRHYAKISDFGL 482 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEEEETTEEEECCCST
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEE-------cCcCCHHHEEEcCCCcEEEeeccC
Confidence 456667766655433221 1233456777889999999999998776 999999999999999999999999
Q ss_pred ceecCCCCcc-cccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 321 ARIFGGNQSE-ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 321 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
++........ .......+++.|+|||++.++.++.++|||||||++|||++ |+.||.... ..+.. .....+
T Consensus 483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~---~~~~~----~~i~~~ 555 (613)
T 2ozo_A 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVM----AFIEQG 555 (613)
T ss_dssp TTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---SHHHH----HHHHTT
T ss_pred cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC---HHHHH----HHHHcC
Confidence 9876433221 11222345689999999999999999999999999999998 999975322 12222 222222
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
.... .+......+.+|+.+||+.||++||++.+|++.|+...
T Consensus 556 ~~~~---------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 556 KRME---------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp CCCC---------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCC---------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111 11223345778999999999999999999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.87 E-value=6e-24 Score=213.99 Aligned_cols=101 Identities=26% Similarity=0.348 Sum_probs=87.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC-------------------------CCCceEeccCc
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH-------------------------EMNPKISDFGM 320 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~-------------------------~~~~kl~DfGl 320 (491)
......++.+++.++.+||..+++ ||||||+|||++. ++.+||+|||+
T Consensus 136 ~~~~~~i~~qi~~aL~~LH~~~iv-------HrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~ 208 (360)
T 3llt_A 136 IEDIKLYCIEILKALNYLRKMSLT-------HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208 (360)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTT
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------eCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccC
Confidence 455677888999999999998777 9999999999975 78899999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCC
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGF 378 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~ 378 (491)
++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 209 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 209 ATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp CEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 9865332 2245789999999999999999999999999999999999999753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.5e-23 Score=208.46 Aligned_cols=183 Identities=16% Similarity=0.163 Sum_probs=125.9
Q ss_pred eeeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC-C---CceEe
Q 011196 243 IRYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE-M---NPKIS 316 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~-~---~~kl~ 316 (491)
..|.++.|..++...... ...........++.+++.++.+||..+++ ||||||+|||+.++ + .+||+
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~giv-------HrDlkp~NIl~~~~~~~~~~~kl~ 162 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV-------HRDLKPSNILYVDESGNPESIRIC 162 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCCGGGEEESSSSCSGGGEEEC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcE-------eccCCHHHEEEecCCCCcCeEEEE
Confidence 345666666555433222 11233556677888999999999998877 99999999998443 3 49999
Q ss_pred ccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh
Q 011196 317 DFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC 396 (491)
Q Consensus 317 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 396 (491)
|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||........ ..+.....
T Consensus 163 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~~~~i~ 236 (342)
T 2qr7_A 163 DFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP----EEILARIG 236 (342)
T ss_dssp CCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH----HHHHHHHH
T ss_pred ECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH----HHHHHHHc
Confidence 9999987654322 12345789999999999988899999999999999999999999864322221 12222222
Q ss_pred cCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 397 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 397 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.+... .. . .........+.+|+.+||+.||++||++.|++++
T Consensus 237 ~~~~~-~~-~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 237 SGKFS-LS-G----GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HCCCC-CC-S----TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cCCcc-cC-c----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22211 00 0 0011122346779999999999999999998863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-23 Score=204.78 Aligned_cols=160 Identities=23% Similarity=0.332 Sum_probs=121.4
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++........ .......+++.|+|
T Consensus 109 ~~~~~~~i~~~i~~~l~~lH~~~i~-------H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~a 180 (288)
T 3kfa_A 109 SAVVLLYMATQISSAMEYLEKKNFI-------HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTA 180 (288)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHTCC-------CSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCC
T ss_pred cHhHHHHHHHHHHHHHHHHHHCCcc-------CCCCCcceEEEcCCCCEEEccCccceeccCCcc-ccccCCccccCcCC
Confidence 3455677888999999999988777 999999999999999999999999986654332 22334567889999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..++.++||||||++++||++ |..||.... ........ ...... ..+......+.++
T Consensus 181 PE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~---~~~~~~~~----~~~~~~---------~~~~~~~~~l~~l 244 (288)
T 3kfa_A 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELL----EKDYRM---------ERPEGCPEKVYEL 244 (288)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGGHHHHH----HTTCCC---------CCCTTCCHHHHHH
T ss_pred hhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----hccCCC---------CCCCCCCHHHHHH
Confidence 999999999999999999999999999 888875322 12222211 111100 1111122457789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+.+||+.||++||++.|+++.|+..
T Consensus 245 i~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 245 MRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhCCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.87 E-value=4.4e-24 Score=207.44 Aligned_cols=160 Identities=23% Similarity=0.331 Sum_probs=119.3
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++........ ......+++.|+|
T Consensus 118 ~~~~~~~i~~qi~~~l~~lH~~~i~-------H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~a 189 (283)
T 3gen_A 118 QTQQLLEMCKDVCEAMEYLESKQFL-------HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSP 189 (283)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH-STTSTTSCGGGCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcc-------CCCCccceEEEcCCCCEEEccccccccccccccc-cccCCccCcccCC
Confidence 3556777888999999999998777 9999999999999999999999999865432211 1222346778999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..++.++||||||+++|||++ |+.||.... ..... .....+... ...... ...+.++
T Consensus 190 PE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~---~~~~~----~~~~~~~~~-----~~~~~~----~~~l~~l 253 (283)
T 3gen_A 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETA----EHIAQGLRL-----YRPHLA----SEKVYTI 253 (283)
T ss_dssp HHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHH----HHHHTTCCC-----CCCTTC----CHHHHHH
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC---hhHHH----HHHhcccCC-----CCCCcC----CHHHHHH
Confidence 999999999999999999999999998 999975322 11111 111111100 000111 2356789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+.+||+.||++|||+.|+++.|+..
T Consensus 254 i~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 254 MYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHHHHHHH
Confidence 9999999999999999999999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.4e-23 Score=208.89 Aligned_cols=170 Identities=17% Similarity=0.148 Sum_probs=118.5
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCc--ccccCceeecCCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQS--EANTNRVVGTYGY 342 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y 342 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... ........||+.|
T Consensus 122 ~~~~~~~i~~qi~~~l~~LH~~~iv-------H~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y 194 (351)
T 3mi9_A 122 TLSEIKRVMQMLLNGLYYIHRNKIL-------HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194 (351)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGG
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCee-------CCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCc
Confidence 3556778899999999999998877 999999999999999999999999987643221 1222345789999
Q ss_pred Chhhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC---Cccccccchh--------cC
Q 011196 343 MAPEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG---HAAELMDSVV--------KQ 410 (491)
Q Consensus 343 ~aPE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d~~l--------~~ 410 (491)
+|||++.+ ..++.++||||||++++||++|+.||.... .......+....... .+........ ..
T Consensus 195 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
T 3mi9_A 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT---EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQ 271 (351)
T ss_dssp CCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSC
T ss_pred cCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCChhhccccccchhhccccccccc
Confidence 99999976 458999999999999999999999975322 222222222211111 1111100000 00
Q ss_pred CCCH-HH------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 411 SCDQ-AE------LLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 411 ~~~~-~~------~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.... +. ...+.+|+.+||+.||++|||+.|++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 272 KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0011 11 2347789999999999999999998863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=3.1e-23 Score=206.06 Aligned_cols=187 Identities=16% Similarity=0.165 Sum_probs=123.6
Q ss_pred eeecccccCCCCccccCCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC-CceEeccCccee
Q 011196 245 YELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM-NPKISDFGMARI 323 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~-~~kl~DfGla~~ 323 (491)
+.++.|+.+....... ..........++.+++.++.+||..+++ ||||||+|||++.++ .+||+|||+++.
T Consensus 109 ~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iv-------H~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLY-QTLTDYDIRFYMYEILKALDYCHSMGIM-------HRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EEEEECCCCCCHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeccCchhHHHHH-HhCCHHHHHHHHHHHHHHHHHHHhCCee-------eCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 4445555444332221 1233455677888999999999998877 999999999999776 899999999987
Q ss_pred cCCCCcccccCceeecCCCChhhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc-----
Q 011196 324 FGGNQSEANTNRVVGTYGYMAPEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE----- 397 (491)
Q Consensus 324 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----- 397 (491)
...... .....|+..|+|||++.+ ..++.++||||||++++||++|+.||... ......+.........
T Consensus 181 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~--~~~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 181 YHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp CCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC--SSHHHHHHHHHHHHCHHHHHH
T ss_pred cCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC--CchHHHHHHHHHhcCCchhhh
Confidence 654332 223578999999999987 66899999999999999999999997321 1111111111111000
Q ss_pred ----CC--------------ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 398 ----GH--------------AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 398 ----~~--------------~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.. ....................+.+++.+||+.||++|||++|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 000000111111111123567889999999999999999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-23 Score=215.38 Aligned_cols=179 Identities=15% Similarity=0.176 Sum_probs=125.8
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeecccccccccccc---CCCCceEecc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLD---HEMNPKISDF 318 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~---~~~~~kl~Df 318 (491)
.|.++.|..++.+.... ...........++.+++.++.+||..+++ ||||||+|||++ .++.+||+||
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~giv-------HrDlKp~NIll~~~~~~~~vkL~DF 157 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV-------HRNLKPENLLLASKLKGAAVKLADF 157 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCB-------CCCCSSTTEEESBSSTTCCEEECCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------ccCCCHHHEEEeccCCCCcEEEccC
Confidence 45556666554432221 12234556777889999999999998777 999999999998 4578999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
|+++........ .....||+.|+|||++.+..++.++||||+||++|||++|..||... ...... .....+
T Consensus 158 G~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~---~~~~~~----~~i~~~ 228 (444)
T 3soa_A 158 GLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE---DQHRLY----QQIKAG 228 (444)
T ss_dssp SSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHH----HHHHHT
T ss_pred ceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc---cHHHHH----HHHHhC
Confidence 999876543221 23467999999999999989999999999999999999999997421 111122 222222
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
... ...+. .... ...+.+++.+||+.||++|||+.|++++
T Consensus 229 ~~~-~~~~~-~~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 229 AYD-FPSPE-WDTV----TPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCC-CCTTT-TTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCC-CCccc-cccC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111 00110 0111 2346789999999999999999998874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=2.8e-23 Score=213.93 Aligned_cols=166 Identities=19% Similarity=0.175 Sum_probs=116.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC-CCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE-MNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~-~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||..+++ ||||||+|||++.+ +.+||+|||+++....... .....||..|+|
T Consensus 155 ~~~~~~~~~qi~~aL~~LH~~~iv-------HrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~a 224 (420)
T 1j1b_A 155 VIYVKLYMYQLFRSLAYIHSFGIC-------HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRA 224 (420)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTTEE-------CSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------ccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCC
Confidence 345667888999999999998777 99999999999965 5689999999987643322 223578999999
Q ss_pred hhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC----------CccccccchhcC---
Q 011196 345 PEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG----------HAAELMDSVVKQ--- 410 (491)
Q Consensus 345 PE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~d~~l~~--- 410 (491)
||++.+. .++.++|||||||++|||++|+.||.... ..+.+..+.+..... ...+...+.+..
T Consensus 225 PE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~---~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~ 301 (420)
T 1j1b_A 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS---GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPW 301 (420)
T ss_dssp HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCH
T ss_pred HHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCH
Confidence 9999765 68999999999999999999999975321 122222222211111 111111111000
Q ss_pred --CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 411 --SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 411 --~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.+.......+.+|+.+||+.||++||++.|++++
T Consensus 302 ~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 302 TKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0111123467889999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=7e-23 Score=209.28 Aligned_cols=175 Identities=14% Similarity=0.175 Sum_probs=126.4
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccc----cCCCCceEeccCcceecCCCCcccccCceeecC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLL----DHEMNPKISDFGMARIFGGNQSEANTNRVVGTY 340 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl----~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~ 340 (491)
.....+.++.+++.++.+||..+++ ||||||+|||+ +.++.+||+|||+++....... .....||.
T Consensus 110 ~~~~~~~i~~qi~~aL~~LH~~~iv-------H~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~ 179 (396)
T 4eut_A 110 PESEFLIVLRDVVGGMNHLRENGIV-------HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTE 179 (396)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG---SSCSSSCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEE-------ECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc---cccccCCc
Confidence 3556778889999999999998877 99999999999 7777899999999987644322 22356899
Q ss_pred CCChhhhhhh--------CCCCcccceeehhHHHHHHHhCCCCCCCccCCC-cccHHHHHHHHhhcCCccccc-------
Q 011196 341 GYMAPEYAME--------GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEH-GPSLLAYIWKLWCEGHAAELM------- 404 (491)
Q Consensus 341 ~y~aPE~~~~--------~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~------- 404 (491)
.|+|||++.+ ..++.++|||||||++|||++|+.||....... .......+........+..+.
T Consensus 180 ~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 259 (396)
T 4eut_A 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPI 259 (396)
T ss_dssp TTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCE
T ss_pred cccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCc
Confidence 9999999875 567889999999999999999999986433322 222222222211111111110
Q ss_pred ----cchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 405 ----DSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 405 ----d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
+..............+.+++.+||+.||++||++.|+++.++...
T Consensus 260 ~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 260 DWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp EEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred ccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 000111334566777889999999999999999999999987653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.87 E-value=7.4e-24 Score=224.87 Aligned_cols=184 Identities=21% Similarity=0.370 Sum_probs=130.4
Q ss_pred eeecccccCCCCccccC----CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 245 YELYRFLVDTPTVTVTA----PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
|.++.|+.++.+..... ........+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iv-------HrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV-------HRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEECGGGCEEECCTTS
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCee-------CCCCCHhhEEEcCCCcEEEccccc
Confidence 45556655444322221 1123455677888999999999988776 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
++....... .......++..|+|||++..+.++.++||||||+++|||++ |+.||.... ..... .....+.
T Consensus 410 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~---~~~~~----~~i~~~~ 481 (535)
T 2h8h_A 410 ARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVL----DQVERGY 481 (535)
T ss_dssp TTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC---HHHHH----HHHHTTC
T ss_pred ceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHH----HHHHcCC
Confidence 986543211 11122346788999999999999999999999999999999 898875321 11122 2222221
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCC
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTL 452 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 452 (491)
.. ..+......+.+|+.+||+.||++|||+.+|+++|+......
T Consensus 482 ~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 482 RM---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 11 111122345778999999999999999999999999876444
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.7e-23 Score=208.66 Aligned_cols=177 Identities=14% Similarity=0.117 Sum_probs=125.5
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC----CceEec
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM----NPKISD 317 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~----~~kl~D 317 (491)
.|.++.|..++.+..... ..........++.+++.++.+||..+++ ||||||+|||++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giv-------HrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIA-------HFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCHHHEEEeCCCCCccCEEEEe
Confidence 455566665544332221 1233556778889999999999998877 999999999998776 799999
Q ss_pred cCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 318 FGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 318 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|..||... ...... ..+..
T Consensus 163 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~---~~~~~~----~~i~~ 232 (361)
T 2yab_A 163 FGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETL----ANITA 232 (361)
T ss_dssp CSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHH----HHHHT
T ss_pred cCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC---CHHHHH----HHHHh
Confidence 999987654322 23457999999999999889999999999999999999999997432 111111 11111
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.... +++...... ...+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~--~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 233 VSYD--FDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TCCC--CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCC--CCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1110 111111112 234677999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=4e-23 Score=213.31 Aligned_cols=101 Identities=19% Similarity=0.235 Sum_probs=87.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC--ceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN--PKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~--~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
......++.+++.++.+||..+++ ||||||+|||++.++. +||+|||++...... .....||+.|+
T Consensus 199 ~~~~~~i~~qi~~aL~~LH~~~iv-------HrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~ 266 (429)
T 3kvw_A 199 LPLVRKFAHSILQCLDALHKNRII-------HCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYR 266 (429)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTEE-------CSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCcc
Confidence 445677889999999999988777 9999999999999887 999999999765322 22357899999
Q ss_pred hhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCC
Q 011196 344 APEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGF 378 (491)
Q Consensus 344 aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~ 378 (491)
|||++.+..++.++|||||||++|||++|..||..
T Consensus 267 aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 267 APEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp CHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999999999999753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-24 Score=208.71 Aligned_cols=168 Identities=26% Similarity=0.351 Sum_probs=126.3
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc-cccCceeecCCCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE-ANTNRVVGTYGYM 343 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~ 343 (491)
.......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++........ .......+++.|+
T Consensus 108 ~~~~~~~~~~qi~~~l~~lH~~~i~-------H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 180 (287)
T 1u59_A 108 PVSNVAELLHQVSMGMKYLEEKNFV-------HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180 (287)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEe-------eCCCchheEEEcCCCCEEECcccceeeeccCcceeecccccccccccc
Confidence 3556778889999999999998877 9999999999999999999999999876543322 1222345688999
Q ss_pred hhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHH
Q 011196 344 APEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 344 aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
|||++.+..++.++||||||+++|||++ |+.||.... ...... ....+.... .+......+.+
T Consensus 181 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~~----~i~~~~~~~---------~~~~~~~~l~~ 244 (287)
T 1u59_A 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVMA----FIEQGKRME---------CPPECPPELYA 244 (287)
T ss_dssp CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---THHHHH----HHHTTCCCC---------CCTTCCHHHHH
T ss_pred CHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---HHHHHH----HHhcCCcCC---------CCCCcCHHHHH
Confidence 9999998889999999999999999998 999975322 112221 122221111 11122345778
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhhcCCCCCCCC
Q 011196 423 IGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKP 455 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p 455 (491)
++.+||+.||++||++.+++++|+....+...+
T Consensus 245 li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 245 LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 999999999999999999999998875554443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-23 Score=200.02 Aligned_cols=157 Identities=25% Similarity=0.324 Sum_probs=116.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++................|+..|+||
T Consensus 104 ~~~~~~~~~~i~~~l~~lH~~~i~-------H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 176 (276)
T 2yex_A 104 EPDAQRFFHQLMAGVVYLHGIGIT-------HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCG
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------ccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccCh
Confidence 456778889999999999998777 9999999999999999999999999876433322223446789999999
Q ss_pred hhhhhCCC-CcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIF-SVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~-s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|.+.+..+ +.++||||||++++||++|+.||....... .. ...+...... ..+ .... ...+.+++
T Consensus 177 E~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~---~~~~~~~~~~--~~~--~~~~----~~~~~~li 242 (276)
T 2yex_A 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QE---YSDWKEKKTY--LNP--WKKI----DSAPLALL 242 (276)
T ss_dssp GGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS---HH---HHHHHTTCTT--STT--GGGS----CHHHHHHH
T ss_pred HHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH---HH---HHHhhhcccc--cCc--hhhc----CHHHHHHH
Confidence 99987665 779999999999999999999985432211 11 1111111110 000 0111 23466799
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 011196 425 LLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~ 443 (491)
.+||+.||++|||+.|+++
T Consensus 243 ~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 243 HKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTT
T ss_pred HHHCCCCchhCCCHHHHhc
Confidence 9999999999999999876
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2e-23 Score=207.30 Aligned_cols=166 Identities=13% Similarity=0.145 Sum_probs=113.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... ......||..|+||
T Consensus 99 ~~~~~~~~~qi~~aL~~LH~~~iv-------H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aP 169 (324)
T 3mtl_A 99 MHNVKLFLFQLLRGLAYCHRQKVL-------HRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPP 169 (324)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------ESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------CCCcCHHHEEECCCCCEEEccCcccccccCCcc--ccccccCcccccCh
Confidence 455677888999999999998877 999999999999999999999999986543221 12235789999999
Q ss_pred hhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC---Cccccccch---------hcCC-
Q 011196 346 EYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG---HAAELMDSV---------VKQS- 411 (491)
Q Consensus 346 E~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d~~---------l~~~- 411 (491)
|++.+ ..++.++||||||+++|||++|+.||.... .......+....... .+....... ....
T Consensus 170 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (324)
T 3mtl_A 170 DILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST---VEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEA 246 (324)
T ss_dssp HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCC
T ss_pred hhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchh
Confidence 99986 568999999999999999999999975422 222333333222111 111111100 0000
Q ss_pred ---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 412 ---CDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 412 ---~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
........+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 247 LLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00011235678999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=8.4e-24 Score=228.60 Aligned_cols=181 Identities=24% Similarity=0.317 Sum_probs=126.5
Q ss_pred eeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 245 YELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
|.++.|..++.+.... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++
T Consensus 445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ii-------HrDLkp~NILl~~~~~~kL~DFGla~ 517 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV-------HRDLAARNVLLVTQHYAKISDFGLSK 517 (635)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEe-------CCCCChHhEEEeCCCCEEEEEcCCcc
Confidence 4555665544432222 12233556678889999999999988776 99999999999999999999999998
Q ss_pred ecCCCCcc-cccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 323 IFGGNQSE-ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 323 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... ... +......+..
T Consensus 518 ~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~---~~~----~~~~i~~~~~ 590 (635)
T 4fl3_A 518 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSE----VTAMLEKGER 590 (635)
T ss_dssp HTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHH----HHHHHHTTCC
T ss_pred ccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHH----HHHHHHcCCC
Confidence 76543321 12223456788999999999999999999999999999998 999975321 111 2222222221
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.. .+......+.+|+.+||+.||++||++.+|++.|+..
T Consensus 591 ~~---------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 591 MG---------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CC---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 1112234577899999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-23 Score=205.59 Aligned_cols=162 Identities=27% Similarity=0.358 Sum_probs=121.2
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCccc-ccCceeecCCCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEA-NTNRVVGTYGYM 343 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~ 343 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++......... ......++..|+
T Consensus 115 ~~~~~~~i~~qi~~~l~~LH~~~i~-------H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 187 (291)
T 1xbb_A 115 KDKNIIELVHQVSMGMKYLEESNFV-------HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 187 (291)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeE-------cCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceee
Confidence 3556778899999999999998877 99999999999999999999999998765433221 122234578899
Q ss_pred hhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHH
Q 011196 344 APEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 344 aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
|||.+.+..++.++||||||+++|||++ |+.||.... .. ........+.... .+......+.+
T Consensus 188 aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~----~~~~~~~~~~~~~---------~~~~~~~~l~~ 251 (291)
T 1xbb_A 188 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GS----EVTAMLEKGERMG---------CPAGCPREMYD 251 (291)
T ss_dssp CHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HH----HHHHHHHTTCCCC---------CCTTCCHHHHH
T ss_pred ChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC---HH----HHHHHHHcCCCCC---------CCCCCCHHHHH
Confidence 9999998889999999999999999999 999975321 11 1222222222111 11122345778
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 423 IGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
++.+||+.||++||++.+|++.|++..
T Consensus 252 li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 252 LMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.6e-23 Score=205.03 Aligned_cols=178 Identities=17% Similarity=0.151 Sum_probs=124.7
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC----CceEec
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM----NPKISD 317 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~----~~kl~D 317 (491)
.|.++.|..++....... ...+......++.+++.++.+||..+++ ||||||+|||++.++ .+||+|
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv-------H~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIA-------HFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeE-------cCCCCHHHEEEecCCCCCCCEEEEE
Confidence 344555554444322221 1233556778889999999999998877 999999999998887 799999
Q ss_pred cCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 318 FGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 318 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|..||... ........+. .
T Consensus 162 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~~~----~ 231 (326)
T 2y0a_A 162 FGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVS----A 231 (326)
T ss_dssp CTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHH----H
T ss_pred CCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC---CHHHHHHHHH----h
Confidence 999987643322 23457899999999999889999999999999999999999997422 1111111111 1
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
... .. ........ ...+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~-~~-~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 232 VNY-EF-EDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp TCC-CC-CHHHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCC-Cc-CccccccC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 110 01 11111111 2346789999999999999999998863
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-22 Score=202.37 Aligned_cols=169 Identities=20% Similarity=0.201 Sum_probs=119.8
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... ......||+.|+|
T Consensus 110 ~~~~~~~~~~qi~~~l~~lH~~~iv-------H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~a 180 (346)
T 1ua2_A 110 TPSHIKAYMLMTLQGLEYLHQHWIL-------HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRA 180 (346)
T ss_dssp CSSHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEE-------CCCCCHHHEEEcCCCCEEEEecccceeccCCcc--cCCcccccccccC
Confidence 3566778899999999999998877 999999999999999999999999986643222 2234578999999
Q ss_pred hhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC---cccc---ccchh---cCCCC-
Q 011196 345 PEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH---AAEL---MDSVV---KQSCD- 413 (491)
Q Consensus 345 PE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~---~d~~l---~~~~~- 413 (491)
||++.+. .++.++||||||+++|||++|.+||... ........+........ +.+. .+... ....+
T Consensus 181 PE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (346)
T 1ua2_A 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD---SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPL 257 (346)
T ss_dssp HHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCH
T ss_pred chHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC---CHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCCh
Confidence 9999764 4889999999999999999999886432 22223333333221111 1110 00000 00011
Q ss_pred ----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 011196 414 ----QAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445 (491)
Q Consensus 414 ----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 445 (491)
......+.+++.+||+.||++|||+.|++++-
T Consensus 258 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 258 HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred HHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 11124678899999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.87 E-value=6.7e-23 Score=206.29 Aligned_cols=182 Identities=16% Similarity=0.209 Sum_probs=125.2
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++.+..... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv-------H~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGII-------YRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCHHHEEECCCCcEEEeeCCCC
Confidence 445666665544322211 1233456677888999999999988776 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhC--CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEG--IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
+........ ......||+.|+|||++.++ .++.++||||||+++|||++|+.||........ .......... ..
T Consensus 207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~-~~ 282 (355)
T 1vzo_A 207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILK-SE 282 (355)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHH-CC
T ss_pred eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhc-cC
Confidence 865432221 22346789999999999863 478999999999999999999999864332221 1111111111 10
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHhh
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAVMLA 446 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L~ 446 (491)
+ ..+......+.+|+.+||+.||++|| ++.|++++.-
T Consensus 283 ------~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 283 ------P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp ------C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred ------C----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 0 11112223467799999999999999 9999987653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.5e-23 Score=209.26 Aligned_cols=175 Identities=21% Similarity=0.245 Sum_probs=124.4
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++.+..... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~giv-------HrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGII-------YRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCB-------CCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEE-------eccCCHHHEEEcCCCcEEEEeCCcc
Confidence 455666665554322211 1233456677888999999999998777 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+...+ ......
T Consensus 169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i----~~~~~~ 239 (353)
T 2i0e_A 169 KENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSI----MEHNVA 239 (353)
T ss_dssp BCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH----HHCCCC
T ss_pred cccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC---CHHHHHHHH----HhCCCC
Confidence 8543222 1233568999999999999999999999999999999999999997532 111222211 111110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT-----MSSVAVM 444 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 444 (491)
++......+.+++.+||+.||++||+ +++|+++
T Consensus 240 ----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 240 ----------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ----------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11112245678999999999999995 5666653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-22 Score=205.20 Aligned_cols=103 Identities=20% Similarity=0.293 Sum_probs=84.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeecccccccccccc--CCCCceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLD--HEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~--~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
......++.+++.++.+||.. ..+++||||||+|||++ .++.+||+|||+++..... .....||+.|+
T Consensus 156 ~~~~~~i~~qi~~al~~lH~~-----~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~ 225 (382)
T 2vx3_A 156 LNLTRKFAQQMCTALLFLATP-----ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYR 225 (382)
T ss_dssp HHHHHHHHHHHHHHHHHHTST-----TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGC
T ss_pred HHHHHHHHHHHHHHHHHhccC-----CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCcccc
Confidence 455667888888899988841 22344999999999994 4778999999999876432 22357899999
Q ss_pred hhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCC
Q 011196 344 APEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGF 378 (491)
Q Consensus 344 aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~ 378 (491)
|||++.+..++.++|||||||++|||++|+.||..
T Consensus 226 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999999999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=5e-23 Score=209.19 Aligned_cols=155 Identities=18% Similarity=0.278 Sum_probs=115.7
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...... ......||+.|+|
T Consensus 113 ~~~~~~~~~~qi~~aL~~LH~~giv-------HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~a 182 (384)
T 4fr4_A 113 KEETVKLFICELVMALDYLQNQRII-------HRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMA 182 (384)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCCCCSCGGGCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCce-------eccCcHHHeEECCCCCEEEeccceeeeccCCC---ceeccCCCccccC
Confidence 3455677888999999999998877 99999999999999999999999998764332 2334679999999
Q ss_pred hhhhhh---CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 345 PEYAME---GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 345 PE~~~~---~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
||++.. ..++.++|||||||++|||++|+.||............ ........ ..+......+.
T Consensus 183 PE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~----~~~~~~~~----------~~p~~~s~~~~ 248 (384)
T 4fr4_A 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV----HTFETTVV----------TYPSAWSQEMV 248 (384)
T ss_dssp GGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH----HHHHHCCC----------CCCTTSCHHHH
T ss_pred CeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH----HHHhhccc----------CCCCcCCHHHH
Confidence 999874 45899999999999999999999998643322221111 11111110 01111224577
Q ss_pred HHHHHcccCCCCCCCC-HHHHHH
Q 011196 422 HIGLLCVQEDPMDRPT-MSSVAV 443 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs-~~evl~ 443 (491)
+|+.+||+.||++||+ +.+|++
T Consensus 249 ~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 249 SLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHhcCCHhHhcccHHHHHc
Confidence 8999999999999998 777764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-22 Score=212.60 Aligned_cols=168 Identities=24% Similarity=0.370 Sum_probs=123.3
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... .....||+.|+|
T Consensus 114 ~~~~~~~i~~qi~~aL~~LH~~giv-------HrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~a 183 (476)
T 2y94_A 114 DEKESRRLFQQILSGVDYCHRHMVV-------HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAA 183 (476)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTTTEE-------CSCCSGGGEEECTTCCEEECCCSSCEECCTTCC---BCCCCSCSTTCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCCC-------cccccHHHEEEecCCCeEEEeccchhhcccccc---ccccCCCcCeEC
Confidence 3556777889999999999998877 999999999999999999999999987654322 234578999999
Q ss_pred hhhhhhCCC-CcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIF-SVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~-s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..+ +.++|||||||++|||++|+.||... ....+.. ....+... . .... ...+.++
T Consensus 184 PE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~---~~~~~~~----~i~~~~~~-~-----p~~~----s~~~~~L 246 (476)
T 2y94_A 184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD---HVPTLFK----KICDGIFY-T-----PQYL----NPSVISL 246 (476)
T ss_dssp HHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS---SSHHHHH----HHHTTCCC-C-----CTTC----CHHHHHH
T ss_pred hhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC---CHHHHHH----HHhcCCcC-C-----CccC----CHHHHHH
Confidence 999988765 68999999999999999999997532 1112221 12222110 0 0111 2346789
Q ss_pred HHHcccCCCCCCCCHHHHHH--HhhcCCCCCCCCCCCC
Q 011196 424 GLLCVQEDPMDRPTMSSVAV--MLASDIVTLPKPTQPA 459 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~--~L~~~~~~~~~p~~p~ 459 (491)
+.+||+.||++|||+.|+++ +++........|..|.
T Consensus 247 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~ 284 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPS 284 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSC
T ss_pred HHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcc
Confidence 99999999999999999997 5665543333343333
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.5e-23 Score=210.04 Aligned_cols=191 Identities=13% Similarity=0.178 Sum_probs=123.1
Q ss_pred eeeecccccCCCCcccc----CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 244 RYELYRFLVDTPTVTVT----APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
.|.++.|+.++...... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv-------HrDlkp~NIll~~~~~~kl~dfg 173 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYV-------HRSVKASHILISVDGKVYLSGLR 173 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECTTCCEEECCGG
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEEcCCCCEEEcccc
Confidence 34555555544432221 12233556777888999999999998877 99999999999999999999999
Q ss_pred cceecCCCCc-----ccccCceeecCCCChhhhhhh--CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHH
Q 011196 320 MARIFGGNQS-----EANTNRVVGTYGYMAPEYAME--GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIW 392 (491)
Q Consensus 320 la~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 392 (491)
.+........ ........||..|+|||++.+ ..++.++|||||||++|||++|+.||....... ......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~ 250 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKL 250 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT---HHHHC-
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHh
Confidence 9865422111 111223468899999999987 578999999999999999999999986432211 111110
Q ss_pred HHhhc-----------------------CCcccccc---c------hhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 011196 393 KLWCE-----------------------GHAAELMD---S------VVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSS 440 (491)
Q Consensus 393 ~~~~~-----------------------~~~~~~~d---~------~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e 440 (491)
..... ....+... + ......+......+.+|+.+||+.||++|||+.|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e 330 (389)
T 3gni_B 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330 (389)
T ss_dssp -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence 00000 00000000 0 0000011122345788999999999999999999
Q ss_pred HHHH
Q 011196 441 VAVM 444 (491)
Q Consensus 441 vl~~ 444 (491)
++++
T Consensus 331 ll~h 334 (389)
T 3gni_B 331 LLNH 334 (389)
T ss_dssp HTTS
T ss_pred HhcC
Confidence 9865
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=6.8e-23 Score=207.26 Aligned_cols=165 Identities=18% Similarity=0.219 Sum_probs=108.2
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++..... .....||..|+|
T Consensus 130 ~~~~~~~i~~qi~~aL~~LH~~giv-------H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~a 197 (367)
T 2fst_X 130 TDDHVQFLIYQILRGLKYIHSADII-------HRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRA 197 (367)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEECTTCCEEECC--------------------CCCTTCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCee-------eCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccC
Confidence 3456677889999999999998777 9999999999999999999999999865322 224578999999
Q ss_pred hhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc---ccc--------ccchhc-CC
Q 011196 345 PEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA---AEL--------MDSVVK-QS 411 (491)
Q Consensus 345 PE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--------~d~~l~-~~ 411 (491)
||++.+ ..++.++|||||||+++||++|+.||.... ....+..+.+....... ..+ +..... ..
T Consensus 198 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (367)
T 2fst_X 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274 (367)
T ss_dssp HHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCC
T ss_pred hHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCC
Confidence 999987 678999999999999999999999975322 12222222221111100 000 000000 00
Q ss_pred CCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 412 CDQ-----AELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 412 ~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.+. .....+.+|+.+||+.||++|||+.|++++
T Consensus 275 ~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 011 112457789999999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.6e-23 Score=205.90 Aligned_cols=153 Identities=20% Similarity=0.265 Sum_probs=115.5
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++........ .....||+.|+|
T Consensus 106 ~~~~~~~i~~qi~~aL~~LH~~giv-------H~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---~~~~~gt~~y~a 175 (336)
T 3h4j_B 106 TEDEGRRFFQQIICAIEYCHRHKIV-------HRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAA 175 (336)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHTCC-------CCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT---TCCCTTSTTTSC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeE-------ecCCchhhEEEcCCCCEEEEEeccceeccCCcc---cccccCCcCcCC
Confidence 3556777889999999999998777 999999999999999999999999986643322 234578999999
Q ss_pred hhhhhhCCC-CcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIF-SVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~-s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..+ +.++||||||+++|||++|+.||......... ..+.... ...+......+.++
T Consensus 176 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i~~~~--~~~p~~~s~~~~~l 238 (336)
T 3h4j_B 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKVNSCV--YVMPDFLSPGAQSL 238 (336)
T ss_dssp GGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCCCSSC--CCCCTTSCHHHHHH
T ss_pred HHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHHcCC--CCCcccCCHHHHHH
Confidence 999987776 68999999999999999999998543221110 0000000 01111123456789
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 011196 424 GLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~ 444 (491)
+.+||+.||++|||+.|++++
T Consensus 239 i~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTTC
T ss_pred HHHHcCCChhHCcCHHHHHhC
Confidence 999999999999999999863
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.87 E-value=6.5e-23 Score=203.28 Aligned_cols=172 Identities=17% Similarity=0.210 Sum_probs=123.3
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++.+.... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv-------HrDlkp~NIll~~~g~~kL~Dfg~a 153 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDII-------YRDLKPENILLDKNGHIKITDFGFA 153 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEE-------CCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------ccCCChheEEEcCCCCEEEeecCcc
Confidence 34555665544432221 11223445667888999999999998877 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||... ....... ... .....
T Consensus 154 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~---~i~-~~~~~ 221 (318)
T 1fot_A 154 KYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYE---KIL-NAELR 221 (318)
T ss_dssp EECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHH---HHH-HCCCC
T ss_pred eecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHH---HHH-hCCCC
Confidence 875432 23457899999999999999999999999999999999999997432 1111111 111 11110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAVM 444 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 444 (491)
++......+.+++.+||+.||++|| ++.||+++
T Consensus 222 ----------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 222 ----------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1111123467789999999999999 88888753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.87 E-value=4.3e-23 Score=208.35 Aligned_cols=178 Identities=16% Similarity=0.196 Sum_probs=124.5
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC---CceEecc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM---NPKISDF 318 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~---~~kl~Df 318 (491)
.|.++.|..++....... ..........++.+++.++.+||..+++ ||||||+|||++.++ .+||+||
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv-------H~Dlkp~NIll~~~~~~~~~kl~Df 175 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV-------HRNLKPENLLLASKAKGAAVKLADF 175 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCB-------CCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------eccCchHHEEEecCCCCCCEEEeec
Confidence 455666665544322221 1223556777888999999999998777 999999999998654 5999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||++|..||... ....+ +.....+
T Consensus 176 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~---~~~~~----~~~i~~~ 245 (362)
T 2bdw_A 176 GLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRL----YAQIKAG 245 (362)
T ss_dssp TTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHH----HHHHHHT
T ss_pred CcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC---CHHHH----HHHHHhC
Confidence 99987643322 23457899999999999989999999999999999999999997421 11111 2222222
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
... ...+. .... ...+.+++.+||+.||++||++.|++++
T Consensus 246 ~~~-~~~~~-~~~~----~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 246 AYD-YPSPE-WDTV----TPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCC-CCTTG-GGGS----CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCC-CCccc-ccCC----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111 00000 0111 2346789999999999999999998864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.4e-23 Score=205.64 Aligned_cols=167 Identities=16% Similarity=0.172 Sum_probs=119.6
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc-------cccCcee
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE-------ANTNRVV 337 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~-------~~~~~~~ 337 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++......... .......
T Consensus 132 ~~~~~~~i~~qi~~~L~~LH~~~iv-------H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (317)
T 2buj_A 132 TEDQILWLLLGICRGLEAIHAKGYA-------HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204 (317)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcc-------cCCCCHHHEEEcCCCCEEEEecCcchhccccccccccccccccccccc
Confidence 3556777889999999999998777 9999999999999999999999998764321110 0011245
Q ss_pred ecCCCChhhhhhhCC---CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCH
Q 011196 338 GTYGYMAPEYAMEGI---FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQ 414 (491)
Q Consensus 338 gt~~y~aPE~~~~~~---~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 414 (491)
|++.|+|||++.+.. ++.++||||||+++|||++|+.||........ ...... .... .. ....
T Consensus 205 gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~----~~~~--~~-------~~~~ 270 (317)
T 2buj_A 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAV----QNQL--SI-------PQSP 270 (317)
T ss_dssp SCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHH----HCC----C-------CCCT
T ss_pred CCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHh----hccC--CC-------Cccc
Confidence 689999999987543 68899999999999999999999753211111 111111 1100 00 0011
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCC
Q 011196 415 AELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTL 452 (491)
Q Consensus 415 ~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 452 (491)
.....+.+++.+||+.||++||++.+|++.|+......
T Consensus 271 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 271 RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 12245778999999999999999999999999875433
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.8e-23 Score=210.48 Aligned_cols=172 Identities=18% Similarity=0.189 Sum_probs=121.2
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++.+..... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~giv-------HrDlkp~NIll~~~g~ikL~DFG~a 186 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIV-------YRDLKPENILLDSQGHIVLTDFGLC 186 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEECTTSCEEECCCCBC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce-------ecCCCHHHEEECCCCCEEEeeCccc
Confidence 455666665544322211 1223445666788899999999988777 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.... .......+ ......
T Consensus 187 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i----~~~~~~ 257 (373)
T 2r5t_A 187 KENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNI----LNKPLQ 257 (373)
T ss_dssp GGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB---HHHHHHHH----HHSCCC
T ss_pred cccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHHHH----HhcccC
Confidence 8643222 12345689999999999999999999999999999999999999975321 11111111 111110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSV 441 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev 441 (491)
..... ...+.+|+.+||+.||++||++.+.
T Consensus 258 ------~~~~~----~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 258 ------LKPNI----TNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp ------CCSSS----CHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred ------CCCCC----CHHHHHHHHHHcccCHHhCCCCCCC
Confidence 01112 2346778999999999999998543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.3e-23 Score=215.01 Aligned_cols=175 Identities=16% Similarity=0.171 Sum_probs=123.3
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhh-eeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLS-TSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.++.|..++.+.... ...........++.+++.++.+||. .+++ ||||||+|||++.++.+||+|||+
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~gii-------HrDlkp~NIll~~~~~~kl~DFG~ 295 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV-------YRDLKLENLMLDKDGHIKITDFGL 295 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCC-------CCCCCGGGEEECSSSCEEECCCCC
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEE-------ECCCCHHHEEECCCCCEEEccCCC
Confidence 45566666554432221 1223345666788889999999997 6666 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+...+ .....
T Consensus 296 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i----~~~~~ 366 (446)
T 4ejn_A 296 CKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHEKLFELI----LMEEI 366 (446)
T ss_dssp CCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH----HHCCC
T ss_pred ceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC---CHHHHHHHH----HhCCC
Confidence 975432221 223467999999999999999999999999999999999999997432 111111111 11111
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAVM 444 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 444 (491)
. ++......+.+|+.+||+.||++|| ++.|++++
T Consensus 367 ~----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 367 R----------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp C----------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C----------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 0 1111123567899999999999999 99998863
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-22 Score=201.70 Aligned_cols=148 Identities=16% Similarity=0.212 Sum_probs=115.1
Q ss_pred CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... .....||+.|+
T Consensus 127 l~~~~~~~i~~qi~~~L~~LH~~~iv-------H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~ 196 (335)
T 3dls_A 127 LDEPLASYIFRQLVSAVGYLRLKDII-------HRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYC 196 (335)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeE-------EeccCHHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCcccc
Confidence 34556677889999999999998877 999999999999999999999999987654322 23467899999
Q ss_pred hhhhhhhCCC-CcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHH
Q 011196 344 APEYAMEGIF-SVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 344 aPE~~~~~~~-s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
|||++.+..+ +.++||||||+++|||++|+.||...... . . ..... .... ...+.+
T Consensus 197 aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~-~----~~~~~--~~~~----~~~l~~ 253 (335)
T 3dls_A 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------V-E----AAIHP--PYLV----SKELMS 253 (335)
T ss_dssp CHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------T-T----TCCCC--SSCC----CHHHHH
T ss_pred ChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------H-h----hccCC--Cccc----CHHHHH
Confidence 9999988876 78999999999999999999997531110 0 0 00000 0011 234678
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 011196 423 IGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~~ 444 (491)
++.+||+.||++|||+.|+++.
T Consensus 254 li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 254 LVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999998874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-22 Score=208.09 Aligned_cols=172 Identities=19% Similarity=0.240 Sum_probs=111.8
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccc----cCCCCceEeccCcceecCCCCc-ccccCceeecC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLL----DHEMNPKISDFGMARIFGGNQS-EANTNRVVGTY 340 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl----~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~ 340 (491)
....+.++.+++.++.+||..+++ ||||||+|||+ +.++.+||+|||+++....... ........||+
T Consensus 127 ~~~~~~i~~qi~~al~~LH~~~iv-------H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~ 199 (405)
T 3rgf_A 127 RGMVKSLLYQILDGIHYLHANWVL-------HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199 (405)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEe-------CCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecC
Confidence 445677888999999999998777 99999999999 6778999999999987643221 12233467899
Q ss_pred CCChhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCC------CcccHHHHHHHHhhcCC---cccccc-----
Q 011196 341 GYMAPEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLE------HGPSLLAYIWKLWCEGH---AAELMD----- 405 (491)
Q Consensus 341 ~y~aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~------~~~~~~~~~~~~~~~~~---~~~~~d----- 405 (491)
.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+..+........ +..+..
T Consensus 200 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 279 (405)
T 3rgf_A 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHS 279 (405)
T ss_dssp TTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHH
T ss_pred cccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchh
Confidence 99999999874 4899999999999999999999998643221 01122222222221111 111100
Q ss_pred -------chhcCCCCH---------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 406 -------SVVKQSCDQ---------AELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 406 -------~~l~~~~~~---------~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
......... .....+.+|+.+||+.||++|||+.|++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 280 TLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 002356789999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.1e-23 Score=204.01 Aligned_cols=162 Identities=20% Similarity=0.210 Sum_probs=117.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC-------------------CCCceEeccCcceecCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH-------------------EMNPKISDFGMARIFGG 326 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~-------------------~~~~kl~DfGla~~~~~ 326 (491)
......++.+++.++.+||..+++ ||||||+|||++. ++.+||+|||+++....
T Consensus 117 ~~~~~~~~~qi~~~l~~lH~~~iv-------H~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~ 189 (339)
T 1z57_A 117 LDHIRKMAYQICKSVNFLHSNKLT-------HTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189 (339)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCc-------CCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc
Confidence 455677889999999999998877 9999999999987 66899999999986533
Q ss_pred CCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcccc---
Q 011196 327 NQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAEL--- 403 (491)
Q Consensus 327 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 403 (491)
. .....||..|+|||++.+..++.++||||||+++|||++|..||..... ............ .....+
T Consensus 190 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~-~~p~~~~~~ 260 (339)
T 1z57_A 190 H-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS---KEHLAMMERILG-PLPKHMIQK 260 (339)
T ss_dssp C-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH---HHHHHHHHHHHC-SCCHHHHHH
T ss_pred c-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhC-CCCHHHHhh
Confidence 2 2235789999999999998999999999999999999999999864321 111111111110 000000
Q ss_pred ---------------------------ccchh-cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 404 ---------------------------MDSVV-KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 404 ---------------------------~d~~l-~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
..+.. ...........+.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 261 TRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp CSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 00000 01122345667889999999999999999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.2e-23 Score=210.87 Aligned_cols=141 Identities=12% Similarity=0.125 Sum_probs=107.1
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhh
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEY 347 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 347 (491)
..+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++..... .....| +.|+|||+
T Consensus 212 ~~~~i~~qi~~aL~~LH~~~ii-------HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~ 278 (413)
T 3dzo_A 212 ARLQLTLQVIRLLASLHHYGLV-------HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPET 278 (413)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-------CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-------cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchh
Confidence 4566778899999999988777 9999999999999999999999999865332 234567 99999999
Q ss_pred h----------hhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHH
Q 011196 348 A----------MEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAEL 417 (491)
Q Consensus 348 ~----------~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 417 (491)
+ .+..++.++|||||||++|||++|+.||........ ...++... ...+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~---------------~~~~~~~~--~~~~---- 337 (413)
T 3dzo_A 279 TAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG---------------SEWIFRSC--KNIP---- 337 (413)
T ss_dssp HHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC---------------SGGGGSSC--CCCC----
T ss_pred hhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhh---------------HHHHHhhc--ccCC----
Confidence 9 444578899999999999999999999753321111 01111100 1222
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHH
Q 011196 418 LKYIHIGLLCVQEDPMDRPTMSSVA 442 (491)
Q Consensus 418 ~~~~~l~~~cl~~dP~~RPs~~evl 442 (491)
..+.+|+.+||+.||++||++.+++
T Consensus 338 ~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 338 QPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHH
Confidence 4577899999999999999976654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.87 E-value=5e-22 Score=200.63 Aligned_cols=167 Identities=17% Similarity=0.194 Sum_probs=117.1
Q ss_pred CcchhhhHhHHHHHHHHHhhe-eeEEeEEeeeccccccccccccC------CCCceEeccCcceecCCCCcccccCceee
Q 011196 266 SKRWITIAEAASAIIVFLLST-SFLWCIIRRRNKRVRASNVLLDH------EMNPKISDFGMARIFGGNQSEANTNRVVG 338 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~iHrDlKp~NILl~~------~~~~kl~DfGla~~~~~~~~~~~~~~~~g 338 (491)
......++.+++.++.+||.. +++ ||||||+|||++. .+.+||+|||+++..... .....|
T Consensus 130 ~~~~~~i~~qi~~aL~~lH~~~~iv-------H~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~ 197 (373)
T 1q8y_A 130 LIYVKQISKQLLLGLDYMHRRCGII-------HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQ 197 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCEE-------CSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCS
T ss_pred HHHHHHHHHHHHHHHHHHHhcCCEE-------ecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCC
Confidence 445677889999999999986 777 9999999999953 347999999999876432 223478
Q ss_pred cCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcc---cHHHHHHHHhhcC-----------------
Q 011196 339 TYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGP---SLLAYIWKLWCEG----------------- 398 (491)
Q Consensus 339 t~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~---~~~~~~~~~~~~~----------------- 398 (491)
|+.|+|||++.+..++.++||||||+++|||++|+.||......... .....+.......
T Consensus 198 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 277 (373)
T 1q8y_A 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS 277 (373)
T ss_dssp CGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC
T ss_pred CccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCC
Confidence 99999999999999999999999999999999999998643322111 1111111111100
Q ss_pred -C-ccccc-------cchh--cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 399 -H-AAELM-------DSVV--KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 399 -~-~~~~~-------d~~l--~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
. ...+. ...+ ....+......+.+|+.+||+.||++|||+.|++++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 278 RGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp --CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred cchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 0 00000 0000 113456677788999999999999999999999873
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.8e-23 Score=211.68 Aligned_cols=182 Identities=13% Similarity=0.134 Sum_probs=127.1
Q ss_pred eeeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 243 IRYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
..|.++.|..++.+..... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gii-------HrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYV-------HRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeE-------ecccCHHHeeEcCCCCEEEcchh
Confidence 3466777776655433321 2233555677888999999999998877 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhh-----hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHH
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAM-----EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKL 394 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 394 (491)
+++........ ......||+.|+|||++. .+.++.++|||||||++|||++|+.||... ........+...
T Consensus 221 la~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~ 296 (437)
T 4aw2_A 221 SCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMNH 296 (437)
T ss_dssp TCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTH
T ss_pred hhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC---ChhHHHHhhhhc
Confidence 99876443322 223467999999999997 456899999999999999999999997532 112222222111
Q ss_pred hhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 011196 395 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMD--RPTMSSVAVM 444 (491)
Q Consensus 395 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~ 444 (491)
...-...... ... ...+.+|+.+||..+|++ ||+++|++++
T Consensus 297 ~~~~~~p~~~-----~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 297 KERFQFPTQV-----TDV----SENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHCCCCSSC-----CCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccccCCccc-----ccC----CHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1111111110 111 234667888999888888 9999998874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.87 E-value=5e-23 Score=224.01 Aligned_cols=176 Identities=20% Similarity=0.228 Sum_probs=127.6
Q ss_pred ceeeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 242 SIRYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 242 ~lry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
...|.++.|..++.+..... ..........++.+++.++.+||..+++ ||||||+||||+.++.+||+|||
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIi-------HrDLKp~NILl~~~g~ikL~DFG 487 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGII-------YRDLKLDNVMLDSEGHIKIADFG 487 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEE-------CCCCCSTTEEECSSSCEEECCCT
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE-------eccCChhhEEEcCCCcEEEeecc
Confidence 34566777776554432221 2233556677888999999999998777 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... +...+.. .+....
T Consensus 488 la~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~----~i~~~~ 558 (674)
T 3pfq_A 488 MCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQ----SIMEHN 558 (674)
T ss_dssp TCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHH----HHHSSC
T ss_pred eeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC---CHHHHHH----HHHhCC
Confidence 9986433222 234578999999999999999999999999999999999999997532 1112222 222211
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTM-----SSVAV 443 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~ 443 (491)
. .++......+.+|+.+||+.||++||++ +||++
T Consensus 559 ~----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 V----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp C----------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred C----------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1 0111223456789999999999999997 66664
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.3e-22 Score=209.35 Aligned_cols=101 Identities=22% Similarity=0.340 Sum_probs=80.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc---------------
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE--------------- 330 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~--------------- 330 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++........
T Consensus 155 ~~~~~~~~~qi~~aL~~LH~~~ii-------HrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 227 (458)
T 3rp9_A 155 ELHIKTLLYNLLVGVKYVHSAGIL-------HRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227 (458)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCB-------CCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC----------
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcC-------CCCCChhhEEECCCCCEeecccccchhccCccccccccccCcccccccc
Confidence 455677889999999999998777 9999999999999999999999999876432111
Q ss_pred ----------cccCceeecCCCChhhhhh-hCCCCcccceeehhHHHHHHHhCC
Q 011196 331 ----------ANTNRVVGTYGYMAPEYAM-EGIFSVKSDVFSFGVVLLEIISGK 373 (491)
Q Consensus 331 ----------~~~~~~~gt~~y~aPE~~~-~~~~s~~sDVwS~Gvvl~elltG~ 373 (491)
......+||+.|+|||++. +..++.++|||||||++|||++|.
T Consensus 228 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp -----------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred ccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 1123457899999999875 556999999999999999999943
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-22 Score=194.89 Aligned_cols=155 Identities=18% Similarity=0.250 Sum_probs=115.3
Q ss_pred CCcchhhhHhHHHHHHHHHhhee--eEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTS--FLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGY 342 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 342 (491)
.......++.+++.++.+||..+ ++ ||||||+|||++.++.+||.|||++..... ....||+.|
T Consensus 109 ~~~~~~~i~~qi~~~l~~lH~~~~~i~-------H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y 174 (271)
T 3kmu_A 109 DQSQAVKFALDMARGMAFLHTLEPLIP-------RHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAW 174 (271)
T ss_dssp CHHHHHHHHHHHHHHHHHHTTSSSCCT-------TCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGG
T ss_pred CHHHHHHHHHHHHHHHHHHhcCCCcee-------cCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccc
Confidence 35567788999999999999876 55 999999999999999999999888754221 234678999
Q ss_pred ChhhhhhhCCCCc---ccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHH
Q 011196 343 MAPEYAMEGIFSV---KSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLK 419 (491)
Q Consensus 343 ~aPE~~~~~~~s~---~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 419 (491)
+|||.+.+..++. ++||||||+++|||++|+.||.... ...........+..... +......
T Consensus 175 ~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~~~~---------~~~~~~~ 239 (271)
T 3kmu_A 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS------NMEIGMKVALEGLRPTI---------PPGISPH 239 (271)
T ss_dssp SCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC------HHHHHHHHHHSCCCCCC---------CTTCCHH
T ss_pred cChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC------hHHHHHHHHhcCCCCCC---------CCCCCHH
Confidence 9999998765544 7999999999999999999975321 11111122222211111 1112235
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 420 YIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 420 ~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+.+++.+||+.||++|||+.|+++.|+..
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 77899999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.8e-23 Score=203.79 Aligned_cols=179 Identities=15% Similarity=0.168 Sum_probs=123.4
Q ss_pred eeeeecccccCCCCccccC----CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC---CCCceE
Q 011196 243 IRYELYRFLVDTPTVTVTA----PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH---EMNPKI 315 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~---~~~~kl 315 (491)
..|.++.|+.++....... ..........++.+++.++.+||..+++ ||||||+|||++. ++.+||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~giv-------H~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV-------HLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCCGGGEEESCBTTBCCEEE
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCee-------cCcCChHHEEEecCCCCCcEEE
Confidence 3455666665554433321 2233456778889999999999998877 9999999999988 789999
Q ss_pred eccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHh
Q 011196 316 SDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLW 395 (491)
Q Consensus 316 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 395 (491)
+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+...
T Consensus 176 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~- 248 (327)
T 3lm5_A 176 VDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETYLNISQV- 248 (327)
T ss_dssp CCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHT-
T ss_pred eeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHHHhc-
Confidence 99999987643322 223578999999999999999999999999999999999999974321 11111111111
Q ss_pred hcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 396 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 396 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
...... + ........+.+++.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~----~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 NVDYSE----E-----TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCCCCT----T-----TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ccccCc----h-----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000000 0 001122346789999999999999999998864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-23 Score=207.18 Aligned_cols=161 Identities=22% Similarity=0.302 Sum_probs=119.2
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++..... .......++..|+|
T Consensus 140 ~~~~~~~i~~qi~~aL~~LH~~~iv-------H~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~a 209 (327)
T 1fvr_A 140 SSQQLLHFAADVARGMDYLSQKQFI-------HRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMA 209 (327)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcc-------CCCCccceEEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccC
Confidence 3556778889999999999998777 9999999999999999999999999743211 11223456889999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..++.++||||||+++|||++ |+.||.... . .........+... ..+......+.++
T Consensus 210 PE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~------~-~~~~~~~~~~~~~---------~~~~~~~~~l~~l 273 (327)
T 1fvr_A 210 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------C-AELYEKLPQGYRL---------EKPLNCDDEVYDL 273 (327)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------H-HHHHHHGGGTCCC---------CCCTTBCHHHHHH
T ss_pred hhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc------H-HHHHHHhhcCCCC---------CCCCCCCHHHHHH
Confidence 999998889999999999999999998 999975321 1 1122222222111 1111122457789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcCCCC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASDIVT 451 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~~~~ 451 (491)
+.+||+.||++||++.|+++.|+.....
T Consensus 274 i~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 274 MRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999876443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=5.7e-23 Score=206.46 Aligned_cols=173 Identities=16% Similarity=0.181 Sum_probs=125.7
Q ss_pred eeeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 243 IRYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
..|.++.|..++.+..... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv-------HrDlkp~NIll~~~g~~kL~DFg~ 187 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLI-------YRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------cccCccceEEECCCCCEEEccccc
Confidence 3456666665544322211 1233456677888999999999998877 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... ..... ...+..+..
T Consensus 188 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~----~~~i~~~~~ 255 (350)
T 1rdq_E 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQI----YEKIVSGKV 255 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHH----HHHHHHCCC
T ss_pred ceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC---CHHHH----HHHHHcCCC
Confidence 9876432 23468999999999999999999999999999999999999997532 11111 122222211
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT-----MSSVAVM 444 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 444 (491)
. .+......+.+++.+||+.||++||+ +.||+++
T Consensus 256 ~----------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 R----------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp C----------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred C----------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 0 11111234678999999999999998 8888754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.86 E-value=7.2e-23 Score=207.09 Aligned_cols=163 Identities=19% Similarity=0.183 Sum_probs=116.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++..... .....||..|+||
T Consensus 127 ~~~~~~~~~qi~~~L~~LH~~~iv-------H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aP 194 (367)
T 1cm8_A 127 EDRIQFLVYQMLKGLRYIHAAGII-------HRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAP 194 (367)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCT
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------ccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCH
Confidence 455677888999999999998877 9999999999999999999999999875432 2235789999999
Q ss_pred hhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC------------------ccccccc
Q 011196 346 EYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH------------------AAELMDS 406 (491)
Q Consensus 346 E~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~d~ 406 (491)
|++.+ ..++.++||||+||+++||++|+.||.... ....+..+........ .......
T Consensus 195 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (367)
T 1cm8_A 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD---HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK 271 (367)
T ss_dssp HHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCC
T ss_pred HHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCC
Confidence 99987 679999999999999999999999975322 1122222211111000 0000000
Q ss_pred hhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 407 VVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 407 ~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
... .........+.+|+.+||+.||++|||+.|++++
T Consensus 272 ~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 272 DFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000 0011123457789999999999999999999884
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2.7e-22 Score=201.54 Aligned_cols=155 Identities=19% Similarity=0.196 Sum_probs=115.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC---ceEeccCcceecCCCCcccccCceeecCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN---PKISDFGMARIFGGNQSEANTNRVVGTYGY 342 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~---~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 342 (491)
......++.+++.++.+||..+++ ||||||+|||++.++. +||+|||+++....... ......||+.|
T Consensus 129 ~~~~~~i~~qi~~al~~lH~~~iv-------HrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y 199 (351)
T 3c0i_A 129 EAVASHYMRQILEALRYCHDNNII-------HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHF 199 (351)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGG
T ss_pred HHHHHHHHHHHHHHHHHHHHCCce-------eccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCc
Confidence 455667888999999999998777 9999999999987654 99999999987654322 22345789999
Q ss_pred ChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHH
Q 011196 343 MAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 343 ~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
+|||++.+..++.++|||||||++|||++|+.||... ... .......+... ..+...... ...+.+
T Consensus 200 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~----~~~~i~~~~~~--~~~~~~~~~----s~~~~~ 265 (351)
T 3c0i_A 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----KER----LFEGIIKGKYK--MNPRQWSHI----SESAKD 265 (351)
T ss_dssp CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----HHH----HHHHHHHTCCC--CCHHHHTTS----CHHHHH
T ss_pred cCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----HHH----HHHHHHcCCCC--CCccccccC----CHHHHH
Confidence 9999999989999999999999999999999997531 111 11111111111 011111112 235678
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 011196 423 IGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~ 443 (491)
++.+||+.||++|||+.|+++
T Consensus 266 li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 266 LVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHCCCChhHCcCHHHHhc
Confidence 999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=8e-23 Score=198.11 Aligned_cols=155 Identities=23% Similarity=0.293 Sum_probs=112.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++...... ....++..|+||
T Consensus 116 ~~~~~~~~~~i~~~l~~lH~~~i~-------H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aP 183 (278)
T 1byg_A 116 GDCLLKFSLDVCEAMEYLEGNNFV-------HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAP 183 (278)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------ccCCCcceEEEeCCCcEEEeeccccccccccc-----cCCCccccccCH
Confidence 344667888899999999988776 99999999999999999999999987553321 123568899999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|.+.+..++.++||||||++++||++ |+.||.... ...... ....+.... .+......+.+++
T Consensus 184 E~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~----~~~~~~~~~---------~~~~~~~~l~~li 247 (278)
T 1byg_A 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVP----RVEKGYKMD---------APDGCPPAVYEVM 247 (278)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---GGGHHH----HHTTTCCCC---------CCTTCCHHHHHHH
T ss_pred HHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC---HHHHHH----HHhcCCCCC---------CcccCCHHHHHHH
Confidence 99999999999999999999999998 999975322 112221 111111111 1112234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++||++.|+++.|+..
T Consensus 248 ~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 248 KNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcCChhhCCCHHHHHHHHHHH
Confidence 999999999999999999999764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.9e-22 Score=203.58 Aligned_cols=180 Identities=18% Similarity=0.168 Sum_probs=115.5
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC--ceEeccC
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN--PKISDFG 319 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~--~kl~DfG 319 (491)
.|.++.|..++...... ...........++.+++.++.+||..+++ ||||||+|||++.++. +||+|||
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~iv-------H~Dlkp~Nill~~~~~~~~kl~Dfg 163 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQIC-------HRDLKLENTLLDGSPAPRLKICDFG 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC-------SCCCCGGGEEECSSSSCCEEECCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCHHHEEEcCCCCceEEEeecC
Confidence 34555665544432221 12234556778899999999999988777 9999999999987765 9999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcc-cceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK-SDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
+++...... ......||+.|+|||++.+..+..+ +||||||+++|||++|+.||...... ............ .
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~~~~~-~ 237 (361)
T 3uc3_A 164 YSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP--RDYRKTIQRILS-V 237 (361)
T ss_dssp CC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C--CCHHHHHHHHHT-T
T ss_pred ccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhc-C
Confidence 997432221 2234579999999999988887665 89999999999999999998643222 122222222111 1
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
... ..+. ... ...+.+|+.+||+.||++|||+.|++++
T Consensus 238 ~~~-~~~~---~~~----s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 238 KYS-IPDD---IRI----SPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCC-CCTT---SCC----CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCC-CCCc---CCC----CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 110 0000 011 2356789999999999999999999875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-22 Score=205.45 Aligned_cols=167 Identities=18% Similarity=0.159 Sum_probs=110.1
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...... ......||+.|+|
T Consensus 125 ~~~~~~~i~~qi~~al~~lH~~~iv-------H~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~a 194 (371)
T 2xrw_A 125 DHERMSYLLYQMLCGIKHLHSAGII-------HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRA 194 (371)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEECTTSCEEECCCCC-------------------CTTCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCee-------cccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccC
Confidence 3455677888999999999998777 99999999999999999999999998654322 1234578999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh-------------------cC-C-----
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC-------------------EG-H----- 399 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~-------------------~~-~----- 399 (491)
||++.+..++.++|||||||+++||++|+.||.... .......+..... .. .
T Consensus 195 PE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (371)
T 2xrw_A 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD---HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYS 271 (371)
T ss_dssp HHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCC
T ss_pred HHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccc
Confidence 999999899999999999999999999999975322 1111111111000 00 0
Q ss_pred ccccccchhcCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 400 AAELMDSVVKQSC---DQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 400 ~~~~~d~~l~~~~---~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
............. .......+.+|+.+||+.||++|||+.|++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 272 FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000000000000 11224568899999999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=8.9e-23 Score=198.69 Aligned_cols=155 Identities=20% Similarity=0.209 Sum_probs=113.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC--------ceEeccCcceecCCCCcccccCcee
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN--------PKISDFGMARIFGGNQSEANTNRVV 337 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~--------~kl~DfGla~~~~~~~~~~~~~~~~ 337 (491)
......++.+++.++.+||..+++ ||||||+|||++.++. +||+|||++..... .....
T Consensus 112 ~~~~~~i~~qi~~~L~~LH~~~iv-------H~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~ 178 (289)
T 4fvq_A 112 ILWKLEVAKQLAAAMHFLEENTLI-------HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------KDILQ 178 (289)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC------HHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhhCCeE-------CCCcCcceEEEecCCcccccccceeeeccCcccccccC------ccccC
Confidence 445667888999999999998777 9999999999998887 99999999865422 12345
Q ss_pred ecCCCChhhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHH
Q 011196 338 GTYGYMAPEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAE 416 (491)
Q Consensus 338 gt~~y~aPE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 416 (491)
|+..|+|||++.+ ..++.++||||||+++|||++|..|+.. .... .................
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~--~~~~---~~~~~~~~~~~~~~~~~------------ 241 (289)
T 4fvq_A 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS--ALDS---QRKLQFYEDRHQLPAPK------------ 241 (289)
T ss_dssp HTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT--TSCH---HHHHHHHHTTCCCCCCS------------
T ss_pred CcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc--ccch---HHHHHHhhccCCCCCCC------------
Confidence 7899999999987 6789999999999999999996555321 1111 11111111111111111
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 011196 417 LLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIV 450 (491)
Q Consensus 417 ~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 450 (491)
...+.+++.+||+.||++|||+.|+++.|+....
T Consensus 242 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 242 AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1235678999999999999999999999998753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.7e-22 Score=204.08 Aligned_cols=180 Identities=19% Similarity=0.285 Sum_probs=126.7
Q ss_pred cceeeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEecc
Q 011196 241 CSIRYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDF 318 (491)
Q Consensus 241 C~lry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~Df 318 (491)
....|.++.|+.+........ ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+||
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~-------H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIV-------HRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEECCCCCEEEEec
Confidence 344566777766554332221 2233556778889999999999998877 9999999999999999999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhhhC------CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHH
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAMEG------IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIW 392 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 392 (491)
|++........ .....||+.|+|||++.+. .++.++||||||+++|||++|+.||... .......
T Consensus 245 G~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~---~~~~~~~--- 315 (365)
T 2y7j_A 245 GFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR---RQILMLR--- 315 (365)
T ss_dssp TTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHH---
T ss_pred CcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC---CHHHHHH---
Confidence 99987654322 2346789999999998743 5889999999999999999999997431 1111111
Q ss_pred HHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 393 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 393 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
....+... ...+.. ... ...+.+++.+||+.||++||++.|+++
T Consensus 316 -~i~~~~~~-~~~~~~-~~~----~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 -MIMEGQYQ-FSSPEW-DDR----SSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -HHHHTCCC-CCHHHH-SSS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHHhCCCC-CCCccc-ccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111 000100 111 234678999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.7e-22 Score=202.98 Aligned_cols=178 Identities=15% Similarity=0.190 Sum_probs=115.4
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC---CCCceEecc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH---EMNPKISDF 318 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~---~~~~kl~Df 318 (491)
.|.++.|+.++....... ..........++.+++.++.+||..+++ ||||||+|||++. ++.+||+||
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv-------H~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV-------HRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------ecCCCcccEEEecCCCCCCEEEccC
Confidence 344555555443322221 1123456778888999999999998776 9999999999975 789999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .. ..........
T Consensus 196 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~----~~~~~~i~~~ 266 (349)
T 2w4o_A 196 GLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER--GD----QFMFRRILNC 266 (349)
T ss_dssp C-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT--CH----HHHHHHHHTT
T ss_pred ccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc--cc----HHHHHHHHhC
Confidence 9998654322 1234578999999999999899999999999999999999999974221 11 1112222222
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
... ...+. .. .....+.+++.+||+.||++|||+.|+++
T Consensus 267 ~~~-~~~~~-~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 267 EYY-FISPW-WD----EVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CCC-CCTTT-TT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCc-cCCch-hh----hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 11110 11 12235678999999999999999999876
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=4e-23 Score=203.49 Aligned_cols=167 Identities=20% Similarity=0.213 Sum_probs=111.6
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++........ .....|+..|+||
T Consensus 101 ~~~~~~i~~~l~~~l~~lH~~~iv-------H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aP 171 (311)
T 4agu_A 101 EHLVKSITWQTLQAVNFCHKHNCI-------HRDVKPENILITKHSVIKLCDFGFARLLTGPSDY--YDDEVATRWYRSP 171 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCc-------CCCCChhhEEEcCCCCEEEeeCCCchhccCcccc--cCCCcCCccccCh
Confidence 455677888999999999998877 9999999999999999999999999876533221 2245789999999
Q ss_pred hhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHh-----------hcCCcc---ccccchhcC
Q 011196 346 EYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLW-----------CEGHAA---ELMDSVVKQ 410 (491)
Q Consensus 346 E~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~---~~~d~~l~~ 410 (491)
|++.+ ..++.++||||||++++||++|+.||..... ......+.... ...... .+.++....
T Consensus 172 E~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (311)
T 4agu_A 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD---VDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDME 248 (311)
T ss_dssp HHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCC
T ss_pred HHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhcccccccccccccccccccCcCCCccccc
Confidence 99986 5689999999999999999999999754321 11111111111 000000 000000000
Q ss_pred C---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 411 S---CDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 411 ~---~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
. ........+.+++.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 249 PLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 000122347789999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.8e-23 Score=204.74 Aligned_cols=162 Identities=19% Similarity=0.231 Sum_probs=117.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccc-------------------cCCCCceEeccCcceecCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLL-------------------DHEMNPKISDFGMARIFGG 326 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl-------------------~~~~~~kl~DfGla~~~~~ 326 (491)
......++.+++.++.+||..+++ ||||||+|||+ +.++.+||+|||+++....
T Consensus 122 ~~~~~~i~~qi~~~L~~lH~~~iv-------H~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~ 194 (355)
T 2eu9_A 122 LPHVRHMAYQLCHALRFLHENQLT-------HTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE 194 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTTEE-------CCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc
Confidence 456777899999999999998777 99999999999 6678999999999986433
Q ss_pred CCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccc--
Q 011196 327 NQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELM-- 404 (491)
Q Consensus 327 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 404 (491)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ............ .....+.
T Consensus 195 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~-~~p~~~~~~ 265 (355)
T 2eu9_A 195 H-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN---REHLVMMEKILG-PIPSHMIHR 265 (355)
T ss_dssp C-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHC-CCCHHHHHH
T ss_pred c-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcC-CCcHHHhhh
Confidence 2 2235789999999999999999999999999999999999999753221 111111111110 0000000
Q ss_pred ----------------------------cch-hcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 405 ----------------------------DSV-VKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 405 ----------------------------d~~-l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+. ........+...+.+|+.+||+.||++|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 266 TRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp CSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 000112234557889999999999999999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=5.9e-23 Score=208.15 Aligned_cols=177 Identities=19% Similarity=0.130 Sum_probs=123.9
Q ss_pred eeeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccc--cCCCCceEecc
Q 011196 244 RYELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLL--DHEMNPKISDF 318 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl--~~~~~~kl~Df 318 (491)
.|.++.|..+..+.... ...........++.+++.++.+||..+++ ||||||+|||+ +.++.+||+||
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv-------H~Dlkp~NIll~~~~~~~~kl~DF 233 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYIL-------HLDLKPENILCVNRDAKQIKIIDF 233 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEEEETTTTEEEECCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------cccCCHHHEEEecCCCCcEEEEeC
Confidence 34555665544332211 11223455667888999999999998877 99999999999 56678999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.. .
T Consensus 234 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~----~ 303 (373)
T 2x4f_A 234 GLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN---DAETLNNILA----C 303 (373)
T ss_dssp SSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHH----T
T ss_pred CCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHh----c
Confidence 99987654332 223468999999999998889999999999999999999999975321 1112221111 1
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+. ...+ ..... ...+.+++.+||+.||++||++.|+++
T Consensus 304 ~~~-~~~~-~~~~~----~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 304 RWD-LEDE-EFQDI----SEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CCC-SCSG-GGTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCC-CChh-hhccC----CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 110 0011 11112 235678999999999999999999987
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-23 Score=209.37 Aligned_cols=173 Identities=20% Similarity=0.226 Sum_probs=123.2
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++.+..... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv-------HrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIV-------YRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCB-------CCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------eCCCChhhEEECCCCCEEEeEChhh
Confidence 455666665544322211 1233455667888999999999998777 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+.. .......
T Consensus 166 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~----~i~~~~~- 235 (345)
T 1xjd_A 166 KENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFH----SIRMDNP- 235 (345)
T ss_dssp BCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHH----HHHHCCC-
T ss_pred hhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC---CHHHHHH----HHHhCCC-
Confidence 85432221 234568999999999999999999999999999999999999997532 1111221 1111111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMS-SVA 442 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl 442 (491)
. ++......+.+++.+||+.||++||++. +|+
T Consensus 236 -----~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 -----F----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----C----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----C----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0 1111123467789999999999999997 665
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=5.9e-23 Score=207.34 Aligned_cols=170 Identities=19% Similarity=0.246 Sum_probs=118.9
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCccc-ccCceeecCCCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEA-NTNRVVGTYGYM 343 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~ 343 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++......... ......||+.|+
T Consensus 126 ~~~~~~~i~~qi~~aL~~LH~~~iv-------H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~ 198 (364)
T 3qyz_A 126 SNDHICYFLYQILRGLKYIHSANVL-------HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198 (364)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCee-------cCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCC
Confidence 3556777889999999999998877 99999999999999999999999998764332211 123467899999
Q ss_pred hhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccc---ccc--------chh-cC
Q 011196 344 APEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAE---LMD--------SVV-KQ 410 (491)
Q Consensus 344 aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~d--------~~l-~~ 410 (491)
|||++.+. .++.++||||||+++|||++|+.||.... .......+........... +.+ ... ..
T Consensus 199 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (364)
T 3qyz_A 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH---YLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKN 275 (364)
T ss_dssp CHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS---GGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCC
T ss_pred CCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCcc
Confidence 99987655 48999999999999999999999975432 2223333222111111000 000 000 00
Q ss_pred CCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 411 SCD-----QAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 411 ~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..+ ......+.+|+.+||+.||++|||+.|++++
T Consensus 276 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 276 KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 001 0112457789999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.9e-22 Score=197.32 Aligned_cols=164 Identities=20% Similarity=0.275 Sum_probs=112.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++....... ......|+..|+||
T Consensus 135 ~~~~~~i~~qi~~~l~~LH~~~i~-------H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aP 205 (310)
T 2wqm_A 135 ERTVWKYFVQLCSALEHMHSRRVM-------HRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSP 205 (310)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEECTTSCEEECCC--------------------CCSSCCH
T ss_pred HHHHHHHHHHHHHHHHHHhhCCee-------CCCCcHHHEEEcCCCCEEEEeccceeeecCCCc--cccccCCCeeEeCh
Confidence 455677888999999999998777 999999999999999999999999976543222 12235789999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|++.+..++.++||||||+++|||++|+.||.... ....... ............ .... ...+.+++.
T Consensus 206 E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~-~~~~~~~~~~~~----~~~~----~~~l~~li~ 272 (310)
T 2wqm_A 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLC-KKIEQCDYPPLP----SDHY----SEELRQLVN 272 (310)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCHHHHH-HHHHTTCSCCCC----TTTS----CHHHHHHHH
T ss_pred HHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc----hhHHHHH-HHhhcccCCCCc----cccc----CHHHHHHHH
Confidence 99999999999999999999999999999974321 1111111 112222211111 1112 234678999
Q ss_pred HcccCCCCCCCCHHHHHHHhhcCCCC
Q 011196 426 LCVQEDPMDRPTMSSVAVMLASDIVT 451 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~~L~~~~~~ 451 (491)
+||+.||++||++.+|++.|+.....
T Consensus 273 ~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 273 MCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 99999999999999999999876433
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.2e-23 Score=200.43 Aligned_cols=160 Identities=24% Similarity=0.300 Sum_probs=118.9
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++....... .......++..|+|
T Consensus 102 ~~~~~~~~~~~i~~~l~~lH~~~i~-------H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~a 173 (267)
T 3t9t_A 102 AAETLLGMCLDVCEGMAYLEEACVI-------HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWAS 173 (267)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcc-------cCCCchheEEECCCCCEEEcccccccccccccc-cccccccccccccC
Confidence 3455677888999999999998777 999999999999999999999999986543211 11223456778999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..++.++||||||++++||++ |+.||... ..... ......+.... .+......+.++
T Consensus 174 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~~~~~----~~~i~~~~~~~---------~~~~~~~~l~~l 237 (267)
T 3t9t_A 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEV----VEDISTGFRLY---------KPRLASTHVYQI 237 (267)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHH----HHHHHTTCCCC---------CCTTSCHHHHHH
T ss_pred hhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC---CHHHH----HHHHhcCCcCC---------CCccCcHHHHHH
Confidence 999999999999999999999999999 88887532 11111 11122211100 011112356789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+.+||+.||++||++.++++.|+..
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-22 Score=215.55 Aligned_cols=179 Identities=19% Similarity=0.195 Sum_probs=127.6
Q ss_pred eeeeecccccCCCCcccc----CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEecc
Q 011196 243 IRYELYRFLVDTPTVTVT----APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDF 318 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~Df 318 (491)
..|.++.|..++.+.... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+||
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIv-------HrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIV-------YRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEe-------ccCCchheEEEeCCCCeEEEec
Confidence 445666776655542221 11133556677888999999999998777 9999999999999999999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+.......
T Consensus 331 Gla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~---~~i~~~i~~~ 404 (576)
T 2acx_A 331 GLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEV 404 (576)
T ss_dssp TTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH---HHHHHHHHHC
T ss_pred ccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH---HHHHHHhhcc
Confidence 99987654332 22357999999999999988999999999999999999999998643322211 1121211111
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAVM 444 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 444 (491)
.. .++......+.+|+.+||+.||++|| ++.||+++
T Consensus 405 ~~----------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 PE----------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CC----------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cc----------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 10 01111123567799999999999999 77888754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.86 E-value=2.4e-22 Score=212.44 Aligned_cols=179 Identities=20% Similarity=0.209 Sum_probs=126.1
Q ss_pred eeeeecccccCCCCcccc------CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEe
Q 011196 243 IRYELYRFLVDTPTVTVT------APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKIS 316 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~ 316 (491)
..|.++.|..++.+.... .+.........++.+++.++.+||..+++ ||||||+|||++.++.+||+
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIv-------HrDLKP~NILl~~~g~vkL~ 331 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII-------YRDLKPENVLLDDDGNVRIS 331 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCc-------ccCCChHHEEEeCCCCEEEe
Confidence 345666776655442221 11233455667788999999999998777 99999999999999999999
Q ss_pred ccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh
Q 011196 317 DFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC 396 (491)
Q Consensus 317 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 396 (491)
|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+.....
T Consensus 332 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~-~~~~~~i~ 406 (543)
T 3c4z_A 332 DLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--N-KELKQRVL 406 (543)
T ss_dssp CCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--H-HHHHHHHH
T ss_pred ecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--H-HHHHHHHh
Confidence 9999987654332 12345899999999999998999999999999999999999999864322111 1 11111111
Q ss_pred cCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 011196 397 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTM-----SSVAV 443 (491)
Q Consensus 397 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~ 443 (491)
.... .++......+.+++.+||+.||++||++ .+|++
T Consensus 407 ~~~~----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 407 EQAV----------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HCCC----------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred hccc----------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1111 0111122456778999999999999975 56653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=8.6e-23 Score=199.96 Aligned_cols=165 Identities=22% Similarity=0.349 Sum_probs=112.2
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCc---ccccCceeecCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQS---EANTNRVVGTYG 341 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~---~~~~~~~~gt~~ 341 (491)
.......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++........ ........|++.
T Consensus 119 ~~~~~~~i~~qi~~~l~~lH~~~i~-------H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (303)
T 2vwi_A 119 DESTIATILREVLEGLEYLHKNGQI-------HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191 (303)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCT
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCCC-------CCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCcc
Confidence 3456777888999999999998777 999999999999999999999999976543221 111234578999
Q ss_pred CChhhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHH
Q 011196 342 YMAPEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKY 420 (491)
Q Consensus 342 y~aPE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 420 (491)
|+|||++.+ ..++.++||||||+++|||++|+.||..... ....................++......+ ..+
T Consensus 192 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 264 (303)
T 2vwi_A 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP---MKVLMLTLQNDPPSLETGVQDKEMLKKYG----KSF 264 (303)
T ss_dssp TCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG---GGHHHHHHTSSCCCTTC-----CCCCCCC----HHH
T ss_pred ccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch---hhHHHHHhccCCCccccccccchhhhhhh----HHH
Confidence 999999976 5689999999999999999999999754321 11111111100000000111111111222 356
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 011196 421 IHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 421 ~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+++.+||+.||++||++.|+++
T Consensus 265 ~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 265 RKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHccCChhhCcCHHHHhh
Confidence 78999999999999999999886
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=9.8e-23 Score=202.42 Aligned_cols=168 Identities=20% Similarity=0.265 Sum_probs=121.2
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc-cccCceeecCCCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE-ANTNRVVGTYGYM 343 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~ 343 (491)
.....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++........ .......++..|+
T Consensus 143 ~~~~~~~i~~qi~~aL~~LH~~~iv-------H~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 215 (326)
T 2w1i_A 143 DHIKLLQYTSQICKGMEYLGTKRYI-------HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 215 (326)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEe-------ccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEE
Confidence 3456677888999999999998777 9999999999999999999999999876543321 1122345677899
Q ss_pred hhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCcc--------CCCc-ccHHHHHHHHhhcCCccccccchhcCCCCH
Q 011196 344 APEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYH--------LEHG-PSLLAYIWKLWCEGHAAELMDSVVKQSCDQ 414 (491)
Q Consensus 344 aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~--------~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 414 (491)
|||.+.+..++.++||||||++++||++|..|+.... .... .............+... ..+.
T Consensus 216 aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 286 (326)
T 2w1i_A 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL---------PRPD 286 (326)
T ss_dssp CHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCC---------CCCT
T ss_pred CchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCC---------CCCC
Confidence 9999999889999999999999999999998864210 0000 00111111111111111 1111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 415 AELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 415 ~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.....+.+++.+||+.||++||++.||++.|+..
T Consensus 287 ~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 287 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2234577899999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.9e-22 Score=205.13 Aligned_cols=165 Identities=16% Similarity=0.144 Sum_probs=116.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeecccccccccccc-CCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLD-HEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||..+++ ||||||+|||++ .++.+||+|||+++....... .....||..|+|
T Consensus 140 ~~~~~~i~~qi~~aL~~LH~~gi~-------H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~a 209 (383)
T 3eb0_A 140 MNLISIYIYQLFRAVGFIHSLGIC-------HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRA 209 (383)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTTEE-------CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCC
T ss_pred HHHHHHHHHHHHHHHHHHHHCcCc-------cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccC
Confidence 455677888999999999998877 999999999998 678999999999987644332 223567999999
Q ss_pred hhhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC---------------ccccccchh
Q 011196 345 PEYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH---------------AAELMDSVV 408 (491)
Q Consensus 345 PE~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~d~~l 408 (491)
||++.+.. ++.++||||+||+++||++|+.||... ...+....+........ ...+.....
T Consensus 210 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (383)
T 3eb0_A 210 PELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGE---TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDW 286 (383)
T ss_dssp HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCH
T ss_pred HHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccH
Confidence 99988754 899999999999999999999997532 12222222222111110 000000000
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 409 KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
....+......+.+|+.+||+.||++|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 287 RKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00111122345788999999999999999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.86 E-value=1.4e-22 Score=206.40 Aligned_cols=178 Identities=16% Similarity=0.157 Sum_probs=125.0
Q ss_pred eeeecccccCCCCccccCC---CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC--CCCceEecc
Q 011196 244 RYELYRFLVDTPTVTVTAP---NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH--EMNPKISDF 318 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~--~~~~kl~Df 318 (491)
.|.++.|..++.+...... .........++.+++.++.+||..+++ ||||||+|||++. .+.+||+||
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~giv-------HrDlkp~NIll~~~~~~~vkL~DF 195 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV-------HLDIKPENIMCETKKASSVKIIDF 195 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEESSTTCCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCee-------ecccchHHeEEecCCCCceEEEec
Confidence 3455566555443222211 233556778889999999999998877 9999999999974 467999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||++|..||... ........+ ...
T Consensus 196 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~---~~~~~~~~i----~~~ 265 (387)
T 1kob_A 196 GLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE---DDLETLQNV----KRC 265 (387)
T ss_dssp TTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHH----HHC
T ss_pred ccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC---CHHHHHHHH----HhC
Confidence 99987654322 22347899999999999989999999999999999999999997532 111112111 111
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
... .++...... ...+.+++.+||+.||++|||+.|++++
T Consensus 266 ~~~--~~~~~~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 266 DWE--FDEDAFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCC--CCSSTTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCC--CCccccccC----CHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 110 011111112 2356789999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.9e-22 Score=196.26 Aligned_cols=155 Identities=22% Similarity=0.326 Sum_probs=105.7
Q ss_pred CCcchhhhHhHHHHHHHHHhhe-eeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 265 TSKRWITIAEAASAIIVFLLST-SFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
.......++.+++.++.+||.. +++ ||||||+|||++.++.+||+|||+++....... .....||+.|+
T Consensus 107 ~~~~~~~i~~qi~~~l~~lH~~~~i~-------H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~ 176 (290)
T 3fme_A 107 PEDILGKIAVSIVKALEHLHSKLSVI-------HRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYM 176 (290)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHSCCC-------CCCCSGGGCEECTTCCEEBCCC------------------CCCCCCS
T ss_pred CHHHHHHHHHHHHHHHHHHhhcCCee-------cCCCCHHHEEECCCCCEEEeecCCccccccccc---ccccCCCcccc
Confidence 3556777889999999999986 766 999999999999999999999999986643322 22346899999
Q ss_pred hhhhh----hhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHH
Q 011196 344 APEYA----MEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLK 419 (491)
Q Consensus 344 aPE~~----~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 419 (491)
|||++ .+..++.++||||||++++||++|+.||.... ................ ... ... ...
T Consensus 177 aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~-~~~----~~~----~~~ 242 (290)
T 3fme_A 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG-----TPFQQLKQVVEEPSPQ-LPA----DKF----SAE 242 (290)
T ss_dssp CHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS-----CHHHHHHHHHHSCCCC-CCT----TTS----CHH
T ss_pred ChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC-----chHHHHHHHhccCCCC-ccc----ccC----CHH
Confidence 99996 45668999999999999999999999975321 1111222222221111 110 111 234
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 011196 420 YIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 420 ~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 243 FVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhhcChhhCcCHHHHHh
Confidence 678999999999999999999876
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.2e-22 Score=202.05 Aligned_cols=152 Identities=26% Similarity=0.364 Sum_probs=114.3
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++..... ....||+.|+|
T Consensus 152 ~~~~~~~i~~qi~~aL~~LH~~~iv-------H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~a 218 (348)
T 1u5q_A 152 QEVEIAAVTHGALQGLAYLHSHNMI-------HRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMA 218 (348)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCB-------CCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCee-------eCCCCHHHEEECCCCCEEEeeccCceecCCC------CcccCCcceeC
Confidence 3556677888999999999998776 9999999999999999999999999765321 23578999999
Q ss_pred hhhhh---hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 345 PEYAM---EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 345 PE~~~---~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
||++. ++.++.++||||||+++|||++|+.||.... ............. .... ....+ ..+.
T Consensus 219 PE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~------~~~~~~~~~~~~~-~~~~----~~~~~----~~l~ 283 (348)
T 1u5q_A 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNES-PALQ----SGHWS----EYFR 283 (348)
T ss_dssp HHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCC-CCCC----CTTSC----HHHH
T ss_pred HhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcCC-CCCC----CCCCC----HHHH
Confidence 99985 4678999999999999999999999974321 1222222222211 1111 11122 3466
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
+++.+||+.||++|||+.+++++
T Consensus 284 ~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 284 NFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHHcccChhhCcCHHHHhhC
Confidence 78999999999999999998864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-22 Score=195.84 Aligned_cols=162 Identities=25% Similarity=0.324 Sum_probs=119.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc-cccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE-ANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||+++........ .......++..|+|
T Consensus 120 ~~~~~~~~~~i~~~l~~lH~~~i~-------H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 192 (291)
T 1u46_A 120 LGTLSRYAVQVAEGMGYLESKRFI-------HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 192 (291)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcc-------cCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeC
Confidence 455677888999999999998777 9999999999999999999999999876543322 12233467788999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..++.++||||||++++||++ |+.||.... ..... ........... .+......+.++
T Consensus 193 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~---~~~~~~~~~~~---------~~~~~~~~l~~l 257 (291)
T 1u46_A 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQIL---HKIDKEGERLP---------RPEDCPQDIYNV 257 (291)
T ss_dssp HHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHH---HHHHTSCCCCC---------CCTTCCHHHHHH
T ss_pred chhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC---HHHHH---HHHHccCCCCC---------CCcCcCHHHHHH
Confidence 999998889999999999999999999 999975321 11111 11111111110 111223457789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
+.+||+.||++||++.++++.|++..
T Consensus 258 i~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 258 MVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHccCCcccCcCHHHHHHHHHHhC
Confidence 99999999999999999999998764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2.2e-23 Score=205.75 Aligned_cols=188 Identities=16% Similarity=0.175 Sum_probs=119.9
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC---ceEecc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN---PKISDF 318 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~---~kl~Df 318 (491)
.|.+++|+.++...... ...........++.+++.++.+||..+++ ||||||+|||++.++. +||+||
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv-------H~dlkp~Nil~~~~~~~~~~kl~Df 158 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIA-------HRDLKPENILCEHPNQVSPVKICDF 158 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEESCSSSSCSEEECCT
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCce-------eCCCCHHHEEEccCCCcCceEEEEc
Confidence 34555665544332221 11223455677888999999999998776 9999999999988765 899999
Q ss_pred CcceecCCCCc-----ccccCceeecCCCChhhhhhh-----CCCCcccceeehhHHHHHHHhCCCCCCCccCCCccc--
Q 011196 319 GMARIFGGNQS-----EANTNRVVGTYGYMAPEYAME-----GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPS-- 386 (491)
Q Consensus 319 Gla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~-- 386 (491)
|+++....... ........||..|+|||++.+ ..++.++||||||+++|||++|+.||......+...
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 238 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence 99876532211 111223468999999999975 558899999999999999999999986433221100
Q ss_pred ------HHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 387 ------LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 387 ------~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
...........+... .... ..... ...+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~i~~~~~~-~~~~-~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 239 GEACPACQNMLFESIQEGKYE-FPDK-DWAHI----SCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp --CCHHHHHHHHHHHHHCCCC-CCHH-HHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccchhHHHHHHHHHhccCcc-cCch-hcccC----CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011112222222110 0000 00111 2357789999999999999999999873
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.2e-23 Score=209.85 Aligned_cols=182 Identities=16% Similarity=0.187 Sum_probs=126.2
Q ss_pred eeeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 243 IRYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
..|.++.|..++.+..... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~giv-------HrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI-------HRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------eccCCHHHeeECCCCCEEEecccee
Confidence 3456666665544322221 1223445666788899999999998777 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCC----CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGI----FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
+....... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||... ........+......
T Consensus 216 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~ 291 (410)
T 3v8s_A 216 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD---SLVGTYSKIMNHKNS 291 (410)
T ss_dssp EECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTHHHH
T ss_pred EeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC---ChhhHHHHHHhcccc
Confidence 87654322 1233568999999999998655 789999999999999999999997522 111222222111000
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHh
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMD--RPTMSSVAVML 445 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~L 445 (491)
-.... .... ...+.+|+.+||+.+|++ ||++.||+++-
T Consensus 292 ~~~p~------~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 292 LTFPD------DNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp CCCCT------TCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred ccCCC------cccc----cHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 00000 0011 234667889999999998 99999999764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-23 Score=207.92 Aligned_cols=167 Identities=19% Similarity=0.185 Sum_probs=112.5
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... ......|+..|+|
T Consensus 122 ~~~~~~~~~~qi~~~l~~LH~~~iv-------H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~a 192 (331)
T 4aaa_A 122 DYQVVQKYLFQIINGIGFCHSHNII-------HRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRA 192 (331)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEE-------ccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccC
Confidence 3556777888999999999998777 999999999999999999999999976543222 1223568999999
Q ss_pred hhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHH-----------hhcC-CccccccchhcCC
Q 011196 345 PEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKL-----------WCEG-HAAELMDSVVKQS 411 (491)
Q Consensus 345 PE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-----------~~~~-~~~~~~d~~l~~~ 411 (491)
||++.+. .++.++||||||+++|||++|+.||..... ......+... +... .......+.+...
T Consensus 193 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
T 4aaa_A 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD---IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKER 269 (331)
T ss_dssp HHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSC
T ss_pred cccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCChhhhhHhhhccccccccCcccccc
Confidence 9999875 689999999999999999999999753221 1111111111 0000 0000101111111
Q ss_pred CCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 412 CDQ-----AELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 412 ~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+. .....+.+|+.+||+.||++|||+.|+++
T Consensus 270 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 270 EPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred chhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111 12346788999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.86 E-value=5.5e-23 Score=205.00 Aligned_cols=162 Identities=20% Similarity=0.355 Sum_probs=114.5
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCccc-ccCceeecCCCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEA-NTNRVVGTYGYM 343 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~ 343 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++......... ......++..|+
T Consensus 145 ~~~~~~~i~~qi~~aL~~LH~~~iv-------H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 217 (333)
T 1mqb_A 145 SVLQLVGMLRGIAAGMKYLANMNYV-------HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217 (333)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGS
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCee-------CCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCcccccc
Confidence 3456777888999999999998777 99999999999999999999999998764332211 122234577899
Q ss_pred hhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHH
Q 011196 344 APEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 344 aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
|||++.+..++.++||||||+++|||++ |+.||.... ... +......+.... .+......+.+
T Consensus 218 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~~----~~~~~~~~~~~~---------~~~~~~~~l~~ 281 (333)
T 1mqb_A 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---NHE----VMKAINDGFRLP---------TPMDCPSAIYQ 281 (333)
T ss_dssp CHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHH----HHHHHHTTCCCC---------CCTTCBHHHHH
T ss_pred CchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC---HHH----HHHHHHCCCcCC---------CcccCCHHHHH
Confidence 9999998899999999999999999998 999974321 111 122222221110 11122345778
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 423 IGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
++.+||+.||++||++.++++.|+...
T Consensus 282 li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 282 LMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-21 Score=195.89 Aligned_cols=156 Identities=15% Similarity=0.109 Sum_probs=110.6
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC--CceEeccCcceecCCCCc--ccccCceeecCCCC
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM--NPKISDFGMARIFGGNQS--EANTNRVVGTYGYM 343 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~--~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~ 343 (491)
....++.+++.++.+||..+++ ||||||+|||++.++ .+||+|||+++....... ........||+.|+
T Consensus 169 ~~~~i~~qi~~~l~~LH~~~iv-------H~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~ 241 (345)
T 3hko_A 169 LISNIMRQIFSALHYLHNQGIC-------HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFV 241 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGC
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-------ccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCcccc
Confidence 3456788899999999998777 999999999998776 899999999987543221 11223467899999
Q ss_pred hhhhhhh--CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 344 APEYAME--GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 344 aPE~~~~--~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
|||++.+ ..++.++||||||+++|||++|+.||.... ............... ..+.. ... ...+.
T Consensus 242 aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~--~~~~~-~~~----~~~~~ 308 (345)
T 3hko_A 242 APEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVN------DADTISQVLNKKLCF--ENPNY-NVL----SPLAR 308 (345)
T ss_dssp CHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCCT--TSGGG-GGS----CHHHH
T ss_pred CchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------hHHHHHHHHhccccc--CCccc-ccC----CHHHH
Confidence 9999975 678999999999999999999999975321 111222222221111 01110 011 23467
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~ 443 (491)
+++.+||+.||++||++.|+++
T Consensus 309 ~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 309 DLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHcCCChhHCCCHHHHhc
Confidence 8999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-22 Score=202.23 Aligned_cols=166 Identities=17% Similarity=0.163 Sum_probs=115.2
Q ss_pred CcchhhhHhHHHHHHHHHh--heeeEEeEEeeeccccccccccccC-CCCceEeccCcceecCCCCcccccCceeecCCC
Q 011196 266 SKRWITIAEAASAIIVFLL--STSFLWCIIRRRNKRVRASNVLLDH-EMNPKISDFGMARIFGGNQSEANTNRVVGTYGY 342 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~--~~~~~~~~~~~iHrDlKp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 342 (491)
......++.+++.++.++| ..+++ ||||||+|||++. ++.+||+|||+++....... .....||..|
T Consensus 128 ~~~~~~~~~qi~~al~~lH~~~~~iv-------H~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y 197 (360)
T 3e3p_A 128 PILIKVFLFQLIRSIGCLHLPSVNVC-------HRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYY 197 (360)
T ss_dssp HHHHHHHHHHHHHHHHHHTSTTTCCB-------CSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGG
T ss_pred HHHHHHHHHHHHHHHHHHhCCCCCee-------cCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcce
Confidence 3445667888888899998 66555 9999999999997 89999999999987654332 2234679999
Q ss_pred ChhhhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC-----------c-ccccc----
Q 011196 343 MAPEYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH-----------A-AELMD---- 405 (491)
Q Consensus 343 ~aPE~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------~-~~~~d---- 405 (491)
+|||++.+.. ++.++||||||+++|||++|+.||.... .......+.+...... . ....+
T Consensus 198 ~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
T 3e3p_A 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN---SAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGI 274 (360)
T ss_dssp CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCC
T ss_pred eCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC---hHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccC
Confidence 9999997654 8999999999999999999999975321 2222222222111100 0 00000
Q ss_pred --chhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 406 --SVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 406 --~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..............+.+|+.+||+.||++|||+.|++++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 275 PWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000011111234578889999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-22 Score=197.03 Aligned_cols=153 Identities=22% Similarity=0.323 Sum_probs=95.3
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++......... .....|++.|+|
T Consensus 110 ~~~~~~~~~~qi~~~l~~lH~~~i~-------H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~a 180 (278)
T 3cok_A 110 SENEARHFMHQIITGMLYLHSHGIL-------HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYIS 180 (278)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CSSCCGGGEEECTTCCEEECCCTTCEECC-------------------
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc--ceeccCCCCcCC
Confidence 3556778899999999999998777 9999999999999999999999999876432221 223578999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||.+.+..++.++||||||++++||++|+.||....... .. ...... .. ..+......+.+++
T Consensus 181 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~---~~-------~~~~~~~~~~~~li 243 (278)
T 3cok_A 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---TL----NKVVLA---DY-------EMPSFLSIEAKDLI 243 (278)
T ss_dssp -----------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSS---CC-------CCCTTSCHHHHHHH
T ss_pred cchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH---HH----HHHhhc---cc-------CCccccCHHHHHHH
Confidence 999998889999999999999999999999975432211 00 000000 00 01111223567899
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 011196 425 LLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~ 443 (491)
.+||+.||++||++.++++
T Consensus 244 ~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 244 HQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HHHSCSSGGGSCCHHHHTT
T ss_pred HHHcccCHhhCCCHHHHhc
Confidence 9999999999999998875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.5e-22 Score=203.96 Aligned_cols=105 Identities=23% Similarity=0.363 Sum_probs=83.5
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc--------------
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE-------------- 330 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~-------------- 330 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++........
T Consensus 127 ~~~~~~~i~~qil~aL~~LH~~giv-------HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 199 (432)
T 3n9x_A 127 TEEHIKTILYNLLLGENFIHESGII-------HRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199 (432)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEECTTCCEEECCCTTCEEC--------------------
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCCC-------CCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccc
Confidence 3556778899999999999998877 9999999999999999999999999876433211
Q ss_pred ------cccCceeecCCCChhhhhh-hCCCCcccceeehhHHHHHHHhCCCCC
Q 011196 331 ------ANTNRVVGTYGYMAPEYAM-EGIFSVKSDVFSFGVVLLEIISGKKSS 376 (491)
Q Consensus 331 ------~~~~~~~gt~~y~aPE~~~-~~~~s~~sDVwS~Gvvl~elltG~~p~ 376 (491)
.......||+.|+|||++. ...++.++|||||||+++||++|..|+
T Consensus 200 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -----------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 1124568899999999874 556999999999999999999865554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=6.3e-23 Score=210.41 Aligned_cols=181 Identities=15% Similarity=0.163 Sum_probs=124.1
Q ss_pred eeeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 243 IRYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
..|.++.|..++.+..... ..........++.+++.++.+||..+++ ||||||+|||++.++++||+|||
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~gii-------HrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYV-------HRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee-------ecccCHHHeeecCCCCEEEeech
Confidence 3456667766555433221 1233455667788899999999998777 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhh-------CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHH
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAME-------GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIW 392 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 392 (491)
+++........ ......||+.|+|||++.. ..++.++|||||||++|||++|+.||... ........+.
T Consensus 208 la~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~~~~i~ 283 (412)
T 2vd5_A 208 SCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD---STAETYGKIV 283 (412)
T ss_dssp TCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHH
T ss_pred hheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC---CHHHHHHHHH
Confidence 99876543321 2234689999999999973 56899999999999999999999997532 1112222221
Q ss_pred HHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 011196 393 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDR---PTMSSVAVM 444 (491)
Q Consensus 393 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~R---Ps~~evl~~ 444 (491)
........ +...... ...+.+++.+||+ +|++| |+++||+++
T Consensus 284 ~~~~~~~~-----p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 284 HYKEHLSL-----PLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp THHHHCCC-----C----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred hcccCcCC-----CccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11000011 1111112 2356778999999 99998 589888764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.5e-23 Score=205.63 Aligned_cols=161 Identities=26% Similarity=0.322 Sum_probs=117.4
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC---CCCceEeccCcceecCCCCcccccCceeecCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH---EMNPKISDFGMARIFGGNQSEANTNRVVGTYGY 342 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~---~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 342 (491)
....+.++.+++.++.+||..+++ ||||||+|||++. +..+||+|||+++...............|++.|
T Consensus 139 ~~~~~~i~~qi~~al~~LH~~~i~-------H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y 211 (327)
T 2yfx_A 139 MLDLLHVARDIACGCQYLEENHFI-------HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGG
T ss_pred HHHHHHHHHHHHHHHHHHhhCCee-------cCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcce
Confidence 445677888999999999998777 9999999999984 456999999999765433332233345678899
Q ss_pred ChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 343 MAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 343 ~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
+|||++.+..++.++||||||+++|||++ |..||... ..... ......+..... +......+.
T Consensus 212 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~---~~~~~----~~~~~~~~~~~~---------~~~~~~~l~ 275 (327)
T 2yfx_A 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEV----LEFVTSGGRMDP---------PKNCPGPVY 275 (327)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHH----HHHHHTTCCCCC---------CTTCCHHHH
T ss_pred eCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc---CHHHH----HHHHhcCCCCCC---------CCCCCHHHH
Confidence 99999999999999999999999999998 88886432 11111 122222211111 111223567
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
+++.+||+.||++||++.+|+++|+...
T Consensus 276 ~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 276 RIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 8999999999999999999999998653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=5.1e-23 Score=204.85 Aligned_cols=167 Identities=17% Similarity=0.156 Sum_probs=109.6
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeecccccccccccc-----CCCCceEeccCcceecCCCCcccccCceeec
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLD-----HEMNPKISDFGMARIFGGNQSEANTNRVVGT 339 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~-----~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt 339 (491)
.......++.+++.++.+||..+++ ||||||+|||++ .++.+||+|||+++....... ......||
T Consensus 130 ~~~~~~~i~~ql~~~l~~LH~~~iv-------H~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t 200 (329)
T 3gbz_A 130 SMRVIKSFLYQLINGVNFCHSRRCL-------HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEIIT 200 (329)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------C
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEE-------CCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc--ccCCCcCC
Confidence 3556677889999999999998777 999999999994 445599999999987643222 12335789
Q ss_pred CCCChhhhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC---Ccccc------------
Q 011196 340 YGYMAPEYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG---HAAEL------------ 403 (491)
Q Consensus 340 ~~y~aPE~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~------------ 403 (491)
..|+|||++.+.. ++.++|||||||+++||++|+.||... ........+....... .+...
T Consensus 201 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (329)
T 3gbz_A 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD---SEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPK 277 (329)
T ss_dssp CTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred ccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC---CHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhh
Confidence 9999999998754 899999999999999999999997532 1122222222211110 00000
Q ss_pred -ccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 404 -MDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 404 -~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
....+...........+.+|+.+||+.||++|||+.|+++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 278 FRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000000001245678999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.86 E-value=4.8e-22 Score=193.81 Aligned_cols=174 Identities=17% Similarity=0.240 Sum_probs=121.7
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhhee--eEEeEEeeecccccccccccc-CCCCceEecc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTS--FLWCIIRRRNKRVRASNVLLD-HEMNPKISDF 318 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~~iHrDlKp~NILl~-~~~~~kl~Df 318 (491)
.|.++.|+.++....... ..........++.+++.++.+||..+ ++ ||||||+|||++ .++.+||+||
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~-------H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII-------HRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCC-------CSCCCGGGEEESSTTSCEEECCT
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEE-------ECCCCHHHEEEECCCCCEEEeeC
Confidence 355566665544322221 22334566778889999999999877 66 999999999997 7889999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
|++....... .....|++.|+|||++. +.++.++||||||++++||++|+.||.... . ..........+
T Consensus 177 g~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~-~~~~~~~~~~~ 245 (290)
T 1t4h_A 177 GLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ-----N-AAQIYRRVTSG 245 (290)
T ss_dssp TGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----S-HHHHHHHHTTT
T ss_pred CCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC-----c-HHHHHHHHhcc
Confidence 9997543322 22346899999999876 568999999999999999999999975321 1 11122222222
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
...... ....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~----~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 246 VKPASF----DKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCCGGG----GGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcccc----CCCCC----HHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111111 11112 34778999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3.2e-22 Score=205.88 Aligned_cols=179 Identities=20% Similarity=0.242 Sum_probs=118.7
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC---CCceEecc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE---MNPKISDF 318 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~---~~~kl~Df 318 (491)
.|.++.|..++.+..... ..........++.+++.++.+||..+++ ||||||+|||++.+ ..+||+||
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iv-------HrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII-------HRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEESSSSSSCCEEECCS
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------ccCCChHhEEEecCCCcceEEEeec
Confidence 356667776655433322 2233556677888999999999988766 99999999999654 45999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhhh---CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHh
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAME---GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLW 395 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 395 (491)
|+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ..+...+
T Consensus 287 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~i---- 357 (419)
T 3i6u_A 287 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQI---- 357 (419)
T ss_dssp STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHHHH----
T ss_pred ccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHHHH----
Confidence 9998764322 2234679999999999853 56889999999999999999999998543221 1222211
Q ss_pred hcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 396 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 396 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..+... .. +...... ...+.+++.+||+.||++||++.|++++
T Consensus 358 ~~~~~~-~~-~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 TSGKYN-FI-PEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HTTCCC-CC-HHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCC-CC-chhhccc----CHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 111111 00 1111111 2357789999999999999999998863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-22 Score=199.68 Aligned_cols=177 Identities=14% Similarity=0.127 Sum_probs=124.3
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC----CceEec
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM----NPKISD 317 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~----~~kl~D 317 (491)
.|.++.|+.+........ ..........++.+++.++.+||..+++ ||||||+|||++.++ .+||+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iv-------H~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIA-------HFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCee-------cCCCChHHEEEecCCCCcCCEEEcc
Confidence 344555554443322221 1223456777889999999999998777 999999999999887 799999
Q ss_pred cCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 318 FGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 318 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..... .....
T Consensus 163 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~----~~i~~ 232 (321)
T 2a2a_A 163 FGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL----ANITS 232 (321)
T ss_dssp CTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHH----HHHHT
T ss_pred CccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC---HHHHH----HHHHh
Confidence 999987654322 234568999999999998999999999999999999999999974321 11111 11111
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
... . .++......+ ..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~-~-~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 233 VSY-D-FDEEFFSHTS----ELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TCC-C-CCHHHHTTCC----HHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccc-c-cChhhhcccC----HHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111 0 1111111222 34678999999999999999999886
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-22 Score=197.05 Aligned_cols=156 Identities=18% Similarity=0.211 Sum_probs=115.2
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC---ceEeccCcceecCCCCcccccCceeecCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN---PKISDFGMARIFGGNQSEANTNRVVGTYG 341 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~---~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 341 (491)
.......++.+++.++.+||..+++ ||||||+||+++.++. +||+|||++........ .....|++.
T Consensus 103 ~~~~~~~~~~~i~~~l~~lH~~~i~-------H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~ 172 (284)
T 3kk8_A 103 SEADASHCIQQILESIAYCHSNGIV-------HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPG 172 (284)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGG
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcC-------cCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcC
Confidence 3556677888999999999998877 9999999999987655 99999999987644322 223578999
Q ss_pred CChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 342 YMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 342 y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
|+|||++.+..++.++||||||++++||++|+.||... ....... ....+... ...+. .... ...+.
T Consensus 173 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~---~~~~~~~----~~~~~~~~-~~~~~-~~~~----~~~~~ 239 (284)
T 3kk8_A 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYA----QIKAGAYD-YPSPE-WDTV----TPEAK 239 (284)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHH----HHHHTCCC-CCTTT-TTTS----CHHHH
T ss_pred CcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC---chhHHHH----HHHhcccc-CCchh-hccc----CHHHH
Confidence 99999999999999999999999999999999997421 1111111 11111111 00000 0111 23467
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~ 443 (491)
+++.+||+.||++|||+.|+++
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHcccChhhCCCHHHHhc
Confidence 8999999999999999999987
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-21 Score=197.48 Aligned_cols=125 Identities=22% Similarity=0.294 Sum_probs=94.7
Q ss_pred eeeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhhe-eeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 243 IRYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLST-SFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
..|.++.|+.+..+..... ..........++.+++.++.+||.. +++ ||||||+|||++.++.+||+|||
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~-------H~dlkp~Nil~~~~~~~kl~Dfg 177 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM-------HRDVKPSNILVNSRGEIKLCDFG 177 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCC-------CSCCSGGGEEECTTCCEEECCCC
T ss_pred EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEE-------cCCccHHHEEECCCCCEEEEECC
Confidence 3456666665544322221 1223445667888888999999875 565 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCC
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGF 378 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~ 378 (491)
++...... ......||+.|+|||++.+..++.++||||||++++||++|+.||..
T Consensus 178 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 178 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp CCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred CCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 98754221 12235789999999999999999999999999999999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=1.7e-22 Score=195.96 Aligned_cols=152 Identities=19% Similarity=0.243 Sum_probs=112.7
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++....... .....|+..|+|
T Consensus 107 ~~~~~~~~~~qi~~~l~~LH~~~i~-------H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~a 175 (279)
T 3fdn_A 107 DEQRTATYITELANALSYCHSKRVI-------HRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLP 175 (279)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTTTCE-------ECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEe-------cccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCCccC
Confidence 3456777888999999999998777 99999999999999999999999986543322 223578999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||.+.+..++.++||||||++++||++|+.||.... ..... ........ ..+......+.+++
T Consensus 176 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~----~~~~~~~~----------~~~~~~~~~~~~li 238 (279)
T 3fdn_A 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETY----KRISRVEF----------TFPDFVTEGARDLI 238 (279)
T ss_dssp HHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHH----HHHHHTCC----------CCCTTSCHHHHHHH
T ss_pred HhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc---HHHHH----HHHHhCCC----------CCCCcCCHHHHHHH
Confidence 999999889999999999999999999999975221 11111 11111110 01111223466799
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 011196 425 LLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~ 444 (491)
.+||+.||++||++.|++++
T Consensus 239 ~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 239 SRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHCCSSGGGSCCHHHHHHC
T ss_pred HHHhccChhhCCCHHHHhhC
Confidence 99999999999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-21 Score=192.32 Aligned_cols=159 Identities=17% Similarity=0.147 Sum_probs=117.4
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++................|+..|+||
T Consensus 108 ~~~~~~~~~qi~~al~~LH~~~i~-------H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 180 (305)
T 2wtk_C 108 VCQAHGYFCQLIDGLEYLHSQGIV-------HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180 (305)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------ecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcCh
Confidence 445677888999999999998777 9999999999999999999999999876533322233345689999999
Q ss_pred hhhhhCC--CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 346 EYAMEGI--FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 346 E~~~~~~--~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
|++.+.. ++.++||||||+++|||++|+.||.... .. ........+... +... ....+.++
T Consensus 181 E~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~-~~~~~i~~~~~~------~~~~----~~~~l~~l 243 (305)
T 2wtk_C 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IY-KLFENIGKGSYA------IPGD----CGPPLSDL 243 (305)
T ss_dssp HHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HH-HHHHHHHHCCCC------CCSS----SCHHHHHH
T ss_pred hhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HH-HHHHHHhcCCCC------CCCc----cCHHHHHH
Confidence 9987644 4779999999999999999999975321 11 111222222110 1111 22346679
Q ss_pred HHHcccCCCCCCCCHHHHHHH--hhcC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVM--LASD 448 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~--L~~~ 448 (491)
+.+||+.||++||++.|++++ +++.
T Consensus 244 i~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 244 LKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp HHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred HHHHccCChhhCCCHHHHhcCcccccC
Confidence 999999999999999999964 4443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.85 E-value=4.7e-22 Score=197.04 Aligned_cols=166 Identities=19% Similarity=0.190 Sum_probs=118.0
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...... ......|+..|+|
T Consensus 118 ~~~~~~~~~~qi~~~l~~lH~~gi~-------H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~a 187 (326)
T 1blx_A 118 PTETIKDMMFQLLRGLDFLHSHRVV-------HRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRA 187 (326)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCce-------eccCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeC
Confidence 3456677888999999999998777 99999999999999999999999997654221 2234578999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccc------cchh-------cCC
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELM------DSVV-------KQS 411 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------d~~l-------~~~ 411 (491)
||++.+..++.++||||||+++|||++|+.||.... .......+............. .... ...
T Consensus 188 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (326)
T 1blx_A 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS---DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEK 264 (326)
T ss_dssp HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGG
T ss_pred HHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhh
Confidence 999999999999999999999999999999975321 122222222221111000000 0000 000
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 412 CDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 412 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
........+.+++.+||+.||++||++.|+++
T Consensus 265 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 265 FVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp TCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11112345678999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2e-22 Score=195.25 Aligned_cols=164 Identities=21% Similarity=0.184 Sum_probs=116.8
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+.. ..+++||||||+|||++.++.+||+|||+++........ .....|+..|+|
T Consensus 109 ~~~~~~~i~~~i~~~l~~lH~~~~~--~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~a 184 (279)
T 2w5a_A 109 DEEFVLRVMTQLTLALKECHRRSDG--GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMS 184 (279)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHC--------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHH--HHHHHSCCTTCC
T ss_pred CHHHHHHHHHHHHHHHHHHhcccCC--CCeeEEeccchhhEEEcCCCCEEEecCchheeecccccc--ccccCCCccccC
Confidence 3456778889999999999987710 112349999999999999999999999999765432211 123468999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||.+.+..++.++||||||+++|||++|+.||.... .... ......+....+ +......+.+++
T Consensus 185 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~----~~~i~~~~~~~~---------~~~~~~~l~~li 248 (279)
T 2w5a_A 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKEL----AGKIREGKFRRI---------PYRYSDELNEII 248 (279)
T ss_dssp HHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH----HHHHHHTCCCCC---------CTTSCHHHHHHH
T ss_pred hHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC---HHHH----HHHHhhcccccC---------CcccCHHHHHHH
Confidence 999998889999999999999999999999975321 1111 122222222111 111224567899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++||++.||++.+...
T Consensus 249 ~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 249 TRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp HHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred HHHcCCCcccCCCHHHHHhChhhh
Confidence 999999999999999999866543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.4e-22 Score=192.65 Aligned_cols=176 Identities=14% Similarity=0.143 Sum_probs=122.2
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccc---cCCCCceEecc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLL---DHEMNPKISDF 318 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl---~~~~~~kl~Df 318 (491)
.|.+++|..+....... ...........++.+++.++.+||..+++ ||||||+|||+ +.++.+||+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~-------H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVA-------HRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc-------CCCCCHHHEEEecCCCCCcEEEEec
Confidence 34555665544332211 12233556778899999999999998877 99999999999 77889999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
|++........ .....||+.|+|||++.+ .++.++||||||++++||++|+.||.... ..... .....+
T Consensus 154 g~~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~----~~~~~~ 222 (277)
T 3f3z_A 154 GLAARFKPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVM----LKIREG 222 (277)
T ss_dssp TTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH----HHHHHC
T ss_pred ccceeccCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC---HHHHH----HHHHhC
Confidence 99987654332 233578999999998865 48999999999999999999999975321 11111 111111
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.... ... ..... ...+.+++.+||+.||++||++.|+++
T Consensus 223 ~~~~-~~~-~~~~~----~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 223 TFTF-PEK-DWLNV----SPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CCCC-CHH-HHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCC-Cch-hhhcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1110 000 00011 245678999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-22 Score=204.23 Aligned_cols=165 Identities=16% Similarity=0.138 Sum_probs=114.2
Q ss_pred CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++..... .....||..|+
T Consensus 123 ~~~~~~~~i~~qi~~al~~LH~~~iv-------H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~ 190 (353)
T 3coi_A 123 FSEEKIQYLVYQMLKGLKYIHSAGVV-------HRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYR 190 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCC-------CSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcC
Confidence 34556777888999999999998776 9999999999999999999999999764322 22357899999
Q ss_pred hhhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC------------------ccccc
Q 011196 344 APEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH------------------AAELM 404 (491)
Q Consensus 344 aPE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~ 404 (491)
|||++.+ ..++.++||||||++++||++|+.||.... .......+........ .....
T Consensus 191 aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (353)
T 3coi_A 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD---YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTP 267 (353)
T ss_dssp CHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC---HHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCS
T ss_pred CHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCC
Confidence 9999987 678999999999999999999999975322 1122222211110000 00000
Q ss_pred cchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 405 DSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 405 d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.+... .........+.+++.+||+.||++|||+.|++++
T Consensus 268 ~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 268 RKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp SCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 0111223467789999999999999999998864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-22 Score=200.54 Aligned_cols=157 Identities=18% Similarity=0.253 Sum_probs=107.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||+++ +.+||+|||+++...............|++.|+||
T Consensus 126 ~~~~~~i~~qi~~aL~~LH~~~iv-------H~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 197 (313)
T 3cek_A 126 PWERKSYWKNMLEAVHTIHQHGIV-------HSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197 (313)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCce-------ecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCH
Confidence 445667888999999999998777 9999999999975 78999999999876543332223345789999999
Q ss_pred hhhhh-----------CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCH
Q 011196 346 EYAME-----------GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQ 414 (491)
Q Consensus 346 E~~~~-----------~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 414 (491)
|++.+ ..++.++||||||+++|||++|+.||.... ................ ..+.
T Consensus 198 E~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~~---------~~~~ 263 (313)
T 3cek_A 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNHEI---------EFPD 263 (313)
T ss_dssp HHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHCTTSCC---------CCCC
T ss_pred HHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-----HHHHHHHHHHhccccc---------CCcc
Confidence 99875 468889999999999999999999975321 1111121211111111 1111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 415 AELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 415 ~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.....+.+++.+||+.||++||++.|+++.
T Consensus 264 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 264 IPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 112356778999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=9.9e-23 Score=199.99 Aligned_cols=155 Identities=24% Similarity=0.357 Sum_probs=117.8
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++........ ......|+..|+|
T Consensus 117 ~~~~~~~~~~qi~~~l~~lH~~~i~-------H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~a 187 (303)
T 3a7i_A 117 DETQIATILREILKGLDYLHSEKKI-------HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMA 187 (303)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCCc-------cCCCChheEEECCCCCEEEeecccceecCcccc--ccCccCCCcCccC
Confidence 3556778889999999999998877 999999999999999999999999987654322 1234578999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||++.+..++.++||||||+++|||++|+.||.... ...... ........ .+....+ ..+.+++
T Consensus 188 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~----~~~~~~~~-----~~~~~~~----~~l~~li 251 (303)
T 3a7i_A 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH---PMKVLF----LIPKNNPP-----TLEGNYS----KPLKEFV 251 (303)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHH----HHHHSCCC-----CCCSSCC----HHHHHHH
T ss_pred HHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC---HHHHHH----HhhcCCCC-----CCccccC----HHHHHHH
Confidence 999999999999999999999999999999975321 111111 11111111 1111222 3467899
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 011196 425 LLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~ 444 (491)
.+||+.||++|||+.|++++
T Consensus 252 ~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 252 EACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHCCSSGGGSCCHHHHTTC
T ss_pred HHHcCCChhhCcCHHHHhhC
Confidence 99999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=8e-22 Score=196.71 Aligned_cols=158 Identities=20% Similarity=0.266 Sum_probs=118.7
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... ......|+..|+|
T Consensus 139 ~~~~~~~i~~qi~~aL~~LH~~~iv-------H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~a 209 (335)
T 2owb_A 139 TEPEARYYLRQIVLGCQYLHRNRVI-------HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIA 209 (335)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCCE-------ecCCCchhEEEcCCCCEEEeeccCceecccCcc--cccccCCCccccC
Confidence 3556777889999999999998777 999999999999999999999999987643222 1234578999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||++.+..++.++||||||+++|||++|+.||.... ... .+......... +.... ...+.+++
T Consensus 210 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~-~~~~~~~~~~~------~~~~~----~~~~~~li 272 (335)
T 2owb_A 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKE-TYLRIKKNEYS------IPKHI----NPVAASLI 272 (335)
T ss_dssp HHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHH-HHHHHHHTCCC------CCTTS----CHHHHHHH
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC------HHH-HHHHHhcCCCC------CCccC----CHHHHHHH
Confidence 999999889999999999999999999999975321 111 11111111110 01111 23466789
Q ss_pred HHcccCCCCCCCCHHHHHH--HhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAV--MLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~--~L~~~ 448 (491)
.+||+.||++||++.|+++ ++.+.
T Consensus 273 ~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 273 QKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999987 34443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=9.9e-23 Score=197.66 Aligned_cols=147 Identities=16% Similarity=0.249 Sum_probs=109.7
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC-------------------CCceEeccCcceecC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE-------------------MNPKISDFGMARIFG 325 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~-------------------~~~kl~DfGla~~~~ 325 (491)
.......++.+++.++.+||..+++ ||||||+|||++.+ ..+||+|||.+....
T Consensus 113 ~~~~~~~i~~qi~~al~~lH~~~iv-------H~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~ 185 (289)
T 1x8b_A 113 KEAELKDLLLQVGRGLRYIHSMSLV-------HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185 (289)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEEC--------------------CCCEEECCCTTCEETT
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEe-------ecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccC
Confidence 4556778899999999999998777 99999999999844 478999999998764
Q ss_pred CCCcccccCceeecCCCChhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccc
Q 011196 326 GNQSEANTNRVVGTYGYMAPEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELM 404 (491)
Q Consensus 326 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (491)
... ...|+..|+|||++.+. .++.++||||||++++||++|.+++... .. +.....+....+
T Consensus 186 ~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~~----~~~~~~~~~~~~- 248 (289)
T 1x8b_A 186 SPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------DQ----WHEIRQGRLPRI- 248 (289)
T ss_dssp CSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------HH----HHHHHTTCCCCC-
T ss_pred Ccc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------hH----HHHHHcCCCCCC-
Confidence 322 23589999999999876 5678999999999999999998774311 11 122222222211
Q ss_pred cchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 405 DSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 405 d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.... ...+.+++.+||+.||++|||+.|+++
T Consensus 249 ----~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 249 ----PQVL----SQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----Cccc----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1112 234678999999999999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.6e-22 Score=199.64 Aligned_cols=153 Identities=17% Similarity=0.209 Sum_probs=110.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... ......||+.|+||
T Consensus 120 ~~~~~~~~~qi~~al~~lH~~~iv-------H~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP 190 (327)
T 3a62_A 120 EDTACFYLAEISMALGHLHQKGII-------YRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAP 190 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEE-------cccCCHHHeEECCCCcEEEEeCCcccccccCCc--cccccCCCcCccCH
Confidence 445667788899999999988777 999999999999999999999999975432221 22345789999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|++.+..++.++||||||+++|||++|+.||... ........+.. ... ..+......+.+++.
T Consensus 191 E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i~~----~~~----------~~p~~~~~~~~~li~ 253 (327)
T 3a62_A 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE---NRKKTIDKILK----CKL----------NLPPYLTQEARDLLK 253 (327)
T ss_dssp HHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHH----TCC----------CCCTTSCHHHHHHHH
T ss_pred hhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC---CHHHHHHHHHh----CCC----------CCCCCCCHHHHHHHH
Confidence 9999989999999999999999999999997532 11112221111 110 011112235678999
Q ss_pred HcccCCCCCCC-----CHHHHHHH
Q 011196 426 LCVQEDPMDRP-----TMSSVAVM 444 (491)
Q Consensus 426 ~cl~~dP~~RP-----s~~evl~~ 444 (491)
+||+.||++|| ++.|++++
T Consensus 254 ~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 254 KLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHhcCHhhccCCCCCCHHHHHcC
Confidence 99999999999 77777653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-21 Score=193.21 Aligned_cols=166 Identities=19% Similarity=0.240 Sum_probs=111.9
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++........ .......|+..|+|
T Consensus 132 ~~~~~~~i~~qi~~~l~~lH~~~i~-------H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~a 203 (309)
T 2h34_A 132 APPRAVAIVRQIGSALDAAHAAGAT-------HRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMA 203 (309)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCcCC-------cCCCChHHEEEcCCCCEEEecCccCcccccccc-ccccccCCCcCccC
Confidence 3556778889999999999998777 999999999999999999999999976543321 12234578999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||++.+..++.++||||||+++|||++|+.||.... .............. . ....... ...+.+++
T Consensus 204 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~-~--~~~~~~~----~~~l~~li 269 (309)
T 2h34_A 204 PERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ-------LSVMGAHINQAIPR-P--STVRPGI----PVAFDAVI 269 (309)
T ss_dssp GGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH-------HHHHHHHHHSCCCC-G--GGTSTTC----CTHHHHHH
T ss_pred HHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch-------HHHHHHHhccCCCC-c--cccCCCC----CHHHHHHH
Confidence 999998889999999999999999999999975321 11111212111110 0 0111112 23466789
Q ss_pred HHcccCCCCCCC-CHHHHHHHhhcCCCCC
Q 011196 425 LLCVQEDPMDRP-TMSSVAVMLASDIVTL 452 (491)
Q Consensus 425 ~~cl~~dP~~RP-s~~evl~~L~~~~~~~ 452 (491)
.+||+.||++|| +++++++.|+......
T Consensus 270 ~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 270 ARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 999999999999 9999999999875444
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.85 E-value=6.9e-22 Score=200.06 Aligned_cols=165 Identities=18% Similarity=0.172 Sum_probs=113.4
Q ss_pred CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++..... .....||+.|+
T Consensus 141 ~~~~~~~~i~~qi~~aL~~LH~~~iv-------H~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~ 208 (371)
T 4exu_A 141 FSEEKIQYLVYQMLKGLKYIHSAGVV-------HRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYR 208 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCc-------CCCcCHHHeEECCCCCEEEEecCcccccccC-----cCCcccCcccc
Confidence 34566777888999999999998777 9999999999999999999999999865332 22346799999
Q ss_pred hhhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccc------------cchhcC
Q 011196 344 APEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELM------------DSVVKQ 410 (491)
Q Consensus 344 aPE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------d~~l~~ 410 (491)
|||++.+ ..++.++||||||++++||++|+.||.... .......+........ .+.. ......
T Consensus 209 aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 284 (371)
T 4exu_A 209 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD---YLDQLTQILKVTGVPG-TEFVQKLNDKAAKSYIQSLPQT 284 (371)
T ss_dssp CHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCC-HHHHTTCSCHHHHHHHHHSCCC
T ss_pred CHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCc-HHHHHHhhhhhhhhhhhccCCC
Confidence 9999987 678999999999999999999999975321 1122222211111000 0000 000000
Q ss_pred -CC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 411 -SC-----DQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 411 -~~-----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.. .......+.+|+.+||+.||++|||+.|++++
T Consensus 285 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 285 PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 00113457789999999999999999998864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=8.5e-22 Score=203.67 Aligned_cols=157 Identities=26% Similarity=0.334 Sum_probs=110.0
Q ss_pred chhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC-------------CCceEeccCcceecCCCCccc--c
Q 011196 268 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE-------------MNPKISDFGMARIFGGNQSEA--N 332 (491)
Q Consensus 268 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~-------------~~~kl~DfGla~~~~~~~~~~--~ 332 (491)
..+.++.+++.++.+||..+++ ||||||+|||++.+ +.+||+|||+++......... .
T Consensus 116 ~~~~i~~qi~~aL~~LH~~~iv-------HrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~ 188 (434)
T 2rio_A 116 NPISLLRQIASGVAHLHSLKII-------HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188 (434)
T ss_dssp CHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------
T ss_pred hHHHHHHHHHHHHHHHHHCCcc-------ccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceee
Confidence 3467889999999999998777 99999999999754 479999999998775433211 1
Q ss_pred cCceeecCCCChhhhhhh-------CCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccc
Q 011196 333 TNRVVGTYGYMAPEYAME-------GIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELM 404 (491)
Q Consensus 333 ~~~~~gt~~y~aPE~~~~-------~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (491)
.....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||..... . ...+... ......
T Consensus 189 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~----~-~~~i~~~--~~~~~~-- 259 (434)
T 2rio_A 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS----R-ESNIIRG--IFSLDE-- 259 (434)
T ss_dssp ------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT----H-HHHHHHT--CCCCCC--
T ss_pred ecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh----h-HHHHhcC--CCCccc--
Confidence 234579999999999975 568999999999999999999 8999743211 1 1111110 001111
Q ss_pred cchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 405 DSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 405 d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.....+......+.+++.+||+.||++|||+.||++
T Consensus 260 ---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 260 ---MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 011123445567889999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.3e-21 Score=187.68 Aligned_cols=176 Identities=19% Similarity=0.219 Sum_probs=117.4
Q ss_pred eeeeecccccCCCCcccc------CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccc---cCCCCc
Q 011196 243 IRYELYRFLVDTPTVTVT------APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLL---DHEMNP 313 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl---~~~~~~ 313 (491)
..|.++.|+.++...... ...........++.+++.++.+||..+++ ||||||+|||+ +.++.+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv-------H~dikp~NIl~~~~~~~~~~ 166 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVV-------HKDLKPENILFQDTSPHSPI 166 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCSGGGEEESSSSTTCCE
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEE-------ECCCCHHHEEEecCCCCCCE
Confidence 345566666554432221 12233556777888999999999998777 99999999999 445789
Q ss_pred eEeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHH
Q 011196 314 KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWK 393 (491)
Q Consensus 314 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 393 (491)
||+|||+++....... .....|+..|+|||++. +.++.++||||||++++||++|+.||.... ........
T Consensus 167 kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~---~~~~~~~~-- 237 (285)
T 3is5_A 167 KIIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS---LEEVQQKA-- 237 (285)
T ss_dssp EECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH--
T ss_pred EEEeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC---HHHHHhhh--
Confidence 9999999986543322 23456899999999875 568999999999999999999999975321 11111111
Q ss_pred HhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 394 LWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 394 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
......... ..... ...+.+++.+||+.||++|||+.||++
T Consensus 238 ~~~~~~~~~-----~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 238 TYKEPNYAV-----ECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHCCCCCCC-------CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccCCccccc-----ccCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111100 00111 234668999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-21 Score=193.13 Aligned_cols=157 Identities=22% Similarity=0.331 Sum_probs=117.6
Q ss_pred CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
........++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++........ ......|+..|+
T Consensus 122 ~~~~~~~~i~~~i~~~l~~lH~~~i~-------H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~ 192 (314)
T 3com_A 122 LTEDEIATILQSTLKGLEYLHFMRKI-------HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWM 192 (314)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCc-------CCCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccCCCCCcc
Confidence 34556778899999999999998877 999999999999999999999999987644322 123357899999
Q ss_pred hhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 344 APEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 344 aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
|||++.+..++.++||||||+++|||++|+.||.... ........... .......+ ......+.++
T Consensus 193 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-~~~~~~~~-------~~~~~~l~~l 258 (314)
T 3com_A 193 APEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH------PMRAIFMIPTN-PPPTFRKP-------ELWSDNFTDF 258 (314)
T ss_dssp CHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHS-CCCCCSSG-------GGSCHHHHHH
T ss_pred ChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhcC-CCcccCCc-------ccCCHHHHHH
Confidence 9999998889999999999999999999999975321 11111111111 11111111 1112356789
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 011196 424 GLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~ 443 (491)
+.+||+.||++||++.++++
T Consensus 259 i~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 259 VKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHccCChhhCcCHHHHHh
Confidence 99999999999999999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.8e-22 Score=200.21 Aligned_cols=185 Identities=17% Similarity=0.145 Sum_probs=106.4
Q ss_pred eeeecccccCCCCccccC----CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC---CCCceEe
Q 011196 244 RYELYRFLVDTPTVTVTA----PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH---EMNPKIS 316 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~---~~~~kl~ 316 (491)
.|.++.|+.++.+..... ..........++.+++.++.+||..+++ ||||||+|||++. ++.+||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~iv-------H~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIA-------HRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCee-------cCCCCHHHEEEEecCCCceEEEe
Confidence 345556655443322221 1233556778899999999999998877 9999999999976 4559999
Q ss_pred ccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh
Q 011196 317 DFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC 396 (491)
Q Consensus 317 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 396 (491)
|||+++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........ .........
T Consensus 174 Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~ 246 (336)
T 3fhr_A 174 DFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI---SPGMKRRIR 246 (336)
T ss_dssp CCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred ccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh---hhhHHHhhh
Confidence 999998654322 2235789999999999888899999999999999999999999753322111 000000000
Q ss_pred cCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcC
Q 011196 397 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV--MLASD 448 (491)
Q Consensus 397 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~ 448 (491)
... .....+ ........+.+++.+||+.||++|||+.|+++ +++..
T Consensus 247 ~~~-~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 247 LGQ-YGFPNP-----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp -----CCCTT-----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ccc-cccCch-----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 000 000000 00112345678999999999999999999998 44443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.6e-22 Score=201.30 Aligned_cols=169 Identities=20% Similarity=0.229 Sum_probs=115.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCccc--------ccCcee
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEA--------NTNRVV 337 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~--------~~~~~~ 337 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++......... ......
T Consensus 111 ~~~~~~~~~qi~~~L~~LH~~~iv-------H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~ 183 (353)
T 2b9h_A 111 DDHIQYFIYQTLRAVKVLHGSNVI-------HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------cCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhcc
Confidence 456677889999999999998777 99999999999999999999999998764322111 122357
Q ss_pred ecCCCChhhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc----cccccch----h
Q 011196 338 GTYGYMAPEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA----AELMDSV----V 408 (491)
Q Consensus 338 gt~~y~aPE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~d~~----l 408 (491)
||..|+|||++.+ ..++.++||||||+++|||++|+.||..... ......+......... ..+.... .
T Consensus 184 gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (353)
T 2b9h_A 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY---RHQLLLIFGIIGTPHSDNDLRCIESPRAREYI 260 (353)
T ss_dssp CCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHH
T ss_pred ccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCchhccccccccchhhHHh
Confidence 8999999998875 6789999999999999999999999753221 1111111111111100 0000000 0
Q ss_pred ----c-CCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 409 ----K-QSCD-----QAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 409 ----~-~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
. .... ......+.+++.+||+.||++|||+.|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 261 KSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0000 0122456789999999999999999999873
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.3e-22 Score=219.96 Aligned_cols=181 Identities=20% Similarity=0.239 Sum_probs=125.9
Q ss_pred eeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.++.|+.++.+..... ........+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~giv-------HrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFV-------HRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEEEETTEEEECCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcc-------ccccchHhEEEeCCCCEEEEecCC
Confidence 345666665544322221 1233455667888999999999988776 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
++........ ......+++.|+|||++.+..++.++||||||+++|||++ |..||.... ....... ...+.
T Consensus 538 a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~---~~~~~~~----i~~~~ 609 (656)
T 2j0j_A 538 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---NNDVIGR----IENGE 609 (656)
T ss_dssp CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHH----HHHTC
T ss_pred CeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHH----HHcCC
Confidence 9876433221 1223456789999999999999999999999999999997 888875321 1122211 11111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
... .+......+.+++.+||+.||++||++.||++.|+..
T Consensus 610 ~~~---------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 610 RLP---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp CCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC---------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 1112234577899999999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.3e-22 Score=193.36 Aligned_cols=154 Identities=19% Similarity=0.253 Sum_probs=117.1
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... ......|+..|+|
T Consensus 113 ~~~~~~~i~~qi~~~l~~lH~~~i~-------H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~a 183 (294)
T 2rku_A 113 TEPEARYYLRQIVLGCQYLHRNRVI-------HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIA 183 (294)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcc-------ccCCChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCC
Confidence 3556777889999999999998777 999999999999999999999999987643222 1233578999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||.+.+..++.++||||||++++||++|+.||.... ... .+......... +.... ...+.+++
T Consensus 184 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~-~~~~~~~~~~~------~~~~~----~~~~~~li 246 (294)
T 2rku_A 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKE-TYLRIKKNEYS------IPKHI----NPVAASLI 246 (294)
T ss_dssp HHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHH-HHHHHHTTCCC------CCTTS----CHHHHHHH
T ss_pred cchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHH-HHHHHhhccCC------Ccccc----CHHHHHHH
Confidence 999998889999999999999999999999975321 111 11111111110 01111 23466789
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 011196 425 LLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~ 444 (491)
.+||+.||++||++.|+++.
T Consensus 247 ~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 247 QKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHTCSSGGGSCCGGGGGGS
T ss_pred HHHcccChhhCcCHHHHhhC
Confidence 99999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.4e-21 Score=190.73 Aligned_cols=155 Identities=22% Similarity=0.312 Sum_probs=111.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC-CCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH-EMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||..+++ ||||||+||+++. ++.+||+|||+++....... ......|+..|+|
T Consensus 121 ~~~~~~~~~qi~~~l~~lH~~~i~-------H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~a 191 (295)
T 2clq_A 121 EQTIGFYTKQILEGLKYLHDNQIV-------HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMA 191 (295)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEE-------ccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCccccC
Confidence 344566788999999999998777 9999999999987 89999999999987643221 1234578999999
Q ss_pred hhhhhhCC--CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHH
Q 011196 345 PEYAMEGI--FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH 422 (491)
Q Consensus 345 PE~~~~~~--~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 422 (491)
||++.++. ++.++||||||+++|||++|+.||..... . ............ .+.+ +......+.+
T Consensus 192 PE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~---~~~~~~~~~~~~-----~~~~----~~~~~~~~~~ 257 (295)
T 2clq_A 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE--P---QAAMFKVGMFKV-----HPEI----PESMSAEAKA 257 (295)
T ss_dssp HHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS--H---HHHHHHHHHHCC-----CCCC----CTTSCHHHHH
T ss_pred hhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc--h---hHHHHhhccccc-----cccc----cccCCHHHHH
Confidence 99998754 78999999999999999999999753211 1 111111110011 0111 1112245677
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 011196 423 IGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 423 l~~~cl~~dP~~RPs~~evl~ 443 (491)
++.+||+.||++||++.|+++
T Consensus 258 li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 258 FILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHHHccCChhhCCCHHHHhc
Confidence 999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.3e-22 Score=198.54 Aligned_cols=157 Identities=24% Similarity=0.375 Sum_probs=95.3
Q ss_pred CcchhhhHhHHHHHHHHHhhe-eeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLST-SFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||.. +++ ||||||+|||++.++.+||+|||+++....... .....|+..|+|
T Consensus 124 ~~~~~~i~~~i~~~l~~lH~~~~iv-------H~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~a 193 (327)
T 3aln_A 124 EEILGKITLATVKALNHLKENLKII-------HRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMA 193 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHSCC-------CSCCCGGGEEEETTTEEEECCCSSSCC---------------------
T ss_pred HHHHHHHHHHHHHHHHHHhccCCEe-------ECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCCCccccC
Confidence 455667888899999999986 666 999999999999999999999999986543221 223468999999
Q ss_pred hhhh----hhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHH
Q 011196 345 PEYA----MEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKY 420 (491)
Q Consensus 345 PE~~----~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 420 (491)
||++ .+..++.++||||||+++|||++|+.||....... ... .....+....+ ...........+
T Consensus 194 PE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~-~~~~~~~~~~~-----~~~~~~~~~~~l 262 (327)
T 3aln_A 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQL-TQVVKGDPPQL-----SNSEEREFSPSF 262 (327)
T ss_dssp ------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCCCCC-----CCCSSCCCCHHH
T ss_pred ceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHH-HHHhcCCCCCC-----CCcccccCCHHH
Confidence 9998 45668999999999999999999999975322110 000 00011111111 110111123457
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 011196 421 IHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 421 ~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+++.+||+.||++||++.||++
T Consensus 263 ~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 263 INFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhhCChhhCcCHHHHHh
Confidence 78999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.84 E-value=9.5e-22 Score=191.12 Aligned_cols=150 Identities=16% Similarity=0.170 Sum_probs=115.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++....... .....|+..|+||
T Consensus 113 ~~~~~~~~~qi~~~l~~lH~~~i~-------H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aP 181 (284)
T 2vgo_A 113 EQRSATFMEELADALHYCHERKVI-------HRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPP 181 (284)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTTEE-------CCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCce-------ecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCH
Confidence 456677888999999999998777 99999999999999999999999997654322 2235689999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 425 (491)
|++.+..++.++||||||++++||++|+.||.... ... .......... ..+......+.+++.
T Consensus 182 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~-~~~~~~~~~~----------~~~~~~~~~~~~li~ 244 (284)
T 2vgo_A 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS------HTE-THRRIVNVDL----------KFPPFLSDGSKDLIS 244 (284)
T ss_dssp HHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHH-HHHHHHTTCC----------CCCTTSCHHHHHHHH
T ss_pred HHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC------HhH-HHHHHhcccc----------CCCCcCCHHHHHHHH
Confidence 99999899999999999999999999999975321 111 1111111111 011111234678999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 011196 426 LCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 426 ~cl~~dP~~RPs~~evl~ 443 (491)
+||+.||++||++.|+++
T Consensus 245 ~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 245 KLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHSCSSGGGSCCHHHHHT
T ss_pred HHhhcCHhhCCCHHHHhh
Confidence 999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-21 Score=193.80 Aligned_cols=156 Identities=22% Similarity=0.263 Sum_probs=113.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC---ceEeccCcceecCCCCcccccCceeecCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN---PKISDFGMARIFGGNQSEANTNRVVGTYGY 342 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~---~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 342 (491)
......++.+++.++.+||..+++ ||||||+|||++.++. +||+|||+++....... .....|+..|
T Consensus 113 ~~~~~~~~~qi~~~l~~lH~~~iv-------H~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y 182 (322)
T 2ycf_A 113 EATCKLYFYQMLLAVQYLHENGII-------HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTY 182 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH---HHHHHSCCTT
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------ccCCCHHHEEEecCCCCCeEEEccCccceecccccc---cccccCCcCc
Confidence 455677888999999999998777 9999999999987654 99999999987643221 1235689999
Q ss_pred Chhhhhh---hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHH
Q 011196 343 MAPEYAM---EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLK 419 (491)
Q Consensus 343 ~aPE~~~---~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 419 (491)
+|||++. ...++.++||||||+++|||++|..||...... ..+...+.. +... . .+...... ...
T Consensus 183 ~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~----~~~~-~-~~~~~~~~----~~~ 250 (322)
T 2ycf_A 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQITS----GKYN-F-IPEVWAEV----SEK 250 (322)
T ss_dssp CCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS--SCHHHHHHH----TCCC-C-CHHHHTTS----CHH
T ss_pred cCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH--HHHHHHHHh----Cccc-c-Cchhhhhc----CHH
Confidence 9999985 456889999999999999999999997533221 122222211 1111 0 01111112 235
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 011196 420 YIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 420 ~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
+.+++.+||+.||++||++.|+++
T Consensus 251 ~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 251 ALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHcccCHhhCCCHHHHhh
Confidence 678999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-21 Score=194.76 Aligned_cols=162 Identities=17% Similarity=0.240 Sum_probs=115.9
Q ss_pred CCcchhhhHhHHHHHHHHHhh-eeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 265 TSKRWITIAEAASAIIVFLLS-TSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
.......++.+++.++.+||. .+++ ||||||+||+++.++.+||+|||++...... ......|+..|+
T Consensus 149 ~~~~~~~i~~qi~~~l~~lH~~~~i~-------H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~ 217 (348)
T 2pml_X 149 PIQVIKCIIKSVLNSFSYIHNEKNIC-------HRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFM 217 (348)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTSCEE-------CCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGC
T ss_pred CHHHHHHHHHHHHHHHHHHhccCCEe-------ecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCcc
Confidence 345667788999999999998 7777 9999999999999999999999999876433 223457899999
Q ss_pred hhhhhhhC-CCCc-ccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcccc------ccchhc---CCC
Q 011196 344 APEYAMEG-IFSV-KSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAEL------MDSVVK---QSC 412 (491)
Q Consensus 344 aPE~~~~~-~~s~-~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~d~~l~---~~~ 412 (491)
|||++.+. .++. ++||||||++++||++|+.||...... .. .......+..... ..+... ...
T Consensus 218 aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (348)
T 2pml_X 218 PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VE----LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCS 291 (348)
T ss_dssp CGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HH----HHHHHTSCCCCCCCSSSSSTTTTCC------
T ss_pred CchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH----HHHHHhccCcCCccchhhhhccccccccccc
Confidence 99999877 6666 999999999999999999997532211 11 1222222211100 000000 000
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 413 DQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 413 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.......+.+++.+||+.||++||++.|+++
T Consensus 292 ~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 292 NNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0122345778999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=5.5e-22 Score=199.76 Aligned_cols=167 Identities=16% Similarity=0.128 Sum_probs=110.0
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++....... .....|+..|+|
T Consensus 132 ~~~~~~~~~~qi~~~l~~lH~~~iv-------H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~a 201 (362)
T 3pg1_A 132 SPQHIQYFMYHILLGLHVLHEAGVV-------HRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRA 201 (362)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEECTTCCEEECCTTC------------------CGGGCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCcCE-------ecCCChHHEEEcCCCCEEEEecCcccccccccc---cceecccceecC
Confidence 3456777889999999999998777 999999999999999999999999975433222 233578999999
Q ss_pred hhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccc-----------cccchhcC--
Q 011196 345 PEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAE-----------LMDSVVKQ-- 410 (491)
Q Consensus 345 PE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~d~~l~~-- 410 (491)
||++.+ ..++.++||||||+++|||++|+.||.... .......+........... ........
T Consensus 202 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (362)
T 3pg1_A 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST---FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP 278 (362)
T ss_dssp HHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCC
T ss_pred cHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCC
Confidence 999987 678999999999999999999999975321 1122222222111111000 00000000
Q ss_pred -----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 411 -----SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 411 -----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.........+.+++.+||+.||++|||+.|++++
T Consensus 279 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 279 ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0001112457789999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.84 E-value=1.9e-21 Score=188.60 Aligned_cols=177 Identities=15% Similarity=0.121 Sum_probs=121.4
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC----CceEec
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM----NPKISD 317 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~----~~kl~D 317 (491)
.|.+++|..+....... ...........++.+++.++.+||..+++ ||||||+||+++.++ .+||+|
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~-------H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIA-------HFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc-------CCCCChHHEEEecCCCCCCceEEEe
Confidence 34455555444332221 11233556778899999999999998777 999999999998877 799999
Q ss_pred cCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 318 FGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 318 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
||++........ .....|++.|+|||++.+..++.++||||||++++||++|+.||.... .. ........
T Consensus 156 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~----~~~~~~~~ 225 (283)
T 3bhy_A 156 FGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET---KQ----ETLTNISA 225 (283)
T ss_dssp CTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS---HH----HHHHHHHT
T ss_pred cccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc---hH----HHHHHhHh
Confidence 999987643322 223568999999999998899999999999999999999999975321 11 11111111
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.... .++...... ...+.+++.+||+.||++||++.|+++
T Consensus 226 ~~~~--~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 226 VNYD--FDEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp TCCC--CCHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccC--CcchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 1110 111111112 234678999999999999999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-21 Score=206.12 Aligned_cols=177 Identities=18% Similarity=0.221 Sum_probs=122.9
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC---CCceEecc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE---MNPKISDF 318 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~---~~~kl~Df 318 (491)
.|.++.|+.++...... ...........++.+++.++.+||..+++ ||||||+|||++.. +.+||+||
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv-------H~Dlkp~Nil~~~~~~~~~~kl~Df 183 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV-------HRDLKPENLLLESKEKDALIKIVDF 183 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCce-------eccCChhhEEEeCCCCCCcEEEEEC
Confidence 45566666554432211 12233456677889999999999998777 99999999999764 45999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
|+++....... .....||+.|+|||++. +.++.++||||+||++|||++|..||.... ...+.. ....+
T Consensus 184 G~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~----~i~~~ 252 (494)
T 3lij_A 184 GLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT---DQEILR----KVEKG 252 (494)
T ss_dssp TTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH----HHHHT
T ss_pred CCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHH----HHHhC
Confidence 99987654322 23457999999999875 569999999999999999999999975321 112222 22222
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
... ...+. ....+ ..+.+++.+||+.||++|||+.|++++
T Consensus 253 ~~~-~~~~~-~~~~s----~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 253 KYT-FDSPE-WKNVS----EGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCC-CCSGG-GTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCC-CCchh-cccCC----HHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 111 00111 11122 346789999999999999999998853
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=7.1e-22 Score=194.81 Aligned_cols=168 Identities=16% Similarity=0.196 Sum_probs=112.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeecccccccccccc-CCCCceEeccCcceecCCCCc-ccccCceeecCCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLD-HEMNPKISDFGMARIFGGNQS-EANTNRVVGTYGYM 343 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~-~~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~ 343 (491)
......++.+++.++.+||..+++ ||||||+|||++ +++.+||+|||+++....... ........++..|+
T Consensus 119 ~~~~~~~~~qi~~~l~~lH~~~i~-------H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 191 (320)
T 2i6l_A 119 EEHARLFMYQLLRGLKYIHSANVL-------HRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCB-------CCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEe-------cCCCCHHHEEEcCCCCeEEEccCccccccCCCccccccccccccccccc
Confidence 455677888999999999998777 999999999997 567899999999986543211 11223346789999
Q ss_pred hhhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC----------Cccccccchhc-CC
Q 011196 344 APEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG----------HAAELMDSVVK-QS 411 (491)
Q Consensus 344 aPE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~d~~l~-~~ 411 (491)
|||.+.+ ..++.++||||||+++|||++|+.||.... .......+....... ........... ..
T Consensus 192 aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (320)
T 2i6l_A 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH---ELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPH 268 (320)
T ss_dssp CHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCC
T ss_pred CcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCC
Confidence 9999876 678999999999999999999999975322 111111111111000 00000000000 00
Q ss_pred CC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 412 CD-----QAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 412 ~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+ ......+.+++.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 269 KPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00 011345778999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.9e-22 Score=192.13 Aligned_cols=153 Identities=21% Similarity=0.342 Sum_probs=107.3
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++........ .....|++.|+|
T Consensus 109 ~~~~~~~~~~qi~~~l~~lH~~~i~-------H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~a 178 (276)
T 2h6d_A 109 EEMEARRLFQQILSAVDYCHRHMVV-------HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAA 178 (276)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHCSS-------CCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCCc-------cCCCChhhEEECCCCCEEEeecccccccCCCcc---eecccCCccccC
Confidence 3456677888999999999988776 999999999999999999999999986643321 223568999999
Q ss_pred hhhhhhCCC-CcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIF-SVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~-s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||.+.+..+ +.++||||||++++||++|+.||... .... .......+... ..... ...+.++
T Consensus 179 PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~----~~~~~~~~~~~------~~~~~----~~~l~~l 241 (276)
T 2h6d_A 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE---HVPT----LFKKIRGGVFY------IPEYL----NRSVATL 241 (276)
T ss_dssp TGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS---SHHH----HHHHHHHCCCC------CCTTS----CHHHHHH
T ss_pred HHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC---cHHH----HHHHhhcCccc------Cchhc----CHHHHHH
Confidence 999987765 68999999999999999999997532 1111 11111111110 01111 2346678
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 011196 424 GLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~ 444 (491)
+.+||+.||++|||+.|++++
T Consensus 242 i~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhhCCCHHHHHhC
Confidence 999999999999999999974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.2e-22 Score=208.83 Aligned_cols=178 Identities=17% Similarity=0.178 Sum_probs=123.8
Q ss_pred eeeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccc---cCCCCceEec
Q 011196 243 IRYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLL---DHEMNPKISD 317 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl---~~~~~~kl~D 317 (491)
..|.+..++.++...... ...........++.+++.++.+||..+++ ||||||+|||+ +.++.+||+|
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv-------H~Dlkp~Nil~~~~~~~~~~kl~D 172 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIV-------HRDLKPENLLLESKSKDANIRIID 172 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee-------eCCCCHHHEEEecCCCCCcEEEEe
Confidence 345566666555432221 12233556777889999999999998777 99999999999 4678899999
Q ss_pred cCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 318 FGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 318 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
||+++....... .....||+.|+|||++.+ .++.++||||+||++|||++|..||... ........ ...
T Consensus 173 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~----i~~ 241 (484)
T 3nyv_A 173 FGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA---NEYDILKK----VEK 241 (484)
T ss_dssp TTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHH----HHH
T ss_pred eeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC---CHHHHHHH----HHc
Confidence 999987644322 223568999999999865 7999999999999999999999997532 11112221 222
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
+...... +.. ... ...+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~-~~~-~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 242 GKYTFEL-PQW-KKV----SESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCCCCCS-GGG-GGS----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCCC-ccc-ccC----CHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 2111000 000 111 2346789999999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.3e-21 Score=190.13 Aligned_cols=155 Identities=21% Similarity=0.350 Sum_probs=104.6
Q ss_pred CcchhhhHhHHHHHHHHHhhe-eeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLST-SFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||.. +++ ||||||+|||++.++.+||+|||++........ .....|++.|+|
T Consensus 123 ~~~~~~~~~~i~~~l~~lH~~~~i~-------H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~a 192 (318)
T 2dyl_A 123 ERILGKMTVAIVKALYYLKEKHGVI-------HRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMA 192 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHCCC-------CCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCC
T ss_pred HHHHHHHHHHHHHHHHHHHhhCCEE-------eCCCCHHHEEECCCCCEEEEECCCchhccCCcc---ccccCCCccccC
Confidence 455667888999999999984 666 999999999999999999999999976543222 223578999999
Q ss_pred hhhhh-----hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHH
Q 011196 345 PEYAM-----EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLK 419 (491)
Q Consensus 345 PE~~~-----~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 419 (491)
||++. ...++.++||||||+++|||++|+.||.... ....... .... +....... ....+ ..
T Consensus 193 PE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~---~~~~-~~~~~~~~---~~~~~----~~ 259 (318)
T 2dyl_A 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK--TDFEVLT---KVLQ-EEPPLLPG---HMGFS----GD 259 (318)
T ss_dssp HHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC--SHHHHHH---HHHH-SCCCCCCS---SSCCC----HH
T ss_pred hhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC--ccHHHHH---HHhc-cCCCCCCc---cCCCC----HH
Confidence 99994 4568899999999999999999999975321 1111111 1111 11111100 00122 34
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 011196 420 YIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 420 ~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
+.+++.+||+.||++||++.|+++
T Consensus 260 l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 260 FQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhh
Confidence 677899999999999999999876
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-21 Score=201.08 Aligned_cols=157 Identities=22% Similarity=0.284 Sum_probs=107.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC-----CCCceEeccCcceecCCCCc-ccccCceeec
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH-----EMNPKISDFGMARIFGGNQS-EANTNRVVGT 339 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~-----~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt 339 (491)
......++.+++.++.+||..+++ ||||||+|||++. ...+||+|||+++....... ........||
T Consensus 117 ~~~~~~i~~qi~~aL~~LH~~~iv-------HrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt 189 (432)
T 3p23_A 117 GLEPITLLQQTTSGLAHLHSLNIV-------HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189 (432)
T ss_dssp SSCHHHHHHHHHHHHHHHHHTTCC-------CCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSC
T ss_pred chhHHHHHHHHHHHHHHHHHCcCE-------eCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCC
Confidence 334567889999999999998777 9999999999943 34578999999987653321 1223346799
Q ss_pred CCCChhhhhh---hCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHH
Q 011196 340 YGYMAPEYAM---EGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 415 (491)
Q Consensus 340 ~~y~aPE~~~---~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 415 (491)
+.|+|||++. ...++.++|||||||+++||++ |..||.... .... ......... .... ....
T Consensus 190 ~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~----~~~~---~~~~~~~~~-~~~~------~~~~ 255 (432)
T 3p23_A 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL----QRQA---NILLGACSL-DCLH------PEKH 255 (432)
T ss_dssp TTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT----THHH---HHHTTCCCC-TTSC------TTCH
T ss_pred cCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh----HHHH---HHHhccCCc-cccC------cccc
Confidence 9999999997 4567889999999999999999 888874211 1111 111111111 1111 1112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 416 ELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 416 ~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
....+.+|+.+||+.||++|||+.||++
T Consensus 256 ~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 256 EDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 3445678999999999999999999984
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-21 Score=205.42 Aligned_cols=177 Identities=20% Similarity=0.210 Sum_probs=123.9
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC---CceEecc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM---NPKISDF 318 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~---~~kl~Df 318 (491)
.|.++.|..++.+.... ...........++.+++.++.+||..+++ ||||||+|||++.++ .+||+||
T Consensus 121 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv-------H~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 121 FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIV-------HRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------eCCCcHHHEEEecCCCCccEEEEEC
Confidence 35556666554432221 12234556778899999999999998877 999999999998775 6899999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
|+++....... .....||+.|+|||++. +.++.++||||+||++|+|++|..||.... ...... ....+
T Consensus 194 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~----~i~~~ 262 (504)
T 3q5i_A 194 GLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN---DQDIIK----KVEKG 262 (504)
T ss_dssp TTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH----HHHHC
T ss_pred CCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHH----HHHcC
Confidence 99987654322 23457899999999986 568999999999999999999999975321 111222 12222
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.... +....... ...+.+++.+||+.||++|||+.|++++
T Consensus 263 ~~~~--~~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 263 KYYF--DFNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCC--CHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCC--CccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1110 00001111 2356789999999999999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.5e-21 Score=201.12 Aligned_cols=177 Identities=19% Similarity=0.196 Sum_probs=121.0
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeecccccccccccc---CCCCceEecc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLD---HEMNPKISDF 318 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~---~~~~~kl~Df 318 (491)
.|.++.|+.++...... ...........++.+++.++.+||..+++ ||||||+|||++ .++.+||+||
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv-------H~Dlkp~Nil~~~~~~~~~~kl~Df 168 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV-------HRDLKPENILLESKEKDCDIKIIDF 168 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEESSSSTTCCEEECSC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE-------eccCchHHEEEecCCCCCCEEEEEC
Confidence 34555665554432211 12233556777889999999999998777 999999999995 4567999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
|+++....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||... ........ ...+
T Consensus 169 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~----i~~~ 237 (486)
T 3mwu_A 169 GLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK---NEYDILKR----VETG 237 (486)
T ss_dssp SCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHH----HHHT
T ss_pred CcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHH----HHhC
Confidence 99986543322 223578999999999864 6999999999999999999999997432 11112211 2222
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
...... +.. ... ...+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~-~~~-~~~----s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 238 KYAFDL-PQW-RTI----SDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CCCSCS-GGG-GGS----CHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCCC-ccc-CCC----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111100 000 111 2346789999999999999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.1e-21 Score=191.24 Aligned_cols=154 Identities=20% Similarity=0.325 Sum_probs=107.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++........ ......|+..|+||
T Consensus 128 ~~~~~~i~~qi~~~l~~lH~~~iv-------H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aP 198 (326)
T 2x7f_A 128 EEWIAYICREILRGLSHLHQHKVI-------HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAP 198 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcc-------ccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccCh
Confidence 445667888999999999998776 999999999999999999999999976543221 12335789999999
Q ss_pred hhhh-----hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHH
Q 011196 346 EYAM-----EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKY 420 (491)
Q Consensus 346 E~~~-----~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 420 (491)
|++. +..++.++||||||+++|||++|+.||.... ............ ..... ....+ ..+
T Consensus 199 E~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~-~~~~~----~~~~~----~~l 263 (326)
T 2x7f_A 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH------PMRALFLIPRNP-APRLK----SKKWS----KKF 263 (326)
T ss_dssp HHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSC-CCCCS----CSCSC----HHH
T ss_pred hhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHhhcCc-cccCC----ccccC----HHH
Confidence 9987 5668999999999999999999999974321 111111111111 11111 11122 356
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 011196 421 IHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 421 ~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+++.+||+.||++||++.++++
T Consensus 264 ~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 264 QSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhccChhhCCCHHHHhh
Confidence 77899999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-21 Score=194.28 Aligned_cols=145 Identities=19% Similarity=0.288 Sum_probs=112.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeecccccccccccc-CCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLD-HEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||..+++ ||||||+|||++ .++.+||+|||+++...... .....||..|+|
T Consensus 148 ~~~~~~i~~qi~~~L~~LH~~~iv-------H~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~a 216 (320)
T 3a99_A 148 EELARSFFWQVLEAVRHCHNCGVL-------HRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSP 216 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcE-------eCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCC
Confidence 445667888999999999998877 999999999999 67899999999998764322 223568999999
Q ss_pred hhhhhhCCC-CcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIF-SVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~-s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..+ +.++||||||+++|||++|+.||.... .. .... . ......+ ..+.++
T Consensus 217 PE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------~~---~~~~-~------~~~~~~~----~~~~~l 273 (320)
T 3a99_A 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EI---IRGQ-V------FFRQRVS----SECQHL 273 (320)
T ss_dssp HHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HH---HHCC-C------CCSSCCC----HHHHHH
T ss_pred hHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------hh---hccc-c------cccccCC----HHHHHH
Confidence 999988776 678999999999999999999974211 01 0110 0 0111222 346789
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 011196 424 GLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~ 444 (491)
+.+||+.||++||++.||++.
T Consensus 274 i~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 274 IRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999873
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.3e-21 Score=191.28 Aligned_cols=156 Identities=21% Similarity=0.283 Sum_probs=115.0
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++........ .....|+..|+|
T Consensus 122 ~~~~~~~~~~qi~~~l~~lH~~~i~-------H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~a 191 (298)
T 1phk_A 122 SEKETRKIMRALLEVICALHKLNIV-------HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLA 191 (298)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcc-------cCCCCcceEEEcCCCcEEEecccchhhcCCCcc---cccccCCccccC
Confidence 3556778899999999999998877 999999999999999999999999987644322 223568999999
Q ss_pred hhhhh------hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHH
Q 011196 345 PEYAM------EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELL 418 (491)
Q Consensus 345 PE~~~------~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 418 (491)
||++. ...++.++||||||++++||++|+.||.... ..... .....+... ...+.. .....
T Consensus 192 PE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~----~~~~~~~~~-~~~~~~-----~~~~~ 258 (298)
T 1phk_A 192 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLML----RMIMSGNYQ-FGSPEW-----DDYSD 258 (298)
T ss_dssp HHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH----HHHHHTCCC-CCTTTG-----GGSCH
T ss_pred HHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---HHHHH----HHHhcCCcc-cCcccc-----cccCH
Confidence 99986 3457899999999999999999999974321 11111 111111111 000100 11224
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 419 KYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 419 ~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+.+++.+||+.||++||++.|+++
T Consensus 259 ~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 259 TVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHccCCcccCCCHHHHHh
Confidence 5778999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1e-21 Score=192.93 Aligned_cols=155 Identities=19% Similarity=0.251 Sum_probs=114.9
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccc---cCCCCceEeccCcceecCCCCcccccCceeecCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLL---DHEMNPKISDFGMARIFGGNQSEANTNRVVGTYG 341 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl---~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 341 (491)
.......++.+++.++.+||..+++ ||||||+||++ +.++.+||+|||+++..... ......|++.
T Consensus 104 ~~~~~~~~~~qi~~~l~~lH~~~i~-------H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~ 172 (304)
T 2jam_A 104 TEKDASLVIQQVLSAVKYLHENGIV-------HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPG 172 (304)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcc-------ccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCC
Confidence 3456677888999999999998777 99999999999 77889999999999754322 1223468999
Q ss_pred CChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 342 YMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 342 y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
|+|||++.+..++.++||||||+++|||++|+.||... ....+.. ....+... . ....... ....+.
T Consensus 173 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~~~~----~i~~~~~~-~-~~~~~~~----~~~~~~ 239 (304)
T 2jam_A 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE---TESKLFE----KIKEGYYE-F-ESPFWDD----ISESAK 239 (304)
T ss_dssp BCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHH----HHHHCCCC-C-CTTTTTT----SCHHHH
T ss_pred ccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC---CHHHHHH----HHHcCCCC-C-Ccccccc----CCHHHH
Confidence 99999999889999999999999999999999997432 1111121 12121110 0 0011111 224577
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~ 443 (491)
+++.+||+.||++||++.|+++
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 240 DFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCChhHCcCHHHHhc
Confidence 8999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.9e-21 Score=188.66 Aligned_cols=145 Identities=17% Similarity=0.278 Sum_probs=112.4
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeecccccccccccc-CCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLD-HEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||..+++ ||||||+||+++ .++.+||+|||+++...... .....|+..|+|
T Consensus 138 ~~~~~~~~~qi~~~l~~lH~~~i~-------H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~a 206 (312)
T 2iwi_A 138 EGPSRCFFGQVVAAIQHCHSRGVV-------HRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSP 206 (312)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTEE-------CCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCee-------ecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccC
Confidence 556777889999999999998777 999999999999 78899999999998765432 223568999999
Q ss_pred hhhhhhCCCC-cccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFS-VKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s-~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+..+. .++||||||+++|||++|+.||.... .... ... ..+......+.++
T Consensus 207 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~~~~----~~~----------~~~~~~~~~~~~l 263 (312)
T 2iwi_A 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------EILE----AEL----------HFPAHVSPDCCAL 263 (312)
T ss_dssp HHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHH----TCC----------CCCTTSCHHHHHH
T ss_pred ceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------HHhh----hcc----------CCcccCCHHHHHH
Confidence 9999887764 58999999999999999999974210 0100 000 0111122346789
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 011196 424 GLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~ 444 (491)
+.+||+.||++||++.|++++
T Consensus 264 i~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 264 IRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999873
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-21 Score=190.95 Aligned_cols=178 Identities=19% Similarity=0.273 Sum_probs=114.2
Q ss_pred eeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.+++++.++....... ..........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~-------H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGII-------HRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp EEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCee-------cccCCHHhEEEcCCCCEEEeeCcc
Confidence 455556665444322211 1122345667888999999999998777 999999999999999999999999
Q ss_pred ceecCCCCc------------ccccCceeecCCCChhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccH
Q 011196 321 ARIFGGNQS------------EANTNRVVGTYGYMAPEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSL 387 (491)
Q Consensus 321 a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~ 387 (491)
++....... ........|+..|+|||++.+. .++.++||||||+++|||++ |+... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-----~~- 233 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-----ME- 233 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-----HH-
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-----hh-
Confidence 986543210 1122345789999999999764 68999999999999999998 33210 01
Q ss_pred HHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 388 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 388 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
............. . .. ...+......+.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~-~-~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 RVNILKKLRSVSI-E-FP----PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHHSTTC-C-CC----TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcccccc-c-cC----ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1111111211110 0 01 1122233345678999999999999999999886
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.4e-21 Score=189.73 Aligned_cols=156 Identities=19% Similarity=0.332 Sum_probs=110.8
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+||+++.++.+||+|||++....... .......|+..|+|
T Consensus 115 ~~~~~~~~~~~i~~~l~~lH~~~i~-------H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~a 185 (302)
T 2j7t_A 115 TEPQIQVVCRQMLEALNFLHSKRII-------HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMA 185 (302)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-----CCGGGCC
T ss_pred CHHHHHHHHHHHHHHHHHHhcCCcc-------cCCCCHHHEEECCCCCEEEEECCCCccccccc--cccccccCChhhcC
Confidence 3556777889999999999998777 99999999999999999999999875432111 11223568999999
Q ss_pred hhhhh-----hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHH
Q 011196 345 PEYAM-----EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLK 419 (491)
Q Consensus 345 PE~~~-----~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 419 (491)
||++. +..++.++||||||+++|||++|+.|+.... ............ ......+ ......
T Consensus 186 PE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~-~~~~~~~-------~~~~~~ 251 (302)
T 2j7t_A 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIAKSD-PPTLLTP-------SKWSVE 251 (302)
T ss_dssp HHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSC-CCCCSSG-------GGSCHH
T ss_pred CeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC------HHHHHHHHhccC-CcccCCc-------cccCHH
Confidence 99984 5668899999999999999999999975321 111111111111 1111111 111235
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 011196 420 YIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 420 ~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
+.+++.+||+.||++|||+.++++
T Consensus 252 l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 252 FRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHcccChhhCCCHHHHhc
Confidence 678999999999999999998875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=5.7e-21 Score=185.97 Aligned_cols=155 Identities=22% Similarity=0.232 Sum_probs=112.6
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC---CCceEeccCcceecCCCCcccccCceeecCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE---MNPKISDFGMARIFGGNQSEANTNRVVGTYG 341 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~---~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 341 (491)
.......++.+++.++.+||..+++ ||||||+||+++.+ +.+||+|||++........ .....|+..
T Consensus 119 ~~~~~~~i~~qi~~~l~~LH~~~i~-------H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~ 188 (287)
T 2wei_A 119 SEHDAARIIKQVFSGITYMHKHNIV-------HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAY 188 (287)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHT
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCee-------ccCCChhhEEEecCCCcccEEEeccCcceeecCCCc---cccccCccc
Confidence 3556778889999999999998777 99999999999764 4699999999986543322 223468999
Q ss_pred CChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 342 YMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 342 y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
|+|||.+.+ .++.++||||||++++||++|+.||.... ... .......+....... ..... ...+.
T Consensus 189 y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~----~~~~~~~~~~~~~~~--~~~~~----~~~~~ 254 (287)
T 2wei_A 189 YIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYD----ILKRVETGKYAFDLP--QWRTI----SDDAK 254 (287)
T ss_dssp TCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH----HHHHHHHCCCCCCSG--GGTTS----CHHHH
T ss_pred ccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC---HHH----HHHHHHcCCCCCCch--hhhhc----CHHHH
Confidence 999998865 58999999999999999999999975321 111 112222221111000 00112 23467
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~ 443 (491)
+++.+||+.||++|||+.|+++
T Consensus 255 ~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 255 DLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcccChhhCcCHHHHhc
Confidence 8999999999999999999987
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.9e-20 Score=204.32 Aligned_cols=166 Identities=17% Similarity=0.228 Sum_probs=119.4
Q ss_pred eeeecccccCCCCccccCCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCccee
Q 011196 244 RYELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARI 323 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~ 323 (491)
.|.++.|..+...........+....+.++.+++.++.++|..+++ ||||||+|||++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gii-------HrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLV-------YNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCe-------ecccChHHeEEeCC-cEEEEecccchh
Confidence 4666777665544333333344567778899999999999998777 99999999999986 899999999987
Q ss_pred cCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcccc
Q 011196 324 FGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAEL 403 (491)
Q Consensus 324 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (491)
.... ....||+.|+|||++.++. +.++||||||++++||++|..|+....... ..+
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~~~- 286 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------LPE- 286 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------CCT-
T ss_pred cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------ccc-
Confidence 6432 3457899999999987765 889999999999999999988754211110 000
Q ss_pred ccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHhhc
Q 011196 404 MDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT-MSSVAVMLAS 447 (491)
Q Consensus 404 ~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~evl~~L~~ 447 (491)
..........+.+|+.+||+.||++||+ ++++...|..
T Consensus 287 ------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 287 ------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0000112245778999999999999995 5556555543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.2e-20 Score=199.21 Aligned_cols=228 Identities=15% Similarity=0.108 Sum_probs=139.9
Q ss_pred ccEEEEEecCCCCCccchhHHHHHHhhccccccCCCCCcEEEce--------ecceeeeecccccCCCCccccC-----C
Q 011196 196 DTLQTTVHCIPDLSKSDCNVCLNSAVAQIPTCSKGKLGARIFCA--------SCSIRYELYRFLVDTPTVTVTA-----P 262 (491)
Q Consensus 196 ~~vyglaQC~~Dls~~dC~~Cl~~~~~~~~~~~~~~~~g~i~~~--------~C~lry~~~~f~~~~~~~~~~~-----~ 262 (491)
+..+++-.+..+.+..+-..-...+... ...-+-++- ++++. .-...|.++.|+.++....... .
T Consensus 39 g~~VAVKvi~~~~~~~~~~~~~~Ei~iL-~~L~HpnIV-~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~ 116 (676)
T 3qa8_A 39 GEQVAIKQCRQELSPKNRERWCLEIQIM-KKLNHPNVV-SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC 116 (676)
T ss_dssp TCCEEECCCCSCCCHHHHHHHHHHHHHH-HHCCBTTBC-CEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTT
T ss_pred CcEEEEEEecccCCHHHHHHHHHHHHHH-HhCCCCCCC-ceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCC
Confidence 4456777777777666655555443221 111111111 11111 1223355666665544322211 1
Q ss_pred CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC---ceEeccCcceecCCCCcccccCceeec
Q 011196 263 NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN---PKISDFGMARIFGGNQSEANTNRVVGT 339 (491)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~---~kl~DfGla~~~~~~~~~~~~~~~~gt 339 (491)
.........++.+++.++.+||..+++ ||||||+|||++.++. +||+|||++........ .....|+
T Consensus 117 ~lse~~i~~I~~QLl~aL~yLHs~gIV-------HrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt 186 (676)
T 3qa8_A 117 GLKEGPIRTLLSDISSALRYLHENRII-------HRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGT 186 (676)
T ss_dssp CCCSSHHHHHHHHHHHHHHHHHHTTBC-------CCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC---CCCCCSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCc-------cCCCCHHHeEeecCCCceeEEEcccccccccccccc---cccccCC
Confidence 234566788899999999999998777 9999999999997665 89999999987644322 2345789
Q ss_pred CCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHH----hhcCCccccc------cch--
Q 011196 340 YGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKL----WCEGHAAELM------DSV-- 407 (491)
Q Consensus 340 ~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~------d~~-- 407 (491)
..|+|||++.+..++.++||||||+++|||++|..||.... ....+.... .......+.. ...
T Consensus 187 ~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-----~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp 261 (676)
T 3qa8_A 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-----QPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLP 261 (676)
T ss_dssp CTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-----HHHHSSTTCC------CCSCCCCSSSCCCCSSSC
T ss_pred cccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-----chhhhhhhhhcccchhhhhhhhhccccccccccC
Confidence 99999999998999999999999999999999999975311 000000000 0000000000 000
Q ss_pred hcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 011196 408 VKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSS 440 (491)
Q Consensus 408 l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e 440 (491)
............+.+++.+||+.||++|||+.|
T Consensus 262 ~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 262 TPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred CchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 011233345567888999999999999999965
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.5e-19 Score=175.58 Aligned_cols=157 Identities=15% Similarity=0.148 Sum_probs=106.2
Q ss_pred eeeecccccCCCCccccC----CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC---CCCceEe
Q 011196 244 RYELYRFLVDTPTVTVTA----PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH---EMNPKIS 316 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~---~~~~kl~ 316 (491)
.|.+++|+.++.+..... ..........++.+++.++.+||..+++ ||||||+|||++. ++.+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~-------H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA-------HRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEESSSSTTCCEEEC
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc-------cCCCCHHHEEEecCCCCCcEEEe
Confidence 455666665544322211 1234556778899999999999998877 9999999999998 7889999
Q ss_pred ccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh
Q 011196 317 DFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC 396 (491)
Q Consensus 317 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 396 (491)
|||++.... +..++.++||||||+++|||++|+.||........ .
T Consensus 163 Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~ 207 (299)
T 3m2w_A 163 DFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------S 207 (299)
T ss_dssp CCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------
T ss_pred ccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------h
Confidence 999987542 13457889999999999999999999753221110 0
Q ss_pred cCCccccccchhcCCCCH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 397 EGHAAELMDSVVKQSCDQ----AELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 397 ~~~~~~~~d~~l~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
......+..... ..+. .....+.+++.+||+.||++|||+.|++++
T Consensus 208 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 208 PGMKTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CCSCCSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000000000 0111 113457789999999999999999999873
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.2e-18 Score=169.98 Aligned_cols=157 Identities=10% Similarity=0.035 Sum_probs=103.9
Q ss_pred eeecccccCCCCccccCCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceec
Q 011196 245 YELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIF 324 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~ 324 (491)
|.++.|..+..+.......+.......++.+++.++.+||..+++ ||||||+|||++.++.+||++++
T Consensus 107 ~lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~giv-------H~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVA-------LSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCc-------cCCCCcccEEEcCCCCEEEEecc-----
Confidence 444555543333222222223345677888999999999998777 99999999999999999997443
Q ss_pred CCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccc
Q 011196 325 GGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELM 404 (491)
Q Consensus 325 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (491)
|++ +++.++||||||+++|||++|+.||............ .... .+ ...
T Consensus 175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~-~~---~~~ 223 (286)
T 3uqc_A 175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDT-AG---QPI 223 (286)
T ss_dssp -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCT-TS---CBC
T ss_pred -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHh-cc---CCC
Confidence 333 2588999999999999999999998643322110000 0000 00 000
Q ss_pred c-chhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 405 D-SVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 405 d-~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
. ....... ...+.+|+.+||+.||++| |+.|+++.|+...
T Consensus 224 ~~~~~~~~~----~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 224 EPADIDRDI----PFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp CHHHHCTTS----CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred ChhhcccCC----CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 0 0111122 2346789999999999999 9999999998753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.70 E-value=4.5e-18 Score=169.40 Aligned_cols=168 Identities=11% Similarity=0.017 Sum_probs=111.9
Q ss_pred eeecccccCCCCcccc-CCCCCCcchhhhHhHHHHHHHHHh-heeeEEeEEeeeccccccccccccCCC-----------
Q 011196 245 YELYRFLVDTPTVTVT-APNKTSKRWITIAEAASAIIVFLL-STSFLWCIIRRRNKRVRASNVLLDHEM----------- 311 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~iHrDlKp~NILl~~~~----------- 311 (491)
|.++.|...+..+... ...........++.+++.++.+|| ..+++ ||||||+|||++.++
T Consensus 138 ~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~iv-------HrDlKp~NILl~~~~~~~~~~~~~~~ 210 (336)
T 2vuw_A 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFE-------HRDLHWGNVLLKKTSLKKLHYTLNGK 210 (336)
T ss_dssp EEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHHHHHCCB-------CSCCCGGGEEEEECSCSEEEEEETTE
T ss_pred EEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHhCCEe-------ECCCCHHHEEEeccCCcceeeeccCc
Confidence 4455554444322221 122345667788999999999999 77777 999999999999887
Q ss_pred ---------CceEeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHH-HHHHHhCCCCCCCccC
Q 011196 312 ---------NPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVV-LLEIISGKKSSGFYHL 381 (491)
Q Consensus 312 ---------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvv-l~elltG~~p~~~~~~ 381 (491)
.+||+|||+++..... ...||+.|+|||++.+.. +.++||||+|++ .++++.|..||...
T Consensus 211 ~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-- 280 (336)
T 2vuw_A 211 SSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-- 280 (336)
T ss_dssp EEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--
T ss_pred cccccCCCceEEEeeccccEecCCC-------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--
Confidence 8999999999876432 357999999999998665 899999998776 77788888885210
Q ss_pred CCcccHHHHHHHHhh-cCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 011196 382 EHGPSLLAYIWKLWC-EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVA 442 (491)
Q Consensus 382 ~~~~~~~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl 442 (491)
........... .......... .........+.+|+.+||+.| |+.|++
T Consensus 281 ----~~~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 281 ----LWLHYLTDKMLKQMTFKTKCNT----PAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp ----HHHHHHHHHHHHTCCCSSCCCS----HHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred ----hhhhHHHHhhhhhhccCcccch----hhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 00011111111 1111100000 112245567889999999976 988887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=5.4e-16 Score=165.21 Aligned_cols=127 Identities=16% Similarity=0.061 Sum_probs=80.7
Q ss_pred EceecceeeeecccccCCCCccccCCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEe
Q 011196 237 FCASCSIRYELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKIS 316 (491)
Q Consensus 237 ~~~~C~lry~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~ 316 (491)
++..-...|.++.|..+.++......... -....++.+++.++.++|..+++ ||||||+||||+.++.+||+
T Consensus 310 ~~ed~~~~yLVMEyv~G~~L~d~i~~~~~-l~~~~I~~QIl~AL~ylH~~GII-------HRDIKPeNILL~~dg~vKL~ 381 (569)
T 4azs_A 310 HGENAQSGWLVMEKLPGRLLSDMLAAGEE-IDREKILGSLLRSLAALEKQGFW-------HDDVRPWNVMVDARQHARLI 381 (569)
T ss_dssp EEECSSEEEEEEECCCSEEHHHHHHTTCC-CCHHHHHHHHHHHHHHHHHTTCE-------ESCCCGGGEEECTTSCEEEC
T ss_pred EEEECCEEEEEEecCCCCcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHCCce-------eccCchHhEEECCCCCEEEe
Confidence 34455677888888877665443322111 12235788999999999998888 99999999999999999999
Q ss_pred ccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCC
Q 011196 317 DFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKK 374 (491)
Q Consensus 317 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~ 374 (491)
|||+++....... .....+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus 382 DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 382 DFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp CCTTEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred ecccCeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 9999987654332 2334689999999999865 56778999999998887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=1.8e-12 Score=137.20 Aligned_cols=118 Identities=16% Similarity=0.173 Sum_probs=89.2
Q ss_pred eeeecccccCCCCccccCCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCccee
Q 011196 244 RYELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARI 323 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~ 323 (491)
.|.+++|..+.++...... ...++.+++.++.+||..+++ ||||||+|||++. .+||+|||+++.
T Consensus 414 ~~lVmE~~~ggsL~~~l~~------~~~i~~qi~~aL~~LH~~gIi-------HrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED------NLDIAYKIGEIVGKLHKNDVI-------HNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT------CTHHHHHHHHHHHHHHHTTEE-------CTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred cEEEEECCCCCCHHHHHHH------HHHHHHHHHHHHHHHHHCcCc-------cCCCCHHHEEECC--eEEEEECccCEE
Confidence 3555666554433222211 567889999999999998877 9999999999998 999999999998
Q ss_pred cCCCCccc-----ccCceeecCCCChhhhhhh--CCCCcccceeehhHHHHHHHhCCCCC
Q 011196 324 FGGNQSEA-----NTNRVVGTYGYMAPEYAME--GIFSVKSDVFSFGVVLLEIISGKKSS 376 (491)
Q Consensus 324 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvvl~elltG~~p~ 376 (491)
........ ......||+.|||||++.. ..|+...|+|+..+-.++.+.++.++
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 75432211 1234689999999999987 55888899999998888888776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=98.70 E-value=5.1e-09 Score=101.31 Aligned_cols=78 Identities=13% Similarity=-0.008 Sum_probs=60.0
Q ss_pred eeecccccCCCCccccCCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceec
Q 011196 245 YELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIF 324 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~ 324 (491)
|.++.|..+.++... .......++.+++.++.++|..+++ ||||||+|||++ ++.+||+|||+++.
T Consensus 176 ~lvmE~~~g~~L~~l-----~~~~~~~i~~qi~~~l~~lH~~gii-------HrDlkp~NILl~-~~~vkl~DFG~a~~- 241 (282)
T 1zar_A 176 AVLMELIDAKELYRV-----RVENPDEVLDMILEEVAKFYHRGIV-------HGDLSQYNVLVS-EEGIWIIDFPQSVE- 241 (282)
T ss_dssp EEEEECCCCEEGGGC-----CCSCHHHHHHHHHHHHHHHHHTTEE-------CSCCSTTSEEEE-TTEEEECCCTTCEE-
T ss_pred EEEEEecCCCcHHHc-----chhhHHHHHHHHHHHHHHHHHCCCE-------eCCCCHHHEEEE-CCcEEEEECCCCeE-
Confidence 566666655444331 1233456889999999999988877 999999999999 99999999999863
Q ss_pred CCCCcccccCceeecCCCChhhhhhh
Q 011196 325 GGNQSEANTNRVVGTYGYMAPEYAME 350 (491)
Q Consensus 325 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 350 (491)
+..++|||++..
T Consensus 242 --------------~~~~~a~e~l~r 253 (282)
T 1zar_A 242 --------------VGEEGWREILER 253 (282)
T ss_dssp --------------TTSTTHHHHHHH
T ss_pred --------------CCCCCHHHHHHH
Confidence 345789998854
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=1.9e-06 Score=81.83 Aligned_cols=49 Identities=12% Similarity=0.091 Sum_probs=43.0
Q ss_pred cchhhhHhHHHHHHHHHh-heeeEEeEEeeeccccccccccccCCCCceEeccCcceec
Q 011196 267 KRWITIAEAASAIIVFLL-STSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIF 324 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~ 324 (491)
.....++.+++.++.++| ..+++ ||||||+|||++. .++|+|||++...
T Consensus 170 ~~~~~i~~qi~~~l~~lH~~~giv-------HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 170 LDVEGIFNDVVENVKRLYQEAELV-------HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCHHHHHHHHHHHHHHHHHTSCEE-------CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEE-------eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 456778889999999999 87777 9999999999998 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=97.10 E-value=0.00029 Score=70.53 Aligned_cols=48 Identities=19% Similarity=0.226 Sum_probs=39.6
Q ss_pred hhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCC----------ceEeccCccee
Q 011196 269 WITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMN----------PKISDFGMARI 323 (491)
Q Consensus 269 ~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~----------~kl~DfGla~~ 323 (491)
...+..+++.++.++|..+++ ||||||.|||+++++. +.|+||+-+..
T Consensus 207 ~~~l~~qll~~l~~lH~~gIV-------HrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 207 PASLYADLIALILRLAKHGLI-------HGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-------CSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHCCCc-------CCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 455777888889999888777 9999999999988763 78999986643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=94.62 E-value=0.042 Score=54.04 Aligned_cols=31 Identities=10% Similarity=0.179 Sum_probs=25.7
Q ss_pred EeeeccccccccccccCCCC--ceEeccCccee
Q 011196 293 IRRRNKRVRASNVLLDHEMN--PKISDFGMARI 323 (491)
Q Consensus 293 ~~~iHrDlKp~NILl~~~~~--~kl~DfGla~~ 323 (491)
..++|+|+++.|||++.++. +.|+||+.+..
T Consensus 216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 45679999999999997753 58999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=94.50 E-value=0.0028 Score=61.11 Aligned_cols=80 Identities=18% Similarity=0.197 Sum_probs=47.4
Q ss_pred eeeccccccccccccC--CCCceEeccCcceecCCCCcccccC------------ceeecCCCCh-hhhhhhCCCCcccc
Q 011196 294 RRRNKRVRASNVLLDH--EMNPKISDFGMARIFGGNQSEANTN------------RVVGTYGYMA-PEYAMEGIFSVKSD 358 (491)
Q Consensus 294 ~~iHrDlKp~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~------------~~~gt~~y~a-PE~~~~~~~s~~sD 358 (491)
.++|+|+++.||++++ ...+.|+||+.+..-.......... ......+... |+..... ....+
T Consensus 192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~--~~~~~ 269 (304)
T 3sg8_A 192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKY--RMKEK 269 (304)
T ss_dssp EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHH--HHHHH
T ss_pred eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHH--HHHHH
Confidence 4569999999999998 4567899999886532111000000 0000111122 2222111 22357
Q ss_pred eeehhHHHHHHHhCCCC
Q 011196 359 VFSFGVVLLEIISGKKS 375 (491)
Q Consensus 359 VwS~Gvvl~elltG~~p 375 (491)
.|+++.++|++.+|..+
T Consensus 270 ~~~l~~~~~~~~~g~~~ 286 (304)
T 3sg8_A 270 YWSFEKIIYGKEYGYMD 286 (304)
T ss_dssp HHHHHHHHHHHHTTCHH
T ss_pred HHHHHHHHHHHHcCCHH
Confidence 89999999999999866
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.27 E-value=0.026 Score=52.36 Aligned_cols=30 Identities=10% Similarity=0.118 Sum_probs=25.3
Q ss_pred EeeeccccccccccccCCCCceEeccCcce
Q 011196 293 IRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 293 ~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
..++|+|++|.|||++++..++|+||+.+.
T Consensus 184 ~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 184 LVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp EEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 346799999999999877667799999875
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=93.77 E-value=0.037 Score=51.64 Aligned_cols=30 Identities=13% Similarity=0.194 Sum_probs=24.8
Q ss_pred EeeeccccccccccccCCCCceEeccCcce
Q 011196 293 IRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 293 ~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
..++|+|+++.|||++++..+.|+||+.+.
T Consensus 183 ~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 446799999999999876666799998764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=86.45 E-value=0.23 Score=47.86 Aligned_cols=29 Identities=14% Similarity=0.122 Sum_probs=25.2
Q ss_pred eeeccccccccccccCCCCceEeccCcce
Q 011196 294 RRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 294 ~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.++|+|+++.|||++.++.+.|+||+.+.
T Consensus 223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 223 NLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred ceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 34599999999999878889999999774
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=86.15 E-value=0.3 Score=49.05 Aligned_cols=30 Identities=7% Similarity=0.106 Sum_probs=25.6
Q ss_pred EeeeccccccccccccCCCCceEeccCccee
Q 011196 293 IRRRNKRVRASNVLLDHEMNPKISDFGMARI 323 (491)
Q Consensus 293 ~~~iHrDlKp~NILl~~~~~~kl~DfGla~~ 323 (491)
..++|+|+++.|||++.++ ++|+||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 3456999999999998876 99999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=82.98 E-value=0.44 Score=45.67 Aligned_cols=30 Identities=17% Similarity=0.074 Sum_probs=24.9
Q ss_pred EeeeccccccccccccCCCCceEeccCcce
Q 011196 293 IRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 293 ~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
..++|+|+++.|||++++..+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 456799999999999987656799998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=82.46 E-value=0.36 Score=44.90 Aligned_cols=29 Identities=14% Similarity=0.086 Sum_probs=24.8
Q ss_pred eeeccccccccccccCCCCceEeccCcce
Q 011196 294 RRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 294 ~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 194 ~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 194 VVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 35699999999999987777799998775
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=80.86 E-value=0.48 Score=46.18 Aligned_cols=30 Identities=20% Similarity=0.079 Sum_probs=24.5
Q ss_pred EeeeccccccccccccCCCCceEeccCcce
Q 011196 293 IRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 293 ~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
..++|+|+++.|||++++..+.|+||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 345699999999999964457899999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=80.42 E-value=0.65 Score=44.41 Aligned_cols=30 Identities=27% Similarity=0.325 Sum_probs=24.1
Q ss_pred eeeccccccccccccC---CCC-ceEeccCccee
Q 011196 294 RRRNKRVRASNVLLDH---EMN-PKISDFGMARI 323 (491)
Q Consensus 294 ~~iHrDlKp~NILl~~---~~~-~kl~DfGla~~ 323 (491)
.++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 4459999999999987 355 47999998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=80.31 E-value=0.62 Score=44.94 Aligned_cols=31 Identities=23% Similarity=0.251 Sum_probs=25.7
Q ss_pred EeeeccccccccccccCC----CCceEeccCccee
Q 011196 293 IRRRNKRVRASNVLLDHE----MNPKISDFGMARI 323 (491)
Q Consensus 293 ~~~iHrDlKp~NILl~~~----~~~kl~DfGla~~ 323 (491)
..++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 345699999999999874 6789999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 491 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-28 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-27 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-26 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-26 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-25 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-25 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-25 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-25 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-25 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-24 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-24 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-24 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-24 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-23 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-23 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-23 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-23 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-22 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-22 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-22 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-22 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-21 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-21 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-20 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-20 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-19 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-19 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-19 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-18 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-18 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-16 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-16 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-15 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-15 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-15 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-14 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-14 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-14 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-14 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-14 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-14 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-14 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-13 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-13 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-13 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-13 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-13 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-12 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-12 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-11 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-11 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-11 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-11 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-08 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-08 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-08 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-07 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-07 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-07 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 4e-32
Identities = 36/167 (21%), Positives = 70/167 (41%), Gaps = 17/167 (10%)
Query: 291 CIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM- 349
II R K ++N+ L ++ KI DFG+A + ++ G+ +MAPE
Sbjct: 124 SIIHRDLK---SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 350 --EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSV 407
+ +S +SDV++FG+VL E+++G+ + I + G+ + + V
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 408 VKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPK 454
+ C+++ +RP + + +LPK
Sbjct: 235 RSNCPKAM-----KRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 3e-28
Identities = 40/170 (23%), Positives = 74/170 (43%), Gaps = 19/170 (11%)
Query: 290 WCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM 349
+ R +RA+N+L+ + K++DFG+AR+ N+ A + APE A+
Sbjct: 132 MNYVHRD---LRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAAL 187
Query: 350 EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK 409
G F++KSDV+SFG++L E+ + + Y +L + + + E +S+
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQVERGYRMPCPPECPESL-- 243
Query: 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPA 459
+ C +++P +RPT + L + QP
Sbjct: 244 -----------HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-27
Identities = 36/197 (18%), Positives = 67/197 (34%), Gaps = 16/197 (8%)
Query: 262 PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321
K ++ A + + + ++ T I R K + N+L+ I+D G+A
Sbjct: 99 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK---SKNILVKKNGTCCIADLGLA 155
Query: 322 RIF--GGNQSEANTNRVVGTYGYMAPEYAMEGI------FSVKSDVFSFGVVLLEIISGK 373
+ + N VGT YMAPE + I ++D+++ G+V EI
Sbjct: 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 215
Query: 374 KSSGFYHLEHGP----SLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH-IGLLCV 428
G + P + + + + + E L+ + I C
Sbjct: 216 SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECW 275
Query: 429 QEDPMDRPTMSSVAVML 445
+ R T + L
Sbjct: 276 YANGAARLTALRIKKTL 292
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-26
Identities = 28/179 (15%), Positives = 69/179 (38%), Gaps = 17/179 (9%)
Query: 276 ASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANT-N 334
++ + + + ++ + A N+L++ + K+SDFG++R+ + T +
Sbjct: 112 LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171
Query: 335 RVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKL 394
+ APE F+ SDV+SFG+V+ E+++ + +
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWE 216
Query: 395 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLP 453
+ ++ + + + C Q++ RP + + +L ++ P
Sbjct: 217 LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL-DKLIRAP 274
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (266), Expect = 2e-26
Identities = 34/156 (21%), Positives = 62/156 (39%), Gaps = 18/156 (11%)
Query: 290 WCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM 349
+ R + N L+ M KI+DFG++R +M PE
Sbjct: 159 RKFVHRD---LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF 215
Query: 350 EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK 409
++ +SDV+++GVVL EI S Y+ ++ Y+ +G+ ++
Sbjct: 216 YNRYTTESDVWAYGVVLWEIFSYGLQ--PYYGMAHEEVIYYV----RDGNILACPENCPL 269
Query: 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
+ ++ LC + P DRP+ S+ +L
Sbjct: 270 E---------LYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 1e-25
Identities = 39/213 (18%), Positives = 74/213 (34%), Gaps = 34/213 (15%)
Query: 267 KRWITIAEAASAIIVFLLSTSFLWC--IIRRRNKRVRASNVLLDHEMNPKISDFGMARIF 324
K I + + ++L ++ R A NVL+ + KI+DFG+A++
Sbjct: 105 KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLL 161
Query: 325 GGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHG 384
G + E + +MA E + I++ +SDV+S+GV + E+++ Y
Sbjct: 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPA 219
Query: 385 PSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444
+ + + +G I + C D RP + +
Sbjct: 220 SEISSIL----EKGERLPQPPICTID---------VYMIMVKCWMIDADSRPKFRELIIE 266
Query: 445 L--------------ASDIVTLPKPTQPAFSVS 463
+ + LP PT F +
Sbjct: 267 FSKMARDPQRYLVIQGDERMHLPSPTDSNFYRA 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 3e-25
Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 19/155 (12%)
Query: 291 CIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME 350
I R + A+N+L+ ++ KI+DFG+AR+ N+ A + APE
Sbjct: 129 NYIHRDLR---AANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINY 184
Query: 351 GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQ 410
G F++KSDV+SFG++L EI++ + Y P ++ + + G+ D+ ++
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNLER----GYRMVRPDNCPEE 238
Query: 411 SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
+ LC +E P DRPT + +L
Sbjct: 239 ---------LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 5e-25
Identities = 41/183 (22%), Positives = 70/183 (38%), Gaps = 22/183 (12%)
Query: 266 SKRWITIAEAASAIIVFL---LSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322
++R + AE + + + ++ C+I R A N L+ K+SDFGM R
Sbjct: 93 TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA---ARNCLVGENQVIKVSDFGMTR 149
Query: 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLE 382
+Q ++ + +PE +S KSDV+SFGV++ E+ S K
Sbjct: 150 FVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI------- 201
Query: 383 HGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVA 442
++ E + + + + I C +E P DRP S +
Sbjct: 202 --------PYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLL 253
Query: 443 VML 445
L
Sbjct: 254 RQL 256
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 6e-25
Identities = 34/167 (20%), Positives = 62/167 (37%), Gaps = 20/167 (11%)
Query: 290 WCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR--VVGTYGYMAPEY 347
+ R N +LD + K++DFG+AR + ++ N+ +MA E
Sbjct: 149 KKFVHRDLAA---RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 348 AMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSV 407
F+ KSDV+SFGV+L E+++ Y + + Y+ + G +
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQ----GRRLLQPEYC 259
Query: 408 VKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPK 454
+ L C RP+ S + +++ T
Sbjct: 260 PDP---------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 9e-25
Identities = 46/188 (24%), Positives = 68/188 (36%), Gaps = 19/188 (10%)
Query: 260 TAPNKTSKRWITIAEAASAIIVFLLSTSFL--WCIIRRRNKRVRASNVLLDHEMNPKISD 317
AP K ++T+ FL I R + A N+LL + KI D
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD---LAARNILLSEKNVVKICD 177
Query: 318 FGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSG 377
FG+AR + +MAPE + +++++SDV+SFGV+L EI S
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----SL 232
Query: 378 FYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT 437
G + + EG D + L C +P RPT
Sbjct: 233 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPT 283
Query: 438 MSSVAVML 445
S + L
Sbjct: 284 FSELVEHL 291
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 100 bits (251), Expect = 2e-24
Identities = 35/180 (19%), Positives = 70/180 (38%), Gaps = 22/180 (12%)
Query: 269 WITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQ 328
I + I + + + + R + A N+L++ + K+SDFG++R +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMNYVHRD----LAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 329 SEANTNRVVG---TYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGP 385
S+ +G + APE F+ SDV+S+G+V+ E++S + Y
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMTNQ 240
Query: 386 SLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
++ I + + + ++ + L C Q+D RP + L
Sbjct: 241 DVINAIEQDYRLPPPMDCPSAL-------------HQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.7 bits (248), Expect = 3e-24
Identities = 37/181 (20%), Positives = 69/181 (38%), Gaps = 27/181 (14%)
Query: 266 SKRWITIAEAASAIIVFLLSTSFLWC----IIRRRNKRVRASNVLLDHE-MNPKISDFGM 320
+ + I S L FL II R K N+ + + KI D G+
Sbjct: 105 RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK---CDNIFITGPTGSVKIGDLGL 161
Query: 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYH 380
A + + V+GT +MAPE E + DV++FG+ +LE+ + + +
Sbjct: 162 ATLKRASF----AKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSE------Y 210
Query: 381 LEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSS 440
A I++ G D V E+++ C++++ +R ++
Sbjct: 211 PYSECQNAAQIYRRVTSGVKPASFDKVAIPEV--KEIIE------GCIRQNKDERYSIKD 262
Query: 441 V 441
+
Sbjct: 263 L 263
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 4e-24
Identities = 34/155 (21%), Positives = 60/155 (38%), Gaps = 19/155 (12%)
Query: 291 CIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME 350
+ R A N L++ + K+SDFG++R ++ ++ + PE M
Sbjct: 120 QFLHRDLA---ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMY 175
Query: 351 GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQ 410
FS KSD+++FGV++ EI S K ++ + AE + ++
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRL 220
Query: 411 SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
K I C E +RPT + +
Sbjct: 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 98.6 bits (245), Expect = 9e-24
Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 19/155 (12%)
Query: 291 CIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME 350
I R A N L+ K++DFG++R+ G+ A+ + APE
Sbjct: 135 NFIHRDLA---ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190
Query: 351 GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQ 410
FS+KSDV++FGV+L EI + S Y L+ +++L + + E + +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS--PYPGID----LSQVYELLEKDYRMERPEGCPE- 243
Query: 411 SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
K + C Q +P DRP+ + +
Sbjct: 244 --------KVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 2e-23
Identities = 43/197 (21%), Positives = 75/197 (38%), Gaps = 21/197 (10%)
Query: 267 KRWITIAEAASAIIVFLLSTSFLWC--IIRRRNKRVRASNVLLDHEMNPKISDFGMARIF 324
+ I ++ A + + +L + R + A NVLL + KISDFG+++
Sbjct: 103 REEIPVSNVAELLHQVSMGMKYLEEKNFVHRD---LAARNVLLVNRHYAKISDFGLSKAL 159
Query: 325 GGNQSEAN-TNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEH 383
G + S + + APE FS +SDV+S+GV + E +S + Y
Sbjct: 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMK 217
Query: 384 GPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443
GP ++A+I +G E + + C DRP +V
Sbjct: 218 GPEVMAFI----EQGKRMECPPECPPELYA---------LMSDCWIYKWEDRPDFLTVEQ 264
Query: 444 MLASDIVTLPKPTQPAF 460
+ + +L +
Sbjct: 265 RMRACYYSLASKVEGHH 281
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 3e-23
Identities = 40/150 (26%), Positives = 63/150 (42%), Gaps = 14/150 (9%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
+ A NVL+ H KI DFG+AR + + +MAPE EGI+++KSDV
Sbjct: 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249
Query: 360 FSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLK 419
+S+G++L EI S + G + A +KL G + ++
Sbjct: 250 WSYGILLWEIFSLGV-----NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYI------ 298
Query: 420 YIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449
I C D RP+ ++ L +
Sbjct: 299 ---IMQSCWAFDSRKRPSFPNLTSFLGCQL 325
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.3 bits (239), Expect = 5e-23
Identities = 37/147 (25%), Positives = 60/147 (40%), Gaps = 16/147 (10%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTN-RVVGTYGYMAPEYAMEGIFSVKSD 358
+ A NVLL + KISDFG+++ +++ + APE FS KSD
Sbjct: 133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD 192
Query: 359 VFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELL 418
V+SFGV++ E S + Y G + A + +G ++
Sbjct: 193 VWSFGVLMWEAFSYGQK--PYRGMKGSEVTAML----EKGERMGCPAGCPRE-------- 238
Query: 419 KYIHIGLLCVQEDPMDRPTMSSVAVML 445
+ LC D +RP ++V + L
Sbjct: 239 -MYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 8e-23
Identities = 47/227 (20%), Positives = 81/227 (35%), Gaps = 25/227 (11%)
Query: 237 FCASCSIRYELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRR 296
++ L V AP SK E A ++ + R
Sbjct: 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG-----MAYLNANKFVHRD 158
Query: 297 NKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
+ A N ++ + KI DFGM R + + +M+PE +G+F+
Sbjct: 159 ---LAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY 215
Query: 357 SDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAE 416
SDV+SFGVVL EI + + Y +L ++ EG + D+
Sbjct: 216 SDVWSFGVVLWEIATLAEQ--PYQGLSNEQVLRFV----MEGGLLDKPDNCPDM------ 263
Query: 417 LLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQPAFSVS 463
+ +C Q +P RP+ + + ++ P + +F S
Sbjct: 264 ---LFELMRMCWQYNPKMRPSFLEIISSIKEEM--EPGFREVSFYYS 305
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.4 bits (234), Expect = 2e-22
Identities = 34/149 (22%), Positives = 54/149 (36%), Gaps = 15/149 (10%)
Query: 298 KRVRASNVLLDHEMNPKISDFGMARIFGGNQSE-ANTNRVVGTYGYMAPEYAMEGIFSVK 356
+ + A N+LL KI DFG+ R N + + APE FS
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA 194
Query: 357 SDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAE 416
SD + FGV L E+ + + G + + K+ EG + +
Sbjct: 195 SDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERLPRPEDCPQ------- 242
Query: 417 LLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
++ + C P DRPT ++ L
Sbjct: 243 --DIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.9 bits (233), Expect = 3e-22
Identities = 41/196 (20%), Positives = 72/196 (36%), Gaps = 23/196 (11%)
Query: 246 ELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNV 305
+L + + R + + A+ + ++ R K +NV
Sbjct: 91 DLASVITKGTKERQYLDEEFVLRVM--TQLTLALKECHRRSDGGHTVLHRDLK---PANV 145
Query: 306 LLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVV 365
LD + N K+ DFG+ARI + S A VGT YM+PE ++ KSD++S G +
Sbjct: 146 FLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCL 203
Query: 366 LLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGL 425
L E+ + + L I EG + S + E++
Sbjct: 204 LYELCALMP---PFTAFSQKELAGKI----REGKFRRIPYRY---SDELNEIIT------ 247
Query: 426 LCVQEDPMDRPTMSSV 441
+ RP++ +
Sbjct: 248 RMLNLKDYHRPSVEEI 263
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.9 bits (233), Expect = 3e-22
Identities = 41/143 (28%), Positives = 63/143 (44%), Gaps = 15/143 (10%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIF-SVKSD 358
++ N+LLD N KISDFG+A +F N E N++ GT Y+APE F + D
Sbjct: 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 188
Query: 359 VFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELL 418
V+S G+VL +++G+ PS + W E ++ K LL
Sbjct: 189 VWSCGIVLTAMLAGE------LPWDQPSDSCQEYSDWKEKK--TYLNPWKKIDSAPLALL 240
Query: 419 KYIHIGLLCVQEDPMDRPTMSSV 441
+ E+P R T+ +
Sbjct: 241 H------KILVENPSARITIPDI 257
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.2 bits (231), Expect = 4e-22
Identities = 35/146 (23%), Positives = 57/146 (39%), Gaps = 20/146 (13%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
+ A NVL+ + K+SDFG+ + Q + + APE E FS KSDV
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDV 183
Query: 360 FSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLK 419
+SFG++L EI S + Y ++ + +G+ + D +
Sbjct: 184 WSFGILLWEIYSFGRV--PYPRIPLKDVVPRV----EKGYKMDAPDGCPPAVYE------ 231
Query: 420 YIHIGLLCVQEDPMDRPTMSSVAVML 445
+ C D RP+ + L
Sbjct: 232 ---VMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 2e-21
Identities = 34/146 (23%), Positives = 61/146 (41%), Gaps = 18/146 (12%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
+ A N+L+ KI+DFG++R G + +MA E +++ SDV
Sbjct: 153 LAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDV 209
Query: 360 FSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLK 419
+S+GV+L EI+S + Y L + + G+ E + +
Sbjct: 210 WSYGVLLWEIVSLGGT--PYCGMTCAELYEKLPQ----GYRLEKPLNCDDE--------- 254
Query: 420 YIHIGLLCVQEDPMDRPTMSSVAVML 445
+ C +E P +RP+ + + V L
Sbjct: 255 VYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.3 bits (226), Expect = 7e-21
Identities = 35/169 (20%), Positives = 65/169 (38%), Gaps = 31/169 (18%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
V+ SN+L++ K+ DFG++ + N VGT YM+PE +SV+SD+
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDI 186
Query: 360 FSFGVVLLEIISGK-----------------------KSSGFYHLEHGPSLLAYIWKLWC 396
+S G+ L+E+ G+ + G L +Y
Sbjct: 187 WSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRP 246
Query: 397 EGHAAELMDSVVKQSCDQAELLKY----IHIGLLCVQEDPMDRPTMSSV 441
EL+D +V + + + C+ ++P +R + +
Sbjct: 247 PMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 3e-20
Identities = 39/159 (24%), Positives = 63/159 (39%), Gaps = 17/159 (10%)
Query: 291 CIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME 350
I R + A N+LL H KI DFG+AR + + +MAPE
Sbjct: 165 NCIHRD---LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221
Query: 351 GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQ 410
+++ +SDV+S+G+ L E+ S S G + + +K+ EG + +
Sbjct: 222 CVYTFESDVWSYGIFLWELFSLGSSP-----YPGMPVDSKFYKMIKEGFRMLSPEHAPAE 276
Query: 411 SCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449
I C DP+ RPT + ++ I
Sbjct: 277 ---------MYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 8e-20
Identities = 40/154 (25%), Positives = 62/154 (40%), Gaps = 18/154 (11%)
Query: 292 IIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEG 351
I R + A NVL+ + KI+DFG+AR T +MAPE +
Sbjct: 156 CIHRD---LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 212
Query: 352 IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQS 411
I++ +SDV+SFGV+L EI + + + ++KL EGH + + +
Sbjct: 213 IYTHQSDVWSFGVLLWEIFTLGG------SPYPGVPVEELFKLLKEGHRMDKPSNCTNE- 265
Query: 412 CDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
+ C P RPT + L
Sbjct: 266 --------LYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 87.0 bits (215), Expect = 2e-19
Identities = 37/145 (25%), Positives = 60/145 (41%), Gaps = 24/145 (16%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM---EGIFSVK 356
V+A N+LL K+ DFG A I A N VGT +MAPE + EG + K
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 357 SDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAE 416
DV+S G+ +E+ K + ++ ++ + + + L +
Sbjct: 195 VDVWSLGITCIELAERK------PPLFNMNAMSALYHI-AQNESPALQSGHWSEYF---- 243
Query: 417 LLKYIHIGLLCVQEDPMDRPTMSSV 441
+ C+Q+ P DRPT +
Sbjct: 244 ----RNFVDSCLQKIPQDRPTSEVL 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (212), Expect = 2e-19
Identities = 36/182 (19%), Positives = 66/182 (36%), Gaps = 17/182 (9%)
Query: 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKR-VRASNVLLDHEMNPKISDFGMARIFG 325
R ++ A+ + + LST+ + +R R + A NVL+ K+ DFG++R
Sbjct: 100 VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159
Query: 326 GNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGP 385
+ ++ +MAPE F+ SDV+ FGV + EI+ +
Sbjct: 160 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND- 217
Query: 386 SLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
+ G + + + C DP RP + + L
Sbjct: 218 -----VIGRIENGERLPMPPNCPPTLYS---------LMTKCWAYDPSRRPRFTELKAQL 263
Query: 446 AS 447
++
Sbjct: 264 ST 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.6 bits (209), Expect = 4e-19
Identities = 28/145 (19%), Positives = 56/145 (38%), Gaps = 27/145 (18%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDV 359
++ N+LL KI+DFG + ++ + GT Y+ PE + K D+
Sbjct: 132 IKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDL 187
Query: 360 FSFGVVLLEIISGK---KSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAE 416
+S GV+ E + GK +++ + S + + + + A +L+
Sbjct: 188 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR---------- 237
Query: 417 LLKYIHIGLLCVQEDPMDRPTMSSV 441
++ +P RP + V
Sbjct: 238 ----------LLKHNPSQRPMLREV 252
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.3 bits (208), Expect = 1e-18
Identities = 37/177 (20%), Positives = 70/177 (39%), Gaps = 21/177 (11%)
Query: 267 KRWITIAEAASAIIVFLLSTSFLW--CIIRRRNKRVRASNVLLDHEMNPKISDFGMARIF 324
+ + + A+ L + FL +I R K + N+LL + + K++DFG
Sbjct: 110 ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK---SDNILLGMDGSVKLTDFGFCAQI 166
Query: 325 GGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHG 384
QS+ +T +VGT +MAPE + K D++S G++ +E+I G+
Sbjct: 167 TPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------PPYLN 218
Query: 385 PSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSV 441
+ L ++ + G + + L C+ D R + +
Sbjct: 219 ENPLRALYLIATNGTPELQNPEKLSAIF--RDFLN------RCLDMDVEKRGSAKEL 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.5 bits (206), Expect = 1e-18
Identities = 33/147 (22%), Positives = 64/147 (43%), Gaps = 21/147 (14%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM-----EGIFS 354
++A N+L + + K++DFG++ ++ +GT +MAPE M + +
Sbjct: 136 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYD 193
Query: 355 VKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQ 414
K+DV+S G+ L+E+ + +H + +L I K E S +
Sbjct: 194 YKADVWSLGITLIEMAEIEP---PHHELNPMRVLLKIAK--SEPPTLAQPSRW---SSNF 245
Query: 415 AELLKYIHIGLLCVQEDPMDRPTMSSV 441
+ LK C++++ R T S +
Sbjct: 246 KDFLK------KCLEKNVDARWTTSQL 266
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.6 bits (188), Expect = 4e-16
Identities = 32/151 (21%), Positives = 61/151 (40%), Gaps = 24/151 (15%)
Query: 291 CIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME 350
II R ++ N+LL+ +M+ +I+DFG A++ +A N VGT Y++PE E
Sbjct: 128 GIIHRD---LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 351 GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQ 410
SD+++ G ++ ++++G + G+ + ++K
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGL-------------------PPFRAGNEYLIFQKIIKL 225
Query: 411 SCDQAELLKYIHIGLL--CVQEDPMDRPTMS 439
D E L+ + D R
Sbjct: 226 EYDFPEKFFPKARDLVEKLLVLDATKRLGCE 256
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 76.0 bits (186), Expect = 7e-16
Identities = 24/154 (15%), Positives = 49/154 (31%), Gaps = 17/154 (11%)
Query: 300 VRASNVL---LDHEMNPKISDFGMARIFGGNQSEAN-----TNRVVGTYGYMAPEYAMEG 351
V+ N L I DFG+A+ + ++ + + GT Y + +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 352 IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQS 411
S + D+ S G VL+ G + + ++ + + +
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSL---PWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 412 CDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
+ A L + C D+P S + +
Sbjct: 246 SEFATYLNF------CRSLRFDDKPDYSYLRQLF 273
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.0 bits (181), Expect = 3e-15
Identities = 42/180 (23%), Positives = 68/180 (37%), Gaps = 30/180 (16%)
Query: 266 SKRWITIAEAASAIIVFLLSTSFLWC--IIRRRNKRVRASNVLLDHEMNPKISDFGMARI 323
S ++ A +L FL I+ R K N+LLD + + KI+DFGM +
Sbjct: 96 SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLK---LDNILLDKDGHIKIADFGMCKE 152
Query: 324 FGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGK---KSSGFYH 380
++ NT GT Y+APE + ++ D +SFGV+L E++ G+
Sbjct: 153 NMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 210
Query: 381 LEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSS 440
L H + + W E A +L+ +P R +
Sbjct: 211 LFHSIRMDNPFYPRWLEKEAKDLLVK--------------------LFVREPEKRLGVRG 250
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 73.5 bits (180), Expect = 4e-15
Identities = 38/178 (21%), Positives = 66/178 (37%), Gaps = 18/178 (10%)
Query: 266 SKRWITIAEAASAIIVFLLSTSFLW--CIIRRRNKRVRASNVLLDHEMNPKISDFGMARI 323
K + T +A+ I L + +L I+ R K LD + ISDFG++++
Sbjct: 100 EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159
Query: 324 FGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEH 383
+ GT GY+APE + +S D +S GV+ ++ G ++ E+
Sbjct: 160 EDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP---PFYDEN 213
Query: 384 GPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSV 441
L I K S + ++ +++DP R T
Sbjct: 214 DAKLFEQILK----AEYEFDSPYWDDISDSAKDFIR------HLMEKDPEKRFTCEQA 261
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 72.9 bits (178), Expect = 7e-15
Identities = 18/156 (11%), Positives = 48/156 (30%), Gaps = 19/156 (12%)
Query: 300 VRASNVLLDHEMNP-----KISDFGMARIFGGNQSEAN-----TNRVVGTYGYMAPEYAM 349
++ N L+ + + DFGM + + ++ + + GT YM+ +
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 350 EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK 409
S + D+ + G V + + G + + ++ + + L +
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSL---PWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243
Query: 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVML 445
+ + + Y P + +
Sbjct: 244 FPEEFYKYMHY------ARNLAFDATPDYDYLQGLF 273
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.1 bits (173), Expect = 3e-14
Identities = 33/164 (20%), Positives = 58/164 (35%), Gaps = 22/164 (13%)
Query: 291 CIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAME 350
++ R K N+L+ K++DFG+ARI+ + VV T Y APE ++
Sbjct: 136 RVVHRDLK---PQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQ 189
Query: 351 GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKL--------WCEGHAAE 402
++ D++S G + E+ K + L I + W A
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 403 LMDSVVKQSCDQAELLKYIHIGLL-----CVQEDPMDRPTMSSV 441
K + + + I C+ +P R + S
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.1 bits (173), Expect = 3e-14
Identities = 36/197 (18%), Positives = 71/197 (36%), Gaps = 21/197 (10%)
Query: 263 NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322
N K ++ + +++ L I+ R ++A+NVL+ + K++DFG+AR
Sbjct: 109 NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRD---MKAANVLITRDGVLKLADFGLAR 165
Query: 323 IFGGNQSEANTNR--VVGTYGYMAPEYAM-EGIFSVKSDVFSFGVVLLEIISGK------ 373
F ++ V T Y PE + E + D++ G ++ E+ +
Sbjct: 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225
Query: 374 --KSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH-----IGLL 426
+ + S+ +W E ++ V Q + LK + L+
Sbjct: 226 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI 285
Query: 427 --CVQEDPMDRPTMSSV 441
+ DP R
Sbjct: 286 DKLLVLDPAQRIDSDDA 302
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 69.7 bits (170), Expect = 6e-14
Identities = 32/148 (21%), Positives = 57/148 (38%), Gaps = 22/148 (14%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI------F 353
++ N+LLD +MN K++DFG + + V GT Y+APE + +
Sbjct: 136 LKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGY 192
Query: 354 SVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCD 413
+ D++S GV++ +++G F+H +L I G+ S
Sbjct: 193 GKEVDMWSTGVIMYTLLAGSPP--FWH-RKQMLMLRMI----MSGNYQFGSPEWDDYSDT 245
Query: 414 QAELLKYIHIGLLCVQEDPMDRPTMSSV 441
+L+ + P R T
Sbjct: 246 VKDLVS------RFLVVQPQKRYTAEEA 267
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 69.8 bits (170), Expect = 7e-14
Identities = 35/148 (23%), Positives = 64/148 (43%), Gaps = 16/148 (10%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFG-GNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSD 358
V+ +N+++ K+ DFG+AR S T V+GT Y++PE A +SD
Sbjct: 137 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 196
Query: 359 VFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELL 418
V+S G VL E+++G+ + + S+ + + S + +L
Sbjct: 197 VYSLGCVLYEVLTGEP---PFTGDSPVSVAYQHVR------EDPIPPSARHEGLSA-DLD 246
Query: 419 KYIHIGLLCVQEDPMDRPTMSSVAVMLA 446
+ L + ++P +R + A M A
Sbjct: 247 AVV---LKALAKNPENRY--QTAAEMRA 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.8 bits (170), Expect = 7e-14
Identities = 30/179 (16%), Positives = 67/179 (37%), Gaps = 20/179 (11%)
Query: 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNP----KISDFGMAR 322
++ E A+ + +L+ + ++ + ++ N++L P KI DFG+A
Sbjct: 106 EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165
Query: 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLE 382
+ GT ++APE +++D++S GV+ ++SG + +
Sbjct: 166 KIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---PFLGD 219
Query: 383 HGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSV 441
LA + + + S + ++ + +DP R T+
Sbjct: 220 TKQETLANV----SAVNYEFEDEYFSNTSALAKDFIR------RLLVKDPKKRMTIQDS 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 70.1 bits (171), Expect = 8e-14
Identities = 27/97 (27%), Positives = 45/97 (46%), Gaps = 8/97 (8%)
Query: 278 AIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVV 337
A + L II R ++ N+LLD + KI+DFG A+ +
Sbjct: 111 AEVCLALEYLHSKDIIYRD---LKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLC 162
Query: 338 GTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKK 374
GT Y+APE ++ D +SFG+++ E+++G
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 70.1 bits (171), Expect = 9e-14
Identities = 27/153 (17%), Positives = 56/153 (36%), Gaps = 21/153 (13%)
Query: 291 CIIRRRNKRVRASNVLLDHEMNP--KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYA 348
+ ++ N++ + + K+ DFG+ QS GT + APE A
Sbjct: 144 NYVHLD---LKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVA 197
Query: 349 MEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVV 408
+D++S GV+ ++SG + E+ L + C+ + + S +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSP---FGGENDDETLRNVKS--CDWNMDDSAFSGI 252
Query: 409 KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSV 441
+ + ++ + DP R T+
Sbjct: 253 SEDG--KDFIR------KLLLADPNTRMTIHQA 277
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.5 bits (169), Expect = 1e-13
Identities = 37/191 (19%), Positives = 68/191 (35%), Gaps = 36/191 (18%)
Query: 290 WCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM 349
I+ R K +N+LLD K++DFG+A+ FG V T Y APE
Sbjct: 119 HWILHRDLK---PNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLF 173
Query: 350 E-GIFSVKSDVFSFGVVLLEIISGK----------------KSSGFYHLEHGPSLLAYIW 392
++ V D+++ G +L E++ ++ G E P + +
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 393 KLWCEGHAAELMDSVVKQSCDQA-ELLKYIHIGLLCVQEDPMDRPTMSSVAVM------- 444
+ + + + + D +L++ +P R T + M
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQ------GLFLFNPCARITATQALKMKYFSNRP 287
Query: 445 LASDIVTLPKP 455
+ LP+P
Sbjct: 288 GPTPGCQLPRP 298
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.4 bits (164), Expect = 6e-13
Identities = 32/182 (17%), Positives = 61/182 (33%), Gaps = 23/182 (12%)
Query: 264 KTSKRWITIAEAASAIIVFLLSTSFLWC--IIRRRNKRVRASNVLLDHEMNP--KISDFG 319
TS + E S + + FL I +R N++ + KI +FG
Sbjct: 93 NTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFD---IRPENIIYQTRRSSTIKIIEFG 149
Query: 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFY 379
AR N + Y APE + S +D++S G ++ ++SG +
Sbjct: 150 QARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN---PF 203
Query: 380 HLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMS 439
E ++ I ++ + S + + + + ++ R T S
Sbjct: 204 LAETNQQIIENI----MNAEYTFDEEAFKEISIEAMDFVDR------LLVKERKSRMTAS 253
Query: 440 SV 441
Sbjct: 254 EA 255
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 67.4 bits (164), Expect = 6e-13
Identities = 26/152 (17%), Positives = 53/152 (34%), Gaps = 21/152 (13%)
Query: 292 IIRRRNKRVRASNVLLDHEMNP--KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM 349
I+ ++ N++ + + KI DFG+A ++ T + APE
Sbjct: 148 IVHLD---IKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVD 201
Query: 350 EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK 409
+D+++ GV+ ++SG G L + D+
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLE-TLQNVKRCDWEFDEDAFSS 254
Query: 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSV 441
S + + +K +Q++P R T+
Sbjct: 255 VSPEAKDFIKN------LLQKEPRKRLTVHDA 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 67.4 bits (164), Expect = 8e-13
Identities = 37/140 (26%), Positives = 61/140 (43%), Gaps = 19/140 (13%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI-FSVKSD 358
++ +N+LLD + +ISD G+A F + + VGT+GYMAPE +G+ + +D
Sbjct: 133 LKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSAD 188
Query: 359 VFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELL 418
FS G +L +++ G +H I ++ EL DS + LL
Sbjct: 189 WFSLGCMLFKLLRGH----SPFRQHKTKDKHEIDRMTLTMA-VELPDSFSPELRS---LL 240
Query: 419 KYIHIGLLCVQEDPMDRPTM 438
+ +Q D R
Sbjct: 241 E------GLLQRDVNRRLGC 254
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.3 bits (161), Expect = 9e-13
Identities = 27/144 (18%), Positives = 47/144 (32%), Gaps = 29/144 (20%)
Query: 300 VRASNVLLDHE-MNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAM-EGIFSVKS 357
++ N+L+D K+ DFG + + GT Y PE+ +
Sbjct: 136 IKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSA 191
Query: 358 DVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAEL 417
V+S G++L +++ G F H E ++ L+
Sbjct: 192 AVWSLGILLYDMVCGD--IPFEHDEE-IIRGQVFFRQRVSSECQHLIRW----------- 237
Query: 418 LKYIHIGLLCVQEDPMDRPTMSSV 441
C+ P DRPT +
Sbjct: 238 ---------CLALRPSDRPTFEEI 252
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.9 bits (157), Expect = 5e-12
Identities = 32/161 (19%), Positives = 61/161 (37%), Gaps = 22/161 (13%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANT-NRVVGTYGYMAPEYAMEGIFSVKS- 357
++ SN+LL+ + KI DFG+AR+ + V T Y APE + KS
Sbjct: 135 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 194
Query: 358 DVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAEL 417
D++S G +L E++S + + +H L +I + +L + ++ +
Sbjct: 195 DIWSVGCILAEMLSNRP---IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 251
Query: 418 LKYIHIGLL-----------------CVQEDPMDRPTMSSV 441
L + + + +P R +
Sbjct: 252 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.7 bits (157), Expect = 5e-12
Identities = 27/145 (18%), Positives = 56/145 (38%), Gaps = 15/145 (10%)
Query: 300 VRASNVLLDHEMNP---KISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVK 356
V+ N+L + K++DFG A+ + S T Y+APE +
Sbjct: 137 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKS 193
Query: 357 SDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAE 416
D++S GV++ ++ G ++ HG ++ + G + S +
Sbjct: 194 CDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 250
Query: 417 LLKYIHIGLLCVQEDPMDRPTMSSV 441
L++ ++ +P R T++
Sbjct: 251 LIR------NLLKTEPTQRMTITEF 269
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.0 bits (152), Expect = 1e-11
Identities = 33/223 (14%), Positives = 68/223 (30%), Gaps = 22/223 (9%)
Query: 236 IFCASCSIRYELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRR 295
I + + LV S E + + LL
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 296 RNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSV 355
++ ++ N+L++ K+++FG+AR FG + VV + ++S
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYST 181
Query: 356 KSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 415
D++S G + E+ + + + L I++L G E + + D
Sbjct: 182 SIDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRLL--GTPTEEQWPSMTKLPDYK 237
Query: 416 ELLKYIHIGLL-----------------CVQEDPMDRPTMSSV 441
Y L ++ +P+ R +
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.6 bits (151), Expect = 2e-11
Identities = 36/199 (18%), Positives = 66/199 (33%), Gaps = 32/199 (16%)
Query: 264 KTSKRWITIAEAASAIIVFLLSTSFLW--CIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321
++ I + S + L +F ++ R ++ N+L++ E K++DFG+A
Sbjct: 93 ASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---LKPQNLLINTEGAIKLADFGLA 149
Query: 322 RIFGGNQSEANTNRVVGTYGYMAPE-YAMEGIFSVKSDVFSFGVVLLEIISGK------- 373
R FG V T Y APE +S D++S G + E+++ +
Sbjct: 150 RAFGVPVRTYTH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 374 -KSSGFYHLEHGPSLLAYIWKLWC----------EGHAAELMDSVVKQSCDQAELLKYIH 422
F + +W + + V D LL
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQ-- 265
Query: 423 IGLLCVQEDPMDRPTMSSV 441
+ DP R + +
Sbjct: 266 ----MLHYDPNKRISAKAA 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 61.8 bits (149), Expect = 3e-11
Identities = 37/196 (18%), Positives = 72/196 (36%), Gaps = 26/196 (13%)
Query: 264 KTSKRWITIAEAASAIIVFLLSTSFLW--CIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321
+ + A S ++ L ++ ++ R K N+L++ E KI+DFG+A
Sbjct: 91 DVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK---PQNLLINREGELKIADFGLA 147
Query: 322 RIFGGNQSEANTNRVVGTYGYMAPEYAM-EGIFSVKSDVFSFGVVLLEIISGKKSSGFYH 380
R FG + + T Y AP+ M +S D++S G + E+++G +
Sbjct: 148 RAFGIPVRKYTH--EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP---LFP 202
Query: 381 LEHGPSLLAYIWKLWCEGHAAELMD----------SVVKQSCDQAELLKYIHIGLL---- 426
L I+++ ++ + V + LK + +
Sbjct: 203 GVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS 262
Query: 427 -CVQEDPMDRPTMSSV 441
++ DP R T
Sbjct: 263 KMLKLDPNQRITAKQA 278
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.1 bits (150), Expect = 3e-11
Identities = 26/108 (24%), Positives = 48/108 (44%), Gaps = 2/108 (1%)
Query: 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFG 325
S+ + E A ++S + ++ N++LD + + KI+DFG+ +
Sbjct: 97 SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE-- 154
Query: 326 GNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGK 373
G A GT Y+APE + + D + GVV+ E++ G+
Sbjct: 155 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 53.1 bits (126), Expect = 3e-08
Identities = 18/111 (16%), Positives = 42/111 (37%), Gaps = 1/111 (0%)
Query: 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE-MNPKISDFGMAR 322
K R I + LL ++ + ++ NVL++ + +A
Sbjct: 116 KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD 175
Query: 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGK 373
+ + + + T Y +PE + + +D++S ++ E+I+G
Sbjct: 176 LGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 52.5 bits (125), Expect = 5e-08
Identities = 23/110 (20%), Positives = 48/110 (43%), Gaps = 10/110 (9%)
Query: 266 SKRWITIAEAASAIIVFLLSTSFLW--CIIRRRNKRVRASNVLLDHEMNPKISDFGMARI 323
+ A +L+ +L +I R ++ N+L+D + +++DFG A+
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD---LKPENLLIDQQGYIQVTDFGFAKR 190
Query: 324 FGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGK 373
G + GT +APE + ++ D ++ GV++ E+ +G
Sbjct: 191 VKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.7 bits (123), Expect = 8e-08
Identities = 33/157 (21%), Positives = 63/157 (40%), Gaps = 20/157 (12%)
Query: 300 VRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGI-FSVKSD 358
++ N+ ++ + KI DFG+AR Q+++ V T Y APE + + ++ D
Sbjct: 147 LKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEVILNWMRYTQTVD 201
Query: 359 VFSFGVVLLEIISGK--------KSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK- 409
++S G ++ E+I+GK ++ + A + A M + +
Sbjct: 202 IWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL 261
Query: 410 QSCDQAELLKYIH---IGLL--CVQEDPMDRPTMSSV 441
+ D A +L + LL + D R T
Sbjct: 262 EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (120), Expect = 2e-07
Identities = 24/100 (24%), Positives = 45/100 (45%), Gaps = 3/100 (3%)
Query: 274 EAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANT 333
E S ++ +L ++ ++ SN+++ + KI DFG+AR G +
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 175
Query: 334 NRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGK 373
V T Y APE + + D++S G ++ E++ K
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.2 bits (119), Expect = 2e-07
Identities = 32/150 (21%), Positives = 63/150 (42%), Gaps = 19/150 (12%)
Query: 292 IIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEG 351
II R ++ N+LLD + ++DFG+++ F +++E GT YMAP+ G
Sbjct: 150 IIYRD---IKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGG 205
Query: 352 I--FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVK 409
D +S GV++ E+++G + ++ + A I + + +
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQAEISRRILKSE-PPYPQEM-- 259
Query: 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMS 439
S +L++ + +DP R
Sbjct: 260 -SALAKDLIQ------RLLMKDPKKRLGCG 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.2 bits (119), Expect = 3e-07
Identities = 27/152 (17%), Positives = 46/152 (30%), Gaps = 14/152 (9%)
Query: 302 ASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFS 361
+ +L K+ DFG A+ + E N + + Y ++ DV+S
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWS 208
Query: 362 FGVVLLEIISGKK----SSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAEL 417
G VL E++ G+ SG L +L + + Q
Sbjct: 209 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWT 268
Query: 418 LKYIH------IGLL--CVQEDPMDRPTMSSV 441
+ I L ++ P R T
Sbjct: 269 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 3e-05
Identities = 27/160 (16%), Positives = 58/160 (36%), Gaps = 18/160 (11%)
Query: 294 RRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIF 353
++ ++ SN+ ++ + KI DFG+AR T V + +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHY 196
Query: 354 SVKSDVFSFGVVLLEIISGK--------KSSGFYHLEHGPSLLAYIWKLWCEGHAAELMD 405
+ D++S G ++ E+++G+ L + A + K A +
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 406 SVVKQ-SCDQAELLKYIH---IGLL--CVQEDPMDRPTMS 439
S+ + + A + + + LL + D R T +
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 491 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.95 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.95 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.95 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.95 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.95 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.95 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.95 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.95 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.95 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.95 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.95 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.95 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.94 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.94 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.94 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.94 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.94 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.94 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.94 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.94 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.94 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.94 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.94 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.94 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.94 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.93 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.93 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.93 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.93 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.93 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.93 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.93 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.93 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.93 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.93 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.92 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.92 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.92 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.92 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.92 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.92 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.92 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.92 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.92 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.91 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.91 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.91 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.91 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.91 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.91 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.91 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.9 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.9 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.9 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.89 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.89 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.88 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.87 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.87 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.86 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 98.7 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 87.27 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 81.83 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 80.67 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.3e-31 Score=254.41 Aligned_cols=171 Identities=20% Similarity=0.346 Sum_probs=120.7
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
+......++.+++.++.|||..+++ ||||||+|||++.++.+||+|||+++...............||+.|||
T Consensus 102 ~~~~~~~i~~qi~~gl~yLH~~~iv-------HrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 174 (276)
T d1uwha_ 102 EMIKLIDIARQTAQGMDYLHAKSII-------HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174 (276)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCC
T ss_pred CHHHHHHHHHHHHHHHHHHhcCCEe-------ccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCC
Confidence 3556778899999999999987766 999999999999999999999999987654433333445689999999
Q ss_pred hhhhhh---CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 345 PEYAME---GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 345 PE~~~~---~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
||++.+ +.++.++|||||||++|||++|+.||.... ..... ......+....... .. +......+.
T Consensus 175 PE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~---~~~~~---~~~~~~~~~~p~~~-~~----~~~~~~~l~ 243 (276)
T d1uwha_ 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN---NRDQI---IFMVGRGYLSPDLS-KV----RSNCPKAMK 243 (276)
T ss_dssp HHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC---CHHHH---HHHHHHTSCCCCGG-GS----CTTCCHHHH
T ss_pred HHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC---hHHHH---HHHHhcCCCCCcch-hc----cccchHHHH
Confidence 999964 358999999999999999999999975321 11111 11111111111110 11 112234577
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhhcCCCCCC
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAVMLASDIVTLP 453 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 453 (491)
+|+.+||+.||++|||++||+++|+.....+|
T Consensus 244 ~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 244 RLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 89999999999999999999999987654444
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.8e-30 Score=256.10 Aligned_cols=160 Identities=27% Similarity=0.335 Sum_probs=124.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++++||+|||+++...............||+.||||
T Consensus 163 ~~~~~~i~~qi~~gl~yLH~~~Ii-------HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 235 (325)
T d1rjba_ 163 FEDLLCFAYQVAKGMEFLEFKSCV-------HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 235 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------eccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCCh
Confidence 445667888999999999998777 9999999999999999999999999876554444444457889999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.++.++.++|||||||++|||++ |+.||..... ...+. +....+... +.+......+.+|+
T Consensus 236 E~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~---~~~~~---~~~~~~~~~---------~~p~~~~~~l~~li 300 (325)
T d1rjba_ 236 ESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV---DANFY---KLIQNGFKM---------DQPFYATEEIYIIM 300 (325)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---SHHHH---HHHHTTCCC---------CCCTTCCHHHHHHH
T ss_pred HHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH---HHHHH---HHHhcCCCC---------CCCCcCCHHHHHHH
Confidence 99999999999999999999999998 8999753221 12221 222222111 11112234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhc
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.+||+.||++|||++||+++|..
T Consensus 301 ~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 301 QSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHHHhC
Confidence 99999999999999999999963
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.3e-29 Score=242.40 Aligned_cols=182 Identities=21% Similarity=0.259 Sum_probs=120.8
Q ss_pred eeeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.++.|...+.+.... .........+.++.+++.++.|+|..+++ ||||||+|||++.++++||+|||+
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~ii-------HrDlKp~Nill~~~~~~Kl~DFGl 147 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI-------HRDLAARNCLVGENQVIKVSDFGM 147 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCC-------CTTCSGGGEEECGGGCEEECSCC-
T ss_pred eEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcccee-------ecccchhheeecCCCCeEecccch
Confidence 34566666655443322 12233556778999999999999987766 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
++........ ......||+.|+|||++.+..++.++|||||||++|||+++..|+. .......+...+. .+..
T Consensus 148 a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~--~~~~~~~~~~~i~----~~~~ 220 (263)
T d1sm2a_ 148 TRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY--ENRSNSEVVEDIS----TGFR 220 (263)
T ss_dssp ------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT--CSCCHHHHHHHHH----HTCC
T ss_pred heeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCC--CCCCHHHHHHHHH----hcCC
Confidence 9876543322 2234578999999999999999999999999999999999654432 1122222222221 1111
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
. .. +.....++.+|+.+||+.||++|||++||+++|++.
T Consensus 221 ~--~~-------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 221 L--YK-------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp C--CC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C--CC-------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 11 111234577899999999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6.3e-29 Score=238.34 Aligned_cols=180 Identities=23% Similarity=0.299 Sum_probs=129.2
Q ss_pred eeeeecccccCCCCccccCC--CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 243 IRYELYRFLVDTPTVTVTAP--NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
..|.++.|..++++...... ..+......+..+++.++.+||..+++ ||||||+|||++.++.+||+|||+
T Consensus 77 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~Ii-------HrDiKp~NILl~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 77 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT-------HRDIKPENLLLDERDNLKISDFGL 149 (271)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCCGGGEEECTTCCEEECCCTT
T ss_pred eeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCc-------cCcccHHHEEECCCCCEEEccchh
Confidence 44566777766555443322 223556778899999999999998877 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCC-CcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIF-SVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
++..............+||+.|||||++.+..+ +.++||||+||++|||++|+.||...... ..... . .....
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~~~~-~---~~~~~ 223 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYS-D---WKEKK 223 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT--SHHHH-H---HHTTC
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH--HHHHH-H---HhcCC
Confidence 997754443333445789999999999988776 57899999999999999999998532211 11111 1 11111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
... .+ .... ...+.+|+.+||+.||++|||++|+++
T Consensus 224 ~~~--~~--~~~~----s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 224 TYL--NP--WKKI----DSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTS--TT--GGGS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCC--Cc--cccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 110 00 0111 234567899999999999999999854
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.4e-29 Score=243.29 Aligned_cols=161 Identities=25% Similarity=0.310 Sum_probs=117.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.|||..+++ ||||||+|||++.++++||+|||+++...............||+.|+||
T Consensus 133 ~~~~~~~~~qi~~gl~ylH~~~iv-------HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 205 (299)
T d1ywna1 133 LEHLICYSFQVAKGMEFLASRKCI-------HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 205 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCc-------CCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccch
Confidence 455677889999999999998776 9999999999999999999999999876554444444557899999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCC-CCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGK-KSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.++.++.++|||||||++|||++|. .||... ....... .....+..... +.....++.+++
T Consensus 206 E~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~---~~~~~~~---~~~~~~~~~~~---------~~~~~~~l~~li 270 (299)
T d1ywna1 206 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV---KIDEEFC---RRLKEGTRMRA---------PDYTTPEMYQTM 270 (299)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CCSHHHH---HHHHHTCCCCC---------CTTCCHHHHHHH
T ss_pred hHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC---CHHHHHH---HHHhcCCCCCC---------CccCCHHHHHHH
Confidence 9999999999999999999999999875 455322 1111221 22222221111 111223577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++|||+.||+++|++.
T Consensus 271 ~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 271 LDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHHHHHH
Confidence 999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=8.3e-29 Score=239.35 Aligned_cols=226 Identities=15% Similarity=0.221 Sum_probs=139.2
Q ss_pred EEEEecCCCCCccchhHHHHHHhhccccccCCCCCcEEEce--ecceeeeecccccCCCCccc---cCCCCCCcchhhhH
Q 011196 199 QTTVHCIPDLSKSDCNVCLNSAVAQIPTCSKGKLGARIFCA--SCSIRYELYRFLVDTPTVTV---TAPNKTSKRWITIA 273 (491)
Q Consensus 199 yglaQC~~Dls~~dC~~Cl~~~~~~~~~~~~~~~~g~i~~~--~C~lry~~~~f~~~~~~~~~---~~~~~~~~~~~~~~ 273 (491)
+++-+-..+.+..+-...++++.. +....+-++ .++++. .-.-.|.++.|...+..... ............++
T Consensus 39 vAvK~~~~~~~~~~~~~~~~E~~i-l~~l~H~nI-v~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~ 116 (283)
T d1mqba_ 39 VAIKTLKAGYTEKQRVDFLGEAGI-MGQFSHHNI-IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 116 (283)
T ss_dssp EEEEEECTTCCHHHHHHHHHHHHH-HHTCCCTTB-CCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHH
T ss_pred EEEEEECcccChHHHHHHHHHHHH-HHhcCCCCE-eeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHH
Confidence 344444455555554555554422 222223222 123322 11233445555544332211 12233455677889
Q ss_pred hHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCccc-ccCceeecCCCChhhhhhhCC
Q 011196 274 EAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEA-NTNRVVGTYGYMAPEYAMEGI 352 (491)
Q Consensus 274 ~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~ 352 (491)
.+++.++.|||..+++ ||||||+||||+.++.+||+|||+++......... ......||+.|+|||++.++.
T Consensus 117 ~~i~~gl~~lH~~~ii-------HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 189 (283)
T d1mqba_ 117 RGIAAGMKYLANMNYV-------HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 189 (283)
T ss_dssp HHHHHHHHHHHHTTCC-------CSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCC
T ss_pred HHHHHhhhhccccccc-------cCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCC
Confidence 9999999999987776 99999999999999999999999998765432221 223356899999999999999
Q ss_pred CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCC
Q 011196 353 FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDP 432 (491)
Q Consensus 353 ~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP 432 (491)
++.++|||||||++|||++|..|+.. ...... +......+... ..+......+.+|+.+||+.||
T Consensus 190 ~~~~sDI~S~Gvil~el~t~~~~~~~--~~~~~~----~~~~i~~~~~~---------~~~~~~~~~l~~li~~cl~~~p 254 (283)
T d1mqba_ 190 FTSASDVWSFGIVMWEVMTYGERPYW--ELSNHE----VMKAINDGFRL---------PTPMDCPSAIYQLMMQCWQQER 254 (283)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTT--TCCHHH----HHHHHHTTCCC---------CCCTTCBHHHHHHHHHHTCSST
T ss_pred CCCcccccccHHHHHHHHhCCCCccc--cCCHHH----HHHHHhccCCC---------CCchhhHHHHHHHHHHHCcCCH
Confidence 99999999999999999997666432 111112 22222222111 1122233457789999999999
Q ss_pred CCCCCHHHHHHHhhcC
Q 011196 433 MDRPTMSSVAVMLASD 448 (491)
Q Consensus 433 ~~RPs~~evl~~L~~~ 448 (491)
++||||.||+++|+..
T Consensus 255 ~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 255 ARRPKFADIVSILDKL 270 (283)
T ss_dssp TTSCCHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHH
Confidence 9999999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.9e-29 Score=238.95 Aligned_cols=180 Identities=24% Similarity=0.416 Sum_probs=129.3
Q ss_pred eeecccccCCCCccccC----CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 245 YELYRFLVDTPTVTVTA----PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
|.++.|...+....... ...+....+.++.+++.++.+||..+++ ||||||+||||++++.+||+|||+
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~iv-------HrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI-------HRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc-------cCccchhheeeecccceeeccccc
Confidence 44556655554322111 1234556778899999999999987776 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
++........ ......||+.|+|||++.++.++.++|||||||++|||++|..|+.. ........ .....+..
T Consensus 156 a~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~--~~~~~~~~----~~i~~~~~ 228 (272)
T d1qpca_ 156 ARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP--GMTNPEVI----QNLERGYR 228 (272)
T ss_dssp CEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST--TCCHHHHH----HHHHTTCC
T ss_pred eEEccCCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC--CCCHHHHH----HHHHhcCC
Confidence 9987543322 22345789999999999999999999999999999999997665321 11111222 22222211
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
... .... ...+.+|+.+||+.||++||||+||+++|+.
T Consensus 229 ~~~-----p~~~----~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 229 MVR-----PDNC----PEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC-----cccC----hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 111 1112 2357789999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4e-29 Score=241.52 Aligned_cols=191 Identities=20% Similarity=0.342 Sum_probs=131.0
Q ss_pred eeecccccCCCCcccc----CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 245 YELYRFLVDTPTVTVT----APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
|.++.|+.++...... ....+....+.++.+++.++.+||..+++ ||||||+||||+.++.+||+|||+
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~iv-------H~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV-------HRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEECGGGCEEECCCCT
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhhee-------cccccceEEEECCCCcEEEcccch
Confidence 4566666655432221 12334667788999999999999998777 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
++........ ......||+.|+|||++..+.++.++|||||||++|||++|..|+.. .......... ...+..
T Consensus 160 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~--~~~~~~~~~~----i~~~~~ 232 (285)
T d1fmka3 160 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--GMVNREVLDQ----VERGYR 232 (285)
T ss_dssp TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST--TCCHHHHHHH----HHTTCC
T ss_pred hhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC--CCCHHHHHHH----HHhcCC
Confidence 9876433322 22335789999999999999999999999999999999997766432 1222222222 222211
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCCCCCCC
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIVTLPKPTQP 458 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~~p 458 (491)
.. .+.....++.+++.+||+.||++||++++|+++|+......+.+.+|
T Consensus 233 ~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 233 MP---------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp CC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred CC---------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 11 11122345778999999999999999999999999876555433333
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.95 E-value=6.3e-29 Score=241.95 Aligned_cols=183 Identities=19% Similarity=0.256 Sum_probs=122.3
Q ss_pred eeeeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 243 IRYELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
..|.++.|..++...... .........+.++.+++.++.|||..+++ ||||||+|||++.++.+||+|||
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ii-------HrDlKp~NILl~~~~~~Kl~DFG 173 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV-------HRDLAARNILVNSNLVCKVSDFG 173 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEECTTCCEEECCC-
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCc-------cCccccceEEECCCCcEEECCcc
Confidence 345566666655443222 12234566778899999999999987766 99999999999999999999999
Q ss_pred cceecCCCCccc---ccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHh
Q 011196 320 MARIFGGNQSEA---NTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLW 395 (491)
Q Consensus 320 la~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 395 (491)
+++......... ......||+.|+|||++.++.++.++|||||||++|||++ |+.||.... ..++... .
T Consensus 174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~---~~~~~~~----i 246 (299)
T d1jpaa_ 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT---NQDVINA----I 246 (299)
T ss_dssp ----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHH----H
T ss_pred cceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC---HHHHHHH----H
Confidence 998765433221 1222457899999999999999999999999999999998 899975321 1222222 2
Q ss_pred hcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 396 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 396 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
..+... ..+.+....+.+|+.+||+.||++|||+.||++.|+..
T Consensus 247 ~~~~~~---------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 247 EQDYRL---------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HcCCCC---------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 222111 11222334577899999999999999999999999764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6.6e-29 Score=242.33 Aligned_cols=201 Identities=17% Similarity=0.164 Sum_probs=137.5
Q ss_pred eeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhheeeEE-eEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLSTSFLW-CIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.+++|...+....... .......++.+..+++.++.++|.....+ +.++++||||||+||||+.++.+||+|||++
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 456777777665433321 23345666788999999999999765543 4567889999999999999999999999999
Q ss_pred eecCCCCcc--cccCceeecCCCChhhhhhhCC------CCcccceeehhHHHHHHHhCCCCCCCccCCC--------cc
Q 011196 322 RIFGGNQSE--ANTNRVVGTYGYMAPEYAMEGI------FSVKSDVFSFGVVLLEIISGKKSSGFYHLEH--------GP 385 (491)
Q Consensus 322 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~--------~~ 385 (491)
+........ .......||+.|+|||++.+.. ++.++|||||||++|||++|..|+....... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 877543322 2234568999999999987542 5779999999999999999988764322111 11
Q ss_pred cHHHHHHHHhhcCCccccccchhcCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 386 SLLAYIWKLWCEGHAAELMDSVVKQS-CDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
............+.. ++.+... .+.+....+.+|+.+||+.||++|||+.||+++|+..
T Consensus 236 ~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 112222222222211 1111111 1224456688899999999999999999999999753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.6e-29 Score=243.50 Aligned_cols=181 Identities=24% Similarity=0.317 Sum_probs=130.1
Q ss_pred eeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 245 YELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
|.++.|..++++.... ....+....+.++.+++.++.|||..+++ ||||||+|||++.++.+||+|||+++
T Consensus 83 ~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ii-------HrDlKp~Nill~~~~~~kl~DFGla~ 155 (277)
T d1xbba_ 83 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV-------HRDLAARNVLLVTQHYAKISDFGLSK 155 (277)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcc-------cCCCcchhhcccccCcccccchhhhh
Confidence 3455555444332221 12234566788999999999999998777 99999999999999999999999998
Q ss_pred ecCCCCcc-cccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 323 IFGGNQSE-ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 323 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
........ .......||+.|+|||++.++.++.++|||||||++|||++ |+.||.... ..+ +......+..
T Consensus 156 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~---~~~----~~~~i~~~~~ 228 (277)
T d1xbba_ 156 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSE----VTAMLEKGER 228 (277)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHH----HHHHHHTTCC
T ss_pred hccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC---HHH----HHHHHHcCCC
Confidence 76543322 22334578999999999999999999999999999999998 899975321 112 2222222221
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.. .+......+.+|+.+||+.||++|||+++|+++|+..
T Consensus 229 ~~---------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 229 MG---------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CC---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CC---------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 11 1112234577899999999999999999999988753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.95 E-value=1.6e-29 Score=244.72 Aligned_cols=182 Identities=22% Similarity=0.297 Sum_probs=131.5
Q ss_pred eeecccccCCCCcccc----CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 245 YELYRFLVDTPTVTVT----APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
|.++.|...+...... ...........++.+++.++.|||..+++ ||||||+|||++.++.+||+|||+
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~ii-------HrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI-------HRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEECGGGCEEECCCCC
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcc-------cCccccCeEEECCCCcEEEccccc
Confidence 4555666555443221 12233456677889999999999987766 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
++........ ......|++.|+|||++.++.++.++|||||||++|||++|..|+.. .... ..+......+..
T Consensus 162 a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~--~~~~----~~~~~~i~~~~~ 234 (287)
T d1opja_ 162 SRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP--GIDL----SQVYELLEKDYR 234 (287)
T ss_dssp TTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST--TCCH----HHHHHHHHTTCC
T ss_pred eeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC--cchH----HHHHHHHhcCCC
Confidence 9876543322 22345789999999999999999999999999999999997776421 1111 122222222211
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
.+ .+.....++.+|+.+||+.||++|||+.||+++|+...
T Consensus 235 ~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 235 ME---------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CC---------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11 11122345778999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.4e-29 Score=243.11 Aligned_cols=182 Identities=23% Similarity=0.280 Sum_probs=133.8
Q ss_pred eeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 245 YELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
|.++.|..++++.... ....+......++.+++.++.|||..+++ ||||||+|||++.++.+||+|||++
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~ii-------HrDlKp~Nill~~~~~~Kl~DFGla 156 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV-------HRDLAARNVLLVNRHYAKISDFGLS 156 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCee-------cCcCchhheeeccCCceeeccchhh
Confidence 4555665554443221 11233556778899999999999998777 9999999999999999999999999
Q ss_pred eecCCCCcc-cccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCC
Q 011196 322 RIFGGNQSE-ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGH 399 (491)
Q Consensus 322 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 399 (491)
+........ .......||+.|+|||++.++.++.++|||||||++|||++ |+.||.... ..++. .....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~---~~~~~----~~i~~~~ 229 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVM----AFIEQGK 229 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---THHHH----HHHHTTC
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC---HHHHH----HHHHcCC
Confidence 987554322 22334568999999999999999999999999999999998 899975322 22222 2222222
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 400 AAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 400 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
..+. +......+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 230 ~~~~---------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 230 RMEC---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp CCCC---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC---------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2211 1122345778999999999999999999999998653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.9e-28 Score=237.51 Aligned_cols=177 Identities=20% Similarity=0.321 Sum_probs=129.3
Q ss_pred eeeecccccCCCCccccC-CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcce
Q 011196 244 RYELYRFLVDTPTVTVTA-PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.|.++.|..++....... ..........++.+++.++.|||..+++ ||||||+|||++.++.+||+|||+++
T Consensus 92 ~~ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ii-------HrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI-------HRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp EEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCc-------ccCCcHHHeEECCCCcEeeccchhhe
Confidence 456677776655433221 2234556778899999999999998877 99999999999999999999999998
Q ss_pred ecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccc
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAE 402 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (491)
.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... . .............. .
T Consensus 165 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~---~~~~~~~~~~~~~~-~ 235 (293)
T d1yhwa1 165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE---N---PLRALYLIATNGTP-E 235 (293)
T ss_dssp ECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS---C---HHHHHHHHHHHCSC-C
T ss_pred eeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC---C---HHHHHHHHHhCCCC-C
Confidence 7654332 233467999999999999999999999999999999999999997422 1 11222222222111 1
Q ss_pred cccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 403 LMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 403 ~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
+.. +......+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~-------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 LQN-------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CSS-------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCC-------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 1111245678999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.8e-29 Score=245.70 Aligned_cols=160 Identities=21% Similarity=0.329 Sum_probs=120.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.|||..+++ ||||||+|||++.++.+||+|||+++...............||+.|+||
T Consensus 110 ~~~~~~i~~qi~~gl~yLH~~~ii-------HrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 182 (317)
T d1xkka_ 110 SQYLLNWCVQIAKGMNYLEDRRLV-------HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182 (317)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCH
T ss_pred HHHHHHHHHHHHHHHHHHHHcCcc-------cCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccCh
Confidence 455677889999999999987766 9999999999999999999999999987654444444456789999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.++.++.++|||||||++|||++ |+.||.... ...+...+. .+... ..+......+.+|+
T Consensus 183 E~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~---~~~~~~~i~----~~~~~---------~~p~~~~~~~~~li 246 (317)
T d1xkka_ 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEISSILE----KGERL---------PQPPICTIDVYMIM 246 (317)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---GGGHHHHHH----HTCCC---------CCCTTBCHHHHHHH
T ss_pred HHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC---HHHHHHHHH----cCCCC---------CCCcccCHHHHHHH
Confidence 99999999999999999999999998 788865322 222222221 11111 11112234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++|||+.||++.|+..
T Consensus 247 ~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 247 VKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhCCCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999988654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.7e-29 Score=237.67 Aligned_cols=172 Identities=17% Similarity=0.217 Sum_probs=127.1
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++...... ...........++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~iv-------HrDiKp~Nill~~~~~~kl~DFG~a 153 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI-------HRDIKPENLLLGSAGELKIADFGWS 153 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEECTTSCEEECCCCSC
T ss_pred EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCee-------eeeeccccceecCCCCEeeccccee
Confidence 35666666655543222 12234566778899999999999998777 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... .... .+.........
T Consensus 154 ~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~----~~~~i~~~~~~ 222 (263)
T d2j4za1 154 VHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQE----TYKRISRVEFT 222 (263)
T ss_dssp SCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHH----HHHHHHTTCCC
T ss_pred eecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC---CHHH----HHHHHHcCCCC
Confidence 8654332 22357999999999999999999999999999999999999997532 1111 22222222110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+......+.+++.+||+.||++|||++|+++
T Consensus 223 ----------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 ----------FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11112235677899999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=7.1e-29 Score=237.87 Aligned_cols=180 Identities=20% Similarity=0.208 Sum_probs=119.5
Q ss_pred eeeecccccCCCCcccc------CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEec
Q 011196 244 RYELYRFLVDTPTVTVT------APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISD 317 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~D 317 (491)
-|.++.|..++++.... .........+.++.+++.++.|||..+.. ..+++||||||+|||++.++.+||+|
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~--~~~IiHrDiKp~NIll~~~~~vkl~D 157 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG--GHTVLHRDLKPANVFLDGKQNVKLGD 157 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC-----------CCGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCC--CCCEEeCcCchhhcCcCCCCcEEEee
Confidence 35667777655543221 12233556778899999999999976421 12456999999999999999999999
Q ss_pred cCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 318 FGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 318 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ...++. .....
T Consensus 158 FG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~---~~~~~~----~~i~~ 228 (269)
T d2java1 158 FGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELA----GKIRE 228 (269)
T ss_dssp HHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHH----HHHHH
T ss_pred ccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC---CHHHHH----HHHHc
Confidence 999987654322 223468999999999999999999999999999999999999997532 111222 22222
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
+....+. ..++ ..+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~-----~~~s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 229 GKFRRIP-----YRYS----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp TCCCCCC-----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCC-----cccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 2222111 1122 34678899999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.94 E-value=1.1e-28 Score=240.61 Aligned_cols=160 Identities=23% Similarity=0.314 Sum_probs=122.1
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.+++|+|..+++ ||||||+|||++.++.+||+|||+++...............|++.|+||
T Consensus 139 ~~~~~~i~~qi~~gl~ylH~~~iv-------HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aP 211 (301)
T d1lufa_ 139 CAEQLCIARQVAAGMAYLSERKFV-------HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 211 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred HHHHHHHHHHHHHHhhhcccCCeE-------eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCH
Confidence 456778899999999999988777 9999999999999999999999999876544433344456789999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCC-CCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKK-SSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++|||||||++|||++|.. |+.. ....+... ....+...+. +.....++.+|+
T Consensus 212 E~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~---~~~~e~~~----~v~~~~~~~~---------p~~~~~~~~~li 275 (301)
T d1lufa_ 212 ESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG---MAHEEVIY----YVRDGNILAC---------PENCPLELYNLM 275 (301)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT---SCHHHHHH----HHHTTCCCCC---------CTTCCHHHHHHH
T ss_pred HHHccCCCChhhhhccchhhHHHHHccCCCCCCC---CCHHHHHH----HHHcCCCCCC---------CccchHHHHHHH
Confidence 99999999999999999999999999864 5432 12222222 2222322211 112234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++||||.||+++|++.
T Consensus 276 ~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 276 RLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHcCCChhHCcCHHHHHHHHHHh
Confidence 999999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4.9e-28 Score=231.99 Aligned_cols=175 Identities=17% Similarity=0.226 Sum_probs=122.6
Q ss_pred eeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeecccccccccccc-CCCCceEeccCcc
Q 011196 245 YELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLD-HEMNPKISDFGMA 321 (491)
Q Consensus 245 y~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~-~~~~~kl~DfGla 321 (491)
|.++.|..++++..... ..........++.+++.++.|||..+ .+++||||||+|||++ +++.+||+|||++
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-----~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-----PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-----SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-----CCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 55667766655433221 22334556778899999999999865 1134999999999996 5789999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+...... .....||+.|+|||++.+ +++.++|||||||++|||++|+.||.... . ...+.+....+...
T Consensus 163 ~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~----~~~~~~~i~~~~~~ 231 (270)
T d1t4ha_ 163 TLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--N----AAQIYRRVTSGVKP 231 (270)
T ss_dssp GGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--S----HHHHHHHHTTTCCC
T ss_pred eeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc--c----HHHHHHHHHcCCCC
Confidence 8643322 234679999999998864 69999999999999999999999974211 1 11222222222211
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.. .....+ .++.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~----~~~~~~----~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 AS----FDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GG----GGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc----cCccCC----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11 111122 24667899999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=6.1e-29 Score=240.57 Aligned_cols=176 Identities=15% Similarity=0.224 Sum_probs=124.0
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++.+.... ...........++.+++.++.++|..+++ ||||||+|||+++++.+||+|||++
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~ii-------HrDiKp~NIll~~~~~vkl~DFG~a 155 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGII-------HRDLKPENILLNEDMHIQITDFGTA 155 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEE-------cCcCCccccccCCCceEEecccccc
Confidence 35566666554432221 12233556777888999999999998877 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+.+.............||+.|+|||++.+..++.++||||+||++|||++|+.||... +...+. ........
T Consensus 156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~----~~i~~~~~- 227 (288)
T d1uu3a_ 156 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIF----QKIIKLEY- 227 (288)
T ss_dssp EECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHH----HHHHTTCC-
T ss_pred eecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc---CHHHHH----HHHHcCCC-
Confidence 9875444333444568999999999999999999999999999999999999997532 111111 11222211
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+ .... ...+.+|+.+||+.||++|||++|++.
T Consensus 228 ~~-----p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 DF-----PEKF----FPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CC-----CTTC----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CC-----CccC----CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 11 1112 234678999999999999999998643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.6e-28 Score=235.32 Aligned_cols=160 Identities=28% Similarity=0.336 Sum_probs=126.2
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.|||..+++ ||||||+|||++.++.+||+|||+++...............|++.|+||
T Consensus 134 ~~~~~~~~~qi~~al~ylH~~~iv-------HrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 206 (299)
T d1fgka_ 134 SKDLVSCAYQVARGMEYLASKKCI-------HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 206 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCH
T ss_pred HHHHHHHHHHHHHHHHHhhhCCEE-------eeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhh
Confidence 455778899999999999998877 9999999999999999999999999977655444445557889999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.++.++.++|||||||++|||++ |..||.... ...++..+..+...+. +.....++.+|+
T Consensus 207 E~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~-------~~~~~~~i~~~~~~~~---------p~~~~~~l~~li 270 (299)
T d1fgka_ 207 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------VEELFKLLKEGHRMDK---------PSNCTNELYMMM 270 (299)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHHHHHTTCCCCC---------CSSCCHHHHHHH
T ss_pred hHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC-------HHHHHHHHHcCCCCCC---------CccchHHHHHHH
Confidence 99999999999999999999999998 677764221 1223333333322221 111224577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++|||+.||++.|++.
T Consensus 271 ~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 271 RDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHHHHHH
Confidence 999999999999999999999865
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.3e-28 Score=240.61 Aligned_cols=124 Identities=23% Similarity=0.311 Sum_probs=95.2
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhhe-eeEEeEEeeeccccccccccccCCCCceEeccCc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLST-SFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGM 320 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGl 320 (491)
.|.++.|..++.+.... ...........++.+++.++.|||.. +++ ||||||+|||++.++.+||+|||+
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~Ii-------HRDiKP~NILl~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM-------HRDVKPSNILVNSRGEIKLCDFGV 151 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCC-------CSCCSGGGEEECTTCCEEECCCCC
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEE-------ccccCHHHeeECCCCCEEEeeCCC
Confidence 34555665544432221 11233455667888888999999864 555 999999999999999999999999
Q ss_pred ceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCC
Q 011196 321 ARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGF 378 (491)
Q Consensus 321 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~ 378 (491)
++..... .....+||+.|+|||++.+.+|+.++||||+||+++||++|+.||..
T Consensus 152 a~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 152 SGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp CHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred ccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9865322 22346899999999999999999999999999999999999999854
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2e-28 Score=233.27 Aligned_cols=158 Identities=23% Similarity=0.347 Sum_probs=121.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++........ ......||+.|+||
T Consensus 99 ~~~~~~i~~qi~~gl~~LH~~~ii-------H~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aP 170 (258)
T d1k2pa_ 99 TQQLLEMCKDVCEAMEYLESKQFL-------HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPP 170 (258)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTBC-------CSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHhhcCcc-------cccccceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCCc
Confidence 456778899999999999987777 9999999999999999999999999876543322 23346789999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.+..++.++|||||||++|||++ |+.||.... ..++.. ....+... ..+ ......+.+++
T Consensus 171 E~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~---~~~~~~----~i~~~~~~--~~p-------~~~~~~l~~li 234 (258)
T d1k2pa_ 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETAE----HIAQGLRL--YRP-------HLASEKVYTIM 234 (258)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHHH----HHHTTCCC--CCC-------TTCCHHHHHHH
T ss_pred HHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC---HHHHHH----HHHhCCCC--CCc-------ccccHHHHHHH
Confidence 99999999999999999999999998 788875322 222222 22222111 111 11224577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhc
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
.+||+.||++|||++||++.|..
T Consensus 235 ~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 235 YSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHccCCHhHCcCHHHHHHHhhC
Confidence 99999999999999999999854
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=8.3e-28 Score=232.59 Aligned_cols=179 Identities=19% Similarity=0.262 Sum_probs=127.8
Q ss_pred ceeeeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEecc
Q 011196 242 SIRYELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDF 318 (491)
Q Consensus 242 ~lry~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~Df 318 (491)
...|.++.|..++.+.... ....+......++.+++.++.|||..+++ ||||||+|||++.++.+||+||
T Consensus 82 ~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~iv-------HrDiKp~NIll~~~~~~Kl~DF 154 (288)
T d2jfla1 82 NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII-------HRDLKAGNILFTLDGDIKLADF 154 (288)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECTTSCEEECCC
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEE-------EeecChhheeECCCCCEEEEec
Confidence 3445677777665543321 12234566788999999999999998877 9999999999999999999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhh-----hCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHH
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAM-----EGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWK 393 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 393 (491)
|+++...... .......||+.|+|||++. +..++.++|||||||++|||++|+.||... ........+..
T Consensus 155 G~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~---~~~~~~~~i~~ 229 (288)
T d2jfla1 155 GVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL---NPMRVLLKIAK 229 (288)
T ss_dssp TTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS---CGGGHHHHHHH
T ss_pred hhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC---CHHHHHHHHHc
Confidence 9997653221 1223467999999999984 456889999999999999999999997532 22222222221
Q ss_pred HhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 394 LWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 394 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
+....+..+ ......+.+|+.+||+.||++|||+.|+++
T Consensus 230 ----~~~~~~~~~-------~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 230 ----SEPPTLAQP-------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----SCCCCCSSG-------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCCCCCCcc-------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111111 111235678999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=9.9e-28 Score=233.61 Aligned_cols=172 Identities=19% Similarity=0.194 Sum_probs=121.6
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++........ .....||+.|+|
T Consensus 98 ~~~~~~~~~~qil~aL~~lH~~~ii-------HrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~~~~~gt~~y~a 168 (299)
T d1ua2a_ 98 TPSHIKAYMLMTLQGLEYLHQHWIL-------HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRA 168 (299)
T ss_dssp CSSHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCC
T ss_pred CHHHHHHHHHHHHHHHHHhhcccee-------cccCCcceEEecCCCccccccCccccccCCCccc--ccceecChhhcc
Confidence 3566778899999999999998877 9999999999999999999999999866443222 234578999999
Q ss_pred hhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccc------h---hcCCCCH
Q 011196 345 PEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDS------V---VKQSCDQ 414 (491)
Q Consensus 345 PE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~------~---l~~~~~~ 414 (491)
||++..+ .++.++|||||||++|||++|+.||... ...+.+..+.+...........+. . .....+.
T Consensus 169 PE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~---~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
T d1ua2a_ 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD---SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPL 245 (299)
T ss_dssp HHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCH
T ss_pred HHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC---CHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCCh
Confidence 9998765 5799999999999999999999997532 222333333332211111000000 0 0000111
Q ss_pred -----HHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcC
Q 011196 415 -----AELLKYIHIGLLCVQEDPMDRPTMSSVAV--MLASD 448 (491)
Q Consensus 415 -----~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~ 448 (491)
.....+.+|+.+||+.||++|||++|+++ ++++.
T Consensus 246 ~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 246 HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred HHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 11245788999999999999999999986 35443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.5e-28 Score=234.79 Aligned_cols=160 Identities=24% Similarity=0.310 Sum_probs=112.7
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.....+.++.+++.++.++|..+++ ||||||+||+++.++.+||+|||+++........ ......||+.|+|
T Consensus 106 ~~~~~~~~~~qi~~gl~ylH~~~ii-------HrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~a 177 (273)
T d1mp8a_ 106 DLASLILYAYQLSTALAYLESKRFV-------HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMA 177 (273)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEEEETTEEEECC--------------------CCGGGCC
T ss_pred CHHHHHHHHHHHHHHhhhhcccCee-------ccccchhheeecCCCcEEEccchhheeccCCcce-eccceecCcccch
Confidence 3556778889999999999998777 9999999999999999999999999876433222 2334578999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.++.++.++|||||||++|||++ |.+|+.... ...+...+. .+....+ +......+.+|
T Consensus 178 pE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~---~~~~~~~i~----~~~~~~~---------~~~~~~~~~~l 241 (273)
T d1mp8a_ 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---NNDVIGRIE----NGERLPM---------PPNCPPTLYSL 241 (273)
T ss_dssp HHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGGHHHHHH----TTCCCCC---------CTTCCHHHHHH
T ss_pred hhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC---HHHHHHHHH----cCCCCCC---------CCCCCHHHHHH
Confidence 999999999999999999999999998 888875332 233333222 2211111 11223457789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 424 GLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
+.+||+.||++|||+.||++.|++.
T Consensus 242 i~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 242 MTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 9999999999999999999999764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.2e-27 Score=229.80 Aligned_cols=162 Identities=25% Similarity=0.340 Sum_probs=120.9
Q ss_pred CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCccc-ccCceeecCCC
Q 011196 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEA-NTNRVVGTYGY 342 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y 342 (491)
........++.+++.++.|||..+++ ||||||+|||++.++.+||+|||+++......... ......|+..|
T Consensus 108 l~~~~~~~~~~qi~~gl~ylH~~~ii-------HrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~ 180 (273)
T d1u46a_ 108 FLLGTLSRYAVQVAEGMGYLESKRFI-------HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180 (273)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHhhhCCEe-------eeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCccc
Confidence 34566778899999999999998777 99999999999999999999999999875443322 22345678899
Q ss_pred ChhhhhhhCCCCcccceeehhHHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHH
Q 011196 343 MAPEYAMEGIFSVKSDVFSFGVVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 421 (491)
Q Consensus 343 ~aPE~~~~~~~s~~sDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 421 (491)
+|||++.+..++.++|||||||++|||++ |+.||... ..... .......+...+.. ... ...+.
T Consensus 181 ~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~---~~~~~---~~~i~~~~~~~~~~-----~~~----~~~l~ 245 (273)
T d1u46a_ 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQI---LHKIDKEGERLPRP-----EDC----PQDIY 245 (273)
T ss_dssp CCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHH---HHHHHTSCCCCCCC-----TTC----CHHHH
T ss_pred CCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc---CHHHH---HHHHHhCCCCCCCc-----ccc----cHHHH
Confidence 99999999999999999999999999998 89997422 22222 22222222111111 112 23577
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhhc
Q 011196 422 HIGLLCVQEDPMDRPTMSSVAVMLAS 447 (491)
Q Consensus 422 ~l~~~cl~~dP~~RPs~~evl~~L~~ 447 (491)
+|+.+||+.||++|||+.||++.|++
T Consensus 246 ~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 246 NVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 89999999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.5e-26 Score=226.08 Aligned_cols=161 Identities=23% Similarity=0.348 Sum_probs=124.4
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||...++ ||||||+|||++.++++||+|||+++...............||+.|+||
T Consensus 132 ~~~~~~i~~~ia~gl~~LH~~~iv-------HrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aP 204 (308)
T d1p4oa_ 132 LSKMIQMAGEIADGMAYLNANKFV-------HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204 (308)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCB-------CSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHhhCCee-------eceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCH
Confidence 445677888999999999987766 9999999999999999999999999877554444444556899999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCC-CCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGK-KSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|.+.++.++.++||||||+++|||++|. .|+.. ....... .....+...+.. ......+.+|+
T Consensus 205 e~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~---~~~~~~~----~~i~~~~~~~~p---------~~~~~~l~~li 268 (308)
T d1p4oa_ 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQVL----RFVMEGGLLDKP---------DNCPDMLFELM 268 (308)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT---SCHHHHH----HHHHTTCCCCCC---------TTCCHHHHHHH
T ss_pred HHHccCCCCcccccccHHHHHHHHHhCCCCCCCC---CCHHHHH----HHHHhCCCCCCc---------ccchHHHHHHH
Confidence 9999999999999999999999999985 55432 1212222 222222222211 11224578899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
.+||+.||++|||+.||+++|++..
T Consensus 269 ~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 269 RMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHcCCChhHCcCHHHHHHHHHHhc
Confidence 9999999999999999999998873
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3e-27 Score=231.18 Aligned_cols=186 Identities=22% Similarity=0.277 Sum_probs=132.2
Q ss_pred eeeeecccccCCCCcccc---CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 243 IRYELYRFLVDTPTVTVT---APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
..|.++.|..++...... .........+.++.+++.++.++|..+++ ||||||+|||+++++.+||+|||
T Consensus 103 ~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~ii-------HrDLK~~NILl~~~~~~kL~DFG 175 (311)
T d1r0pa_ 103 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV-------HRDLAARNCMLDEKFTVKVADFG 175 (311)
T ss_dssp EEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEECTTCCEEECSSG
T ss_pred ceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcc-------cCCccHHhEeECCCCCEEEeccc
Confidence 345666776665543322 11222445667888999999999988777 99999999999999999999999
Q ss_pred cceecCCCCcc--cccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 320 MARIFGGNQSE--ANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 320 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
+++........ .......||..|+|||.+..+.++.++||||||+++|||++|..|+.... ...+....+. .
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~--~~~~~~~~i~----~ 249 (311)
T d1r0pa_ 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLL----Q 249 (311)
T ss_dssp GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH----T
T ss_pred chhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC--CHHHHHHHHH----c
Confidence 99876543222 12233578999999999999999999999999999999999888754221 2222222221 1
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDIV 450 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 450 (491)
+.... .+ ......+.+|+.+||+.||++||+|.||+++|++...
T Consensus 250 g~~~~--~p-------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 250 GRRLL--QP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp TCCCC--CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCC--Cc-------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 21111 11 1122457789999999999999999999999987743
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.93 E-value=2.2e-27 Score=231.71 Aligned_cols=179 Identities=17% Similarity=0.180 Sum_probs=117.5
Q ss_pred eeeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeecccccccccccc---CCCCceEec
Q 011196 243 IRYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLD---HEMNPKISD 317 (491)
Q Consensus 243 lry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~---~~~~~kl~D 317 (491)
..|.++.|..++++..... ...+......++.+++.++.|||..+++ ||||||+|||+. +++.+||+|
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~ii-------HrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV-------HRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceee-------eEEecccceeecccCCCceEEEec
Confidence 3466777776655433321 2234566778899999999999998777 999999999994 578999999
Q ss_pred cCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 318 FGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 318 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+. .....
T Consensus 154 FG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~----~~i~~ 223 (307)
T d1a06a_ 154 FGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLF----EQILK 223 (307)
T ss_dssp C---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHH----HHHHT
T ss_pred cceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC---CHHHHH----HHHhc
Confidence 999986643322 23467999999999999999999999999999999999999997531 111111 22222
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.... . ........ ...+.+|+.+||+.||++|||+.|++++
T Consensus 224 ~~~~-~-~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 224 AEYE-F-DSPYWDDI----SDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TCCC-C-CTTTTTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCCC-C-CCccccCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111 0 01111112 2457789999999999999999999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=8.8e-28 Score=229.20 Aligned_cols=209 Identities=19% Similarity=0.238 Sum_probs=138.3
Q ss_pred cchhHHHHHHhhccccccCCCCCcEEEceec---ceeeeecccccCCCCccccCC----CCCCcchhhhHhHHHHHHHHH
Q 011196 211 SDCNVCLNSAVAQIPTCSKGKLGARIFCASC---SIRYELYRFLVDTPTVTVTAP----NKTSKRWITIAEAASAIIVFL 283 (491)
Q Consensus 211 ~dC~~Cl~~~~~~~~~~~~~~~~g~i~~~~C---~lry~~~~f~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l 283 (491)
+....++..=+..+....+-++ .++++... .-.|.++.|+.++........ .......+.++.+++.++.||
T Consensus 41 ~~~~~~~~~E~~~l~~l~HpnI-v~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~yl 119 (262)
T d1byga_ 41 DATAQAFLAEASVMTQLRHSNL-VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119 (262)
T ss_dssp CC--HHHHHTHHHHTTCCCTTB-CCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCE-eeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccc
Confidence 3445566555555555544333 23333221 123677788776655433211 123556778899999999999
Q ss_pred hheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehh
Q 011196 284 LSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFG 363 (491)
Q Consensus 284 ~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~G 363 (491)
|...++ ||||||+|||++.++.+||+|||+++...... ....++..|+|||++.+++++.++||||||
T Consensus 120 H~~~iv-------H~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG 187 (262)
T d1byga_ 120 EGNNFV-------HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFG 187 (262)
T ss_dssp HHTTCC-------CSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHH
T ss_pred ccCcee-------ccccchHhheecCCCCEeecccccceecCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHH
Confidence 987766 99999999999999999999999998654322 234678999999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 011196 364 VVLLEIIS-GKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVA 442 (491)
Q Consensus 364 vvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl 442 (491)
|++|||++ |+.|+.. ....++...+ ..+...+ .+.....++.+|+.+||+.||++|||+.||+
T Consensus 188 ~il~el~t~~~~p~~~---~~~~~~~~~i----~~~~~~~---------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~ 251 (262)
T d1byga_ 188 ILLWEIYSFGRVPYPR---IPLKDVVPRV----EKGYKMD---------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251 (262)
T ss_dssp HHHHHHHTTSCCSCTT---SCGGGHHHHH----TTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHCCCCCCCC---CCHHHHHHHH----HcCCCCC---------CCccCCHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 99999998 6776542 2222333322 1221111 1122224567899999999999999999999
Q ss_pred HHhhcC
Q 011196 443 VMLASD 448 (491)
Q Consensus 443 ~~L~~~ 448 (491)
++|+..
T Consensus 252 ~~L~~i 257 (262)
T d1byga_ 252 EQLEHI 257 (262)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999753
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.4e-27 Score=232.14 Aligned_cols=161 Identities=24% Similarity=0.357 Sum_probs=124.0
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...............||+.|+||
T Consensus 144 ~~~~~~~~~qi~~gl~~LH~~~iv-------HrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aP 216 (311)
T d1t46a_ 144 LEDLLSFSYQVAKGMAFLASKNCI-------HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCee-------ecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCH
Confidence 456778899999999999998877 9999999999999999999999999987655444445567899999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCC-CCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKS-SGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|++.++.++.++|||||||++|||+++..| +... .....+. +....+... ..+......+.+|+
T Consensus 217 E~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~---~~~~~~~---~~i~~~~~~---------~~~~~~~~~l~~Li 281 (311)
T d1t46a_ 217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM---PVDSKFY---KMIKEGFRM---------LSPEHAPAEMYDIM 281 (311)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---CSSHHHH---HHHHHTCCC---------CCCTTSCHHHHHHH
T ss_pred HHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC---CHHHHHH---HHHhcCCCC---------CCcccccHHHHHHH
Confidence 999999999999999999999999995544 3221 1222222 222222111 11111234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.+||+.||++|||+.||+++|++.
T Consensus 282 ~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 282 KTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHHHHHh
Confidence 999999999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.93 E-value=7.1e-27 Score=232.07 Aligned_cols=180 Identities=16% Similarity=0.186 Sum_probs=130.0
Q ss_pred ceeeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC--CCCceEe
Q 011196 242 SIRYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH--EMNPKIS 316 (491)
Q Consensus 242 ~lry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~--~~~~kl~ 316 (491)
.-.|.++.|+.++.+..... ..........++.+++.++.+||..+++ ||||||+|||++. ++.+||+
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~ii-------HrDiKp~NIll~~~~~~~vkL~ 168 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV-------HLDLKPENIMFTTKRSNELKLI 168 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEESSTTSCCEEEC
T ss_pred CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCe-------eeeechhHeeeccCCCCeEEEe
Confidence 34566777777665533321 1234566778899999999999998877 9999999999964 5789999
Q ss_pred ccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh
Q 011196 317 DFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC 396 (491)
Q Consensus 317 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 396 (491)
|||+++.+..... .....||+.|||||++.+..++.++|||||||++|||++|+.||... ........+ .
T Consensus 169 DFG~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i----~ 238 (350)
T d1koaa2 169 DFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNV----K 238 (350)
T ss_dssp CCTTCEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH----H
T ss_pred ecchheecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHH----H
Confidence 9999987654332 23467899999999999999999999999999999999999997532 222222222 1
Q ss_pred cCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 397 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 397 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..... . +.......+ ..+.+|+.+||+.||++|||+.|++++
T Consensus 239 ~~~~~-~-~~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 239 SCDWN-M-DDSAFSGIS----EDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HTCCC-S-CCGGGGGCC----HHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred hCCCC-C-CcccccCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11110 0 111111122 346788999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=4.5e-27 Score=229.93 Aligned_cols=158 Identities=23% Similarity=0.277 Sum_probs=118.4
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.++|..+++ ||||||+|||++.++.+||+|||+++...... ......||..|+||
T Consensus 126 ~~~~~~~~~qia~gl~~lH~~~ii-------HrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aP 195 (309)
T d1fvra_ 126 SQQLLHFAADVARGMDYLSQKQFI-------HRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAI 195 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCH
T ss_pred HHHHHHHHHHHHHHHHhhhcCCcc-------ccccccceEEEcCCCceEEccccccccccccc---cccceecCCcccch
Confidence 445677899999999999998877 99999999999999999999999998653221 22345689999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCC-CCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKK-SSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
|.+.++.++.++|||||||++|||++|.. ||.. .....+. .....+...+ .+.....++.+|+
T Consensus 196 E~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~---~~~~~~~----~~i~~~~~~~---------~~~~~~~~~~~li 259 (309)
T d1fvra_ 196 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG---MTCAELY----EKLPQGYRLE---------KPLNCDDEVYDLM 259 (309)
T ss_dssp HHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHH----HHGGGTCCCC---------CCTTBCHHHHHHH
T ss_pred HHhccCCCCccceeehhHHHHHHHHhcCCCCCCC---CCHHHHH----HHHHhcCCCC---------CCccCCHHHHHHH
Confidence 99999999999999999999999999765 4432 2212222 2222221111 1112234577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 425 LLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 425 ~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
.+||+.||++||||+||++.|++..
T Consensus 260 ~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 260 RQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHHHHHHH
Confidence 9999999999999999999998764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.93 E-value=8.8e-27 Score=227.50 Aligned_cols=152 Identities=25% Similarity=0.360 Sum_probs=115.6
Q ss_pred CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCC
Q 011196 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYM 343 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 343 (491)
.+......++.+++.++.|||..+++ ||||||+|||++.++.+||+|||+++.... .....||+.|+
T Consensus 112 l~e~~~~~i~~qi~~aL~yLH~~~ii-------HrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~ 178 (309)
T d1u5ra_ 112 LQEVEIAAVTHGALQGLAYLHSHNMI-------HRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWM 178 (309)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCB-------CCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEe-------ccCCCcceEEECCCCCEEEeecccccccCC------CCccccCcccc
Confidence 34566778999999999999998777 999999999999999999999999986432 22457999999
Q ss_pred hhhhhhh---CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHH
Q 011196 344 APEYAME---GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKY 420 (491)
Q Consensus 344 aPE~~~~---~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 420 (491)
|||++.+ ++|+.++|||||||++|||++|+.||... ............. ...... ...+ ..+
T Consensus 179 APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~------~~~~~~~~i~~~~-~~~~~~----~~~s----~~~ 243 (309)
T d1u5ra_ 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQNE-SPALQS----GHWS----EYF 243 (309)
T ss_dssp CHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHSC-CCCCSC----TTSC----HHH
T ss_pred CHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhCC-CCCCCC----CCCC----HHH
Confidence 9999864 46899999999999999999999997422 1112222222221 111111 1122 356
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 011196 421 IHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 421 ~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 244 RNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHCcCChhHCcCHHHHHh
Confidence 78899999999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.93 E-value=1.1e-26 Score=230.99 Aligned_cols=183 Identities=17% Similarity=0.159 Sum_probs=131.4
Q ss_pred eeeecccccCCCCccccC---CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeecccccccccccc--CCCCceEecc
Q 011196 244 RYELYRFLVDTPTVTVTA---PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLD--HEMNPKISDF 318 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~--~~~~~kl~Df 318 (491)
.|.++.|..++.+..... .+.+......++.+++.++.+||..+++ ||||||+|||++ .++.+||+||
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~ii-------HRDiKp~NILl~~~~~~~vkL~DF 173 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV-------HLDIKPENIMCETKKASSVKIIDF 173 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEESSTTCCCEEECCC
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee-------ecccccccccccccCCCeEEEeec
Confidence 456677776665432221 1234566778899999999999998887 999999999998 5689999999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
|+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||... ........+. ..
T Consensus 174 Gla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~~~~i~----~~ 243 (352)
T d1koba_ 174 GLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE---DDLETLQNVK----RC 243 (352)
T ss_dssp TTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHH----HC
T ss_pred ccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHH----hC
Confidence 99988754332 23467899999999999999999999999999999999999997532 1112222221 11
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCC
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM--LASDI 449 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 449 (491)
... ......... ...+.+|+.+||+.||++|||+.|++++ ++...
T Consensus 244 ~~~--~~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 244 DWE--FDEDAFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp CCC--CCSSTTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred CCC--CCcccccCC----CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 111 001111112 2346789999999999999999999874 55543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=6.9e-27 Score=233.50 Aligned_cols=175 Identities=19% Similarity=0.193 Sum_probs=126.0
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++.+.... ...........++.+++.++.|||..+++ ||||||+|||++.++.+||+|||++
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~ii-------HrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV-------YRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECSSSCEEECCCTTC
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCcc-------ceeeccceeEEcCCCcEEEeeecee
Confidence 45667777665543322 12223456777888999999999998877 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
+...... .....||+.|+|||++..+ .++.++|||||||++|||++|+.||...... .... +.+......
T Consensus 155 ~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~-~~~~~~~~~- 225 (364)
T d1omwa3 155 CDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---DKHE-IDRMTLTMA- 225 (364)
T ss_dssp EECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS---CHHH-HHHHSSSCC-
T ss_pred eecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH---HHHH-HHHhcccCC-
Confidence 8765432 2345799999999999754 5899999999999999999999998643222 1111 111111111
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT-----MSSVAV 443 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~ 443 (491)
.. .....+ ..+.+|+.+||+.||++||| ++|+++
T Consensus 226 ~~-----~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 VE-----LPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CC-----CCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CC-----CCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 10 111122 34678999999999999999 688875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.6e-26 Score=225.42 Aligned_cols=166 Identities=19% Similarity=0.184 Sum_probs=118.5
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...... ......||+.|+||
T Consensus 115 ~~~~~~~~~qi~~aL~yLH~~~iv-------HrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~AP 184 (305)
T d1blxa_ 115 TETIKDMMFQLLRGLDFLHSHRVV-------HRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAP 184 (305)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEE-------ecCCCccEEEEcCCCCeeecchhhhhhhcccc---cCCCcccChhhcCc
Confidence 455667899999999999998777 99999999999999999999999987653222 23456899999999
Q ss_pred hhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcccc------ccch-------hcCCC
Q 011196 346 EYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAEL------MDSV-------VKQSC 412 (491)
Q Consensus 346 E~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~d~~-------l~~~~ 412 (491)
|++.+.+++.++||||+||++|||++|+.||... ...+.+..+............ .... .....
T Consensus 185 E~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (305)
T d1blxa_ 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS---SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKF 261 (305)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGT
T ss_pred chhcCCCCChhehhhchHHHHHHHHHCCCCCCCC---CHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhc
Confidence 9999999999999999999999999999997532 222222222221111100000 0000 00001
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 413 DQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 413 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.......+.+|+.+||+.||++|||+.|++++
T Consensus 262 ~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 262 VTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 11112356788999999999999999998763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=8.9e-27 Score=230.06 Aligned_cols=175 Identities=17% Similarity=0.185 Sum_probs=126.1
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++.+..... ..........++.+++.++.|+|..+++ ||||||+|||++.++.+||+|||++
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~ii-------HRDlKP~NILl~~~g~vkl~DFG~a 152 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV-------YRDIKLENLMLDKDGHIKITDFGLC 152 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCB-------CCCCCGGGEEECTTSCEEECCCTTC
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCcc-------ccccCHHHeEecCCCCEEEeecccc
Confidence 455666666554422211 1223455667788899999999998887 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+....... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.... ...+. +....+...
T Consensus 153 ~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~----~~i~~~~~~ 223 (337)
T d1o6la_ 153 KEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLF----ELILMEEIR 223 (337)
T ss_dssp BCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH----HHHHHCCCC
T ss_pred cccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC---HHHHH----HHHhcCCCC
Confidence 86543222 2345789999999999999999999999999999999999999975321 11122 222222111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT-----MSSVAVM 444 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 444 (491)
++.....++.+|+.+||+.||++||+ +.|++++
T Consensus 224 ----------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 224 ----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11112234678999999999999995 7888763
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.92 E-value=2.5e-26 Score=228.18 Aligned_cols=150 Identities=18% Similarity=0.225 Sum_probs=116.2
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++..... .....||+.|||
T Consensus 139 ~e~~~~~i~~qi~~aL~yLH~~~ii-------HRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~A 206 (350)
T d1rdqe_ 139 SEPHARFYAAQIVLTFEYLHSLDLI-------YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALA 206 (350)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEe-------cCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccCC
Confidence 3556777889999999999998877 9999999999999999999999999876432 234689999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHHH
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 424 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 424 (491)
||++.+..++.++|||||||++|||++|+.||... ....+...+ ..+... . .... ...+.+++
T Consensus 207 PE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i----~~~~~~-~-----p~~~----s~~~~~li 269 (350)
T d1rdqe_ 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKI----VSGKVR-F-----PSHF----SSDLKDLL 269 (350)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH----HHCCCC-C-----CTTC----CHHHHHHH
T ss_pred HHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHHHH----hcCCCC-C-----CccC----CHHHHHHH
Confidence 99999999999999999999999999999997521 111222211 111110 0 0112 23467899
Q ss_pred HHcccCCCCCCC-----CHHHHHH
Q 011196 425 LLCVQEDPMDRP-----TMSSVAV 443 (491)
Q Consensus 425 ~~cl~~dP~~RP-----s~~evl~ 443 (491)
.+||+.||++|+ |++|+++
T Consensus 270 ~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 270 RNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhhhCHHhccccccccHHHHHc
Confidence 999999999994 8999886
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.92 E-value=1.3e-26 Score=227.03 Aligned_cols=172 Identities=17% Similarity=0.222 Sum_probs=123.9
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.+..|..++...... ...........+..+++.++.++|..+++ ||||||+|||++.++.+||+|||++
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ii-------HrDiKp~NILl~~~g~vkL~DFG~a 151 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDII-------YRDLKPENILLDKNGHIKITDFGFA 151 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEE-------CCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEE-------ccccCchheeEcCCCCEEEecCccc
Confidence 35566666554432221 11222344566788999999999998877 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||... ........+ ..+...
T Consensus 152 ~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i----~~~~~~ 219 (316)
T d1fota_ 152 KYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKI----LNAELR 219 (316)
T ss_dssp EECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHH----HHCCCC
T ss_pred eEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc---CHHHHHHHH----HcCCCC
Confidence 876432 22467999999999999999999999999999999999999997532 111111111 111110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-----TMSSVAVM 444 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 444 (491)
+ ....+ ..+.+++.+||+.||++|| |+++++++
T Consensus 220 -~-----p~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 -F-----PPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -C-----CTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -C-----CCCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 0 01122 3467789999999999996 89998763
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.7e-26 Score=228.05 Aligned_cols=182 Identities=17% Similarity=0.138 Sum_probs=127.7
Q ss_pred eeeecccccCCCCccccC----CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC---CCCceEe
Q 011196 244 RYELYRFLVDTPTVTVTA----PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH---EMNPKIS 316 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~---~~~~kl~ 316 (491)
.|.++.|..++++..... ...+......++.+++.++.|||..+++ ||||||+|||++. .+.+||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~ii-------HRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA-------HRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCc-------ccccccccccccccccccccccc
Confidence 466777776655433221 1223556778899999999999998887 9999999999986 4579999
Q ss_pred ccCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh
Q 011196 317 DFGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC 396 (491)
Q Consensus 317 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 396 (491)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 157 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~---~~~~~~~~i~ 230 (335)
T d2ozaa1 157 DFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKTRIR 230 (335)
T ss_dssp CCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCC
T ss_pred ccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH---HHHHHHHHHh
Confidence 9999987654332 234679999999999999999999999999999999999999985432221 1111111111
Q ss_pred cCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 397 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 397 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
.... ....+ .......++.+|+.+||+.||++|||+.|++++
T Consensus 231 ~~~~-~~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 231 MGQY-EFPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCSS-SCCTT-----HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCC-CCCCc-----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1110 00000 001223467889999999999999999999883
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.92 E-value=5.5e-26 Score=218.67 Aligned_cols=184 Identities=22% Similarity=0.328 Sum_probs=124.6
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++...... ...........++.+++.++.+||..+++ ||||||+|||++.++..+|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ii-------HrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGII-------HRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCcc-------CccccCcccccCccccceeehhhhh
Confidence 45666666554332221 12234566778899999999999998877 9999999999999999999999998
Q ss_pred eecCCCC-cccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc
Q 011196 322 RIFGGNQ-SEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA 400 (491)
Q Consensus 322 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (491)
+...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+...........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~------~~~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD------SPVSVAYQHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc------CHHHHHHHHHhcCCC
Confidence 7654322 222334568999999999999999999999999999999999999997521 122222233322211
Q ss_pred cccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhc
Q 011196 401 AELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRP-TMSSVAVMLAS 447 (491)
Q Consensus 401 ~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~ 447 (491)
.. .......+ ..+.+++.+||+.||++|| |++++++.|..
T Consensus 233 ~~---~~~~~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 233 PP---SARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CG---GGTSSSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CC---chhccCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 10 11111222 3567789999999999999 89999887754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.92 E-value=9.3e-26 Score=219.45 Aligned_cols=168 Identities=17% Similarity=0.183 Sum_probs=121.2
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeecccccccccccc---CCCCceEeccCcceecCCCCcc-----cccCce
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLD---HEMNPKISDFGMARIFGGNQSE-----ANTNRV 336 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~---~~~~~kl~DfGla~~~~~~~~~-----~~~~~~ 336 (491)
+......++.+++.++.+||..+++ ||||||+|||++ .+..+||+|||+++........ ......
T Consensus 101 ~~~~~~~~~~qi~~~l~~lH~~~ii-------HrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~ 173 (299)
T d1ckia_ 101 SLKTVLLLADQMISRIEYIHSKNFI-------HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173 (299)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSC
T ss_pred cHHHHHHHHHHHHHHHHHHHHCCee-------eccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCc
Confidence 3556777888999999999998877 999999999865 4567999999999987543321 223456
Q ss_pred eecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHH
Q 011196 337 VGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAE 416 (491)
Q Consensus 337 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 416 (491)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||....................... .+.+....+
T Consensus 174 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~p--- 245 (299)
T d1ckia_ 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-----IEVLCKGYP--- 245 (299)
T ss_dssp CCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-----HHHHTTTSC---
T ss_pred CCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-----hhHhccCCC---
Confidence 899999999999999999999999999999999999999865443332222221111111110 111112222
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 011196 417 LLKYIHIGLLCVQEDPMDRPTMSSVAVMLASD 448 (491)
Q Consensus 417 ~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 448 (491)
.++.+++.+||+.||++||++.++.+.|+..
T Consensus 246 -~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 246 -SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred -HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 3467789999999999999999998888764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3.3e-26 Score=222.08 Aligned_cols=177 Identities=15% Similarity=0.130 Sum_probs=126.9
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC----CceEec
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM----NPKISD 317 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~----~~kl~D 317 (491)
.|.++.|..++++.... ...........++.+++.++.+||..+++ ||||||+|||++.++ .+||+|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~iv-------HrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIA-------HFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhccee-------ecccccceEEEecCCCcccceEecc
Confidence 45666776665543322 12234566778899999999999998887 999999999998776 489999
Q ss_pred cCcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 318 FGMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 318 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... ...... .....
T Consensus 161 fG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~----~~i~~ 230 (293)
T d1jksa_ 161 FGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETL----ANVSA 230 (293)
T ss_dssp CTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHH----HHHHT
T ss_pred hhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC---CHHHHH----HHHHh
Confidence 999987654332 23457899999999999989999999999999999999999997532 111111 11212
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.... . .+...... ...+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~-~-~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 231 VNYE-F-EDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp TCCC-C-CHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCC-C-CchhcCCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1110 0 01111112 234678999999999999999999876
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.92 E-value=1.3e-25 Score=217.70 Aligned_cols=170 Identities=12% Similarity=0.106 Sum_probs=125.1
Q ss_pred CCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccC-----CCCceEeccCcceecCCCCcc-----ccc
Q 011196 264 KTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDH-----EMNPKISDFGMARIFGGNQSE-----ANT 333 (491)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~-----~~~~kl~DfGla~~~~~~~~~-----~~~ 333 (491)
........++.+++.++.++|..+++ ||||||+|||++. ++.+||+|||+++........ ...
T Consensus 98 ~~~~~~~~i~~q~~~~l~~lH~~gii-------HrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~ 170 (293)
T d1csna_ 98 FSVKTVAMAAKQMLARVQSIHEKSLV-------YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170 (293)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEE-------CCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHHCCce-------eccCCccceeecCcccccCCceEEcccceeEEcccCccccceeeccc
Confidence 34556778899999999999998888 9999999999974 567999999999976533221 123
Q ss_pred CceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCC
Q 011196 334 NRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCD 413 (491)
Q Consensus 334 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 413 (491)
....||+.|||||++.+..++.++||||||+++|||++|+.||..............+......... +.+....+
T Consensus 171 ~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-----~~l~~~~p 245 (293)
T d1csna_ 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL-----RELCAGFP 245 (293)
T ss_dssp CCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH-----HHHTTTSC
T ss_pred CceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh-----HHhcCCCC
Confidence 3568999999999999999999999999999999999999998654433332222222211111111 11112233
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 011196 414 QAELLKYIHIGLLCVQEDPMDRPTMSSVAVMLASDI 449 (491)
Q Consensus 414 ~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 449 (491)
.++.+++..|++.+|++||+++.+.+.|+...
T Consensus 246 ----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 246 ----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp ----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 34677888999999999999999988887653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.1e-25 Score=220.80 Aligned_cols=169 Identities=17% Similarity=0.165 Sum_probs=116.4
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc--cccCceeecCCCC
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE--ANTNRVVGTYGYM 343 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~ 343 (491)
....+.++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++........ .......||+.|+
T Consensus 116 ~~~~~~i~~qil~~l~~lH~~~iv-------HrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~ 188 (318)
T d3blha1 116 LSEIKRVMQMLLNGLYYIHRNKIL-------HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGC
T ss_pred cHHHHHHHHHHHHHHHHhccCCEE-------ecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHh
Confidence 445667888999999999998887 9999999999999999999999999876533221 1223357999999
Q ss_pred hhhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC---Ccccc--------ccchhcCC
Q 011196 344 APEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG---HAAEL--------MDSVVKQS 411 (491)
Q Consensus 344 aPE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--------~d~~l~~~ 411 (491)
|||++.+. .++.++||||+||+++||++|+.||... ........+.+..... ..... ........
T Consensus 189 aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T d3blha1 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN---TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQK 265 (318)
T ss_dssp CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCC
T ss_pred hHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC---CHHHHHHHHHHhcCCCChhhccccchhhhhhhhccccccc
Confidence 99998765 5899999999999999999999997532 1222222222211110 00000 00000001
Q ss_pred CCHHH-------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 412 CDQAE-------LLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 412 ~~~~~-------~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
....+ ...+++|+.+||+.||++|||++|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 266 RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp BCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 11111 2346689999999999999999998864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3.5e-25 Score=215.23 Aligned_cols=168 Identities=20% Similarity=0.172 Sum_probs=119.3
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.|||..+++ ||||||+|||++.++.+||+|||+++....... ......||+.|+|
T Consensus 100 ~e~~~~~~~~qil~~L~yLH~~~Ii-------HrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~a 170 (298)
T d1gz8a_ 100 PLPLIKSYLFQLLQGLAFCHSHRVL-------HRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRA 170 (298)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CTTCCBCCCTTCC
T ss_pred CHHHHHHHHHHHHHHHHHhhcCCEE-------ccccCchheeecccCcceeccCCcceeccCCcc--cceeecccceeee
Confidence 4567778899999999999998877 999999999999999999999999987644332 2334679999999
Q ss_pred hhhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCC---ccccc------cchhc-CCCC
Q 011196 345 PEYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGH---AAELM------DSVVK-QSCD 413 (491)
Q Consensus 345 PE~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~------d~~l~-~~~~ 413 (491)
||.+.... ++.++||||+||++|||++|+.||... ........+........ +.... ..... ...+
T Consensus 171 pE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
T d1gz8a_ 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD---SEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 247 (298)
T ss_dssp HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCC
T ss_pred hhhhccccCCCccccccccchhhhHHhhCCCCCCCC---CHHHHHHHHHHhcCCCchhhccccccccccccccccccccc
Confidence 99987766 578999999999999999999997532 22222222222211110 00000 00000 0000
Q ss_pred H-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 414 Q-----AELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 414 ~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
. .....+.+++.+||+.||++|||+.|++++
T Consensus 248 ~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp HHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 112457789999999999999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.91 E-value=1.3e-25 Score=215.90 Aligned_cols=178 Identities=17% Similarity=0.240 Sum_probs=128.3
Q ss_pred eeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.+++|..++++.... ..+.+......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||++
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~iv-------HrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIV-------HRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCc-------ccccccceEEEcCCCCeEEccchhe
Confidence 35677777666543222 12334667888999999999999998888 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhh------CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHh
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAME------GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLW 395 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 395 (491)
+....... .....||..|+|||++.+ ..++.++||||+||+++||++|+.||... .... .....
T Consensus 158 ~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~---~~~~----~~~~i 227 (277)
T d1phka_ 158 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR---KQML----MLRMI 227 (277)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHH----HHHHH
T ss_pred eEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC---CHHH----HHHHH
Confidence 87754332 234679999999999874 34688999999999999999999997532 1111 12222
Q ss_pred hcCCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 396 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 396 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..+... ...+. ....+ .++.+++.+||+.||++|||+.||+++
T Consensus 228 ~~~~~~-~~~~~-~~~~s----~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGNYQ-FGSPE-WDDYS----DTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTCCC-CCTTT-GGGSC----HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhCCCC-CCCcc-cccCC----HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 222211 11110 11122 357789999999999999999998753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2.8e-26 Score=225.07 Aligned_cols=174 Identities=20% Similarity=0.229 Sum_probs=126.4
Q ss_pred eeeecccccCCCCccccC--CCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcc
Q 011196 244 RYELYRFLVDTPTVTVTA--PNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMA 321 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla 321 (491)
.|.++.|..++.+..... ..........++.+++.++.|||..+++ ||||||+|||++.++++||+|||++
T Consensus 78 ~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~ii-------HrDikp~NiL~~~~~~~kl~DFG~a 150 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIV-------YRDLKLDNILLDKDGHIKIADFGMC 150 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCB-------CCCCCGGGEEECTTSCEEECCCTTC
T ss_pred eeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCee-------eccCcccceeecCCCceeccccchh
Confidence 456667766554433221 1223456777889999999999998777 9999999999999999999999999
Q ss_pred eecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcc
Q 011196 322 RIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAA 401 (491)
Q Consensus 322 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (491)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+ +.....+..
T Consensus 151 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~---~~~~~----~~~i~~~~~- 220 (320)
T d1xjda_ 151 KENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEEL----FHSIRMDNP- 220 (320)
T ss_dssp BCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHH----HHHHHHCCC-
T ss_pred hhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC---CHHHH----HHHHHcCCC-
Confidence 86543322 233467999999999999999999999999999999999999997532 11122 222222211
Q ss_pred ccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 011196 402 ELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMS-SVAV 443 (491)
Q Consensus 402 ~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl~ 443 (491)
...... ...+.+|+.+||+.||++||++. |+++
T Consensus 221 -----~~p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 -----FYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -----CCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----CCCccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 011112 23467899999999999999995 6754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.3e-25 Score=215.50 Aligned_cols=144 Identities=19% Similarity=0.321 Sum_probs=111.7
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC-CCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE-MNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~-~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.+||..+++ ||||||+|||++.+ +.+||+|||+++...... .....||+.|+|
T Consensus 109 e~~~~~~~~qi~~al~~lH~~~ii-------HrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~a 177 (273)
T d1xwsa_ 109 EELARSFFWQVLEAVRHCHNCGVL-------HRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSP 177 (273)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CSCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCc-------cccCcccceEEecCCCeEEECccccceeccccc----ccccccCCCcCC
Confidence 455677889999999999998777 99999999999855 789999999998754322 234679999999
Q ss_pred hhhhhhCCC-CcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccccchhcCCCCHHHHHHHHHH
Q 011196 345 PEYAMEGIF-SVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHI 423 (491)
Q Consensus 345 PE~~~~~~~-s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 423 (491)
||++.+.++ +.++||||+||++|||++|+.||.... .+.+ ... ......+ .++.++
T Consensus 178 PE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------~i~~----~~~------~~~~~~s----~~~~~l 234 (273)
T d1xwsa_ 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIR----GQV------FFRQRVS----SECQHL 234 (273)
T ss_dssp HHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHH----CCC------CCSSCCC----HHHHHH
T ss_pred HHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------HHhh----ccc------CCCCCCC----HHHHHH
Confidence 999988776 567899999999999999999975311 1111 100 0111222 346789
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 011196 424 GLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 424 ~~~cl~~dP~~RPs~~evl~ 443 (491)
+.+||+.||++|||++|+++
T Consensus 235 i~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 235 IRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHccCCHhHCcCHHHHhc
Confidence 99999999999999999876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3e-25 Score=217.87 Aligned_cols=182 Identities=15% Similarity=0.218 Sum_probs=129.8
Q ss_pred eeeecccccCCCCccccCC---CCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCC--CCceEecc
Q 011196 244 RYELYRFLVDTPTVTVTAP---NKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHE--MNPKISDF 318 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~--~~~kl~Df 318 (491)
.|.++.|..++.+...... ..+......++.+++.++.|||..+++ ||||||+|||++.+ ..+||+||
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~ii-------HrDlKp~NIll~~~~~~~ikl~DF 148 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG-------HFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEESSSSCCCEEECCC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCC-------cccccccceeecCCCceEEEEccc
Confidence 4667777766554332221 234566778899999999999998888 99999999999854 47899999
Q ss_pred CcceecCCCCcccccCceeecCCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC
Q 011196 319 GMARIFGGNQSEANTNRVVGTYGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG 398 (491)
Q Consensus 319 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 398 (491)
|+++....... .....|++.|+|||.+.+..++.++||||+||++|||++|+.||... ........+. ..
T Consensus 149 G~~~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~---~~~~~~~~i~----~~ 218 (321)
T d1tkia_ 149 GQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENIM----NA 218 (321)
T ss_dssp TTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHH----HT
T ss_pred chhhccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC---CHHHHHHHHH----hC
Confidence 99987644322 23457899999999999999999999999999999999999997532 1112222221 11
Q ss_pred CccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcC
Q 011196 399 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV--MLASD 448 (491)
Q Consensus 399 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~ 448 (491)
... ++.......+ .++.+++.+||+.||++|||+.|+++ +++..
T Consensus 219 ~~~--~~~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 219 EYT--FDEEAFKEIS----IEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp CCC--CCHHHHTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCC--CChhhccCCC----HHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 110 1111111122 34678999999999999999999987 35443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=4.1e-25 Score=219.71 Aligned_cols=166 Identities=18% Similarity=0.163 Sum_probs=116.9
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC-CceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM-NPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
......++.+++.++.|||..+++ ||||||+|||++.++ .+||+|||+++....... .....|+..|+|
T Consensus 121 ~~~~~~i~~qil~aL~yLH~~~Ii-------HrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~a 190 (350)
T d1q5ka_ 121 VIYVKLYMYQLFRSLAYIHSFGIC-------HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRA 190 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTTEE-------CCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC---CCSCCSCTTSCC
T ss_pred HHHHHHHHHHHHHHHHHHHhcCCc-------ccCCCcceEEEecCCCceeEecccchhhccCCcc---cccccccccccC
Confidence 456677899999999999998877 999999999999775 899999999987654332 223578999999
Q ss_pred hhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHH-----------hhcC----Cccccccchh
Q 011196 345 PEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKL-----------WCEG----HAAELMDSVV 408 (491)
Q Consensus 345 PE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-----------~~~~----~~~~~~d~~l 408 (491)
||.+.+ ..++.++||||+||++|||++|+.||.... ..+.+..+.+. .... ..........
T Consensus 191 PE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~---~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (350)
T d1q5ka_ 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS---GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPW 267 (350)
T ss_dssp HHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS---HHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCG
T ss_pred hHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC---HHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCch
Confidence 998875 468999999999999999999999975322 11222221111 1111 0111100000
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 409 KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
...........+.+|+.+||+.||++|||+.|++++
T Consensus 268 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 268 TKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp GGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001111223457789999999999999999999863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.90 E-value=7.4e-25 Score=211.65 Aligned_cols=167 Identities=20% Similarity=0.227 Sum_probs=114.8
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++++||..+++ ||||||+|||++.++.+||+|||.+........ ......|++.|+|
T Consensus 98 ~~~~~~~i~~qi~~~L~~LH~~~Iv-------HrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~ 168 (286)
T d1ob3a_ 98 ESVTAKSFLLQLLNGIAYCHDRRVL-------HRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRA 168 (286)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCC
T ss_pred chhhhHHHHHHHHHHHHHhccCcEE-------ecCCCCceeeEcCCCCEEecccccceecccCcc--ccceecccchhhh
Confidence 3566778899999999999988777 999999999999999999999999987643322 2233568999999
Q ss_pred hhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccccc---------------cchh
Q 011196 345 PEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAELM---------------DSVV 408 (491)
Q Consensus 345 PE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------d~~l 408 (491)
||.+.+. .++.++||||+||+++||++|+.||.... ..+....+............. .+..
T Consensus 169 pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (286)
T d1ob3a_ 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS---EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLP 245 (286)
T ss_dssp HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCC
T ss_pred HHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC---HHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcc
Confidence 9999764 46899999999999999999999975321 222222222221111100000 0000
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 409 KQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
...........+.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 246 WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011111245778999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=3e-24 Score=212.94 Aligned_cols=170 Identities=19% Similarity=0.229 Sum_probs=117.5
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcc-cccCceeecCCCC
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSE-ANTNRVVGTYGYM 343 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~ 343 (491)
+......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++........ .......||+.|+
T Consensus 107 ~~~~i~~i~~qil~al~yLH~~~ii-------HRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~ 179 (345)
T d1pmea_ 107 SNDHICYFLYQILRGLKYIHSANVL-------HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCCc-------CCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceec
Confidence 3556778999999999999998877 9999999999999999999999999876433221 2234567899999
Q ss_pred hhhhhhh-CCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCccc--------ccc---ch-hcC
Q 011196 344 APEYAME-GIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAE--------LMD---SV-VKQ 410 (491)
Q Consensus 344 aPE~~~~-~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~d---~~-l~~ 410 (491)
|||++.. ..++.++||||+||+++||++|+.||..... .................. ... .. ...
T Consensus 180 aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (345)
T d1pmea_ 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY---LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKN 256 (345)
T ss_dssp CGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCC
T ss_pred hHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH---HHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccC
Confidence 9999865 4578999999999999999999999753221 111111111111100000 000 00 000
Q ss_pred CCCHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 411 SCDQA-----ELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 411 ~~~~~-----~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
..+.. ...++++++.+||+.||++|||+.|++++
T Consensus 257 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 257 KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00111 11357789999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.8e-24 Score=214.77 Aligned_cols=180 Identities=19% Similarity=0.177 Sum_probs=121.0
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+||+|||+++...... ....||+.|+|
T Consensus 119 ~~~~~~~~~~qi~~aL~~LH~~~Ii-------HrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~a 186 (346)
T d1cm8a_ 119 GEDRIQFLVYQMLKGLRYIHAAGII-------HRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRA 186 (346)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCCGGGEEECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCC
T ss_pred cHHHHHHHHHHHHHHHHHHHhCCCc-------ccccCcchhhcccccccccccccceeccCCcc-----ccccccccccC
Confidence 4556778899999999999998877 99999999999999999999999998764322 24578999999
Q ss_pred hhhhhhC-CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcC--------C----------cccccc
Q 011196 345 PEYAMEG-IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEG--------H----------AAELMD 405 (491)
Q Consensus 345 PE~~~~~-~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------~----------~~~~~d 405 (491)
||++.+. .++.++||||+||+++||++|+.||.... ............... . ..+...
T Consensus 187 PE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (346)
T d1cm8a_ 187 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD---HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEK 263 (346)
T ss_dssp THHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCC
T ss_pred HHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC---hHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccc
Confidence 9999864 46899999999999999999999975321 111111111110000 0 000000
Q ss_pred chhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCCCCCCCCCCCCe
Q 011196 406 SVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM--LASDIVTLPKPTQPAF 460 (491)
Q Consensus 406 ~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~p~~p~~ 460 (491)
..+. .........+++|+.+||+.||++|||+.|++++ ++.....-..|..+.+
T Consensus 264 ~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~~~ 319 (346)
T d1cm8a_ 264 KDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKY 319 (346)
T ss_dssp CCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCCC
T ss_pred cchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCCCC
Confidence 0000 0001112346789999999999999999999985 6554333333444433
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.89 E-value=6.2e-24 Score=209.16 Aligned_cols=187 Identities=17% Similarity=0.152 Sum_probs=124.5
Q ss_pred eeeecccccCCCCccccCCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCC-CceEeccCcce
Q 011196 244 RYELYRFLVDTPTVTVTAPNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEM-NPKISDFGMAR 322 (491)
Q Consensus 244 ry~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~-~~kl~DfGla~ 322 (491)
.|.++.|...+..... ....+......++.+++.++.+||..+++ ||||||+|||++.++ .+||+|||+++
T Consensus 107 ~~~v~e~~~~~~L~~~-~~~l~e~~i~~i~~qil~aL~~LH~~gIv-------HrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 107 PALVFEHVNNTDFKQL-YQTLTDYDIRFYMYEILKALDYCHSMGIM-------HRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEEEEECCCSCBGGGT-TTSCCHHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred eeEEEeecCCCcHHHH-hcCCCHHHHHHHHHHHHHHHHHHhhcccc-------cccccccceEEcCCCCeeeecccccce
Confidence 3445555554443222 22344566778899999999999998887 999999999998765 58999999998
Q ss_pred ecCCCCcccccCceeecCCCChhhhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHH-------
Q 011196 323 IFGGNQSEANTNRVVGTYGYMAPEYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKL------- 394 (491)
Q Consensus 323 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~------- 394 (491)
....... .....||+.|+|||.+.+.. ++.++||||+||+++|+++|+.||..... .......+...
T Consensus 179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~--~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 179 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCHHHHH
T ss_pred eccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch--hHHHHHHHHHHHCCchhh
Confidence 7654332 23457899999999988754 79999999999999999999999753221 11111111100
Q ss_pred --hh---cCCccc---c--------ccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 395 --WC---EGHAAE---L--------MDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 395 --~~---~~~~~~---~--------~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
.. ...... . ...............++.+|+.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000000 0 0000011111112245778999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=6.7e-24 Score=208.22 Aligned_cols=181 Identities=17% Similarity=0.202 Sum_probs=124.1
Q ss_pred ceeeeecccccCCCCcccc--CCCCCCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccC
Q 011196 242 SIRYELYRFLVDTPTVTVT--APNKTSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFG 319 (491)
Q Consensus 242 ~lry~~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfG 319 (491)
...|.++.++.++...... ...........++.+++.++.++|..+++ ||||||+|||++.++.+||+|||
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~iv-------HrDiKp~Nill~~~~~vkL~DFG 174 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGII-------YRDIKLENILLDSNGHVVLTDFG 174 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEECTTSCEEESCSS
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEE-------eccCCccceeecCCCCEEEeecc
Confidence 3444555555544432221 11222445666788899999999988777 99999999999999999999999
Q ss_pred cceecCCCCcccccCceeecCCCChhhhhhhC--CCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhc
Q 011196 320 MARIFGGNQSEANTNRVVGTYGYMAPEYAMEG--IFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCE 397 (491)
Q Consensus 320 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 397 (491)
+++.+...... ......|++.|++||.+.+. .++.++|||||||++|||++|+.||....... ....+.+....
T Consensus 175 ~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~---~~~~i~~~~~~ 250 (322)
T d1vzoa_ 175 LSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILK 250 (322)
T ss_dssp EEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---CHHHHHHHHHH
T ss_pred chhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhccc
Confidence 99876433222 23346789999999999765 36789999999999999999999986443332 22222222211
Q ss_pred CCccccccchhcCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 011196 398 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQEDPMDRPT-----MSSVAV 443 (491)
Q Consensus 398 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~ 443 (491)
... ..+.....++.+++.+||+.||++||| ++|+++
T Consensus 251 ~~~----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 251 SEP----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCC----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCC----------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111 011122345778999999999999994 788875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=9.2e-24 Score=204.25 Aligned_cols=167 Identities=16% Similarity=0.156 Sum_probs=117.3
Q ss_pred CcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh
Q 011196 266 SKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP 345 (491)
Q Consensus 266 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 345 (491)
......+..+++.++.+||..+++ ||||||+|||++.++.+||+|||.++........ .....++..|+||
T Consensus 100 ~~~~~~~~~q~~~aL~~lH~~~Iv-------HrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~~~p 170 (292)
T d1unla_ 100 PEIVKSFLFQLLKGLGFCHSRNVL-------HRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPP 170 (292)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEE-------CCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCH
T ss_pred hhHHHHHHHHHHHHHHHhhcCCEe-------eecccCcccccccCCceeeeecchhhcccCCCcc--ceeeccccchhhh
Confidence 445667888899999999998777 9999999999999999999999999876543322 2234568899999
Q ss_pred hhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCcccc------cc--------c-hhc
Q 011196 346 EYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHAAEL------MD--------S-VVK 409 (491)
Q Consensus 346 E~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~d--------~-~l~ 409 (491)
|++.... ++.++||||+||+++||++|+.||. ...+..+....+............ .+ . ...
T Consensus 171 e~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (292)
T d1unla_ 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF--PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSL 248 (292)
T ss_dssp HHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC--CCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCC
T ss_pred hHhccCCCCCchhhccccchHHHHHhhCCCCCC--CCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchh
Confidence 9988765 6899999999999999999999963 223333333333332222110000 00 0 000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 011196 410 QSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAV 443 (491)
Q Consensus 410 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 443 (491)
..........+.+|+.+||+.||++|||++||++
T Consensus 249 ~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 249 VNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111122345778899999999999999999876
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.87 E-value=9.3e-23 Score=203.24 Aligned_cols=182 Identities=16% Similarity=0.181 Sum_probs=121.0
Q ss_pred cchhhhHhHHHHHHHHHhh-eeeEEeEEeeeccccccccccccCCCC------ceEeccCcceecCCCCcccccCceeec
Q 011196 267 KRWITIAEAASAIIVFLLS-TSFLWCIIRRRNKRVRASNVLLDHEMN------PKISDFGMARIFGGNQSEANTNRVVGT 339 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~iHrDlKp~NILl~~~~~------~kl~DfGla~~~~~~~~~~~~~~~~gt 339 (491)
.....+..+++.++.+||. .+++ ||||||+|||++.++. +|++|||.+...... .....||
T Consensus 125 ~~i~~i~~qil~al~~lh~~~~Iv-------HrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt 192 (362)
T d1q8ya_ 125 IYVKQISKQLLLGLDYMHRRCGII-------HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQT 192 (362)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCEE-------CSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSC
T ss_pred HHHHHHHHHHHHHHHHHhhhcCcc-------cccCChhHeeeeccCcccccceeeEeecccccccccc-----ccccccc
Confidence 3456678888888888886 6666 9999999999987654 899999999865322 2345789
Q ss_pred CCCChhhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHH---HHHhhc------------------C
Q 011196 340 YGYMAPEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYI---WKLWCE------------------G 398 (491)
Q Consensus 340 ~~y~aPE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~---~~~~~~------------------~ 398 (491)
+.|+|||++....++.++||||+||+++||++|+.||............... ...... .
T Consensus 193 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~ 272 (362)
T d1q8ya_ 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSR 272 (362)
T ss_dssp GGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC-
T ss_pred ccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccc
Confidence 9999999999999999999999999999999999997643322211111111 111000 0
Q ss_pred Cc----cccc----cc--hhcCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcC--CCCCCCCCCCCe
Q 011196 399 HA----AELM----DS--VVKQSCDQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM--LASD--IVTLPKPTQPAF 460 (491)
Q Consensus 399 ~~----~~~~----d~--~l~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~--~~~~~~p~~p~~ 460 (491)
.. .... .. .............+.+|+.+||+.||++|||++|++++ ++.. ..+...|.+|..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 273 GLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 348 (362)
T ss_dssp -CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTTCCCTTSCTT
T ss_pred hhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCCcccCCCCCcccC
Confidence 00 0000 00 01123445677889999999999999999999999874 4422 223344544444
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=2e-23 Score=207.76 Aligned_cols=167 Identities=18% Similarity=0.160 Sum_probs=111.9
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+|++|||+++...... ......||+.|+|
T Consensus 117 ~~~~i~~~~~qil~gl~~LH~~gii-------HrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~a 186 (355)
T d2b1pa1 117 DHERMSYLLYQMLCGIKHLHSAGII-------HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRA 186 (355)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CSCCCGGGEEECTTCCEEECCCCC------------------CCTTCC
T ss_pred CHHHHHHHHHHHHHHHHHhhhcccc-------cccCCccccccccccceeeechhhhhcccccc---ccccccccccccC
Confidence 3556777889999999999998877 99999999999999999999999988654332 2234578999999
Q ss_pred hhhhhhCCCCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhh------------------cCC-------
Q 011196 345 PEYAMEGIFSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWC------------------EGH------- 399 (491)
Q Consensus 345 PE~~~~~~~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~------------------~~~------- 399 (491)
||++.+..++.++||||+||+++||++|+.||...+ .......+..... ...
T Consensus 187 PE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (355)
T d2b1pa1 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD---YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLT 263 (355)
T ss_dssp HHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCC
T ss_pred hhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC---HHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccc
Confidence 999999999999999999999999999999975321 1111111111000 000
Q ss_pred ccccccchhcCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 011196 400 AAELMDSVVKQSC---DQAELLKYIHIGLLCVQEDPMDRPTMSSVAVM 444 (491)
Q Consensus 400 ~~~~~d~~l~~~~---~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 444 (491)
............. .......+.+|+.+||+.||++|||++||+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 264 FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0011111111111 12335578899999999999999999998753
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=1.4e-23 Score=208.26 Aligned_cols=181 Identities=18% Similarity=0.221 Sum_probs=118.0
Q ss_pred CCcchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCCh
Q 011196 265 TSKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMA 344 (491)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 344 (491)
.......++.+++.++.+||..+++ ||||||+|||++.++.+|++|||++..... ......|+..|+|
T Consensus 119 ~e~~~~~i~~qil~aL~~LH~~gii-------HrDiKp~NILi~~~~~~kl~dfg~a~~~~~-----~~~~~~g~~~y~a 186 (348)
T d2gfsa1 119 TDDHVQFLIYQILRGLKYIHSADII-------HRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRA 186 (348)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCC-------CCCCCGGGEEECTTCCEEECCC----CCTG-----GGSSSCHHHHTSC
T ss_pred cHHHHHHHHHHHHHHHHHHHhCCCc-------ccccCCccccccccccccccccchhcccCc-----ccccccccccccC
Confidence 3556778899999999999998877 999999999999999999999999975432 2234578999999
Q ss_pred hhhhhhCC-CCcccceeehhHHHHHHHhCCCCCCCccCCCcccHHHHHHHHhhcCCc-------cc----cccchhc-CC
Q 011196 345 PEYAMEGI-FSVKSDVFSFGVVLLEIISGKKSSGFYHLEHGPSLLAYIWKLWCEGHA-------AE----LMDSVVK-QS 411 (491)
Q Consensus 345 PE~~~~~~-~s~~sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~----~~d~~l~-~~ 411 (491)
||...+.. ++.++||||+||+++||++|+.||...+ .......+......... .. ....... ..
T Consensus 187 pE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (348)
T d2gfsa1 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 263 (348)
T ss_dssp HHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCC
T ss_pred chhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCC
Confidence 99887754 6889999999999999999999975322 11122222111111000 00 0000000 00
Q ss_pred CCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcCCCCCCCCCCCCe
Q 011196 412 CDQ-----AELLKYIHIGLLCVQEDPMDRPTMSSVAV--MLASDIVTLPKPTQPAF 460 (491)
Q Consensus 412 ~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~~~~~~~p~~p~~ 460 (491)
... .....+.+|+.+||+.||++|||+.|+++ +++.....-+.|..++|
T Consensus 264 ~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~ 319 (348)
T d2gfsa1 264 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY 319 (348)
T ss_dssp CCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCC
T ss_pred cchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCC
Confidence 000 11235678999999999999999999987 45543322233444444
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=98.70 E-value=2.8e-09 Score=94.62 Aligned_cols=81 Identities=12% Similarity=0.056 Sum_probs=57.2
Q ss_pred cchhhhHhHHHHHHHHHhheeeEEeEEeeeccccccccccccCCCCceEeccCcceecCCCCcccccCceeecCCCChh-
Q 011196 267 KRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRVRASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRVVGTYGYMAP- 345 (491)
Q Consensus 267 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP- 345 (491)
.....++.+++.++.+||..+++ ||||||+|||+++++ ++|+|||.+.....+.... |...
T Consensus 103 ~~~~~i~~ql~~~l~~lH~~gii-------HrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~~~----------~l~rd 164 (191)
T d1zara2 103 ENPDEVLDMILEEVAKFYHRGIV-------HGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWRE----------ILERD 164 (191)
T ss_dssp SCHHHHHHHHHHHHHHHHHTTEE-------CSCCSTTSEEEETTE-EEECCCTTCEETTSTTHHH----------HHHHH
T ss_pred HHHHHHHHHHHHHHHHHhhCCEE-------EccCChhheeeeCCC-EEEEECCCcccCCCCCcHH----------HHHHH
Confidence 34556888999999999998887 999999999999654 8999999997654322110 1111
Q ss_pred -hh---hhhCCCCcccceeehhHH
Q 011196 346 -EY---AMEGIFSVKSDVFSFGVV 365 (491)
Q Consensus 346 -E~---~~~~~~s~~sDVwS~Gvv 365 (491)
+. .....|+.++|+||..--
T Consensus 165 ~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 165 VRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp HHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred HHHHHHHHcCCCCCcccHHHHHHH
Confidence 10 113467889999996543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=87.27 E-value=0.12 Score=47.36 Aligned_cols=32 Identities=16% Similarity=0.027 Sum_probs=27.2
Q ss_pred eEEeeeccccccccccccCCCCceEeccCcce
Q 011196 291 CIIRRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 291 ~~~~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
....+||+|+.+.||+++.+...-|.||+.+.
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccccCCcchhhhhcccccceeEecccccc
Confidence 34667799999999999988777899999874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=81.83 E-value=0.29 Score=42.84 Aligned_cols=29 Identities=10% Similarity=0.090 Sum_probs=24.6
Q ss_pred eeeccccccccccccCCCCceEeccCcce
Q 011196 294 RRRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 294 ~~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 35699999999999987667899998764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=80.67 E-value=0.23 Score=43.67 Aligned_cols=28 Identities=14% Similarity=0.198 Sum_probs=24.1
Q ss_pred eeccccccccccccCCCCceEeccCcce
Q 011196 295 RRNKRVRASNVLLDHEMNPKISDFGMAR 322 (491)
Q Consensus 295 ~iHrDlKp~NILl~~~~~~kl~DfGla~ 322 (491)
++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEeeccCcceeecCCceEEEeechhcc
Confidence 4599999999999987767799998774
|